data_2lre_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lre _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.67 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 1.3 p . . . . . 0 N--CA 1.451 -0.379 0 CA-C-O 120.749 0.309 . . . . 0.0 111.072 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.49 28.3 0.08 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.448 ' H ' ' C ' ' A' ' 13' ' ' CYS . . . -138.38 -64.34 0.53 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.929 0.395 . . . . 0.0 110.27 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.42 -43.83 47.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.943 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.67 ' HB ' ' O ' ' A' ' 13' ' ' CYS . 10.6 mt -70.28 -38.2 73.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.117 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.1 -39.01 88.33 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.823 178.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.6 -31.52 44.93 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.966 -0.635 . . . . 0.0 111.886 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.59 -28.84 61.09 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.302 0.573 . . . . 0.0 110.293 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.799 HG13 ' HA2' ' A' ' 26' ' ' GLY . 1.2 t -68.3 -37.36 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.235 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.82 -6.27 40.35 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.616 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.84 -2.33 58.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.491 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.6 t -147.05 55.23 1.1 Allowed 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.977 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.38 -53.41 4.21 Favored Glycine 0 N--CA 1.455 -0.088 0 C-N-CA 121.2 -0.524 . . . . 0.0 113.936 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.799 ' HA2' HG13 ' A' ' 21' ' ' VAL . . . 131.79 116.66 1.8 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.969 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.409 ' H ' HG13 ' A' ' 21' ' ' VAL . 43.9 mm 72.83 78.62 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.505 -0.773 0 CA-C-O 122.787 1.279 . . . . 0.0 111.58 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.69 ' OD2' ' HB3' ' A' ' 31' ' ' CYS . 40.1 t0 -148.63 161.61 41.37 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-N 112.683 -2.053 . . . . 0.0 107.298 177.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.597 ' HB3' ' HD3' ' A' ' 30' ' ' PRO . 36.0 tp -126.12 -52.63 0.03 OUTLIER Pre-proline 0 C--N 1.296 -1.729 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.026 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.665 ' HA ' HG11 ' A' ' 54' ' ' VAL . 47.2 Cg_exo -54.84 -41.7 75.76 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 121.907 1.738 . . . . 0.0 112.632 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.69 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 5.6 t -85.82 -38.96 17.59 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.187 -178.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.601 HG22 ' HB3' ' A' ' 28' ' ' ASP . 93.0 t -73.44 -16.23 17.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.605 HD21 ' HB ' ' A' ' 54' ' ' VAL . 44.8 tp -55.27 -31.08 61.28 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -56.67 -37.05 70.28 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -104.44 4.37 33.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.808 0.337 . . . . 0.0 111.112 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 52.3 tp -85.87 -25.55 26.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.869 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.82 46.47 1.18 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.451 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -136.59 134.87 37.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.802 -0.181 . . . . 0.0 111.336 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 65.37 -165.54 0.23 Allowed 'General case' 0 N--CA 1.468 0.474 0 O-C-N 123.968 0.793 . . . . 0.0 111.838 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -124.14 53.88 1.38 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.189 0.518 . . . . 0.0 112.005 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -134.39 52.54 0.81 Allowed Glycine 0 CA--C 1.517 0.17 0 C-N-CA 121.062 -0.589 . . . . 0.0 111.881 178.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -127.09 -104.74 0.33 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.733 -0.234 . . . . 0.0 111.089 -179.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 57.99 -154.1 0.36 Allowed 'General case' 0 C--O 1.239 0.503 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 178.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.8 p -66.82 32.88 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -176.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 43.8 t -107.87 -31.56 7.96 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 176.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.575 ' O ' ' HD2' ' A' ' 50' ' ' HIS . 1.1 t80 -103.52 -65.53 1.0 Allowed 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.299 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.424 ' HA ' ' HB2' ' A' ' 50' ' ' HIS . 7.6 m -75.77 23.6 0.13 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -177.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.578 ' HA ' ' OE1' ' A' ' 48' ' ' GLU . 7.3 tp10 -69.1 -68.02 0.43 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.95 0.405 . . . . 0.0 110.581 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -79.79 -14.49 58.66 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.575 ' HD2' ' O ' ' A' ' 46' ' ' PHE . 85.2 m-70 -100.44 63.43 1.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.669 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -115.02 68.42 0.7 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.876 0.37 . . . . 0.0 110.595 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -107.82 -64.07 1.25 Allowed 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.276 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.481 ' HA3' ' HB2' ' B' ' 92' ' ' CYS . . . -134.12 -107.54 0.98 Allowed Glycine 0 C--O 1.219 -0.835 0 C-N-CA 120.031 -1.08 . . . . 0.0 113.799 -178.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.665 HG11 ' HA ' ' A' ' 30' ' ' PRO . 2.9 m -12.51 -67.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 N-CA-C 116.496 2.036 . . . . 0.0 116.496 -178.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.563 ' H ' HG21 ' A' ' 54' ' ' VAL . 32.4 t -73.38 -39.79 64.84 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -177.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.7 tttm -63.46 -24.75 67.96 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.02 0.438 . . . . 0.0 109.941 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -62.18 -32.68 73.33 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.213 178.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 60.5 mt -94.36 -4.69 48.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.44 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 66.2 t-80 64.79 84.04 0.16 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.851 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.488 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 8.1 mp -126.98 27.35 5.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.026 178.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.903 0 CA-C-O 118.213 -0.898 . . . . 0.0 109.462 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 74' ' ' CYS . . . . . 0.726 ' HB2' HD12 ' B' ' 78' ' ' ILE . 31.2 p . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.788 0.327 . . . . 0.0 111.305 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 75' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' B' ' 79' ' ' ALA . . . -69.53 -6.34 30.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.89 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -102.25 -47.91 4.36 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.65 -41.42 13.4 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -178.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.978 HD13 ' HB2' ' B' ' 107' ' ' PHE . 84.3 mt -76.27 -43.01 37.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.646 0.26 . . . . 0.0 110.713 -179.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 79' ' ' ALA . . . . . 0.415 ' HB2' ' O ' ' B' ' 75' ' ' ALA . . . -78.74 -16.99 56.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.925 0.393 . . . . 0.0 110.906 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -86.62 -34.29 11.92 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.591 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . 0.509 ' HB2' HG12 ' B' ' 93' ' ' VAL . . . -67.69 -19.58 65.19 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.652 0.263 . . . . 0.0 111.354 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 82' ' ' VAL . . . . . 0.538 HG22 HD11 ' B' ' 88' ' ' ILE . 77.4 t -62.13 -54.75 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.121 178.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.41 -26.47 65.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.225 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.54 -40.89 96.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.84 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 7.2 t -110.75 25.38 11.84 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.411 -0.516 . . . . 0.0 111.668 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.73 -51.48 4.58 Favored Glycine 0 CA--C 1.518 0.245 0 N-CA-C 114.858 0.703 . . . . 0.0 114.858 178.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . -138.25 -177.4 15.24 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.036 -1.078 . . . . 0.0 113.837 -178.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 88' ' ' ILE . . . . . 0.538 HD11 HG22 ' B' ' 82' ' ' VAL . 3.9 tp -102.11 137.0 31.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.217 0.532 . . . . 0.0 111.187 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -171.2 -104.64 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 90' ' ' LEU . . . . . 0.731 HD23 ' HB2' ' B' ' 116' ' ' CYS . 56.0 tp -176.16 -50.61 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.388 0 CA-C-O 119.476 -0.297 . . . . 0.0 111.494 178.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 91' ' ' PRO . . . . . 0.628 ' HD2' ' N ' ' B' ' 90' ' ' LEU . 3.4 Cg_exo -40.73 -39.83 3.23 Favored 'Trans proline' 0 C--N 1.364 1.344 0 C-N-CA 124.051 3.167 . . . . 0.0 114.67 -179.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 92' ' ' CYS . . . . . 0.481 ' HB2' ' HA3' ' A' ' 53' ' ' GLY . 19.6 t -113.16 -14.8 12.86 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.067 0.461 . . . . 0.0 111.726 -178.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 93' ' ' VAL . . . . . 0.509 HG12 ' HB2' ' B' ' 81' ' ' ALA . 12.3 t -72.62 -17.68 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.395 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 94' ' ' LEU . . . . . 0.898 ' HB2' HG23 ' B' ' 115' ' ' VAL . 23.8 tp -62.22 -35.58 79.34 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.46 -54.89 26.33 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 -178.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -87.38 7.97 26.6 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 59.8 tp -79.0 -31.02 44.63 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.288 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt . . . . . 0 C--O 1.234 0.279 0 CA-C-O 121.551 0.691 . . . . 0.0 110.743 179.528 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.235 0.314 0 CA-C-O 120.559 0.219 . . . . 0.0 110.49 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . 53.87 -155.24 0.23 Allowed 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.66 33.97 0.05 Allowed 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 115.18 -0.918 . . . . 0.0 113.47 -178.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 38.8 t -105.86 -28.68 10.47 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 177.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . 0.978 ' HB2' HD13 ' B' ' 78' ' ' ILE . 0.0 OUTLIER -123.48 162.4 22.94 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 113.94 -1.482 . . . . 0.0 107.055 176.24 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 108' ' ' CYS . . . . . 0.448 ' SG ' HD21 ' B' ' 121' ' ' LEU . 66.9 m 68.2 -3.94 1.17 Allowed 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 179.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -62.08 -85.41 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 118.563 0.62 . . . . 0.0 111.043 179.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -86.62 -7.96 57.89 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 178.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -101.16 36.17 2.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.324 -1.307 . . . . 0.0 111.158 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.79 63.77 3.37 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 113' ' ' HIS . . . . . 0.477 ' NE2' ' HB2' ' A' ' 28' ' ' ASP . 9.5 t-160 -122.57 -54.48 1.86 Allowed 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.549 -178.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 114' ' ' GLY . . . . . 0.532 ' O ' ' HG3' ' B' ' 117' ' ' LYS . . . -84.01 -137.24 3.37 Favored Glycine 0 C--O 1.227 -0.295 0 C-N-CA 120.511 -0.852 . . . . 0.0 113.452 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . 0.898 HG23 ' HB2' ' B' ' 94' ' ' LEU . 16.8 m -58.96 -10.76 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 116' ' ' CYS . . . . . 0.731 ' HB2' HD23 ' B' ' 90' ' ' LEU . 0.0 OUTLIER -65.21 -32.0 73.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.707 0.289 . . . . 0.0 111.469 -179.714 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 117' ' ' LYS . . . . . 0.532 ' HG3' ' O ' ' B' ' 114' ' ' GLY . 0.3 OUTLIER -87.23 -26.21 23.61 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.272 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.2 -42.62 96.54 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.5 178.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 1.8 tt -101.41 63.13 0.96 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 176.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 65.0 t-80 -20.38 114.57 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 113.732 -1.576 . . . . 0.0 114.725 -176.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 121' ' ' LEU . . . . . 0.448 HD21 ' SG ' ' B' ' 108' ' ' CYS . 1.0 OUTLIER -134.03 -33.46 1.03 Allowed 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.451 -1.25 . . . . 0.0 109.293 178.372 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 122' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.247 0.923 0 CA-C-O 118.405 -0.807 . . . . 0.0 109.94 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 17.0 p . . . . . 0 N--CA 1.476 0.871 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.413 ' O ' ' HB1' ' A' ' 15' ' ' ALA . . . -87.07 178.12 7.01 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 178.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.413 ' HB1' ' O ' ' A' ' 14' ' ' ALA . . . 72.2 -50.35 0.7 Allowed 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.692 0.62 . . . . 0.0 110.161 -178.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.441 ' O ' ' HB3' ' A' ' 20' ' ' ALA . . . -70.07 -34.34 73.06 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.598 HG12 ' CD1' ' A' ' 46' ' ' PHE . 6.2 tp -89.43 -58.36 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-O 121.022 0.439 . . . . 0.0 110.607 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.489 ' H ' HG22 ' A' ' 17' ' ' ILE . . . -54.75 -34.12 62.11 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.231 -0.895 . . . . 0.0 112.024 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.31 -27.94 50.35 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.231 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.578 ' HB2' HG13 ' A' ' 32' ' ' VAL . . . -76.24 -15.83 59.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.845 0.355 . . . . 0.0 110.838 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' ' 17' ' ' ILE . 66.9 t -63.57 -40.46 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.483 179.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.32 -18.65 63.09 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.889 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -72.32 -35.24 68.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.835 0.35 . . . . 0.0 111.442 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.517 ' HB3' ' CG ' ' B' ' 113' ' ' HIS . 71.0 m -99.48 -29.29 12.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.685 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.32 80.02 1.47 Allowed Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.249 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.85 166.08 16.72 Favored Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.491 HG22 ' O ' ' A' ' 27' ' ' ILE . 0.0 OUTLIER -105.94 96.91 4.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.922 0.868 . . . . 0.0 111.283 -179.626 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.653 ' HB2' ' CE1' ' B' ' 113' ' ' HIS . 33.5 m-20 -115.81 -105.72 0.39 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.693 ' HB3' ' HD3' ' A' ' 30' ' ' PRO . 60.2 tp -177.86 -53.7 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.362 0 N-CA-C 111.911 0.338 . . . . 0.0 111.911 178.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.693 ' HD3' ' HB3' ' A' ' 29' ' ' LEU . 15.2 Cg_exo -70.9 49.07 0.9 Allowed 'Trans proline' 0 C--N 1.362 1.25 0 C-N-CA 122.97 2.447 . . . . 0.0 114.624 -178.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.581 ' HB2' ' O ' ' B' ' 113' ' ' HIS . 50.5 t -168.29 -49.27 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.578 HG13 ' HB2' ' A' ' 20' ' ' ALA . 21.8 t -73.91 -29.76 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.679 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -55.66 -45.36 77.71 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.112 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.06 3.88 3.1 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -101.46 -38.78 7.85 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.64 0.257 . . . . 0.0 111.239 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -104.63 6.33 34.35 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.454 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -62.72 -47.8 82.03 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 119.431 -0.319 . . . . 0.0 111.625 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.421 ' HB3' ' H ' ' A' ' 39' ' ' ALA . . . 45.32 -101.59 0.05 Allowed 'General case' 0 N--CA 1.469 0.494 0 O-C-N 123.812 0.695 . . . . 0.0 111.194 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.421 ' H ' ' HB3' ' A' ' 38' ' ' ALA . . . -99.05 -106.66 0.2 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -145.79 155.06 42.68 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.787 0.327 . . . . 0.0 110.598 178.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.13 37.94 63.64 Favored Glycine 0 C--O 1.229 -0.165 0 C-N-CA 121.101 -0.571 . . . . 0.0 113.516 179.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -126.16 -16.46 5.5 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 122.447 -0.443 . . . . 0.0 111.924 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -109.32 15.36 23.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.931 0.396 . . . . 0.0 111.155 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.5 p -66.4 -53.57 34.34 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.713 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.588 ' O ' ' HG2' ' A' ' 48' ' ' GLU . 1.6 p -55.11 -44.94 75.44 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.725 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.598 ' CD1' HG12 ' A' ' 17' ' ' ILE . 65.2 t80 -63.26 -45.48 91.33 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.591 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.432 ' CB ' ' SG ' ' A' ' 61' ' ' CYS . 98.4 m -94.92 37.98 1.13 Allowed 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -177.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.588 ' HG2' ' O ' ' A' ' 45' ' ' CYS . 62.6 mm-40 -44.69 -76.27 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 118.742 0.701 . . . . 0.0 112.499 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -99.03 -14.04 19.61 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.693 0.758 . . . . 0.0 109.461 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -90.36 68.73 6.91 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.703 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 5.8 t -132.53 60.24 1.7 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.958 -177.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.585 ' ND1' ' HB3' ' B' ' 92' ' ' CYS . 5.8 p80 -131.35 17.69 4.91 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.795 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.615 ' O ' ' HG3' ' A' ' 56' ' ' LYS . . . -128.27 -137.89 4.48 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.485 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.499 ' CG2' ' HA ' ' A' ' 30' ' ' PRO . 35.6 m -58.98 -17.29 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-O 120.892 0.377 . . . . 0.0 111.807 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.543 ' HB2' HD11 ' A' ' 29' ' ' LEU . 3.9 t -78.54 -36.37 44.81 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.134 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.615 ' HG3' ' O ' ' A' ' 53' ' ' GLY . 0.0 OUTLIER -81.08 -5.57 57.79 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.158 0.504 . . . . 0.0 110.373 179.364 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -66.38 -27.42 67.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.705 178.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 45.0 mt -100.6 -19.15 16.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.502 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.414 ' C ' HD11 ' A' ' 60' ' ' LEU . 16.1 t-80 66.4 78.03 0.27 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.669 0.788 . . . . 0.0 111.021 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.414 HD11 ' C ' ' A' ' 59' ' ' HIS . 11.0 mp -123.48 -20.81 5.46 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.398 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.432 ' SG ' ' CB ' ' A' ' 47' ' ' CYS . 0.6 OUTLIER . . . . . 0 C--O 1.246 0.873 0 CA-C-O 118.391 -0.814 . . . . 0.0 111.511 -177.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 20.9 p . . . . . 0 N--CA 1.466 0.37 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 75' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' B' ' 76' ' ' ALA . . . -89.9 -175.56 4.64 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.045 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . 0.406 ' HB2' ' O ' ' B' ' 75' ' ' ALA . . . 71.46 -50.08 0.69 Allowed 'General case' 0 N--CA 1.474 0.744 0 O-C-N 123.713 0.633 . . . . 0.0 110.514 -178.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -76.5 -50.39 14.11 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.085 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.67 ' HB ' HD13 ' B' ' 97' ' ' LEU . 8.9 tp -80.26 -42.25 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-O 121.215 0.531 . . . . 0.0 110.094 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 79' ' ' ALA . . . . . 0.564 ' N ' HG22 ' B' ' 78' ' ' ILE . . . -65.59 -29.69 70.33 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.616 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -82.44 -33.21 25.99 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.772 -0.728 . . . . 0.0 111.581 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . 0.634 ' HB2' HG13 ' B' ' 93' ' ' VAL . . . -69.13 -19.53 64.03 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.82 0.343 . . . . 0.0 110.898 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 82' ' ' VAL . . . . . 0.742 HG23 ' HB ' ' B' ' 88' ' ' ILE . 75.4 t -60.76 -52.32 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.054 178.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.9 -36.36 62.23 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.999 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.34 -43.02 96.84 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.006 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 2.3 t -90.94 -8.93 47.94 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.3 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 74.47 48.49 13.64 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.95 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 143.5 135.98 3.07 Favored Glycine 0 CA--C 1.509 -0.288 0 C-N-CA 120.896 -0.668 . . . . 0.0 111.777 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 88' ' ' ILE . . . . . 0.742 ' HB ' HG23 ' B' ' 82' ' ' VAL . 0.0 OUTLIER -100.9 107.99 22.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.682 0.753 . . . . 0.0 110.645 -179.806 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 89' ' ' ASP . . . . . 0.583 ' HB2' ' HE1' ' A' ' 52' ' ' HIS . 44.0 m-20 -120.9 -86.43 0.65 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 90' ' ' LEU . . . . . 0.718 HD22 ' HA3' ' B' ' 114' ' ' GLY . 59.3 tp 179.09 -52.43 0.0 OUTLIER Pre-proline 0 C--O 1.217 -0.655 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.108 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 91' ' ' PRO . . . . . 0.96 ' HA ' HG22 ' B' ' 115' ' ' VAL . 1.0 OUTLIER -43.17 -70.49 0.07 OUTLIER 'Trans proline' 0 C--N 1.36 1.177 0 C-N-CA 123.351 2.701 . . . . 0.0 114.767 -179.413 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 92' ' ' CYS . . . . . 0.585 ' HB3' ' ND1' ' A' ' 52' ' ' HIS . 0.8 OUTLIER -72.83 -38.62 67.06 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -178.17 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 93' ' ' VAL . . . . . 0.634 HG13 ' HB2' ' B' ' 81' ' ' ALA . 0.6 OUTLIER -66.41 -24.5 33.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -178.199 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 94' ' ' LEU . . . . . 0.649 ' HB2' ' O ' ' B' ' 90' ' ' LEU . 1.3 tm? -67.96 -41.94 81.66 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.52 -9.45 8.7 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -178.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -87.67 -37.43 16.74 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 97' ' ' LEU . . . . . 0.67 HD13 ' HB ' ' B' ' 78' ' ' ILE . 1.7 pt? -115.03 17.56 16.76 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -178.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? . . . . . 0 C--N 1.324 -0.519 0 C-N-CA 120.801 -0.36 . . . . 0.0 111.408 -178.611 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 92.6 m . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.741 0.305 . . . . 0.0 111.416 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -96.08 2.71 53.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.187 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 4.3 m -54.43 -42.78 70.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.117 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 1.8 p -55.42 -61.49 2.31 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.045 0.45 . . . . 0.0 111.216 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . 0.593 ' O ' ' HD2' ' B' ' 111' ' ' HIS . 0.8 OUTLIER -58.49 -55.31 36.73 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.342 -179.652 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 12.4 m -76.29 22.63 0.16 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -178.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -63.4 -58.24 7.72 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 118.296 0.498 . . . . 0.0 111.155 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -93.93 -21.48 19.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.293 0.568 . . . . 0.0 109.998 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 111' ' ' HIS . . . . . 0.593 ' HD2' ' O ' ' B' ' 107' ' ' PHE . 45.1 m-70 -92.6 89.9 6.9 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.588 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 96.1 m -123.1 46.36 2.2 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -177.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 113' ' ' HIS . . . . . 0.848 ' HA ' ' HG2' ' B' ' 117' ' ' LYS . 23.1 p80 -140.74 5.96 2.01 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 119.608 -0.837 . . . . 0.0 111.798 177.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 114' ' ' GLY . . . . . 0.718 ' HA3' HD22 ' B' ' 90' ' ' LEU . . . -98.1 -152.6 28.23 Favored Glycine 0 C--O 1.226 -0.348 0 C-N-CA 120.489 -0.862 . . . . 0.0 111.393 177.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . 0.96 HG22 ' HA ' ' B' ' 91' ' ' PRO . 35.1 m -66.17 -5.92 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 117.411 0.606 . . . . 0.0 111.701 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 116' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -79.79 -25.28 40.97 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 117' ' ' LYS . . . . . 0.848 ' HG2' ' HA ' ' B' ' 113' ' ' HIS . 0.0 OUTLIER -96.03 3.51 53.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.359 178.19 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -44.97 -42.46 8.23 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 119' ' ' LEU . . . . . 0.687 ' O ' ' HB2' ' B' ' 120' ' ' HIS . 87.9 mt -106.66 -64.77 1.14 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 174.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 120' ' ' HIS . . . . . 0.687 ' HB2' ' O ' ' B' ' 119' ' ' LEU . 11.4 t-80 145.16 91.57 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.881 1.672 . . . . 0.0 108.883 177.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 62.1 mt -114.98 31.78 6.46 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -177.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 122' ' ' CYS . . . . . . . . . . . . . 6.3 p . . . . . 0 C--O 1.242 0.699 0 CA-C-O 118.408 -0.806 . . . . 0.0 110.965 178.653 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 55.9 m . . . . . 0 N--CA 1.474 0.748 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.86 -34.55 71.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.742 0.306 . . . . 0.0 111.736 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.82 38.81 0.66 Allowed 'General case' 0 C--N 1.326 -0.443 0 O-C-N 122.103 -0.373 . . . . 0.0 111.95 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -167.66 -53.06 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.1 0.476 . . . . 0.0 111.017 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.638 HG12 ' HD2' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -78.04 -42.4 27.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.036 -179.748 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.97 -31.3 70.93 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.962 0.41 . . . . 0.0 110.721 178.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -76.11 -26.19 64.77 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.663 -0.779 . . . . 0.0 111.84 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.44 -24.44 60.24 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 120.882 0.372 . . . . 0.0 110.743 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 98.9 t -66.35 -47.02 85.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.641 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.43 -22.06 66.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.722 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.11 -40.13 86.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.462 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.5 t -99.78 -12.86 19.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.009 0.433 . . . . 0.0 111.207 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.84 -61.76 0.35 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.097 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -105.74 170.23 16.88 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.249 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.6 tp -98.04 104.98 16.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.57 0.7 . . . . 0.0 111.581 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.585 ' OD1' HG22 ' A' ' 32' ' ' VAL . 18.1 p-10 -129.2 -111.33 0.27 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.726 178.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.632 ' HG ' HG23 ' A' ' 54' ' ' VAL . 43.3 tp -178.72 -47.03 0.0 OUTLIER Pre-proline 0 C--N 1.324 -0.505 0 C-N-CA 123.575 0.75 . . . . 0.0 110.682 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.821 ' HA ' HG21 ' A' ' 54' ' ' VAL . 32.5 Cg_exo -55.37 -31.59 77.94 Favored 'Trans proline' 0 C--N 1.367 1.528 0 C-N-CA 122.455 2.103 . . . . 0.0 113.227 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 19.5 t -106.93 -25.98 11.41 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.383 -178.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.585 HG22 ' OD1' ' A' ' 28' ' ' ASP . 65.8 t -72.13 -14.28 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.736 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.693 ' HA ' ' HB3' ' A' ' 36' ' ' LEU . 1.0 OUTLIER -59.19 -15.3 14.13 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.896 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.593 ' N ' HD13 ' A' ' 33' ' ' LEU . . . -54.3 -53.92 47.26 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.935 0.398 . . . . 0.0 111.66 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -103.3 28.29 6.51 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.222 0.534 . . . . 0.0 109.851 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.693 ' HB3' ' HA ' ' A' ' 33' ' ' LEU . 42.6 tp -122.67 -48.88 2.02 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.791 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.477 ' HE3' ' HB2' ' A' ' 58' ' ' LEU . 84.3 tttt -73.71 96.01 2.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.868 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -144.93 -80.14 0.17 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.66 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -113.27 150.74 32.02 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.497 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -67.45 143.03 56.45 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.562 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.43 -9.36 77.78 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.506 -0.854 . . . . 0.0 113.572 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 85.6 m -86.34 -23.15 26.33 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 117.331 0.565 . . . . 0.0 110.952 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.597 ' HB3' HD12 ' A' ' 36' ' ' LEU . . . -111.54 23.76 13.56 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.681 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 34.7 p -78.95 -49.71 12.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.552 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.7 p -54.55 -36.13 63.98 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.547 0.689 . . . . 0.0 111.103 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.638 ' HD2' HG12 ' A' ' 17' ' ' ILE . 0.8 OUTLIER -83.6 -68.62 0.7 Allowed 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.652 -1.158 . . . . 0.0 111.441 -178.982 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.5 ' HA ' ' HB2' ' A' ' 50' ' ' HIS . 37.4 m -77.57 32.16 0.16 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -65.35 -57.61 7.96 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.363 0.601 . . . . 0.0 109.385 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -90.4 -10.83 42.44 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.117 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.5 ' HB2' ' HA ' ' A' ' 47' ' ' CYS . 36.7 m-70 -106.23 60.43 0.65 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.119 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 5.2 t -111.18 50.22 0.83 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.033 0.444 . . . . 0.0 111.108 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.463 ' HA ' ' HD2' ' A' ' 56' ' ' LYS . 20.6 p-80 -140.92 -7.46 1.07 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 0.0 112.05 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.419 ' O ' ' HG2' ' A' ' 56' ' ' LYS . . . -104.05 -151.71 22.11 Favored Glycine 0 CA--C 1.521 0.428 0 C-N-CA 120.519 -0.848 . . . . 0.0 113.01 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.821 HG21 ' HA ' ' A' ' 30' ' ' PRO . 31.1 m -55.03 -17.23 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.527 ' HB2' HD22 ' A' ' 29' ' ' LEU . 1.8 t -70.61 -24.52 62.75 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.71 -179.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.576 ' C ' ' H ' ' A' ' 58' ' ' LEU . 10.0 ptmt -94.19 17.17 13.11 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.373 178.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -83.99 29.59 0.55 Allowed 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 123.057 1.408 . . . . 0.0 107.926 177.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.576 ' H ' ' C ' ' A' ' 56' ' ' LYS . 6.9 tt -170.16 -37.3 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 32.6 t60 71.07 91.37 0.09 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 113.88 -1.509 . . . . 0.0 111.834 178.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.529 ' C ' HD23 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -131.09 16.07 5.12 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.377 179.927 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.879 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 74' ' ' CYS . . . . . 0.626 ' O ' ' HB ' ' B' ' 78' ' ' ILE . 2.0 p . . . . . 0 N--CA 1.468 0.464 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -100.4 7.75 44.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.156 0.503 . . . . 0.0 110.575 178.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -89.61 -64.5 1.13 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.342 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . 0.429 ' O ' ' HB2' ' B' ' 81' ' ' ALA . . . -87.67 -24.71 23.81 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.635 HD13 ' HB2' ' B' ' 107' ' ' PHE . 23.9 mt -89.13 -55.18 6.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.553 0.216 . . . . 0.0 111.082 -179.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.17 -21.19 46.78 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.391 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.03 -34.16 42.95 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.705 -0.76 . . . . 0.0 111.626 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . 0.503 ' HB1' HG13 ' B' ' 93' ' ' VAL . . . -71.29 -18.15 62.43 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 120.956 0.408 . . . . 0.0 110.702 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 82' ' ' VAL . . . . . 0.436 HG23 ' O ' ' B' ' 78' ' ' ILE . 69.9 t -64.07 -41.73 93.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.857 178.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.02 -22.57 60.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.057 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.82 -39.54 30.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.547 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 22.7 t -89.5 -25.37 21.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.757 0.313 . . . . 0.0 110.865 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 96.46 34.5 5.79 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.367 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 147.6 163.8 10.86 Favored Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 111.399 -0.68 . . . . 0.0 111.399 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.36 127.42 63.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 117.199 0.5 . . . . 0.0 110.666 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 89' ' ' ASP . . . . . 0.558 ' OD2' ' HG2' ' B' ' 91' ' ' PRO . 30.2 p-10 -144.67 -59.22 0.37 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.449 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 90' ' ' LEU . . . . . 0.608 HD13 ' HB2' ' B' ' 116' ' ' CYS . 61.0 tp 133.55 -51.63 0.0 OUTLIER Pre-proline 0 N--CA 1.484 1.269 0 C-N-CA 126.2 1.8 . . . . 0.0 110.337 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 91' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' B' ' 90' ' ' LEU . 4.5 Cg_exo -44.06 -38.41 10.5 Favored 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 123.539 2.826 . . . . 0.0 114.686 -179.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 31.5 p -104.98 -31.14 9.36 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 120.241 -0.583 . . . . 0.0 111.581 -179.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 93' ' ' VAL . . . . . 0.503 HG13 ' HB1' ' B' ' 81' ' ' ALA . 3.9 t -63.29 -7.37 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.43 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 94' ' ' LEU . . . . . 0.792 HD22 ' HB ' ' B' ' 115' ' ' VAL . 4.3 pp -61.66 -22.61 65.45 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 122.343 -0.223 . . . . 0.0 111.2 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -53.2 -60.46 3.26 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -178.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.11 -15.58 58.75 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.223 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 18.1 tp -74.61 -41.38 60.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.898 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . 0.732 ' HA ' HD12 ' B' ' 119' ' ' LEU . 43.9 mtpt . . . . . 0 N--CA 1.462 0.172 0 CA-C-O 120.777 0.323 . . . . 0.0 111.195 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 60.8 m . . . . . 0 N--CA 1.462 0.156 0 CA-C-O 120.649 0.261 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 104' ' ' ALA . . . . . 0.551 ' HB2' HD21 ' B' ' 121' ' ' LEU . . . -100.46 27.17 5.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.227 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 3.0 p -73.96 -61.07 1.98 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.952 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 4.5 p -55.63 -37.74 68.58 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.556 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . 0.635 ' HB2' HD13 ' B' ' 78' ' ' ILE . 1.1 t80 -79.38 -75.71 0.24 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.069 -0.969 . . . . 0.0 112.514 -177.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 74.3 m -73.12 33.57 0.07 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -177.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -59.53 -57.92 10.84 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.332 0.587 . . . . 0.0 109.531 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -98.15 -19.65 17.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.483 178.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 -93.77 65.34 3.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.722 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 4.6 t -123.53 58.91 1.12 Allowed 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.466 -0.493 . . . . 0.0 111.0 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 113' ' ' HIS . . . . . 0.563 ' O ' ' HE2' ' B' ' 117' ' ' LYS . 20.7 p-80 -139.96 -25.34 0.81 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 114' ' ' GLY . . . . . 0.423 ' C ' ' H ' ' B' ' 116' ' ' CYS . . . -127.8 129.85 6.52 Favored Glycine 0 C--O 1.226 -0.396 0 C-N-CA 120.184 -1.008 . . . . 0.0 112.695 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . 0.792 ' HB ' HD22 ' B' ' 94' ' ' LEU . 24.4 m 54.82 -31.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 C-N-CA 126.164 1.786 . . . . 0.0 115.204 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 116' ' ' CYS . . . . . 0.608 ' HB2' HD13 ' B' ' 90' ' ' LEU . 35.2 t -81.18 -37.69 28.3 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 121.807 -0.558 . . . . 0.0 111.291 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 117' ' ' LYS . . . . . 0.563 ' HE2' ' O ' ' B' ' 113' ' ' HIS . 52.1 pttt -77.7 15.05 0.89 Allowed 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 119.697 -0.801 . . . . 0.0 110.957 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 118' ' ' ASP . . . . . 0.432 ' H ' ' C ' ' B' ' 116' ' ' CYS . 1.2 t70 -75.38 -24.1 57.18 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 106.824 -1.546 . . . . 0.0 106.824 175.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 119' ' ' LEU . . . . . 0.732 HD12 ' HA ' ' B' ' 98' ' ' LYS . 53.1 mt -94.75 -31.7 13.66 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 114.137 -1.392 . . . . 0.0 107.704 176.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 12.7 t60 55.9 76.28 0.29 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 113.886 -1.507 . . . . 0.0 112.437 178.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 121' ' ' LEU . . . . . 0.617 HD13 ' H ' ' B' ' 121' ' ' LEU . 0.0 OUTLIER -131.69 -3.34 3.71 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-O 120.959 0.409 . . . . 0.0 110.821 179.885 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 122' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.246 0.882 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.39 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.409 ' HB3' HD12 ' A' ' 17' ' ' ILE . 6.5 m . . . . . 0 N--CA 1.472 0.646 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.474 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -79.51 -13.47 59.53 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -178.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -98.04 15.62 23.58 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.912 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.47 -59.53 0.24 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.135 0.493 . . . . 0.0 111.3 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.438 HD11 ' HB3' ' A' ' 46' ' ' PHE . 80.6 mt -75.17 -42.77 44.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.354 -179.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 14' ' ' ALA . . . -59.54 -34.06 72.18 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -179.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -85.99 -33.1 15.9 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.646 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.6 -34.78 74.6 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.011 0.434 . . . . 0.0 111.343 -179.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.4 t -64.07 -44.36 97.7 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.784 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.15 -22.53 66.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.648 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.65 -43.2 66.52 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.48 ' SG ' HG23 ' A' ' 32' ' ' VAL . 60.3 m -104.03 0.64 30.08 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 -178.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.18 42.95 10.06 Favored Glycine 0 CA--C 1.517 0.197 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.884 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 130.32 -178.88 17.28 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 121.062 -0.589 . . . . 0.0 111.634 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.2 pp -74.18 134.35 29.73 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 CA-C-O 121.748 0.785 . . . . 0.0 110.343 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.85 ' HB3' HG22 ' A' ' 32' ' ' VAL . 32.9 t70 -148.59 -127.7 0.05 Allowed 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.564 -1.198 . . . . 0.0 108.007 -178.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.573 HD22 ' HB2' ' A' ' 55' ' ' CYS . 20.6 tp 175.27 -56.3 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.461 0 O-C-N 123.418 0.449 . . . . 0.0 112.042 178.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.545 ' HD3' ' HG3' ' B' ' 91' ' ' PRO . 3.8 Cg_endo -49.92 -34.78 38.37 Favored 'Trans proline' 0 C--N 1.364 1.353 0 C-N-CA 122.752 2.301 . . . . 0.0 113.308 -179.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 17.3 p -110.59 -28.85 8.3 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.216 0.531 . . . . 0.0 110.979 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.85 HG22 ' HB3' ' A' ' 28' ' ' ASP . 51.6 t -67.72 -23.91 30.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.44 -179.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.8 pp -54.9 -26.56 36.66 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.95 -61.04 2.66 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -178.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.46 -21.64 52.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.74 0.305 . . . . 0.0 111.389 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.666 HD22 HD22 ' A' ' 60' ' ' LEU . 52.6 tp -68.05 -36.47 79.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.498 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -66.12 -39.74 90.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.457 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 58.12 -100.25 0.11 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.577 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -132.64 18.81 4.27 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.715 -0.221 . . . . 0.0 111.396 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -168.26 -110.49 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -110.98 -64.32 0.51 Allowed Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 178.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 12.0 m 48.71 29.4 2.19 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.485 0.714 . . . . 0.0 112.916 177.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.56 ' CB ' ' HG ' ' A' ' 60' ' ' LEU . . . -115.35 -15.99 11.5 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.448 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 2.5 m -58.02 -19.18 29.2 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.013 0.435 . . . . 0.0 111.812 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 42.5 t -64.99 -53.38 47.16 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.604 ' HE2' HD11 ' A' ' 36' ' ' LEU . 0.3 OUTLIER -107.92 -46.63 3.74 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.294 -179.641 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.577 ' O ' ' HB3' ' A' ' 51' ' ' CYS . 0.1 OUTLIER -68.31 21.0 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.634 179.737 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.546 ' H ' ' C ' ' A' ' 46' ' ' PHE . 38.9 tp10 -63.52 -76.2 0.07 Allowed 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 123.246 0.618 . . . . 0.0 111.903 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -69.86 -44.69 69.34 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.858 -178.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -103.3 111.52 23.97 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.168 0.509 . . . . 0.0 111.901 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.672 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 13.5 p -164.99 35.33 0.06 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.613 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.494 ' HA ' ' HE3' ' A' ' 56' ' ' LYS . 3.7 p-80 -82.81 -16.33 48.19 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.509 ' HA3' ' HG2' ' B' ' 91' ' ' PRO . . . -76.86 -123.89 0.21 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.384 -0.913 . . . . 0.0 112.04 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.468 HG13 ' HA ' ' A' ' 30' ' ' PRO . 8.9 p -85.9 18.84 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.745 0.783 . . . . 0.0 110.265 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.672 ' SG ' ' HB2' ' A' ' 51' ' ' CYS . 5.3 t -91.64 -48.43 6.84 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.494 ' HE3' ' HA ' ' A' ' 52' ' ' HIS . 19.8 pttp -89.27 14.07 11.91 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 120.976 -0.289 . . . . 0.0 110.662 178.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -56.13 -41.63 75.62 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.259 0.552 . . . . 0.0 109.727 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.5 tt -135.67 -79.16 0.43 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 177.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -155.1 118.25 4.41 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.977 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.666 HD22 HD22 ' A' ' 36' ' ' LEU . 8.1 tp -153.87 -50.97 0.1 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.92 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.533 ' HB3' ' O ' ' A' ' 47' ' ' CYS . 0.8 OUTLIER . . . . . 0 C--O 1.243 0.759 0 CA-C-O 118.474 -0.774 . . . . 0.0 110.518 178.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 74' ' ' CYS . . . . . 0.477 ' O ' ' HB ' ' B' ' 78' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.26 0 CA-C-O 120.618 0.247 . . . . 0.0 111.603 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.68 -53.79 8.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.858 0.361 . . . . 0.0 110.965 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.85 42.68 0.72 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.973 0.416 . . . . 0.0 111.381 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -159.21 -44.87 0.05 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.582 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.915 HD12 ' HB2' ' B' ' 107' ' ' PHE . 12.5 mt -100.79 -52.44 8.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.203 -179.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.88 -33.63 73.38 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.15 -37.62 17.84 Favored Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.645 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . 0.517 ' HB3' ' HB3' ' B' ' 96' ' ' ALA . . . -72.78 -29.54 63.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.052 0.453 . . . . 0.0 111.49 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 82' ' ' VAL . . . . . 0.614 HG22 HG21 ' B' ' 88' ' ' ILE . 2.6 t -66.13 -40.17 86.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.607 179.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.4 -24.05 66.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.261 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.9 -39.08 44.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.319 -0.401 . . . . 0.0 112.049 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 4.8 t -85.52 -25.51 26.78 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.871 -0.331 . . . . 0.0 111.123 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 104.71 39.79 2.29 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.474 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 124.45 170.99 13.31 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.025 -0.607 . . . . 0.0 111.613 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 88' ' ' ILE . . . . . 0.614 HG21 HG22 ' B' ' 82' ' ' VAL . 1.2 pt -66.12 143.14 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.438 0 CA-C-O 121.416 0.627 . . . . 0.0 110.436 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 89' ' ' ASP . . . . . 0.482 ' O ' ' HB2' ' B' ' 90' ' ' LEU . 29.6 t70 -157.26 -127.4 0.03 OUTLIER 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.728 -178.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 90' ' ' LEU . . . . . 0.607 HD13 ' HB2' ' B' ' 116' ' ' CYS . 36.5 tp 170.73 -58.14 0.0 OUTLIER Pre-proline 0 C--N 1.323 -0.558 0 O-C-N 123.867 0.73 . . . . 0.0 110.563 178.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 91' ' ' PRO . . . . . 0.545 ' HG3' ' HD3' ' A' ' 30' ' ' PRO . 14.3 Cg_endo -57.8 -16.11 24.14 Favored 'Trans proline' 0 C--N 1.365 1.409 0 C-N-CA 122.681 2.254 . . . . 0.0 113.585 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 20.3 p -110.23 -34.02 6.49 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.217 0.532 . . . . 0.0 110.37 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 93' ' ' VAL . . . . . 0.453 HG12 ' HB2' ' B' ' 97' ' ' LEU . 3.0 t -74.26 -18.05 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.141 -178.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 94' ' ' LEU . . . . . 0.6 HD22 HG11 ' B' ' 115' ' ' VAL . 0.6 OUTLIER -40.95 -31.74 0.19 Allowed 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 -178.206 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.28 -54.53 4.73 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 118.442 0.564 . . . . 0.0 112.257 -178.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . 0.517 ' HB3' ' HB3' ' B' ' 81' ' ' ALA . . . -71.8 -17.48 62.16 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.6 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 97' ' ' LEU . . . . . 0.453 ' HB2' HG12 ' B' ' 93' ' ' VAL . 20.0 tp -67.97 -38.12 82.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.478 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 44.5 mttm . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.757 179.728 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 58.2 m . . . . . 0 N--CA 1.468 0.452 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -113.22 16.31 19.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.864 0.364 . . . . 0.0 110.693 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 105' ' ' SER . . . . . 0.638 ' O ' ' HG2' ' B' ' 109' ' ' GLU . 3.9 p -58.67 -52.05 67.33 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.142 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 18.7 p -53.95 -41.28 67.61 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.78 0.8 . . . . 0.0 111.517 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . 0.915 ' HB2' HD12 ' B' ' 78' ' ' ILE . 0.9 OUTLIER -69.36 -72.32 0.19 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.27 -1.332 . . . . 0.0 112.908 -177.928 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 108' ' ' CYS . . . . . 0.822 ' HA ' ' HB2' ' B' ' 111' ' ' HIS . 36.3 m -81.11 34.8 0.37 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -176.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 109' ' ' GLU . . . . . 0.638 ' HG2' ' O ' ' B' ' 105' ' ' SER . 13.1 mm-40 -60.59 -60.89 3.09 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 177.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -96.69 -0.18 48.74 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 111' ' ' HIS . . . . . 0.822 ' HB2' ' HA ' ' B' ' 108' ' ' CYS . 55.4 m-70 -108.59 39.48 1.99 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.962 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 2.1 t -98.0 49.31 1.01 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 113' ' ' HIS . . . . . . . . . . . . . 22.3 p-80 -123.24 -33.18 3.32 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.097 -178.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 114' ' ' GLY . . . . . 0.455 ' C ' ' H ' ' B' ' 116' ' ' CYS . . . -85.15 -146.33 8.29 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.857 -0.687 . . . . 0.0 113.425 -179.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . 0.6 HG11 HD22 ' B' ' 94' ' ' LEU . 7.7 p -74.65 37.34 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 122.331 1.062 . . . . 0.0 111.436 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 116' ' ' CYS . . . . . 0.607 ' HB2' HD13 ' B' ' 90' ' ' LEU . 2.5 t -120.31 -25.88 5.56 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.527 -0.76 . . . . 0.0 108.986 178.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.78 -9.83 39.11 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.909 178.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -49.54 -52.2 31.52 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.636 -179.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 73.1 mt -107.4 -104.34 0.35 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 177.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -151.18 93.33 1.9 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.228 0.537 . . . . 0.0 109.9 177.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 121' ' ' LEU . . . . . 0.504 HD23 ' SG ' ' B' ' 116' ' ' CYS . 9.4 mp -121.58 -28.01 4.65 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.982 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 122' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.245 0.859 0 CA-C-O 118.437 -0.792 . . . . 0.0 110.802 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.465 0.298 0 CA-C-O 120.832 0.348 . . . . 0.0 111.125 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.484 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -81.21 21.41 0.74 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.619 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -109.75 -42.74 4.19 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.283 0.563 . . . . 0.0 109.838 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.27 -40.8 43.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.979 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.615 HG12 ' CD2' ' A' ' 46' ' ' PHE . 10.9 tp -72.38 -32.16 41.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.517 0.675 . . . . 0.0 110.194 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.488 ' N ' HG23 ' A' ' 17' ' ' ILE . . . -56.3 -27.66 56.21 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.527 -1.215 . . . . 0.0 111.595 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.48 -29.67 51.97 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.437 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.732 ' HB2' ' HB1' ' A' ' 35' ' ' ALA . . . -72.92 -28.83 62.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.064 0.459 . . . . 0.0 110.477 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.666 HG11 ' HB ' ' A' ' 27' ' ' ILE . 96.5 t -66.04 -48.88 80.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.297 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.96 -33.91 76.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.179 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.61 -34.66 78.75 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.783 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.534 ' SG ' ' HB2' ' B' ' 113' ' ' HIS . 3.9 t -89.21 -28.93 19.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.772 0.32 . . . . 0.0 111.109 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.6 40.8 3.54 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.362 -0.923 . . . . 0.0 112.209 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 148.11 163.03 10.49 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.761 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.666 ' HB ' HG11 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -108.18 135.58 46.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.255 0.55 . . . . 0.0 111.938 -179.268 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.642 ' HB2' ' HE1' ' B' ' 113' ' ' HIS . 7.9 t70 -160.59 -97.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.047 -0.979 . . . . 0.0 108.798 178.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.567 ' HG ' ' CG2' ' A' ' 54' ' ' VAL . 49.4 tp -178.85 -53.86 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.254 0 CA-C-O 119.263 -0.399 . . . . 0.0 111.484 178.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.732 ' HA ' HG23 ' A' ' 54' ' ' VAL . 96.3 Cg_exo -41.35 -65.47 0.19 Allowed 'Trans proline' 0 C--N 1.36 1.183 0 C-N-CA 123.203 2.602 . . . . 0.0 114.463 -178.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.501 ' HB3' ' O ' ' B' ' 113' ' ' HIS . 14.0 p -79.2 -32.49 44.1 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.878 -178.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.464 HG11 ' HB3' ' A' ' 20' ' ' ALA . 2.6 t -62.57 -31.05 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.988 -179.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.416 HD21 ' HB ' ' A' ' 54' ' ' VAL . 23.6 tp -65.76 -45.57 82.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.306 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.38 -43.76 68.07 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -178.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.732 ' HB1' ' HB2' ' A' ' 20' ' ' ALA . . . -67.57 -20.22 65.36 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -179.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.2 tt -99.05 -23.91 15.1 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.152 0.501 . . . . 0.0 110.214 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.9 mmmt -75.11 99.07 3.83 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -178.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -126.48 -24.88 3.54 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 175.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -171.63 -166.03 0.42 Allowed 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 112.235 -2.257 . . . . 0.0 105.612 178.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -70.15 -59.96 2.58 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 119.92 -0.712 . . . . 0.0 110.258 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 56.45 -118.45 11.57 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 121.133 -0.556 . . . . 0.0 112.59 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.403 ' HB3' ' H ' ' A' ' 43' ' ' ALA . 10.5 t -96.64 -94.12 0.21 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.403 ' H ' ' HB3' ' A' ' 42' ' ' CYS . . . 66.93 -51.54 0.47 Allowed 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 178.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.1 p -54.84 -22.28 14.02 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 113.715 1.005 . . . . 0.0 113.715 -178.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.1 t -66.75 -49.98 64.23 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.494 0.664 . . . . 0.0 109.924 178.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.615 ' CD2' HG12 ' A' ' 17' ' ' ILE . 0.8 OUTLIER -72.2 -43.57 64.28 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 178.271 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.532 ' SG ' HD12 ' A' ' 29' ' ' LEU . 86.1 m -94.14 67.58 3.62 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.832 -1.077 . . . . 0.0 109.611 178.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -92.9 -105.33 0.12 Allowed 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.2 p30 -72.85 -10.57 59.94 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 121.934 0.873 . . . . 0.0 108.972 177.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -103.35 99.06 8.89 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 113.687 -1.597 . . . . 0.0 106.793 177.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 44.9 t -169.07 79.92 0.13 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -177.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.491 ' CE1' ' HB2' ' B' ' 89' ' ' ASP . 3.5 p80 -138.93 18.03 2.65 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.415 0.626 . . . . 0.0 110.454 176.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.661 ' HA3' ' HG2' ' B' ' 91' ' ' PRO . . . -119.33 -135.36 5.08 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.657 -0.702 . . . . 0.0 112.337 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.732 HG23 ' HA ' ' A' ' 30' ' ' PRO . 16.1 m -55.54 -27.94 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -74.38 -38.23 63.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.448 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.587 ' HD3' ' O ' ' A' ' 53' ' ' GLY . 0.0 OUTLIER -65.61 -24.91 67.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.697 0.284 . . . . 0.0 111.062 -179.773 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -58.36 -26.09 62.75 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.441 -179.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.495 ' O ' ' HB2' ' A' ' 59' ' ' HIS . 3.2 mm? -90.72 -23.66 20.64 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.495 ' HB2' ' O ' ' A' ' 58' ' ' LEU . 39.3 m-70 74.72 63.83 0.07 Allowed 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.144 0.578 . . . . 0.0 111.994 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -140.48 14.98 2.37 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.947 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.425 ' HB3' ' O ' ' A' ' 47' ' ' CYS . 1.5 p . . . . . 0 C--O 1.245 0.829 0 CA-C-O 118.136 -0.935 . . . . 0.0 111.287 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 74' ' ' CYS . . . . . 0.636 ' HB3' ' SG ' ' B' ' 103' ' ' CYS . 15.0 p . . . . . 0 C--O 1.225 -0.213 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -69.8 -3.69 16.73 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -105.15 -46.91 4.12 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.172 0.511 . . . . 0.0 109.741 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.6 -39.97 70.16 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.32 -0.855 . . . . 0.0 112.079 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.642 HG23 ' N ' ' B' ' 79' ' ' ALA . 6.0 tp -73.23 -37.37 51.96 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 CA-C-O 121.323 0.582 . . . . 0.0 109.706 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 79' ' ' ALA . . . . . 0.642 ' N ' HG23 ' B' ' 78' ' ' ILE . . . -63.32 -33.09 74.76 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.915 -1.038 . . . . 0.0 110.713 179.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -74.96 -30.96 58.52 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.646 -0.787 . . . . 0.0 111.699 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.76 -21.43 61.74 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.206 0.527 . . . . 0.0 110.47 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 44.4 t -64.46 -51.72 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.081 178.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.45 -19.72 63.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.126 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.65 -39.64 57.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.737 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 1.4 t -88.36 -30.8 19.27 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.804 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 114.66 40.37 0.93 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.299 -0.953 . . . . 0.0 113.806 178.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 136.15 175.05 13.61 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.072 -1.061 . . . . 0.0 112.936 179.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 6.1 tp -91.3 134.3 30.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.183 0.516 . . . . 0.0 111.098 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 89' ' ' ASP . . . . . 0.495 ' OD1' ' HD2' ' B' ' 91' ' ' PRO . 2.6 t0 -156.46 -119.01 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 90' ' ' LEU . . . . . 0.704 HD22 ' HA3' ' B' ' 114' ' ' GLY . 47.1 tp -177.66 -53.63 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.461 0 C-N-CA 123.077 0.551 . . . . 0.0 111.121 177.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 91' ' ' PRO . . . . . 0.663 ' HD3' ' HG3' ' A' ' 30' ' ' PRO . 2.9 Cg_endo -48.36 -48.96 15.46 Favored 'Trans proline' 0 C--N 1.359 1.093 0 C-N-CA 123.018 2.479 . . . . 0.0 113.634 -179.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 4.2 t -81.64 -40.34 23.06 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.935 0.398 . . . . 0.0 111.583 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 2.2 t -62.3 -24.49 35.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.409 -179.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 94' ' ' LEU . . . . . 0.726 ' HG ' ' HG3' ' B' ' 98' ' ' LYS . 22.5 tp -63.48 -26.72 68.85 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.27 0.471 . . . . 0.0 112.27 -179.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.05 -31.89 61.47 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -178.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -83.59 -1.85 54.78 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 97' ' ' LEU . . . . . 0.407 HD12 ' CD1' ' B' ' 78' ' ' ILE . 21.0 mt -136.75 14.88 3.13 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -178.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . 0.726 ' HG3' ' HG ' ' B' ' 94' ' ' LEU . 12.6 mtpt . . . . . 0 C--N 1.322 -0.621 0 C-N-CA 119.554 -0.859 . . . . 0.0 111.73 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 103' ' ' CYS . . . . . 0.636 ' SG ' ' HB3' ' B' ' 74' ' ' CYS . 45.9 t . . . . . 0 N--CA 1.454 -0.266 0 CA-C-O 119.757 -0.163 . . . . 0.0 110.616 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 104' ' ' ALA . . . . . 0.418 ' N ' ' SG ' ' B' ' 103' ' ' CYS . . . 67.82 -59.06 0.43 Allowed 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.682 0.793 . . . . 0.0 112.4 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 105' ' ' SER . . . . . 0.531 ' HA ' ' HB2' ' B' ' 108' ' ' CYS . 5.0 p -63.94 2.8 0.46 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -178.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 8.7 t -72.81 -47.27 47.86 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . 0.623 ' CD2' HG12 ' B' ' 78' ' ' ILE . 1.0 OUTLIER -74.24 -25.93 59.93 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 177.216 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 108' ' ' CYS . . . . . 0.587 ' O ' ' HB3' ' B' ' 122' ' ' CYS . 2.5 m -103.36 67.35 0.92 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.42 -1.263 . . . . 0.0 110.279 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -96.53 -108.04 0.16 Allowed 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 45.8 p30 -72.95 -11.45 60.58 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 177.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -103.03 99.12 8.98 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 113.087 -1.87 . . . . 0.0 106.877 177.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 42.6 t -144.96 83.06 1.68 Allowed 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.791 -176.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 113' ' ' HIS . . . . . 0.687 ' HA ' ' HD2' ' B' ' 117' ' ' LYS . 1.0 OUTLIER -150.01 2.41 0.51 Allowed 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.8 0.666 . . . . 0.0 112.8 179.668 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 114' ' ' GLY . . . . . 0.704 ' HA3' HD22 ' B' ' 90' ' ' LEU . . . -98.72 -156.48 29.34 Favored Glycine 0 C--O 1.227 -0.293 0 C-N-CA 120.048 -1.072 . . . . 0.0 112.728 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . 0.646 ' CG2' ' HA ' ' B' ' 91' ' ' PRO . 19.6 m -56.63 -11.19 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 122.959 0.504 . . . . 0.0 112.35 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 116' ' ' CYS . . . . . 0.51 ' O ' HD23 ' B' ' 121' ' ' LEU . 35.7 t -84.25 -39.75 18.89 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.377 -178.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 117' ' ' LYS . . . . . 0.687 ' HD2' ' HA ' ' B' ' 113' ' ' HIS . 6.3 ptmm? -64.99 -14.37 60.12 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.71 0.291 . . . . 0.0 110.737 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -57.08 -25.33 58.56 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.138 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 119' ' ' LEU . . . . . 0.611 ' HB2' HD22 ' B' ' 121' ' ' LEU . 3.1 mm? -99.26 -13.18 19.8 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 122.072 -0.392 . . . . 0.0 111.483 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 22.2 m-70 67.34 76.03 0.29 Allowed 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 122.943 0.497 . . . . 0.0 111.365 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 121' ' ' LEU . . . . . 0.623 HD21 ' N ' ' B' ' 121' ' ' LEU . 1.0 OUTLIER -140.02 18.56 2.46 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.487 -179.334 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 122' ' ' CYS . . . . . 0.587 ' HB3' ' O ' ' B' ' 108' ' ' CYS . 0.9 OUTLIER . . . . . 0 C--O 1.246 0.889 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.767 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.673 ' HB2' ' CD1' ' A' ' 17' ' ' ILE . 1.8 p . . . . . 0 N--CA 1.47 0.56 0 CA-C-O 121.847 0.832 . . . . 0.0 110.737 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.62 65.23 8.43 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 114.258 -1.337 . . . . 0.0 110.545 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -145.61 -88.6 0.1 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.765 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.59 -21.74 44.63 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.325 0.584 . . . . 0.0 111.732 -178.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.9 HD13 ' HB2' ' A' ' 46' ' ' PHE . 64.5 mt -80.76 -8.79 11.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-O 121.836 0.827 . . . . 0.0 110.808 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -111.01 -9.9 14.39 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.529 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -115.18 -53.69 0.39 Allowed Glycine 0 C--O 1.228 -0.264 0 C-N-CA 120.568 -0.825 . . . . 0.0 113.013 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.88 -22.9 65.08 Favored 'General case' 0 C--O 1.226 -0.172 0 CA-C-N 117.207 0.504 . . . . 0.0 111.469 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.649 HG13 HD12 ' A' ' 27' ' ' ILE . 2.6 t -66.7 -41.9 88.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 O-C-N 122.09 -0.381 . . . . 0.0 110.824 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.03 -30.08 69.22 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.456 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.86 -30.82 71.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.092 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.0 t -87.09 -23.35 24.93 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.787 0.327 . . . . 0.0 110.664 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.64 39.32 4.19 Favored Glycine 0 N--CA 1.453 -0.177 0 C-N-CA 120.51 -0.852 . . . . 0.0 113.115 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 135.14 174.25 13.36 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.188 -1.006 . . . . 0.0 112.782 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.649 HD12 HG13 ' A' ' 21' ' ' VAL . 23.0 mm -72.73 125.85 32.28 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 CA-C-O 121.261 0.553 . . . . 0.0 111.412 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.412 ' HB2' ' CD2' ' B' ' 113' ' ' HIS . 35.5 t70 -144.31 -122.01 0.08 Allowed 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.737 -1.12 . . . . 0.0 108.421 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.759 ' HG ' HG22 ' A' ' 54' ' ' VAL . 12.1 tp 165.65 -61.02 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.407 0 C-N-CA 124.134 0.973 . . . . 0.0 109.645 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 1.029 ' HA ' HG11 ' A' ' 54' ' ' VAL . 9.5 Cg_endo -54.32 -41.22 78.31 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.044 1.83 . . . . 0.0 113.216 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.759 ' HB3' ' HA2' ' B' ' 114' ' ' GLY . 23.4 p -81.2 -38.07 27.64 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.552 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.42 HG21 ' SG ' ' A' ' 31' ' ' CYS . 24.1 t -67.51 -25.11 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.74 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.692 ' HA ' ' HB3' ' A' ' 36' ' ' LEU . 22.2 tp -52.35 -32.43 38.21 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.563 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -45.36 -43.98 11.41 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -115.83 22.41 13.08 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.104 0.478 . . . . 0.0 109.873 178.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.692 ' HB3' ' HA ' ' A' ' 33' ' ' LEU . 27.9 tp -114.81 -14.2 11.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.898 -178.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.593 ' HD3' ' O ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -69.36 85.11 0.4 Allowed 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.794 0.807 . . . . 0.0 111.674 -179.143 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.37 -159.06 0.98 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.047 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -125.06 -162.78 1.13 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.799 0.333 . . . . 0.0 111.539 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 58.11 -129.46 1.46 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.331 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.517 ' O ' ' HB3' ' A' ' 13' ' ' CYS . . . -62.12 -25.41 66.29 Favored Glycine 0 C--N 1.332 0.341 0 CA-C-N 115.892 -0.595 . . . . 0.0 114.429 -178.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 98.1 m -86.48 -0.45 56.08 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 117.711 0.755 . . . . 0.0 111.579 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' A' ' 47' ' ' CYS . . . -113.61 -61.15 1.78 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.679 0.276 . . . . 0.0 111.534 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 18.4 m -89.22 50.95 2.02 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -178.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.433 ' HB3' ' HB3' ' A' ' 13' ' ' CYS . 11.2 t -150.83 -56.28 0.16 Allowed 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.9 ' HB2' HD13 ' A' ' 17' ' ' ILE . 0.9 OUTLIER -87.99 -47.61 8.41 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.866 178.808 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 43' ' ' ALA . 95.5 m -81.98 47.82 1.16 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.102 -0.954 . . . . 0.0 112.144 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -84.79 -74.94 0.37 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 178.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -100.63 -21.46 15.25 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.356 178.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 55.2 m-70 -84.82 98.43 10.29 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 177.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.66 ' CB ' ' HG2' ' A' ' 56' ' ' LYS . 81.1 m -142.86 -10.28 0.79 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -177.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.637 ' O ' ' HB2' ' B' ' 91' ' ' PRO . 45.6 m80 -30.15 95.9 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 115.459 1.652 . . . . 0.0 115.459 -178.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 64.44 -6.71 0.74 Allowed Glycine 0 CA--C 1.526 0.753 0 N-CA-C 116.287 1.275 . . . . 0.0 116.287 176.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 1.029 HG11 ' HA ' ' A' ' 30' ' ' PRO . 0.1 OUTLIER -106.59 -72.62 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 118.359 1.08 . . . . 0.0 110.896 -179.806 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.724 ' SG ' HD12 ' A' ' 29' ' ' LEU . 57.5 m -71.23 -23.3 61.98 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.66 ' HG2' ' CB ' ' A' ' 51' ' ' CYS . 53.3 mmtt -72.19 -32.65 66.99 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.084 177.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -62.65 -39.2 93.12 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.654 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 38.9 mt -77.45 -16.03 59.0 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.397 178.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 12.4 t-160 58.78 65.19 1.27 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.112 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.1 mt -131.61 13.8 4.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.389 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 7.9 p . . . . . 0 C--O 1.245 0.851 0 CA-C-O 117.793 -1.099 . . . . 0.0 109.573 -179.823 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 74' ' ' CYS . . . . . 0.641 ' HB3' ' CD1' ' B' ' 78' ' ' ILE . 2.7 m . . . . . 0 C--O 1.233 0.222 0 CA-C-O 121.275 0.559 . . . . 0.0 109.893 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -78.98 64.47 3.92 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -177.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -163.04 -77.07 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.923 0.392 . . . . 0.0 111.127 178.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . 0.537 ' HB3' ' HA ' ' B' ' 97' ' ' LEU . . . -86.51 -2.52 58.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.211 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.649 HG12 ' HD2' ' B' ' 107' ' ' PHE . 44.8 mt -119.03 -68.09 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.637 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -84.57 52.46 2.38 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.563 0.697 . . . . 0.0 109.472 177.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -165.21 -38.68 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 110.306 -1.117 . . . . 0.0 110.306 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . 0.664 ' HB2' ' HB1' ' B' ' 96' ' ' ALA . . . -76.15 -11.44 59.93 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-O 121.253 0.549 . . . . 0.0 109.724 178.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 82' ' ' VAL . . . . . 0.91 HG22 ' HB ' ' B' ' 88' ' ' ILE . 15.3 t -65.43 -36.98 78.97 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.272 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -77.07 -8.77 58.04 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.593 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -103.88 -17.94 14.83 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.779 0.323 . . . . 0.0 111.251 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -109.42 -7.57 15.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.375 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 69.44 56.37 8.74 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.569 -0.824 . . . . 0.0 111.858 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 120.79 152.58 8.88 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.85 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 88' ' ' ILE . . . . . 0.91 ' HB ' HG22 ' B' ' 82' ' ' VAL . 4.3 tp -98.64 137.2 26.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.946 0.403 . . . . 0.0 112.042 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 89' ' ' ASP . . . . . 0.446 ' O ' ' HZ ' ' B' ' 107' ' ' PHE . 7.0 t70 -161.65 -96.3 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.591 -0.732 . . . . 0.0 109.324 178.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 90' ' ' LEU . . . . . 0.557 ' N ' ' HD2' ' B' ' 91' ' ' PRO . 52.6 tp -179.29 -54.42 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.586 0 CA-C-O 119.514 -0.279 . . . . 0.0 111.686 178.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 91' ' ' PRO . . . . . 0.637 ' HB2' ' O ' ' A' ' 52' ' ' HIS . 2.7 Cg_endo -41.44 -58.36 1.13 Allowed 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 123.522 2.815 . . . . 0.0 114.486 -178.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 8.8 p -86.91 -34.01 19.53 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.4 -0.52 . . . . 0.0 111.408 -179.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 2.8 t -58.86 -22.16 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.515 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 94' ' ' LEU . . . . . 0.887 HD21 ' HB ' ' B' ' 115' ' ' VAL . 15.1 tp -54.43 -34.54 61.58 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.527 179.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.82 -46.3 81.73 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . 0.664 ' HB1' ' HB2' ' B' ' 81' ' ' ALA . . . -102.83 10.81 38.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.558 0.218 . . . . 0.0 111.504 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 97' ' ' LEU . . . . . 0.537 ' HA ' ' HB3' ' B' ' 77' ' ' ALA . 23.0 tp -81.84 -9.54 59.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.1 0.476 . . . . 0.0 110.294 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.037 179.249 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 13.3 m . . . . . 0 CA--C 1.524 -0.035 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -74.1 -33.61 63.68 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.922 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 13.3 m -85.61 4.28 36.97 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -178.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 32.1 p -110.04 -37.45 5.59 Favored 'General case' 0 C--N 1.327 -0.383 0 O-C-N 121.494 -0.754 . . . . 0.0 110.498 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . 0.649 ' HD2' HG12 ' B' ' 78' ' ' ILE . 0.6 OUTLIER -88.65 -74.28 0.47 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.133 -179.54 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 108' ' ' CYS . . . . . 0.654 ' HB3' ' SG ' ' B' ' 122' ' ' CYS . 13.4 m -66.49 15.19 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 109' ' ' GLU . . . . . 0.55 ' H ' ' C ' ' B' ' 107' ' ' PHE . 19.4 tp10 -71.86 -69.6 0.38 Allowed 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.925 -179.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -59.93 -45.65 91.92 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.72 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -111.32 100.28 8.92 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.994 177.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 112' ' ' CYS . . . . . 0.483 ' O ' ' HD2' ' B' ' 117' ' ' LYS . 35.9 t -114.63 63.35 0.67 Allowed 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.394 -178.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 113' ' ' HIS . . . . . 0.42 ' HA ' ' HG3' ' B' ' 117' ' ' LYS . 13.6 p-80 -146.61 -172.35 3.95 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 114' ' ' GLY . . . . . 0.759 ' HA2' ' HB3' ' A' ' 31' ' ' CYS . . . 72.57 -144.29 35.33 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.747 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . 0.887 ' HB ' HD21 ' B' ' 94' ' ' LEU . 1.4 m -62.77 -22.28 29.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 116' ' ' CYS . . . . . 0.492 ' SG ' ' HB2' ' B' ' 121' ' ' LEU . 4.6 t -65.03 -31.86 73.3 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.304 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 117' ' ' LYS . . . . . 0.483 ' HD2' ' O ' ' B' ' 112' ' ' CYS . 8.8 mtpm? -89.31 -22.81 22.48 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.318 -0.401 . . . . 0.0 109.963 178.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -57.19 -42.86 82.03 Favored 'General case' 0 CA--C 1.522 -0.109 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 119' ' ' LEU . . . . . 0.534 ' O ' ' HB2' ' B' ' 120' ' ' HIS . 5.3 tt -89.54 -72.82 0.54 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 177.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 120' ' ' HIS . . . . . 0.534 ' HB2' ' O ' ' B' ' 119' ' ' LEU . 14.2 t-160 134.02 91.18 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 125.829 1.652 . . . . 0.0 109.733 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 121' ' ' LEU . . . . . 0.678 HD12 HD11 ' B' ' 94' ' ' LEU . 88.2 mt -117.14 -53.53 2.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.935 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 122' ' ' CYS . . . . . 0.654 ' SG ' ' HB3' ' B' ' 108' ' ' CYS . 1.8 p . . . . . 0 C--O 1.244 0.812 0 CA-C-O 118.607 -0.711 . . . . 0.0 109.398 178.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.437 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 0.5 OUTLIER . . . . . 0 N--CA 1.475 0.824 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -44.89 -81.7 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 115.588 1.699 . . . . 0.0 115.588 -177.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -49.75 -35.43 22.27 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -177.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.76 ' HB3' HD22 ' A' ' 36' ' ' LEU . . . -78.82 -28.6 44.48 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -178.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.701 HG12 ' CD1' ' A' ' 46' ' ' PHE . 7.2 tp -86.4 -43.04 16.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.27 0.557 . . . . 0.0 110.883 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.465 ' N ' HG21 ' A' ' 17' ' ' ILE . . . -61.5 -38.08 86.03 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.824 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.19 -17.7 79.64 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.052 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.442 ' HB3' HG11 ' A' ' 32' ' ' VAL . . . -82.79 -25.52 32.67 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.857 0.361 . . . . 0.0 111.0 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 93.7 t -62.04 -47.76 91.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.569 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.82 -41.21 97.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.665 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.78 -29.4 67.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.453 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.2 t -85.63 -7.21 58.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.266 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.06 24.12 72.54 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.52 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 146.2 176.93 20.46 Favored Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.586 HG12 ' N ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -79.53 151.14 4.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.564 0.697 . . . . 0.0 110.598 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.632 ' OD2' ' HA2' ' B' ' 114' ' ' GLY . 44.8 t0 -158.85 -122.94 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.294 -178.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.837 HD12 ' HE2' ' A' ' 46' ' ' PHE . 23.1 tp 174.0 -62.93 0.0 OUTLIER Pre-proline 0 C--O 1.214 -0.77 0 C-N-CA 124.836 1.254 . . . . 0.0 108.905 178.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.771 ' HA ' HG21 ' A' ' 54' ' ' VAL . 9.3 Cg_endo -54.91 -37.16 93.24 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 121.687 1.592 . . . . 0.0 112.155 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.463 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 0.1 OUTLIER -87.37 -43.34 12.19 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.656 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.48 HG21 ' HB3' ' A' ' 28' ' ' ASP . 10.6 t -70.11 -34.77 60.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -178.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.56 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 0.8 OUTLIER -60.52 -35.6 76.37 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.098 0.475 . . . . 0.0 110.273 179.792 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -54.61 -31.48 57.19 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.467 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -72.57 -24.91 61.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.814 0.34 . . . . 0.0 110.843 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.76 HD22 ' HB3' ' A' ' 16' ' ' ALA . 11.8 mt -92.25 9.5 33.55 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.794 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.495 ' O ' ' HB1' ' A' ' 38' ' ' ALA . 18.8 mmtp -68.58 -175.23 0.64 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.834 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.495 ' HB1' ' O ' ' A' ' 37' ' ' LYS . . . 76.61 -42.9 0.44 Allowed 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.676 0.79 . . . . 0.0 110.318 -178.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -131.22 63.93 1.59 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 178.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -63.37 -8.77 9.66 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -177.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -59.29 -32.64 72.63 Favored Glycine 0 CA--C 1.518 0.244 0 C-N-CA 121.01 -0.614 . . . . 0.0 113.632 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 64.5 m -107.54 24.91 12.15 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 122.385 -0.479 . . . . 0.0 111.321 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -88.99 -19.81 25.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.531 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.7 p -56.36 -33.43 65.68 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.331 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.437 ' HB3' ' HB3' ' A' ' 13' ' ' CYS . 7.6 t -47.7 -46.53 29.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.693 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.837 ' HE2' HD12 ' A' ' 29' ' ' LEU . 72.4 t80 -71.31 -50.82 28.65 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -179.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.679 ' HA ' ' HB2' ' A' ' 50' ' ' HIS . 0.1 OUTLIER -86.76 26.8 1.06 Allowed 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 -177.202 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -53.12 -53.68 46.84 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 119.428 1.013 . . . . 0.0 110.48 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -103.77 20.11 18.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.225 0.536 . . . . 0.0 109.789 178.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.679 ' HB2' ' HA ' ' A' ' 47' ' ' CYS . 90.9 m-70 -126.29 62.22 1.27 Allowed 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.278 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 64.6 m -92.49 49.4 1.48 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.632 0.729 . . . . 0.0 109.758 178.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.593 ' CE1' ' HB3' ' B' ' 92' ' ' CYS . 49.7 t-80 -132.33 94.19 3.39 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.551 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.538 ' HA3' ' HB2' ' B' ' 91' ' ' PRO . . . 130.89 -144.91 16.4 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 119.485 -1.341 . . . . 0.0 114.839 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.771 HG21 ' HA ' ' A' ' 30' ' ' PRO . 14.3 m -60.4 -25.97 35.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -177.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.532 ' SG ' ' HB2' ' A' ' 60' ' ' LEU . 34.9 t -76.83 -44.08 33.84 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.044 -0.662 . . . . 0.0 111.826 -178.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.48 -13.45 61.06 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.062 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -66.99 -40.84 87.47 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.988 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.411 ' HA ' HD21 ' A' ' 58' ' ' LEU . 96.6 mt -93.48 2.7 56.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.517 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 58.98 54.16 5.19 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.619 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.532 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 87.1 mt -94.48 -39.91 10.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.741 -179.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 26.3 p . . . . . 0 C--O 1.245 0.866 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.302 179.751 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 3.2 m . . . . . 0 N--CA 1.469 0.506 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.66 -45.88 88.4 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -177.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.81 -3.06 11.01 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -123.49 -20.11 5.67 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.594 HG21 ' N ' ' B' ' 79' ' ' ALA . 4.0 tp -112.0 -44.95 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.722 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 79' ' ' ALA . . . . . 0.594 ' N ' HG21 ' B' ' 78' ' ' ILE . . . -66.64 -32.83 74.4 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.186 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.02 -24.01 60.5 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.366 -0.921 . . . . 0.0 111.724 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.4 -19.69 57.87 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.586 0.231 . . . . 0.0 111.332 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 82' ' ' VAL . . . . . 0.521 HG13 ' HB ' ' B' ' 88' ' ' ILE . 80.9 t -65.1 -52.51 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.691 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.89 -34.46 77.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.736 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.64 -38.51 89.59 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.44 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 16.0 t -85.84 -26.21 25.82 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.344 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.76 46.04 7.45 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.02 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 152.94 132.71 1.79 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.986 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 88' ' ' ILE . . . . . 0.521 ' HB ' HG13 ' B' ' 82' ' ' VAL . 4.7 tp -93.19 135.89 26.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.312 0.577 . . . . 0.0 111.261 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 89' ' ' ASP . . . . . 0.402 ' HB3' ' CE1' ' A' ' 52' ' ' HIS . 47.2 t0 -163.85 -98.82 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 90' ' ' LEU . . . . . 0.912 HD11 ' HB2' ' B' ' 94' ' ' LEU . 59.8 tp -170.11 -58.93 0.0 OUTLIER Pre-proline 0 C--O 1.223 -0.332 0 CA-C-O 119.187 -0.435 . . . . 0.0 111.03 178.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 91' ' ' PRO . . . . . 0.538 ' HB2' ' HA3' ' A' ' 53' ' ' GLY . 2.0 Cg_endo -39.59 -58.79 0.77 Allowed 'Trans proline' 0 C--N 1.363 1.301 0 C-N-CA 123.623 2.882 . . . . 0.0 114.705 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 92' ' ' CYS . . . . . 0.593 ' HB3' ' CE1' ' A' ' 52' ' ' HIS . 8.6 t -84.2 -30.71 25.56 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -178.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 93' ' ' VAL . . . . . 0.54 HG11 HD11 ' B' ' 78' ' ' ILE . 2.6 t -71.69 -49.62 44.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -178.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 94' ' ' LEU . . . . . 0.912 ' HB2' HD11 ' B' ' 90' ' ' LEU . 2.1 tm? -63.43 -35.16 79.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.955 0.407 . . . . 0.0 110.91 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -53.83 -33.28 55.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.431 -179.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -82.61 -16.96 46.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.95 0.405 . . . . 0.0 111.37 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 97' ' ' LEU . . . . . 0.555 HD13 HD13 ' B' ' 78' ' ' ILE . 6.6 tt -81.69 -10.16 59.46 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.732 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 42.5 mtpt . . . . . 0 CA--C 1.535 0.379 0 CA-C-O 121.063 0.459 . . . . 0.0 111.924 -179.61 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 71.6 m . . . . . 0 C--O 1.224 -0.284 0 N-CA-C 111.537 0.199 . . . . 0.0 111.537 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.16 -13.62 13.07 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 13.0 m -64.94 -27.25 68.71 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.517 0.192 . . . . 0.0 111.517 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 106' ' ' CYS . . . . . 0.429 ' SG ' ' N ' ' B' ' 107' ' ' PHE . 16.6 p -48.9 -57.42 6.48 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.276 0.56 . . . . 0.0 111.415 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . 0.538 ' CD2' HG12 ' B' ' 78' ' ' ILE . 0.5 OUTLIER -80.27 -54.21 5.94 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.574 -179.693 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 76.1 m -82.27 42.84 0.76 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -178.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -77.11 -62.36 1.68 Allowed 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -90.92 7.35 40.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.876 178.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 40.4 m-70 -126.58 79.55 1.87 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.976 -1.011 . . . . 0.0 108.294 178.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 4.0 t -98.28 32.59 2.42 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -177.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 113' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -121.87 -160.38 0.86 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 178.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 114' ' ' GLY . . . . . 0.656 ' HA2' ' HG2' ' A' ' 30' ' ' PRO . . . 66.86 -145.13 46.25 Favored Glycine 0 C--O 1.226 -0.346 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.364 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . 0.646 HG21 ' HB3' ' B' ' 94' ' ' LEU . 8.2 m -78.56 -2.82 5.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 117.228 0.514 . . . . 0.0 110.518 178.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 116' ' ' CYS . . . . . 0.465 ' SG ' ' HG ' ' B' ' 94' ' ' LEU . 0.5 OUTLIER -82.56 -26.86 32.01 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.709 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 117' ' ' LYS . . . . . 0.544 ' HG2' ' O ' ' B' ' 114' ' ' GLY . 14.0 ptmm? -84.33 -6.67 59.42 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 177.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -65.17 -45.77 83.55 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 178.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 66.0 mt -87.13 -33.62 19.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.974 -1.012 . . . . 0.0 108.585 177.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 58.75 75.28 0.4 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 114.464 -1.243 . . . . 0.0 111.866 179.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.97 21.75 4.15 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.856 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 122' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.243 0.759 0 CA-C-O 118.426 -0.797 . . . . 0.0 110.753 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.489 ' O ' HG21 ' A' ' 17' ' ' ILE . 18.1 p . . . . . 0 N--CA 1.476 0.869 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.76 -34.77 72.18 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 118.213 0.46 . . . . 0.0 112.134 -179.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.83 -6.25 36.53 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.97 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -114.34 -35.18 5.05 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.5 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.817 HG12 ' CD2' ' A' ' 46' ' ' PHE . 5.3 tp -93.53 -50.81 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.114 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.619 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.441 ' N ' HG23 ' A' ' 17' ' ' ILE . . . -63.71 -31.64 72.88 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.119 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.53 -24.67 74.34 Favored Glycine 0 N--CA 1.451 -0.357 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 177.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.567 ' HB2' HG11 ' A' ' 32' ' ' VAL . . . -76.31 -26.58 55.98 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.114 0.483 . . . . 0.0 110.392 178.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.46 HG21 ' O ' ' A' ' 17' ' ' ILE . 57.9 t -63.46 -50.08 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.473 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.51 -31.64 71.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.93 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.7 -41.67 78.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.759 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.6 t -84.77 -22.97 29.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.861 0.363 . . . . 0.0 110.74 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 111.1 -38.38 3.31 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.683 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -137.19 167.25 24.75 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.236 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.8 tp -96.2 133.86 35.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.071 0.463 . . . . 0.0 111.061 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.502 ' OD2' ' HD2' ' A' ' 30' ' ' PRO . 9.2 t70 -163.82 -111.16 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.669 HD12 ' HB2' ' A' ' 55' ' ' CYS . 38.8 tp -168.16 -54.01 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 178.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.724 ' HB2' ' HA3' ' B' ' 114' ' ' GLY . 86.5 Cg_exo -46.7 -53.03 6.65 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 122.596 2.197 . . . . 0.0 113.887 -179.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.626 ' HB3' ' CE1' ' B' ' 113' ' ' HIS . 7.7 t -81.33 -33.11 32.71 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.555 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.567 HG11 ' HB2' ' A' ' 20' ' ' ALA . 2.8 t -65.14 -28.72 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-O 121.055 0.455 . . . . 0.0 110.895 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.433 ' O ' HD11 ' A' ' 33' ' ' LEU . 1.9 tm? -61.98 -39.0 90.67 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.641 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.33 -46.23 89.18 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.428 ' HB3' ' CB ' ' A' ' 20' ' ' ALA . . . -78.84 -13.61 59.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.785 0.326 . . . . 0.0 111.402 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 23.0 tp -73.76 -53.05 11.18 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -167.11 -21.99 0.02 OUTLIER 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.251 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 66.61 25.78 9.88 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.118 -179.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -166.57 -170.64 1.67 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.79 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.555 ' HA ' HD11 ' A' ' 60' ' ' LEU . 48.2 mt-10 -64.22 131.37 47.19 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 123.064 0.228 . . . . 0.0 111.249 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 145.7 140.59 3.53 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 119.945 -1.122 . . . . 0.0 113.371 179.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 90.2 m 61.64 31.85 18.61 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.609 ' CB ' ' HB3' ' A' ' 60' ' ' LEU . . . -80.59 -44.36 19.07 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.384 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.444 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 12.2 m -68.8 -16.11 63.69 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.903 0.383 . . . . 0.0 111.268 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 42.5 t -78.09 -54.91 5.73 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.944 0.402 . . . . 0.0 111.276 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.817 ' CD2' HG12 ' A' ' 17' ' ' ILE . 3.6 t80 -102.18 -49.75 3.82 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -178.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.415 ' SG ' ' HD1' ' A' ' 46' ' ' PHE . 21.2 m -72.96 13.56 0.38 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -177.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.444 ' HB2' ' O ' ' A' ' 44' ' ' SER . 16.5 tp10 -69.6 -53.66 17.72 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.142 0.496 . . . . 0.0 111.185 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -66.38 -23.95 66.41 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.079 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -135.23 103.78 5.65 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 96.0 m -112.65 81.07 1.42 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 177.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.625 ' CE1' ' HB3' ' B' ' 92' ' ' CYS . 2.6 t-80 -142.16 -34.52 0.46 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -177.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.774 ' HA2' ' HB2' ' B' ' 91' ' ' PRO . . . -87.16 -162.45 37.7 Favored Glycine 0 CA--C 1.518 0.266 0 N-CA-C 115.587 0.995 . . . . 0.0 115.587 -178.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.538 ' O ' HG21 ' A' ' 54' ' ' VAL . 7.7 p -58.44 -10.49 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 124.409 1.084 . . . . 0.0 112.575 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.669 ' HB2' HD12 ' A' ' 29' ' ' LEU . 18.0 t -77.99 -31.49 50.73 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 121.999 -0.438 . . . . 0.0 111.071 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.604 ' HG3' ' O ' ' A' ' 53' ' ' GLY . 0.1 OUTLIER -90.34 -2.35 57.98 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.466 179.819 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.415 ' O ' ' HB3' ' A' ' 58' ' ' LEU . 52.9 t0 -56.46 122.47 12.0 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.647 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.67 ' O ' ' HB2' ' A' ' 59' ' ' HIS . 45.2 tp 90.24 -64.94 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.029 1.332 . . . . 0.0 108.699 -177.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.67 ' HB2' ' O ' ' A' ' 58' ' ' LEU . 26.5 t-80 153.03 121.13 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.911 0 O-C-N 124.763 1.289 . . . . 0.0 109.303 178.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.609 ' HB3' ' CB ' ' A' ' 43' ' ' ALA . 22.1 mt -147.3 -55.85 0.24 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 19.1 p . . . . . 0 C--O 1.246 0.906 0 CA-C-O 118.435 -0.793 . . . . 0.0 110.747 -179.812 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 9.7 p . . . . . 0 N--CA 1.478 0.936 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 75' ' ' ALA . . . . . 0.542 ' O ' ' HB1' ' B' ' 79' ' ' ALA . . . -67.13 -26.32 66.62 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.82 -9.09 25.65 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -120.75 -34.28 3.61 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.615 HD11 HD13 ' B' ' 97' ' ' LEU . 7.8 tp -82.79 -48.5 17.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.118 0.485 . . . . 0.0 111.683 -179.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 79' ' ' ALA . . . . . 0.602 ' H ' HG22 ' B' ' 78' ' ' ILE . . . -57.81 -24.9 59.54 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.106 -179.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.18 -22.85 70.0 Favored Glycine 0 C--N 1.329 0.183 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.12 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -80.65 -17.81 50.04 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.092 0.472 . . . . 0.0 110.623 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 82' ' ' VAL . . . . . 0.433 HG11 ' HB ' ' B' ' 88' ' ' ILE . 60.4 t -66.78 -43.44 89.86 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.453 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.24 6.48 11.76 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.917 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -110.26 -19.68 12.92 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 3.0 t -120.03 12.23 11.9 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.515 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 71.06 33.82 65.08 Favored Glycine 0 CA--C 1.519 0.285 0 N-CA-C 114.693 0.637 . . . . 0.0 114.693 178.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 148.36 -177.05 26.87 Favored Glycine 0 CA--C 1.51 -0.269 0 C-N-CA 119.864 -1.16 . . . . 0.0 112.543 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 88' ' ' ILE . . . . . 0.433 ' HB ' HG11 ' B' ' 82' ' ' VAL . 4.4 tp -123.23 134.7 65.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.994 0.426 . . . . 0.0 111.043 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 89' ' ' ASP . . . . . 0.518 ' HB3' ' CE1' ' A' ' 52' ' ' HIS . 28.7 t70 -156.47 -102.38 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 90' ' ' LEU . . . . . 0.601 HD13 ' HE2' ' B' ' 107' ' ' PHE . 22.1 tp -167.09 -59.06 0.01 OUTLIER Pre-proline 0 N--CA 1.469 0.488 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 177.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 91' ' ' PRO . . . . . 0.774 ' HB2' ' HA2' ' A' ' 53' ' ' GLY . 2.1 Cg_endo -43.87 -56.2 2.58 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 123.049 2.499 . . . . 0.0 114.631 -178.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 92' ' ' CYS . . . . . 0.625 ' HB3' ' CE1' ' A' ' 52' ' ' HIS . 12.3 t -81.22 -32.85 33.25 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 93' ' ' VAL . . . . . 0.59 HG11 HD12 ' B' ' 78' ' ' ILE . 0.2 OUTLIER -68.02 -29.2 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-O 120.668 0.27 . . . . 0.0 111.217 -179.197 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -62.21 -39.15 91.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.222 0.534 . . . . 0.0 110.252 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.35 -43.53 85.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.206 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.6 19.51 4.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.68 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 97' ' ' LEU . . . . . 0.615 HD13 HD11 ' B' ' 78' ' ' ILE . 35.8 tp -77.04 -52.62 9.01 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.17 0.509 . . . . 0.0 109.708 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.181 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 87.7 m . . . . . 0 N--CA 1.468 0.429 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -90.1 -24.92 20.99 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 18.0 t -64.45 -47.2 79.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.72 0.295 . . . . 0.0 110.863 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 37.0 t -60.16 -50.24 74.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.917 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . 0.612 ' CD1' HG12 ' B' ' 78' ' ' ILE . 52.9 t80 -73.09 -58.55 3.23 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -178.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 21.7 m -79.03 34.14 0.23 Allowed 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -177.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 19.1 tp10 -63.31 -80.99 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 118.154 0.433 . . . . 0.0 110.373 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -76.32 -30.55 57.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.505 0.669 . . . . 0.0 109.294 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 111' ' ' HIS . . . . . 0.427 ' HD2' ' O ' ' B' ' 107' ' ' PHE . 5.6 m-70 -81.87 71.07 8.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.647 179.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 9.8 t -128.84 84.47 2.23 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.116 0.484 . . . . 0.0 110.057 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 113' ' ' HIS . . . . . 0.626 ' CE1' ' HB3' ' A' ' 31' ' ' CYS . 9.3 t-80 -126.08 -47.48 1.63 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.289 -178.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 114' ' ' GLY . . . . . 0.724 ' HA3' ' HB2' ' A' ' 30' ' ' PRO . . . -147.41 164.68 28.71 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 119.997 -1.097 . . . . 0.0 113.401 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . 0.616 HG11 ' HA ' ' B' ' 91' ' ' PRO . 0.5 OUTLIER 61.88 -45.0 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 125.581 1.552 . . . . 0.0 113.253 179.626 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 116' ' ' CYS . . . . . 0.541 ' N ' HG12 ' B' ' 115' ' ' VAL . 6.9 t -87.2 -30.23 21.14 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -90.74 4.47 51.47 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.375 178.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -63.01 -32.44 73.8 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.352 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 25.5 tp -112.78 -114.71 0.33 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -141.51 59.13 1.51 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 86.2 mt -99.24 -35.93 9.81 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 122' ' ' CYS . . . . . . . . . . . . . 3.4 p . . . . . 0 C--O 1.245 0.824 0 CA-C-O 118.345 -0.836 . . . . 0.0 110.286 179.339 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.689 ' HB3' HD11 ' A' ' 17' ' ' ILE . 76.4 m . . . . . 0 N--CA 1.471 0.605 0 N-CA-C 112.97 0.729 . . . . 0.0 112.97 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.7 16.99 0.17 Allowed 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.4 ' H ' ' C ' ' A' ' 13' ' ' CYS . . . -104.44 -31.46 9.48 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.733 0.302 . . . . 0.0 111.109 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -123.37 -48.84 1.94 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.476 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.689 HD11 ' HB3' ' A' ' 13' ' ' CYS . 69.3 mt -64.19 -45.92 94.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-O 121.42 0.629 . . . . 0.0 109.569 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -110.44 31.71 5.73 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.156 178.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -129.63 -43.23 0.21 Allowed Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.73 -0.747 . . . . 0.0 111.968 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.67 ' HB3' HG12 ' A' ' 32' ' ' VAL . . . -87.35 19.92 3.05 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.997 0.427 . . . . 0.0 111.343 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.561 HG22 ' HB ' ' A' ' 27' ' ' ILE . 12.5 p -65.92 -45.57 90.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.974 0.892 . . . . 0.0 110.286 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.442 ' N ' HG13 ' A' ' 21' ' ' VAL . . . -64.46 -26.42 68.44 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.555 -1.202 . . . . 0.0 111.629 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.8 -40.06 95.73 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.577 ' SG ' ' HA3' ' B' ' 114' ' ' GLY . 4.5 t -97.07 1.6 50.27 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.768 0.318 . . . . 0.0 110.801 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.42 42.43 82.02 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.519 -0.848 . . . . 0.0 111.426 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 144.35 156.03 6.66 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.561 ' HB ' HG22 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -87.19 133.92 28.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 117.595 0.697 . . . . 0.0 111.389 -179.035 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.619 ' OD1' ' HB3' ' A' ' 31' ' ' CYS . 1.2 p30 -143.55 -112.25 0.11 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.308 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.639 ' HB3' ' HD3' ' A' ' 30' ' ' PRO . 12.5 tp -179.28 -56.56 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.449 0 C-N-CA 122.358 0.263 . . . . 0.0 111.7 178.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.789 ' HA ' HG23 ' A' ' 54' ' ' VAL . 8.7 Cg_exo -76.05 -4.12 14.73 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 121.874 1.716 . . . . 0.0 113.177 -178.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.619 ' HB3' ' OD1' ' A' ' 28' ' ' ASP . 21.6 t -104.88 -38.95 6.45 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 177.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.67 HG12 ' HB3' ' A' ' 20' ' ' ALA . 42.3 t -78.64 -10.77 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.221 178.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.576 ' HG ' ' HB2' ' A' ' 37' ' ' LYS . 6.3 tp -54.21 -29.17 45.23 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.945 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -46.95 -45.82 21.04 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -178.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -102.88 33.23 3.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.982 0.42 . . . . 0.0 111.16 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.438 HD22 ' HD2' ' A' ' 46' ' ' PHE . 5.5 tp -137.14 -41.59 0.58 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.761 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.576 ' HB2' ' HG ' ' A' ' 33' ' ' LEU . 1.8 tmtp? -59.96 -35.11 74.25 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -177.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.23 -64.18 1.04 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -178.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -93.81 55.01 2.07 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -178.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.772 ' HG2' ' H ' ' A' ' 42' ' ' CYS . 85.0 tt0 70.83 137.63 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.337 0.589 . . . . 0.0 111.517 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.537 ' HA3' HD13 ' A' ' 60' ' ' LEU . . . -79.32 -11.23 85.19 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.715 -0.755 . . . . 0.0 113.186 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.772 ' H ' ' HG2' ' A' ' 40' ' ' GLU . 33.9 m 69.75 94.61 0.07 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 122.96 0.504 . . . . 0.0 111.193 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.476 ' C ' ' H ' ' A' ' 45' ' ' CYS . . . -65.96 153.43 42.11 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.902 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.6 p 66.76 -29.09 0.13 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.624 1.169 . . . . 0.0 112.365 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.476 ' H ' ' C ' ' A' ' 43' ' ' ALA . 6.0 t -78.15 -70.13 0.51 Allowed 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.559 ' HD1' ' CE1' ' A' ' 50' ' ' HIS . 0.1 OUTLIER -90.18 165.31 14.03 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 175.514 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.777 ' HB3' ' SG ' ' A' ' 61' ' ' CYS . 73.4 m 72.66 -0.68 3.24 Favored 'General case' 0 C--O 1.216 -0.68 0 O-C-N 123.364 0.415 . . . . 0.0 111.642 -178.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.553 ' HA ' ' OE1' ' A' ' 48' ' ' GLU . 5.1 tp10 -61.35 -93.32 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.274 0.559 . . . . 0.0 111.187 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.446 ' H ' ' HB3' ' A' ' 48' ' ' GLU . 17.8 t70 -70.35 -33.33 71.33 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 178.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.559 ' CE1' ' HD1' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -88.61 56.95 3.97 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 112.466 -2.152 . . . . 0.0 109.535 178.463 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 14.8 t -93.63 63.77 3.46 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 17.2 t-160 -163.49 136.25 5.35 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.06 -177.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 117.0 -157.7 14.91 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 119.864 -1.16 . . . . 0.0 113.78 178.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.789 HG23 ' HA ' ' A' ' 30' ' ' PRO . 3.5 m -70.73 -5.13 5.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.39 -0.405 . . . . 0.0 112.001 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.445 ' HB3' ' CD2' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -76.79 -40.94 46.46 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.119 0.485 . . . . 0.0 110.573 -178.98 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.409 ' HE2' ' HB3' ' A' ' 56' ' ' LYS . 31.6 mtpt -67.46 -10.75 54.45 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.818 179.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -65.59 -33.03 74.96 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.558 ' O ' HD22 ' A' ' 58' ' ' LEU . 2.4 tt -90.19 -21.16 22.31 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.937 178.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 75.06 97.87 0.07 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.377 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.634 ' HB2' ' SG ' ' A' ' 47' ' ' CYS . 26.3 mt -136.84 2.37 2.61 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.144 -179.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.777 ' SG ' ' HB3' ' A' ' 47' ' ' CYS . 29.2 p . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.107 -0.949 . . . . 0.0 109.707 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 74' ' ' CYS . . . . . 0.697 ' HB3' HD13 ' B' ' 78' ' ' ILE . 12.2 m . . . . . 0 N--CA 1.466 0.34 0 N-CA-C 112.854 0.686 . . . . 0.0 112.854 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 75' ' ' ALA . . . . . 0.557 ' HA ' ' CB ' ' B' ' 79' ' ' ALA . . . -82.6 6.62 17.11 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . 0.402 ' O ' ' HA3' ' B' ' 80' ' ' GLY . . . -99.17 -57.52 2.14 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.733 0.302 . . . . 0.0 111.789 -179.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.19 -38.66 12.57 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.697 HD13 ' HB3' ' B' ' 74' ' ' CYS . 71.9 mt -81.71 -55.5 7.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.979 0.419 . . . . 0.0 110.383 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 79' ' ' ALA . . . . . 0.557 ' CB ' ' HA ' ' B' ' 75' ' ' ALA . . . -83.39 14.47 3.61 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.276 0.56 . . . . 0.0 110.853 178.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 80' ' ' GLY . . . . . 0.402 ' HA3' ' O ' ' B' ' 76' ' ' ALA . . . -114.24 -41.22 0.9 Allowed Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 178.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . 0.508 ' HB1' HG12 ' B' ' 93' ' ' VAL . . . -73.51 -7.31 51.31 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-O 120.976 0.417 . . . . 0.0 110.358 178.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 82' ' ' VAL . . . . . 0.593 HG21 HG12 ' B' ' 88' ' ' ILE . 13.0 p -60.14 -42.16 89.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-O 121.619 0.723 . . . . 0.0 109.445 178.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . 0.476 ' N ' HG12 ' B' ' 82' ' ' VAL . . . -70.36 -27.29 64.22 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.429 -1.26 . . . . 0.0 111.467 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.69 -46.06 14.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.84 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 38.0 t -79.33 -48.33 14.27 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.903 0.382 . . . . 0.0 110.85 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 117.98 41.09 0.67 Allowed Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.908 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 140.1 176.19 14.89 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.525 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 88' ' ' ILE . . . . . 0.593 HG12 HG21 ' B' ' 82' ' ' VAL . 18.1 mm -104.65 118.85 52.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.158 0.504 . . . . 0.0 111.232 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 89' ' ' ASP . . . . . 0.467 ' CG ' ' H ' ' B' ' 90' ' ' LEU . 7.7 p-10 -138.24 -108.5 0.18 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.029 178.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 90' ' ' LEU . . . . . 0.777 HD11 ' SG ' ' B' ' 108' ' ' CYS . 0.1 OUTLIER -174.87 -53.76 0.0 OUTLIER Pre-proline 0 N--CA 1.451 -0.402 0 C-N-CA 122.367 0.267 . . . . 0.0 111.105 179.621 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 91' ' ' PRO . . . . . 0.896 ' HB3' HG13 ' B' ' 115' ' ' VAL . 27.1 Cg_exo -63.97 -29.9 66.76 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.212 1.941 . . . . 0.0 115.293 -176.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 14.3 p -92.07 -40.5 11.04 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 119.695 -0.802 . . . . 0.0 110.042 179.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 93' ' ' VAL . . . . . 0.508 HG12 ' HB1' ' B' ' 81' ' ' ALA . 2.5 t -65.83 -27.76 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.699 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 26.1 tp -55.43 -45.3 76.81 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.355 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.8 -45.66 91.63 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.245 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.25 -21.27 59.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.178 0.514 . . . . 0.0 110.787 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 10.2 tt -78.66 -29.02 45.48 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.086 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . 0.655 ' HE2' HD11 ' B' ' 119' ' ' LEU . 29.5 tttm . . . . . 0 C--O 1.235 0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 112.115 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 82.5 m . . . . . 0 N--CA 1.466 0.329 0 CA-C-O 121.7 0.762 . . . . 0.0 110.711 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -114.64 -160.28 0.73 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 177.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 105' ' ' SER . . . . . 0.513 ' O ' ' HB2' ' B' ' 109' ' ' GLU . 15.0 m 68.37 -56.15 0.51 Allowed 'General case' 0 N--CA 1.467 0.418 0 O-C-N 123.584 0.553 . . . . 0.0 112.317 178.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 29.9 p -80.04 -35.74 36.74 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 122.001 -0.437 . . . . 0.0 110.566 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . 0.586 ' CE1' HD22 ' B' ' 90' ' ' LEU . 0.7 OUTLIER -88.63 -97.78 0.09 Allowed 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.248 -178.536 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 108' ' ' CYS . . . . . 0.777 ' SG ' HD11 ' B' ' 90' ' ' LEU . 33.7 m -63.43 33.75 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 115.011 1.486 . . . . 0.0 115.011 -177.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 109' ' ' GLU . . . . . 0.513 ' HB2' ' O ' ' B' ' 105' ' ' SER . 44.3 tp10 -59.92 -70.44 0.17 Allowed 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 119.301 0.955 . . . . 0.0 110.709 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -92.53 -20.31 21.07 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.082 0.468 . . . . 0.0 110.137 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 111' ' ' HIS . . . . . 0.482 ' HB2' HD21 ' B' ' 90' ' ' LEU . 0.5 OUTLIER -86.88 86.63 7.33 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.034 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 112' ' ' CYS . . . . . 0.415 ' O ' ' HE2' ' B' ' 117' ' ' LYS . 1.6 t -121.05 43.03 2.9 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.942 0.401 . . . . 0.0 110.416 -178.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 113' ' ' HIS . . . . . 0.462 ' O ' HG22 ' B' ' 115' ' ' VAL . 3.8 t-160 -88.37 121.03 30.31 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.556 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 114' ' ' GLY . . . . . 0.577 ' HA3' ' SG ' ' A' ' 24' ' ' CYS . . . 45.45 -99.86 0.02 OUTLIER Glycine 0 C--O 1.223 -0.566 0 N-CA-C 115.681 1.032 . . . . 0.0 115.681 177.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . 0.896 HG13 ' HB3' ' B' ' 91' ' ' PRO . 12.5 m -29.57 -60.54 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 -177.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 116' ' ' CYS . . . . . 0.544 ' O ' HD21 ' B' ' 121' ' ' LEU . 0.9 OUTLIER -73.34 -30.5 63.38 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.102 -0.639 . . . . 0.0 112.019 -177.755 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 117' ' ' LYS . . . . . 0.415 ' HE2' ' O ' ' B' ' 112' ' ' CYS . 11.9 ttmm -76.08 -11.05 59.87 Favored 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 122.024 -0.422 . . . . 0.0 110.09 178.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -67.83 -43.29 79.89 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 178.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 119' ' ' LEU . . . . . 0.655 HD11 ' HE2' ' B' ' 98' ' ' LYS . 5.1 tt -78.28 -36.47 46.68 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 177.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 14.1 t-80 78.82 75.58 0.05 Allowed 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 114.693 -1.14 . . . . 0.0 111.656 178.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 121' ' ' LEU . . . . . 0.572 ' CD2' ' HB3' ' B' ' 119' ' ' LEU . 0.4 OUTLIER -128.16 13.39 6.68 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.378 179.47 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 122' ' ' CYS . . . . . . . . . . . . . 3.6 p . . . . . 0 C--O 1.246 0.869 0 CA-C-O 118.293 -0.861 . . . . 0.0 110.478 179.212 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.418 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 95.7 m . . . . . 0 N--CA 1.475 0.803 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.665 ' HA ' ' HB2' ' A' ' 18' ' ' ALA . . . -99.31 14.86 28.13 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.41 -68.97 0.79 Allowed 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -87.65 -3.15 58.98 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -178.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.552 HD12 ' HB2' ' A' ' 46' ' ' PHE . 45.3 mt -112.64 -62.86 2.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.548 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.665 ' HB2' ' HA ' ' A' ' 14' ' ' ALA . . . -59.27 -34.72 72.6 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.86 -37.84 18.03 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.689 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.46 ' HB2' HG13 ' A' ' 32' ' ' VAL . . . -75.04 -28.21 60.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.021 0.439 . . . . 0.0 111.677 -179.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.507 HG12 ' HA ' ' A' ' 27' ' ' ILE . 1.9 t -66.36 -43.17 91.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.617 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.64 -25.66 64.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.149 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.75 -24.39 63.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.651 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 12.4 t -89.17 -31.93 17.71 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.755 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 128.55 17.23 1.95 Allowed Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.093 -1.051 . . . . 0.0 113.88 178.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 116.14 114.65 2.86 Favored Glycine 0 C--O 1.227 -0.309 0 C-N-CA 120.24 -0.981 . . . . 0.0 112.29 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.507 ' HA ' HG12 ' A' ' 21' ' ' VAL . 1.4 tt 19.13 94.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.594 ' CG ' ' HB3' ' A' ' 31' ' ' CYS . 6.8 t0 -127.73 143.34 51.15 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 114.18 -1.373 . . . . 0.0 107.616 177.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.774 ' HB3' ' HD3' ' A' ' 30' ' ' PRO . 36.7 tp -106.88 -58.49 0.05 OUTLIER Pre-proline 0 C--N 1.303 -1.429 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.232 -179.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.864 ' HA ' HG11 ' A' ' 54' ' ' VAL . 25.9 Cg_exo -62.59 -28.22 77.0 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 121.93 1.753 . . . . 0.0 112.594 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.594 ' HB3' ' CG ' ' A' ' 28' ' ' ASP . 0.1 OUTLIER -84.46 -41.31 16.73 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.764 -179.147 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.46 HG13 ' HB2' ' A' ' 20' ' ' ALA . 45.1 t -84.91 -6.22 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-O 121.174 0.511 . . . . 0.0 111.021 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.625 HD23 ' HA ' ' A' ' 55' ' ' CYS . 2.4 tm? -54.37 -45.46 72.79 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.326 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.77 -36.86 80.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.529 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.08 2.02 52.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.805 0.336 . . . . 0.0 111.493 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 57.4 tp -97.3 -32.32 11.95 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.322 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -75.93 -26.5 56.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.19 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -106.9 -179.71 4.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.628 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 57.49 31.91 20.99 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 123.568 0.542 . . . . 0.0 112.286 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 53.69 67.91 0.93 Allowed 'General case' 0 CA--C 1.534 0.348 0 O-C-N 123.611 0.569 . . . . 0.0 110.509 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -79.5 -166.07 31.67 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.73 -0.668 . . . . 0.0 113.493 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 47.0 t -160.31 88.83 0.82 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.618 ' CB ' ' HB3' ' A' ' 60' ' ' LEU . . . -68.44 -42.03 79.46 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -178.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.4 p -75.56 28.4 0.1 Allowed 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.363 0.602 . . . . 0.0 112.438 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.48 ' H ' ' C ' ' A' ' 43' ' ' ALA . 20.1 t -139.6 -18.21 0.97 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.552 ' HB2' HD12 ' A' ' 17' ' ' ILE . 0.8 OUTLIER -111.0 -63.17 1.43 Allowed 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.785 -179.311 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.548 ' SG ' HD13 ' A' ' 29' ' ' LEU . 19.8 m -79.12 25.34 0.29 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.473 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.435 ' H ' ' C ' ' A' ' 46' ' ' PHE . 41.5 tp10 -52.94 -62.31 1.74 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.642 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -92.74 -31.8 14.93 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -79.47 76.05 6.07 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.423 ' SG ' ' HB3' ' A' ' 56' ' ' LYS . 4.0 t -128.31 52.45 1.9 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -177.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 15.9 p-80 -122.46 82.64 2.0 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.637 0.732 . . . . 0.0 110.712 178.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.75 172.77 44.21 Favored Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.479 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.864 HG11 ' HA ' ' A' ' 30' ' ' PRO . 44.9 t 63.61 -73.32 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 123.297 0.639 . . . . 0.0 112.59 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.625 ' HA ' HD23 ' A' ' 33' ' ' LEU . 38.9 t -71.72 -44.38 64.23 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.407 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.423 ' HB3' ' SG ' ' A' ' 51' ' ' CYS . 0.1 OUTLIER -88.05 13.31 11.4 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 119.899 -0.72 . . . . 0.0 110.603 179.17 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -69.14 -35.35 76.26 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 177.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -95.58 -4.13 45.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 113.972 -1.467 . . . . 0.0 108.521 177.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 75.1 m-70 65.91 75.25 0.35 Allowed 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 114.414 -1.266 . . . . 0.0 110.912 -178.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.618 ' HB3' ' CB ' ' A' ' 43' ' ' ALA . 88.6 mt -106.06 -31.29 8.79 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.36 -179.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.7 p . . . . . 0 C--O 1.245 0.845 0 CA-C-O 118.304 -0.855 . . . . 0.0 110.179 179.059 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 74' ' ' CYS . . . . . 0.448 ' O ' ' HB ' ' B' ' 78' ' ' ILE . 30.3 m . . . . . 0 N--CA 1.475 0.788 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -90.64 -31.23 16.72 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -178.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -71.15 -75.16 0.13 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -178.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.01 29.67 0.13 Allowed 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -177.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.448 ' HB ' ' O ' ' B' ' 74' ' ' CYS . 23.2 mt -142.2 -58.3 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 O-C-N 122.246 -0.284 . . . . 0.0 110.408 178.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.79 -35.58 77.21 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.927 0.394 . . . . 0.0 110.65 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -75.34 -23.82 72.61 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.363 178.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.78 -28.32 63.54 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.783 0.325 . . . . 0.0 110.747 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 82' ' ' VAL . . . . . 0.447 HG23 ' O ' ' B' ' 78' ' ' ILE . 52.8 t -70.72 -28.11 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.031 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.44 -32.81 72.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.089 0.471 . . . . 0.0 109.883 178.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -87.12 1.3 53.43 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.754 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 64.3 m -148.49 64.97 1.07 Allowed 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -28.72 -48.09 0.08 OUTLIER Glycine 0 N--CA 1.469 0.899 0 O-C-N 124.881 1.363 . . . . 0.0 114.414 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . -96.36 86.41 0.91 Allowed Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 177.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 88' ' ' ILE . . . . . 0.465 HD11 HG21 ' B' ' 88' ' ' ILE . 0.0 OUTLIER -62.08 135.77 26.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.637 0.732 . . . . 0.0 112.406 -177.551 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 89' ' ' ASP . . . . . 0.472 ' O ' ' HB2' ' B' ' 90' ' ' LEU . 10.3 t70 -146.92 -71.47 0.23 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.146 178.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 90' ' ' LEU . . . . . 0.659 ' N ' ' HD2' ' B' ' 91' ' ' PRO . 29.1 tp 172.37 -49.54 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.434 0 O-C-N 123.995 0.81 . . . . 0.0 109.844 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 91' ' ' PRO . . . . . 0.659 ' HD2' ' N ' ' B' ' 90' ' ' LEU . 5.4 Cg_exo -31.9 -70.11 0.05 OUTLIER 'Trans proline' 0 C--N 1.367 1.505 0 C-N-CA 124.842 3.695 . . . . 0.0 115.341 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 26.8 p -83.81 -31.84 25.64 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -177.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 1.1 t -62.02 -22.49 28.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.943 0.401 . . . . 0.0 111.002 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 94' ' ' LEU . . . . . 0.638 ' HG ' HG13 ' B' ' 115' ' ' VAL . 2.8 tm? -67.97 -37.12 81.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.663 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.53 -47.32 79.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.978 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -83.48 -2.52 56.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.684 0.278 . . . . 0.0 111.717 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 27.1 tp -86.84 -21.66 26.28 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.27 0.557 . . . . 0.0 110.055 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.442 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 103' ' ' CYS . . . . . 0.651 ' SG ' ' HB2' ' B' ' 106' ' ' CYS . 35.3 t . . . . . 0 C--O 1.234 0.279 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 104' ' ' ALA . . . . . 0.56 ' CB ' ' HB3' ' B' ' 121' ' ' LEU . . . -67.0 -40.14 87.26 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -178.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 8.0 t -75.94 29.94 0.11 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.168 0.508 . . . . 0.0 111.488 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 106' ' ' CYS . . . . . 0.651 ' HB2' ' SG ' ' B' ' 103' ' ' CYS . 44.6 t -118.73 -50.17 2.42 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.756 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . 0.467 ' C ' ' H ' ' B' ' 109' ' ' GLU . 0.1 OUTLIER -102.41 -46.0 4.92 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.35 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -70.26 30.13 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.487 -0.778 . . . . 0.0 112.727 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 109' ' ' GLU . . . . . 0.467 ' H ' ' C ' ' B' ' 107' ' ' PHE . 23.5 tt0 -69.06 -64.2 0.91 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.49 0.186 . . . . 0.0 110.581 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -76.15 -31.68 58.71 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 59.2 m-70 -74.16 85.67 1.87 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.97 -1.014 . . . . 0.0 108.826 178.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 112' ' ' CYS . . . . . 0.449 ' SG ' ' HG3' ' B' ' 117' ' ' LYS . 4.5 t -151.0 71.58 1.03 Allowed 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.264 -0.574 . . . . 0.0 112.097 -177.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 113' ' ' HIS . . . . . . . . . . . . . 49.4 p-80 -128.64 -17.4 4.09 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 179.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -155.25 -73.18 0.01 OUTLIER Glycine 0 C--O 1.226 -0.396 0 C-N-CA 119.06 -1.543 . . . . 0.0 114.713 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . 0.731 HG22 ' HG2' ' A' ' 30' ' ' PRO . 2.8 t -58.42 -55.6 21.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -177.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 116' ' ' CYS . . . . . 0.568 ' SG ' HD21 ' B' ' 94' ' ' LEU . 1.0 OUTLIER -73.07 -19.86 61.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.831 0.348 . . . . 0.0 111.675 -179.607 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 117' ' ' LYS . . . . . 0.449 ' HG3' ' SG ' ' B' ' 112' ' ' CYS . 15.5 mttm -82.72 -24.44 33.58 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.877 178.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -63.43 -45.42 91.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.93 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -90.24 7.66 37.08 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.23 -0.441 . . . . 0.0 112.053 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 53.3 62.52 2.62 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.022 0.439 . . . . 0.0 110.683 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 121' ' ' LEU . . . . . 0.56 ' HB3' ' CB ' ' B' ' 104' ' ' ALA . 96.3 mt -110.13 -12.55 14.49 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -178.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 122' ' ' CYS . . . . . 0.418 ' SG ' ' HB3' ' B' ' 116' ' ' CYS . 1.8 p . . . . . 0 C--O 1.245 0.848 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.402 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 6.1 p . . . . . 0 CA--C 1.515 -0.387 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.562 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -64.21 -38.87 92.62 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.12 -12.69 60.01 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -101.79 -38.57 7.8 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.618 HG12 ' CD2' ' A' ' 46' ' ' PHE . 10.9 tp -73.28 -35.06 45.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.42 0.628 . . . . 0.0 111.017 -179.244 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 14' ' ' ALA . . . -58.34 -22.39 53.1 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.973 -1.012 . . . . 0.0 112.806 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -77.79 -29.38 54.93 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.349 -179.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.14 -17.37 52.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.65 0.262 . . . . 0.0 111.143 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.497 HG13 ' HB ' ' A' ' 27' ' ' ILE . 59.1 t -63.07 -46.34 96.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 CA-C-O 120.898 0.38 . . . . 0.0 110.733 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.7 -23.75 64.41 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.165 -0.471 . . . . 0.0 112.201 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -85.71 -23.91 27.19 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.551 0.691 . . . . 0.0 110.947 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.554 ' SG ' ' CD2' ' B' ' 113' ' ' HIS . 0.7 OUTLIER -86.17 -28.1 24.14 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.151 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.21 39.62 9.08 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.131 -1.033 . . . . 0.0 110.684 -179.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 143.63 178.16 19.17 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 -178.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.619 HD11 HG22 ' A' ' 32' ' ' VAL . 3.0 tp -129.47 121.81 54.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 117.871 0.836 . . . . 0.0 112.117 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.562 ' HB3' ' HD2' ' A' ' 30' ' ' PRO . 2.1 m-20 -140.45 -75.83 0.33 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.051 178.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.673 ' HG ' ' CG2' ' A' ' 54' ' ' VAL . 26.6 tp 172.26 -49.63 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.411 0 O-C-N 124.136 0.898 . . . . 0.0 111.354 179.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.734 ' HA ' HG12 ' A' ' 54' ' ' VAL . 5.4 Cg_endo -48.23 -63.66 0.3 Allowed 'Trans proline' 0 C--N 1.359 1.11 0 C-N-CA 123.093 2.529 . . . . 0.0 114.31 -179.206 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.428 ' HB3' ' O ' ' B' ' 113' ' ' HIS . 4.4 p -66.93 -37.87 85.12 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.41 -178.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.619 HG22 HD11 ' A' ' 27' ' ' ILE . 0.2 OUTLIER -70.57 -18.29 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.722 -178.486 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.566 HD23 HD11 ' A' ' 58' ' ' LEU . 58.9 tp -64.88 -21.7 66.86 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.722 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.34 -31.86 35.45 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -178.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -121.43 43.56 2.79 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.838 0.352 . . . . 0.0 110.744 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.548 HD22 ' SG ' ' A' ' 47' ' ' CYS . 14.3 tp -133.91 -6.2 2.77 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -178.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.451 ' O ' ' HB1' ' A' ' 38' ' ' ALA . 77.9 tttt -85.49 74.42 10.33 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 122.032 -0.418 . . . . 0.0 111.989 -179.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.451 ' HB1' ' O ' ' A' ' 37' ' ' LYS . . . 171.79 169.82 0.1 Allowed 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.124 0.569 . . . . 0.0 110.523 179.061 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.96 -39.32 87.21 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.418 ' HG2' ' H ' ' A' ' 40' ' ' GLU . 3.2 pt-20 -78.03 88.59 4.17 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 176.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 13' ' ' CYS . . . 137.94 -39.53 1.59 Allowed Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 108.05 -2.02 . . . . 0.0 108.05 -176.125 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 1.1 m 55.07 93.38 0.02 OUTLIER 'General case' 0 C--O 1.235 0.325 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 176.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.499 ' HA ' ' HG ' ' A' ' 36' ' ' LEU . . . -70.59 -24.99 62.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.476 176.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.8 p -76.15 12.9 1.01 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.925 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 37.8 t -113.14 -56.35 2.42 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.618 ' CD2' HG12 ' A' ' 17' ' ' ILE . 1.1 t80 -77.03 -54.65 6.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.755 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.572 ' O ' ' HB2' ' A' ' 51' ' ' CYS . 53.9 m -68.49 6.23 0.86 Allowed 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -178.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -66.98 -71.02 0.22 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.279 0.561 . . . . 0.0 110.685 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.06 -17.56 58.67 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.372 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.426 ' HD2' ' O ' ' A' ' 46' ' ' PHE . 39.8 m-70 -113.08 83.26 1.8 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.481 -0.782 . . . . 0.0 109.943 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.572 ' HB2' ' O ' ' A' ' 47' ' ' CYS . 22.2 t -140.03 86.94 2.12 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.158 -0.617 . . . . 0.0 112.526 -178.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.686 ' O ' ' HB3' ' B' ' 92' ' ' CYS . 0.0 OUTLIER -144.11 -3.02 0.87 Allowed 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.022 0.439 . . . . 0.0 110.444 177.742 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.843 ' HA3' ' HB2' ' B' ' 91' ' ' PRO . . . -157.42 163.97 32.76 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-O 118.914 -0.936 . . . . 0.0 111.695 178.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.734 HG12 ' HA ' ' A' ' 30' ' ' PRO . 6.0 m 46.55 -64.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 115.377 1.621 . . . . 0.0 115.377 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.462 ' N ' ' O ' ' A' ' 53' ' ' GLY . 0.6 OUTLIER -63.04 -34.13 76.91 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 122.111 -0.368 . . . . 0.0 111.16 -178.676 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.0 pttp -70.58 -28.53 64.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.009 0.433 . . . . 0.0 110.321 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -65.83 -39.34 90.73 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.395 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.566 HD11 HD23 ' A' ' 33' ' ' LEU . 91.3 mt -87.24 4.21 43.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.74 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 58.5 m170 59.5 57.65 3.22 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 123.425 0.453 . . . . 0.0 111.809 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 80.4 mt -112.55 -2.68 14.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.02 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.436 ' SG ' ' HB3' ' A' ' 47' ' ' CYS . 6.3 p . . . . . 0 C--O 1.247 0.946 0 CA-C-O 117.907 -1.044 . . . . 0.0 109.513 179.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 74' ' ' CYS . . . . . 0.497 ' HB3' ' HB3' ' B' ' 106' ' ' CYS . 4.6 p . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.937 0.399 . . . . 0.0 110.774 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -68.4 -5.67 20.32 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.539 -179.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.77 -27.39 63.89 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.359 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -128.79 -29.99 2.31 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.697 HG12 ' CD2' ' B' ' 107' ' ' PHE . 6.4 tp -73.68 -36.22 46.23 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 C-N-CA 120.634 -0.426 . . . . 0.0 111.309 -178.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 79' ' ' ALA . . . . . 0.65 ' N ' HG21 ' B' ' 78' ' ' ILE . . . -59.05 -34.02 71.45 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.869 -178.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -76.69 -33.83 45.78 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.381 -0.914 . . . . 0.0 111.297 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . 0.414 ' O ' ' HB2' ' B' ' 85' ' ' CYS . . . -66.65 -24.81 66.34 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.687 0.28 . . . . 0.0 111.478 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 91.6 t -58.23 -38.5 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-O 121.156 0.503 . . . . 0.0 110.663 179.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.79 -33.25 12.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.373 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.78 -19.15 64.3 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -179.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 85' ' ' CYS . . . . . 0.414 ' HB2' ' O ' ' B' ' 81' ' ' ALA . 0.8 OUTLIER -98.94 -1.01 41.03 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 121.21 -0.196 . . . . 0.0 111.506 -179.858 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 59.68 37.03 91.73 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.298 -179.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 143.35 137.81 3.33 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 110.106 -1.197 . . . . 0.0 110.106 -178.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 3.4 tp -103.25 118.54 50.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 121.493 0.663 . . . . 0.0 112.639 -178.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -133.52 -83.54 0.46 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.261 -0.882 . . . . 0.0 108.876 178.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 90' ' ' LEU . . . . . 0.612 ' N ' ' HD2' ' B' ' 91' ' ' PRO . 38.0 tp 176.85 -51.79 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.94 179.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 91' ' ' PRO . . . . . 0.843 ' HB2' ' HA3' ' A' ' 53' ' ' GLY . 4.0 Cg_exo -38.93 -60.99 0.43 Allowed 'Trans proline' 0 C--N 1.363 1.334 0 C-N-CA 123.66 2.907 . . . . 0.0 114.587 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 92' ' ' CYS . . . . . 0.686 ' HB3' ' O ' ' A' ' 52' ' ' HIS . 24.5 p -83.15 -33.02 26.34 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -178.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 93' ' ' VAL . . . . . 0.431 HG12 HD11 ' B' ' 78' ' ' ILE . 1.8 t -59.24 -21.44 20.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.881 -178.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 94' ' ' LEU . . . . . 0.876 HD22 ' HB ' ' B' ' 115' ' ' VAL . 15.9 tp -63.17 -35.19 79.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.654 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.35 -28.91 70.09 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -103.58 10.0 37.17 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.93 0.395 . . . . 0.0 111.375 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 97' ' ' LEU . . . . . 0.527 HD21 ' HA ' ' B' ' 104' ' ' ALA . 40.9 tp -93.81 -28.89 15.63 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.571 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 81.4 tttt . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.472 179.693 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.68 0 N-CA-C 110.892 -0.04 . . . . 0.0 110.892 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 104' ' ' ALA . . . . . 0.672 ' HB2' ' HB3' ' B' ' 121' ' ' LEU . . . 70.51 -59.69 0.52 Allowed 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 178.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 12.8 p -50.07 -43.84 51.49 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -178.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 106' ' ' CYS . . . . . 0.497 ' HB3' ' HB3' ' B' ' 74' ' ' CYS . 0.0 OUTLIER -52.35 -45.71 65.81 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.108 0.48 . . . . 0.0 111.711 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . 0.697 ' CD2' HG12 ' B' ' 78' ' ' ILE . 20.3 t80 -75.57 -60.88 2.11 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.339 -179.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 108' ' ' CYS . . . . . 0.647 ' HA ' ' HB2' ' B' ' 111' ' ' HIS . 38.1 m -78.84 43.54 0.5 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -178.103 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -74.99 -52.39 11.24 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -102.84 12.84 35.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.894 0.854 . . . . 0.0 108.737 178.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 111' ' ' HIS . . . . . 0.647 ' HB2' ' HA ' ' B' ' 108' ' ' CYS . 89.4 m-70 -119.68 58.45 0.89 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.684 -179.057 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 72.0 m -110.61 61.73 0.61 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.02 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 113' ' ' HIS . . . . . 0.554 ' CD2' ' SG ' ' A' ' 24' ' ' CYS . 0.2 OUTLIER -138.24 -15.68 1.27 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.219 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 114' ' ' GLY . . . . . 0.419 ' O ' ' HG3' ' B' ' 117' ' ' LYS . . . -120.17 -145.08 7.34 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 119.8 -1.19 . . . . 0.0 113.86 -179.124 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . 0.876 ' HB ' HD22 ' B' ' 94' ' ' LEU . 20.2 m -46.16 -28.76 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -179.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 116' ' ' CYS . . . . . 0.614 ' HA ' HD13 ' B' ' 94' ' ' LEU . 2.8 t -71.23 -39.3 71.78 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -177.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 117' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' B' ' 114' ' ' GLY . 0.0 OUTLIER -77.28 -14.72 59.7 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.214 -179.949 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 118' ' ' ASP . . . . . 0.413 ' N ' ' HD3' ' B' ' 117' ' ' LYS . 12.3 t70 -70.0 -37.61 75.75 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.653 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 89.0 mt -94.89 6.95 47.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.417 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 56.5 m170 60.36 69.02 0.72 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.341 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 121' ' ' LEU . . . . . 0.672 ' HB3' ' HB2' ' B' ' 104' ' ' ALA . 98.3 mt -112.7 3.19 16.42 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 122' ' ' CYS . . . . . . . . . . . . . 25.3 p . . . . . 0 C--O 1.246 0.906 0 CA-C-O 118.028 -0.986 . . . . 0.0 109.874 178.078 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.79 ' HB3' HD12 ' A' ' 17' ' ' ILE . 24.0 m . . . . . 0 N--CA 1.467 0.401 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.67 -66.92 0.49 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.65 38.32 0.19 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -147.46 -52.02 0.2 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.102 0.477 . . . . 0.0 110.497 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.79 HD12 ' HB3' ' A' ' 13' ' ' CYS . 5.3 mt -83.81 -46.8 18.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.343 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.22 -20.09 60.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.137 0.494 . . . . 0.0 109.838 177.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -82.01 -34.94 22.81 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 111.291 -0.724 . . . . 0.0 111.291 178.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.574 ' HB3' HG11 ' A' ' 32' ' ' VAL . . . -63.91 -26.71 68.72 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 121.085 0.469 . . . . 0.0 110.881 179.161 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.493 HG21 ' HB ' ' A' ' 27' ' ' ILE . 57.0 t -63.76 -45.24 97.8 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.299 179.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.42 -18.99 62.31 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.461 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.14 -47.07 15.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.775 0.322 . . . . 0.0 111.844 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.7 t -88.33 -15.31 36.03 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.93 -179.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 108.51 -63.15 0.28 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.216 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -122.53 155.36 17.0 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.334 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.493 ' HB ' HG21 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -86.38 141.89 13.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.06 0.457 . . . . 0.0 111.15 -179.482 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.438 ' OD2' ' HD2' ' A' ' 30' ' ' PRO . 26.6 t70 -163.97 -98.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 178.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.558 HD12 ' SG ' ' A' ' 55' ' ' CYS . 32.8 tp -174.07 -55.32 0.0 OUTLIER Pre-proline 0 C--O 1.222 -0.363 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 178.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 29' ' ' LEU . 3.4 Cg_endo -47.74 -61.71 0.56 Allowed 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 122.786 2.324 . . . . 0.0 114.262 -178.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 13.0 p -76.6 -33.11 58.43 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.459 -178.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.574 HG11 ' HB3' ' A' ' 20' ' ' ALA . 13.0 t -63.09 -26.22 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.727 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.766 ' HG ' HG23 ' A' ' 54' ' ' VAL . 3.1 tm? -55.56 -38.59 69.52 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.767 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -57.45 -41.92 81.46 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.284 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -98.35 12.28 35.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.263 0.554 . . . . 0.0 110.743 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 46.5 tp -99.34 -61.91 1.31 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.654 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.16 167.24 10.33 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.372 0.606 . . . . 0.0 111.539 -179.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.504 ' HB2' ' H ' ' A' ' 39' ' ' ALA . . . -172.56 -112.05 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.504 ' H ' ' HB2' ' A' ' 38' ' ' ALA . . . -92.26 73.08 5.37 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 176.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 39' ' ' ALA . 93.0 mt-10 71.22 92.16 0.09 Allowed 'General case' 0 N--CA 1.464 0.272 0 O-C-N 124.084 0.865 . . . . 0.0 109.707 -177.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -115.43 -173.73 17.67 Favored Glycine 0 C--N 1.33 0.209 0 C-N-CA 120.556 -0.831 . . . . 0.0 113.063 -179.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.419 ' HB3' ' SG ' ' A' ' 13' ' ' CYS . 57.3 m -82.56 62.41 6.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.751 0.31 . . . . 0.0 111.714 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -96.56 -7.59 34.1 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.809 0.338 . . . . 0.0 110.829 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.4 m -81.54 -16.27 52.24 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.886 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.412 ' SG ' ' HB3' ' A' ' 42' ' ' CYS . 6.3 p -98.48 -33.47 11.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.296 0.569 . . . . 0.0 111.131 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.783 ' HB2' HD13 ' A' ' 17' ' ' ILE . 0.9 OUTLIER -86.13 -60.99 1.85 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.665 -178.511 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 4.5 m -72.61 14.08 0.3 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.637 -177.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -51.84 -74.98 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 121.179 0.514 . . . . 0.0 110.457 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -84.86 -27.01 27.01 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 53.7 m-70 -86.71 56.58 4.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.019 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.404 ' O ' ' HB2' ' A' ' 56' ' ' LYS . 7.6 t -108.37 39.62 1.94 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.243 0.544 . . . . 0.0 110.126 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.6 ' CD2' ' HB2' ' B' ' 89' ' ' ASP . 7.8 p-80 -117.82 -12.91 10.14 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.55 -179.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.508 ' O ' ' HB3' ' A' ' 56' ' ' LYS . . . -95.32 -136.14 8.46 Favored Glycine 0 C--O 1.228 -0.226 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.812 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.766 HG23 ' HG ' ' A' ' 33' ' ' LEU . 2.2 p -70.19 -16.11 19.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 120.747 0.308 . . . . 0.0 111.561 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.558 ' SG ' HD12 ' A' ' 29' ' ' LEU . 89.2 m -72.21 -21.17 61.45 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.603 0.716 . . . . 0.0 109.112 176.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.508 ' HB3' ' O ' ' A' ' 53' ' ' GLY . 22.7 tptm -79.6 -20.38 47.04 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.474 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -59.44 -50.25 74.65 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.291 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.52 HD21 ' O ' ' A' ' 58' ' ' LEU . 5.7 tt -83.26 -29.37 28.47 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 9.6 t-160 64.26 55.86 1.4 Allowed 'General case' 0 C--O 1.235 0.301 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.04 179.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.52 20.4 16.13 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.473 179.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.244 0.805 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.541 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 74' ' ' CYS . . . . . 0.722 ' O ' ' HB ' ' B' ' 78' ' ' ILE . 8.5 p . . . . . 0 N--CA 1.475 0.818 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -88.87 -3.14 58.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.741 0.305 . . . . 0.0 110.86 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -98.74 22.76 9.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.214 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -163.58 -38.17 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.378 0.608 . . . . 0.0 110.285 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.722 ' HB ' ' O ' ' B' ' 74' ' ' CYS . 1.4 mt -83.66 -46.69 18.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.741 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.8 -29.27 68.41 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.883 0.373 . . . . 0.0 110.682 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.4 -35.71 28.79 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.045 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.61 -26.57 64.5 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.181 0.515 . . . . 0.0 110.626 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 25.5 t -65.82 -43.14 93.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.567 178.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.38 -27.4 67.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.063 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.05 -44.57 46.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.651 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 73.0 m -83.43 -11.83 57.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.762 0.315 . . . . 0.0 110.725 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.3 42.6 10.34 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.605 -0.807 . . . . 0.0 113.171 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.05 176.71 14.51 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.56 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 88' ' ' ILE . . . . . 0.433 HD11 ' CZ ' ' B' ' 107' ' ' PHE . 7.4 tp -74.87 132.93 32.54 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 CA-C-O 121.388 0.613 . . . . 0.0 110.191 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 89' ' ' ASP . . . . . 0.6 ' HB2' ' CD2' ' A' ' 52' ' ' HIS . 32.5 t70 -152.9 -133.85 0.05 OUTLIER 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.479 -178.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 90' ' ' LEU . . . . . 0.717 ' HB3' ' HD3' ' B' ' 91' ' ' PRO . 31.9 tp 179.61 -57.4 0.0 OUTLIER Pre-proline 0 C--N 1.317 -0.826 0 C-N-CA 123.804 0.841 . . . . 0.0 110.129 179.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 91' ' ' PRO . . . . . 0.717 ' HD3' ' HB3' ' B' ' 90' ' ' LEU . 74.2 Cg_exo -51.77 -38.63 67.49 Favored 'Trans proline' 0 C--N 1.363 1.321 0 C-N-CA 122.347 2.031 . . . . 0.0 112.225 179.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 9.4 t -88.83 -40.43 13.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.676 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 93' ' ' VAL . . . . . 0.674 HG13 ' HE2' ' B' ' 107' ' ' PHE . 7.3 t -66.6 -23.4 31.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.779 -179.204 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 94' ' ' LEU . . . . . 0.799 HD11 ' HG2' ' B' ' 98' ' ' LYS . 2.7 tm? -50.35 -38.76 43.81 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 123.19 0.596 . . . . 0.0 111.929 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -42.67 -51.32 5.3 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -179.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -108.79 21.66 16.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.021 0.438 . . . . 0.0 111.07 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 97' ' ' LEU . . . . . 0.686 ' HG ' ' HB1' ' B' ' 104' ' ' ALA . 32.4 tp -105.25 -49.31 3.49 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.476 -179.073 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . 0.799 ' HG2' HD11 ' B' ' 94' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.275 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -178.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 103' ' ' CYS . . . . . 0.433 ' HA ' ' HB3' ' B' ' 74' ' ' CYS . 58.5 m . . . . . 0 N--CA 1.451 -0.415 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 104' ' ' ALA . . . . . 0.686 ' HB1' ' HG ' ' B' ' 97' ' ' LEU . . . -66.65 -16.24 64.06 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.445 179.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 19.8 m -72.95 -39.45 66.17 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.623 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 13.4 p -63.6 -24.77 67.93 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 122.077 0.941 . . . . 0.0 109.679 179.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . 0.674 ' HE2' HG13 ' B' ' 93' ' ' VAL . 0.8 OUTLIER -88.81 -69.94 0.68 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.099 -1.41 . . . . 0.0 111.959 -178.87 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 82.5 m -74.27 28.42 0.08 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -177.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -53.69 -69.73 0.11 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.17 0.51 . . . . 0.0 110.266 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -89.93 -35.16 15.74 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -79.51 70.71 6.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.763 179.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 13.0 t -127.46 54.68 1.65 Allowed 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.924 -178.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 113' ' ' HIS . . . . . 0.419 ' HE1' ' CB ' ' A' ' 28' ' ' ASP . 0.1 OUTLIER -129.95 -12.38 4.2 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -179.843 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -94.69 -142.95 13.15 Favored Glycine 0 C--O 1.228 -0.272 0 C-N-CA 120.442 -0.885 . . . . 0.0 113.333 -179.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . 0.627 HG21 ' HG ' ' B' ' 94' ' ' LEU . 14.6 p -62.86 -15.46 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-O 121.142 0.496 . . . . 0.0 111.605 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 116' ' ' CYS . . . . . 0.591 ' HB2' HD12 ' B' ' 90' ' ' LEU . 6.8 t -76.19 -22.83 54.84 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.408 0.623 . . . . 0.0 109.76 178.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 117' ' ' LYS . . . . . 0.471 ' O ' ' HG3' ' B' ' 117' ' ' LYS . 13.5 tptt -79.16 -19.33 51.25 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.134 179.33 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -57.01 -41.55 78.69 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.2 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 119' ' ' LEU . . . . . 0.417 HD13 ' HB2' ' B' ' 98' ' ' LYS . 5.7 tt -86.19 -29.58 23.09 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 65.51 75.03 0.36 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.721 179.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 121' ' ' LEU . . . . . 0.408 HD12 ' HB2' ' B' ' 104' ' ' ALA . 0.4 OUTLIER -124.33 7.59 8.42 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.586 -0.733 . . . . 0.0 111.522 -179.701 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 122' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.244 0.803 0 CA-C-O 118.545 -0.741 . . . . 0.0 110.461 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.489 ' HB2' HD13 ' A' ' 17' ' ' ILE . 8.4 p . . . . . 0 N--CA 1.47 0.537 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -112.09 16.45 20.19 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 120.934 0.397 . . . . 0.0 110.547 178.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -91.46 -82.61 0.3 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.028 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.99 -27.72 60.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.945 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.489 HD13 ' HB2' ' A' ' 13' ' ' CYS . 49.2 mt -74.08 -46.84 44.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.69 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.401 ' HB2' ' O ' ' A' ' 14' ' ' ALA . . . -82.18 -15.89 51.64 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.197 179.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -82.79 -33.64 23.92 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.115 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.28 -13.5 60.78 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.831 0.348 . . . . 0.0 110.914 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 78.7 t -64.34 -39.46 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.043 179.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.92 -31.18 67.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.112 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.13 -43.76 66.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.688 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.413 ' HB3' ' CG ' ' B' ' 113' ' ' HIS . 56.6 m -82.42 -19.34 39.21 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.099 -179.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.14 59.1 3.01 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 -179.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 122.0 156.63 9.75 Favored Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -177.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.516 HD12 HG23 ' A' ' 27' ' ' ILE . 5.0 tt -98.87 147.08 7.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 118.125 0.963 . . . . 0.0 112.484 -178.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.49 ' N ' HG12 ' A' ' 27' ' ' ILE . 34.4 t0 -161.42 -106.13 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.48 -1.236 . . . . 0.0 107.967 179.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.731 HD11 ' HB2' ' A' ' 55' ' ' CYS . 40.2 tp -174.5 -47.94 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 178.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 29' ' ' LEU . 11.1 Cg_endo -54.52 -15.3 8.6 Favored 'Trans proline' 0 C--N 1.358 1.031 0 C-N-CA 122.959 2.44 . . . . 0.0 114.593 -178.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.548 ' HB2' ' O ' ' B' ' 113' ' ' HIS . 11.0 t -117.89 -31.72 5.01 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.275 0.56 . . . . 0.0 110.744 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.7 t -73.26 -9.17 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-N 115.74 -0.663 . . . . 0.0 112.375 -178.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -71.87 -14.82 62.06 Favored 'General case' 0 CA--C 1.531 0.25 0 O-C-N 122.221 -0.299 . . . . 0.0 111.64 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -56.72 -55.09 38.62 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.876 0.37 . . . . 0.0 111.844 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -89.26 16.72 6.91 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.651 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.0 tp -112.69 -0.25 15.12 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.708 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.6 ttpt -98.55 154.52 17.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.256 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 71.89 63.12 0.14 Allowed 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.587 0.755 . . . . 0.0 111.607 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -163.39 163.05 25.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.639 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -84.31 70.52 10.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.025 0.44 . . . . 0.0 110.025 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.418 ' C ' ' H ' ' A' ' 43' ' ' ALA . . . 89.34 -111.18 3.8 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.493 -0.861 . . . . 0.0 111.887 -179.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 81.1 m 73.09 -34.93 0.31 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.237 0.615 . . . . 0.0 112.318 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.418 ' H ' ' C ' ' A' ' 41' ' ' GLY . . . -79.49 17.16 0.9 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.4 m -66.82 -59.12 3.81 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.768 0.318 . . . . 0.0 110.763 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -66.91 -24.98 66.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.662 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.441 ' CD2' HG12 ' A' ' 17' ' ' ILE . 1.0 OUTLIER -81.4 -72.75 0.41 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.523 -178.948 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.441 ' HB3' ' O ' ' A' ' 50' ' ' HIS . 23.7 m -78.44 39.88 0.34 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.4 -178.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -73.05 -54.23 9.07 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.979 0.895 . . . . 0.0 109.161 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -87.84 -9.31 54.19 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.364 -1.289 . . . . 0.0 109.682 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.441 ' O ' ' HB3' ' A' ' 47' ' ' CYS . 45.4 m-70 -109.98 90.97 3.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.314 -178.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 72.9 m -136.4 55.28 1.85 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.642 ' HB2' ' OD2' ' B' ' 89' ' ' ASP . 40.8 m80 -115.68 -54.73 2.49 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.356 178.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 55' ' ' CYS . . . -134.63 -171.62 12.56 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-O 119.171 -0.794 . . . . 0.0 112.059 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.768 HG11 ' HB3' ' B' ' 91' ' ' PRO . 14.2 m 43.75 -62.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 N-CA-C 115.97 1.841 . . . . 0.0 115.97 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.731 ' HB2' HD11 ' A' ' 29' ' ' LEU . 15.7 t -70.16 -44.56 68.56 Favored 'General case' 0 C--N 1.322 -0.601 0 O-C-N 121.641 -0.662 . . . . 0.0 111.457 -179.032 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.412 ' HE3' ' HB2' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -81.13 12.68 3.26 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.958 179.403 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -76.94 -27.57 54.89 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 175.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 32.3 mt -98.51 -16.49 19.15 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 113.596 -1.638 . . . . 0.0 108.981 177.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 64.89 82.45 0.19 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.91 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.411 ' HA ' HD22 ' A' ' 60' ' ' LEU . 87.2 mt -125.15 -7.42 7.11 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -178.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 26.3 p . . . . . 0 C--O 1.245 0.836 0 CA-C-O 118.41 -0.805 . . . . 0.0 110.591 178.67 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 74' ' ' CYS . . . . . 0.541 ' HB2' HD13 ' B' ' 78' ' ' ILE . 18.1 p . . . . . 0 N--CA 1.47 0.55 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.97 4.3 23.13 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 120.997 0.427 . . . . 0.0 110.897 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.8 -76.33 0.09 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.426 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . 0.431 ' HB1' ' O ' ' B' ' 96' ' ' ALA . . . -93.85 -10.06 35.22 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -178.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.75 HD12 ' HB2' ' B' ' 107' ' ' PHE . 40.8 mt -89.17 -47.38 15.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.661 -179.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.83 -18.27 38.18 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.923 0.392 . . . . 0.0 111.229 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.8 -25.69 62.05 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.336 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . 0.557 ' HB3' ' HB2' ' B' ' 96' ' ' ALA . . . -82.93 -9.99 59.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.972 0.415 . . . . 0.0 111.027 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 69.2 t -68.31 -37.16 77.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.998 179.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -79.79 10.17 4.41 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.444 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -109.73 -48.2 3.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.968 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 63.1 m -88.94 -9.57 51.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.329 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.78 44.39 6.09 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.686 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 132.6 173.81 13.42 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.056 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 88' ' ' ILE . . . . . 0.501 HG12 ' N ' ' B' ' 89' ' ' ASP . 0.0 OUTLIER -77.05 136.86 23.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.049 0.452 . . . . 0.0 110.936 179.714 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 89' ' ' ASP . . . . . 0.642 ' OD2' ' HB2' ' A' ' 52' ' ' HIS . 40.5 t0 -153.87 -122.96 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.525 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 90' ' ' LEU . . . . . 0.715 ' HB3' ' HD3' ' B' ' 91' ' ' PRO . 41.5 tp 173.02 -57.81 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 124.318 1.047 . . . . 0.0 109.6 179.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 91' ' ' PRO . . . . . 0.768 ' HB3' HG11 ' A' ' 54' ' ' VAL . 51.8 Cg_exo -54.19 -25.52 38.34 Favored 'Trans proline' 0 C--N 1.363 1.323 0 C-N-CA 122.684 2.256 . . . . 0.0 112.992 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 29.9 t -107.94 -34.61 6.86 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.18 0.514 . . . . 0.0 110.329 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 93' ' ' VAL . . . . . 0.635 HG23 ' HB3' ' B' ' 89' ' ' ASP . 38.6 t -70.42 -16.62 20.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.821 -179.043 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 94' ' ' LEU . . . . . 0.751 HD13 ' HB ' ' B' ' 115' ' ' VAL . 1.2 pt? -61.45 -18.02 57.03 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 122.25 -0.281 . . . . 0.0 111.743 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.53 -34.2 73.78 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . 0.557 ' HB2' ' HB3' ' B' ' 81' ' ' ALA . . . -100.64 -3.49 30.27 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.862 0.363 . . . . 0.0 110.643 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 23.6 tp -92.99 3.07 56.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.379 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt . . . . . 0 C--O 1.235 0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.405 179.574 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 79.0 m . . . . . 0 N--CA 1.466 0.347 0 CA-C-O 120.732 0.301 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -102.68 20.38 17.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.409 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -69.36 -31.77 70.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.83 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 4.2 p -101.97 -29.37 11.84 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.255 0.55 . . . . 0.0 110.29 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . 0.75 ' HB2' HD12 ' B' ' 78' ' ' ILE . 1.0 OUTLIER -81.99 -90.86 0.07 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.985 -178.228 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 36.2 m -70.44 40.99 0.05 Allowed 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 -178.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 109' ' ' GLU . . . . . 0.413 ' H ' ' C ' ' B' ' 107' ' ' PHE . 4.9 tp10 -77.23 -53.51 7.65 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.48 0.657 . . . . 0.0 109.455 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -97.96 1.08 47.55 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.744 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 22.4 m-70 -112.33 88.89 2.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.47 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 71.0 m -135.78 46.79 2.31 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 114.665 1.358 . . . . 0.0 114.665 -177.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 113' ' ' HIS . . . . . 0.548 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 2.9 p80 -135.24 -0.46 2.72 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 118.994 -1.082 . . . . 0.0 111.982 177.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 114' ' ' GLY . . . . . 0.443 ' HA3' ' HB2' ' A' ' 30' ' ' PRO . . . -154.64 145.9 13.47 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 119.914 -1.136 . . . . 0.0 112.664 179.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . 0.751 ' HB ' HD13 ' B' ' 94' ' ' LEU . 27.6 m 50.28 -48.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 C-N-CA 126.648 1.979 . . . . 0.0 115.936 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 116' ' ' CYS . . . . . 0.627 ' HB2' HD13 ' B' ' 90' ' ' LEU . 3.9 t -73.84 -25.65 60.18 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 121.543 -0.723 . . . . 0.0 110.094 -179.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 19.3 ttmt -77.58 -22.89 50.25 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.422 178.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -64.2 -40.16 95.5 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 43.1 mt -81.84 -22.6 36.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.14 178.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 64.91 79.89 0.24 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.226 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 121' ' ' LEU . . . . . 0.408 ' HA ' HD23 ' B' ' 121' ' ' LEU . 86.5 mt -123.82 -6.59 7.94 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -178.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 122' ' ' CYS . . . . . . . . . . . . . 26.1 p . . . . . 0 C--O 1.245 0.818 0 CA-C-O 118.473 -0.775 . . . . 0.0 110.59 179.111 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.817 ' HB2' HD11 ' A' ' 17' ' ' ILE . 11.7 p . . . . . 0 N--CA 1.467 0.394 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.84 -26.85 62.6 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -177.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -109.4 29.03 7.93 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.387 -0.525 . . . . 0.0 112.019 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -151.03 -53.12 0.14 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.222 0.534 . . . . 0.0 110.93 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.817 HD11 ' HB2' ' A' ' 13' ' ' CYS . 73.6 mt -74.69 -42.64 47.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.329 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.79 -30.99 72.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.458 178.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.9 -30.83 37.37 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.649 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.28 -24.18 63.0 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 121.031 0.443 . . . . 0.0 110.381 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.402 HG21 ' O ' ' A' ' 17' ' ' ILE . 49.7 t -65.26 -46.55 90.34 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.669 178.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.69 -18.12 62.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.16 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -81.17 -51.04 8.86 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.165 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 49.1 t -76.01 -33.79 59.69 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.913 0.387 . . . . 0.0 110.132 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.18 36.29 2.54 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.47 -0.872 . . . . 0.0 112.532 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 147.73 152.57 5.71 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.127 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -81.9 132.58 31.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.288 0.566 . . . . 0.0 109.767 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -158.85 -115.45 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.41 -178.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.499 HD11 ' HB2' ' A' ' 55' ' ' CYS . 35.0 tp -174.95 -57.47 0.0 OUTLIER Pre-proline 0 C--O 1.22 -0.48 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.16 178.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 1.029 ' HA ' HG12 ' A' ' 54' ' ' VAL . 1.0 OUTLIER -45.42 -52.71 6.3 Favored 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 122.959 2.439 . . . . 0.0 114.117 -178.971 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 19.7 p -84.08 -35.7 23.56 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.087 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.514 HG11 ' CE2' ' A' ' 46' ' ' PHE . 3.5 t -63.45 -29.78 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.161 -179.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.715 HD23 HG13 ' A' ' 54' ' ' VAL . 29.9 tp -63.53 -32.28 73.69 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.086 0.469 . . . . 0.0 110.515 179.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.83 -37.55 79.24 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.07 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.53 -9.25 58.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.115 0.484 . . . . 0.0 110.601 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 23.8 tp -76.09 -6.93 53.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.453 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -86.01 5.37 33.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.102 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.66 -4.77 47.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.967 0.413 . . . . 0.0 110.354 178.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -147.17 175.46 10.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.703 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -87.14 120.05 28.01 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.53 0.205 . . . . 0.0 110.866 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.71 -105.79 1.27 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.988 179.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.413 ' O ' HD12 ' A' ' 17' ' ' ILE . 0.6 OUTLIER 64.04 15.72 9.44 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.082 0.553 . . . . 0.0 111.175 -179.352 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -97.05 -6.81 34.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.048 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 40.7 t -66.12 -9.44 31.4 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.22 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.547 ' HB3' ' HB3' ' A' ' 13' ' ' CYS . 33.6 t -118.95 -31.8 4.66 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.309 0.575 . . . . 0.0 110.151 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.603 ' HB2' HD13 ' A' ' 17' ' ' ILE . 0.6 OUTLIER -73.88 -78.55 0.09 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.327 -0.851 . . . . 0.0 113.228 -178.496 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.522 ' HA ' ' HB2' ' A' ' 50' ' ' HIS . 84.9 m -72.99 27.29 0.06 Allowed 'General case' 0 C--O 1.219 -0.505 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -176.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -67.61 -61.82 1.71 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 118.953 0.797 . . . . 0.0 109.762 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -91.14 -7.46 51.49 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.522 ' HB2' ' HA ' ' A' ' 47' ' ' CYS . 62.2 m-70 -107.73 62.24 0.62 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.497 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.505 ' O ' ' HB3' ' A' ' 56' ' ' LYS . 62.6 m -95.95 33.56 1.68 Allowed 'General case' 0 C--N 1.327 -0.393 0 O-C-N 122.031 -0.418 . . . . 0.0 110.908 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.676 ' ND1' ' HB3' ' B' ' 92' ' ' CYS . 27.6 p80 -129.82 157.71 41.47 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.732 0.301 . . . . 0.0 110.782 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.86 ' HA3' ' HB2' ' B' ' 91' ' ' PRO . . . 92.43 -132.99 11.52 Favored Glycine 0 C--O 1.227 -0.34 0 C-N-CA 120.494 -0.86 . . . . 0.0 113.267 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 1.029 HG12 ' HA ' ' A' ' 30' ' ' PRO . 8.9 p -78.01 -21.74 13.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 122.562 -0.375 . . . . 0.0 111.881 -178.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.499 ' HB2' HD11 ' A' ' 29' ' ' LEU . 7.5 t -77.03 -28.86 55.04 Favored 'General case' 0 C--O 1.224 -0.285 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.747 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.532 ' HG3' ' O ' ' A' ' 53' ' ' GLY . 0.0 OUTLIER -73.96 -31.19 62.91 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.0 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -69.61 -56.33 7.58 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.7 65.6 3.09 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 106.579 -1.638 . . . . 0.0 106.579 176.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 20.3 t60 -35.42 124.44 0.64 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 114.238 -1.347 . . . . 0.0 113.968 -176.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 13.7 mt -146.37 21.84 1.34 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.793 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 8.9 p . . . . . 0 C--O 1.245 0.825 0 CA-C-O 118.124 -0.941 . . . . 0.0 110.756 178.425 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 74' ' ' CYS . . . . . 0.409 ' O ' ' HB ' ' B' ' 78' ' ' ILE . 21.9 m . . . . . 0 N--CA 1.468 0.473 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -73.23 -59.98 2.45 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -80.46 48.03 0.99 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.945 0.402 . . . . 0.0 111.509 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -162.18 -53.74 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.877 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.698 HD13 ' HB2' ' B' ' 107' ' ' PHE . 51.7 mt -92.94 -49.15 13.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.395 -179.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 79' ' ' ALA . . . . . 0.732 ' HA ' HG23 ' B' ' 82' ' ' VAL . . . -64.48 -19.36 65.53 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.669 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -75.66 -24.32 70.39 Favored Glycine 0 N--CA 1.452 -0.28 0 N-CA-C 111.53 -0.628 . . . . 0.0 111.53 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . 0.435 ' HB3' ' HA ' ' B' ' 93' ' ' VAL . . . -80.94 -30.22 35.28 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.021 0.439 . . . . 0.0 110.469 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 82' ' ' VAL . . . . . 0.732 HG23 ' HA ' ' B' ' 79' ' ' ALA . 32.0 t -56.76 -40.86 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.904 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.54 -34.62 78.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.543 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.61 -28.23 56.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.997 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 15.7 m -94.15 -14.9 25.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.745 -178.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.67 31.43 60.54 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.246 -178.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 152.46 151.7 5.74 Favored Glycine 0 N--CA 1.449 -0.47 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 88' ' ' ILE . . . . . 0.646 ' HB ' HG13 ' B' ' 82' ' ' VAL . 0.0 OUTLIER -103.76 129.76 55.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.726 0.774 . . . . 0.0 111.786 -178.983 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 89' ' ' ASP . . . . . 0.412 ' HB2' ' CE1' ' A' ' 52' ' ' HIS . 28.4 m-20 -144.8 -82.73 0.15 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.462 -1.245 . . . . 0.0 108.526 178.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 90' ' ' LEU . . . . . 0.759 HD13 ' HB2' ' B' ' 116' ' ' CYS . 51.9 tp 179.44 -54.38 0.0 OUTLIER Pre-proline 0 C--O 1.227 -0.13 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.292 178.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 91' ' ' PRO . . . . . 0.86 ' HB2' ' HA3' ' A' ' 53' ' ' GLY . 4.9 Cg_exo -38.53 -65.94 0.15 Allowed 'Trans proline' 0 C--N 1.361 1.225 0 C-N-CA 123.487 2.792 . . . . 0.0 114.31 -179.014 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 92' ' ' CYS . . . . . 0.676 ' HB3' ' ND1' ' A' ' 52' ' ' HIS . 1.5 t -82.04 -31.42 30.93 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -179.066 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 93' ' ' VAL . . . . . 0.545 ' HB ' ' HZ ' ' B' ' 107' ' ' PHE . 1.5 t -64.81 -16.31 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-O 120.804 0.335 . . . . 0.0 111.761 -179.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 94' ' ' LEU . . . . . 0.439 HD11 HD21 ' B' ' 97' ' ' LEU . 22.7 tp -73.5 -19.12 61.01 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.859 0.361 . . . . 0.0 111.008 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.07 -53.21 60.84 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.114 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.96 -14.15 60.24 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 111.617 0.228 . . . . 0.0 111.617 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 97' ' ' LEU . . . . . 0.439 HD21 HD11 ' B' ' 94' ' ' LEU . 17.6 tp -72.69 -28.74 62.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.979 0.419 . . . . 0.0 110.051 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp . . . . . 0 C--N 1.332 -0.195 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.216 178.881 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 36.3 m . . . . . 0 N--CA 1.465 0.286 0 CA-C-O 121.407 0.623 . . . . 0.0 110.502 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 104' ' ' ALA . . . . . 0.75 ' HB1' ' HB2' ' B' ' 108' ' ' CYS . . . -95.63 -6.55 39.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.451 -179.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 26.6 p -63.26 -20.3 65.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.998 0.428 . . . . 0.0 111.797 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 24.7 p -106.8 -29.2 9.67 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.294 0.569 . . . . 0.0 111.101 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . 0.698 ' HB2' HD13 ' B' ' 78' ' ' ILE . 1.0 OUTLIER -100.88 -79.72 0.5 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -177.518 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 108' ' ' CYS . . . . . 0.75 ' HB2' ' HB1' ' B' ' 104' ' ' ALA . 1.8 m -67.45 24.19 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -177.117 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -81.36 -68.31 0.7 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 118.583 0.629 . . . . 0.0 109.715 178.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -73.36 -15.02 61.39 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 177.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 61.3 m-70 -110.07 65.88 0.62 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.421 -1.263 . . . . 0.0 107.973 178.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 36.6 t -106.45 49.46 0.8 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.95 0.405 . . . . 0.0 111.757 -177.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 113' ' ' HIS . . . . . 0.486 ' HA ' ' HG2' ' B' ' 117' ' ' LYS . 18.1 p-80 -156.55 -165.74 1.96 Allowed 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . 64.64 -137.73 39.69 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.977 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . 0.529 HG11 ' HA ' ' B' ' 91' ' ' PRO . 11.3 p -79.66 -16.71 13.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.814 0.34 . . . . 0.0 111.076 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 116' ' ' CYS . . . . . 0.759 ' HB2' HD13 ' B' ' 90' ' ' LEU . 2.1 t -57.92 -59.75 4.77 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 120.808 0.337 . . . . 0.0 110.716 178.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 117' ' ' LYS . . . . . 0.486 ' HG2' ' HA ' ' B' ' 113' ' ' HIS . 45.3 pttt -101.4 31.94 3.52 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.742 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 118' ' ' ASP . . . . . 0.457 ' HB2' ' HA ' ' B' ' 115' ' ' VAL . 10.3 t70 -54.44 -39.16 67.11 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 178.146 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 119' ' ' LEU . . . . . 0.592 ' O ' ' HB2' ' B' ' 120' ' ' HIS . 3.3 mm? -103.32 -52.66 2.97 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 174.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 120' ' ' HIS . . . . . 0.592 ' HB2' ' O ' ' B' ' 119' ' ' LEU . 42.3 t60 153.6 129.26 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.862 0 O-C-N 124.951 1.407 . . . . 0.0 110.422 176.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 121' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' B' ' 120' ' ' HIS . 14.4 mt -160.33 41.26 0.18 Allowed 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 122' ' ' CYS . . . . . 0.433 ' HB3' ' O ' ' B' ' 108' ' ' CYS . 1.4 p . . . . . 0 C--O 1.246 0.9 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.711 178.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 13.0 p . . . . . 0 CA--C 1.528 0.101 0 CA-C-O 120.836 0.35 . . . . 0.0 111.409 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.534 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -64.85 -19.49 65.91 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.228 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.09 0.82 23.2 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -132.19 -22.48 2.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.777 0.322 . . . . 0.0 111.76 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.615 HG22 ' H ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -92.93 -44.58 13.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.945 0.403 . . . . 0.0 111.484 -178.923 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.615 ' H ' HG22 ' A' ' 17' ' ' ILE . . . -57.18 -32.38 66.39 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.769 -178.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.98 -24.04 74.86 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.313 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.499 ' HB1' ' HB3' ' A' ' 35' ' ' ALA . . . -83.92 -24.79 30.6 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 120.821 0.343 . . . . 0.0 111.039 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 86.8 t -66.36 -46.65 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.551 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.34 -28.38 65.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.462 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -75.84 -44.9 38.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 112.061 -179.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.8 t -84.87 -37.28 20.84 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.729 0.299 . . . . 0.0 110.869 -179.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.99 48.9 1.3 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.405 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.41 ' CA ' ' HE2' ' B' ' 113' ' ' HIS . . . 143.67 -179.51 21.03 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.217 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.524 HD12 HD11 ' A' ' 17' ' ' ILE . 6.0 tp -113.23 117.23 54.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.489 0.661 . . . . 0.0 111.988 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.558 ' OD1' ' HD2' ' A' ' 30' ' ' PRO . 30.6 t0 -134.28 -108.89 0.22 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.771 ' HG ' HG21 ' A' ' 54' ' ' VAL . 41.0 tp -175.01 -57.03 0.0 OUTLIER Pre-proline 0 C--O 1.223 -0.326 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.291 178.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.864 ' HA ' HG12 ' A' ' 54' ' ' VAL . 2.3 Cg_endo -46.24 -60.18 0.95 Allowed 'Trans proline' 0 C--N 1.361 1.231 0 C-N-CA 123.005 2.47 . . . . 0.0 114.357 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 19.9 p -79.41 -33.84 42.29 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.655 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.46 HG13 ' HB3' ' A' ' 20' ' ' ALA . 2.4 t -67.1 -17.62 22.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.552 -179.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 30.0 tp -64.26 -26.13 68.36 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.495 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.37 -59.73 4.2 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -178.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.499 ' HB3' ' HB1' ' A' ' 20' ' ' ALA . . . -75.15 -17.0 60.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.747 0.308 . . . . 0.0 111.791 -179.107 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.565 HD21 ' CD2' ' A' ' 46' ' ' PHE . 32.8 tp -75.16 -10.33 59.37 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.931 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -74.4 93.13 2.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.894 0.378 . . . . 0.0 110.363 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -111.22 -5.55 14.69 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.698 -179.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 72.69 -61.92 0.48 Allowed 'General case' 0 N--CA 1.473 0.694 0 O-C-N 123.989 0.806 . . . . 0.0 113.02 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -60.67 -69.11 0.24 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.834 0.35 . . . . 0.0 111.826 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 42' ' ' CYS . . . -156.16 -139.63 2.79 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.146 -1.026 . . . . 0.0 112.779 -179.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 41' ' ' GLY . 96.5 m 73.17 8.81 5.31 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.16 0.584 . . . . 0.0 111.197 -179.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -95.51 -21.76 18.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.869 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.7 p -79.89 11.51 3.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.488 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 46.8 t -109.65 -62.29 1.52 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.565 ' CD2' HD21 ' A' ' 36' ' ' LEU . 0.8 OUTLIER -67.48 -59.28 3.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.713 178.697 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.609 ' HA ' ' HB2' ' A' ' 50' ' ' HIS . 87.9 m -74.6 15.54 0.35 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -55.86 -52.55 63.67 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.334 0.587 . . . . 0.0 110.386 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -94.79 -20.07 19.8 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.914 178.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.609 ' HB2' ' HA ' ' A' ' 47' ' ' CYS . 70.0 m-70 -98.56 72.56 2.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.443 -179.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 97.0 m -92.16 -2.16 56.73 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -178.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.996 ' HA ' ' HB3' ' A' ' 56' ' ' LYS . 9.6 p80 -117.2 -160.16 0.76 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 119.808 -0.757 . . . . 0.0 111.112 179.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 68.47 -130.99 26.58 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.571 -0.823 . . . . 0.0 111.794 -178.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.864 HG12 ' HA ' ' A' ' 30' ' ' PRO . 30.0 m -75.97 -18.99 15.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.858 0.329 . . . . 0.0 111.633 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.441 ' HB2' HD12 ' A' ' 29' ' ' LEU . 1.4 t -82.57 -23.29 34.53 Favored 'General case' 0 C--O 1.216 -0.691 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.184 -179.08 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.996 ' HB3' ' HA ' ' A' ' 52' ' ' HIS . 0.0 OUTLIER -77.58 -13.39 59.92 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.352 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -90.45 -59.86 2.07 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.749 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 20.6 tp -80.12 -75.58 0.25 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.592 0.234 . . . . 0.0 111.316 -179.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 58.1 m-70 -90.28 -129.5 0.09 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.421 ' HB3' ' H ' ' A' ' 61' ' ' CYS . 8.1 tp -169.83 -87.56 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 177.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.584 ' HB3' ' O ' ' A' ' 47' ' ' CYS . 1.8 p . . . . . 0 C--O 1.245 0.82 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.651 178.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 31.7 p . . . . . 0 CA--C 1.515 -0.404 0 N-CA-C 111.634 0.235 . . . . 0.0 111.634 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.21 -35.66 74.0 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 123.253 0.345 . . . . 0.0 111.209 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -74.11 -0.53 16.87 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . 0.454 ' O ' ' HA ' ' B' ' 97' ' ' LEU . . . -124.66 -12.73 7.13 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.658 HG23 ' H ' ' B' ' 79' ' ' ALA . 0.0 OUTLIER -106.5 -46.54 8.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.097 0.475 . . . . 0.0 110.91 -179.238 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 79' ' ' ALA . . . . . 0.658 ' H ' HG23 ' B' ' 78' ' ' ILE . . . -56.91 -23.47 45.17 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.947 -179.049 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -75.39 -25.26 68.62 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.403 -0.904 . . . . 0.0 112.151 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -82.21 -16.9 48.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.763 0.316 . . . . 0.0 111.348 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 82' ' ' VAL . . . . . 0.593 HG23 HD11 ' B' ' 88' ' ' ILE . 59.6 t -62.46 -45.78 97.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-O 121.033 0.444 . . . . 0.0 110.77 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.87 -31.19 70.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.473 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.19 -36.27 79.3 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.516 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 26.6 m -92.99 -12.27 31.1 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 69.55 42.27 73.2 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.488 -0.863 . . . . 0.0 111.319 -178.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 151.81 137.66 2.65 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 88' ' ' ILE . . . . . 0.593 HD11 HG23 ' B' ' 82' ' ' VAL . 2.9 tp -91.23 114.1 27.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.34 0.59 . . . . 0.0 111.944 -179.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 89' ' ' ASP . . . . . 0.564 ' OD2' ' HA ' ' A' ' 50' ' ' HIS . 0.9 OUTLIER -130.44 -91.91 0.44 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.641 179.038 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 90' ' ' LEU . . . . . 0.455 ' HG ' ' CG2' ' B' ' 115' ' ' VAL . 10.8 tp 175.93 -54.4 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.481 0 C-N-CA 123.484 0.714 . . . . 0.0 110.357 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 91' ' ' PRO . . . . . 0.652 ' HG3' ' HD3' ' A' ' 30' ' ' PRO . 60.9 Cg_exo -35.67 -63.11 0.2 Allowed 'Trans proline' 0 C--N 1.365 1.438 0 C-N-CA 123.492 2.795 . . . . 0.0 115.009 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 29.3 p -90.94 -31.32 16.42 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -178.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 3.2 t -57.58 -29.5 34.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.079 0.466 . . . . 0.0 111.561 -179.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 5.5 tp -62.46 -33.46 74.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.834 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.92 -15.16 54.39 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -177.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -129.07 20.81 5.83 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.667 0.618 . . . . 0.0 112.667 -179.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 97' ' ' LEU . . . . . 0.505 ' O ' ' HG ' ' B' ' 97' ' ' LEU . 0.0 OUTLIER -106.21 -9.12 17.02 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.431 179.827 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 60.4 tttm . . . . . 0 N--CA 1.47 0.532 0 O-C-N 123.994 0.809 . . . . 0.0 112.044 -179.457 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 5.5 m . . . . . 0 N--CA 1.466 0.342 0 CA-C-O 120.657 0.265 . . . . 0.0 111.28 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -112.07 -9.48 13.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.038 0.447 . . . . 0.0 110.215 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 8.4 p -79.18 -17.89 54.05 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.603 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 4.0 p -78.3 -62.02 1.82 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.287 0.565 . . . . 0.0 110.511 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . 0.527 ' CD2' HG13 ' B' ' 78' ' ' ILE . 0.9 OUTLIER -61.62 -61.03 2.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.168 -0.923 . . . . 0.0 110.75 -179.839 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 108' ' ' CYS . . . . . 0.74 ' O ' ' HB3' ' B' ' 122' ' ' CYS . 61.0 m -90.11 54.12 2.71 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.9 -179.039 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -74.24 -62.89 1.36 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.204 0.526 . . . . 0.0 110.125 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -86.13 -8.74 57.64 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 111' ' ' HIS . . . . . 0.694 ' O ' ' HB3' ' B' ' 108' ' ' CYS . 3.5 m-70 -106.99 88.26 2.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.554 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 90.3 m -114.48 37.66 3.33 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.381 -0.528 . . . . 0.0 112.101 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 113' ' ' HIS . . . . . 0.747 ' HA ' ' HB3' ' B' ' 117' ' ' LYS . 2.1 p80 -144.38 -149.69 0.29 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 110.202 -0.295 . . . . 0.0 110.202 178.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 114' ' ' GLY . . . . . 0.414 ' HA3' ' HG2' ' A' ' 30' ' ' PRO . . . 58.04 -106.37 0.8 Allowed Glycine 0 C--N 1.332 0.34 0 C-N-CA 121.205 -0.522 . . . . 0.0 112.973 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . 0.466 HG12 ' HG3' ' A' ' 30' ' ' PRO . 5.4 m -106.36 -23.76 4.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.582 0.23 . . . . 0.0 111.064 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 116' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -76.22 1.83 14.83 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 121.274 0.559 . . . . 0.0 110.966 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 117' ' ' LYS . . . . . 0.747 ' HB3' ' HA ' ' B' ' 113' ' ' HIS . 0.1 OUTLIER -100.27 -3.2 31.88 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.181 178.058 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -102.48 110.58 22.56 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.219 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 39.7 tp 77.55 -51.48 0.53 Allowed 'General case' 0 N--CA 1.474 0.729 0 O-C-N 124.108 0.88 . . . . 0.0 110.666 -178.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 -94.82 169.06 10.42 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 121' ' ' LEU . . . . . 0.505 ' HA ' HD13 ' B' ' 121' ' ' LEU . 11.4 tp -167.95 64.79 0.07 Allowed 'General case' 0 C--O 1.233 0.203 0 C-N-CA 120.068 -0.653 . . . . 0.0 112.542 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 122' ' ' CYS . . . . . 0.74 ' HB3' ' O ' ' B' ' 108' ' ' CYS . 0.8 OUTLIER . . . . . 0 C--O 1.248 0.996 0 O-C-N 124.043 0.839 . . . . 0.0 113.162 179.069 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.577 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 18.9 m . . . . . 0 N--CA 1.468 0.47 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.847 ' HA ' ' HB1' ' A' ' 18' ' ' ALA . . . -89.88 28.38 1.37 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -108.39 -94.81 0.4 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.807 0.337 . . . . 0.0 110.997 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.455 ' O ' ' HB1' ' A' ' 20' ' ' ALA . . . -74.16 -0.21 16.02 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.594 HG12 ' CD2' ' A' ' 46' ' ' PHE . 60.5 mt -107.99 -61.64 2.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.787 -0.188 . . . . 0.0 111.206 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.847 ' HB1' ' HA ' ' A' ' 14' ' ' ALA . . . -67.58 -31.36 71.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.999 0.428 . . . . 0.0 110.535 179.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.33 -20.48 72.11 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.638 179.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.576 ' HB3' HG13 ' A' ' 32' ' ' VAL . . . -77.3 -22.63 51.71 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.161 0.505 . . . . 0.0 110.016 179.101 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 75.3 t -64.55 -44.19 96.82 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.594 178.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.78 -16.44 61.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.349 179.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.88 -44.38 32.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.121 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.511 ' SG ' ' HB2' ' B' ' 113' ' ' HIS . 24.8 t -85.67 -28.98 24.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.032 0.444 . . . . 0.0 110.831 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 103.52 38.14 2.87 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.432 -0.89 . . . . 0.0 112.198 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 145.62 165.68 11.47 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.916 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.9 tp -95.81 109.59 22.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.256 0.551 . . . . 0.0 110.362 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.713 ' C ' ' HD2' ' A' ' 30' ' ' PRO . 15.9 p-10 -128.73 -50.3 1.25 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 118.963 -0.541 . . . . 0.0 111.27 -179.463 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.659 ' HB3' ' O ' ' A' ' 28' ' ' ASP . 17.0 tp 107.14 -54.39 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 124.913 1.383 . . . . 0.0 111.794 -179.034 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.878 ' HA ' HG22 ' A' ' 54' ' ' VAL . 10.6 Cg_endo -53.75 -36.55 82.5 Favored 'Trans proline' 0 C--N 1.364 1.38 0 C-N-CA 122.325 2.017 . . . . 0.0 112.869 179.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 2.4 t -93.9 -36.43 12.21 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.109 0.48 . . . . 0.0 110.711 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.576 HG13 ' HB3' ' A' ' 20' ' ' ALA . 94.0 t -64.25 -25.93 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.359 -179.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.9 pp -57.69 -33.27 68.2 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.789 0.328 . . . . 0.0 111.139 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.61 -38.13 62.65 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.67 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.28 -13.46 60.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.47 -179.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.427 HD22 ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -93.11 -41.54 9.89 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.362 -179.709 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.9 ttmm 55.1 77.42 0.22 Allowed 'General case' 0 N--CA 1.47 0.546 0 O-C-N 123.464 0.478 . . . . 0.0 110.281 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.427 ' HB3' HD22 ' A' ' 36' ' ' LEU . . . -99.59 138.44 36.67 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.117 0.485 . . . . 0.0 111.972 -178.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -115.71 -99.96 0.44 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.3 178.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -86.42 78.28 9.29 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.463 0.649 . . . . 0.0 110.23 178.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 102.77 -128.94 9.71 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.482 -179.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 3.9 m 70.29 -57.49 0.57 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.336 0.654 . . . . 0.0 111.657 179.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -87.7 13.63 10.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.529 0.204 . . . . 0.0 111.116 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.24 -44.89 96.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.863 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 8.0 p -80.01 -32.5 39.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.17 0.51 . . . . 0.0 110.514 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.594 ' CD2' HG12 ' A' ' 17' ' ' ILE . 0.9 OUTLIER -59.68 -61.12 2.86 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.554 -179.801 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 62.6 m -80.32 52.59 1.62 Allowed 'General case' 0 C--O 1.211 -0.94 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.137 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -78.3 -59.58 2.72 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -101.08 -13.3 18.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.239 179.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -96.88 76.21 2.73 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.198 -0.91 . . . . 0.0 108.955 179.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 88.9 m -117.7 19.64 13.76 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -177.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 9.0 p-80 -123.31 -20.98 5.48 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 119.439 -0.904 . . . . 0.0 113.192 -179.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.711 ' O ' HG21 ' A' ' 54' ' ' VAL . . . -106.21 119.57 6.06 Favored Glycine 0 C--O 1.221 -0.682 0 C-N-CA 120.034 -1.079 . . . . 0.0 112.606 179.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.878 HG22 ' HA ' ' A' ' 30' ' ' PRO . 14.3 m 54.54 -33.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 13.4 t -72.87 -37.75 67.23 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 121.471 -0.768 . . . . 0.0 110.938 -178.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 35.7 tttp -67.29 -8.62 33.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.703 179.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -71.97 -22.86 61.38 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 178.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.4 mp -114.4 -21.56 10.31 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.854 178.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 67.18 87.51 0.12 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.05 0.54 . . . . 0.0 111.059 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.7 mt -125.31 19.58 8.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.707 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 10.6 p . . . . . 0 C--O 1.245 0.817 0 CA-C-O 118.063 -0.97 . . . . 0.0 109.786 179.385 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 74' ' ' CYS . . . . . 0.546 ' O ' ' HB ' ' B' ' 78' ' ' ILE . 51.6 m . . . . . 0 N--CA 1.465 0.322 0 CA-C-O 120.608 0.242 . . . . 0.0 111.564 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -90.45 -43.24 10.4 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -178.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.89 -66.55 0.53 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -177.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.89 10.48 2.78 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -177.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.802 HD11 ' HB2' ' B' ' 107' ' ' PHE . 20.8 mt -130.8 -55.37 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 O-C-N 121.778 -0.576 . . . . 0.0 111.432 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.78 -36.22 70.28 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.282 178.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -75.53 -23.7 72.41 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.281 178.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . 0.49 ' CB ' ' HB3' ' B' ' 96' ' ' ALA . . . -69.63 -22.59 63.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.029 0.442 . . . . 0.0 110.693 179.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 54.7 t -65.84 -38.83 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.574 179.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -76.52 -13.98 60.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.805 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.53 -35.01 30.85 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.519 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 54.0 t -92.61 -40.26 10.87 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 121.005 -0.278 . . . . 0.0 111.508 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.02 37.27 1.54 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.502 -0.856 . . . . 0.0 111.628 -179.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 158.4 167.11 18.77 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 121.028 -0.606 . . . . 0.0 111.687 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 3.1 tp -102.48 123.45 55.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.915 0.388 . . . . 0.0 111.363 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 89' ' ' ASP . . . . . 0.528 ' CG ' ' H ' ' B' ' 90' ' ' LEU . 9.9 p-10 -163.7 -111.89 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.581 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 90' ' ' LEU . . . . . 0.64 ' N ' ' HD2' ' B' ' 91' ' ' PRO . 37.1 tp -179.32 -49.99 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.404 0 C-N-CA 123.843 0.857 . . . . 0.0 110.454 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 91' ' ' PRO . . . . . 0.726 ' HG3' ' HD3' ' A' ' 30' ' ' PRO . 5.4 Cg_endo -46.9 -34.28 15.98 Favored 'Trans proline' 0 C--N 1.366 1.465 0 C-N-CA 123.39 2.727 . . . . 0.0 114.575 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 15.2 p -108.64 -27.99 9.52 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.161 0.505 . . . . 0.0 110.755 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 93' ' ' VAL . . . . . 0.575 HG11 ' HE2' ' B' ' 107' ' ' PHE . 48.2 t -60.67 -20.15 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.705 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 94' ' ' LEU . . . . . 0.606 HD21 HG21 ' B' ' 115' ' ' VAL . 0.8 OUTLIER -53.77 -24.33 14.8 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 179.953 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.5 -55.36 34.36 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -178.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . 0.49 ' HB3' ' CB ' ' B' ' 81' ' ' ALA . . . -82.75 -21.57 34.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.783 0.325 . . . . 0.0 110.705 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 44.1 tp -62.22 -51.83 66.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.292 178.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 51.1 tttm . . . . . 0 N--CA 1.465 0.277 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.697 177.957 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 39.9 m . . . . . 0 N--CA 1.469 0.525 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 104' ' ' ALA . . . . . 0.432 ' HB3' HD13 ' B' ' 121' ' ' LEU . . . -79.37 -9.66 59.64 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -179.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 54.4 p -52.46 -52.43 54.22 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 4.8 p -62.37 -30.49 71.22 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.031 0.444 . . . . 0.0 111.179 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . 0.802 ' HB2' HD11 ' B' ' 78' ' ' ILE . 0.5 OUTLIER -69.18 -56.7 6.84 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.31 -179.189 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 108' ' ' CYS . . . . . 0.617 ' SG ' ' HB3' ' B' ' 122' ' ' CYS . 0.8 OUTLIER -79.57 18.21 0.77 Allowed 'General case' 0 CA--C 1.514 -0.407 0 C-N-CA 120.631 -0.427 . . . . 0.0 111.973 179.914 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -55.22 -65.11 0.64 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.378 0.609 . . . . 0.0 110.201 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -89.13 -10.36 47.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.254 178.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 47.3 m-70 -110.69 64.95 0.61 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.928 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 1.7 m -91.2 39.54 1.0 Allowed 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 112.046 0.388 . . . . 0.0 112.046 -178.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 113' ' ' HIS . . . . . 0.511 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 14.1 p-80 -143.22 -15.39 0.68 Allowed 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.341 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -77.25 -159.97 11.4 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.762 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . 0.606 HG21 HD21 ' B' ' 94' ' ' LEU . 24.4 m -64.39 -4.96 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -179.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 116' ' ' CYS . . . . . 0.502 ' SG ' ' HB2' ' B' ' 121' ' ' LEU . 7.0 t -78.77 -23.45 45.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.685 0.755 . . . . 0.0 109.115 178.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 4.0 ttmt -81.79 -7.57 59.61 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.146 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -65.01 -31.92 73.39 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 16.6 tp -114.23 -8.13 12.95 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.188 178.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 66.51 79.52 0.24 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.024 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 121' ' ' LEU . . . . . 0.502 ' HB2' ' SG ' ' B' ' 116' ' ' CYS . 96.6 mt -116.5 4.64 13.29 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 122' ' ' CYS . . . . . 0.617 ' HB3' ' SG ' ' B' ' 108' ' ' CYS . 21.2 p . . . . . 0 C--O 1.248 0.977 0 CA-C-O 118.177 -0.915 . . . . 0.0 109.335 178.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.54 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 26.7 m . . . . . 0 C--O 1.227 -0.099 0 CA-C-O 120.941 0.401 . . . . 0.0 111.122 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.431 ' HA ' ' HB1' ' A' ' 18' ' ' ALA . . . -106.56 -13.99 15.17 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.789 0.328 . . . . 0.0 111.261 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -88.23 -69.27 0.71 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.442 ' HB1' ' HA ' ' A' ' 36' ' ' LEU . . . -88.87 2.87 53.01 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.697 HG12 ' HD2' ' A' ' 46' ' ' PHE . 66.9 mt -119.0 -64.79 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 121.218 -0.193 . . . . 0.0 110.932 -179.584 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.484 ' HA ' HG21 ' A' ' 21' ' ' VAL . . . -68.27 -26.68 65.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.126 0.489 . . . . 0.0 110.057 178.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -87.47 10.35 69.77 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 178.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.417 ' CB ' ' HB2' ' A' ' 35' ' ' ALA . . . -125.12 -2.21 7.65 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 122.801 0.44 . . . . 0.0 110.456 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.484 HG21 ' HA ' ' A' ' 18' ' ' ALA . 64.3 t -66.5 -43.51 90.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.22 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.19 -4.57 30.09 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -84.17 -13.87 51.64 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -149.03 40.85 0.89 Allowed 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.47 -48.27 2.52 Favored Glycine 0 C--O 1.227 -0.336 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.882 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -168.57 176.49 42.88 Favored Glycine 0 N--CA 1.442 -0.907 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 179.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -49.86 110.83 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.607 0.718 . . . . 0.0 112.18 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.979 ' HB3' HG22 ' A' ' 32' ' ' VAL . 49.2 t0 -121.47 -118.82 0.3 Allowed 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.786 ' HG ' HG22 ' A' ' 54' ' ' VAL . 16.1 tp 173.01 -57.94 0.0 OUTLIER Pre-proline 0 C--O 1.223 -0.296 0 O-C-N 123.612 0.57 . . . . 0.0 111.429 178.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.712 ' HD3' ' HB3' ' A' ' 29' ' ' LEU . 54.3 Cg_exo -52.06 -49.21 18.1 Favored 'Trans proline' 0 C--N 1.358 1.048 0 C-N-CA 122.268 1.979 . . . . 0.0 113.225 -179.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 25.5 p -92.42 -35.15 13.83 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.238 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.979 HG22 ' HB3' ' A' ' 28' ' ' ASP . 65.4 t -65.06 -18.92 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.241 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.572 HD11 ' HA ' ' A' ' 55' ' ' CYS . 25.9 tp -57.93 -25.78 61.36 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.893 178.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.05 -41.13 99.42 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.648 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.417 ' HB2' ' CB ' ' A' ' 20' ' ' ALA . . . -86.36 -8.87 57.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.971 0.415 . . . . 0.0 111.057 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.442 ' HA ' ' HB1' ' A' ' 16' ' ' ALA . 33.5 tp -89.17 62.11 6.05 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 178.356 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.552 ' HD3' ' H ' ' A' ' 37' ' ' LYS . 0.3 OUTLIER -75.27 45.08 0.27 Allowed 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -177.1 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.61 156.83 16.61 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 122.189 -0.319 . . . . 0.0 110.386 178.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -115.23 -40.97 3.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.983 0.421 . . . . 0.0 110.583 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -93.53 -169.1 2.04 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.069 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -75.31 56.65 2.83 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 121.015 -0.612 . . . . 0.0 113.851 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 19.7 m -97.66 5.0 49.94 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 122.466 -0.432 . . . . 0.0 110.396 179.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.519 ' CB ' HD13 ' A' ' 60' ' ' LEU . . . -126.07 16.56 7.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.193 179.034 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.552 ' O ' ' HG2' ' A' ' 48' ' ' GLU . 5.9 m -61.86 -32.08 72.4 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.704 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 12.7 p -66.25 -26.74 67.5 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.124 0.488 . . . . 0.0 111.058 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.697 ' HD2' HG12 ' A' ' 17' ' ' ILE . 1.0 OUTLIER -93.29 -63.89 1.16 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.843 -178.67 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.611 ' SG ' HD11 ' A' ' 29' ' ' LEU . 72.9 m -82.84 45.44 1.0 Allowed 'General case' 0 C--O 1.217 -0.621 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -177.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.552 ' HG2' ' O ' ' A' ' 44' ' ' SER . 0.9 OUTLIER -72.81 -71.15 0.31 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 119.147 0.885 . . . . 0.0 110.401 179.406 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -78.36 -5.92 53.66 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.495 ' HB2' ' HA ' ' A' ' 47' ' ' CYS . 36.2 m-70 -104.29 66.17 0.81 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.924 -179.203 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.4 ' O ' ' HD2' ' A' ' 56' ' ' LYS . 72.4 m -120.41 50.08 1.36 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 178.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.434 ' HB3' ' SG ' ' B' ' 85' ' ' CYS . 13.1 m80 -96.92 -77.01 0.5 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.594 0.712 . . . . 0.0 110.185 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.632 ' O ' HG23 ' A' ' 54' ' ' VAL . . . -120.86 -174.99 15.15 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 179.05 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.786 HG22 ' HG ' ' A' ' 29' ' ' LEU . 9.3 m 47.02 -64.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.572 ' HA ' HD11 ' A' ' 33' ' ' LEU . 8.8 t -64.78 -48.89 72.84 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 121.664 -0.647 . . . . 0.0 111.836 -178.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.4 ' HD2' ' O ' ' A' ' 51' ' ' CYS . 17.0 ptmt -75.23 -2.01 26.02 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 119.42 -0.912 . . . . 0.0 111.296 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -65.97 -35.52 80.8 Favored 'General case' 0 N--CA 1.461 0.114 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 177.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.9 tt -90.26 -33.13 16.26 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 114.58 -1.191 . . . . 0.0 108.011 177.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 22.5 t-160 77.25 86.6 0.08 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.274 178.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.612 HD22 ' N ' ' A' ' 60' ' ' LEU . 0.7 OUTLIER -140.57 25.45 2.19 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -179.932 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 6.0 p . . . . . 0 C--O 1.244 0.791 0 CA-C-O 118.17 -0.919 . . . . 0.0 109.856 176.853 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 74' ' ' CYS . . . . . 0.564 ' HA ' HD13 ' B' ' 78' ' ' ILE . 13.0 p . . . . . 0 CA--C 1.521 -0.137 0 CA-C-O 120.85 0.357 . . . . 0.0 111.285 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -115.61 13.16 16.26 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 120.906 0.384 . . . . 0.0 110.661 178.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -128.48 -76.36 0.56 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.391 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.45 -39.44 90.84 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.884 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.827 HD12 ' HB2' ' B' ' 107' ' ' PHE . 13.5 mt -74.01 -41.2 52.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.03 0.443 . . . . 0.0 110.995 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.53 -32.75 71.77 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.161 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.63 -35.64 9.18 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.872 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . 0.432 ' HB1' HG13 ' B' ' 93' ' ' VAL . . . -73.25 -26.51 61.14 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -178.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 82' ' ' VAL . . . . . 0.516 HG12 HG22 ' B' ' 88' ' ' ILE . 3.2 t -66.76 -50.51 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.298 179.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.34 -26.11 67.13 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.006 0.431 . . . . 0.0 111.34 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.69 -25.14 64.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.033 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 85' ' ' CYS . . . . . 0.434 ' SG ' ' HB3' ' A' ' 52' ' ' HIS . 1.5 t -88.92 -22.62 23.01 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.962 -179.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 99.66 43.99 2.38 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.166 -1.016 . . . . 0.0 113.804 179.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 114.87 52.01 0.44 Allowed Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.05 -1.072 . . . . 0.0 113.893 178.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 88' ' ' ILE . . . . . 0.516 HG22 HG12 ' B' ' 82' ' ' VAL . 0.5 OUTLIER 56.04 174.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 124.29 1.036 . . . . 0.0 113.184 179.142 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 89' ' ' ASP . . . . . 0.577 ' CG ' ' HD2' ' B' ' 91' ' ' PRO . 39.2 t0 170.41 -124.62 0.0 OUTLIER 'General case' 0 C--O 1.233 0.212 0 CA-C-N 114.348 -1.296 . . . . 0.0 108.403 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 90' ' ' LEU . . . . . 0.744 HD13 ' SG ' ' B' ' 116' ' ' CYS . 21.1 tp 172.46 -58.5 0.0 OUTLIER Pre-proline 0 C--N 1.324 -0.542 0 C-N-CA 124.364 1.066 . . . . 0.0 109.34 178.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 91' ' ' PRO . . . . . 0.824 ' HA ' HG11 ' B' ' 115' ' ' VAL . 50.8 Cg_exo -54.07 -43.25 59.99 Favored 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 122.031 1.821 . . . . 0.0 112.281 179.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 24.7 p -79.85 -35.82 37.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.055 0.455 . . . . 0.0 110.87 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 93' ' ' VAL . . . . . 0.614 HG12 ' HE2' ' B' ' 107' ' ' PHE . 5.8 t -71.02 -25.4 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.481 -178.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 30.8 tp -60.16 -28.33 67.83 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 120.828 0.347 . . . . 0.0 110.934 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.86 -36.62 81.76 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.408 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -99.37 9.86 42.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.297 0.57 . . . . 0.0 110.089 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 24.3 tp -107.55 68.24 0.71 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.167 -0.924 . . . . 0.0 108.708 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . 0.405 ' NZ ' ' HB2' ' B' ' 98' ' ' LYS . 8.1 mtmp? . . . . . 0 N--CA 1.468 0.469 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.426 -178.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 79.4 m . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 120.976 0.417 . . . . 0.0 109.932 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -109.74 -25.63 10.28 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.843 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 22.0 p -60.58 -25.93 66.57 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.754 0.312 . . . . 0.0 111.21 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 106' ' ' CYS . . . . . 0.499 ' HB3' ' HB3' ' B' ' 74' ' ' CYS . 43.5 t -60.33 -18.73 51.81 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.382 0.611 . . . . 0.0 110.389 178.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . 0.827 ' HB2' HD12 ' B' ' 78' ' ' ILE . 0.6 OUTLIER -104.16 -65.06 1.05 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.519 -179.535 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 108' ' ' CYS . . . . . 0.448 ' HB2' ' HB3' ' B' ' 122' ' ' CYS . 0.0 OUTLIER -73.69 15.77 0.25 Allowed 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -178.504 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -37.49 -73.23 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.181 0.592 . . . . 0.0 112.364 -178.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -98.71 -33.91 10.74 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -70.63 87.07 0.66 Allowed 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 112' ' ' CYS . . . . . 0.587 ' HB3' ' HG2' ' B' ' 117' ' ' LYS . 0.5 OUTLIER -154.21 136.63 14.99 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -178.622 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 113' ' ' HIS . . . . . 0.431 ' CD2' ' HB2' ' A' ' 28' ' ' ASP . 1.5 t60 -153.22 -49.63 0.1 Allowed 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 178.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -127.14 -159.38 10.14 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 177.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . 0.824 HG11 ' HA ' ' B' ' 91' ' ' PRO . 0.4 OUTLIER 41.45 -86.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 123.903 0.881 . . . . 0.0 113.31 179.644 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 116' ' ' CYS . . . . . 0.744 ' SG ' HD13 ' B' ' 90' ' ' LEU . 36.5 m -61.36 -33.13 73.13 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 118.431 0.56 . . . . 0.0 109.831 178.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 117' ' ' LYS . . . . . 0.587 ' HG2' ' HB3' ' B' ' 112' ' ' CYS . 3.9 mmmm -77.53 -21.0 53.31 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.244 178.469 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -62.38 -47.86 82.28 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 7.9 tt -79.77 -29.28 40.39 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 177.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 8.5 t-160 76.01 67.67 0.06 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.529 178.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 121' ' ' LEU . . . . . 0.48 HD21 ' H ' ' B' ' 121' ' ' LEU . 0.9 OUTLIER -126.81 8.97 6.91 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.475 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 122' ' ' CYS . . . . . 0.448 ' HB3' ' HB2' ' B' ' 108' ' ' CYS . 0.8 OUTLIER . . . . . 0 C--O 1.245 0.852 0 CA-C-O 118.173 -0.918 . . . . 0.0 110.208 178.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 120.704 0.288 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 51.7 mtt -107.67 116.75 32.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.505 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -162.36 45.95 0.35 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 119.836 -1.174 . . . . 0.0 113.63 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.466 ' H ' ' HG3' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -71.3 99.72 1.99 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.113 0.482 . . . . 0.0 110.261 178.911 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.418 ' H ' ' CB ' ' A' ' 40' ' ' GLU . 13.9 t 63.07 56.6 1.75 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.216 -178.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.0 t -94.35 -159.01 0.67 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.401 -178.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.697 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 0.2 OUTLIER -90.31 -173.76 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.545 -178.588 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.697 ' HG ' ' O ' ' A' ' 7' ' ' VAL . 2.8 pp 62.17 -59.36 0.12 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.582 1.553 . . . . 0.0 113.358 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -87.08 17.9 3.94 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 121.817 -0.552 . . . . 0.0 110.481 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -76.97 -8.85 58.12 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.225 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.459 ' C ' ' H ' ' A' ' 13' ' ' CYS . 2.5 t -78.83 -3.96 6.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.938 179.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.69 7.03 4.13 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.672 0.748 . . . . 0.0 109.65 177.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.67 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 1.3 p -58.23 -35.3 71.48 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.072 179.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.49 28.3 0.08 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.448 ' H ' ' C ' ' A' ' 13' ' ' CYS . . . -138.38 -64.34 0.53 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.929 0.395 . . . . 0.0 110.27 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.42 -43.83 47.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.943 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.67 ' HB ' ' O ' ' A' ' 13' ' ' CYS . 10.6 mt -70.28 -38.2 73.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.117 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.1 -39.01 88.33 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.823 178.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.6 -31.52 44.93 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.966 -0.635 . . . . 0.0 111.886 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.59 -28.84 61.09 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.302 0.573 . . . . 0.0 110.293 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.799 HG13 ' HA2' ' A' ' 26' ' ' GLY . 1.2 t -68.3 -37.36 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.235 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.82 -6.27 40.35 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.616 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.84 -2.33 58.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.491 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.6 t -147.05 55.23 1.1 Allowed 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.977 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.38 -53.41 4.21 Favored Glycine 0 N--CA 1.455 -0.088 0 C-N-CA 121.2 -0.524 . . . . 0.0 113.936 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.799 ' HA2' HG13 ' A' ' 21' ' ' VAL . . . 131.79 116.66 1.8 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.969 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.409 ' H ' HG13 ' A' ' 21' ' ' VAL . 43.9 mm 72.83 78.62 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.505 -0.773 0 CA-C-O 122.787 1.279 . . . . 0.0 111.58 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.69 ' OD2' ' HB3' ' A' ' 31' ' ' CYS . 40.1 t0 -148.63 161.61 41.37 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-N 112.683 -2.053 . . . . 0.0 107.298 177.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.597 ' HB3' ' HD3' ' A' ' 30' ' ' PRO . 36.0 tp -126.12 -52.63 0.03 OUTLIER Pre-proline 0 C--N 1.296 -1.729 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.026 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.665 ' HA ' HG11 ' A' ' 54' ' ' VAL . 47.2 Cg_exo -54.84 -41.7 75.76 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 121.907 1.738 . . . . 0.0 112.632 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.69 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 5.6 t -85.82 -38.96 17.59 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.187 -178.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.601 HG22 ' HB3' ' A' ' 28' ' ' ASP . 93.0 t -73.44 -16.23 17.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.605 HD21 ' HB ' ' A' ' 54' ' ' VAL . 44.8 tp -55.27 -31.08 61.28 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -56.67 -37.05 70.28 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -104.44 4.37 33.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.808 0.337 . . . . 0.0 111.112 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 52.3 tp -85.87 -25.55 26.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.869 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.82 46.47 1.18 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.451 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -136.59 134.87 37.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.802 -0.181 . . . . 0.0 111.336 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 65.37 -165.54 0.23 Allowed 'General case' 0 N--CA 1.468 0.474 0 O-C-N 123.968 0.793 . . . . 0.0 111.838 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.418 ' CB ' ' H ' ' A' ' 5' ' ' CYS . 6.0 pt-20 -124.14 53.88 1.38 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.189 0.518 . . . . 0.0 112.005 -179.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -134.39 52.54 0.81 Allowed Glycine 0 CA--C 1.517 0.17 0 C-N-CA 121.062 -0.589 . . . . 0.0 111.881 178.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -127.09 -104.74 0.33 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.733 -0.234 . . . . 0.0 111.089 -179.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 57.99 -154.1 0.36 Allowed 'General case' 0 C--O 1.239 0.503 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 178.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.8 p -66.82 32.88 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -176.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 43.8 t -107.87 -31.56 7.96 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 176.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.575 ' O ' ' HD2' ' A' ' 50' ' ' HIS . 1.1 t80 -103.52 -65.53 1.0 Allowed 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.299 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.424 ' HA ' ' HB2' ' A' ' 50' ' ' HIS . 7.6 m -75.77 23.6 0.13 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -177.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.578 ' HA ' ' OE1' ' A' ' 48' ' ' GLU . 7.3 tp10 -69.1 -68.02 0.43 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.95 0.405 . . . . 0.0 110.581 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -79.79 -14.49 58.66 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.575 ' HD2' ' O ' ' A' ' 46' ' ' PHE . 85.2 m-70 -100.44 63.43 1.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.669 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -115.02 68.42 0.7 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.876 0.37 . . . . 0.0 110.595 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -107.82 -64.07 1.25 Allowed 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.276 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.481 ' HA3' ' HB2' ' B' ' 92' ' ' CYS . . . -134.12 -107.54 0.98 Allowed Glycine 0 C--O 1.219 -0.835 0 C-N-CA 120.031 -1.08 . . . . 0.0 113.799 -178.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.665 HG11 ' HA ' ' A' ' 30' ' ' PRO . 2.9 m -12.51 -67.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 N-CA-C 116.496 2.036 . . . . 0.0 116.496 -178.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.563 ' H ' HG21 ' A' ' 54' ' ' VAL . 32.4 t -73.38 -39.79 64.84 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -177.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.7 tttm -63.46 -24.75 67.96 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.02 0.438 . . . . 0.0 109.941 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -62.18 -32.68 73.33 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.213 178.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 60.5 mt -94.36 -4.69 48.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.44 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 66.2 t-80 64.79 84.04 0.16 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.851 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.488 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 8.1 mp -126.98 27.35 5.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.026 178.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.903 0 CA-C-O 118.213 -0.898 . . . . 0.0 109.462 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.082 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -96.73 70.76 2.55 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.189 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -149.08 78.11 0.23 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 119.861 -1.161 . . . . 0.0 113.743 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -88.04 125.11 34.38 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' CYS . . . . . . . . . . . . . 43.9 t 55.91 52.86 10.01 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.322 0.582 . . . . 0.0 109.778 -178.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 9.9 p -105.27 169.37 8.49 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.579 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 14.8 t -75.5 85.78 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.577 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.466 ' C ' ' H ' ' B' ' 71' ' ' LYS . 42.4 tp -178.45 -53.21 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' LYS . . . . . 0.437 ' HZ2' ' CD ' ' B' ' 101' ' ' GLU . 51.4 mtmt -87.5 31.52 0.74 Allowed 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.016 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . 0.466 ' H ' ' C ' ' B' ' 69' ' ' LEU . 3.1 tmmm? -71.34 -30.28 66.0 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 113.957 -1.474 . . . . 0.0 110.215 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 12.5 t -62.88 -24.77 36.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.275 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.61 11.04 1.43 Allowed 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' CYS . . . . . 0.726 ' HB2' HD12 ' B' ' 78' ' ' ILE . 31.2 p -73.56 -15.08 61.3 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.788 0.327 . . . . 0.0 111.305 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' B' ' 79' ' ' ALA . . . -69.53 -6.34 30.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.89 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -102.25 -47.91 4.36 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.65 -41.42 13.4 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -178.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.978 HD13 ' HB2' ' B' ' 107' ' ' PHE . 84.3 mt -76.27 -43.01 37.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.646 0.26 . . . . 0.0 110.713 -179.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' ALA . . . . . 0.415 ' HB2' ' O ' ' B' ' 75' ' ' ALA . . . -78.74 -16.99 56.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.925 0.393 . . . . 0.0 110.906 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -86.62 -34.29 11.92 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.591 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . 0.509 ' HB2' HG12 ' B' ' 93' ' ' VAL . . . -67.69 -19.58 65.19 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.652 0.263 . . . . 0.0 111.354 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 82' ' ' VAL . . . . . 0.538 HG22 HD11 ' B' ' 88' ' ' ILE . 77.4 t -62.13 -54.75 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.121 178.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.41 -26.47 65.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.225 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.54 -40.89 96.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.84 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 7.2 t -110.75 25.38 11.84 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.411 -0.516 . . . . 0.0 111.668 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.73 -51.48 4.58 Favored Glycine 0 CA--C 1.518 0.245 0 N-CA-C 114.858 0.703 . . . . 0.0 114.858 178.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . -138.25 -177.4 15.24 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.036 -1.078 . . . . 0.0 113.837 -178.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 88' ' ' ILE . . . . . 0.538 HD11 HG22 ' B' ' 82' ' ' VAL . 3.9 tp -102.11 137.0 31.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.217 0.532 . . . . 0.0 111.187 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -171.2 -104.64 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 90' ' ' LEU . . . . . 0.731 HD23 ' HB2' ' B' ' 116' ' ' CYS . 56.0 tp -176.16 -50.61 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.388 0 CA-C-O 119.476 -0.297 . . . . 0.0 111.494 178.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 91' ' ' PRO . . . . . 0.628 ' HD2' ' N ' ' B' ' 90' ' ' LEU . 3.4 Cg_exo -40.73 -39.83 3.23 Favored 'Trans proline' 0 C--N 1.364 1.344 0 C-N-CA 124.051 3.167 . . . . 0.0 114.67 -179.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 92' ' ' CYS . . . . . 0.481 ' HB2' ' HA3' ' A' ' 53' ' ' GLY . 19.6 t -113.16 -14.8 12.86 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.067 0.461 . . . . 0.0 111.726 -178.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . 0.509 HG12 ' HB2' ' B' ' 81' ' ' ALA . 12.3 t -72.62 -17.68 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.395 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 94' ' ' LEU . . . . . 0.898 ' HB2' HG23 ' B' ' 115' ' ' VAL . 23.8 tp -62.22 -35.58 79.34 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.46 -54.89 26.33 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 -178.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -87.38 7.97 26.6 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 59.8 tp -79.0 -31.02 44.63 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.288 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -88.53 66.92 8.39 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.551 0.691 . . . . 0.0 110.743 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -104.99 64.53 0.72 Allowed 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . 77.03 -66.69 0.24 Allowed 'General case' 0 N--CA 1.467 0.414 0 O-C-N 124.439 1.087 . . . . 0.0 109.074 -176.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . 0.437 ' CD ' ' HZ2' ' B' ' 70' ' ' LYS . 5.3 pt-20 -160.71 -138.19 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.761 177.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . 0.576 ' O ' ' HA ' ' B' ' 74' ' ' CYS . . . 73.8 25.05 72.87 Favored Glycine 0 N--CA 1.453 -0.18 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.068 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -106.55 -84.73 0.51 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.559 0.219 . . . . 0.0 110.49 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . 53.87 -155.24 0.23 Allowed 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.66 33.97 0.05 Allowed 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 115.18 -0.918 . . . . 0.0 113.47 -178.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 38.8 t -105.86 -28.68 10.47 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 177.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . 0.978 ' HB2' HD13 ' B' ' 78' ' ' ILE . 0.0 OUTLIER -123.48 162.4 22.94 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 113.94 -1.482 . . . . 0.0 107.055 176.24 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 108' ' ' CYS . . . . . 0.448 ' SG ' HD21 ' B' ' 121' ' ' LEU . 66.9 m 68.2 -3.94 1.17 Allowed 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 179.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -62.08 -85.41 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 118.563 0.62 . . . . 0.0 111.043 179.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -86.62 -7.96 57.89 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 178.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -101.16 36.17 2.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.324 -1.307 . . . . 0.0 111.158 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.79 63.77 3.37 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 113' ' ' HIS . . . . . 0.477 ' NE2' ' HB2' ' A' ' 28' ' ' ASP . 9.5 t-160 -122.57 -54.48 1.86 Allowed 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.549 -178.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 114' ' ' GLY . . . . . 0.532 ' O ' ' HG3' ' B' ' 117' ' ' LYS . . . -84.01 -137.24 3.37 Favored Glycine 0 C--O 1.227 -0.295 0 C-N-CA 120.511 -0.852 . . . . 0.0 113.452 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . 0.898 HG23 ' HB2' ' B' ' 94' ' ' LEU . 16.8 m -58.96 -10.76 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 116' ' ' CYS . . . . . 0.731 ' HB2' HD23 ' B' ' 90' ' ' LEU . 0.0 OUTLIER -65.21 -32.0 73.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.707 0.289 . . . . 0.0 111.469 -179.714 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 117' ' ' LYS . . . . . 0.532 ' HG3' ' O ' ' B' ' 114' ' ' GLY . 0.3 OUTLIER -87.23 -26.21 23.61 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.272 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.2 -42.62 96.54 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.5 178.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 1.8 tt -101.41 63.13 0.96 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 176.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 65.0 t-80 -20.38 114.57 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 113.732 -1.576 . . . . 0.0 114.725 -176.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 121' ' ' LEU . . . . . 0.448 HD21 ' SG ' ' B' ' 108' ' ' CYS . 1.0 OUTLIER -134.03 -33.46 1.03 Allowed 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.451 -1.25 . . . . 0.0 109.293 178.372 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 122' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.247 0.923 0 CA-C-O 118.405 -0.807 . . . . 0.0 109.94 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.307 0 CA-C-O 120.553 0.216 . . . . 0.0 110.618 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -75.18 95.39 3.11 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 97.76 -135.51 12.23 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.236 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.2 mtpp 58.73 -112.23 0.61 Allowed 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 122.624 0.37 . . . . 0.0 110.63 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.48 ' SG ' ' HB3' ' A' ' 38' ' ' ALA . 8.7 m -108.77 7.48 26.32 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 45.1 t -66.67 104.59 1.33 Allowed 'General case' 0 C--O 1.224 -0.27 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 32.8 t -45.44 -60.44 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -177.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 44.2 tp -64.47 -38.13 89.96 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 36.2 mtpt -88.95 27.15 1.39 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.661 0.743 . . . . 0.0 111.529 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.4 tptm -137.55 38.87 2.44 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.8 t 55.77 44.04 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.749 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 55.91 46.17 22.59 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.352 -178.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 17.0 p 52.51 12.24 0.23 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.201 1.401 . . . . 0.0 113.956 -178.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.413 ' O ' ' HB1' ' A' ' 15' ' ' ALA . . . -87.07 178.12 7.01 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 178.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.413 ' HB1' ' O ' ' A' ' 14' ' ' ALA . . . 72.2 -50.35 0.7 Allowed 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.692 0.62 . . . . 0.0 110.161 -178.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.441 ' O ' ' HB3' ' A' ' 20' ' ' ALA . . . -70.07 -34.34 73.06 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.598 HG12 ' CD1' ' A' ' 46' ' ' PHE . 6.2 tp -89.43 -58.36 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-O 121.022 0.439 . . . . 0.0 110.607 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.489 ' H ' HG22 ' A' ' 17' ' ' ILE . . . -54.75 -34.12 62.11 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.231 -0.895 . . . . 0.0 112.024 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.31 -27.94 50.35 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.231 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.578 ' HB2' HG13 ' A' ' 32' ' ' VAL . . . -76.24 -15.83 59.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.845 0.355 . . . . 0.0 110.838 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' ' 17' ' ' ILE . 66.9 t -63.57 -40.46 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.483 179.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.32 -18.65 63.09 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.889 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -72.32 -35.24 68.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.835 0.35 . . . . 0.0 111.442 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.517 ' HB3' ' CG ' ' B' ' 113' ' ' HIS . 71.0 m -99.48 -29.29 12.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.685 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.32 80.02 1.47 Allowed Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.249 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.85 166.08 16.72 Favored Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.491 HG22 ' O ' ' A' ' 27' ' ' ILE . 0.0 OUTLIER -105.94 96.91 4.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.922 0.868 . . . . 0.0 111.283 -179.626 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.653 ' HB2' ' CE1' ' B' ' 113' ' ' HIS . 33.5 m-20 -115.81 -105.72 0.39 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.693 ' HB3' ' HD3' ' A' ' 30' ' ' PRO . 60.2 tp -177.86 -53.7 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.362 0 N-CA-C 111.911 0.338 . . . . 0.0 111.911 178.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.693 ' HD3' ' HB3' ' A' ' 29' ' ' LEU . 15.2 Cg_exo -70.9 49.07 0.9 Allowed 'Trans proline' 0 C--N 1.362 1.25 0 C-N-CA 122.97 2.447 . . . . 0.0 114.624 -178.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.581 ' HB2' ' O ' ' B' ' 113' ' ' HIS . 50.5 t -168.29 -49.27 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.578 HG13 ' HB2' ' A' ' 20' ' ' ALA . 21.8 t -73.91 -29.76 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.679 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -55.66 -45.36 77.71 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.112 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.06 3.88 3.1 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -101.46 -38.78 7.85 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.64 0.257 . . . . 0.0 111.239 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -104.63 6.33 34.35 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.454 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -62.72 -47.8 82.03 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 119.431 -0.319 . . . . 0.0 111.625 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.48 ' HB3' ' SG ' ' A' ' 5' ' ' CYS . . . 45.32 -101.59 0.05 Allowed 'General case' 0 N--CA 1.469 0.494 0 O-C-N 123.812 0.695 . . . . 0.0 111.194 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.421 ' H ' ' HB3' ' A' ' 38' ' ' ALA . . . -99.05 -106.66 0.2 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -145.79 155.06 42.68 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.787 0.327 . . . . 0.0 110.598 178.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.13 37.94 63.64 Favored Glycine 0 C--O 1.229 -0.165 0 C-N-CA 121.101 -0.571 . . . . 0.0 113.516 179.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -126.16 -16.46 5.5 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 122.447 -0.443 . . . . 0.0 111.924 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -109.32 15.36 23.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.931 0.396 . . . . 0.0 111.155 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.5 p -66.4 -53.57 34.34 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.713 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.588 ' O ' ' HG2' ' A' ' 48' ' ' GLU . 1.6 p -55.11 -44.94 75.44 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.725 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.598 ' CD1' HG12 ' A' ' 17' ' ' ILE . 65.2 t80 -63.26 -45.48 91.33 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.591 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.432 ' CB ' ' SG ' ' A' ' 61' ' ' CYS . 98.4 m -94.92 37.98 1.13 Allowed 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -177.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.588 ' HG2' ' O ' ' A' ' 45' ' ' CYS . 62.6 mm-40 -44.69 -76.27 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 118.742 0.701 . . . . 0.0 112.499 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -99.03 -14.04 19.61 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.693 0.758 . . . . 0.0 109.461 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -90.36 68.73 6.91 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.703 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 5.8 t -132.53 60.24 1.7 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.958 -177.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.585 ' ND1' ' HB3' ' B' ' 92' ' ' CYS . 5.8 p80 -131.35 17.69 4.91 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.795 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.615 ' O ' ' HG3' ' A' ' 56' ' ' LYS . . . -128.27 -137.89 4.48 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.485 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.499 ' CG2' ' HA ' ' A' ' 30' ' ' PRO . 35.6 m -58.98 -17.29 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-O 120.892 0.377 . . . . 0.0 111.807 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.543 ' HB2' HD11 ' A' ' 29' ' ' LEU . 3.9 t -78.54 -36.37 44.81 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.134 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.615 ' HG3' ' O ' ' A' ' 53' ' ' GLY . 0.0 OUTLIER -81.08 -5.57 57.79 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.158 0.504 . . . . 0.0 110.373 179.364 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -66.38 -27.42 67.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.705 178.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 45.0 mt -100.6 -19.15 16.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.502 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.414 ' C ' HD11 ' A' ' 60' ' ' LEU . 16.1 t-80 66.4 78.03 0.27 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.669 0.788 . . . . 0.0 111.021 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.414 HD11 ' C ' ' A' ' 59' ' ' HIS . 11.0 mp -123.48 -20.81 5.46 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.398 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.432 ' SG ' ' CB ' ' A' ' 47' ' ' CYS . 0.6 OUTLIER . . . . . 0 C--O 1.246 0.873 0 CA-C-O 118.391 -0.814 . . . . 0.0 111.511 -177.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.273 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' MET . . . . . . . . . . . . . 2.2 tmt? -129.12 132.97 47.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.865 0.364 . . . . 0.0 111.508 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 97.06 -116.83 5.6 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.585 -0.817 . . . . 0.0 114.17 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp 64.95 -109.09 0.18 Allowed 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 122.895 0.478 . . . . 0.0 109.996 -177.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' CYS . . . . . . . . . . . . . 3.2 t -167.03 91.36 0.4 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.771 0.32 . . . . 0.0 110.443 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.456 ' HB3' ' HB2' ' B' ' 70' ' ' LYS . 33.7 t -124.56 164.74 19.16 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.192 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 21.8 t -98.52 -56.55 5.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.922 0.391 . . . . 0.0 110.726 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 52.5 tp -67.11 -47.44 71.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.236 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 70' ' ' LYS . . . . . 0.456 ' HB2' ' HB3' ' B' ' 67' ' ' SER . 97.2 mttt -61.76 -19.94 63.01 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 120.848 0.356 . . . . 0.0 111.832 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . 0.422 ' HB3' ' HA ' ' B' ' 74' ' ' CYS . 6.3 mmtp -86.94 30.47 0.75 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.694 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 17.0 t 56.5 47.44 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . 58.13 38.43 26.43 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.236 -0.893 . . . . 0.0 108.782 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 74' ' ' CYS . . . . . 0.422 ' HA ' ' HB3' ' B' ' 71' ' ' LYS . 20.9 p 48.66 26.66 1.28 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 114.076 -1.42 . . . . 0.0 112.94 -178.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 75' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' B' ' 76' ' ' ALA . . . -89.9 -175.56 4.64 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.045 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . 0.406 ' HB2' ' O ' ' B' ' 75' ' ' ALA . . . 71.46 -50.08 0.69 Allowed 'General case' 0 N--CA 1.474 0.744 0 O-C-N 123.713 0.633 . . . . 0.0 110.514 -178.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -76.5 -50.39 14.11 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.085 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.67 ' HB ' HD13 ' B' ' 97' ' ' LEU . 8.9 tp -80.26 -42.25 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-O 121.215 0.531 . . . . 0.0 110.094 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 79' ' ' ALA . . . . . 0.564 ' N ' HG22 ' B' ' 78' ' ' ILE . . . -65.59 -29.69 70.33 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.616 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -82.44 -33.21 25.99 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.772 -0.728 . . . . 0.0 111.581 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . 0.634 ' HB2' HG13 ' B' ' 93' ' ' VAL . . . -69.13 -19.53 64.03 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.82 0.343 . . . . 0.0 110.898 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 82' ' ' VAL . . . . . 0.742 HG23 ' HB ' ' B' ' 88' ' ' ILE . 75.4 t -60.76 -52.32 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.054 178.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.9 -36.36 62.23 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.999 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.34 -43.02 96.84 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.006 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 2.3 t -90.94 -8.93 47.94 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.3 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 74.47 48.49 13.64 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.95 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 143.5 135.98 3.07 Favored Glycine 0 CA--C 1.509 -0.288 0 C-N-CA 120.896 -0.668 . . . . 0.0 111.777 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 88' ' ' ILE . . . . . 0.742 ' HB ' HG23 ' B' ' 82' ' ' VAL . 0.0 OUTLIER -100.9 107.99 22.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.682 0.753 . . . . 0.0 110.645 -179.806 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 89' ' ' ASP . . . . . 0.583 ' HB2' ' HE1' ' A' ' 52' ' ' HIS . 44.0 m-20 -120.9 -86.43 0.65 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 90' ' ' LEU . . . . . 0.718 HD22 ' HA3' ' B' ' 114' ' ' GLY . 59.3 tp 179.09 -52.43 0.0 OUTLIER Pre-proline 0 C--O 1.217 -0.655 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.108 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 91' ' ' PRO . . . . . 0.96 ' HA ' HG22 ' B' ' 115' ' ' VAL . 1.0 OUTLIER -43.17 -70.49 0.07 OUTLIER 'Trans proline' 0 C--N 1.36 1.177 0 C-N-CA 123.351 2.701 . . . . 0.0 114.767 -179.413 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 92' ' ' CYS . . . . . 0.585 ' HB3' ' ND1' ' A' ' 52' ' ' HIS . 0.8 OUTLIER -72.83 -38.62 67.06 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -178.17 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . 0.634 HG13 ' HB2' ' B' ' 81' ' ' ALA . 0.6 OUTLIER -66.41 -24.5 33.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -178.199 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 94' ' ' LEU . . . . . 0.649 ' HB2' ' O ' ' B' ' 90' ' ' LEU . 1.3 tm? -67.96 -41.94 81.66 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.52 -9.45 8.7 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -178.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -87.67 -37.43 16.74 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 97' ' ' LEU . . . . . 0.67 HD13 ' HB ' ' B' ' 78' ' ' ILE . 1.7 pt? -115.03 17.56 16.76 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -178.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -70.67 -83.95 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.801 -0.36 . . . . 0.0 111.408 -178.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . 65.6 -84.05 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 O-C-N 123.562 0.539 . . . . 0.0 111.186 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.86 -163.65 1.43 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.396 -0.224 . . . . 0.0 110.396 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -84.11 131.68 34.77 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.655 0.264 . . . . 0.0 110.923 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 110.07 6.89 27.58 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.38 -0.914 . . . . 0.0 113.767 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 92.6 m -110.56 -43.26 3.89 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 117.405 0.603 . . . . 0.0 111.416 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -96.08 2.71 53.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.187 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 4.3 m -54.43 -42.78 70.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.117 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 1.8 p -55.42 -61.49 2.31 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.045 0.45 . . . . 0.0 111.216 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . 0.593 ' O ' ' HD2' ' B' ' 111' ' ' HIS . 0.8 OUTLIER -58.49 -55.31 36.73 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.342 -179.652 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 12.4 m -76.29 22.63 0.16 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -178.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -63.4 -58.24 7.72 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 118.296 0.498 . . . . 0.0 111.155 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -93.93 -21.48 19.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.293 0.568 . . . . 0.0 109.998 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 111' ' ' HIS . . . . . 0.593 ' HD2' ' O ' ' B' ' 107' ' ' PHE . 45.1 m-70 -92.6 89.9 6.9 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.588 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 96.1 m -123.1 46.36 2.2 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -177.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 113' ' ' HIS . . . . . 0.848 ' HA ' ' HG2' ' B' ' 117' ' ' LYS . 23.1 p80 -140.74 5.96 2.01 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 119.608 -0.837 . . . . 0.0 111.798 177.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 114' ' ' GLY . . . . . 0.718 ' HA3' HD22 ' B' ' 90' ' ' LEU . . . -98.1 -152.6 28.23 Favored Glycine 0 C--O 1.226 -0.348 0 C-N-CA 120.489 -0.862 . . . . 0.0 111.393 177.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . 0.96 HG22 ' HA ' ' B' ' 91' ' ' PRO . 35.1 m -66.17 -5.92 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 117.411 0.606 . . . . 0.0 111.701 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 116' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -79.79 -25.28 40.97 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 117' ' ' LYS . . . . . 0.848 ' HG2' ' HA ' ' B' ' 113' ' ' HIS . 0.0 OUTLIER -96.03 3.51 53.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.359 178.19 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -44.97 -42.46 8.23 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 119' ' ' LEU . . . . . 0.687 ' O ' ' HB2' ' B' ' 120' ' ' HIS . 87.9 mt -106.66 -64.77 1.14 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 174.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 120' ' ' HIS . . . . . 0.687 ' HB2' ' O ' ' B' ' 119' ' ' LEU . 11.4 t-80 145.16 91.57 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.881 1.672 . . . . 0.0 108.883 177.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 62.1 mt -114.98 31.78 6.46 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -177.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 122' ' ' CYS . . . . . . . . . . . . . 6.3 p . . . . . 0 C--O 1.242 0.699 0 CA-C-O 118.408 -0.806 . . . . 0.0 110.965 178.653 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.197 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -100.02 144.55 28.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.747 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -77.79 99.41 1.5 Allowed Glycine 0 CA--C 1.509 -0.339 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.471 ' HD3' ' OG ' ' A' ' 44' ' ' SER . 64.2 mttp 67.77 -84.01 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -177.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.428 ' HB3' ' O ' ' A' ' 40' ' ' GLU . 13.7 p -159.81 20.18 0.17 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 177.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.574 ' HB3' ' HD3' ' A' ' 9' ' ' LYS . 14.5 m 64.79 55.5 1.23 Allowed 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.106 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.478 HG11 ' HA ' ' A' ' 42' ' ' CYS . 0.0 OUTLIER -87.0 -16.1 9.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.349 179.713 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.499 HD11 ' N ' ' A' ' 9' ' ' LYS . 3.3 pp -68.61 -35.16 76.94 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.574 ' HD3' ' HB3' ' A' ' 6' ' ' SER . 0.0 OUTLIER -88.51 3.28 50.8 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 121.304 0.573 . . . . 0.0 110.408 178.783 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.4 tptt -98.42 37.65 1.44 Allowed 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 177.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.495 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 20.7 t 58.79 41.84 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.972 -178.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 55.71 48.89 17.43 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.035 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 55.9 m 71.58 -4.82 1.78 Allowed 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.495 ' HB3' ' O ' ' A' ' 11' ' ' VAL . . . -70.86 -34.55 71.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.742 0.306 . . . . 0.0 111.736 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.82 38.81 0.66 Allowed 'General case' 0 C--N 1.326 -0.443 0 O-C-N 122.103 -0.373 . . . . 0.0 111.95 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -167.66 -53.06 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.1 0.476 . . . . 0.0 111.017 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.638 HG12 ' HD2' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -78.04 -42.4 27.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.036 -179.748 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.97 -31.3 70.93 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.962 0.41 . . . . 0.0 110.721 178.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -76.11 -26.19 64.77 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.663 -0.779 . . . . 0.0 111.84 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.44 -24.44 60.24 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 120.882 0.372 . . . . 0.0 110.743 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 98.9 t -66.35 -47.02 85.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.641 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.43 -22.06 66.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.722 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.11 -40.13 86.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.462 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.5 t -99.78 -12.86 19.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.009 0.433 . . . . 0.0 111.207 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.84 -61.76 0.35 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.097 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -105.74 170.23 16.88 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.249 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.6 tp -98.04 104.98 16.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.57 0.7 . . . . 0.0 111.581 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.585 ' OD1' HG22 ' A' ' 32' ' ' VAL . 18.1 p-10 -129.2 -111.33 0.27 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.726 178.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.632 ' HG ' HG23 ' A' ' 54' ' ' VAL . 43.3 tp -178.72 -47.03 0.0 OUTLIER Pre-proline 0 C--N 1.324 -0.505 0 C-N-CA 123.575 0.75 . . . . 0.0 110.682 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.821 ' HA ' HG21 ' A' ' 54' ' ' VAL . 32.5 Cg_exo -55.37 -31.59 77.94 Favored 'Trans proline' 0 C--N 1.367 1.528 0 C-N-CA 122.455 2.103 . . . . 0.0 113.227 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 19.5 t -106.93 -25.98 11.41 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.383 -178.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.585 HG22 ' OD1' ' A' ' 28' ' ' ASP . 65.8 t -72.13 -14.28 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.736 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.693 ' HA ' ' HB3' ' A' ' 36' ' ' LEU . 1.0 OUTLIER -59.19 -15.3 14.13 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.896 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.593 ' N ' HD13 ' A' ' 33' ' ' LEU . . . -54.3 -53.92 47.26 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.935 0.398 . . . . 0.0 111.66 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -103.3 28.29 6.51 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.222 0.534 . . . . 0.0 109.851 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.693 ' HB3' ' HA ' ' A' ' 33' ' ' LEU . 42.6 tp -122.67 -48.88 2.02 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.791 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.477 ' HE3' ' HB2' ' A' ' 58' ' ' LEU . 84.3 tttt -73.71 96.01 2.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.868 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -144.93 -80.14 0.17 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.66 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -113.27 150.74 32.02 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.497 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.428 ' O ' ' HB3' ' A' ' 5' ' ' CYS . 4.7 mp0 -67.45 143.03 56.45 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.562 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.43 -9.36 77.78 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.506 -0.854 . . . . 0.0 113.572 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.478 ' HA ' HG11 ' A' ' 7' ' ' VAL . 85.6 m -86.34 -23.15 26.33 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 117.331 0.565 . . . . 0.0 110.952 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.597 ' HB3' HD12 ' A' ' 36' ' ' LEU . . . -111.54 23.76 13.56 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.681 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.471 ' OG ' ' HD3' ' A' ' 4' ' ' LYS . 34.7 p -78.95 -49.71 12.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.552 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.7 p -54.55 -36.13 63.98 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.547 0.689 . . . . 0.0 111.103 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.638 ' HD2' HG12 ' A' ' 17' ' ' ILE . 0.8 OUTLIER -83.6 -68.62 0.7 Allowed 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.652 -1.158 . . . . 0.0 111.441 -178.982 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.5 ' HA ' ' HB2' ' A' ' 50' ' ' HIS . 37.4 m -77.57 32.16 0.16 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -65.35 -57.61 7.96 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.363 0.601 . . . . 0.0 109.385 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -90.4 -10.83 42.44 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.117 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.5 ' HB2' ' HA ' ' A' ' 47' ' ' CYS . 36.7 m-70 -106.23 60.43 0.65 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.119 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 5.2 t -111.18 50.22 0.83 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.033 0.444 . . . . 0.0 111.108 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.463 ' HA ' ' HD2' ' A' ' 56' ' ' LYS . 20.6 p-80 -140.92 -7.46 1.07 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 0.0 112.05 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.419 ' O ' ' HG2' ' A' ' 56' ' ' LYS . . . -104.05 -151.71 22.11 Favored Glycine 0 CA--C 1.521 0.428 0 C-N-CA 120.519 -0.848 . . . . 0.0 113.01 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.821 HG21 ' HA ' ' A' ' 30' ' ' PRO . 31.1 m -55.03 -17.23 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.527 ' HB2' HD22 ' A' ' 29' ' ' LEU . 1.8 t -70.61 -24.52 62.75 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.71 -179.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.576 ' C ' ' H ' ' A' ' 58' ' ' LEU . 10.0 ptmt -94.19 17.17 13.11 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.373 178.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -83.99 29.59 0.55 Allowed 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 123.057 1.408 . . . . 0.0 107.926 177.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.576 ' H ' ' C ' ' A' ' 56' ' ' LYS . 6.9 tt -170.16 -37.3 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 32.6 t60 71.07 91.37 0.09 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 113.88 -1.509 . . . . 0.0 111.834 178.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.529 ' C ' HD23 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -131.09 16.07 5.12 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.377 179.927 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.879 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.131 0 CA-C-O 120.733 0.302 . . . . 0.0 110.373 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -81.31 114.92 20.41 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.715 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -78.93 80.35 1.5 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.615 -0.802 . . . . 0.0 111.651 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . 0.427 ' HE2' ' HB3' ' B' ' 65' ' ' LYS . 6.1 ptpt 46.93 -80.92 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.638 1.175 . . . . 0.0 113.414 -179.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' CYS . . . . . . . . . . . . . 29.5 p -154.75 17.33 0.45 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.565 ' HB3' ' HG2' ' B' ' 70' ' ' LYS . 18.9 m 55.59 70.2 0.66 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.347 0.594 . . . . 0.0 110.116 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 42.5 t -65.73 -37.26 79.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -177.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.419 ' HG ' ' N ' ' B' ' 70' ' ' LYS . 0.7 OUTLIER -65.88 -44.48 85.24 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -178.629 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 70' ' ' LYS . . . . . 0.565 ' HG2' ' HB3' ' B' ' 67' ' ' SER . 18.7 pttp -77.96 -1.54 32.47 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.126 0.488 . . . . 0.0 110.861 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 10.9 tttt -96.57 41.07 1.12 Allowed 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 177.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . 0.537 ' O ' ' HB3' ' B' ' 75' ' ' ALA . 12.5 t 59.73 39.78 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 114.499 -1.228 . . . . 0.0 110.422 -179.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . 51.55 51.47 16.66 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.997 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 74' ' ' CYS . . . . . 0.626 ' O ' ' HB ' ' B' ' 78' ' ' ILE . 2.0 p 48.14 37.5 8.18 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 114.506 -1.225 . . . . 0.0 113.638 -178.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 75' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' B' ' 72' ' ' VAL . . . -100.4 7.75 44.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.156 0.503 . . . . 0.0 110.575 178.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -89.61 -64.5 1.13 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.342 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . 0.429 ' O ' ' HB2' ' B' ' 81' ' ' ALA . . . -87.67 -24.71 23.81 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.635 HD13 ' HB2' ' B' ' 107' ' ' PHE . 23.9 mt -89.13 -55.18 6.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.553 0.216 . . . . 0.0 111.082 -179.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.17 -21.19 46.78 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.391 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.03 -34.16 42.95 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.705 -0.76 . . . . 0.0 111.626 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . 0.503 ' HB1' HG13 ' B' ' 93' ' ' VAL . . . -71.29 -18.15 62.43 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 120.956 0.408 . . . . 0.0 110.702 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 82' ' ' VAL . . . . . 0.436 HG23 ' O ' ' B' ' 78' ' ' ILE . 69.9 t -64.07 -41.73 93.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.857 178.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.02 -22.57 60.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.057 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.82 -39.54 30.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.547 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 22.7 t -89.5 -25.37 21.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.757 0.313 . . . . 0.0 110.865 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 96.46 34.5 5.79 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.367 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 147.6 163.8 10.86 Favored Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 111.399 -0.68 . . . . 0.0 111.399 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.36 127.42 63.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 117.199 0.5 . . . . 0.0 110.666 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 89' ' ' ASP . . . . . 0.558 ' OD2' ' HG2' ' B' ' 91' ' ' PRO . 30.2 p-10 -144.67 -59.22 0.37 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.449 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 90' ' ' LEU . . . . . 0.608 HD13 ' HB2' ' B' ' 116' ' ' CYS . 61.0 tp 133.55 -51.63 0.0 OUTLIER Pre-proline 0 N--CA 1.484 1.269 0 C-N-CA 126.2 1.8 . . . . 0.0 110.337 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 91' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' B' ' 90' ' ' LEU . 4.5 Cg_exo -44.06 -38.41 10.5 Favored 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 123.539 2.826 . . . . 0.0 114.686 -179.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 31.5 p -104.98 -31.14 9.36 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 120.241 -0.583 . . . . 0.0 111.581 -179.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . 0.503 HG13 ' HB1' ' B' ' 81' ' ' ALA . 3.9 t -63.29 -7.37 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.43 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 94' ' ' LEU . . . . . 0.792 HD22 ' HB ' ' B' ' 115' ' ' VAL . 4.3 pp -61.66 -22.61 65.45 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 122.343 -0.223 . . . . 0.0 111.2 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -53.2 -60.46 3.26 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -178.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.11 -15.58 58.75 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.223 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 18.1 tp -74.61 -41.38 60.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.898 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . 0.732 ' HA ' HD12 ' B' ' 119' ' ' LEU . 43.9 mtpt -67.74 -20.26 65.22 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.777 0.323 . . . . 0.0 111.195 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -78.91 -11.1 59.99 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.617 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . 0.632 ' HB3' ' SG ' ' B' ' 103' ' ' CYS . . . -108.43 111.5 23.42 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.816 0.341 . . . . 0.0 110.951 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 12.0 mp0 -67.17 99.24 0.66 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.46 -178.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 70.77 35.45 66.33 Favored Glycine 0 CA--C 1.517 0.194 0 N-CA-C 114.396 0.518 . . . . 0.0 114.396 177.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 103' ' ' CYS . . . . . 0.632 ' SG ' ' HB3' ' B' ' 100' ' ' ALA . 60.8 m -107.38 13.88 26.55 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 117.567 0.683 . . . . 0.0 111.178 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 104' ' ' ALA . . . . . 0.551 ' HB2' HD21 ' B' ' 121' ' ' LEU . . . -100.46 27.17 5.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.227 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 3.0 p -73.96 -61.07 1.98 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.952 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 4.5 p -55.63 -37.74 68.58 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.556 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . 0.635 ' HB2' HD13 ' B' ' 78' ' ' ILE . 1.1 t80 -79.38 -75.71 0.24 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.069 -0.969 . . . . 0.0 112.514 -177.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 74.3 m -73.12 33.57 0.07 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -177.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -59.53 -57.92 10.84 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.332 0.587 . . . . 0.0 109.531 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -98.15 -19.65 17.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.483 178.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 -93.77 65.34 3.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.722 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 4.6 t -123.53 58.91 1.12 Allowed 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.466 -0.493 . . . . 0.0 111.0 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 113' ' ' HIS . . . . . 0.563 ' O ' ' HE2' ' B' ' 117' ' ' LYS . 20.7 p-80 -139.96 -25.34 0.81 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 114' ' ' GLY . . . . . 0.423 ' C ' ' H ' ' B' ' 116' ' ' CYS . . . -127.8 129.85 6.52 Favored Glycine 0 C--O 1.226 -0.396 0 C-N-CA 120.184 -1.008 . . . . 0.0 112.695 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . 0.792 ' HB ' HD22 ' B' ' 94' ' ' LEU . 24.4 m 54.82 -31.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 C-N-CA 126.164 1.786 . . . . 0.0 115.204 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 116' ' ' CYS . . . . . 0.608 ' HB2' HD13 ' B' ' 90' ' ' LEU . 35.2 t -81.18 -37.69 28.3 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 121.807 -0.558 . . . . 0.0 111.291 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 117' ' ' LYS . . . . . 0.563 ' HE2' ' O ' ' B' ' 113' ' ' HIS . 52.1 pttt -77.7 15.05 0.89 Allowed 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 119.697 -0.801 . . . . 0.0 110.957 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 118' ' ' ASP . . . . . 0.432 ' H ' ' C ' ' B' ' 116' ' ' CYS . 1.2 t70 -75.38 -24.1 57.18 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 106.824 -1.546 . . . . 0.0 106.824 175.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 119' ' ' LEU . . . . . 0.732 HD12 ' HA ' ' B' ' 98' ' ' LYS . 53.1 mt -94.75 -31.7 13.66 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 114.137 -1.392 . . . . 0.0 107.704 176.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 12.7 t60 55.9 76.28 0.29 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 113.886 -1.507 . . . . 0.0 112.437 178.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 121' ' ' LEU . . . . . 0.617 HD13 ' H ' ' B' ' 121' ' ' LEU . 0.0 OUTLIER -131.69 -3.34 3.71 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-O 120.959 0.409 . . . . 0.0 110.821 179.885 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 122' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.246 0.882 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.39 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.595 ' O ' ' HE2' ' A' ' 9' ' ' LYS . . . . . . . . 0 N--CA 1.484 1.259 0 CA-C-O 120.663 0.268 . . . . 0.0 110.549 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 7.7 mtp -101.54 114.52 28.62 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -105.49 176.55 22.45 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.466 -0.873 . . . . 0.0 113.552 -178.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.0 ptmm? -95.14 -27.03 15.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.836 0.351 . . . . 0.0 110.337 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 9.3 t -176.46 65.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.705 ' HB2' ' HB2' ' A' ' 9' ' ' LYS . 16.6 m -70.99 168.57 16.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.336 -178.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.0 m -75.56 -46.79 36.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -178.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.426 HD13 ' HG2' ' A' ' 9' ' ' LYS . 3.5 pp -89.48 -22.15 22.61 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 119.879 -0.728 . . . . 0.0 109.582 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.705 ' HB2' ' HB2' ' A' ' 6' ' ' SER . 19.1 mtpp -96.29 30.82 2.38 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 177.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -73.78 -6.35 46.48 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.697 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.6 t 58.45 41.44 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.355 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 51.57 28.72 4.86 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 114.569 -1.196 . . . . 0.0 112.791 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.409 ' HB3' HD12 ' A' ' 17' ' ' ILE . 6.5 m 66.74 5.58 4.02 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.474 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -79.51 -13.47 59.53 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -178.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -98.04 15.62 23.58 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.912 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.47 -59.53 0.24 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.135 0.493 . . . . 0.0 111.3 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.438 HD11 ' HB3' ' A' ' 46' ' ' PHE . 80.6 mt -75.17 -42.77 44.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.354 -179.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 14' ' ' ALA . . . -59.54 -34.06 72.18 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -179.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -85.99 -33.1 15.9 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.646 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.6 -34.78 74.6 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.011 0.434 . . . . 0.0 111.343 -179.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.4 t -64.07 -44.36 97.7 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.784 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.15 -22.53 66.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.648 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.65 -43.2 66.52 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.48 ' SG ' HG23 ' A' ' 32' ' ' VAL . 60.3 m -104.03 0.64 30.08 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 -178.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.18 42.95 10.06 Favored Glycine 0 CA--C 1.517 0.197 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.884 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 130.32 -178.88 17.28 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 121.062 -0.589 . . . . 0.0 111.634 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.2 pp -74.18 134.35 29.73 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 CA-C-O 121.748 0.785 . . . . 0.0 110.343 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.85 ' HB3' HG22 ' A' ' 32' ' ' VAL . 32.9 t70 -148.59 -127.7 0.05 Allowed 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.564 -1.198 . . . . 0.0 108.007 -178.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.573 HD22 ' HB2' ' A' ' 55' ' ' CYS . 20.6 tp 175.27 -56.3 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.461 0 O-C-N 123.418 0.449 . . . . 0.0 112.042 178.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.545 ' HD3' ' HG3' ' B' ' 91' ' ' PRO . 3.8 Cg_endo -49.92 -34.78 38.37 Favored 'Trans proline' 0 C--N 1.364 1.353 0 C-N-CA 122.752 2.301 . . . . 0.0 113.308 -179.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 17.3 p -110.59 -28.85 8.3 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.216 0.531 . . . . 0.0 110.979 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.85 HG22 ' HB3' ' A' ' 28' ' ' ASP . 51.6 t -67.72 -23.91 30.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.44 -179.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.8 pp -54.9 -26.56 36.66 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.95 -61.04 2.66 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -178.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.46 -21.64 52.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.74 0.305 . . . . 0.0 111.389 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.666 HD22 HD22 ' A' ' 60' ' ' LEU . 52.6 tp -68.05 -36.47 79.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.498 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -66.12 -39.74 90.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.457 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 58.12 -100.25 0.11 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.577 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -132.64 18.81 4.27 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.715 -0.221 . . . . 0.0 111.396 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -168.26 -110.49 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -110.98 -64.32 0.51 Allowed Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 178.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 12.0 m 48.71 29.4 2.19 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.485 0.714 . . . . 0.0 112.916 177.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.56 ' CB ' ' HG ' ' A' ' 60' ' ' LEU . . . -115.35 -15.99 11.5 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.448 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 2.5 m -58.02 -19.18 29.2 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.013 0.435 . . . . 0.0 111.812 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 42.5 t -64.99 -53.38 47.16 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.604 ' HE2' HD11 ' A' ' 36' ' ' LEU . 0.3 OUTLIER -107.92 -46.63 3.74 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.294 -179.641 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.577 ' O ' ' HB3' ' A' ' 51' ' ' CYS . 0.1 OUTLIER -68.31 21.0 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.634 179.737 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.546 ' H ' ' C ' ' A' ' 46' ' ' PHE . 38.9 tp10 -63.52 -76.2 0.07 Allowed 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 123.246 0.618 . . . . 0.0 111.903 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -69.86 -44.69 69.34 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.858 -178.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -103.3 111.52 23.97 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.168 0.509 . . . . 0.0 111.901 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.672 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 13.5 p -164.99 35.33 0.06 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.613 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.494 ' HA ' ' HE3' ' A' ' 56' ' ' LYS . 3.7 p-80 -82.81 -16.33 48.19 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.509 ' HA3' ' HG2' ' B' ' 91' ' ' PRO . . . -76.86 -123.89 0.21 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.384 -0.913 . . . . 0.0 112.04 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.468 HG13 ' HA ' ' A' ' 30' ' ' PRO . 8.9 p -85.9 18.84 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.745 0.783 . . . . 0.0 110.265 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.672 ' SG ' ' HB2' ' A' ' 51' ' ' CYS . 5.3 t -91.64 -48.43 6.84 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.494 ' HE3' ' HA ' ' A' ' 52' ' ' HIS . 19.8 pttp -89.27 14.07 11.91 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 120.976 -0.289 . . . . 0.0 110.662 178.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -56.13 -41.63 75.62 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.259 0.552 . . . . 0.0 109.727 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.5 tt -135.67 -79.16 0.43 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 177.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -155.1 118.25 4.41 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.977 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.666 HD22 HD22 ' A' ' 36' ' ' LEU . 8.1 tp -153.87 -50.97 0.1 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.92 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.533 ' HB3' ' O ' ' A' ' 47' ' ' CYS . 0.8 OUTLIER . . . . . 0 C--O 1.243 0.759 0 CA-C-O 118.474 -0.774 . . . . 0.0 110.518 178.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.044 0 CA-C-O 120.771 0.319 . . . . 0.0 110.945 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' MET . . . . . . . . . . . . . 23.7 mmt -73.67 134.46 43.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.48 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -80.78 118.03 4.56 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.897 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . 0.606 ' HE2' ' O ' ' B' ' 100' ' ' ALA . 69.6 tttt -73.25 -63.03 1.27 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.869 0.366 . . . . 0.0 110.052 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' CYS . . . . . 0.921 ' HB3' ' HB3' ' B' ' 101' ' ' GLU . 32.1 t 177.6 152.94 0.26 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 15.8 t -162.06 -170.55 2.54 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 27.5 m -94.25 -13.03 8.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.012 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -108.5 -45.68 3.83 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 121.281 -0.168 . . . . 0.0 111.228 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 70' ' ' LYS . . . . . 0.502 ' HE3' ' HB2' ' B' ' 70' ' ' LYS . 14.9 ptmt -96.24 38.29 1.2 Allowed 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 122.05 0.928 . . . . 0.0 109.075 178.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -74.23 -11.42 60.28 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 114.113 -1.403 . . . . 0.0 107.726 177.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 6.7 t 58.33 43.09 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 113.981 -1.463 . . . . 0.0 110.435 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . 51.25 24.99 2.26 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.171 -178.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 74' ' ' CYS . . . . . 0.477 ' O ' ' HB ' ' B' ' 78' ' ' ILE . 0.0 OUTLIER 53.49 27.25 6.29 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.603 -178.714 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.68 -53.79 8.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.858 0.361 . . . . 0.0 110.965 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.85 42.68 0.72 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.973 0.416 . . . . 0.0 111.381 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -159.21 -44.87 0.05 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.582 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.915 HD12 ' HB2' ' B' ' 107' ' ' PHE . 12.5 mt -100.79 -52.44 8.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.203 -179.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.88 -33.63 73.38 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.15 -37.62 17.84 Favored Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.645 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . 0.517 ' HB3' ' HB3' ' B' ' 96' ' ' ALA . . . -72.78 -29.54 63.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.052 0.453 . . . . 0.0 111.49 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 82' ' ' VAL . . . . . 0.614 HG22 HG21 ' B' ' 88' ' ' ILE . 2.6 t -66.13 -40.17 86.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.607 179.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.4 -24.05 66.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.261 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.9 -39.08 44.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.319 -0.401 . . . . 0.0 112.049 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 4.8 t -85.52 -25.51 26.78 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.871 -0.331 . . . . 0.0 111.123 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 104.71 39.79 2.29 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.474 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 124.45 170.99 13.31 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.025 -0.607 . . . . 0.0 111.613 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 88' ' ' ILE . . . . . 0.614 HG21 HG22 ' B' ' 82' ' ' VAL . 1.2 pt -66.12 143.14 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.438 0 CA-C-O 121.416 0.627 . . . . 0.0 110.436 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 89' ' ' ASP . . . . . 0.482 ' O ' ' HB2' ' B' ' 90' ' ' LEU . 29.6 t70 -157.26 -127.4 0.03 OUTLIER 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.728 -178.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 90' ' ' LEU . . . . . 0.607 HD13 ' HB2' ' B' ' 116' ' ' CYS . 36.5 tp 170.73 -58.14 0.0 OUTLIER Pre-proline 0 C--N 1.323 -0.558 0 O-C-N 123.867 0.73 . . . . 0.0 110.563 178.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 91' ' ' PRO . . . . . 0.545 ' HG3' ' HD3' ' A' ' 30' ' ' PRO . 14.3 Cg_endo -57.8 -16.11 24.14 Favored 'Trans proline' 0 C--N 1.365 1.409 0 C-N-CA 122.681 2.254 . . . . 0.0 113.585 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 20.3 p -110.23 -34.02 6.49 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.217 0.532 . . . . 0.0 110.37 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . 0.453 HG12 ' HB2' ' B' ' 97' ' ' LEU . 3.0 t -74.26 -18.05 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.141 -178.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 94' ' ' LEU . . . . . 0.6 HD22 HG11 ' B' ' 115' ' ' VAL . 0.6 OUTLIER -40.95 -31.74 0.19 Allowed 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 -178.206 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.28 -54.53 4.73 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 118.442 0.564 . . . . 0.0 112.257 -178.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . 0.517 ' HB3' ' HB3' ' B' ' 81' ' ' ALA . . . -71.8 -17.48 62.16 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.6 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 97' ' ' LEU . . . . . 0.453 ' HB2' HG12 ' B' ' 93' ' ' VAL . 20.0 tp -67.97 -38.12 82.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.478 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 44.5 mttm -56.69 -51.86 67.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.757 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . 72.01 -54.94 0.67 Allowed 'General case' 0 N--CA 1.471 0.612 0 O-C-N 124.024 0.828 . . . . 0.0 110.68 -178.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . 0.606 ' O ' ' HE2' ' B' ' 65' ' ' LYS . . . -163.39 -27.11 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.547 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . 0.921 ' HB3' ' HB3' ' B' ' 66' ' ' CYS . 32.1 tt0 -141.79 -85.28 0.18 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.043 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.99 -85.06 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 58.2 m 59.37 24.85 13.45 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 178.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -113.22 16.31 19.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.864 0.364 . . . . 0.0 110.693 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 105' ' ' SER . . . . . 0.638 ' O ' ' HG2' ' B' ' 109' ' ' GLU . 3.9 p -58.67 -52.05 67.33 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.142 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 18.7 p -53.95 -41.28 67.61 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.78 0.8 . . . . 0.0 111.517 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . 0.915 ' HB2' HD12 ' B' ' 78' ' ' ILE . 0.9 OUTLIER -69.36 -72.32 0.19 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.27 -1.332 . . . . 0.0 112.908 -177.928 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 108' ' ' CYS . . . . . 0.822 ' HA ' ' HB2' ' B' ' 111' ' ' HIS . 36.3 m -81.11 34.8 0.37 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -176.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . 0.638 ' HG2' ' O ' ' B' ' 105' ' ' SER . 13.1 mm-40 -60.59 -60.89 3.09 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 177.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -96.69 -0.18 48.74 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 111' ' ' HIS . . . . . 0.822 ' HB2' ' HA ' ' B' ' 108' ' ' CYS . 55.4 m-70 -108.59 39.48 1.99 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.962 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 2.1 t -98.0 49.31 1.01 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 113' ' ' HIS . . . . . . . . . . . . . 22.3 p-80 -123.24 -33.18 3.32 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.097 -178.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 114' ' ' GLY . . . . . 0.455 ' C ' ' H ' ' B' ' 116' ' ' CYS . . . -85.15 -146.33 8.29 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.857 -0.687 . . . . 0.0 113.425 -179.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . 0.6 HG11 HD22 ' B' ' 94' ' ' LEU . 7.7 p -74.65 37.34 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 122.331 1.062 . . . . 0.0 111.436 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 116' ' ' CYS . . . . . 0.607 ' HB2' HD13 ' B' ' 90' ' ' LEU . 2.5 t -120.31 -25.88 5.56 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.527 -0.76 . . . . 0.0 108.986 178.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.78 -9.83 39.11 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.909 178.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -49.54 -52.2 31.52 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.636 -179.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 73.1 mt -107.4 -104.34 0.35 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 177.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -151.18 93.33 1.9 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.228 0.537 . . . . 0.0 109.9 177.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 121' ' ' LEU . . . . . 0.504 HD23 ' SG ' ' B' ' 116' ' ' CYS . 9.4 mp -121.58 -28.01 4.65 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.982 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 122' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.245 0.859 0 CA-C-O 118.437 -0.792 . . . . 0.0 110.802 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.243 0 CA-C-O 120.624 0.249 . . . . 0.0 110.74 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 54.1 mtm -80.8 178.44 8.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.03 0.443 . . . . 0.0 110.943 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -95.19 80.49 0.86 Allowed Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.01 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 0.9 OUTLIER -78.55 53.35 1.3 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.47 0.176 . . . . 0.0 111.41 -179.746 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.753 ' HA ' ' HB3' ' A' ' 9' ' ' LYS . 28.5 m 56.78 45.2 22.14 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.169 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.8 m -97.22 123.21 40.94 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 22.0 t 49.19 -83.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 O-C-N 124.318 1.011 . . . . 0.0 113.59 178.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.467 HD11 ' HA ' ' A' ' 8' ' ' LEU . 16.7 tp -65.06 -48.29 74.29 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.712 0.291 . . . . 0.0 110.519 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.753 ' HB3' ' HA ' ' A' ' 5' ' ' CYS . 0.0 OUTLIER -73.46 10.73 0.95 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.191 178.904 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.426 ' H ' ' C ' ' A' ' 8' ' ' LEU . 0.5 OUTLIER -97.0 -19.39 18.79 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.749 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.4 t -119.66 -43.1 2.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.044 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.4 16.86 1.19 Allowed 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -80.02 -17.11 53.66 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.832 0.348 . . . . 0.0 111.125 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.484 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -81.21 21.41 0.74 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.619 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -109.75 -42.74 4.19 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.283 0.563 . . . . 0.0 109.838 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.27 -40.8 43.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.979 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.615 HG12 ' CD2' ' A' ' 46' ' ' PHE . 10.9 tp -72.38 -32.16 41.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.517 0.675 . . . . 0.0 110.194 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.488 ' N ' HG23 ' A' ' 17' ' ' ILE . . . -56.3 -27.66 56.21 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.527 -1.215 . . . . 0.0 111.595 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.48 -29.67 51.97 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.437 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.732 ' HB2' ' HB1' ' A' ' 35' ' ' ALA . . . -72.92 -28.83 62.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.064 0.459 . . . . 0.0 110.477 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.666 HG11 ' HB ' ' A' ' 27' ' ' ILE . 96.5 t -66.04 -48.88 80.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.297 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.96 -33.91 76.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.179 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.61 -34.66 78.75 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.783 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.534 ' SG ' ' HB2' ' B' ' 113' ' ' HIS . 3.9 t -89.21 -28.93 19.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.772 0.32 . . . . 0.0 111.109 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.6 40.8 3.54 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.362 -0.923 . . . . 0.0 112.209 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 148.11 163.03 10.49 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.761 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.666 ' HB ' HG11 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -108.18 135.58 46.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.255 0.55 . . . . 0.0 111.938 -179.268 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.642 ' HB2' ' HE1' ' B' ' 113' ' ' HIS . 7.9 t70 -160.59 -97.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.047 -0.979 . . . . 0.0 108.798 178.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.567 ' HG ' ' CG2' ' A' ' 54' ' ' VAL . 49.4 tp -178.85 -53.86 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.254 0 CA-C-O 119.263 -0.399 . . . . 0.0 111.484 178.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.732 ' HA ' HG23 ' A' ' 54' ' ' VAL . 96.3 Cg_exo -41.35 -65.47 0.19 Allowed 'Trans proline' 0 C--N 1.36 1.183 0 C-N-CA 123.203 2.602 . . . . 0.0 114.463 -178.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.501 ' HB3' ' O ' ' B' ' 113' ' ' HIS . 14.0 p -79.2 -32.49 44.1 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.878 -178.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.464 HG11 ' HB3' ' A' ' 20' ' ' ALA . 2.6 t -62.57 -31.05 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.988 -179.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.416 HD21 ' HB ' ' A' ' 54' ' ' VAL . 23.6 tp -65.76 -45.57 82.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.306 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.38 -43.76 68.07 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -178.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.732 ' HB1' ' HB2' ' A' ' 20' ' ' ALA . . . -67.57 -20.22 65.36 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -179.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.2 tt -99.05 -23.91 15.1 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.152 0.501 . . . . 0.0 110.214 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.9 mmmt -75.11 99.07 3.83 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -178.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -126.48 -24.88 3.54 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 175.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -171.63 -166.03 0.42 Allowed 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 112.235 -2.257 . . . . 0.0 105.612 178.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -70.15 -59.96 2.58 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 119.92 -0.712 . . . . 0.0 110.258 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 4' ' ' LYS . . . 56.45 -118.45 11.57 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 121.133 -0.556 . . . . 0.0 112.59 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.403 ' HB3' ' H ' ' A' ' 43' ' ' ALA . 10.5 t -96.64 -94.12 0.21 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.403 ' H ' ' HB3' ' A' ' 42' ' ' CYS . . . 66.93 -51.54 0.47 Allowed 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 178.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.1 p -54.84 -22.28 14.02 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 113.715 1.005 . . . . 0.0 113.715 -178.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.1 t -66.75 -49.98 64.23 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.494 0.664 . . . . 0.0 109.924 178.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.615 ' CD2' HG12 ' A' ' 17' ' ' ILE . 0.8 OUTLIER -72.2 -43.57 64.28 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 178.271 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.532 ' SG ' HD12 ' A' ' 29' ' ' LEU . 86.1 m -94.14 67.58 3.62 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.832 -1.077 . . . . 0.0 109.611 178.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -92.9 -105.33 0.12 Allowed 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.2 p30 -72.85 -10.57 59.94 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 121.934 0.873 . . . . 0.0 108.972 177.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -103.35 99.06 8.89 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 113.687 -1.597 . . . . 0.0 106.793 177.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 44.9 t -169.07 79.92 0.13 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -177.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.491 ' CE1' ' HB2' ' B' ' 89' ' ' ASP . 3.5 p80 -138.93 18.03 2.65 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.415 0.626 . . . . 0.0 110.454 176.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.661 ' HA3' ' HG2' ' B' ' 91' ' ' PRO . . . -119.33 -135.36 5.08 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.657 -0.702 . . . . 0.0 112.337 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.732 HG23 ' HA ' ' A' ' 30' ' ' PRO . 16.1 m -55.54 -27.94 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -74.38 -38.23 63.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.448 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.587 ' HD3' ' O ' ' A' ' 53' ' ' GLY . 0.0 OUTLIER -65.61 -24.91 67.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.697 0.284 . . . . 0.0 111.062 -179.773 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -58.36 -26.09 62.75 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.441 -179.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.495 ' O ' ' HB2' ' A' ' 59' ' ' HIS . 3.2 mm? -90.72 -23.66 20.64 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.495 ' HB2' ' O ' ' A' ' 58' ' ' LEU . 39.3 m-70 74.72 63.83 0.07 Allowed 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.144 0.578 . . . . 0.0 111.994 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -140.48 14.98 2.37 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.947 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.425 ' HB3' ' O ' ' A' ' 47' ' ' CYS . 1.5 p . . . . . 0 C--O 1.245 0.829 0 CA-C-O 118.136 -0.935 . . . . 0.0 111.287 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.286 0 CA-C-O 120.763 0.316 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' MET . . . . . 0.56 ' HG3' ' H ' ' B' ' 64' ' ' GLY . 6.0 ptt? -89.69 -85.47 0.21 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.533 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . 0.56 ' H ' ' HG3' ' B' ' 63' ' ' MET . . . 79.16 175.65 47.36 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.608 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 21.8 mttp -111.16 94.27 4.9 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 122.619 -0.342 . . . . 0.0 110.972 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 66' ' ' CYS . . . . . 0.71 ' HA ' ' CB ' ' B' ' 70' ' ' LYS . 0.0 OUTLIER 56.39 60.37 3.17 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.328 178.964 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 1.7 p -102.24 131.18 48.95 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.289 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . 0.506 ' O ' ' HB2' ' B' ' 71' ' ' LYS . 12.0 t 51.14 -95.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 123.984 0.914 . . . . 0.0 113.411 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 46.1 tp -60.29 -42.25 95.09 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 120.836 0.351 . . . . 0.0 111.341 -178.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 70' ' ' LYS . . . . . 0.71 ' CB ' ' HA ' ' B' ' 66' ' ' CYS . 17.9 mmtm -64.45 -23.35 67.25 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.614 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . 0.506 ' HB2' ' O ' ' B' ' 68' ' ' VAL . 0.0 OUTLIER -65.64 -25.88 67.56 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.009 179.85 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 4.9 t -94.38 -16.95 7.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.43 0.633 . . . . 0.0 109.755 179.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.65 -33.96 40.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.761 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 74' ' ' CYS . . . . . 0.636 ' HB3' ' SG ' ' B' ' 103' ' ' CYS . 15.0 p -64.67 -43.28 94.08 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.772 -179.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -69.8 -3.69 16.73 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -105.15 -46.91 4.12 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.172 0.511 . . . . 0.0 109.741 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.6 -39.97 70.16 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.32 -0.855 . . . . 0.0 112.079 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.642 HG23 ' N ' ' B' ' 79' ' ' ALA . 6.0 tp -73.23 -37.37 51.96 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 CA-C-O 121.323 0.582 . . . . 0.0 109.706 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 79' ' ' ALA . . . . . 0.642 ' N ' HG23 ' B' ' 78' ' ' ILE . . . -63.32 -33.09 74.76 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.915 -1.038 . . . . 0.0 110.713 179.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -74.96 -30.96 58.52 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.646 -0.787 . . . . 0.0 111.699 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.76 -21.43 61.74 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.206 0.527 . . . . 0.0 110.47 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 44.4 t -64.46 -51.72 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.081 178.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.45 -19.72 63.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.126 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.65 -39.64 57.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.737 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 1.4 t -88.36 -30.8 19.27 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.804 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 114.66 40.37 0.93 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.299 -0.953 . . . . 0.0 113.806 178.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 136.15 175.05 13.61 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.072 -1.061 . . . . 0.0 112.936 179.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 6.1 tp -91.3 134.3 30.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.183 0.516 . . . . 0.0 111.098 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 89' ' ' ASP . . . . . 0.495 ' OD1' ' HD2' ' B' ' 91' ' ' PRO . 2.6 t0 -156.46 -119.01 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 90' ' ' LEU . . . . . 0.704 HD22 ' HA3' ' B' ' 114' ' ' GLY . 47.1 tp -177.66 -53.63 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.461 0 C-N-CA 123.077 0.551 . . . . 0.0 111.121 177.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 91' ' ' PRO . . . . . 0.663 ' HD3' ' HG3' ' A' ' 30' ' ' PRO . 2.9 Cg_endo -48.36 -48.96 15.46 Favored 'Trans proline' 0 C--N 1.359 1.093 0 C-N-CA 123.018 2.479 . . . . 0.0 113.634 -179.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 4.2 t -81.64 -40.34 23.06 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.935 0.398 . . . . 0.0 111.583 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 2.2 t -62.3 -24.49 35.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.409 -179.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 94' ' ' LEU . . . . . 0.726 ' HG ' ' HG3' ' B' ' 98' ' ' LYS . 22.5 tp -63.48 -26.72 68.85 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.27 0.471 . . . . 0.0 112.27 -179.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.05 -31.89 61.47 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -178.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -83.59 -1.85 54.78 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 97' ' ' LEU . . . . . 0.407 HD12 ' CD1' ' B' ' 78' ' ' ILE . 21.0 mt -136.75 14.88 3.13 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -178.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . 0.726 ' HG3' ' HG ' ' B' ' 94' ' ' LEU . 12.6 mtpt -84.68 102.54 13.04 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 119.554 -0.859 . . . . 0.0 111.73 -179.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -162.16 170.9 18.3 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.35 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -80.09 127.38 32.23 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 58.23 -143.75 0.63 Allowed 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -178.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.37 -72.45 1.19 Allowed Glycine 0 C--N 1.329 0.189 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.676 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 103' ' ' CYS . . . . . 0.636 ' SG ' ' HB3' ' B' ' 74' ' ' CYS . 45.9 t -164.56 -109.63 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 119.757 -0.163 . . . . 0.0 110.616 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 104' ' ' ALA . . . . . 0.418 ' N ' ' SG ' ' B' ' 103' ' ' CYS . . . 67.82 -59.06 0.43 Allowed 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.682 0.793 . . . . 0.0 112.4 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 105' ' ' SER . . . . . 0.531 ' HA ' ' HB2' ' B' ' 108' ' ' CYS . 5.0 p -63.94 2.8 0.46 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -178.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 106' ' ' CYS . . . . . 0.437 ' HB2' ' SG ' ' B' ' 66' ' ' CYS . 8.7 t -72.81 -47.27 47.86 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . 0.623 ' CD2' HG12 ' B' ' 78' ' ' ILE . 1.0 OUTLIER -74.24 -25.93 59.93 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 177.216 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 108' ' ' CYS . . . . . 0.587 ' O ' ' HB3' ' B' ' 122' ' ' CYS . 2.5 m -103.36 67.35 0.92 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.42 -1.263 . . . . 0.0 110.279 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -96.53 -108.04 0.16 Allowed 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 45.8 p30 -72.95 -11.45 60.58 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 177.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -103.03 99.12 8.98 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 113.087 -1.87 . . . . 0.0 106.877 177.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 42.6 t -144.96 83.06 1.68 Allowed 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.791 -176.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 113' ' ' HIS . . . . . 0.687 ' HA ' ' HD2' ' B' ' 117' ' ' LYS . 1.0 OUTLIER -150.01 2.41 0.51 Allowed 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.8 0.666 . . . . 0.0 112.8 179.668 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 114' ' ' GLY . . . . . 0.704 ' HA3' HD22 ' B' ' 90' ' ' LEU . . . -98.72 -156.48 29.34 Favored Glycine 0 C--O 1.227 -0.293 0 C-N-CA 120.048 -1.072 . . . . 0.0 112.728 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . 0.646 ' CG2' ' HA ' ' B' ' 91' ' ' PRO . 19.6 m -56.63 -11.19 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 122.959 0.504 . . . . 0.0 112.35 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 116' ' ' CYS . . . . . 0.51 ' O ' HD23 ' B' ' 121' ' ' LEU . 35.7 t -84.25 -39.75 18.89 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.377 -178.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 117' ' ' LYS . . . . . 0.687 ' HD2' ' HA ' ' B' ' 113' ' ' HIS . 6.3 ptmm? -64.99 -14.37 60.12 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.71 0.291 . . . . 0.0 110.737 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -57.08 -25.33 58.56 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.138 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 119' ' ' LEU . . . . . 0.611 ' HB2' HD22 ' B' ' 121' ' ' LEU . 3.1 mm? -99.26 -13.18 19.8 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 122.072 -0.392 . . . . 0.0 111.483 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 22.2 m-70 67.34 76.03 0.29 Allowed 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 122.943 0.497 . . . . 0.0 111.365 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 121' ' ' LEU . . . . . 0.623 HD21 ' N ' ' B' ' 121' ' ' LEU . 1.0 OUTLIER -140.02 18.56 2.46 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.487 -179.334 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 122' ' ' CYS . . . . . 0.587 ' HB3' ' O ' ' B' ' 108' ' ' CYS . 0.9 OUTLIER . . . . . 0 C--O 1.246 0.889 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.767 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.191 0 CA-C-O 120.801 0.334 . . . . 0.0 110.762 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 4.6 ptm -148.18 172.84 13.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.306 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 144.67 178.28 20.18 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.646 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 27.3 mtmm -89.42 144.94 25.67 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.521 0.201 . . . . 0.0 110.87 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 34.6 m 64.85 29.93 12.35 Favored 'General case' 0 N--CA 1.463 0.203 0 O-C-N 123.852 0.72 . . . . 0.0 110.883 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.473 ' HG ' ' HG3' ' A' ' 40' ' ' GLU . 27.2 m -99.57 164.97 11.85 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -179.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.505 ' CG1' ' H ' ' A' ' 8' ' ' LEU . 5.7 p 36.76 -92.25 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 179.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.552 ' O ' HG21 ' A' ' 11' ' ' VAL . 22.0 tp -66.74 -31.41 72.04 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 117.957 0.344 . . . . 0.0 111.63 -177.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.2 mmmm -91.71 12.59 20.74 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.48 ' O ' ' HG3' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -111.47 11.56 21.4 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.609 -179.84 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.552 HG21 ' O ' ' A' ' 8' ' ' LEU . 95.0 t -51.31 -55.14 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 121.243 0.544 . . . . 0.0 110.624 178.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -167.32 62.49 0.08 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.975 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.673 ' HB2' ' CD1' ' A' ' 17' ' ' ILE . 1.8 p 46.98 33.1 2.11 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 124.129 0.893 . . . . 0.0 110.737 -177.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.62 65.23 8.43 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 114.258 -1.337 . . . . 0.0 110.545 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -145.61 -88.6 0.1 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.765 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.59 -21.74 44.63 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.325 0.584 . . . . 0.0 111.732 -178.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.9 HD13 ' HB2' ' A' ' 46' ' ' PHE . 64.5 mt -80.76 -8.79 11.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-O 121.836 0.827 . . . . 0.0 110.808 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -111.01 -9.9 14.39 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.529 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -115.18 -53.69 0.39 Allowed Glycine 0 C--O 1.228 -0.264 0 C-N-CA 120.568 -0.825 . . . . 0.0 113.013 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.88 -22.9 65.08 Favored 'General case' 0 C--O 1.226 -0.172 0 CA-C-N 117.207 0.504 . . . . 0.0 111.469 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.649 HG13 HD12 ' A' ' 27' ' ' ILE . 2.6 t -66.7 -41.9 88.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 O-C-N 122.09 -0.381 . . . . 0.0 110.824 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.03 -30.08 69.22 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.456 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.86 -30.82 71.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.092 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.0 t -87.09 -23.35 24.93 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.787 0.327 . . . . 0.0 110.664 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.64 39.32 4.19 Favored Glycine 0 N--CA 1.453 -0.177 0 C-N-CA 120.51 -0.852 . . . . 0.0 113.115 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 135.14 174.25 13.36 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.188 -1.006 . . . . 0.0 112.782 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.649 HD12 HG13 ' A' ' 21' ' ' VAL . 23.0 mm -72.73 125.85 32.28 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 CA-C-O 121.261 0.553 . . . . 0.0 111.412 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.412 ' HB2' ' CD2' ' B' ' 113' ' ' HIS . 35.5 t70 -144.31 -122.01 0.08 Allowed 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.737 -1.12 . . . . 0.0 108.421 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.759 ' HG ' HG22 ' A' ' 54' ' ' VAL . 12.1 tp 165.65 -61.02 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.407 0 C-N-CA 124.134 0.973 . . . . 0.0 109.645 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 1.029 ' HA ' HG11 ' A' ' 54' ' ' VAL . 9.5 Cg_endo -54.32 -41.22 78.31 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.044 1.83 . . . . 0.0 113.216 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.759 ' HB3' ' HA2' ' B' ' 114' ' ' GLY . 23.4 p -81.2 -38.07 27.64 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.552 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.42 HG21 ' SG ' ' A' ' 31' ' ' CYS . 24.1 t -67.51 -25.11 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.74 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.692 ' HA ' ' HB3' ' A' ' 36' ' ' LEU . 22.2 tp -52.35 -32.43 38.21 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.563 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -45.36 -43.98 11.41 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -115.83 22.41 13.08 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.104 0.478 . . . . 0.0 109.873 178.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.692 ' HB3' ' HA ' ' A' ' 33' ' ' LEU . 27.9 tp -114.81 -14.2 11.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.898 -178.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.593 ' HD3' ' O ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -69.36 85.11 0.4 Allowed 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.794 0.807 . . . . 0.0 111.674 -179.143 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.37 -159.06 0.98 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.047 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -125.06 -162.78 1.13 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.799 0.333 . . . . 0.0 111.539 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.473 ' HG3' ' HG ' ' A' ' 6' ' ' SER . 64.6 mm-40 58.11 -129.46 1.46 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.331 179.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.517 ' O ' ' HB3' ' A' ' 13' ' ' CYS . . . -62.12 -25.41 66.29 Favored Glycine 0 C--N 1.332 0.341 0 CA-C-N 115.892 -0.595 . . . . 0.0 114.429 -178.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 98.1 m -86.48 -0.45 56.08 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 117.711 0.755 . . . . 0.0 111.579 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' A' ' 47' ' ' CYS . . . -113.61 -61.15 1.78 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.679 0.276 . . . . 0.0 111.534 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 18.4 m -89.22 50.95 2.02 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -178.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.433 ' HB3' ' HB3' ' A' ' 13' ' ' CYS . 11.2 t -150.83 -56.28 0.16 Allowed 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.9 ' HB2' HD13 ' A' ' 17' ' ' ILE . 0.9 OUTLIER -87.99 -47.61 8.41 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.866 178.808 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 43' ' ' ALA . 95.5 m -81.98 47.82 1.16 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.102 -0.954 . . . . 0.0 112.144 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -84.79 -74.94 0.37 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 178.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -100.63 -21.46 15.25 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.356 178.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 55.2 m-70 -84.82 98.43 10.29 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 177.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.66 ' CB ' ' HG2' ' A' ' 56' ' ' LYS . 81.1 m -142.86 -10.28 0.79 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -177.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.637 ' O ' ' HB2' ' B' ' 91' ' ' PRO . 45.6 m80 -30.15 95.9 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 115.459 1.652 . . . . 0.0 115.459 -178.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 64.44 -6.71 0.74 Allowed Glycine 0 CA--C 1.526 0.753 0 N-CA-C 116.287 1.275 . . . . 0.0 116.287 176.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 1.029 HG11 ' HA ' ' A' ' 30' ' ' PRO . 0.1 OUTLIER -106.59 -72.62 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 118.359 1.08 . . . . 0.0 110.896 -179.806 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.724 ' SG ' HD12 ' A' ' 29' ' ' LEU . 57.5 m -71.23 -23.3 61.98 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.66 ' HG2' ' CB ' ' A' ' 51' ' ' CYS . 53.3 mmtt -72.19 -32.65 66.99 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.084 177.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -62.65 -39.2 93.12 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.654 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 38.9 mt -77.45 -16.03 59.0 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.397 178.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 12.4 t-160 58.78 65.19 1.27 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.112 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.1 mt -131.61 13.8 4.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.389 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 7.9 p . . . . . 0 C--O 1.245 0.851 0 CA-C-O 117.793 -1.099 . . . . 0.0 109.573 -179.823 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.264 0 CA-C-O 120.7 0.286 . . . . 0.0 110.831 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' MET . . . . . . . . . . . . . 16.1 ptp -93.69 164.74 13.03 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 140.74 166.75 10.81 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.185 -1.007 . . . . 0.0 113.153 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 29.7 mttm -69.27 120.61 15.37 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.516 0.198 . . . . 0.0 111.084 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 66' ' ' CYS . . . . . 0.531 ' SG ' ' HB2' ' B' ' 76' ' ' ALA . 30.9 m 65.38 55.95 1.02 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.407 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 71.0 m -79.46 -85.84 0.08 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.676 -0.238 . . . . 0.0 110.992 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 4.2 p -122.6 -58.68 2.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.679 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 31.5 tp -73.73 -23.84 59.82 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.247 0.546 . . . . 0.0 110.135 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 70' ' ' LYS . . . . . 0.575 ' HB3' ' HB3' ' B' ' 76' ' ' ALA . 1.0 OUTLIER -88.38 11.18 17.52 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.912 178.789 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . 0.55 ' HG3' ' HA3' ' B' ' 102' ' ' GLY . 25.1 ttpp -114.78 17.73 16.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.611 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 63.1 t -71.92 -59.81 3.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 120.836 0.351 . . . . 0.0 110.755 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -141.61 55.62 1.51 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.874 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 74' ' ' CYS . . . . . 0.641 ' HB3' ' CD1' ' B' ' 78' ' ' ILE . 2.7 m 58.56 29.68 18.77 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.893 -179.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -78.98 64.47 3.92 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -177.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . 0.575 ' HB3' ' HB3' ' B' ' 70' ' ' LYS . . . -163.04 -77.07 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.923 0.392 . . . . 0.0 111.127 178.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . 0.537 ' HB3' ' HA ' ' B' ' 97' ' ' LEU . . . -86.51 -2.52 58.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.211 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.649 HG12 ' HD2' ' B' ' 107' ' ' PHE . 44.8 mt -119.03 -68.09 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.637 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -84.57 52.46 2.38 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.563 0.697 . . . . 0.0 109.472 177.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -165.21 -38.68 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 110.306 -1.117 . . . . 0.0 110.306 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . 0.664 ' HB2' ' HB1' ' B' ' 96' ' ' ALA . . . -76.15 -11.44 59.93 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-O 121.253 0.549 . . . . 0.0 109.724 178.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 82' ' ' VAL . . . . . 0.91 HG22 ' HB ' ' B' ' 88' ' ' ILE . 15.3 t -65.43 -36.98 78.97 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.272 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -77.07 -8.77 58.04 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.593 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -103.88 -17.94 14.83 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.779 0.323 . . . . 0.0 111.251 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -109.42 -7.57 15.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.375 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 69.44 56.37 8.74 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.569 -0.824 . . . . 0.0 111.858 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 120.79 152.58 8.88 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.85 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 88' ' ' ILE . . . . . 0.91 ' HB ' HG22 ' B' ' 82' ' ' VAL . 4.3 tp -98.64 137.2 26.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.946 0.403 . . . . 0.0 112.042 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 89' ' ' ASP . . . . . 0.446 ' O ' ' HZ ' ' B' ' 107' ' ' PHE . 7.0 t70 -161.65 -96.3 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.591 -0.732 . . . . 0.0 109.324 178.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 90' ' ' LEU . . . . . 0.557 ' N ' ' HD2' ' B' ' 91' ' ' PRO . 52.6 tp -179.29 -54.42 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.586 0 CA-C-O 119.514 -0.279 . . . . 0.0 111.686 178.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 91' ' ' PRO . . . . . 0.637 ' HB2' ' O ' ' A' ' 52' ' ' HIS . 2.7 Cg_endo -41.44 -58.36 1.13 Allowed 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 123.522 2.815 . . . . 0.0 114.486 -178.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 8.8 p -86.91 -34.01 19.53 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.4 -0.52 . . . . 0.0 111.408 -179.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 2.8 t -58.86 -22.16 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.515 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 94' ' ' LEU . . . . . 0.887 HD21 ' HB ' ' B' ' 115' ' ' VAL . 15.1 tp -54.43 -34.54 61.58 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.527 179.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.82 -46.3 81.73 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . 0.664 ' HB1' ' HB2' ' B' ' 81' ' ' ALA . . . -102.83 10.81 38.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.558 0.218 . . . . 0.0 111.504 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 97' ' ' LEU . . . . . 0.537 ' HA ' ' HB3' ' B' ' 77' ' ' ALA . 23.0 tp -81.84 -9.54 59.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.1 0.476 . . . . 0.0 110.294 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -62.89 101.24 0.25 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.037 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -130.46 -179.68 5.41 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.987 0.422 . . . . 0.0 111.867 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -92.04 -87.52 0.21 Allowed 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.041 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -119.83 155.85 31.81 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -178.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . 0.55 ' HA3' ' HG3' ' B' ' 71' ' ' LYS . . . 63.4 30.05 76.39 Favored Glycine 0 C--N 1.332 0.336 0 N-CA-C 115.559 0.983 . . . . 0.0 115.559 177.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 13.3 m -138.25 -42.56 0.51 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 118.053 0.926 . . . . 0.0 111.897 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -74.1 -33.61 63.68 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.922 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 13.3 m -85.61 4.28 36.97 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -178.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 32.1 p -110.04 -37.45 5.59 Favored 'General case' 0 C--N 1.327 -0.383 0 O-C-N 121.494 -0.754 . . . . 0.0 110.498 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . 0.649 ' HD2' HG12 ' B' ' 78' ' ' ILE . 0.6 OUTLIER -88.65 -74.28 0.47 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.133 -179.54 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 108' ' ' CYS . . . . . 0.654 ' HB3' ' SG ' ' B' ' 122' ' ' CYS . 13.4 m -66.49 15.19 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . 0.55 ' H ' ' C ' ' B' ' 107' ' ' PHE . 19.4 tp10 -71.86 -69.6 0.38 Allowed 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.925 -179.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -59.93 -45.65 91.92 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.72 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -111.32 100.28 8.92 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.994 177.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 112' ' ' CYS . . . . . 0.483 ' O ' ' HD2' ' B' ' 117' ' ' LYS . 35.9 t -114.63 63.35 0.67 Allowed 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.394 -178.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 113' ' ' HIS . . . . . 0.42 ' HA ' ' HG3' ' B' ' 117' ' ' LYS . 13.6 p-80 -146.61 -172.35 3.95 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 114' ' ' GLY . . . . . 0.759 ' HA2' ' HB3' ' A' ' 31' ' ' CYS . . . 72.57 -144.29 35.33 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.747 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . 0.887 ' HB ' HD21 ' B' ' 94' ' ' LEU . 1.4 m -62.77 -22.28 29.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 116' ' ' CYS . . . . . 0.492 ' SG ' ' HB2' ' B' ' 121' ' ' LEU . 4.6 t -65.03 -31.86 73.3 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.304 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 117' ' ' LYS . . . . . 0.483 ' HD2' ' O ' ' B' ' 112' ' ' CYS . 8.8 mtpm? -89.31 -22.81 22.48 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.318 -0.401 . . . . 0.0 109.963 178.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -57.19 -42.86 82.03 Favored 'General case' 0 CA--C 1.522 -0.109 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 119' ' ' LEU . . . . . 0.534 ' O ' ' HB2' ' B' ' 120' ' ' HIS . 5.3 tt -89.54 -72.82 0.54 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 177.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 120' ' ' HIS . . . . . 0.534 ' HB2' ' O ' ' B' ' 119' ' ' LEU . 14.2 t-160 134.02 91.18 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 125.829 1.652 . . . . 0.0 109.733 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 121' ' ' LEU . . . . . 0.678 HD12 HD11 ' B' ' 94' ' ' LEU . 88.2 mt -117.14 -53.53 2.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.935 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 122' ' ' CYS . . . . . 0.654 ' SG ' ' HB3' ' B' ' 108' ' ' CYS . 1.8 p . . . . . 0 C--O 1.244 0.812 0 CA-C-O 118.607 -0.711 . . . . 0.0 109.398 178.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.595 0.236 . . . . 0.0 110.407 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 15.1 mmt -126.14 64.46 1.23 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.882 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -125.82 29.37 4.69 Favored Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.209 -0.996 . . . . 0.0 114.047 -178.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.477 ' O ' ' HB2' ' A' ' 5' ' ' CYS . 0.0 OUTLIER -77.43 134.58 38.36 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.281 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.604 ' O ' ' HG3' ' A' ' 9' ' ' LYS . 52.8 m 73.62 23.19 2.45 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.3 m 37.45 -113.8 0.11 Allowed 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 178.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.597 HG21 ' H ' ' A' ' 8' ' ' LEU . 9.2 m -123.34 -54.3 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -177.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.597 ' H ' HG21 ' A' ' 7' ' ' VAL . 0.3 OUTLIER -67.08 -47.2 71.97 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 120.726 0.298 . . . . 0.0 111.743 -178.799 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.604 ' HG3' ' O ' ' A' ' 5' ' ' CYS . 0.4 OUTLIER -83.98 11.75 7.34 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.058 0.456 . . . . 0.0 109.93 179.131 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 51.1 tptt -81.38 13.85 2.75 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.436 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 18.7 t -60.61 -11.54 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 176.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.456 ' C ' ' H ' ' A' ' 14' ' ' ALA . . . 60.04 29.51 19.07 Favored 'General case' 0 C--N 1.344 0.351 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.529 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.437 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 0.5 OUTLIER 66.22 -30.58 0.14 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 114.318 -1.31 . . . . 0.0 113.543 179.774 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.456 ' H ' ' C ' ' A' ' 12' ' ' ALA . . . -44.89 -81.7 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 115.588 1.699 . . . . 0.0 115.588 -177.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -49.75 -35.43 22.27 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -177.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.76 ' HB3' HD22 ' A' ' 36' ' ' LEU . . . -78.82 -28.6 44.48 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -178.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.701 HG12 ' CD1' ' A' ' 46' ' ' PHE . 7.2 tp -86.4 -43.04 16.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.27 0.557 . . . . 0.0 110.883 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.465 ' N ' HG21 ' A' ' 17' ' ' ILE . . . -61.5 -38.08 86.03 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.824 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.19 -17.7 79.64 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.052 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.442 ' HB3' HG11 ' A' ' 32' ' ' VAL . . . -82.79 -25.52 32.67 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.857 0.361 . . . . 0.0 111.0 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 93.7 t -62.04 -47.76 91.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.569 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.82 -41.21 97.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.665 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.78 -29.4 67.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.453 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.2 t -85.63 -7.21 58.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.266 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.06 24.12 72.54 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.52 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 146.2 176.93 20.46 Favored Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.586 HG12 ' N ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -79.53 151.14 4.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.564 0.697 . . . . 0.0 110.598 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.632 ' OD2' ' HA2' ' B' ' 114' ' ' GLY . 44.8 t0 -158.85 -122.94 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.294 -178.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.837 HD12 ' HE2' ' A' ' 46' ' ' PHE . 23.1 tp 174.0 -62.93 0.0 OUTLIER Pre-proline 0 C--O 1.214 -0.77 0 C-N-CA 124.836 1.254 . . . . 0.0 108.905 178.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.771 ' HA ' HG21 ' A' ' 54' ' ' VAL . 9.3 Cg_endo -54.91 -37.16 93.24 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 121.687 1.592 . . . . 0.0 112.155 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.463 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 0.1 OUTLIER -87.37 -43.34 12.19 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.656 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.48 HG21 ' HB3' ' A' ' 28' ' ' ASP . 10.6 t -70.11 -34.77 60.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -178.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.56 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 0.8 OUTLIER -60.52 -35.6 76.37 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.098 0.475 . . . . 0.0 110.273 179.792 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -54.61 -31.48 57.19 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.467 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -72.57 -24.91 61.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.814 0.34 . . . . 0.0 110.843 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.76 HD22 ' HB3' ' A' ' 16' ' ' ALA . 11.8 mt -92.25 9.5 33.55 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.794 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.495 ' O ' ' HB1' ' A' ' 38' ' ' ALA . 18.8 mmtp -68.58 -175.23 0.64 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.834 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.495 ' HB1' ' O ' ' A' ' 37' ' ' LYS . . . 76.61 -42.9 0.44 Allowed 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.676 0.79 . . . . 0.0 110.318 -178.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -131.22 63.93 1.59 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 178.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -63.37 -8.77 9.66 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -177.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -59.29 -32.64 72.63 Favored Glycine 0 CA--C 1.518 0.244 0 C-N-CA 121.01 -0.614 . . . . 0.0 113.632 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.511 ' SG ' ' HB2' ' A' ' 9' ' ' LYS . 64.5 m -107.54 24.91 12.15 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 122.385 -0.479 . . . . 0.0 111.321 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -88.99 -19.81 25.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.531 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.7 p -56.36 -33.43 65.68 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.331 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.437 ' HB3' ' HB3' ' A' ' 13' ' ' CYS . 7.6 t -47.7 -46.53 29.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.693 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.837 ' HE2' HD12 ' A' ' 29' ' ' LEU . 72.4 t80 -71.31 -50.82 28.65 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -179.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.679 ' HA ' ' HB2' ' A' ' 50' ' ' HIS . 0.1 OUTLIER -86.76 26.8 1.06 Allowed 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 -177.202 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -53.12 -53.68 46.84 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 119.428 1.013 . . . . 0.0 110.48 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -103.77 20.11 18.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.225 0.536 . . . . 0.0 109.789 178.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.679 ' HB2' ' HA ' ' A' ' 47' ' ' CYS . 90.9 m-70 -126.29 62.22 1.27 Allowed 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.278 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 64.6 m -92.49 49.4 1.48 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.632 0.729 . . . . 0.0 109.758 178.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.593 ' CE1' ' HB3' ' B' ' 92' ' ' CYS . 49.7 t-80 -132.33 94.19 3.39 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.551 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.538 ' HA3' ' HB2' ' B' ' 91' ' ' PRO . . . 130.89 -144.91 16.4 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 119.485 -1.341 . . . . 0.0 114.839 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.771 HG21 ' HA ' ' A' ' 30' ' ' PRO . 14.3 m -60.4 -25.97 35.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -177.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.532 ' SG ' ' HB2' ' A' ' 60' ' ' LEU . 34.9 t -76.83 -44.08 33.84 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.044 -0.662 . . . . 0.0 111.826 -178.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.48 -13.45 61.06 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.062 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -66.99 -40.84 87.47 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.988 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.411 ' HA ' HD21 ' A' ' 58' ' ' LEU . 96.6 mt -93.48 2.7 56.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.517 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 58.98 54.16 5.19 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.619 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.532 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 87.1 mt -94.48 -39.91 10.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.741 -179.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 26.3 p . . . . . 0 C--O 1.245 0.866 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.302 179.751 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.261 0 CA-C-O 120.597 0.237 . . . . 0.0 110.468 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' MET . . . . . . . . . . . . . 15.4 ptp -132.88 -22.02 2.11 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.751 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -164.38 -161.64 13.83 Favored Glycine 0 CA--C 1.507 -0.439 0 C-N-CA 120.387 -0.911 . . . . 0.0 112.458 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -115.38 -53.54 2.6 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 121.005 -0.278 . . . . 0.0 111.255 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 66' ' ' CYS . . . . . . . . . . . . . 46.0 t -111.64 105.22 13.69 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -178.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.555 ' OG ' ' HE2' ' B' ' 70' ' ' LYS . 49.1 m 53.59 -160.96 0.13 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.258 -0.883 . . . . 0.0 113.377 178.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . 0.48 HG22 ' H ' ' B' ' 69' ' ' LEU . 13.3 m -120.62 -50.29 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.995 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.48 ' H ' HG22 ' B' ' 68' ' ' VAL . 3.9 pp -86.22 -18.51 31.94 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.479 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 70' ' ' LYS . . . . . 0.555 ' HE2' ' OG ' ' B' ' 67' ' ' SER . 37.1 mtmt -91.87 14.87 14.32 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 177.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . 0.449 ' C ' ' H ' ' B' ' 73' ' ' ALA . 70.0 tttt -89.11 22.22 2.87 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.026 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 2.4 t -68.66 0.01 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-O 121.252 0.549 . . . . 0.0 109.816 178.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.449 ' H ' ' C ' ' B' ' 71' ' ' LYS . . . 72.29 25.82 2.79 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.558 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 3.2 m 64.04 -5.97 0.28 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.378 -0.828 . . . . 0.0 113.182 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 75' ' ' ALA . . . . . 0.412 ' H ' ' C ' ' B' ' 73' ' ' ALA . . . -58.66 -45.88 88.4 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -177.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.81 -3.06 11.01 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -123.49 -20.11 5.67 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.594 HG21 ' N ' ' B' ' 79' ' ' ALA . 4.0 tp -112.0 -44.95 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.722 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 79' ' ' ALA . . . . . 0.594 ' N ' HG21 ' B' ' 78' ' ' ILE . . . -66.64 -32.83 74.4 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.186 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.02 -24.01 60.5 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.366 -0.921 . . . . 0.0 111.724 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.4 -19.69 57.87 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.586 0.231 . . . . 0.0 111.332 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 82' ' ' VAL . . . . . 0.521 HG13 ' HB ' ' B' ' 88' ' ' ILE . 80.9 t -65.1 -52.51 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.691 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.89 -34.46 77.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.736 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.64 -38.51 89.59 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.44 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 16.0 t -85.84 -26.21 25.82 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.344 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.76 46.04 7.45 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.02 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 152.94 132.71 1.79 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.986 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 88' ' ' ILE . . . . . 0.521 ' HB ' HG13 ' B' ' 82' ' ' VAL . 4.7 tp -93.19 135.89 26.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.312 0.577 . . . . 0.0 111.261 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 89' ' ' ASP . . . . . 0.402 ' HB3' ' CE1' ' A' ' 52' ' ' HIS . 47.2 t0 -163.85 -98.82 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 90' ' ' LEU . . . . . 0.912 HD11 ' HB2' ' B' ' 94' ' ' LEU . 59.8 tp -170.11 -58.93 0.0 OUTLIER Pre-proline 0 C--O 1.223 -0.332 0 CA-C-O 119.187 -0.435 . . . . 0.0 111.03 178.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 91' ' ' PRO . . . . . 0.538 ' HB2' ' HA3' ' A' ' 53' ' ' GLY . 2.0 Cg_endo -39.59 -58.79 0.77 Allowed 'Trans proline' 0 C--N 1.363 1.301 0 C-N-CA 123.623 2.882 . . . . 0.0 114.705 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 92' ' ' CYS . . . . . 0.593 ' HB3' ' CE1' ' A' ' 52' ' ' HIS . 8.6 t -84.2 -30.71 25.56 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -178.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . 0.54 HG11 HD11 ' B' ' 78' ' ' ILE . 2.6 t -71.69 -49.62 44.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -178.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 94' ' ' LEU . . . . . 0.912 ' HB2' HD11 ' B' ' 90' ' ' LEU . 2.1 tm? -63.43 -35.16 79.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.955 0.407 . . . . 0.0 110.91 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -53.83 -33.28 55.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.431 -179.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -82.61 -16.96 46.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.95 0.405 . . . . 0.0 111.37 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 97' ' ' LEU . . . . . 0.555 HD13 HD13 ' B' ' 78' ' ' ILE . 6.6 tt -81.69 -10.16 59.46 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.732 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 42.5 mtpt -67.16 72.17 0.11 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.063 0.459 . . . . 0.0 111.924 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -156.67 -40.18 0.07 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -110.25 63.72 0.61 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.874 178.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -59.22 162.42 4.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.06 -178.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 88.05 -45.55 3.31 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.312 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 71.6 m -78.38 -6.26 54.66 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 111.537 0.199 . . . . 0.0 111.537 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.16 -13.62 13.07 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 13.0 m -64.94 -27.25 68.71 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.517 0.192 . . . . 0.0 111.517 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 106' ' ' CYS . . . . . 0.429 ' SG ' ' N ' ' B' ' 107' ' ' PHE . 16.6 p -48.9 -57.42 6.48 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.276 0.56 . . . . 0.0 111.415 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . 0.538 ' CD2' HG12 ' B' ' 78' ' ' ILE . 0.5 OUTLIER -80.27 -54.21 5.94 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.574 -179.693 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 76.1 m -82.27 42.84 0.76 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -178.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -77.11 -62.36 1.68 Allowed 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -90.92 7.35 40.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.876 178.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 40.4 m-70 -126.58 79.55 1.87 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.976 -1.011 . . . . 0.0 108.294 178.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 4.0 t -98.28 32.59 2.42 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -177.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 113' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -121.87 -160.38 0.86 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 178.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 114' ' ' GLY . . . . . 0.656 ' HA2' ' HG2' ' A' ' 30' ' ' PRO . . . 66.86 -145.13 46.25 Favored Glycine 0 C--O 1.226 -0.346 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.364 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . 0.646 HG21 ' HB3' ' B' ' 94' ' ' LEU . 8.2 m -78.56 -2.82 5.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 117.228 0.514 . . . . 0.0 110.518 178.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 116' ' ' CYS . . . . . 0.465 ' SG ' ' HG ' ' B' ' 94' ' ' LEU . 0.5 OUTLIER -82.56 -26.86 32.01 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.709 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 117' ' ' LYS . . . . . 0.544 ' HG2' ' O ' ' B' ' 114' ' ' GLY . 14.0 ptmm? -84.33 -6.67 59.42 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 177.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -65.17 -45.77 83.55 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 178.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 66.0 mt -87.13 -33.62 19.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.974 -1.012 . . . . 0.0 108.585 177.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 58.75 75.28 0.4 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 114.464 -1.243 . . . . 0.0 111.866 179.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.97 21.75 4.15 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.856 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 122' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.243 0.759 0 CA-C-O 118.426 -0.797 . . . . 0.0 110.753 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.291 0 CA-C-O 120.88 0.371 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 85.8 mtp -127.74 168.18 15.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.826 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -166.72 159.95 33.44 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.321 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -76.49 -61.43 1.96 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.997 0.427 . . . . 0.0 110.078 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 14.4 t -122.86 26.82 8.0 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.513 0.673 . . . . 0.0 109.375 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.1 p -131.5 -175.92 3.86 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.29 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 49.5 t 66.56 -74.99 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 O-C-N 123.649 0.593 . . . . 0.0 111.327 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 28.7 tp -82.52 -32.94 28.45 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.5 mptt -88.34 19.83 3.6 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.906 177.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -66.68 -15.19 63.32 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.681 179.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.3 t -90.96 35.02 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.883 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 60.32 46.57 9.95 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.319 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.489 ' O ' HG21 ' A' ' 17' ' ' ILE . 18.1 p 50.38 9.31 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.76 -34.77 72.18 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 118.213 0.46 . . . . 0.0 112.134 -179.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.83 -6.25 36.53 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.97 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -114.34 -35.18 5.05 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.5 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.817 HG12 ' CD2' ' A' ' 46' ' ' PHE . 5.3 tp -93.53 -50.81 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.114 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.619 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.441 ' N ' HG23 ' A' ' 17' ' ' ILE . . . -63.71 -31.64 72.88 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.119 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.53 -24.67 74.34 Favored Glycine 0 N--CA 1.451 -0.357 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 177.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.567 ' HB2' HG11 ' A' ' 32' ' ' VAL . . . -76.31 -26.58 55.98 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.114 0.483 . . . . 0.0 110.392 178.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.46 HG21 ' O ' ' A' ' 17' ' ' ILE . 57.9 t -63.46 -50.08 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.473 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.51 -31.64 71.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.93 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.7 -41.67 78.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.759 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.6 t -84.77 -22.97 29.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.861 0.363 . . . . 0.0 110.74 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 111.1 -38.38 3.31 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.683 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -137.19 167.25 24.75 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.236 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.8 tp -96.2 133.86 35.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.071 0.463 . . . . 0.0 111.061 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.502 ' OD2' ' HD2' ' A' ' 30' ' ' PRO . 9.2 t70 -163.82 -111.16 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.669 HD12 ' HB2' ' A' ' 55' ' ' CYS . 38.8 tp -168.16 -54.01 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 178.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.724 ' HB2' ' HA3' ' B' ' 114' ' ' GLY . 86.5 Cg_exo -46.7 -53.03 6.65 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 122.596 2.197 . . . . 0.0 113.887 -179.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.626 ' HB3' ' CE1' ' B' ' 113' ' ' HIS . 7.7 t -81.33 -33.11 32.71 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.555 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.567 HG11 ' HB2' ' A' ' 20' ' ' ALA . 2.8 t -65.14 -28.72 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-O 121.055 0.455 . . . . 0.0 110.895 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.433 ' O ' HD11 ' A' ' 33' ' ' LEU . 1.9 tm? -61.98 -39.0 90.67 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.641 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.33 -46.23 89.18 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.428 ' HB3' ' CB ' ' A' ' 20' ' ' ALA . . . -78.84 -13.61 59.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.785 0.326 . . . . 0.0 111.402 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 23.0 tp -73.76 -53.05 11.18 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -167.11 -21.99 0.02 OUTLIER 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.251 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 66.61 25.78 9.88 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.118 -179.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -166.57 -170.64 1.67 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.79 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.555 ' HA ' HD11 ' A' ' 60' ' ' LEU . 48.2 mt-10 -64.22 131.37 47.19 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 123.064 0.228 . . . . 0.0 111.249 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 145.7 140.59 3.53 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 119.945 -1.122 . . . . 0.0 113.371 179.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 90.2 m 61.64 31.85 18.61 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.609 ' CB ' ' HB3' ' A' ' 60' ' ' LEU . . . -80.59 -44.36 19.07 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.384 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.444 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 12.2 m -68.8 -16.11 63.69 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.903 0.383 . . . . 0.0 111.268 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 42.5 t -78.09 -54.91 5.73 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.944 0.402 . . . . 0.0 111.276 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.817 ' CD2' HG12 ' A' ' 17' ' ' ILE . 3.6 t80 -102.18 -49.75 3.82 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -178.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.415 ' SG ' ' HD1' ' A' ' 46' ' ' PHE . 21.2 m -72.96 13.56 0.38 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -177.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.444 ' HB2' ' O ' ' A' ' 44' ' ' SER . 16.5 tp10 -69.6 -53.66 17.72 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.142 0.496 . . . . 0.0 111.185 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -66.38 -23.95 66.41 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.079 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -135.23 103.78 5.65 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 96.0 m -112.65 81.07 1.42 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 177.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.625 ' CE1' ' HB3' ' B' ' 92' ' ' CYS . 2.6 t-80 -142.16 -34.52 0.46 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -177.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.774 ' HA2' ' HB2' ' B' ' 91' ' ' PRO . . . -87.16 -162.45 37.7 Favored Glycine 0 CA--C 1.518 0.266 0 N-CA-C 115.587 0.995 . . . . 0.0 115.587 -178.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.538 ' O ' HG21 ' A' ' 54' ' ' VAL . 7.7 p -58.44 -10.49 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 124.409 1.084 . . . . 0.0 112.575 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.669 ' HB2' HD12 ' A' ' 29' ' ' LEU . 18.0 t -77.99 -31.49 50.73 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 121.999 -0.438 . . . . 0.0 111.071 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.604 ' HG3' ' O ' ' A' ' 53' ' ' GLY . 0.1 OUTLIER -90.34 -2.35 57.98 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.466 179.819 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.415 ' O ' ' HB3' ' A' ' 58' ' ' LEU . 52.9 t0 -56.46 122.47 12.0 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.647 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.67 ' O ' ' HB2' ' A' ' 59' ' ' HIS . 45.2 tp 90.24 -64.94 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.029 1.332 . . . . 0.0 108.699 -177.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.67 ' HB2' ' O ' ' A' ' 58' ' ' LEU . 26.5 t-80 153.03 121.13 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.911 0 O-C-N 124.763 1.289 . . . . 0.0 109.303 178.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.609 ' HB3' ' CB ' ' A' ' 43' ' ' ALA . 22.1 mt -147.3 -55.85 0.24 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 19.1 p . . . . . 0 C--O 1.246 0.906 0 CA-C-O 118.435 -0.793 . . . . 0.0 110.747 -179.812 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.199 0 CA-C-O 120.738 0.304 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' MET . . . . . . . . . . . . . 9.9 ptm -149.33 -37.49 0.16 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.074 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 48.11 -144.47 6.36 Favored Glycine 0 C--N 1.334 0.446 0 N-CA-C 115.05 0.78 . . . . 0.0 115.05 178.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . 0.439 ' O ' ' HD3' ' B' ' 70' ' ' LYS . 33.9 ttmt -89.41 -98.83 0.1 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.201 -0.5 . . . . 0.0 110.017 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 66' ' ' CYS . . . . . . . . . . . . . 66.0 m -119.47 19.87 12.58 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.342 0.591 . . . . 0.0 109.872 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 10.3 p -127.05 -176.99 3.88 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.225 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 22.7 t 64.68 -80.64 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 O-C-N 123.704 0.627 . . . . 0.0 111.519 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 44.2 tp -78.75 -38.48 38.67 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 70' ' ' LYS . . . . . 0.439 ' HD3' ' O ' ' B' ' 65' ' ' LYS . 6.6 mptt -87.15 22.27 2.13 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.258 178.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . 0.486 ' C ' ' H ' ' B' ' 73' ' ' ALA . 33.0 ttmt -66.41 -15.18 63.11 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.863 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 2.3 t -80.54 33.55 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.015 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.486 ' H ' ' C ' ' B' ' 71' ' ' LYS . . . 62.03 55.45 2.51 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.863 -1.062 . . . . 0.0 112.048 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 9.7 p 57.58 -4.18 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.624 1.169 . . . . 0.0 114.138 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 75' ' ' ALA . . . . . 0.542 ' O ' ' HB1' ' B' ' 79' ' ' ALA . . . -67.13 -26.32 66.62 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.82 -9.09 25.65 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -120.75 -34.28 3.61 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.615 HD11 HD13 ' B' ' 97' ' ' LEU . 7.8 tp -82.79 -48.5 17.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.118 0.485 . . . . 0.0 111.683 -179.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 79' ' ' ALA . . . . . 0.602 ' H ' HG22 ' B' ' 78' ' ' ILE . . . -57.81 -24.9 59.54 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.106 -179.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.18 -22.85 70.0 Favored Glycine 0 C--N 1.329 0.183 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.12 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -80.65 -17.81 50.04 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.092 0.472 . . . . 0.0 110.623 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 82' ' ' VAL . . . . . 0.433 HG11 ' HB ' ' B' ' 88' ' ' ILE . 60.4 t -66.78 -43.44 89.86 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.453 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.24 6.48 11.76 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.917 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -110.26 -19.68 12.92 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 3.0 t -120.03 12.23 11.9 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.515 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 71.06 33.82 65.08 Favored Glycine 0 CA--C 1.519 0.285 0 N-CA-C 114.693 0.637 . . . . 0.0 114.693 178.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 148.36 -177.05 26.87 Favored Glycine 0 CA--C 1.51 -0.269 0 C-N-CA 119.864 -1.16 . . . . 0.0 112.543 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 88' ' ' ILE . . . . . 0.433 ' HB ' HG11 ' B' ' 82' ' ' VAL . 4.4 tp -123.23 134.7 65.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.994 0.426 . . . . 0.0 111.043 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 89' ' ' ASP . . . . . 0.518 ' HB3' ' CE1' ' A' ' 52' ' ' HIS . 28.7 t70 -156.47 -102.38 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 90' ' ' LEU . . . . . 0.601 HD13 ' HE2' ' B' ' 107' ' ' PHE . 22.1 tp -167.09 -59.06 0.01 OUTLIER Pre-proline 0 N--CA 1.469 0.488 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 177.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 91' ' ' PRO . . . . . 0.774 ' HB2' ' HA2' ' A' ' 53' ' ' GLY . 2.1 Cg_endo -43.87 -56.2 2.58 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 123.049 2.499 . . . . 0.0 114.631 -178.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 92' ' ' CYS . . . . . 0.625 ' HB3' ' CE1' ' A' ' 52' ' ' HIS . 12.3 t -81.22 -32.85 33.25 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . 0.59 HG11 HD12 ' B' ' 78' ' ' ILE . 0.2 OUTLIER -68.02 -29.2 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-O 120.668 0.27 . . . . 0.0 111.217 -179.197 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -62.21 -39.15 91.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.222 0.534 . . . . 0.0 110.252 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.35 -43.53 85.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.206 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.6 19.51 4.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.68 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 97' ' ' LEU . . . . . 0.615 HD13 HD11 ' B' ' 78' ' ' ILE . 35.8 tp -77.04 -52.62 9.01 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.17 0.509 . . . . 0.0 109.708 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -140.82 -64.33 0.46 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.181 179.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -176.35 -60.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.893 -1.049 . . . . 0.0 108.578 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -131.89 -56.28 0.99 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.116 178.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -130.56 156.46 44.8 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.883 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 128.91 127.12 2.93 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 119.86 -1.162 . . . . 0.0 114.002 178.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 87.7 m 58.43 31.81 21.38 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -90.1 -24.92 20.99 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 18.0 t -64.45 -47.2 79.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.72 0.295 . . . . 0.0 110.863 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 37.0 t -60.16 -50.24 74.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.917 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . 0.612 ' CD1' HG12 ' B' ' 78' ' ' ILE . 52.9 t80 -73.09 -58.55 3.23 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -178.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 21.7 m -79.03 34.14 0.23 Allowed 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -177.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 19.1 tp10 -63.31 -80.99 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 118.154 0.433 . . . . 0.0 110.373 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -76.32 -30.55 57.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.505 0.669 . . . . 0.0 109.294 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 111' ' ' HIS . . . . . 0.427 ' HD2' ' O ' ' B' ' 107' ' ' PHE . 5.6 m-70 -81.87 71.07 8.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.647 179.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 9.8 t -128.84 84.47 2.23 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.116 0.484 . . . . 0.0 110.057 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 113' ' ' HIS . . . . . 0.626 ' CE1' ' HB3' ' A' ' 31' ' ' CYS . 9.3 t-80 -126.08 -47.48 1.63 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.289 -178.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 114' ' ' GLY . . . . . 0.724 ' HA3' ' HB2' ' A' ' 30' ' ' PRO . . . -147.41 164.68 28.71 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 119.997 -1.097 . . . . 0.0 113.401 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . 0.616 HG11 ' HA ' ' B' ' 91' ' ' PRO . 0.5 OUTLIER 61.88 -45.0 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 125.581 1.552 . . . . 0.0 113.253 179.626 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 116' ' ' CYS . . . . . 0.541 ' N ' HG12 ' B' ' 115' ' ' VAL . 6.9 t -87.2 -30.23 21.14 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -90.74 4.47 51.47 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.375 178.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -63.01 -32.44 73.8 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.352 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 25.5 tp -112.78 -114.71 0.33 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -141.51 59.13 1.51 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 86.2 mt -99.24 -35.93 9.81 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 122' ' ' CYS . . . . . . . . . . . . . 3.4 p . . . . . 0 C--O 1.245 0.824 0 CA-C-O 118.345 -0.836 . . . . 0.0 110.286 179.339 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.231 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 18.9 ptm -72.18 125.35 27.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.947 0.403 . . . . 0.0 110.54 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 128.85 128.31 3.05 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.77 -0.728 . . . . 0.0 111.904 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.4 ttmm -67.02 -30.09 70.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.175 0.512 . . . . 0.0 110.747 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 52.3 t -67.19 -40.47 86.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.338 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.1 p -76.79 29.88 0.13 Allowed 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 46.2 t -120.78 -55.98 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 178.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 34.9 tp -98.99 -39.11 8.7 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.504 ' N ' ' HD3' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -92.24 26.15 2.65 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 176.915 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.549 ' C ' ' H ' ' A' ' 12' ' ' ALA . 46.7 pttt -59.64 -17.79 36.52 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.098 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.501 HG23 ' HB1' ' A' ' 15' ' ' ALA . 3.5 t -75.2 26.38 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.043 179.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.549 ' H ' ' C ' ' A' ' 10' ' ' LYS . . . 60.36 51.07 5.58 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.709 0.804 . . . . 0.0 111.9 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.689 ' HB3' HD11 ' A' ' 17' ' ' ILE . 76.4 m 73.21 -17.97 0.39 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.97 0.729 . . . . 0.0 112.97 179.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.7 16.99 0.17 Allowed 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.501 ' HB1' HG23 ' A' ' 11' ' ' VAL . . . -104.44 -31.46 9.48 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.733 0.302 . . . . 0.0 111.109 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -123.37 -48.84 1.94 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.476 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.689 HD11 ' HB3' ' A' ' 13' ' ' CYS . 69.3 mt -64.19 -45.92 94.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-O 121.42 0.629 . . . . 0.0 109.569 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -110.44 31.71 5.73 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.156 178.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -129.63 -43.23 0.21 Allowed Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.73 -0.747 . . . . 0.0 111.968 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.67 ' HB3' HG12 ' A' ' 32' ' ' VAL . . . -87.35 19.92 3.05 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.997 0.427 . . . . 0.0 111.343 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.561 HG22 ' HB ' ' A' ' 27' ' ' ILE . 12.5 p -65.92 -45.57 90.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.974 0.892 . . . . 0.0 110.286 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.442 ' N ' HG13 ' A' ' 21' ' ' VAL . . . -64.46 -26.42 68.44 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.555 -1.202 . . . . 0.0 111.629 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.8 -40.06 95.73 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.577 ' SG ' ' HA3' ' B' ' 114' ' ' GLY . 4.5 t -97.07 1.6 50.27 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.768 0.318 . . . . 0.0 110.801 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.42 42.43 82.02 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.519 -0.848 . . . . 0.0 111.426 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 144.35 156.03 6.66 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.561 ' HB ' HG22 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -87.19 133.92 28.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 117.595 0.697 . . . . 0.0 111.389 -179.035 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.619 ' OD1' ' HB3' ' A' ' 31' ' ' CYS . 1.2 p30 -143.55 -112.25 0.11 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.308 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.639 ' HB3' ' HD3' ' A' ' 30' ' ' PRO . 12.5 tp -179.28 -56.56 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.449 0 C-N-CA 122.358 0.263 . . . . 0.0 111.7 178.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.789 ' HA ' HG23 ' A' ' 54' ' ' VAL . 8.7 Cg_exo -76.05 -4.12 14.73 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 121.874 1.716 . . . . 0.0 113.177 -178.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.619 ' HB3' ' OD1' ' A' ' 28' ' ' ASP . 21.6 t -104.88 -38.95 6.45 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 177.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.67 HG12 ' HB3' ' A' ' 20' ' ' ALA . 42.3 t -78.64 -10.77 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.221 178.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.576 ' HG ' ' HB2' ' A' ' 37' ' ' LYS . 6.3 tp -54.21 -29.17 45.23 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.945 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -46.95 -45.82 21.04 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -178.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -102.88 33.23 3.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.982 0.42 . . . . 0.0 111.16 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.438 HD22 ' HD2' ' A' ' 46' ' ' PHE . 5.5 tp -137.14 -41.59 0.58 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.761 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.576 ' HB2' ' HG ' ' A' ' 33' ' ' LEU . 1.8 tmtp? -59.96 -35.11 74.25 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -177.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.23 -64.18 1.04 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -178.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.471 ' O ' ' HE2' ' A' ' 9' ' ' LYS . . . -93.81 55.01 2.07 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -178.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.772 ' HG2' ' H ' ' A' ' 42' ' ' CYS . 85.0 tt0 70.83 137.63 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.337 0.589 . . . . 0.0 111.517 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.537 ' HA3' HD13 ' A' ' 60' ' ' LEU . . . -79.32 -11.23 85.19 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.715 -0.755 . . . . 0.0 113.186 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.772 ' H ' ' HG2' ' A' ' 40' ' ' GLU . 33.9 m 69.75 94.61 0.07 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 122.96 0.504 . . . . 0.0 111.193 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.476 ' C ' ' H ' ' A' ' 45' ' ' CYS . . . -65.96 153.43 42.11 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.902 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.6 p 66.76 -29.09 0.13 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.624 1.169 . . . . 0.0 112.365 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.476 ' H ' ' C ' ' A' ' 43' ' ' ALA . 6.0 t -78.15 -70.13 0.51 Allowed 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.559 ' HD1' ' CE1' ' A' ' 50' ' ' HIS . 0.1 OUTLIER -90.18 165.31 14.03 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 175.514 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.777 ' HB3' ' SG ' ' A' ' 61' ' ' CYS . 73.4 m 72.66 -0.68 3.24 Favored 'General case' 0 C--O 1.216 -0.68 0 O-C-N 123.364 0.415 . . . . 0.0 111.642 -178.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.553 ' HA ' ' OE1' ' A' ' 48' ' ' GLU . 5.1 tp10 -61.35 -93.32 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.274 0.559 . . . . 0.0 111.187 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.446 ' H ' ' HB3' ' A' ' 48' ' ' GLU . 17.8 t70 -70.35 -33.33 71.33 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 178.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.559 ' CE1' ' HD1' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -88.61 56.95 3.97 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 112.466 -2.152 . . . . 0.0 109.535 178.463 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 14.8 t -93.63 63.77 3.46 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 17.2 t-160 -163.49 136.25 5.35 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.06 -177.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 117.0 -157.7 14.91 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 119.864 -1.16 . . . . 0.0 113.78 178.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.789 HG23 ' HA ' ' A' ' 30' ' ' PRO . 3.5 m -70.73 -5.13 5.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.39 -0.405 . . . . 0.0 112.001 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.445 ' HB3' ' CD2' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -76.79 -40.94 46.46 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.119 0.485 . . . . 0.0 110.573 -178.98 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.409 ' HE2' ' HB3' ' A' ' 56' ' ' LYS . 31.6 mtpt -67.46 -10.75 54.45 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.818 179.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -65.59 -33.03 74.96 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.558 ' O ' HD22 ' A' ' 58' ' ' LEU . 2.4 tt -90.19 -21.16 22.31 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.937 178.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 75.06 97.87 0.07 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.377 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.634 ' HB2' ' SG ' ' A' ' 47' ' ' CYS . 26.3 mt -136.84 2.37 2.61 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.144 -179.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.777 ' SG ' ' HB3' ' A' ' 47' ' ' CYS . 29.2 p . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.107 -0.949 . . . . 0.0 109.707 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.169 0 CA-C-O 120.707 0.289 . . . . 0.0 110.399 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' MET . . . . . . . . . . . . . 22.9 ptm -111.01 151.87 27.49 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.395 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.65 173.16 26.87 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.077 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 3.4 ttpm? -131.84 44.59 2.89 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.346 0.593 . . . . 0.0 109.832 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 66' ' ' CYS . . . . . 0.563 ' HB2' ' O ' ' B' ' 101' ' ' GLU . 48.9 t -120.38 -40.89 2.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.274 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 35.1 m -74.17 34.31 0.09 Allowed 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . 0.428 ' H ' ' C ' ' B' ' 66' ' ' CYS . 22.8 t -122.69 -59.01 2.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.432 ' C ' ' H ' ' B' ' 71' ' ' LYS . 52.3 tp -96.04 -40.3 9.32 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 70' ' ' LYS . . . . . 0.412 ' HG3' ' HB3' ' B' ' 76' ' ' ALA . 0.8 OUTLIER -85.26 24.68 1.1 Allowed 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 177.227 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . 0.577 ' C ' ' H ' ' B' ' 73' ' ' ALA . 0.0 OUTLIER -65.51 -10.09 31.62 Favored 'General case' 0 C--N 1.341 0.223 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.558 179.819 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 2.4 t -70.76 21.58 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.868 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.577 ' H ' ' C ' ' B' ' 71' ' ' LYS . . . 63.79 56.98 1.43 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.844 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 74' ' ' CYS . . . . . 0.697 ' HB3' HD13 ' B' ' 78' ' ' ILE . 12.2 m 67.45 0.74 2.26 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.854 0.686 . . . . 0.0 112.854 178.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 75' ' ' ALA . . . . . 0.557 ' HA ' ' CB ' ' B' ' 79' ' ' ALA . . . -82.6 6.62 17.11 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . 0.412 ' HB3' ' HG3' ' B' ' 70' ' ' LYS . . . -99.17 -57.52 2.14 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.733 0.302 . . . . 0.0 111.789 -179.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.19 -38.66 12.57 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.697 HD13 ' HB3' ' B' ' 74' ' ' CYS . 71.9 mt -81.71 -55.5 7.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.979 0.419 . . . . 0.0 110.383 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 79' ' ' ALA . . . . . 0.557 ' CB ' ' HA ' ' B' ' 75' ' ' ALA . . . -83.39 14.47 3.61 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.276 0.56 . . . . 0.0 110.853 178.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . 0.402 ' HA3' ' O ' ' B' ' 76' ' ' ALA . . . -114.24 -41.22 0.9 Allowed Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 178.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . 0.508 ' HB1' HG12 ' B' ' 93' ' ' VAL . . . -73.51 -7.31 51.31 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-O 120.976 0.417 . . . . 0.0 110.358 178.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 82' ' ' VAL . . . . . 0.593 HG21 HG12 ' B' ' 88' ' ' ILE . 13.0 p -60.14 -42.16 89.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-O 121.619 0.723 . . . . 0.0 109.445 178.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . 0.476 ' N ' HG12 ' B' ' 82' ' ' VAL . . . -70.36 -27.29 64.22 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.429 -1.26 . . . . 0.0 111.467 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.69 -46.06 14.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.84 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 38.0 t -79.33 -48.33 14.27 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.903 0.382 . . . . 0.0 110.85 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 117.98 41.09 0.67 Allowed Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.908 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 140.1 176.19 14.89 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.525 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 88' ' ' ILE . . . . . 0.593 HG12 HG21 ' B' ' 82' ' ' VAL . 18.1 mm -104.65 118.85 52.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.158 0.504 . . . . 0.0 111.232 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 89' ' ' ASP . . . . . 0.467 ' CG ' ' H ' ' B' ' 90' ' ' LEU . 7.7 p-10 -138.24 -108.5 0.18 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.029 178.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 90' ' ' LEU . . . . . 0.777 HD11 ' SG ' ' B' ' 108' ' ' CYS . 0.1 OUTLIER -174.87 -53.76 0.0 OUTLIER Pre-proline 0 N--CA 1.451 -0.402 0 C-N-CA 122.367 0.267 . . . . 0.0 111.105 179.621 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 91' ' ' PRO . . . . . 0.896 ' HB3' HG13 ' B' ' 115' ' ' VAL . 27.1 Cg_exo -63.97 -29.9 66.76 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.212 1.941 . . . . 0.0 115.293 -176.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 14.3 p -92.07 -40.5 11.04 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 119.695 -0.802 . . . . 0.0 110.042 179.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . 0.508 HG12 ' HB1' ' B' ' 81' ' ' ALA . 2.5 t -65.83 -27.76 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.699 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 26.1 tp -55.43 -45.3 76.81 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.355 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.8 -45.66 91.63 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.245 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.25 -21.27 59.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.178 0.514 . . . . 0.0 110.787 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 10.2 tt -78.66 -29.02 45.48 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.086 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . 0.655 ' HE2' HD11 ' B' ' 119' ' ' LEU . 29.5 tttm -74.7 45.8 0.26 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 112.115 -179.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -98.87 -12.4 20.81 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -151.37 -150.33 0.34 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.504 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . 0.563 ' O ' ' HB2' ' B' ' 66' ' ' CYS . 47.1 mt-10 -112.33 160.64 17.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.765 0.317 . . . . 0.0 111.461 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.35 -141.29 29.69 Favored Glycine 0 N--CA 1.452 -0.285 0 CA-C-N 115.801 -0.636 . . . . 0.0 113.724 178.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 82.5 m 72.79 40.13 0.62 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.7 0.762 . . . . 0.0 110.711 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -114.64 -160.28 0.73 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 177.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 105' ' ' SER . . . . . 0.513 ' O ' ' HB2' ' B' ' 109' ' ' GLU . 15.0 m 68.37 -56.15 0.51 Allowed 'General case' 0 N--CA 1.467 0.418 0 O-C-N 123.584 0.553 . . . . 0.0 112.317 178.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 29.9 p -80.04 -35.74 36.74 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 122.001 -0.437 . . . . 0.0 110.566 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . 0.586 ' CE1' HD22 ' B' ' 90' ' ' LEU . 0.7 OUTLIER -88.63 -97.78 0.09 Allowed 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.248 -178.536 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 108' ' ' CYS . . . . . 0.777 ' SG ' HD11 ' B' ' 90' ' ' LEU . 33.7 m -63.43 33.75 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 115.011 1.486 . . . . 0.0 115.011 -177.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . 0.513 ' HB2' ' O ' ' B' ' 105' ' ' SER . 44.3 tp10 -59.92 -70.44 0.17 Allowed 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 119.301 0.955 . . . . 0.0 110.709 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -92.53 -20.31 21.07 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.082 0.468 . . . . 0.0 110.137 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 111' ' ' HIS . . . . . 0.482 ' HB2' HD21 ' B' ' 90' ' ' LEU . 0.5 OUTLIER -86.88 86.63 7.33 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.034 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 112' ' ' CYS . . . . . 0.415 ' O ' ' HE2' ' B' ' 117' ' ' LYS . 1.6 t -121.05 43.03 2.9 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.942 0.401 . . . . 0.0 110.416 -178.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 113' ' ' HIS . . . . . 0.462 ' O ' HG22 ' B' ' 115' ' ' VAL . 3.8 t-160 -88.37 121.03 30.31 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.556 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 114' ' ' GLY . . . . . 0.577 ' HA3' ' SG ' ' A' ' 24' ' ' CYS . . . 45.45 -99.86 0.02 OUTLIER Glycine 0 C--O 1.223 -0.566 0 N-CA-C 115.681 1.032 . . . . 0.0 115.681 177.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . 0.896 HG13 ' HB3' ' B' ' 91' ' ' PRO . 12.5 m -29.57 -60.54 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 -177.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 116' ' ' CYS . . . . . 0.544 ' O ' HD21 ' B' ' 121' ' ' LEU . 0.9 OUTLIER -73.34 -30.5 63.38 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.102 -0.639 . . . . 0.0 112.019 -177.755 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 117' ' ' LYS . . . . . 0.415 ' HE2' ' O ' ' B' ' 112' ' ' CYS . 11.9 ttmm -76.08 -11.05 59.87 Favored 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 122.024 -0.422 . . . . 0.0 110.09 178.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -67.83 -43.29 79.89 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 178.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 119' ' ' LEU . . . . . 0.655 HD11 ' HE2' ' B' ' 98' ' ' LYS . 5.1 tt -78.28 -36.47 46.68 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 177.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 14.1 t-80 78.82 75.58 0.05 Allowed 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 114.693 -1.14 . . . . 0.0 111.656 178.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 121' ' ' LEU . . . . . 0.572 ' CD2' ' HB3' ' B' ' 119' ' ' LEU . 0.4 OUTLIER -128.16 13.39 6.68 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.378 179.47 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 122' ' ' CYS . . . . . . . . . . . . . 3.6 p . . . . . 0 C--O 1.246 0.869 0 CA-C-O 118.293 -0.861 . . . . 0.0 110.478 179.212 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.242 0 CA-C-O 120.527 0.203 . . . . 0.0 111.012 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 73.8 mtp -124.06 -11.71 7.53 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -71.17 92.27 0.48 Allowed Glycine 0 CA--C 1.516 0.128 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.872 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.4 tptm 57.45 -93.62 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.422 0.689 . . . . 0.0 110.575 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.596 ' HB2' ' OG ' ' A' ' 44' ' ' SER . 49.5 t -141.75 143.05 33.3 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.494 ' HB2' ' HE2' ' A' ' 10' ' ' LYS . 6.2 m -66.17 117.57 8.66 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.8 m -119.71 -27.2 2.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.433 ' H ' HD22 ' A' ' 8' ' ' LEU . 0.4 OUTLIER -73.2 -51.07 19.13 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 -178.826 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.7 mmtt -83.79 -12.96 54.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.716 0.293 . . . . 0.0 111.333 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.671 ' HZ1' ' HG3' ' A' ' 40' ' ' GLU . 16.7 ttmm -91.81 33.8 1.02 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.703 0.287 . . . . 0.0 111.335 -178.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.3 t 53.15 41.33 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 123.514 0.726 . . . . 0.0 112.138 178.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 51.68 36.18 16.86 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.973 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.418 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 95.7 m 64.89 14.14 9.05 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.665 ' HA ' ' HB2' ' A' ' 18' ' ' ALA . . . -99.31 14.86 28.13 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.41 -68.97 0.79 Allowed 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -87.65 -3.15 58.98 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -178.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.552 HD12 ' HB2' ' A' ' 46' ' ' PHE . 45.3 mt -112.64 -62.86 2.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.548 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.665 ' HB2' ' HA ' ' A' ' 14' ' ' ALA . . . -59.27 -34.72 72.6 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.86 -37.84 18.03 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.689 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.46 ' HB2' HG13 ' A' ' 32' ' ' VAL . . . -75.04 -28.21 60.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.021 0.439 . . . . 0.0 111.677 -179.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.507 HG12 ' HA ' ' A' ' 27' ' ' ILE . 1.9 t -66.36 -43.17 91.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.617 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.64 -25.66 64.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.149 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.75 -24.39 63.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.651 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 12.4 t -89.17 -31.93 17.71 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.755 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 128.55 17.23 1.95 Allowed Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.093 -1.051 . . . . 0.0 113.88 178.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 116.14 114.65 2.86 Favored Glycine 0 C--O 1.227 -0.309 0 C-N-CA 120.24 -0.981 . . . . 0.0 112.29 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.507 ' HA ' HG12 ' A' ' 21' ' ' VAL . 1.4 tt 19.13 94.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.594 ' CG ' ' HB3' ' A' ' 31' ' ' CYS . 6.8 t0 -127.73 143.34 51.15 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 114.18 -1.373 . . . . 0.0 107.616 177.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.774 ' HB3' ' HD3' ' A' ' 30' ' ' PRO . 36.7 tp -106.88 -58.49 0.05 OUTLIER Pre-proline 0 C--N 1.303 -1.429 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.232 -179.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.864 ' HA ' HG11 ' A' ' 54' ' ' VAL . 25.9 Cg_exo -62.59 -28.22 77.0 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 121.93 1.753 . . . . 0.0 112.594 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.594 ' HB3' ' CG ' ' A' ' 28' ' ' ASP . 0.1 OUTLIER -84.46 -41.31 16.73 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.764 -179.147 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.46 HG13 ' HB2' ' A' ' 20' ' ' ALA . 45.1 t -84.91 -6.22 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-O 121.174 0.511 . . . . 0.0 111.021 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.625 HD23 ' HA ' ' A' ' 55' ' ' CYS . 2.4 tm? -54.37 -45.46 72.79 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.326 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.77 -36.86 80.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.529 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.08 2.02 52.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.805 0.336 . . . . 0.0 111.493 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 57.4 tp -97.3 -32.32 11.95 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.322 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -75.93 -26.5 56.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.19 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -106.9 -179.71 4.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.628 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 57.49 31.91 20.99 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 123.568 0.542 . . . . 0.0 112.286 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.671 ' HG3' ' HZ1' ' A' ' 10' ' ' LYS . 11.6 tp10 53.69 67.91 0.93 Allowed 'General case' 0 CA--C 1.534 0.348 0 O-C-N 123.611 0.569 . . . . 0.0 110.509 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -79.5 -166.07 31.67 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.73 -0.668 . . . . 0.0 113.493 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.474 ' HB2' ' CD ' ' A' ' 10' ' ' LYS . 47.0 t -160.31 88.83 0.82 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.618 ' CB ' ' HB3' ' A' ' 60' ' ' LEU . . . -68.44 -42.03 79.46 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -178.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.596 ' OG ' ' HB2' ' A' ' 5' ' ' CYS . 2.4 p -75.56 28.4 0.1 Allowed 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.363 0.602 . . . . 0.0 112.438 -179.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.48 ' H ' ' C ' ' A' ' 43' ' ' ALA . 20.1 t -139.6 -18.21 0.97 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.552 ' HB2' HD12 ' A' ' 17' ' ' ILE . 0.8 OUTLIER -111.0 -63.17 1.43 Allowed 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.785 -179.311 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.548 ' SG ' HD13 ' A' ' 29' ' ' LEU . 19.8 m -79.12 25.34 0.29 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.473 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.435 ' H ' ' C ' ' A' ' 46' ' ' PHE . 41.5 tp10 -52.94 -62.31 1.74 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.642 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -92.74 -31.8 14.93 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -79.47 76.05 6.07 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.423 ' SG ' ' HB3' ' A' ' 56' ' ' LYS . 4.0 t -128.31 52.45 1.9 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -177.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 15.9 p-80 -122.46 82.64 2.0 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.637 0.732 . . . . 0.0 110.712 178.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.75 172.77 44.21 Favored Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.479 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.864 HG11 ' HA ' ' A' ' 30' ' ' PRO . 44.9 t 63.61 -73.32 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 123.297 0.639 . . . . 0.0 112.59 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.625 ' HA ' HD23 ' A' ' 33' ' ' LEU . 38.9 t -71.72 -44.38 64.23 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.407 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.423 ' HB3' ' SG ' ' A' ' 51' ' ' CYS . 0.1 OUTLIER -88.05 13.31 11.4 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 119.899 -0.72 . . . . 0.0 110.603 179.17 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -69.14 -35.35 76.26 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 177.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -95.58 -4.13 45.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 113.972 -1.467 . . . . 0.0 108.521 177.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 75.1 m-70 65.91 75.25 0.35 Allowed 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 114.414 -1.266 . . . . 0.0 110.912 -178.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.618 ' HB3' ' CB ' ' A' ' 43' ' ' ALA . 88.6 mt -106.06 -31.29 8.79 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.36 -179.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.7 p . . . . . 0 C--O 1.245 0.845 0 CA-C-O 118.304 -0.855 . . . . 0.0 110.179 179.059 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' B' ' 63' ' ' MET . . . . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 120.454 0.169 . . . . 0.0 111.017 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' MET . . . . . 0.415 ' HB2' ' O ' ' B' ' 62' ' ' ALA . 56.9 mtp 73.03 -76.17 0.07 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.577 0.751 . . . . 0.0 112.434 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -153.61 173.28 32.36 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 119.871 -1.157 . . . . 0.0 113.361 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 38.6 mtpt 53.09 -104.15 0.19 Allowed 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.435 0.694 . . . . 0.0 111.81 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 66' ' ' CYS . . . . . 0.449 ' SG ' ' HE3' ' B' ' 71' ' ' LYS . 42.2 t -161.02 133.27 5.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.562 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 31.1 m -80.94 86.06 6.14 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . 0.432 HG12 ' SG ' ' B' ' 74' ' ' CYS . 27.7 m -63.37 -38.94 83.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -176.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.71 -43.93 93.91 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -177.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 70' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -91.29 12.51 20.1 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.712 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . 0.78 ' HD2' ' HB2' ' B' ' 103' ' ' CYS . 13.0 ttmm -122.64 38.67 4.11 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.87 0.367 . . . . 0.0 110.824 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 9.7 t 56.1 32.91 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 123.57 0.748 . . . . 0.0 112.087 179.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . 50.58 34.41 9.58 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 178.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 74' ' ' CYS . . . . . 0.448 ' O ' ' HB ' ' B' ' 78' ' ' ILE . 30.3 m 66.15 23.65 10.93 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 178.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -90.64 -31.23 16.72 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -178.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -71.15 -75.16 0.13 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -178.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.01 29.67 0.13 Allowed 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -177.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.448 ' HB ' ' O ' ' B' ' 74' ' ' CYS . 23.2 mt -142.2 -58.3 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 O-C-N 122.246 -0.284 . . . . 0.0 110.408 178.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.79 -35.58 77.21 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.927 0.394 . . . . 0.0 110.65 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -75.34 -23.82 72.61 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.363 178.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.78 -28.32 63.54 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.783 0.325 . . . . 0.0 110.747 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 82' ' ' VAL . . . . . 0.447 HG23 ' O ' ' B' ' 78' ' ' ILE . 52.8 t -70.72 -28.11 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.031 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.44 -32.81 72.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.089 0.471 . . . . 0.0 109.883 178.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -87.12 1.3 53.43 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.754 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 64.3 m -148.49 64.97 1.07 Allowed 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -28.72 -48.09 0.08 OUTLIER Glycine 0 N--CA 1.469 0.899 0 O-C-N 124.881 1.363 . . . . 0.0 114.414 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . -96.36 86.41 0.91 Allowed Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 177.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 88' ' ' ILE . . . . . 0.465 HD11 HG21 ' B' ' 88' ' ' ILE . 0.0 OUTLIER -62.08 135.77 26.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.637 0.732 . . . . 0.0 112.406 -177.551 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 89' ' ' ASP . . . . . 0.472 ' O ' ' HB2' ' B' ' 90' ' ' LEU . 10.3 t70 -146.92 -71.47 0.23 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.146 178.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 90' ' ' LEU . . . . . 0.659 ' N ' ' HD2' ' B' ' 91' ' ' PRO . 29.1 tp 172.37 -49.54 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.434 0 O-C-N 123.995 0.81 . . . . 0.0 109.844 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 91' ' ' PRO . . . . . 0.659 ' HD2' ' N ' ' B' ' 90' ' ' LEU . 5.4 Cg_exo -31.9 -70.11 0.05 OUTLIER 'Trans proline' 0 C--N 1.367 1.505 0 C-N-CA 124.842 3.695 . . . . 0.0 115.341 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 26.8 p -83.81 -31.84 25.64 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -177.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 1.1 t -62.02 -22.49 28.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.943 0.401 . . . . 0.0 111.002 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 94' ' ' LEU . . . . . 0.638 ' HG ' HG13 ' B' ' 115' ' ' VAL . 2.8 tm? -67.97 -37.12 81.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.663 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.53 -47.32 79.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.978 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -83.48 -2.52 56.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.684 0.278 . . . . 0.0 111.717 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 27.1 tp -86.84 -21.66 26.28 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.27 0.557 . . . . 0.0 110.055 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.25 -3.02 27.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.442 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -121.84 160.7 24.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.651 0.262 . . . . 0.0 111.457 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . 55.92 56.61 5.85 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.161 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 52.53 60.45 3.8 Favored 'General case' 0 N--CA 1.465 0.277 0 O-C-N 123.728 0.642 . . . . 0.0 110.533 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -77.66 164.89 52.31 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.847 -0.692 . . . . 0.0 113.328 -178.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 103' ' ' CYS . . . . . 0.78 ' HB2' ' HD2' ' B' ' 71' ' ' LYS . 35.3 t -136.44 77.73 1.67 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 104' ' ' ALA . . . . . 0.56 ' CB ' ' HB3' ' B' ' 121' ' ' LEU . . . -67.0 -40.14 87.26 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -178.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 8.0 t -75.94 29.94 0.11 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.168 0.508 . . . . 0.0 111.488 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 106' ' ' CYS . . . . . 0.651 ' HB2' ' SG ' ' B' ' 103' ' ' CYS . 44.6 t -118.73 -50.17 2.42 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.756 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . 0.467 ' C ' ' H ' ' B' ' 109' ' ' GLU . 0.1 OUTLIER -102.41 -46.0 4.92 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.35 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -70.26 30.13 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.487 -0.778 . . . . 0.0 112.727 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . 0.467 ' H ' ' C ' ' B' ' 107' ' ' PHE . 23.5 tt0 -69.06 -64.2 0.91 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.49 0.186 . . . . 0.0 110.581 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -76.15 -31.68 58.71 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 59.2 m-70 -74.16 85.67 1.87 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.97 -1.014 . . . . 0.0 108.826 178.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 112' ' ' CYS . . . . . 0.449 ' SG ' ' HG3' ' B' ' 117' ' ' LYS . 4.5 t -151.0 71.58 1.03 Allowed 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.264 -0.574 . . . . 0.0 112.097 -177.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 113' ' ' HIS . . . . . . . . . . . . . 49.4 p-80 -128.64 -17.4 4.09 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 179.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -155.25 -73.18 0.01 OUTLIER Glycine 0 C--O 1.226 -0.396 0 C-N-CA 119.06 -1.543 . . . . 0.0 114.713 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . 0.731 HG22 ' HG2' ' A' ' 30' ' ' PRO . 2.8 t -58.42 -55.6 21.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -177.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 116' ' ' CYS . . . . . 0.568 ' SG ' HD21 ' B' ' 94' ' ' LEU . 1.0 OUTLIER -73.07 -19.86 61.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.831 0.348 . . . . 0.0 111.675 -179.607 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 117' ' ' LYS . . . . . 0.449 ' HG3' ' SG ' ' B' ' 112' ' ' CYS . 15.5 mttm -82.72 -24.44 33.58 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.877 178.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -63.43 -45.42 91.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.93 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -90.24 7.66 37.08 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.23 -0.441 . . . . 0.0 112.053 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 53.3 62.52 2.62 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.022 0.439 . . . . 0.0 110.683 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 121' ' ' LEU . . . . . 0.56 ' HB3' ' CB ' ' B' ' 104' ' ' ALA . 96.3 mt -110.13 -12.55 14.49 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -178.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 122' ' ' CYS . . . . . 0.418 ' SG ' ' HB3' ' B' ' 116' ' ' CYS . 1.8 p . . . . . 0 C--O 1.245 0.848 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.402 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.169 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 4.0 ptm 46.48 -170.22 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.193 0.997 . . . . 0.0 113.553 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -122.19 58.33 0.6 Allowed Glycine 0 CA--C 1.505 -0.549 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.547 -179.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 67.0 mttm 57.03 -122.51 1.62 Allowed 'General case' 0 C--N 1.328 -0.328 0 O-C-N 123.882 0.401 . . . . 0.0 109.991 -179.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 59.2 m -137.47 139.59 40.69 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.311 -0.556 . . . . 0.0 111.989 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.5 p -106.99 -164.45 0.99 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.284 -0.871 . . . . 0.0 108.919 178.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.5 p -78.39 -19.6 13.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.558 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.531 HD21 ' H ' ' A' ' 8' ' ' LEU . 1.0 OUTLIER -96.8 -35.46 10.95 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 121.052 -0.259 . . . . 0.0 110.408 178.728 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.515 ' HD2' ' HG ' ' A' ' 8' ' ' LEU . 1.7 mptm? -84.18 22.96 1.12 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.811 0.339 . . . . 0.0 110.322 178.076 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.7 -9.46 58.61 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 121.433 0.635 . . . . 0.0 110.299 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.6 t -67.27 -22.62 29.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.783 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -81.76 -10.26 59.4 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -178.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 6.1 p -104.36 -47.78 4.02 Favored 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 119.806 -0.757 . . . . 0.0 112.326 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.562 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -64.21 -38.87 92.62 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.12 -12.69 60.01 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -101.79 -38.57 7.8 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.618 HG12 ' CD2' ' A' ' 46' ' ' PHE . 10.9 tp -73.28 -35.06 45.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.42 0.628 . . . . 0.0 111.017 -179.244 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 14' ' ' ALA . . . -58.34 -22.39 53.1 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.973 -1.012 . . . . 0.0 112.806 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -77.79 -29.38 54.93 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.349 -179.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.14 -17.37 52.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.65 0.262 . . . . 0.0 111.143 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.497 HG13 ' HB ' ' A' ' 27' ' ' ILE . 59.1 t -63.07 -46.34 96.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 CA-C-O 120.898 0.38 . . . . 0.0 110.733 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.7 -23.75 64.41 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.165 -0.471 . . . . 0.0 112.201 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -85.71 -23.91 27.19 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.551 0.691 . . . . 0.0 110.947 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.554 ' SG ' ' CD2' ' B' ' 113' ' ' HIS . 0.7 OUTLIER -86.17 -28.1 24.14 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.151 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.21 39.62 9.08 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.131 -1.033 . . . . 0.0 110.684 -179.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 143.63 178.16 19.17 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 -178.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.619 HD11 HG22 ' A' ' 32' ' ' VAL . 3.0 tp -129.47 121.81 54.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 117.871 0.836 . . . . 0.0 112.117 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.562 ' HB3' ' HD2' ' A' ' 30' ' ' PRO . 2.1 m-20 -140.45 -75.83 0.33 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.051 178.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.673 ' HG ' ' CG2' ' A' ' 54' ' ' VAL . 26.6 tp 172.26 -49.63 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.411 0 O-C-N 124.136 0.898 . . . . 0.0 111.354 179.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.734 ' HA ' HG12 ' A' ' 54' ' ' VAL . 5.4 Cg_endo -48.23 -63.66 0.3 Allowed 'Trans proline' 0 C--N 1.359 1.11 0 C-N-CA 123.093 2.529 . . . . 0.0 114.31 -179.206 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.428 ' HB3' ' O ' ' B' ' 113' ' ' HIS . 4.4 p -66.93 -37.87 85.12 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.41 -178.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.619 HG22 HD11 ' A' ' 27' ' ' ILE . 0.2 OUTLIER -70.57 -18.29 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.722 -178.486 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.566 HD23 HD11 ' A' ' 58' ' ' LEU . 58.9 tp -64.88 -21.7 66.86 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.722 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.34 -31.86 35.45 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -178.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -121.43 43.56 2.79 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.838 0.352 . . . . 0.0 110.744 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.548 HD22 ' SG ' ' A' ' 47' ' ' CYS . 14.3 tp -133.91 -6.2 2.77 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -178.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.451 ' O ' ' HB1' ' A' ' 38' ' ' ALA . 77.9 tttt -85.49 74.42 10.33 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 122.032 -0.418 . . . . 0.0 111.989 -179.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.451 ' HB1' ' O ' ' A' ' 37' ' ' LYS . . . 171.79 169.82 0.1 Allowed 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.124 0.569 . . . . 0.0 110.523 179.061 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.96 -39.32 87.21 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.418 ' HG2' ' H ' ' A' ' 40' ' ' GLU . 3.2 pt-20 -78.03 88.59 4.17 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 176.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 13' ' ' CYS . . . 137.94 -39.53 1.59 Allowed Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 108.05 -2.02 . . . . 0.0 108.05 -176.125 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 1.1 m 55.07 93.38 0.02 OUTLIER 'General case' 0 C--O 1.235 0.325 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 176.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.499 ' HA ' ' HG ' ' A' ' 36' ' ' LEU . . . -70.59 -24.99 62.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.476 176.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.8 p -76.15 12.9 1.01 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.925 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 37.8 t -113.14 -56.35 2.42 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.618 ' CD2' HG12 ' A' ' 17' ' ' ILE . 1.1 t80 -77.03 -54.65 6.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.755 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.572 ' O ' ' HB2' ' A' ' 51' ' ' CYS . 53.9 m -68.49 6.23 0.86 Allowed 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -178.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -66.98 -71.02 0.22 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.279 0.561 . . . . 0.0 110.685 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.06 -17.56 58.67 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.372 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.426 ' HD2' ' O ' ' A' ' 46' ' ' PHE . 39.8 m-70 -113.08 83.26 1.8 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.481 -0.782 . . . . 0.0 109.943 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.572 ' HB2' ' O ' ' A' ' 47' ' ' CYS . 22.2 t -140.03 86.94 2.12 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.158 -0.617 . . . . 0.0 112.526 -178.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.686 ' O ' ' HB3' ' B' ' 92' ' ' CYS . 0.0 OUTLIER -144.11 -3.02 0.87 Allowed 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.022 0.439 . . . . 0.0 110.444 177.742 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.843 ' HA3' ' HB2' ' B' ' 91' ' ' PRO . . . -157.42 163.97 32.76 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-O 118.914 -0.936 . . . . 0.0 111.695 178.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.734 HG12 ' HA ' ' A' ' 30' ' ' PRO . 6.0 m 46.55 -64.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 115.377 1.621 . . . . 0.0 115.377 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.462 ' N ' ' O ' ' A' ' 53' ' ' GLY . 0.6 OUTLIER -63.04 -34.13 76.91 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 122.111 -0.368 . . . . 0.0 111.16 -178.676 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.0 pttp -70.58 -28.53 64.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.009 0.433 . . . . 0.0 110.321 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -65.83 -39.34 90.73 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.395 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.566 HD11 HD23 ' A' ' 33' ' ' LEU . 91.3 mt -87.24 4.21 43.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.74 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 58.5 m170 59.5 57.65 3.22 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 123.425 0.453 . . . . 0.0 111.809 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 80.4 mt -112.55 -2.68 14.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.02 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.436 ' SG ' ' HB3' ' A' ' 47' ' ' CYS . 6.3 p . . . . . 0 C--O 1.247 0.946 0 CA-C-O 117.907 -1.044 . . . . 0.0 109.513 179.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 120.587 0.232 . . . . 0.0 110.602 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 63' ' ' MET . . . . . . . . . . . . . 4.9 mtm 71.86 -40.89 0.49 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.125 0.97 . . . . 0.0 112.369 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.23 -36.56 4.21 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.711 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 45.2 mttp 56.24 -154.7 0.32 Allowed 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 122.893 0.477 . . . . 0.0 111.15 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -96.19 71.86 2.85 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 14.5 p -87.81 -131.04 0.07 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.16 -179.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . 0.427 HG11 ' N ' ' B' ' 69' ' ' LEU . 6.0 p -103.12 -41.96 7.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.657 0.265 . . . . 0.0 111.239 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.427 ' N ' HG11 ' B' ' 68' ' ' VAL . 2.4 pt? -86.56 -39.75 15.89 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.349 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 70' ' ' LYS . . . . . 0.474 ' O ' ' HB2' ' B' ' 73' ' ' ALA . 7.5 mtpm? -89.03 24.81 1.99 Allowed 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.257 0.551 . . . . 0.0 110.572 179.064 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.55 -27.24 63.03 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.28 178.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 2.7 t -82.48 6.71 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.448 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.474 ' HB2' ' O ' ' B' ' 70' ' ' LYS . . . -67.11 -8.59 31.89 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.483 0.659 . . . . 0.0 110.456 178.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 74' ' ' CYS . . . . . 0.497 ' HB3' ' HB3' ' B' ' 106' ' ' CYS . 4.6 p -71.42 -30.69 66.37 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.774 179.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -68.4 -5.67 20.32 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.539 -179.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.77 -27.39 63.89 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.359 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -128.79 -29.99 2.31 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.697 HG12 ' CD2' ' B' ' 107' ' ' PHE . 6.4 tp -73.68 -36.22 46.23 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 C-N-CA 120.634 -0.426 . . . . 0.0 111.309 -178.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 79' ' ' ALA . . . . . 0.65 ' N ' HG21 ' B' ' 78' ' ' ILE . . . -59.05 -34.02 71.45 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.869 -178.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -76.69 -33.83 45.78 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.381 -0.914 . . . . 0.0 111.297 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . 0.414 ' O ' ' HB2' ' B' ' 85' ' ' CYS . . . -66.65 -24.81 66.34 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.687 0.28 . . . . 0.0 111.478 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 91.6 t -58.23 -38.5 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-O 121.156 0.503 . . . . 0.0 110.663 179.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.79 -33.25 12.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.373 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.78 -19.15 64.3 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -179.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 85' ' ' CYS . . . . . 0.414 ' HB2' ' O ' ' B' ' 81' ' ' ALA . 0.8 OUTLIER -98.94 -1.01 41.03 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 121.21 -0.196 . . . . 0.0 111.506 -179.858 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 59.68 37.03 91.73 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.298 -179.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 143.35 137.81 3.33 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 110.106 -1.197 . . . . 0.0 110.106 -178.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 3.4 tp -103.25 118.54 50.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 121.493 0.663 . . . . 0.0 112.639 -178.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -133.52 -83.54 0.46 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.261 -0.882 . . . . 0.0 108.876 178.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 90' ' ' LEU . . . . . 0.612 ' N ' ' HD2' ' B' ' 91' ' ' PRO . 38.0 tp 176.85 -51.79 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.94 179.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 91' ' ' PRO . . . . . 0.843 ' HB2' ' HA3' ' A' ' 53' ' ' GLY . 4.0 Cg_exo -38.93 -60.99 0.43 Allowed 'Trans proline' 0 C--N 1.363 1.334 0 C-N-CA 123.66 2.907 . . . . 0.0 114.587 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 92' ' ' CYS . . . . . 0.686 ' HB3' ' O ' ' A' ' 52' ' ' HIS . 24.5 p -83.15 -33.02 26.34 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -178.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . 0.431 HG12 HD11 ' B' ' 78' ' ' ILE . 1.8 t -59.24 -21.44 20.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.881 -178.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 94' ' ' LEU . . . . . 0.876 HD22 ' HB ' ' B' ' 115' ' ' VAL . 15.9 tp -63.17 -35.19 79.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.654 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.35 -28.91 70.09 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -103.58 10.0 37.17 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.93 0.395 . . . . 0.0 111.375 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 97' ' ' LEU . . . . . 0.527 HD21 ' HA ' ' B' ' 104' ' ' ALA . 40.9 tp -93.81 -28.89 15.63 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.571 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -81.8 103.04 11.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.472 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -158.56 -175.34 5.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.302 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -80.25 -0.21 35.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.231 0.538 . . . . 0.0 110.3 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -147.36 47.09 1.13 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.217 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' B' ' 74' ' ' CYS . . . -103.9 -44.68 1.6 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.303 -0.951 . . . . 0.0 113.426 -178.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 75.74 -51.25 0.63 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.136 0.574 . . . . 0.0 110.892 -179.126 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 104' ' ' ALA . . . . . 0.672 ' HB2' ' HB3' ' B' ' 121' ' ' LEU . . . 70.51 -59.69 0.52 Allowed 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 178.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 12.8 p -50.07 -43.84 51.49 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -178.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 106' ' ' CYS . . . . . 0.497 ' HB3' ' HB3' ' B' ' 74' ' ' CYS . 0.0 OUTLIER -52.35 -45.71 65.81 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.108 0.48 . . . . 0.0 111.711 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . 0.697 ' CD2' HG12 ' B' ' 78' ' ' ILE . 20.3 t80 -75.57 -60.88 2.11 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.339 -179.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 108' ' ' CYS . . . . . 0.647 ' HA ' ' HB2' ' B' ' 111' ' ' HIS . 38.1 m -78.84 43.54 0.5 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -178.103 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -74.99 -52.39 11.24 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -102.84 12.84 35.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.894 0.854 . . . . 0.0 108.737 178.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 111' ' ' HIS . . . . . 0.647 ' HB2' ' HA ' ' B' ' 108' ' ' CYS . 89.4 m-70 -119.68 58.45 0.89 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.684 -179.057 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 72.0 m -110.61 61.73 0.61 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.02 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 113' ' ' HIS . . . . . 0.554 ' CD2' ' SG ' ' A' ' 24' ' ' CYS . 0.2 OUTLIER -138.24 -15.68 1.27 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.219 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 114' ' ' GLY . . . . . 0.419 ' O ' ' HG3' ' B' ' 117' ' ' LYS . . . -120.17 -145.08 7.34 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 119.8 -1.19 . . . . 0.0 113.86 -179.124 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . 0.876 ' HB ' HD22 ' B' ' 94' ' ' LEU . 20.2 m -46.16 -28.76 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -179.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 116' ' ' CYS . . . . . 0.614 ' HA ' HD13 ' B' ' 94' ' ' LEU . 2.8 t -71.23 -39.3 71.78 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -177.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 117' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' B' ' 114' ' ' GLY . 0.0 OUTLIER -77.28 -14.72 59.7 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.214 -179.949 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 118' ' ' ASP . . . . . 0.413 ' N ' ' HD3' ' B' ' 117' ' ' LYS . 12.3 t70 -70.0 -37.61 75.75 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.653 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 89.0 mt -94.89 6.95 47.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.417 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 56.5 m170 60.36 69.02 0.72 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.341 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 121' ' ' LEU . . . . . 0.672 ' HB3' ' HB2' ' B' ' 104' ' ' ALA . 98.3 mt -112.7 3.19 16.42 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 122' ' ' CYS . . . . . . . . . . . . . 25.3 p . . . . . 0 C--O 1.246 0.906 0 CA-C-O 118.028 -0.986 . . . . 0.0 109.874 178.078 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.854 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 21.2 ptp -81.45 167.62 19.19 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.212 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 145.82 82.05 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.408 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -62.63 -50.0 72.95 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.839 0.352 . . . . 0.0 110.349 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 75.1 m -81.9 -64.1 1.25 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.228 0.537 . . . . 0.0 110.677 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.484 ' HB3' ' HB2' ' A' ' 9' ' ' LYS . 34.6 t -160.71 -176.89 5.81 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.838 -178.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.1 p -79.27 -28.66 13.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.783 0.325 . . . . 0.0 110.794 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.449 HD23 ' OG ' ' A' ' 6' ' ' SER . 1.1 pt? -94.04 -27.66 16.17 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 121.162 0.506 . . . . 0.0 109.828 178.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.484 ' HB2' ' HB3' ' A' ' 6' ' ' SER . 10.4 mtmt -91.74 29.0 1.62 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 177.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.498 ' C ' ' H ' ' A' ' 12' ' ' ALA . 32.5 tttm -81.11 -4.59 55.79 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 114.071 -1.422 . . . . 0.0 110.227 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.3 t -69.75 13.14 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.64 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.498 ' H ' ' C ' ' A' ' 10' ' ' LYS . . . 59.11 48.65 10.3 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 123.429 0.692 . . . . 0.0 112.55 178.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.79 ' HB3' HD12 ' A' ' 17' ' ' ILE . 24.0 m 67.02 1.75 2.45 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 178.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.67 -66.92 0.49 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.65 38.32 0.19 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -147.46 -52.02 0.2 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.102 0.477 . . . . 0.0 110.497 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.79 HD12 ' HB3' ' A' ' 13' ' ' CYS . 5.3 mt -83.81 -46.8 18.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.343 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.22 -20.09 60.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.137 0.494 . . . . 0.0 109.838 177.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -82.01 -34.94 22.81 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 111.291 -0.724 . . . . 0.0 111.291 178.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.574 ' HB3' HG11 ' A' ' 32' ' ' VAL . . . -63.91 -26.71 68.72 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 121.085 0.469 . . . . 0.0 110.881 179.161 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.493 HG21 ' HB ' ' A' ' 27' ' ' ILE . 57.0 t -63.76 -45.24 97.8 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.299 179.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.42 -18.99 62.31 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.461 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.14 -47.07 15.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.775 0.322 . . . . 0.0 111.844 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.7 t -88.33 -15.31 36.03 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.93 -179.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 108.51 -63.15 0.28 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.216 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -122.53 155.36 17.0 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.334 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.493 ' HB ' HG21 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -86.38 141.89 13.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.06 0.457 . . . . 0.0 111.15 -179.482 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.438 ' OD2' ' HD2' ' A' ' 30' ' ' PRO . 26.6 t70 -163.97 -98.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 178.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.558 HD12 ' SG ' ' A' ' 55' ' ' CYS . 32.8 tp -174.07 -55.32 0.0 OUTLIER Pre-proline 0 C--O 1.222 -0.363 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 178.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 29' ' ' LEU . 3.4 Cg_endo -47.74 -61.71 0.56 Allowed 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 122.786 2.324 . . . . 0.0 114.262 -178.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 13.0 p -76.6 -33.11 58.43 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.459 -178.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.574 HG11 ' HB3' ' A' ' 20' ' ' ALA . 13.0 t -63.09 -26.22 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.727 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.766 ' HG ' HG23 ' A' ' 54' ' ' VAL . 3.1 tm? -55.56 -38.59 69.52 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.767 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -57.45 -41.92 81.46 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.284 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -98.35 12.28 35.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.263 0.554 . . . . 0.0 110.743 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 46.5 tp -99.34 -61.91 1.31 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.654 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.16 167.24 10.33 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.372 0.606 . . . . 0.0 111.539 -179.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.504 ' HB2' ' H ' ' A' ' 39' ' ' ALA . . . -172.56 -112.05 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.504 ' H ' ' HB2' ' A' ' 38' ' ' ALA . . . -92.26 73.08 5.37 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 176.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 39' ' ' ALA . 93.0 mt-10 71.22 92.16 0.09 Allowed 'General case' 0 N--CA 1.464 0.272 0 O-C-N 124.084 0.865 . . . . 0.0 109.707 -177.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -115.43 -173.73 17.67 Favored Glycine 0 C--N 1.33 0.209 0 C-N-CA 120.556 -0.831 . . . . 0.0 113.063 -179.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.419 ' HB3' ' SG ' ' A' ' 13' ' ' CYS . 57.3 m -82.56 62.41 6.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.751 0.31 . . . . 0.0 111.714 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -96.56 -7.59 34.1 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.809 0.338 . . . . 0.0 110.829 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.4 m -81.54 -16.27 52.24 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.886 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.412 ' SG ' ' HB3' ' A' ' 42' ' ' CYS . 6.3 p -98.48 -33.47 11.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.296 0.569 . . . . 0.0 111.131 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.783 ' HB2' HD13 ' A' ' 17' ' ' ILE . 0.9 OUTLIER -86.13 -60.99 1.85 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.665 -178.511 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 4.5 m -72.61 14.08 0.3 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.637 -177.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -51.84 -74.98 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 121.179 0.514 . . . . 0.0 110.457 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -84.86 -27.01 27.01 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 53.7 m-70 -86.71 56.58 4.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.019 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.404 ' O ' ' HB2' ' A' ' 56' ' ' LYS . 7.6 t -108.37 39.62 1.94 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.243 0.544 . . . . 0.0 110.126 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.6 ' CD2' ' HB2' ' B' ' 89' ' ' ASP . 7.8 p-80 -117.82 -12.91 10.14 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.55 -179.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.508 ' O ' ' HB3' ' A' ' 56' ' ' LYS . . . -95.32 -136.14 8.46 Favored Glycine 0 C--O 1.228 -0.226 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.812 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.766 HG23 ' HG ' ' A' ' 33' ' ' LEU . 2.2 p -70.19 -16.11 19.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 120.747 0.308 . . . . 0.0 111.561 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.558 ' SG ' HD12 ' A' ' 29' ' ' LEU . 89.2 m -72.21 -21.17 61.45 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.603 0.716 . . . . 0.0 109.112 176.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.508 ' HB3' ' O ' ' A' ' 53' ' ' GLY . 22.7 tptm -79.6 -20.38 47.04 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.474 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -59.44 -50.25 74.65 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.291 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.52 HD21 ' O ' ' A' ' 58' ' ' LEU . 5.7 tt -83.26 -29.37 28.47 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 9.6 t-160 64.26 55.86 1.4 Allowed 'General case' 0 C--O 1.235 0.301 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.04 179.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.52 20.4 16.13 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.473 179.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.244 0.805 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.541 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.272 0 CA-C-O 120.867 0.365 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 63' ' ' MET . . . . . . . . . . . . . 8.9 ptp -136.13 131.45 34.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.98 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -99.29 49.46 1.22 Allowed Glycine 0 C--O 1.229 -0.209 0 C-N-CA 120.542 -0.837 . . . . 0.0 114.734 -177.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 12.2 mtmt -133.36 -35.98 1.0 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 117.245 0.522 . . . . 0.0 110.427 178.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 66' ' ' CYS . . . . . 0.455 ' HB3' ' HB2' ' B' ' 70' ' ' LYS . 10.4 m -153.71 -108.25 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.656 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 30.0 t -142.65 -179.6 6.41 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 14.0 p -68.61 -28.07 38.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 CA-C-O 120.554 0.216 . . . . 0.0 111.307 -179.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.402 ' C ' ' H ' ' B' ' 71' ' ' LYS . 1.4 pt? -98.38 -26.74 14.38 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.089 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 70' ' ' LYS . . . . . 0.455 ' HB2' ' HB3' ' B' ' 66' ' ' CYS . 25.2 mmtp -87.16 21.46 2.37 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 177.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . 0.404 ' C ' ' H ' ' B' ' 73' ' ' ALA . 15.0 ptmm? -66.83 -6.23 15.42 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.592 -179.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . 0.464 HG22 ' HB3' ' B' ' 76' ' ' ALA . 2.7 t -71.84 12.82 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.654 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.404 ' H ' ' C ' ' B' ' 71' ' ' LYS . . . 62.76 67.02 0.72 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.009 0.523 . . . . 0.0 111.763 179.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 74' ' ' CYS . . . . . 0.722 ' O ' ' HB ' ' B' ' 78' ' ' ILE . 8.5 p 52.77 7.99 0.08 Allowed 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 114.381 -1.282 . . . . 0.0 113.593 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 75' ' ' ALA . . . . . 0.42 ' HB2' ' O ' ' B' ' 72' ' ' VAL . . . -88.87 -3.14 58.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.741 0.305 . . . . 0.0 110.86 179.033 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . 0.464 ' HB3' HG22 ' B' ' 72' ' ' VAL . . . -98.74 22.76 9.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.214 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -163.58 -38.17 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.378 0.608 . . . . 0.0 110.285 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.722 ' HB ' ' O ' ' B' ' 74' ' ' CYS . 1.4 mt -83.66 -46.69 18.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.741 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.8 -29.27 68.41 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.883 0.373 . . . . 0.0 110.682 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.4 -35.71 28.79 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.045 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.61 -26.57 64.5 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.181 0.515 . . . . 0.0 110.626 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 25.5 t -65.82 -43.14 93.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.567 178.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.38 -27.4 67.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.063 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.05 -44.57 46.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.651 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 73.0 m -83.43 -11.83 57.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.762 0.315 . . . . 0.0 110.725 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.3 42.6 10.34 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.605 -0.807 . . . . 0.0 113.171 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.05 176.71 14.51 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.56 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 88' ' ' ILE . . . . . 0.433 HD11 ' CZ ' ' B' ' 107' ' ' PHE . 7.4 tp -74.87 132.93 32.54 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 CA-C-O 121.388 0.613 . . . . 0.0 110.191 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 89' ' ' ASP . . . . . 0.6 ' HB2' ' CD2' ' A' ' 52' ' ' HIS . 32.5 t70 -152.9 -133.85 0.05 OUTLIER 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.479 -178.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 90' ' ' LEU . . . . . 0.717 ' HB3' ' HD3' ' B' ' 91' ' ' PRO . 31.9 tp 179.61 -57.4 0.0 OUTLIER Pre-proline 0 C--N 1.317 -0.826 0 C-N-CA 123.804 0.841 . . . . 0.0 110.129 179.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 91' ' ' PRO . . . . . 0.717 ' HD3' ' HB3' ' B' ' 90' ' ' LEU . 74.2 Cg_exo -51.77 -38.63 67.49 Favored 'Trans proline' 0 C--N 1.363 1.321 0 C-N-CA 122.347 2.031 . . . . 0.0 112.225 179.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 9.4 t -88.83 -40.43 13.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.676 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . 0.674 HG13 ' HE2' ' B' ' 107' ' ' PHE . 7.3 t -66.6 -23.4 31.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.779 -179.204 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 94' ' ' LEU . . . . . 0.799 HD11 ' HG2' ' B' ' 98' ' ' LYS . 2.7 tm? -50.35 -38.76 43.81 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 123.19 0.596 . . . . 0.0 111.929 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -42.67 -51.32 5.3 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -179.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -108.79 21.66 16.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.021 0.438 . . . . 0.0 111.07 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 97' ' ' LEU . . . . . 0.686 ' HG ' ' HB1' ' B' ' 104' ' ' ALA . 32.4 tp -105.25 -49.31 3.49 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.476 -179.073 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . 0.799 ' HG2' HD11 ' B' ' 94' ' ' LEU . 0.0 OUTLIER -63.45 -19.56 64.83 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -178.989 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.74 -23.87 41.99 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -179.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -109.33 93.1 4.33 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -66.69 148.79 51.43 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 83.39 -46.98 3.74 Favored Glycine 0 N--CA 1.451 -0.345 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 -178.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 103' ' ' CYS . . . . . 0.433 ' HA ' ' HB3' ' B' ' 74' ' ' CYS . 58.5 m -66.75 -45.48 78.47 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 104' ' ' ALA . . . . . 0.686 ' HB1' ' HG ' ' B' ' 97' ' ' LEU . . . -66.65 -16.24 64.06 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.445 179.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 19.8 m -72.95 -39.45 66.17 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.623 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 13.4 p -63.6 -24.77 67.93 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 122.077 0.941 . . . . 0.0 109.679 179.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . 0.674 ' HE2' HG13 ' B' ' 93' ' ' VAL . 0.8 OUTLIER -88.81 -69.94 0.68 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.099 -1.41 . . . . 0.0 111.959 -178.87 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 82.5 m -74.27 28.42 0.08 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -177.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -53.69 -69.73 0.11 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.17 0.51 . . . . 0.0 110.266 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -89.93 -35.16 15.74 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -79.51 70.71 6.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.763 179.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 13.0 t -127.46 54.68 1.65 Allowed 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.924 -178.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 113' ' ' HIS . . . . . 0.419 ' HE1' ' CB ' ' A' ' 28' ' ' ASP . 0.1 OUTLIER -129.95 -12.38 4.2 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -179.843 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -94.69 -142.95 13.15 Favored Glycine 0 C--O 1.228 -0.272 0 C-N-CA 120.442 -0.885 . . . . 0.0 113.333 -179.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . 0.627 HG21 ' HG ' ' B' ' 94' ' ' LEU . 14.6 p -62.86 -15.46 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-O 121.142 0.496 . . . . 0.0 111.605 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 116' ' ' CYS . . . . . 0.591 ' HB2' HD12 ' B' ' 90' ' ' LEU . 6.8 t -76.19 -22.83 54.84 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.408 0.623 . . . . 0.0 109.76 178.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 117' ' ' LYS . . . . . 0.471 ' O ' ' HG3' ' B' ' 117' ' ' LYS . 13.5 tptt -79.16 -19.33 51.25 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.134 179.33 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -57.01 -41.55 78.69 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.2 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 119' ' ' LEU . . . . . 0.417 HD13 ' HB2' ' B' ' 98' ' ' LYS . 5.7 tt -86.19 -29.58 23.09 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 65.51 75.03 0.36 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.721 179.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 121' ' ' LEU . . . . . 0.408 HD12 ' HB2' ' B' ' 104' ' ' ALA . 0.4 OUTLIER -124.33 7.59 8.42 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.586 -0.733 . . . . 0.0 111.522 -179.701 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 122' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.244 0.803 0 CA-C-O 118.545 -0.741 . . . . 0.0 110.461 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.606 0.241 . . . . 0.0 110.827 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 84.7 mtp 61.84 -160.66 0.3 Allowed 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.669 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 96.95 -91.05 1.19 Allowed Glycine 0 N--CA 1.451 -0.349 0 N-CA-C 111.336 -0.705 . . . . 0.0 111.336 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -122.6 150.76 42.2 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 25.8 p -88.9 1.56 55.19 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -178.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 45.8 m 58.63 99.24 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.389 0.614 . . . . 0.0 111.634 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 57.3 t -54.46 -45.48 70.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.085 -0.961 . . . . 0.0 113.308 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 45.2 tp -54.14 -58.52 7.03 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -178.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -72.29 -1.35 15.01 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -178.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 51.1 tttt -111.79 44.51 1.37 Allowed 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.282 178.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.43 ' O ' HG12 ' A' ' 11' ' ' VAL . 10.7 t 52.77 36.96 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.15 178.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 50.27 48.58 22.01 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.891 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.489 ' HB2' HD13 ' A' ' 17' ' ' ILE . 8.4 p 45.06 40.53 4.73 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.018 -0.992 . . . . 0.0 112.963 -179.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -112.09 16.45 20.19 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 120.934 0.397 . . . . 0.0 110.547 178.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -91.46 -82.61 0.3 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.028 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.99 -27.72 60.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.945 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.489 HD13 ' HB2' ' A' ' 13' ' ' CYS . 49.2 mt -74.08 -46.84 44.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.69 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.401 ' HB2' ' O ' ' A' ' 14' ' ' ALA . . . -82.18 -15.89 51.64 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.197 179.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -82.79 -33.64 23.92 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.115 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.28 -13.5 60.78 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.831 0.348 . . . . 0.0 110.914 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 78.7 t -64.34 -39.46 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.043 179.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.92 -31.18 67.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.112 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.13 -43.76 66.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.688 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.413 ' HB3' ' CG ' ' B' ' 113' ' ' HIS . 56.6 m -82.42 -19.34 39.21 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.099 -179.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.14 59.1 3.01 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 -179.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 122.0 156.63 9.75 Favored Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -177.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.516 HD12 HG23 ' A' ' 27' ' ' ILE . 5.0 tt -98.87 147.08 7.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 118.125 0.963 . . . . 0.0 112.484 -178.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.49 ' N ' HG12 ' A' ' 27' ' ' ILE . 34.4 t0 -161.42 -106.13 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.48 -1.236 . . . . 0.0 107.967 179.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.731 HD11 ' HB2' ' A' ' 55' ' ' CYS . 40.2 tp -174.5 -47.94 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 178.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 29' ' ' LEU . 11.1 Cg_endo -54.52 -15.3 8.6 Favored 'Trans proline' 0 C--N 1.358 1.031 0 C-N-CA 122.959 2.44 . . . . 0.0 114.593 -178.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.548 ' HB2' ' O ' ' B' ' 113' ' ' HIS . 11.0 t -117.89 -31.72 5.01 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.275 0.56 . . . . 0.0 110.744 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.7 t -73.26 -9.17 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-N 115.74 -0.663 . . . . 0.0 112.375 -178.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -71.87 -14.82 62.06 Favored 'General case' 0 CA--C 1.531 0.25 0 O-C-N 122.221 -0.299 . . . . 0.0 111.64 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -56.72 -55.09 38.62 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.876 0.37 . . . . 0.0 111.844 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -89.26 16.72 6.91 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.651 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.0 tp -112.69 -0.25 15.12 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.708 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.6 ttpt -98.55 154.52 17.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.256 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 71.89 63.12 0.14 Allowed 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.587 0.755 . . . . 0.0 111.607 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -163.39 163.05 25.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.639 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -84.31 70.52 10.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.025 0.44 . . . . 0.0 110.025 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.418 ' C ' ' H ' ' A' ' 43' ' ' ALA . . . 89.34 -111.18 3.8 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.493 -0.861 . . . . 0.0 111.887 -179.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 81.1 m 73.09 -34.93 0.31 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.237 0.615 . . . . 0.0 112.318 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.418 ' H ' ' C ' ' A' ' 41' ' ' GLY . . . -79.49 17.16 0.9 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.4 m -66.82 -59.12 3.81 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.768 0.318 . . . . 0.0 110.763 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -66.91 -24.98 66.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.662 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.441 ' CD2' HG12 ' A' ' 17' ' ' ILE . 1.0 OUTLIER -81.4 -72.75 0.41 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.523 -178.948 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.441 ' HB3' ' O ' ' A' ' 50' ' ' HIS . 23.7 m -78.44 39.88 0.34 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.4 -178.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -73.05 -54.23 9.07 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.979 0.895 . . . . 0.0 109.161 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -87.84 -9.31 54.19 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.364 -1.289 . . . . 0.0 109.682 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.441 ' O ' ' HB3' ' A' ' 47' ' ' CYS . 45.4 m-70 -109.98 90.97 3.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.314 -178.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 72.9 m -136.4 55.28 1.85 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.642 ' HB2' ' OD2' ' B' ' 89' ' ' ASP . 40.8 m80 -115.68 -54.73 2.49 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.356 178.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 55' ' ' CYS . . . -134.63 -171.62 12.56 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-O 119.171 -0.794 . . . . 0.0 112.059 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.768 HG11 ' HB3' ' B' ' 91' ' ' PRO . 14.2 m 43.75 -62.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 N-CA-C 115.97 1.841 . . . . 0.0 115.97 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.731 ' HB2' HD11 ' A' ' 29' ' ' LEU . 15.7 t -70.16 -44.56 68.56 Favored 'General case' 0 C--N 1.322 -0.601 0 O-C-N 121.641 -0.662 . . . . 0.0 111.457 -179.032 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.412 ' HE3' ' HB2' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -81.13 12.68 3.26 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.958 179.403 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -76.94 -27.57 54.89 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 175.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 32.3 mt -98.51 -16.49 19.15 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 113.596 -1.638 . . . . 0.0 108.981 177.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 64.89 82.45 0.19 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.91 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.411 ' HA ' HD22 ' A' ' 60' ' ' LEU . 87.2 mt -125.15 -7.42 7.11 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -178.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 26.3 p . . . . . 0 C--O 1.245 0.836 0 CA-C-O 118.41 -0.805 . . . . 0.0 110.591 178.67 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.286 0 CA-C-O 120.458 0.17 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 63' ' ' MET . . . . . 0.561 ' HA ' ' HG2' ' B' ' 101' ' ' GLU . 33.3 mtt 61.16 75.95 0.39 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.006 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -107.44 -131.08 6.53 Favored Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 111.433 -0.667 . . . . 0.0 111.433 178.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.94 129.12 53.33 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 178.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 66' ' ' CYS . . . . . . . . . . . . . 43.2 m -64.71 -58.06 7.3 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -177.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 19.2 m 70.13 -167.77 0.16 Allowed 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -176.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 43.2 t -122.46 -56.24 2.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 C-N-CA 120.646 -0.421 . . . . 0.0 110.724 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 54.0 tp -58.1 -36.54 73.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.476 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 70' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -84.81 13.42 5.86 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -179.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 14.0 mmtt -138.66 43.95 2.1 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.856 -0.156 . . . . 0.0 110.725 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 6.5 t 51.02 42.41 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 O-C-N 123.899 0.75 . . . . 0.0 109.994 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . 56.24 45.92 22.24 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.059 -178.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 74' ' ' CYS . . . . . 0.541 ' HB2' HD13 ' B' ' 78' ' ' ILE . 18.1 p 44.9 45.01 8.38 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 114.555 -1.202 . . . . 0.0 112.442 -178.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.97 4.3 23.13 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 120.997 0.427 . . . . 0.0 110.897 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.8 -76.33 0.09 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.426 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . 0.431 ' HB1' ' O ' ' B' ' 96' ' ' ALA . . . -93.85 -10.06 35.22 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -178.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.75 HD12 ' HB2' ' B' ' 107' ' ' PHE . 40.8 mt -89.17 -47.38 15.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.661 -179.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.83 -18.27 38.18 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.923 0.392 . . . . 0.0 111.229 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.8 -25.69 62.05 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.336 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . 0.557 ' HB3' ' HB2' ' B' ' 96' ' ' ALA . . . -82.93 -9.99 59.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.972 0.415 . . . . 0.0 111.027 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 69.2 t -68.31 -37.16 77.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.998 179.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -79.79 10.17 4.41 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.444 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -109.73 -48.2 3.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.968 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 63.1 m -88.94 -9.57 51.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.329 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.78 44.39 6.09 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.686 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 132.6 173.81 13.42 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.056 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 88' ' ' ILE . . . . . 0.501 HG12 ' N ' ' B' ' 89' ' ' ASP . 0.0 OUTLIER -77.05 136.86 23.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.049 0.452 . . . . 0.0 110.936 179.714 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 89' ' ' ASP . . . . . 0.642 ' OD2' ' HB2' ' A' ' 52' ' ' HIS . 40.5 t0 -153.87 -122.96 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.525 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 90' ' ' LEU . . . . . 0.715 ' HB3' ' HD3' ' B' ' 91' ' ' PRO . 41.5 tp 173.02 -57.81 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 124.318 1.047 . . . . 0.0 109.6 179.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 91' ' ' PRO . . . . . 0.768 ' HB3' HG11 ' A' ' 54' ' ' VAL . 51.8 Cg_exo -54.19 -25.52 38.34 Favored 'Trans proline' 0 C--N 1.363 1.323 0 C-N-CA 122.684 2.256 . . . . 0.0 112.992 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 29.9 t -107.94 -34.61 6.86 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.18 0.514 . . . . 0.0 110.329 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . 0.635 HG23 ' HB3' ' B' ' 89' ' ' ASP . 38.6 t -70.42 -16.62 20.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.821 -179.043 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 94' ' ' LEU . . . . . 0.751 HD13 ' HB ' ' B' ' 115' ' ' VAL . 1.2 pt? -61.45 -18.02 57.03 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 122.25 -0.281 . . . . 0.0 111.743 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.53 -34.2 73.78 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . 0.557 ' HB2' ' HB3' ' B' ' 81' ' ' ALA . . . -100.64 -3.49 30.27 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.862 0.363 . . . . 0.0 110.643 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 23.6 tp -92.99 3.07 56.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.379 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -75.78 139.03 41.58 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.405 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . 61.33 -145.89 0.44 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.783 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . 56.93 30.55 18.22 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 122.749 0.42 . . . . 0.0 111.927 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . 0.561 ' HG2' ' HA ' ' B' ' 63' ' ' MET . 93.9 mt-10 65.46 21.07 11.82 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 123.754 0.659 . . . . 0.0 112.242 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . 0.56 ' HA2' HD21 ' B' ' 121' ' ' LEU . . . 85.18 -84.04 1.61 Allowed Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.944 -0.646 . . . . 0.0 113.119 178.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 79.0 m 67.84 37.24 3.21 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 122.594 0.358 . . . . 0.0 111.169 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -102.68 20.38 17.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.409 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -69.36 -31.77 70.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.83 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 4.2 p -101.97 -29.37 11.84 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.255 0.55 . . . . 0.0 110.29 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . 0.75 ' HB2' HD12 ' B' ' 78' ' ' ILE . 1.0 OUTLIER -81.99 -90.86 0.07 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.985 -178.228 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 36.2 m -70.44 40.99 0.05 Allowed 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 -178.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . 0.413 ' H ' ' C ' ' B' ' 107' ' ' PHE . 4.9 tp10 -77.23 -53.51 7.65 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.48 0.657 . . . . 0.0 109.455 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -97.96 1.08 47.55 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.744 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 22.4 m-70 -112.33 88.89 2.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.47 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 71.0 m -135.78 46.79 2.31 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 114.665 1.358 . . . . 0.0 114.665 -177.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 113' ' ' HIS . . . . . 0.548 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 2.9 p80 -135.24 -0.46 2.72 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 118.994 -1.082 . . . . 0.0 111.982 177.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 114' ' ' GLY . . . . . 0.443 ' HA3' ' HB2' ' A' ' 30' ' ' PRO . . . -154.64 145.9 13.47 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 119.914 -1.136 . . . . 0.0 112.664 179.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . 0.751 ' HB ' HD13 ' B' ' 94' ' ' LEU . 27.6 m 50.28 -48.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 C-N-CA 126.648 1.979 . . . . 0.0 115.936 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 116' ' ' CYS . . . . . 0.627 ' HB2' HD13 ' B' ' 90' ' ' LEU . 3.9 t -73.84 -25.65 60.18 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 121.543 -0.723 . . . . 0.0 110.094 -179.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 19.3 ttmt -77.58 -22.89 50.25 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.422 178.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -64.2 -40.16 95.5 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 43.1 mt -81.84 -22.6 36.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.14 178.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 64.91 79.89 0.24 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.226 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 121' ' ' LEU . . . . . 0.56 HD21 ' HA2' ' B' ' 102' ' ' GLY . 86.5 mt -123.82 -6.59 7.94 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -178.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 122' ' ' CYS . . . . . . . . . . . . . 26.1 p . . . . . 0 C--O 1.245 0.818 0 CA-C-O 118.473 -0.775 . . . . 0.0 110.59 179.111 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.193 0 N-CA-C 110.4 -0.222 . . . . 0.0 110.4 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 27.9 ttt 60.76 72.79 0.51 Allowed 'General case' 0 N--CA 1.465 0.303 0 O-C-N 123.773 0.67 . . . . 0.0 111.004 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 172.25 -172.83 45.07 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.106 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -111.52 10.61 21.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.528 0.164 . . . . 0.0 110.784 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.585 ' HA ' ' O ' ' A' ' 40' ' ' GLU . 0.6 OUTLIER -156.74 -147.42 0.19 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.627 -179.328 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.4 m -92.56 -134.89 0.15 Allowed 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -178.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.0 m -109.66 -23.79 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -178.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.424 ' C ' ' H ' ' A' ' 10' ' ' LYS . 57.0 tp -104.84 -45.24 4.62 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.708 ' HA ' ' HB2' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -86.95 27.65 0.99 Allowed 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 177.52 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.624 ' C ' ' H ' ' A' ' 12' ' ' ALA . 22.2 ptmt -79.09 0.8 26.54 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.036 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.519 HG12 ' HB1' ' A' ' 14' ' ' ALA . 2.4 t -69.94 14.68 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 CA-C-O 121.421 0.629 . . . . 0.0 109.86 178.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.624 ' H ' ' C ' ' A' ' 10' ' ' LYS . . . 75.18 -13.69 0.83 Allowed 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 125.312 1.445 . . . . 0.0 113.805 178.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.817 ' HB2' HD11 ' A' ' 17' ' ' ILE . 11.7 p 170.25 -32.22 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 O-C-N 123.456 0.472 . . . . 0.0 112.197 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.519 ' HB1' HG12 ' A' ' 11' ' ' VAL . . . -57.84 -26.85 62.6 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -177.149 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.708 ' HB2' ' HA ' ' A' ' 9' ' ' LYS . . . -109.4 29.03 7.93 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.387 -0.525 . . . . 0.0 112.019 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -151.03 -53.12 0.14 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.222 0.534 . . . . 0.0 110.93 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.817 HD11 ' HB2' ' A' ' 13' ' ' CYS . 73.6 mt -74.69 -42.64 47.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.329 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.79 -30.99 72.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.458 178.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.9 -30.83 37.37 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.649 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.28 -24.18 63.0 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 121.031 0.443 . . . . 0.0 110.381 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.402 HG21 ' O ' ' A' ' 17' ' ' ILE . 49.7 t -65.26 -46.55 90.34 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.669 178.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.69 -18.12 62.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.16 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -81.17 -51.04 8.86 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.165 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 49.1 t -76.01 -33.79 59.69 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.913 0.387 . . . . 0.0 110.132 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.18 36.29 2.54 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.47 -0.872 . . . . 0.0 112.532 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 147.73 152.57 5.71 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.127 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -81.9 132.58 31.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.288 0.566 . . . . 0.0 109.767 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -158.85 -115.45 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.41 -178.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.499 HD11 ' HB2' ' A' ' 55' ' ' CYS . 35.0 tp -174.95 -57.47 0.0 OUTLIER Pre-proline 0 C--O 1.22 -0.48 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.16 178.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 1.029 ' HA ' HG12 ' A' ' 54' ' ' VAL . 1.0 OUTLIER -45.42 -52.71 6.3 Favored 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 122.959 2.439 . . . . 0.0 114.117 -178.971 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 19.7 p -84.08 -35.7 23.56 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.087 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.514 HG11 ' CE2' ' A' ' 46' ' ' PHE . 3.5 t -63.45 -29.78 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.161 -179.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.715 HD23 HG13 ' A' ' 54' ' ' VAL . 29.9 tp -63.53 -32.28 73.69 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.086 0.469 . . . . 0.0 110.515 179.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.83 -37.55 79.24 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.07 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.53 -9.25 58.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.115 0.484 . . . . 0.0 110.601 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 23.8 tp -76.09 -6.93 53.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.453 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -86.01 5.37 33.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.102 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.66 -4.77 47.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.967 0.413 . . . . 0.0 110.354 178.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.444 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . . . -147.17 175.46 10.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.703 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.585 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 43.0 mt-10 -87.14 120.05 28.01 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.53 0.205 . . . . 0.0 110.866 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.71 -105.79 1.27 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.988 179.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.413 ' O ' HD12 ' A' ' 17' ' ' ILE . 0.6 OUTLIER 64.04 15.72 9.44 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.082 0.553 . . . . 0.0 111.175 -179.352 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -97.05 -6.81 34.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.048 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 40.7 t -66.12 -9.44 31.4 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.22 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.547 ' HB3' ' HB3' ' A' ' 13' ' ' CYS . 33.6 t -118.95 -31.8 4.66 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.309 0.575 . . . . 0.0 110.151 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.603 ' HB2' HD13 ' A' ' 17' ' ' ILE . 0.6 OUTLIER -73.88 -78.55 0.09 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.327 -0.851 . . . . 0.0 113.228 -178.496 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.522 ' HA ' ' HB2' ' A' ' 50' ' ' HIS . 84.9 m -72.99 27.29 0.06 Allowed 'General case' 0 C--O 1.219 -0.505 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -176.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -67.61 -61.82 1.71 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 118.953 0.797 . . . . 0.0 109.762 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -91.14 -7.46 51.49 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.522 ' HB2' ' HA ' ' A' ' 47' ' ' CYS . 62.2 m-70 -107.73 62.24 0.62 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.497 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.505 ' O ' ' HB3' ' A' ' 56' ' ' LYS . 62.6 m -95.95 33.56 1.68 Allowed 'General case' 0 C--N 1.327 -0.393 0 O-C-N 122.031 -0.418 . . . . 0.0 110.908 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.676 ' ND1' ' HB3' ' B' ' 92' ' ' CYS . 27.6 p80 -129.82 157.71 41.47 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.732 0.301 . . . . 0.0 110.782 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.86 ' HA3' ' HB2' ' B' ' 91' ' ' PRO . . . 92.43 -132.99 11.52 Favored Glycine 0 C--O 1.227 -0.34 0 C-N-CA 120.494 -0.86 . . . . 0.0 113.267 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 1.029 HG12 ' HA ' ' A' ' 30' ' ' PRO . 8.9 p -78.01 -21.74 13.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 122.562 -0.375 . . . . 0.0 111.881 -178.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.499 ' HB2' HD11 ' A' ' 29' ' ' LEU . 7.5 t -77.03 -28.86 55.04 Favored 'General case' 0 C--O 1.224 -0.285 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.747 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.532 ' HG3' ' O ' ' A' ' 53' ' ' GLY . 0.0 OUTLIER -73.96 -31.19 62.91 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.0 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -69.61 -56.33 7.58 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.7 65.6 3.09 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 106.579 -1.638 . . . . 0.0 106.579 176.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 20.3 t60 -35.42 124.44 0.64 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 114.238 -1.347 . . . . 0.0 113.968 -176.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 13.7 mt -146.37 21.84 1.34 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.793 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 8.9 p . . . . . 0 C--O 1.245 0.825 0 CA-C-O 118.124 -0.941 . . . . 0.0 110.756 178.425 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.211 0 CA-C-O 120.264 0.078 . . . . 0.0 110.821 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 63' ' ' MET . . . . . . . . . . . . . 22.7 mtp 51.95 -137.15 1.23 Allowed 'General case' 0 N--CA 1.466 0.334 0 O-C-N 123.707 0.63 . . . . 0.0 110.665 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 60.75 43.25 99.35 Favored Glycine 0 C--N 1.329 0.183 0 C-N-CA 120.953 -0.641 . . . . 0.0 113.096 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 40.2 mttm 60.44 -112.67 0.55 Allowed 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 122.631 0.372 . . . . 0.0 111.568 179.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 66' ' ' CYS . . . . . 0.654 ' O ' ' HB2' ' B' ' 70' ' ' LYS . 13.8 m -130.94 107.41 9.08 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 48.9 m 67.51 175.36 0.26 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.268 0.556 . . . . 0.0 112.028 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . 0.552 ' O ' ' HG2' ' B' ' 71' ' ' LYS . 21.4 t -88.43 -34.84 7.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.478 -179.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.446 ' O ' HG23 ' B' ' 72' ' ' VAL . 44.2 tp -75.61 -31.53 59.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.936 0.398 . . . . 0.0 111.262 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 70' ' ' LYS . . . . . 0.679 ' HD3' ' HB3' ' B' ' 77' ' ' ALA . 77.6 mttt -93.79 20.41 7.64 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 120.698 0.285 . . . . 0.0 111.683 -178.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . 0.552 ' HG2' ' O ' ' B' ' 68' ' ' VAL . 59.8 pttt -91.68 9.19 33.43 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . 0.446 HG23 ' O ' ' B' ' 69' ' ' LEU . 4.2 t -82.85 27.94 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.114 179.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.437 ' H ' ' C ' ' B' ' 71' ' ' LYS . . . 69.49 59.52 0.31 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 114.91 -1.041 . . . . 0.0 113.426 178.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 74' ' ' CYS . . . . . 0.409 ' O ' ' HB ' ' B' ' 78' ' ' ILE . 21.9 m 62.53 8.97 3.15 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 177.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -73.23 -59.98 2.45 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . 0.401 ' O ' ' HG2' ' B' ' 70' ' ' LYS . . . -80.46 48.03 0.99 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.945 0.402 . . . . 0.0 111.509 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . 0.679 ' HB3' ' HD3' ' B' ' 70' ' ' LYS . . . -162.18 -53.74 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.877 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.698 HD13 ' HB2' ' B' ' 107' ' ' PHE . 51.7 mt -92.94 -49.15 13.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.395 -179.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 79' ' ' ALA . . . . . 0.732 ' HA ' HG23 ' B' ' 82' ' ' VAL . . . -64.48 -19.36 65.53 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.669 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -75.66 -24.32 70.39 Favored Glycine 0 N--CA 1.452 -0.28 0 N-CA-C 111.53 -0.628 . . . . 0.0 111.53 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . 0.435 ' HB3' ' HA ' ' B' ' 93' ' ' VAL . . . -80.94 -30.22 35.28 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.021 0.439 . . . . 0.0 110.469 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 82' ' ' VAL . . . . . 0.732 HG23 ' HA ' ' B' ' 79' ' ' ALA . 32.0 t -56.76 -40.86 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.904 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.54 -34.62 78.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.543 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.61 -28.23 56.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.997 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 15.7 m -94.15 -14.9 25.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.745 -178.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.67 31.43 60.54 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.246 -178.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 152.46 151.7 5.74 Favored Glycine 0 N--CA 1.449 -0.47 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 88' ' ' ILE . . . . . 0.646 ' HB ' HG13 ' B' ' 82' ' ' VAL . 0.0 OUTLIER -103.76 129.76 55.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.726 0.774 . . . . 0.0 111.786 -178.983 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 89' ' ' ASP . . . . . 0.412 ' HB2' ' CE1' ' A' ' 52' ' ' HIS . 28.4 m-20 -144.8 -82.73 0.15 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.462 -1.245 . . . . 0.0 108.526 178.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 90' ' ' LEU . . . . . 0.759 HD13 ' HB2' ' B' ' 116' ' ' CYS . 51.9 tp 179.44 -54.38 0.0 OUTLIER Pre-proline 0 C--O 1.227 -0.13 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.292 178.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 91' ' ' PRO . . . . . 0.86 ' HB2' ' HA3' ' A' ' 53' ' ' GLY . 4.9 Cg_exo -38.53 -65.94 0.15 Allowed 'Trans proline' 0 C--N 1.361 1.225 0 C-N-CA 123.487 2.792 . . . . 0.0 114.31 -179.014 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 92' ' ' CYS . . . . . 0.676 ' HB3' ' ND1' ' A' ' 52' ' ' HIS . 1.5 t -82.04 -31.42 30.93 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -179.066 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . 0.545 ' HB ' ' HZ ' ' B' ' 107' ' ' PHE . 1.5 t -64.81 -16.31 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-O 120.804 0.335 . . . . 0.0 111.761 -179.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 94' ' ' LEU . . . . . 0.439 HD11 HD21 ' B' ' 97' ' ' LEU . 22.7 tp -73.5 -19.12 61.01 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.859 0.361 . . . . 0.0 111.008 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.07 -53.21 60.84 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.114 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.96 -14.15 60.24 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 111.617 0.228 . . . . 0.0 111.617 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 97' ' ' LEU . . . . . 0.439 HD21 HD11 ' B' ' 94' ' ' LEU . 17.6 tp -72.69 -28.74 62.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.979 0.419 . . . . 0.0 110.051 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -65.53 -24.38 67.1 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.216 178.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -81.0 -13.77 58.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.77 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -100.57 -9.04 22.38 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.98 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 71.17 -61.8 0.47 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.683 0.793 . . . . 0.0 112.285 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -127.82 -125.38 2.78 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.858 -179.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 36.3 m 61.29 48.73 5.91 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.407 0.623 . . . . 0.0 110.502 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 104' ' ' ALA . . . . . 0.75 ' HB1' ' HB2' ' B' ' 108' ' ' CYS . . . -95.63 -6.55 39.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.451 -179.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 26.6 p -63.26 -20.3 65.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.998 0.428 . . . . 0.0 111.797 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 24.7 p -106.8 -29.2 9.67 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.294 0.569 . . . . 0.0 111.101 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . 0.698 ' HB2' HD13 ' B' ' 78' ' ' ILE . 1.0 OUTLIER -100.88 -79.72 0.5 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -177.518 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 108' ' ' CYS . . . . . 0.75 ' HB2' ' HB1' ' B' ' 104' ' ' ALA . 1.8 m -67.45 24.19 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -177.117 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -81.36 -68.31 0.7 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 118.583 0.629 . . . . 0.0 109.715 178.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -73.36 -15.02 61.39 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 177.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 61.3 m-70 -110.07 65.88 0.62 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.421 -1.263 . . . . 0.0 107.973 178.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 36.6 t -106.45 49.46 0.8 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.95 0.405 . . . . 0.0 111.757 -177.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 113' ' ' HIS . . . . . 0.486 ' HA ' ' HG2' ' B' ' 117' ' ' LYS . 18.1 p-80 -156.55 -165.74 1.96 Allowed 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . 64.64 -137.73 39.69 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.977 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . 0.529 HG11 ' HA ' ' B' ' 91' ' ' PRO . 11.3 p -79.66 -16.71 13.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.814 0.34 . . . . 0.0 111.076 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 116' ' ' CYS . . . . . 0.759 ' HB2' HD13 ' B' ' 90' ' ' LEU . 2.1 t -57.92 -59.75 4.77 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 120.808 0.337 . . . . 0.0 110.716 178.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 117' ' ' LYS . . . . . 0.486 ' HG2' ' HA ' ' B' ' 113' ' ' HIS . 45.3 pttt -101.4 31.94 3.52 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.742 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 118' ' ' ASP . . . . . 0.457 ' HB2' ' HA ' ' B' ' 115' ' ' VAL . 10.3 t70 -54.44 -39.16 67.11 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 178.146 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 119' ' ' LEU . . . . . 0.592 ' O ' ' HB2' ' B' ' 120' ' ' HIS . 3.3 mm? -103.32 -52.66 2.97 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 174.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 120' ' ' HIS . . . . . 0.592 ' HB2' ' O ' ' B' ' 119' ' ' LEU . 42.3 t60 153.6 129.26 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.862 0 O-C-N 124.951 1.407 . . . . 0.0 110.422 176.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 121' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' B' ' 120' ' ' HIS . 14.4 mt -160.33 41.26 0.18 Allowed 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 122' ' ' CYS . . . . . 0.433 ' HB3' ' O ' ' B' ' 108' ' ' CYS . 1.4 p . . . . . 0 C--O 1.246 0.9 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.711 178.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.4 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.458 ' HB3' ' HE2' ' A' ' 2' ' ' MET . 43.6 ttp -136.46 133.41 36.57 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.015 -179.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 114.75 151.41 10.17 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.037 -1.078 . . . . 0.0 113.786 178.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.506 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 36.5 mtmt -101.19 -14.64 17.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.857 0.361 . . . . 0.0 110.413 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 7.5 t -126.16 66.22 1.21 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.021 0.439 . . . . 0.0 110.84 -178.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.1 m -84.9 -162.68 0.72 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.131 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 24.7 t -71.29 -41.6 74.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.924 0.392 . . . . 0.0 110.158 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.2 tp -76.51 -33.18 58.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.872 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.506 ' HD3' ' O ' ' A' ' 4' ' ' LYS . 8.9 mttp -90.69 28.96 1.4 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.966 178.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -70.58 -21.03 62.72 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.414 ' H ' HG23 ' A' ' 11' ' ' VAL . 4.3 t -66.79 -16.84 21.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.933 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.02 9.49 1.92 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.92 0.391 . . . . 0.0 111.329 179.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 13.0 p -65.28 -24.95 67.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.409 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.534 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -64.85 -19.49 65.91 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.228 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.09 0.82 23.2 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -132.19 -22.48 2.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.777 0.322 . . . . 0.0 111.76 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.615 HG22 ' H ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -92.93 -44.58 13.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.945 0.403 . . . . 0.0 111.484 -178.923 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.615 ' H ' HG22 ' A' ' 17' ' ' ILE . . . -57.18 -32.38 66.39 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.769 -178.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.98 -24.04 74.86 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.313 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.499 ' HB1' ' HB3' ' A' ' 35' ' ' ALA . . . -83.92 -24.79 30.6 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 120.821 0.343 . . . . 0.0 111.039 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 86.8 t -66.36 -46.65 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.551 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.34 -28.38 65.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.462 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -75.84 -44.9 38.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 112.061 -179.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.8 t -84.87 -37.28 20.84 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.729 0.299 . . . . 0.0 110.869 -179.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.99 48.9 1.3 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.405 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.41 ' CA ' ' HE2' ' B' ' 113' ' ' HIS . . . 143.67 -179.51 21.03 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.217 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.524 HD12 HD11 ' A' ' 17' ' ' ILE . 6.0 tp -113.23 117.23 54.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.489 0.661 . . . . 0.0 111.988 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.558 ' OD1' ' HD2' ' A' ' 30' ' ' PRO . 30.6 t0 -134.28 -108.89 0.22 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.771 ' HG ' HG21 ' A' ' 54' ' ' VAL . 41.0 tp -175.01 -57.03 0.0 OUTLIER Pre-proline 0 C--O 1.223 -0.326 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.291 178.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.864 ' HA ' HG12 ' A' ' 54' ' ' VAL . 2.3 Cg_endo -46.24 -60.18 0.95 Allowed 'Trans proline' 0 C--N 1.361 1.231 0 C-N-CA 123.005 2.47 . . . . 0.0 114.357 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 19.9 p -79.41 -33.84 42.29 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.655 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.46 HG13 ' HB3' ' A' ' 20' ' ' ALA . 2.4 t -67.1 -17.62 22.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.552 -179.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 30.0 tp -64.26 -26.13 68.36 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.495 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.37 -59.73 4.2 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -178.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.499 ' HB3' ' HB1' ' A' ' 20' ' ' ALA . . . -75.15 -17.0 60.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.747 0.308 . . . . 0.0 111.791 -179.107 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.565 HD21 ' CD2' ' A' ' 46' ' ' PHE . 32.8 tp -75.16 -10.33 59.37 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.931 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -74.4 93.13 2.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.894 0.378 . . . . 0.0 110.363 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -111.22 -5.55 14.69 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.698 -179.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 72.69 -61.92 0.48 Allowed 'General case' 0 N--CA 1.473 0.694 0 O-C-N 123.989 0.806 . . . . 0.0 113.02 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -60.67 -69.11 0.24 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.834 0.35 . . . . 0.0 111.826 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 42' ' ' CYS . . . -156.16 -139.63 2.79 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.146 -1.026 . . . . 0.0 112.779 -179.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 41' ' ' GLY . 96.5 m 73.17 8.81 5.31 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.16 0.584 . . . . 0.0 111.197 -179.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -95.51 -21.76 18.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.869 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.7 p -79.89 11.51 3.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.488 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 46.8 t -109.65 -62.29 1.52 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.565 ' CD2' HD21 ' A' ' 36' ' ' LEU . 0.8 OUTLIER -67.48 -59.28 3.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.713 178.697 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.609 ' HA ' ' HB2' ' A' ' 50' ' ' HIS . 87.9 m -74.6 15.54 0.35 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -55.86 -52.55 63.67 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.334 0.587 . . . . 0.0 110.386 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -94.79 -20.07 19.8 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.914 178.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.609 ' HB2' ' HA ' ' A' ' 47' ' ' CYS . 70.0 m-70 -98.56 72.56 2.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.443 -179.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 97.0 m -92.16 -2.16 56.73 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -178.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.996 ' HA ' ' HB3' ' A' ' 56' ' ' LYS . 9.6 p80 -117.2 -160.16 0.76 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 119.808 -0.757 . . . . 0.0 111.112 179.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 68.47 -130.99 26.58 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.571 -0.823 . . . . 0.0 111.794 -178.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.864 HG12 ' HA ' ' A' ' 30' ' ' PRO . 30.0 m -75.97 -18.99 15.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.858 0.329 . . . . 0.0 111.633 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.441 ' HB2' HD12 ' A' ' 29' ' ' LEU . 1.4 t -82.57 -23.29 34.53 Favored 'General case' 0 C--O 1.216 -0.691 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.184 -179.08 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.996 ' HB3' ' HA ' ' A' ' 52' ' ' HIS . 0.0 OUTLIER -77.58 -13.39 59.92 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.352 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -90.45 -59.86 2.07 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.749 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 20.6 tp -80.12 -75.58 0.25 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.592 0.234 . . . . 0.0 111.316 -179.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 58.1 m-70 -90.28 -129.5 0.09 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.421 ' HB3' ' H ' ' A' ' 61' ' ' CYS . 8.1 tp -169.83 -87.56 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 177.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.584 ' HB3' ' O ' ' A' ' 47' ' ' CYS . 1.8 p . . . . . 0 C--O 1.245 0.82 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.651 178.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.137 0 CA-C-O 120.808 0.337 . . . . 0.0 111.005 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 63' ' ' MET . . . . . . . . . . . . . 18.9 ptp -104.95 129.08 53.44 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.009 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 111.22 170.64 19.13 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.341 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -99.91 -39.02 8.38 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.846 0.355 . . . . 0.0 110.924 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 66' ' ' CYS . . . . . . . . . . . . . 51.6 m -109.74 157.61 18.96 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -178.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 77.4 p -178.27 -167.03 0.12 Allowed 'General case' 0 C--O 1.236 0.351 0 CA-C-N 114.373 -1.285 . . . . 0.0 107.887 178.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 7.5 t -87.03 -27.61 5.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.169 0.509 . . . . 0.0 109.775 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 39.8 tp -89.92 -39.39 13.05 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 70' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -87.08 28.24 0.94 Allowed 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -64.48 -19.73 65.75 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.443 179.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 3.8 t -60.74 -19.09 18.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.506 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -93.29 25.82 3.19 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 122.263 -0.273 . . . . 0.0 111.719 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 31.7 p -95.33 -12.91 25.29 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.308 -0.557 . . . . 0.0 111.634 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.21 -35.66 74.0 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 123.253 0.345 . . . . 0.0 111.209 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -74.11 -0.53 16.87 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . 0.454 ' O ' ' HA ' ' B' ' 97' ' ' LEU . . . -124.66 -12.73 7.13 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.658 HG23 ' H ' ' B' ' 79' ' ' ALA . 0.0 OUTLIER -106.5 -46.54 8.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.097 0.475 . . . . 0.0 110.91 -179.238 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 79' ' ' ALA . . . . . 0.658 ' H ' HG23 ' B' ' 78' ' ' ILE . . . -56.91 -23.47 45.17 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.947 -179.049 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -75.39 -25.26 68.62 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.403 -0.904 . . . . 0.0 112.151 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -82.21 -16.9 48.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.763 0.316 . . . . 0.0 111.348 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 82' ' ' VAL . . . . . 0.593 HG23 HD11 ' B' ' 88' ' ' ILE . 59.6 t -62.46 -45.78 97.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-O 121.033 0.444 . . . . 0.0 110.77 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.87 -31.19 70.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.473 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.19 -36.27 79.3 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.516 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 26.6 m -92.99 -12.27 31.1 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 69.55 42.27 73.2 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.488 -0.863 . . . . 0.0 111.319 -178.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 151.81 137.66 2.65 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 88' ' ' ILE . . . . . 0.593 HD11 HG23 ' B' ' 82' ' ' VAL . 2.9 tp -91.23 114.1 27.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.34 0.59 . . . . 0.0 111.944 -179.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 89' ' ' ASP . . . . . 0.564 ' OD2' ' HA ' ' A' ' 50' ' ' HIS . 0.9 OUTLIER -130.44 -91.91 0.44 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.641 179.038 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 90' ' ' LEU . . . . . 0.455 ' HG ' ' CG2' ' B' ' 115' ' ' VAL . 10.8 tp 175.93 -54.4 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.481 0 C-N-CA 123.484 0.714 . . . . 0.0 110.357 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 91' ' ' PRO . . . . . 0.652 ' HG3' ' HD3' ' A' ' 30' ' ' PRO . 60.9 Cg_exo -35.67 -63.11 0.2 Allowed 'Trans proline' 0 C--N 1.365 1.438 0 C-N-CA 123.492 2.795 . . . . 0.0 115.009 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 29.3 p -90.94 -31.32 16.42 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -178.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 3.2 t -57.58 -29.5 34.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.079 0.466 . . . . 0.0 111.561 -179.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 5.5 tp -62.46 -33.46 74.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.834 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.92 -15.16 54.39 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -177.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -129.07 20.81 5.83 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.667 0.618 . . . . 0.0 112.667 -179.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 97' ' ' LEU . . . . . 0.505 ' O ' ' HG ' ' B' ' 97' ' ' LEU . 0.0 OUTLIER -106.21 -9.12 17.02 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.431 179.827 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -40.18 110.37 0.15 Allowed 'General case' 0 N--CA 1.47 0.532 0 O-C-N 123.994 0.809 . . . . 0.0 112.044 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -109.36 -0.94 18.8 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.066 -179.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . 72.58 -78.84 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -83.53 48.81 1.47 Allowed 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -177.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' B' ' 103' ' ' CYS . . . 103.55 -145.51 16.2 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 119.828 -1.177 . . . . 0.0 113.671 178.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 103' ' ' CYS . . . . . 0.43 ' HB2' ' O ' ' B' ' 102' ' ' GLY . 5.5 m 71.94 20.0 4.56 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 122.953 0.501 . . . . 0.0 111.28 -178.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -112.07 -9.48 13.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.038 0.447 . . . . 0.0 110.215 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 8.4 p -79.18 -17.89 54.05 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.603 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 4.0 p -78.3 -62.02 1.82 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.287 0.565 . . . . 0.0 110.511 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . 0.527 ' CD2' HG13 ' B' ' 78' ' ' ILE . 0.9 OUTLIER -61.62 -61.03 2.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.168 -0.923 . . . . 0.0 110.75 -179.839 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 108' ' ' CYS . . . . . 0.74 ' O ' ' HB3' ' B' ' 122' ' ' CYS . 61.0 m -90.11 54.12 2.71 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.9 -179.039 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -74.24 -62.89 1.36 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.204 0.526 . . . . 0.0 110.125 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -86.13 -8.74 57.64 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 111' ' ' HIS . . . . . 0.694 ' O ' ' HB3' ' B' ' 108' ' ' CYS . 3.5 m-70 -106.99 88.26 2.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.554 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 90.3 m -114.48 37.66 3.33 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.381 -0.528 . . . . 0.0 112.101 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 113' ' ' HIS . . . . . 0.747 ' HA ' ' HB3' ' B' ' 117' ' ' LYS . 2.1 p80 -144.38 -149.69 0.29 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 110.202 -0.295 . . . . 0.0 110.202 178.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 114' ' ' GLY . . . . . 0.414 ' HA3' ' HG2' ' A' ' 30' ' ' PRO . . . 58.04 -106.37 0.8 Allowed Glycine 0 C--N 1.332 0.34 0 C-N-CA 121.205 -0.522 . . . . 0.0 112.973 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . 0.466 HG12 ' HG3' ' A' ' 30' ' ' PRO . 5.4 m -106.36 -23.76 4.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.582 0.23 . . . . 0.0 111.064 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 116' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -76.22 1.83 14.83 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 121.274 0.559 . . . . 0.0 110.966 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 117' ' ' LYS . . . . . 0.747 ' HB3' ' HA ' ' B' ' 113' ' ' HIS . 0.1 OUTLIER -100.27 -3.2 31.88 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.181 178.058 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -102.48 110.58 22.56 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.219 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 39.7 tp 77.55 -51.48 0.53 Allowed 'General case' 0 N--CA 1.474 0.729 0 O-C-N 124.108 0.88 . . . . 0.0 110.666 -178.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 -94.82 169.06 10.42 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 121' ' ' LEU . . . . . 0.505 ' HA ' HD13 ' B' ' 121' ' ' LEU . 11.4 tp -167.95 64.79 0.07 Allowed 'General case' 0 C--O 1.233 0.203 0 C-N-CA 120.068 -0.653 . . . . 0.0 112.542 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 122' ' ' CYS . . . . . 0.74 ' HB3' ' O ' ' B' ' 108' ' ' CYS . 0.8 OUTLIER . . . . . 0 C--O 1.248 0.996 0 O-C-N 124.043 0.839 . . . . 0.0 113.162 179.069 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.253 0 CA-C-O 120.684 0.278 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 26.1 mmt -87.47 78.93 8.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.951 0.405 . . . . 0.0 111.026 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 115.34 -169.05 12.75 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.424 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 12.4 mtpt -85.68 44.81 1.14 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.045 0.45 . . . . 0.0 111.078 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.7 t -176.28 170.99 2.52 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.2 t -134.8 -142.74 0.19 Allowed 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.672 HG23 HG22 ' A' ' 11' ' ' VAL . 3.1 m -69.99 81.91 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.1 0.476 . . . . 0.0 111.21 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.67 ' HG ' ' H ' ' A' ' 9' ' ' LYS . 0.6 OUTLIER -74.46 -60.51 2.24 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.594 -179.284 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.67 ' H ' ' HG ' ' A' ' 8' ' ' LEU . 34.9 mtmt -96.06 -19.11 19.69 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 30.8 mtpp -58.0 -50.91 71.79 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -177.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.672 HG22 HG23 ' A' ' 7' ' ' VAL . 8.2 t -89.97 34.14 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.51 0.671 . . . . 0.0 109.457 179.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 56.72 30.42 17.56 Favored 'General case' 0 N--CA 1.461 0.089 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.863 -179.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.577 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 18.9 m 63.78 17.92 10.8 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.154 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.847 ' HA ' ' HB1' ' A' ' 18' ' ' ALA . . . -89.88 28.38 1.37 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -108.39 -94.81 0.4 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.807 0.337 . . . . 0.0 110.997 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.455 ' O ' ' HB1' ' A' ' 20' ' ' ALA . . . -74.16 -0.21 16.02 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.594 HG12 ' CD2' ' A' ' 46' ' ' PHE . 60.5 mt -107.99 -61.64 2.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.787 -0.188 . . . . 0.0 111.206 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.847 ' HB1' ' HA ' ' A' ' 14' ' ' ALA . . . -67.58 -31.36 71.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.999 0.428 . . . . 0.0 110.535 179.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.33 -20.48 72.11 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.638 179.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.576 ' HB3' HG13 ' A' ' 32' ' ' VAL . . . -77.3 -22.63 51.71 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.161 0.505 . . . . 0.0 110.016 179.101 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 75.3 t -64.55 -44.19 96.82 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.594 178.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.78 -16.44 61.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.349 179.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.88 -44.38 32.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.121 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.511 ' SG ' ' HB2' ' B' ' 113' ' ' HIS . 24.8 t -85.67 -28.98 24.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.032 0.444 . . . . 0.0 110.831 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 103.52 38.14 2.87 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.432 -0.89 . . . . 0.0 112.198 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 145.62 165.68 11.47 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.916 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.9 tp -95.81 109.59 22.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.256 0.551 . . . . 0.0 110.362 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.713 ' C ' ' HD2' ' A' ' 30' ' ' PRO . 15.9 p-10 -128.73 -50.3 1.25 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 118.963 -0.541 . . . . 0.0 111.27 -179.463 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.659 ' HB3' ' O ' ' A' ' 28' ' ' ASP . 17.0 tp 107.14 -54.39 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 124.913 1.383 . . . . 0.0 111.794 -179.034 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.878 ' HA ' HG22 ' A' ' 54' ' ' VAL . 10.6 Cg_endo -53.75 -36.55 82.5 Favored 'Trans proline' 0 C--N 1.364 1.38 0 C-N-CA 122.325 2.017 . . . . 0.0 112.869 179.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 2.4 t -93.9 -36.43 12.21 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.109 0.48 . . . . 0.0 110.711 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.576 HG13 ' HB3' ' A' ' 20' ' ' ALA . 94.0 t -64.25 -25.93 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.359 -179.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.9 pp -57.69 -33.27 68.2 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.789 0.328 . . . . 0.0 111.139 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.61 -38.13 62.65 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.67 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.28 -13.46 60.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.47 -179.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.427 HD22 ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -93.11 -41.54 9.89 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.362 -179.709 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.9 ttmm 55.1 77.42 0.22 Allowed 'General case' 0 N--CA 1.47 0.546 0 O-C-N 123.464 0.478 . . . . 0.0 110.281 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.427 ' HB3' HD22 ' A' ' 36' ' ' LEU . . . -99.59 138.44 36.67 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.117 0.485 . . . . 0.0 111.972 -178.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -115.71 -99.96 0.44 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.3 178.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -86.42 78.28 9.29 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.463 0.649 . . . . 0.0 110.23 178.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 102.77 -128.94 9.71 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.482 -179.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.406 ' HA ' ' CB ' ' A' ' 8' ' ' LEU . 3.9 m 70.29 -57.49 0.57 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.336 0.654 . . . . 0.0 111.657 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -87.7 13.63 10.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.529 0.204 . . . . 0.0 111.116 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.24 -44.89 96.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.863 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 8.0 p -80.01 -32.5 39.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.17 0.51 . . . . 0.0 110.514 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.594 ' CD2' HG12 ' A' ' 17' ' ' ILE . 0.9 OUTLIER -59.68 -61.12 2.86 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.554 -179.801 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 62.6 m -80.32 52.59 1.62 Allowed 'General case' 0 C--O 1.211 -0.94 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.137 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -78.3 -59.58 2.72 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -101.08 -13.3 18.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.239 179.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -96.88 76.21 2.73 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.198 -0.91 . . . . 0.0 108.955 179.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 88.9 m -117.7 19.64 13.76 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -177.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 9.0 p-80 -123.31 -20.98 5.48 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 119.439 -0.904 . . . . 0.0 113.192 -179.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.711 ' O ' HG21 ' A' ' 54' ' ' VAL . . . -106.21 119.57 6.06 Favored Glycine 0 C--O 1.221 -0.682 0 C-N-CA 120.034 -1.079 . . . . 0.0 112.606 179.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.878 HG22 ' HA ' ' A' ' 30' ' ' PRO . 14.3 m 54.54 -33.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 13.4 t -72.87 -37.75 67.23 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 121.471 -0.768 . . . . 0.0 110.938 -178.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 35.7 tttp -67.29 -8.62 33.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.703 179.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -71.97 -22.86 61.38 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 178.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.4 mp -114.4 -21.56 10.31 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.854 178.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 67.18 87.51 0.12 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.05 0.54 . . . . 0.0 111.059 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.7 mt -125.31 19.58 8.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.707 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 10.6 p . . . . . 0 C--O 1.245 0.817 0 CA-C-O 118.063 -0.97 . . . . 0.0 109.786 179.385 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.167 0 CA-C-O 120.826 0.346 . . . . 0.0 110.578 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 63' ' ' MET . . . . . . . . . . . . . 26.3 mmt -81.74 -49.7 10.13 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.54 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -154.29 -163.41 11.91 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.237 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 31.1 mtmm -94.57 3.14 55.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.105 0.478 . . . . 0.0 110.503 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 66' ' ' CYS . . . . . 0.489 ' HB2' ' CG ' ' B' ' 101' ' ' GLU . 0.0 OUTLIER -152.75 -74.19 0.14 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.589 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 70.1 m 66.48 -58.66 0.36 Allowed 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 178.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . 0.592 HG11 HG23 ' B' ' 72' ' ' VAL . 17.0 m -83.92 43.86 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 -178.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.748 ' HB3' ' HA ' ' B' ' 103' ' ' CYS . 0.2 OUTLIER -83.43 -121.81 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.617 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 70' ' ' LYS . . . . . 0.484 ' HA ' ' SG ' ' B' ' 74' ' ' CYS . 0.0 OUTLIER -74.93 4.83 5.87 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 121.96 -0.463 . . . . 0.0 110.387 178.576 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 6.0 mtmt -73.11 -56.5 5.02 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.136 -0.484 . . . . 0.0 112.085 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . 0.592 HG23 HG11 ' B' ' 68' ' ' VAL . 2.1 t -92.25 36.72 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . 55.96 28.67 13.02 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 114.69 -1.141 . . . . 0.0 111.1 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 74' ' ' CYS . . . . . 0.546 ' O ' ' HB ' ' B' ' 78' ' ' ILE . 51.6 m 54.29 44.16 29.43 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.564 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -90.45 -43.24 10.4 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -178.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.89 -66.55 0.53 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -177.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.89 10.48 2.78 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -177.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.802 HD11 ' HB2' ' B' ' 107' ' ' PHE . 20.8 mt -130.8 -55.37 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 O-C-N 121.778 -0.576 . . . . 0.0 111.432 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.78 -36.22 70.28 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.282 178.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -75.53 -23.7 72.41 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.281 178.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . 0.49 ' CB ' ' HB3' ' B' ' 96' ' ' ALA . . . -69.63 -22.59 63.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.029 0.442 . . . . 0.0 110.693 179.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 54.7 t -65.84 -38.83 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.574 179.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -76.52 -13.98 60.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.805 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.53 -35.01 30.85 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.519 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 54.0 t -92.61 -40.26 10.87 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 121.005 -0.278 . . . . 0.0 111.508 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.02 37.27 1.54 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.502 -0.856 . . . . 0.0 111.628 -179.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 158.4 167.11 18.77 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 121.028 -0.606 . . . . 0.0 111.687 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 3.1 tp -102.48 123.45 55.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.915 0.388 . . . . 0.0 111.363 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 89' ' ' ASP . . . . . 0.528 ' CG ' ' H ' ' B' ' 90' ' ' LEU . 9.9 p-10 -163.7 -111.89 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.581 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 90' ' ' LEU . . . . . 0.64 ' N ' ' HD2' ' B' ' 91' ' ' PRO . 37.1 tp -179.32 -49.99 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.404 0 C-N-CA 123.843 0.857 . . . . 0.0 110.454 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 91' ' ' PRO . . . . . 0.726 ' HG3' ' HD3' ' A' ' 30' ' ' PRO . 5.4 Cg_endo -46.9 -34.28 15.98 Favored 'Trans proline' 0 C--N 1.366 1.465 0 C-N-CA 123.39 2.727 . . . . 0.0 114.575 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 15.2 p -108.64 -27.99 9.52 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.161 0.505 . . . . 0.0 110.755 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . 0.575 HG11 ' HE2' ' B' ' 107' ' ' PHE . 48.2 t -60.67 -20.15 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.705 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 94' ' ' LEU . . . . . 0.606 HD21 HG21 ' B' ' 115' ' ' VAL . 0.8 OUTLIER -53.77 -24.33 14.8 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 179.953 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.5 -55.36 34.36 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -178.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . 0.49 ' HB3' ' CB ' ' B' ' 81' ' ' ALA . . . -82.75 -21.57 34.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.783 0.325 . . . . 0.0 110.705 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 44.1 tp -62.22 -51.83 66.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.292 178.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 51.1 tttm 63.52 113.11 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.697 177.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 99' ' ' ALA . . . . . 0.463 ' HB3' HD21 ' B' ' 119' ' ' LEU . . . -87.29 82.86 7.48 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.823 179.346 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -102.47 -103.11 0.28 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.846 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . 0.489 ' CG ' ' HB2' ' B' ' 66' ' ' CYS . 22.4 pt-20 -102.98 43.3 1.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.539 0.685 . . . . 0.0 109.949 179.226 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . 0.448 ' O ' ' HB2' ' B' ' 103' ' ' CYS . . . 116.33 -128.08 7.8 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.444 -179.29 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 103' ' ' CYS . . . . . 0.748 ' HA ' ' HB3' ' B' ' 69' ' ' LEU . 39.9 m 72.93 -48.41 0.69 Allowed 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.281 0.633 . . . . 0.0 112.428 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 104' ' ' ALA . . . . . 0.432 ' HB3' HD13 ' B' ' 121' ' ' LEU . . . -79.37 -9.66 59.64 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -179.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 54.4 p -52.46 -52.43 54.22 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 4.8 p -62.37 -30.49 71.22 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.031 0.444 . . . . 0.0 111.179 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . 0.802 ' HB2' HD11 ' B' ' 78' ' ' ILE . 0.5 OUTLIER -69.18 -56.7 6.84 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.31 -179.189 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 108' ' ' CYS . . . . . 0.617 ' SG ' ' HB3' ' B' ' 122' ' ' CYS . 0.8 OUTLIER -79.57 18.21 0.77 Allowed 'General case' 0 CA--C 1.514 -0.407 0 C-N-CA 120.631 -0.427 . . . . 0.0 111.973 179.914 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -55.22 -65.11 0.64 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.378 0.609 . . . . 0.0 110.201 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -89.13 -10.36 47.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.254 178.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 47.3 m-70 -110.69 64.95 0.61 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.928 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 1.7 m -91.2 39.54 1.0 Allowed 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 112.046 0.388 . . . . 0.0 112.046 -178.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 113' ' ' HIS . . . . . 0.511 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 14.1 p-80 -143.22 -15.39 0.68 Allowed 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.341 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -77.25 -159.97 11.4 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.762 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . 0.606 HG21 HD21 ' B' ' 94' ' ' LEU . 24.4 m -64.39 -4.96 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -179.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 116' ' ' CYS . . . . . 0.502 ' SG ' ' HB2' ' B' ' 121' ' ' LEU . 7.0 t -78.77 -23.45 45.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.685 0.755 . . . . 0.0 109.115 178.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 4.0 ttmt -81.79 -7.57 59.61 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.146 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -65.01 -31.92 73.39 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 119' ' ' LEU . . . . . 0.463 HD21 ' HB3' ' B' ' 99' ' ' ALA . 16.6 tp -114.23 -8.13 12.95 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.188 178.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 66.51 79.52 0.24 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.024 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 121' ' ' LEU . . . . . 0.502 ' HB2' ' SG ' ' B' ' 116' ' ' CYS . 96.6 mt -116.5 4.64 13.29 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 122' ' ' CYS . . . . . 0.617 ' HB3' ' SG ' ' B' ' 108' ' ' CYS . 21.2 p . . . . . 0 C--O 1.248 0.977 0 CA-C-O 118.177 -0.915 . . . . 0.0 109.335 178.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.186 0 N-CA-C 110.499 -0.186 . . . . 0.0 110.499 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.88 -158.78 0.75 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.058 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 170.47 169.35 33.48 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.936 -0.65 . . . . 0.0 111.667 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 31.1 tttm -95.88 -62.08 1.34 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 117.14 0.47 . . . . 0.0 109.998 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.639 ' HB2' ' HB2' ' A' ' 40' ' ' GLU . 26.1 t -131.96 66.65 1.54 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.766 179.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.401 ' O ' HG22 ' A' ' 7' ' ' VAL . 13.8 m -78.89 152.97 30.89 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.356 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.766 HG21 ' HB ' ' A' ' 11' ' ' VAL . 29.3 m 38.18 46.43 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 123.991 0.916 . . . . 0.0 112.409 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.432 ' HB2' ' HA ' ' A' ' 42' ' ' CYS . 0.7 OUTLIER -51.56 -54.13 30.74 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.809 -178.987 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.574 ' HA ' ' SG ' ' A' ' 13' ' ' CYS . 11.6 ptmm? -106.22 30.14 6.19 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 121.063 0.459 . . . . 0.0 110.652 -179.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.62 ' HB3' ' HB ' ' A' ' 7' ' ' VAL . 87.7 tttt -122.09 -64.18 1.23 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.379 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.766 ' HB ' HG21 ' A' ' 7' ' ' VAL . 21.3 t -110.57 -28.7 2.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.128 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.78 -28.83 67.76 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.655 0.264 . . . . 0.0 111.562 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.574 ' SG ' ' HA ' ' A' ' 9' ' ' LYS . 26.7 m -69.77 -16.58 63.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.941 0.401 . . . . 0.0 111.122 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.431 ' HA ' ' HB1' ' A' ' 18' ' ' ALA . . . -106.56 -13.99 15.17 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.789 0.328 . . . . 0.0 111.261 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -88.23 -69.27 0.71 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.442 ' HB1' ' HA ' ' A' ' 36' ' ' LEU . . . -88.87 2.87 53.01 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.697 HG12 ' HD2' ' A' ' 46' ' ' PHE . 66.9 mt -119.0 -64.79 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 121.218 -0.193 . . . . 0.0 110.932 -179.584 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.484 ' HA ' HG21 ' A' ' 21' ' ' VAL . . . -68.27 -26.68 65.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.126 0.489 . . . . 0.0 110.057 178.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -87.47 10.35 69.77 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 178.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.417 ' CB ' ' HB2' ' A' ' 35' ' ' ALA . . . -125.12 -2.21 7.65 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 122.801 0.44 . . . . 0.0 110.456 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.484 HG21 ' HA ' ' A' ' 18' ' ' ALA . 64.3 t -66.5 -43.51 90.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.22 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.19 -4.57 30.09 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -84.17 -13.87 51.64 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -149.03 40.85 0.89 Allowed 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.47 -48.27 2.52 Favored Glycine 0 C--O 1.227 -0.336 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.882 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -168.57 176.49 42.88 Favored Glycine 0 N--CA 1.442 -0.907 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 179.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -49.86 110.83 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.607 0.718 . . . . 0.0 112.18 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.979 ' HB3' HG22 ' A' ' 32' ' ' VAL . 49.2 t0 -121.47 -118.82 0.3 Allowed 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.786 ' HG ' HG22 ' A' ' 54' ' ' VAL . 16.1 tp 173.01 -57.94 0.0 OUTLIER Pre-proline 0 C--O 1.223 -0.296 0 O-C-N 123.612 0.57 . . . . 0.0 111.429 178.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.712 ' HD3' ' HB3' ' A' ' 29' ' ' LEU . 54.3 Cg_exo -52.06 -49.21 18.1 Favored 'Trans proline' 0 C--N 1.358 1.048 0 C-N-CA 122.268 1.979 . . . . 0.0 113.225 -179.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 25.5 p -92.42 -35.15 13.83 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.238 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.979 HG22 ' HB3' ' A' ' 28' ' ' ASP . 65.4 t -65.06 -18.92 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.241 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.572 HD11 ' HA ' ' A' ' 55' ' ' CYS . 25.9 tp -57.93 -25.78 61.36 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.893 178.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.05 -41.13 99.42 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.648 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.417 ' HB2' ' CB ' ' A' ' 20' ' ' ALA . . . -86.36 -8.87 57.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.971 0.415 . . . . 0.0 111.057 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.442 ' HA ' ' HB1' ' A' ' 16' ' ' ALA . 33.5 tp -89.17 62.11 6.05 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 178.356 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.552 ' HD3' ' H ' ' A' ' 37' ' ' LYS . 0.3 OUTLIER -75.27 45.08 0.27 Allowed 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -177.1 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.61 156.83 16.61 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 122.189 -0.319 . . . . 0.0 110.386 178.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -115.23 -40.97 3.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.983 0.421 . . . . 0.0 110.583 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.639 ' HB2' ' HB2' ' A' ' 5' ' ' CYS . 60.3 mm-40 -93.53 -169.1 2.04 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.069 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -75.31 56.65 2.83 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 121.015 -0.612 . . . . 0.0 113.851 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.432 ' HA ' ' HB2' ' A' ' 8' ' ' LEU . 19.7 m -97.66 5.0 49.94 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 122.466 -0.432 . . . . 0.0 110.396 179.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.519 ' CB ' HD13 ' A' ' 60' ' ' LEU . . . -126.07 16.56 7.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.193 179.034 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.552 ' O ' ' HG2' ' A' ' 48' ' ' GLU . 5.9 m -61.86 -32.08 72.4 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.704 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 12.7 p -66.25 -26.74 67.5 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.124 0.488 . . . . 0.0 111.058 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.697 ' HD2' HG12 ' A' ' 17' ' ' ILE . 1.0 OUTLIER -93.29 -63.89 1.16 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.843 -178.67 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.611 ' SG ' HD11 ' A' ' 29' ' ' LEU . 72.9 m -82.84 45.44 1.0 Allowed 'General case' 0 C--O 1.217 -0.621 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -177.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.552 ' HG2' ' O ' ' A' ' 44' ' ' SER . 0.9 OUTLIER -72.81 -71.15 0.31 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 119.147 0.885 . . . . 0.0 110.401 179.406 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -78.36 -5.92 53.66 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.495 ' HB2' ' HA ' ' A' ' 47' ' ' CYS . 36.2 m-70 -104.29 66.17 0.81 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.924 -179.203 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.4 ' O ' ' HD2' ' A' ' 56' ' ' LYS . 72.4 m -120.41 50.08 1.36 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 178.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.434 ' HB3' ' SG ' ' B' ' 85' ' ' CYS . 13.1 m80 -96.92 -77.01 0.5 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.594 0.712 . . . . 0.0 110.185 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.632 ' O ' HG23 ' A' ' 54' ' ' VAL . . . -120.86 -174.99 15.15 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 179.05 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.786 HG22 ' HG ' ' A' ' 29' ' ' LEU . 9.3 m 47.02 -64.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.572 ' HA ' HD11 ' A' ' 33' ' ' LEU . 8.8 t -64.78 -48.89 72.84 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 121.664 -0.647 . . . . 0.0 111.836 -178.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.4 ' HD2' ' O ' ' A' ' 51' ' ' CYS . 17.0 ptmt -75.23 -2.01 26.02 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 119.42 -0.912 . . . . 0.0 111.296 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -65.97 -35.52 80.8 Favored 'General case' 0 N--CA 1.461 0.114 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 177.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.9 tt -90.26 -33.13 16.26 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 114.58 -1.191 . . . . 0.0 108.011 177.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 22.5 t-160 77.25 86.6 0.08 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.274 178.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.612 HD22 ' N ' ' A' ' 60' ' ' LEU . 0.7 OUTLIER -140.57 25.45 2.19 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -179.932 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 6.0 p . . . . . 0 C--O 1.244 0.791 0 CA-C-O 118.17 -0.919 . . . . 0.0 109.856 176.853 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.179 0 CA-C-O 120.788 0.328 . . . . 0.0 111.094 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 63' ' ' MET . . . . . . . . . . . . . 36.5 ttm -75.67 139.15 41.8 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -133.05 119.13 2.3 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 119.594 -1.288 . . . . 0.0 114.208 -178.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 20.8 tttt -120.41 -29.8 4.71 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 66' ' ' CYS . . . . . 0.627 ' SG ' ' HB3' ' B' ' 69' ' ' LEU . 42.7 t -156.97 52.57 0.5 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.328 -1.305 . . . . 0.0 107.981 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.426 ' C ' HG23 ' B' ' 68' ' ' VAL . 25.0 m -54.9 142.28 30.21 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.14 -178.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . 0.649 ' HB ' ' HB3' ' B' ' 71' ' ' LYS . 23.6 m 40.41 48.27 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 O-C-N 124.251 0.97 . . . . 0.0 112.393 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.627 ' HB3' ' SG ' ' B' ' 66' ' ' CYS . 0.3 OUTLIER -46.19 -72.86 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.039 -0.982 . . . . 0.0 113.17 -179.666 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 70' ' ' LYS . . . . . . . . . . . . . 17.8 mtpp -92.94 27.9 2.27 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.001 0.429 . . . . 0.0 110.036 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . 0.649 ' HB3' ' HB ' ' B' ' 68' ' ' VAL . 4.4 tmtp? -116.56 -67.82 0.97 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.638 -178.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 18.6 t -116.12 -24.82 3.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.811 0.339 . . . . 0.0 111.033 -179.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.86 -35.39 76.46 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 74' ' ' CYS . . . . . 0.564 ' HA ' HD13 ' B' ' 78' ' ' ILE . 13.0 p -89.94 2.86 54.58 Favored 'General case' 0 CA--C 1.521 -0.137 0 C-N-CA 119.538 -0.865 . . . . 0.0 111.285 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -115.61 13.16 16.26 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 120.906 0.384 . . . . 0.0 110.661 178.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -128.48 -76.36 0.56 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.391 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.45 -39.44 90.84 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.884 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.827 HD12 ' HB2' ' B' ' 107' ' ' PHE . 13.5 mt -74.01 -41.2 52.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.03 0.443 . . . . 0.0 110.995 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.53 -32.75 71.77 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.161 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.63 -35.64 9.18 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.872 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . 0.432 ' HB1' HG13 ' B' ' 93' ' ' VAL . . . -73.25 -26.51 61.14 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -178.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 82' ' ' VAL . . . . . 0.516 HG12 HG22 ' B' ' 88' ' ' ILE . 3.2 t -66.76 -50.51 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.298 179.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.34 -26.11 67.13 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.006 0.431 . . . . 0.0 111.34 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.69 -25.14 64.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.033 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 85' ' ' CYS . . . . . 0.434 ' SG ' ' HB3' ' A' ' 52' ' ' HIS . 1.5 t -88.92 -22.62 23.01 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.962 -179.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 99.66 43.99 2.38 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.166 -1.016 . . . . 0.0 113.804 179.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 114.87 52.01 0.44 Allowed Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.05 -1.072 . . . . 0.0 113.893 178.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 88' ' ' ILE . . . . . 0.516 HG22 HG12 ' B' ' 82' ' ' VAL . 0.5 OUTLIER 56.04 174.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 124.29 1.036 . . . . 0.0 113.184 179.142 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 89' ' ' ASP . . . . . 0.577 ' CG ' ' HD2' ' B' ' 91' ' ' PRO . 39.2 t0 170.41 -124.62 0.0 OUTLIER 'General case' 0 C--O 1.233 0.212 0 CA-C-N 114.348 -1.296 . . . . 0.0 108.403 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 90' ' ' LEU . . . . . 0.744 HD13 ' SG ' ' B' ' 116' ' ' CYS . 21.1 tp 172.46 -58.5 0.0 OUTLIER Pre-proline 0 C--N 1.324 -0.542 0 C-N-CA 124.364 1.066 . . . . 0.0 109.34 178.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 91' ' ' PRO . . . . . 0.824 ' HA ' HG11 ' B' ' 115' ' ' VAL . 50.8 Cg_exo -54.07 -43.25 59.99 Favored 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 122.031 1.821 . . . . 0.0 112.281 179.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 24.7 p -79.85 -35.82 37.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.055 0.455 . . . . 0.0 110.87 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . 0.614 HG12 ' HE2' ' B' ' 107' ' ' PHE . 5.8 t -71.02 -25.4 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.481 -178.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 30.8 tp -60.16 -28.33 67.83 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 120.828 0.347 . . . . 0.0 110.934 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.86 -36.62 81.76 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.408 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -99.37 9.86 42.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.297 0.57 . . . . 0.0 110.089 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 24.3 tp -107.55 68.24 0.71 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.167 -0.924 . . . . 0.0 108.708 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . 0.405 ' NZ ' ' HB2' ' B' ' 98' ' ' LYS . 8.1 mtmp? -77.24 30.26 0.14 Allowed 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.426 -178.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 99' ' ' ALA . . . . . 0.463 ' O ' ' HB3' ' B' ' 104' ' ' ALA . . . -118.34 87.49 2.73 Favored 'General case' 0 C--N 1.321 -0.671 0 O-C-N 122.271 -0.268 . . . . 0.0 110.857 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -79.74 47.81 0.89 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.492 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . 0.427 ' HB3' ' H ' ' B' ' 102' ' ' GLY . 60.3 mm-40 -142.96 -155.71 0.62 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.944 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . 0.427 ' H ' ' HB3' ' B' ' 101' ' ' GLU . . . -71.17 -3.26 51.94 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.183 178.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 103' ' ' CYS . . . . . 0.455 ' N ' ' SG ' ' B' ' 66' ' ' CYS . 79.4 m -75.38 -15.12 60.49 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.976 0.417 . . . . 0.0 109.932 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 104' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' B' ' 99' ' ' ALA . . . -109.74 -25.63 10.28 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.843 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 22.0 p -60.58 -25.93 66.57 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.754 0.312 . . . . 0.0 111.21 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 106' ' ' CYS . . . . . 0.499 ' HB3' ' HB3' ' B' ' 74' ' ' CYS . 43.5 t -60.33 -18.73 51.81 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.382 0.611 . . . . 0.0 110.389 178.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . 0.827 ' HB2' HD12 ' B' ' 78' ' ' ILE . 0.6 OUTLIER -104.16 -65.06 1.05 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.519 -179.535 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 108' ' ' CYS . . . . . 0.448 ' HB2' ' HB3' ' B' ' 122' ' ' CYS . 0.0 OUTLIER -73.69 15.77 0.25 Allowed 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -178.504 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -37.49 -73.23 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.181 0.592 . . . . 0.0 112.364 -178.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -98.71 -33.91 10.74 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -70.63 87.07 0.66 Allowed 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 112' ' ' CYS . . . . . 0.587 ' HB3' ' HG2' ' B' ' 117' ' ' LYS . 0.5 OUTLIER -154.21 136.63 14.99 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -178.622 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 113' ' ' HIS . . . . . 0.431 ' CD2' ' HB2' ' A' ' 28' ' ' ASP . 1.5 t60 -153.22 -49.63 0.1 Allowed 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 178.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -127.14 -159.38 10.14 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 177.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . 0.824 HG11 ' HA ' ' B' ' 91' ' ' PRO . 0.4 OUTLIER 41.45 -86.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 123.903 0.881 . . . . 0.0 113.31 179.644 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 116' ' ' CYS . . . . . 0.744 ' SG ' HD13 ' B' ' 90' ' ' LEU . 36.5 m -61.36 -33.13 73.13 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 118.431 0.56 . . . . 0.0 109.831 178.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 117' ' ' LYS . . . . . 0.587 ' HG2' ' HB3' ' B' ' 112' ' ' CYS . 3.9 mmmm -77.53 -21.0 53.31 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.244 178.469 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -62.38 -47.86 82.28 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 7.9 tt -79.77 -29.28 40.39 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 177.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 8.5 t-160 76.01 67.67 0.06 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.529 178.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 121' ' ' LEU . . . . . 0.48 HD21 ' H ' ' B' ' 121' ' ' LEU . 0.9 OUTLIER -126.81 8.97 6.91 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.475 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 122' ' ' CYS . . . . . 0.448 ' HB3' ' HB2' ' B' ' 108' ' ' CYS . 0.8 OUTLIER . . . . . 0 C--O 1.245 0.852 0 CA-C-O 118.173 -0.918 . . . . 0.0 110.208 178.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.687 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 1.3 p . . . . . 0 N--CA 1.451 -0.379 0 CA-C-O 120.749 0.309 . . . . 0.0 111.072 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.49 28.3 0.08 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.409 ' H ' ' C ' ' A' ' 13' ' ' CYS . . . -138.38 -64.34 0.53 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.929 0.395 . . . . 0.0 110.27 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.42 -43.83 47.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.943 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.838 HD13 ' HB2' ' A' ' 46' ' ' PHE . 10.6 mt -70.28 -38.2 73.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.117 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.1 -39.01 88.33 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.823 178.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.6 -31.52 44.93 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.966 -0.635 . . . . 0.0 111.886 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.59 -28.84 61.09 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.302 0.573 . . . . 0.0 110.293 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.724 HG13 ' H ' ' A' ' 27' ' ' ILE . 1.2 t -68.3 -37.36 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.235 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.82 -6.27 40.35 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.616 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.84 -2.33 58.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.491 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.6 t -147.05 55.23 1.1 Allowed 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.977 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.38 -53.41 4.21 Favored Glycine 0 N--CA 1.455 -0.088 0 C-N-CA 121.2 -0.524 . . . . 0.0 113.936 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.695 ' HA2' HG13 ' A' ' 21' ' ' VAL . . . 131.79 116.66 1.8 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.969 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.724 ' H ' HG13 ' A' ' 21' ' ' VAL . 43.9 mm 72.83 78.62 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.505 -0.773 0 CA-C-O 122.787 1.279 . . . . 0.0 111.58 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.705 ' OD2' ' HB3' ' A' ' 31' ' ' CYS . 40.1 t0 -148.63 161.61 41.37 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-N 112.683 -2.053 . . . . 0.0 107.298 177.418 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.613 ' HB3' ' HD3' ' A' ' 30' ' ' PRO . 36.0 tp -126.12 -52.63 0.03 OUTLIER Pre-proline 0 C--N 1.296 -1.729 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.026 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.838 ' HB3' HG13 ' B' ' 115' ' ' VAL . 47.2 Cg_exo -54.84 -41.7 75.76 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 121.907 1.738 . . . . 0.0 112.632 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.705 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 5.6 t -85.82 -38.96 17.59 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.187 -178.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.675 HG23 ' HB3' ' A' ' 28' ' ' ASP . 93.0 t -73.44 -16.23 17.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.799 HD22 ' HB ' ' A' ' 54' ' ' VAL . 44.8 tp -55.27 -31.08 61.28 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -56.67 -37.05 70.28 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -104.44 4.37 33.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.808 0.337 . . . . 0.0 111.112 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 52.3 tp -85.87 -25.55 26.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.869 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.82 46.47 1.18 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.451 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -136.59 134.87 37.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.802 -0.181 . . . . 0.0 111.336 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 65.37 -165.54 0.23 Allowed 'General case' 0 N--CA 1.468 0.474 0 O-C-N 123.968 0.793 . . . . 0.0 111.838 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -124.14 53.88 1.38 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.189 0.518 . . . . 0.0 112.005 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -134.39 52.54 0.81 Allowed Glycine 0 CA--C 1.517 0.17 0 C-N-CA 121.062 -0.589 . . . . 0.0 111.881 178.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -127.09 -104.74 0.33 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.733 -0.234 . . . . 0.0 111.089 -179.208 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 57.99 -154.1 0.36 Allowed 'General case' 0 C--O 1.239 0.503 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 178.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.8 p -66.82 32.88 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -176.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 43.8 t -107.87 -31.56 7.96 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 176.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.838 ' HB2' HD13 ' A' ' 17' ' ' ILE . 1.1 t80 -103.52 -65.53 1.0 Allowed 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.299 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.456 ' HA ' ' HB2' ' A' ' 50' ' ' HIS . 7.6 m -75.77 23.6 0.13 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -177.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.582 ' HA ' ' OE1' ' A' ' 48' ' ' GLU . 7.3 tp10 -69.1 -68.02 0.43 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.95 0.405 . . . . 0.0 110.581 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -79.79 -14.49 58.66 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.456 ' HB2' ' HA ' ' A' ' 47' ' ' CYS . 32.5 m80 -100.44 63.43 1.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.669 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -115.02 68.42 0.7 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.876 0.37 . . . . 0.0 110.595 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -107.82 -64.07 1.25 Allowed 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.276 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.508 ' HA3' ' HB2' ' B' ' 92' ' ' CYS . . . -134.12 -107.54 0.98 Allowed Glycine 0 C--O 1.219 -0.835 0 C-N-CA 120.031 -1.08 . . . . 0.0 113.799 -178.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.799 ' HB ' HD22 ' A' ' 33' ' ' LEU . 2.9 m -12.51 -67.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 N-CA-C 116.496 2.036 . . . . 0.0 116.496 -178.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.595 ' H ' HG23 ' A' ' 54' ' ' VAL . 32.4 t -73.38 -39.79 64.84 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -177.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.7 tttm -63.46 -24.75 67.96 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.02 0.438 . . . . 0.0 109.941 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -62.18 -32.68 73.33 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.213 178.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 60.5 mt -94.36 -4.69 48.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.44 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 66.2 t-80 64.79 84.04 0.16 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.851 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.503 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 8.1 mp -126.98 27.35 5.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.026 178.516 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.903 0 CA-C-O 118.213 -0.898 . . . . 0.0 109.462 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 74' ' ' CYS . . . . . 1.114 ' HB2' HD12 ' B' ' 78' ' ' ILE . 31.2 p . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.788 0.327 . . . . 0.0 111.305 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 75' ' ' ALA . . . . . 0.45 ' O ' ' HB3' ' B' ' 79' ' ' ALA . . . -69.53 -6.34 30.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.89 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -102.25 -47.91 4.36 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.65 -41.42 13.4 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -178.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 1.114 HD12 ' HB2' ' B' ' 74' ' ' CYS . 84.3 mt -76.27 -43.01 37.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.646 0.26 . . . . 0.0 110.713 -179.193 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 79' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' B' ' 75' ' ' ALA . . . -78.74 -16.99 56.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.925 0.393 . . . . 0.0 110.906 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -86.62 -34.29 11.92 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.591 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.69 -19.58 65.19 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.652 0.263 . . . . 0.0 111.354 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 77.4 t -62.13 -54.75 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.121 178.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.41 -26.47 65.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.225 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.54 -40.89 96.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.84 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 7.2 t -110.75 25.38 11.84 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.411 -0.516 . . . . 0.0 111.668 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.73 -51.48 4.58 Favored Glycine 0 CA--C 1.518 0.245 0 N-CA-C 114.858 0.703 . . . . 0.0 114.858 178.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . -138.25 -177.4 15.24 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.036 -1.078 . . . . 0.0 113.837 -178.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 3.9 tp -102.11 137.0 31.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.217 0.532 . . . . 0.0 111.187 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 89' ' ' ASP . . . . . 0.428 ' H ' HG21 ' B' ' 93' ' ' VAL . 38.9 t0 -171.2 -104.64 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.226 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 90' ' ' LEU . . . . . 0.675 HD21 ' HB2' ' B' ' 116' ' ' CYS . 56.0 tp -176.16 -50.61 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.388 0 CA-C-O 119.476 -0.297 . . . . 0.0 111.494 178.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 91' ' ' PRO . . . . . 0.625 ' HD2' ' N ' ' B' ' 90' ' ' LEU . 3.4 Cg_exo -40.73 -39.83 3.23 Favored 'Trans proline' 0 C--N 1.364 1.344 0 C-N-CA 124.051 3.167 . . . . 0.0 114.67 -179.266 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 92' ' ' CYS . . . . . 0.508 ' HB2' ' HA3' ' A' ' 53' ' ' GLY . 19.6 t -113.16 -14.8 12.86 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.067 0.461 . . . . 0.0 111.726 -178.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 93' ' ' VAL . . . . . 0.428 HG21 ' H ' ' B' ' 89' ' ' ASP . 12.3 t -72.62 -17.68 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.395 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 94' ' ' LEU . . . . . 0.954 HD22 ' HB ' ' B' ' 115' ' ' VAL . 23.8 tp -62.22 -35.58 79.34 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.46 -54.89 26.33 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 -178.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -87.38 7.97 26.6 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 97' ' ' LEU . . . . . 0.495 HD23 HD12 ' B' ' 94' ' ' LEU . 59.8 tp -79.0 -31.02 44.63 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.288 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 98' ' ' LYS . . . . . 0.641 ' HE3' HD11 ' B' ' 119' ' ' LEU . 39.0 ttmt . . . . . 0 C--O 1.234 0.279 0 CA-C-O 121.551 0.691 . . . . 0.0 110.743 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 103' ' ' CYS . . . . . 0.826 ' HB2' HD21 ' B' ' 121' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.235 0.314 0 CA-C-O 120.559 0.219 . . . . 0.0 110.49 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . 53.87 -155.24 0.23 Allowed 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.66 33.97 0.05 Allowed 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 115.18 -0.918 . . . . 0.0 113.47 -178.032 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 38.8 t -105.86 -28.68 10.47 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 177.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 107' ' ' PHE . . . . . 0.57 ' HB2' HD11 ' B' ' 78' ' ' ILE . 0.0 OUTLIER -123.48 162.4 22.94 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 113.94 -1.482 . . . . 0.0 107.055 176.24 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 66.9 m 68.2 -3.94 1.17 Allowed 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -62.08 -85.41 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 118.563 0.62 . . . . 0.0 111.043 179.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -86.62 -7.96 57.89 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 178.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -101.16 36.17 2.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.324 -1.307 . . . . 0.0 111.158 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.79 63.77 3.37 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 113' ' ' HIS . . . . . 0.484 ' NE2' ' HB2' ' A' ' 28' ' ' ASP . 9.5 t-160 -122.57 -54.48 1.86 Allowed 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.549 -178.407 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 114' ' ' GLY . . . . . 0.548 ' O ' ' HG3' ' B' ' 117' ' ' LYS . . . -84.01 -137.24 3.37 Favored Glycine 0 C--O 1.227 -0.295 0 C-N-CA 120.511 -0.852 . . . . 0.0 113.452 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 115' ' ' VAL . . . . . 0.954 ' HB ' HD22 ' B' ' 94' ' ' LEU . 16.8 m -58.96 -10.76 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 116' ' ' CYS . . . . . 0.675 ' HB2' HD21 ' B' ' 90' ' ' LEU . 0.0 OUTLIER -65.21 -32.0 73.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.707 0.289 . . . . 0.0 111.469 -179.714 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 117' ' ' LYS . . . . . 0.548 ' HG3' ' O ' ' B' ' 114' ' ' GLY . 0.3 OUTLIER -87.23 -26.21 23.61 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.272 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.2 -42.62 96.54 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.5 178.67 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 119' ' ' LEU . . . . . 0.641 HD11 ' HE3' ' B' ' 98' ' ' LYS . 1.8 tt -101.41 63.13 0.96 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 176.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 65.0 t-80 -20.38 114.57 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 113.732 -1.576 . . . . 0.0 114.725 -176.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 121' ' ' LEU . . . . . 0.826 HD21 ' HB2' ' B' ' 103' ' ' CYS . 1.0 OUTLIER -134.03 -33.46 1.03 Allowed 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.451 -1.25 . . . . 0.0 109.293 178.372 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 122' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.247 0.923 0 CA-C-O 118.405 -0.807 . . . . 0.0 109.94 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 17.0 p . . . . . 0 N--CA 1.476 0.871 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.07 178.12 7.01 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 178.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 72.2 -50.35 0.7 Allowed 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.692 0.62 . . . . 0.0 110.161 -178.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.07 -34.34 73.06 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.586 HG12 ' CD1' ' A' ' 46' ' ' PHE . 6.2 tp -89.43 -58.36 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-O 121.022 0.439 . . . . 0.0 110.607 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.489 ' H ' HG23 ' A' ' 17' ' ' ILE . . . -54.75 -34.12 62.11 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.231 -0.895 . . . . 0.0 112.024 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.31 -27.94 50.35 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.231 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.24 -15.83 59.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.845 0.355 . . . . 0.0 110.838 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 17' ' ' ILE . 66.9 t -63.57 -40.46 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.483 179.177 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.32 -18.65 63.09 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.889 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -72.32 -35.24 68.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.835 0.35 . . . . 0.0 111.442 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.537 ' HB3' ' CG ' ' B' ' 113' ' ' HIS . 71.0 m -99.48 -29.29 12.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.685 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.32 80.02 1.47 Allowed Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.249 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.85 166.08 16.72 Favored Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.407 ' O ' HG23 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -105.94 96.91 4.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.922 0.868 . . . . 0.0 111.283 -179.626 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.649 ' HB2' ' CE1' ' B' ' 113' ' ' HIS . 33.5 m-20 -115.81 -105.72 0.39 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.685 ' HB3' ' HD3' ' A' ' 30' ' ' PRO . 60.2 tp -177.86 -53.7 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.362 0 N-CA-C 111.911 0.338 . . . . 0.0 111.911 178.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.695 ' HA ' HG21 ' A' ' 54' ' ' VAL . 15.2 Cg_exo -70.9 49.07 0.9 Allowed 'Trans proline' 0 C--N 1.362 1.25 0 C-N-CA 122.97 2.447 . . . . 0.0 114.624 -178.235 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.594 ' HB2' ' O ' ' B' ' 113' ' ' HIS . 50.5 t -168.29 -49.27 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.8 t -73.91 -29.76 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.679 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -55.66 -45.36 77.71 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.112 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.06 3.88 3.1 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -101.46 -38.78 7.85 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.64 0.257 . . . . 0.0 111.239 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.553 ' H ' HD23 ' A' ' 36' ' ' LEU . 2.5 pt? -104.63 6.33 34.35 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.454 -179.527 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -62.72 -47.8 82.03 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 119.431 -0.319 . . . . 0.0 111.625 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 45.32 -101.59 0.05 Allowed 'General case' 0 N--CA 1.469 0.494 0 O-C-N 123.812 0.695 . . . . 0.0 111.194 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -99.05 -106.66 0.2 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.083 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -145.79 155.06 42.68 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.787 0.327 . . . . 0.0 110.598 178.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.428 ' H ' HD21 ' A' ' 60' ' ' LEU . . . 71.13 37.94 63.64 Favored Glycine 0 C--O 1.229 -0.165 0 C-N-CA 121.101 -0.571 . . . . 0.0 113.516 179.033 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -126.16 -16.46 5.5 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 122.447 -0.443 . . . . 0.0 111.924 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -109.32 15.36 23.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.931 0.396 . . . . 0.0 111.155 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.5 p -66.4 -53.57 34.34 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.713 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.602 ' O ' ' HG2' ' A' ' 48' ' ' GLU . 1.6 p -55.11 -44.94 75.44 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.725 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.586 ' CD1' HG12 ' A' ' 17' ' ' ILE . 65.2 t80 -63.26 -45.48 91.33 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.591 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.432 ' CB ' ' SG ' ' A' ' 61' ' ' CYS . 98.4 m -94.92 37.98 1.13 Allowed 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -177.39 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.602 ' HG2' ' O ' ' A' ' 45' ' ' CYS . 62.6 mm-40 -44.69 -76.27 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 118.742 0.701 . . . . 0.0 112.499 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -99.03 -14.04 19.61 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.693 0.758 . . . . 0.0 109.461 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.433 ' CD2' ' N ' ' A' ' 50' ' ' HIS . 0.0 OUTLIER -90.36 68.73 6.91 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.703 179.457 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 5.8 t -132.53 60.24 1.7 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.958 -177.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.601 ' ND1' ' HB3' ' B' ' 92' ' ' CYS . 5.8 p80 -131.35 17.69 4.91 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.795 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.625 ' O ' ' HG3' ' A' ' 56' ' ' LYS . . . -128.27 -137.89 4.48 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.485 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.695 HG21 ' HA ' ' A' ' 30' ' ' PRO . 35.6 m -58.98 -17.29 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-O 120.892 0.377 . . . . 0.0 111.807 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.586 ' HB2' HD11 ' A' ' 29' ' ' LEU . 3.9 t -78.54 -36.37 44.81 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.134 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.625 ' HG3' ' O ' ' A' ' 53' ' ' GLY . 0.0 OUTLIER -81.08 -5.57 57.79 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.158 0.504 . . . . 0.0 110.373 179.364 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -66.38 -27.42 67.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.705 178.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.474 ' HB2' HD13 ' A' ' 60' ' ' LEU . 45.0 mt -100.6 -19.15 16.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.502 179.472 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 66.4 78.03 0.27 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.669 0.788 . . . . 0.0 111.021 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.474 HD13 ' HB2' ' A' ' 58' ' ' LEU . 11.0 mp -123.48 -20.81 5.46 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.398 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.432 ' SG ' ' CB ' ' A' ' 47' ' ' CYS . 0.6 OUTLIER . . . . . 0 C--O 1.246 0.873 0 CA-C-O 118.391 -0.814 . . . . 0.0 111.511 -177.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 20.9 p . . . . . 0 N--CA 1.466 0.37 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -89.9 -175.56 4.64 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.045 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . 71.46 -50.08 0.69 Allowed 'General case' 0 N--CA 1.474 0.744 0 O-C-N 123.713 0.633 . . . . 0.0 110.514 -178.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -76.5 -50.39 14.11 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.085 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.723 ' HB ' HD13 ' B' ' 97' ' ' LEU . 8.9 tp -80.26 -42.25 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-O 121.215 0.531 . . . . 0.0 110.094 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.59 -29.69 70.33 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.616 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -82.44 -33.21 25.99 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.772 -0.728 . . . . 0.0 111.581 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.13 -19.53 64.03 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.82 0.343 . . . . 0.0 110.898 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 82' ' ' VAL . . . . . 0.653 HG23 ' O ' ' B' ' 78' ' ' ILE . 75.4 t -60.76 -52.32 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.054 178.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.9 -36.36 62.23 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.999 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.34 -43.02 96.84 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.006 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 2.3 t -90.94 -8.93 47.94 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.3 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 74.47 48.49 13.64 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.95 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 143.5 135.98 3.07 Favored Glycine 0 CA--C 1.509 -0.288 0 C-N-CA 120.896 -0.668 . . . . 0.0 111.777 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 88' ' ' ILE . . . . . 0.591 ' HB ' HG22 ' B' ' 82' ' ' VAL . 0.0 OUTLIER -100.9 107.99 22.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.682 0.753 . . . . 0.0 110.645 -179.806 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 89' ' ' ASP . . . . . 0.568 ' HB2' ' HE1' ' A' ' 52' ' ' HIS . 44.0 m-20 -120.9 -86.43 0.65 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 90' ' ' LEU . . . . . 0.659 ' O ' ' HB2' ' B' ' 94' ' ' LEU . 59.3 tp 179.09 -52.43 0.0 OUTLIER Pre-proline 0 C--O 1.217 -0.655 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.108 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 91' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' B' ' 90' ' ' LEU . 1.0 OUTLIER -43.17 -70.49 0.07 OUTLIER 'Trans proline' 0 C--N 1.36 1.177 0 C-N-CA 123.351 2.701 . . . . 0.0 114.767 -179.413 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 92' ' ' CYS . . . . . 0.601 ' HB3' ' ND1' ' A' ' 52' ' ' HIS . 0.8 OUTLIER -72.83 -38.62 67.06 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -178.17 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 93' ' ' VAL . . . . . 0.579 HG12 HD12 ' B' ' 78' ' ' ILE . 0.6 OUTLIER -66.41 -24.5 33.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -178.199 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 94' ' ' LEU . . . . . 0.659 ' HB2' ' O ' ' B' ' 90' ' ' LEU . 1.3 tm? -67.96 -41.94 81.66 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.52 -9.45 8.7 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -178.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -87.67 -37.43 16.74 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 97' ' ' LEU . . . . . 0.723 HD13 ' HB ' ' B' ' 78' ' ' ILE . 1.7 pt? -115.03 17.56 16.76 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -178.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? . . . . . 0 C--N 1.324 -0.519 0 C-N-CA 120.801 -0.36 . . . . 0.0 111.408 -178.611 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 92.6 m . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.741 0.305 . . . . 0.0 111.416 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -96.08 2.71 53.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.187 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 4.3 m -54.43 -42.78 70.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.117 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 1.8 p -55.42 -61.49 2.31 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.045 0.45 . . . . 0.0 111.216 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 107' ' ' PHE . . . . . 0.447 ' CD2' HG12 ' B' ' 78' ' ' ILE . 0.8 OUTLIER -58.49 -55.31 36.73 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.342 -179.652 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 12.4 m -76.29 22.63 0.16 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -178.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -63.4 -58.24 7.72 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 118.296 0.498 . . . . 0.0 111.155 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -93.93 -21.48 19.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.293 0.568 . . . . 0.0 109.998 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 18.1 m80 -92.6 89.9 6.9 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.588 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 96.1 m -123.1 46.36 2.2 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -177.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 113' ' ' HIS . . . . . 0.854 ' HA ' ' HG2' ' B' ' 117' ' ' LYS . 23.1 p80 -140.74 5.96 2.01 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 119.608 -0.837 . . . . 0.0 111.798 177.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 114' ' ' GLY . . . . . 0.59 ' O ' ' HG3' ' B' ' 117' ' ' LYS . . . -98.1 -152.6 28.23 Favored Glycine 0 C--O 1.226 -0.348 0 C-N-CA 120.489 -0.862 . . . . 0.0 111.393 177.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 115' ' ' VAL . . . . . 0.549 ' CG2' ' HA ' ' B' ' 91' ' ' PRO . 35.1 m -66.17 -5.92 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 117.411 0.606 . . . . 0.0 111.701 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 116' ' ' CYS . . . . . 0.436 ' SG ' HD21 ' B' ' 94' ' ' LEU . 0.9 OUTLIER -79.79 -25.28 40.97 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.294 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 117' ' ' LYS . . . . . 0.854 ' HG2' ' HA ' ' B' ' 113' ' ' HIS . 0.0 OUTLIER -96.03 3.51 53.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.359 178.19 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -44.97 -42.46 8.23 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 119' ' ' LEU . . . . . 0.704 ' O ' ' HB2' ' B' ' 120' ' ' HIS . 87.9 mt -106.66 -64.77 1.14 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 174.244 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 120' ' ' HIS . . . . . 0.704 ' HB2' ' O ' ' B' ' 119' ' ' LEU . 11.4 t-80 145.16 91.57 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.881 1.672 . . . . 0.0 108.883 177.218 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 62.1 mt -114.98 31.78 6.46 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -177.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 122' ' ' CYS . . . . . . . . . . . . . 6.3 p . . . . . 0 C--O 1.242 0.699 0 CA-C-O 118.408 -0.806 . . . . 0.0 110.965 178.653 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.422 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 55.9 m . . . . . 0 N--CA 1.474 0.748 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.458 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -70.86 -34.55 71.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.742 0.306 . . . . 0.0 111.736 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.82 38.81 0.66 Allowed 'General case' 0 C--N 1.326 -0.443 0 O-C-N 122.103 -0.373 . . . . 0.0 111.95 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -167.66 -53.06 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.1 0.476 . . . . 0.0 111.017 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.732 HD13 ' HB2' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -78.04 -42.4 27.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.036 -179.748 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' A' ' 14' ' ' ALA . . . -67.97 -31.3 70.93 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.962 0.41 . . . . 0.0 110.721 178.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -76.11 -26.19 64.77 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.663 -0.779 . . . . 0.0 111.84 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.44 -24.44 60.24 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 120.882 0.372 . . . . 0.0 110.743 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 17' ' ' ILE . 98.9 t -66.35 -47.02 85.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.641 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.43 -22.06 66.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.722 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.11 -40.13 86.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.462 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.5 t -99.78 -12.86 19.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.009 0.433 . . . . 0.0 111.207 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.84 -61.76 0.35 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.097 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -105.74 170.23 16.88 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.249 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.456 HD13 HG22 ' A' ' 21' ' ' VAL . 2.6 tp -98.04 104.98 16.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.57 0.7 . . . . 0.0 111.581 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.558 ' OD1' HG23 ' A' ' 32' ' ' VAL . 18.1 p-10 -129.2 -111.33 0.27 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.726 178.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.62 ' HG ' ' CG2' ' A' ' 54' ' ' VAL . 43.3 tp -178.72 -47.03 0.0 OUTLIER Pre-proline 0 C--N 1.324 -0.505 0 C-N-CA 123.575 0.75 . . . . 0.0 110.682 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.832 ' HA ' HG21 ' A' ' 54' ' ' VAL . 32.5 Cg_exo -55.37 -31.59 77.94 Favored 'Trans proline' 0 C--N 1.367 1.528 0 C-N-CA 122.455 2.103 . . . . 0.0 113.227 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 19.5 t -106.93 -25.98 11.41 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.383 -178.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.558 HG23 ' OD1' ' A' ' 28' ' ' ASP . 65.8 t -72.13 -14.28 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.736 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.722 ' HA ' ' HB3' ' A' ' 36' ' ' LEU . 1.0 OUTLIER -59.19 -15.3 14.13 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.896 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.514 ' N ' HD12 ' A' ' 33' ' ' LEU . . . -54.3 -53.92 47.26 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.935 0.398 . . . . 0.0 111.66 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -103.3 28.29 6.51 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.222 0.534 . . . . 0.0 109.851 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.722 ' HB3' ' HA ' ' A' ' 33' ' ' LEU . 42.6 tp -122.67 -48.88 2.02 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.791 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.509 ' HE3' ' HB2' ' A' ' 58' ' ' LEU . 84.3 tttt -73.71 96.01 2.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.868 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -144.93 -80.14 0.17 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.66 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -113.27 150.74 32.02 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.497 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -67.45 143.03 56.45 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.562 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.43 -9.36 77.78 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.506 -0.854 . . . . 0.0 113.572 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 85.6 m -86.34 -23.15 26.33 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 117.331 0.565 . . . . 0.0 110.952 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.469 ' HB3' ' CD2' ' A' ' 60' ' ' LEU . . . -111.54 23.76 13.56 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.681 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 34.7 p -78.95 -49.71 12.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.552 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.7 p -54.55 -36.13 63.98 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.547 0.689 . . . . 0.0 111.103 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.732 ' HB2' HD13 ' A' ' 17' ' ' ILE . 0.8 OUTLIER -83.6 -68.62 0.7 Allowed 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.652 -1.158 . . . . 0.0 111.441 -178.982 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.483 ' HA ' ' HB2' ' A' ' 50' ' ' HIS . 37.4 m -77.57 32.16 0.16 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.218 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -65.35 -57.61 7.96 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.363 0.601 . . . . 0.0 109.385 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -90.4 -10.83 42.44 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.117 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.483 ' HB2' ' HA ' ' A' ' 47' ' ' CYS . 12.9 m80 -106.23 60.43 0.65 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.119 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 5.2 t -111.18 50.22 0.83 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.033 0.444 . . . . 0.0 111.108 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.501 ' HA ' ' HD2' ' A' ' 56' ' ' LYS . 20.6 p-80 -140.92 -7.46 1.07 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 0.0 112.05 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.427 ' O ' ' HG2' ' A' ' 56' ' ' LYS . . . -104.05 -151.71 22.11 Favored Glycine 0 CA--C 1.521 0.428 0 C-N-CA 120.519 -0.848 . . . . 0.0 113.01 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.832 HG21 ' HA ' ' A' ' 30' ' ' PRO . 31.1 m -55.03 -17.23 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.581 ' HB2' HD21 ' A' ' 29' ' ' LEU . 1.8 t -70.61 -24.52 62.75 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.71 -179.196 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.546 ' C ' ' H ' ' A' ' 58' ' ' LEU . 10.0 ptmt -94.19 17.17 13.11 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.373 178.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -83.99 29.59 0.55 Allowed 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 123.057 1.408 . . . . 0.0 107.926 177.181 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.546 ' H ' ' C ' ' A' ' 56' ' ' LYS . 6.9 tt -170.16 -37.3 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 32.6 t60 71.07 91.37 0.09 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 113.88 -1.509 . . . . 0.0 111.834 178.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.546 HD12 HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -131.09 16.07 5.12 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.377 179.927 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.879 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 74' ' ' CYS . . . . . 0.753 ' HB2' HD12 ' B' ' 78' ' ' ILE . 2.0 p . . . . . 0 N--CA 1.468 0.464 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -100.4 7.75 44.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.156 0.503 . . . . 0.0 110.575 178.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -89.61 -64.5 1.13 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.342 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.67 -24.71 23.81 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.812 HD13 ' HB2' ' B' ' 107' ' ' PHE . 23.9 mt -89.13 -55.18 6.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.553 0.216 . . . . 0.0 111.082 -179.167 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.17 -21.19 46.78 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.391 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.03 -34.16 42.95 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.705 -0.76 . . . . 0.0 111.626 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 81' ' ' ALA . . . . . 0.523 ' HB2' ' HB3' ' B' ' 96' ' ' ALA . . . -71.29 -18.15 62.43 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 120.956 0.408 . . . . 0.0 110.702 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 82' ' ' VAL . . . . . 0.463 HG23 ' O ' ' B' ' 78' ' ' ILE . 69.9 t -64.07 -41.73 93.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.857 178.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.02 -22.57 60.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.057 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.82 -39.54 30.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.547 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 22.7 t -89.5 -25.37 21.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.757 0.313 . . . . 0.0 110.865 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 96.46 34.5 5.79 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.367 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 147.6 163.8 10.86 Favored Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 111.399 -0.68 . . . . 0.0 111.399 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.36 127.42 63.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 117.199 0.5 . . . . 0.0 110.666 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 89' ' ' ASP . . . . . 0.558 ' OD2' ' HG2' ' B' ' 91' ' ' PRO . 30.2 p-10 -144.67 -59.22 0.37 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.449 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 90' ' ' LEU . . . . . 0.679 HD11 ' HB2' ' B' ' 116' ' ' CYS . 61.0 tp 133.55 -51.63 0.0 OUTLIER Pre-proline 0 N--CA 1.484 1.269 0 C-N-CA 126.2 1.8 . . . . 0.0 110.337 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 91' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' B' ' 90' ' ' LEU . 4.5 Cg_exo -44.06 -38.41 10.5 Favored 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 123.539 2.826 . . . . 0.0 114.686 -179.235 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 31.5 p -104.98 -31.14 9.36 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 120.241 -0.583 . . . . 0.0 111.581 -179.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 93' ' ' VAL . . . . . 0.493 HG13 ' HB3' ' B' ' 81' ' ' ALA . 3.9 t -63.29 -7.37 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.43 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 94' ' ' LEU . . . . . 0.447 HD22 ' HB ' ' B' ' 115' ' ' VAL . 4.3 pp -61.66 -22.61 65.45 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 122.343 -0.223 . . . . 0.0 111.2 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -53.2 -60.46 3.26 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -178.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 96' ' ' ALA . . . . . 0.523 ' HB3' ' HB2' ' B' ' 81' ' ' ALA . . . -78.11 -15.58 58.75 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.223 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 18.1 tp -74.61 -41.38 60.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.898 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 98' ' ' LYS . . . . . 0.746 ' HA ' HD11 ' B' ' 119' ' ' LEU . 43.9 mtpt . . . . . 0 N--CA 1.462 0.172 0 CA-C-O 120.777 0.323 . . . . 0.0 111.195 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 60.8 m . . . . . 0 N--CA 1.462 0.156 0 CA-C-O 120.649 0.261 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 104' ' ' ALA . . . . . 0.563 ' HB3' HD21 ' B' ' 121' ' ' LEU . . . -100.46 27.17 5.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.227 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 3.0 p -73.96 -61.07 1.98 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.952 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 4.5 p -55.63 -37.74 68.58 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.556 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 107' ' ' PHE . . . . . 0.812 ' HB2' HD13 ' B' ' 78' ' ' ILE . 1.1 t80 -79.38 -75.71 0.24 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.069 -0.969 . . . . 0.0 112.514 -177.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 74.3 m -73.12 33.57 0.07 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -177.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -59.53 -57.92 10.84 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.332 0.587 . . . . 0.0 109.531 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -98.15 -19.65 17.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.483 178.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 7.3 m80 -93.77 65.34 3.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.722 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 4.6 t -123.53 58.91 1.12 Allowed 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.466 -0.493 . . . . 0.0 111.0 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 113' ' ' HIS . . . . . 0.57 ' O ' ' HE2' ' B' ' 117' ' ' LYS . 20.7 p-80 -139.96 -25.34 0.81 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 114' ' ' GLY . . . . . 0.447 ' O ' HG22 ' B' ' 115' ' ' VAL . . . -127.8 129.85 6.52 Favored Glycine 0 C--O 1.226 -0.396 0 C-N-CA 120.184 -1.008 . . . . 0.0 112.695 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 115' ' ' VAL . . . . . 0.447 HG22 ' O ' ' B' ' 114' ' ' GLY . 24.4 m 54.82 -31.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 C-N-CA 126.164 1.786 . . . . 0.0 115.204 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 116' ' ' CYS . . . . . 0.679 ' HB2' HD11 ' B' ' 90' ' ' LEU . 35.2 t -81.18 -37.69 28.3 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 121.807 -0.558 . . . . 0.0 111.291 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 117' ' ' LYS . . . . . 0.57 ' HE2' ' O ' ' B' ' 113' ' ' HIS . 52.1 pttt -77.7 15.05 0.89 Allowed 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 119.697 -0.801 . . . . 0.0 110.957 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -75.38 -24.1 57.18 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 106.824 -1.546 . . . . 0.0 106.824 175.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 119' ' ' LEU . . . . . 0.746 HD11 ' HA ' ' B' ' 98' ' ' LYS . 53.1 mt -94.75 -31.7 13.66 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 114.137 -1.392 . . . . 0.0 107.704 176.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 12.7 t60 55.9 76.28 0.29 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 113.886 -1.507 . . . . 0.0 112.437 178.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 121' ' ' LEU . . . . . 0.609 HD13 ' H ' ' B' ' 121' ' ' LEU . 0.0 OUTLIER -131.69 -3.34 3.71 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-O 120.959 0.409 . . . . 0.0 110.821 179.885 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 122' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.246 0.882 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.39 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.529 ' HB3' HD12 ' A' ' 17' ' ' ILE . 6.5 m . . . . . 0 N--CA 1.472 0.646 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.47 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -79.51 -13.47 59.53 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -178.598 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -98.04 15.62 23.58 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.912 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.47 -59.53 0.24 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.135 0.493 . . . . 0.0 111.3 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.723 HD13 ' HB3' ' A' ' 46' ' ' PHE . 80.6 mt -75.17 -42.77 44.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.354 -179.429 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 14' ' ' ALA . . . -59.54 -34.06 72.18 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -179.151 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -85.99 -33.1 15.9 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.646 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.811 ' HB1' HG13 ' A' ' 32' ' ' VAL . . . -69.6 -34.78 74.6 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.011 0.434 . . . . 0.0 111.343 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.4 t -64.07 -44.36 97.7 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.784 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.15 -22.53 66.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.648 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.65 -43.2 66.52 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 60.3 m -104.03 0.64 30.08 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 -178.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.18 42.95 10.06 Favored Glycine 0 CA--C 1.517 0.197 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.884 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 130.32 -178.88 17.28 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 121.062 -0.589 . . . . 0.0 111.634 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.2 pp -74.18 134.35 29.73 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 CA-C-O 121.748 0.785 . . . . 0.0 110.343 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.532 ' HB3' HG23 ' A' ' 32' ' ' VAL . 32.9 t70 -148.59 -127.7 0.05 Allowed 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.564 -1.198 . . . . 0.0 108.007 -178.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.869 HD21 ' HB2' ' A' ' 55' ' ' CYS . 20.6 tp 175.27 -56.3 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.461 0 O-C-N 123.418 0.449 . . . . 0.0 112.042 178.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.589 ' HA ' HG11 ' A' ' 54' ' ' VAL . 3.8 Cg_endo -49.92 -34.78 38.37 Favored 'Trans proline' 0 C--N 1.364 1.353 0 C-N-CA 122.752 2.301 . . . . 0.0 113.308 -179.235 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 17.3 p -110.59 -28.85 8.3 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.216 0.531 . . . . 0.0 110.979 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.811 HG13 ' HB1' ' A' ' 20' ' ' ALA . 51.6 t -67.72 -23.91 30.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.44 -179.38 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.8 pp -54.9 -26.56 36.66 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.95 -61.04 2.66 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -178.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.471 ' HB3' ' HB2' ' A' ' 20' ' ' ALA . . . -77.46 -21.64 52.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.74 0.305 . . . . 0.0 111.389 -179.354 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 52.6 tp -68.05 -36.47 79.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.498 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -66.12 -39.74 90.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.457 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 58.12 -100.25 0.11 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.577 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -132.64 18.81 4.27 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.715 -0.221 . . . . 0.0 111.396 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -168.26 -110.49 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -110.98 -64.32 0.51 Allowed Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 178.001 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 12.0 m 48.71 29.4 2.19 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.485 0.714 . . . . 0.0 112.916 177.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.572 ' CB ' ' HG ' ' A' ' 60' ' ' LEU . . . -115.35 -15.99 11.5 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.457 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 2.5 m -58.02 -19.18 29.2 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.013 0.435 . . . . 0.0 111.812 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 42.5 t -64.99 -53.38 47.16 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.723 ' HB3' HD13 ' A' ' 17' ' ' ILE . 0.3 OUTLIER -107.92 -46.63 3.74 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.294 -179.641 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.58 ' O ' ' HB3' ' A' ' 51' ' ' CYS . 0.1 OUTLIER -68.31 21.0 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.634 179.737 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.508 ' H ' ' C ' ' A' ' 46' ' ' PHE . 38.9 tp10 -63.52 -76.2 0.07 Allowed 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 123.246 0.618 . . . . 0.0 111.903 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -69.86 -44.69 69.34 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.858 -178.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -103.3 111.52 23.97 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.168 0.509 . . . . 0.0 111.901 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.695 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 13.5 p -164.99 35.33 0.06 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.613 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.492 ' HA ' ' HE3' ' A' ' 56' ' ' LYS . 3.7 p-80 -82.81 -16.33 48.19 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.541 ' HA3' ' HG2' ' B' ' 91' ' ' PRO . . . -76.86 -123.89 0.21 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.384 -0.913 . . . . 0.0 112.04 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.589 HG11 ' HA ' ' A' ' 30' ' ' PRO . 8.9 p -85.9 18.84 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.745 0.783 . . . . 0.0 110.265 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.869 ' HB2' HD21 ' A' ' 29' ' ' LEU . 5.3 t -91.64 -48.43 6.84 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.295 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.492 ' HE3' ' HA ' ' A' ' 52' ' ' HIS . 19.8 pttp -89.27 14.07 11.91 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 120.976 -0.289 . . . . 0.0 110.662 178.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -56.13 -41.63 75.62 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.259 0.552 . . . . 0.0 109.727 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.5 tt -135.67 -79.16 0.43 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 177.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -155.1 118.25 4.41 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.977 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.572 ' HG ' ' CB ' ' A' ' 43' ' ' ALA . 8.1 tp -153.87 -50.97 0.1 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.92 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.533 ' HB3' ' O ' ' A' ' 47' ' ' CYS . 0.8 OUTLIER . . . . . 0 C--O 1.243 0.759 0 CA-C-O 118.474 -0.774 . . . . 0.0 110.518 178.445 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 74' ' ' CYS . . . . . 0.521 ' HB3' HD12 ' B' ' 78' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.26 0 CA-C-O 120.618 0.247 . . . . 0.0 111.603 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.68 -53.79 8.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.858 0.361 . . . . 0.0 110.965 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.85 42.68 0.72 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.973 0.416 . . . . 0.0 111.381 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -159.21 -44.87 0.05 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.582 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.674 HD13 ' HB2' ' B' ' 107' ' ' PHE . 12.5 mt -100.79 -52.44 8.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.203 -179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.88 -33.63 73.38 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.15 -37.62 17.84 Favored Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.645 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.78 -29.54 63.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.052 0.453 . . . . 0.0 111.49 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 82' ' ' VAL . . . . . 0.478 HG22 ' HA ' ' B' ' 88' ' ' ILE . 2.6 t -66.13 -40.17 86.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.607 179.368 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.4 -24.05 66.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.261 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.9 -39.08 44.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.319 -0.401 . . . . 0.0 112.049 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 4.8 t -85.52 -25.51 26.78 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.871 -0.331 . . . . 0.0 111.123 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 104.71 39.79 2.29 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.474 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 87' ' ' GLY . . . . . 0.434 ' C ' HG13 ' B' ' 82' ' ' VAL . . . 124.45 170.99 13.31 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.025 -0.607 . . . . 0.0 111.613 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 88' ' ' ILE . . . . . 0.478 ' HA ' HG22 ' B' ' 82' ' ' VAL . 1.2 pt -66.12 143.14 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.438 0 CA-C-O 121.416 0.627 . . . . 0.0 110.436 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 89' ' ' ASP . . . . . 0.484 ' O ' ' HB2' ' B' ' 90' ' ' LEU . 29.6 t70 -157.26 -127.4 0.03 OUTLIER 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.728 -178.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 90' ' ' LEU . . . . . 0.555 HD21 ' HB2' ' B' ' 116' ' ' CYS . 36.5 tp 170.73 -58.14 0.0 OUTLIER Pre-proline 0 C--N 1.323 -0.558 0 O-C-N 123.867 0.73 . . . . 0.0 110.563 178.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 91' ' ' PRO . . . . . 0.541 ' HG2' ' HA3' ' A' ' 53' ' ' GLY . 14.3 Cg_endo -57.8 -16.11 24.14 Favored 'Trans proline' 0 C--N 1.365 1.409 0 C-N-CA 122.681 2.254 . . . . 0.0 113.585 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 20.3 p -110.23 -34.02 6.49 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.217 0.532 . . . . 0.0 110.37 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 93' ' ' VAL . . . . . 0.41 HG12 ' HB2' ' B' ' 97' ' ' LEU . 3.0 t -74.26 -18.05 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.141 -178.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 94' ' ' LEU . . . . . 0.654 HD23 HG11 ' B' ' 115' ' ' VAL . 0.6 OUTLIER -40.95 -31.74 0.19 Allowed 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 -178.206 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 95' ' ' ALA . . . . . 0.555 ' N ' HD12 ' B' ' 94' ' ' LEU . . . -84.28 -54.53 4.73 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 118.442 0.564 . . . . 0.0 112.257 -178.309 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.8 -17.48 62.16 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.6 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 97' ' ' LEU . . . . . 0.41 ' HB2' HG12 ' B' ' 93' ' ' VAL . 20.0 tp -67.97 -38.12 82.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.478 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 44.5 mttm . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.757 179.728 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 58.2 m . . . . . 0 N--CA 1.468 0.452 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -113.22 16.31 19.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.864 0.364 . . . . 0.0 110.693 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 105' ' ' SER . . . . . 0.648 ' O ' ' HG2' ' B' ' 109' ' ' GLU . 3.9 p -58.67 -52.05 67.33 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.142 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 18.7 p -53.95 -41.28 67.61 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.78 0.8 . . . . 0.0 111.517 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 107' ' ' PHE . . . . . 0.674 ' HB2' HD13 ' B' ' 78' ' ' ILE . 0.9 OUTLIER -69.36 -72.32 0.19 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.27 -1.332 . . . . 0.0 112.908 -177.928 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 108' ' ' CYS . . . . . 0.813 ' HA ' ' HB2' ' B' ' 111' ' ' HIS . 36.3 m -81.11 34.8 0.37 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -176.499 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 109' ' ' GLU . . . . . 0.648 ' HG2' ' O ' ' B' ' 105' ' ' SER . 13.1 mm-40 -60.59 -60.89 3.09 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 177.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -96.69 -0.18 48.74 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 111' ' ' HIS . . . . . 0.813 ' HB2' ' HA ' ' B' ' 108' ' ' CYS . 55.4 m-70 -108.59 39.48 1.99 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.962 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 2.1 t -98.0 49.31 1.01 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 113' ' ' HIS . . . . . . . . . . . . . 22.3 p-80 -123.24 -33.18 3.32 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.097 -178.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 114' ' ' GLY . . . . . 0.427 ' C ' ' H ' ' B' ' 116' ' ' CYS . . . -85.15 -146.33 8.29 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.857 -0.687 . . . . 0.0 113.425 -179.052 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 115' ' ' VAL . . . . . 0.654 HG11 HD23 ' B' ' 94' ' ' LEU . 7.7 p -74.65 37.34 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 122.331 1.062 . . . . 0.0 111.436 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 116' ' ' CYS . . . . . 0.555 ' HB2' HD21 ' B' ' 90' ' ' LEU . 2.5 t -120.31 -25.88 5.56 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.527 -0.76 . . . . 0.0 108.986 178.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.78 -9.83 39.11 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.909 178.305 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -49.54 -52.2 31.52 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.636 -179.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 73.1 mt -107.4 -104.34 0.35 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 177.272 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -151.18 93.33 1.9 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.228 0.537 . . . . 0.0 109.9 177.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 121' ' ' LEU . . . . . 0.411 ' HB2' ' O ' ' B' ' 116' ' ' CYS . 9.4 mp -121.58 -28.01 4.65 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.982 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 122' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.245 0.859 0 CA-C-O 118.437 -0.792 . . . . 0.0 110.802 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.465 0.298 0 CA-C-O 120.832 0.348 . . . . 0.0 111.125 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -81.21 21.41 0.74 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.619 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -109.75 -42.74 4.19 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.283 0.563 . . . . 0.0 109.838 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.27 -40.8 43.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.979 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.609 HG12 ' CD2' ' A' ' 46' ' ' PHE . 10.9 tp -72.38 -32.16 41.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.517 0.675 . . . . 0.0 110.194 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.404 ' HB2' ' O ' ' A' ' 14' ' ' ALA . . . -56.3 -27.66 56.21 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.527 -1.215 . . . . 0.0 111.595 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.48 -29.67 51.97 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.437 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.92 -28.83 62.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.064 0.459 . . . . 0.0 110.477 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 96.5 t -66.04 -48.88 80.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.297 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.96 -33.91 76.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.179 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.61 -34.66 78.75 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.783 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.545 ' SG ' ' HB2' ' B' ' 113' ' ' HIS . 3.9 t -89.21 -28.93 19.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.772 0.32 . . . . 0.0 111.109 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.6 40.8 3.54 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.362 -0.923 . . . . 0.0 112.209 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 148.11 163.03 10.49 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.761 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -108.18 135.58 46.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.255 0.55 . . . . 0.0 111.938 -179.268 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.465 ' HB3' ' H ' ' A' ' 29' ' ' LEU . 7.9 t70 -160.59 -97.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.047 -0.979 . . . . 0.0 108.798 178.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.689 HD21 ' HB2' ' A' ' 55' ' ' CYS . 49.4 tp -178.85 -53.86 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.254 0 CA-C-O 119.263 -0.399 . . . . 0.0 111.484 178.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.664 ' HG3' ' HD3' ' B' ' 91' ' ' PRO . 96.3 Cg_exo -41.35 -65.47 0.19 Allowed 'Trans proline' 0 C--N 1.36 1.183 0 C-N-CA 123.203 2.602 . . . . 0.0 114.463 -178.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.503 ' HB3' ' O ' ' B' ' 113' ' ' HIS . 14.0 p -79.2 -32.49 44.1 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.878 -178.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.519 HG12 HD11 ' A' ' 17' ' ' ILE . 2.6 t -62.57 -31.05 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.988 -179.305 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 23.6 tp -65.76 -45.57 82.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.306 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.38 -43.76 68.07 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -178.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.57 -20.22 65.36 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -179.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.406 HD13 HD13 ' A' ' 17' ' ' ILE . 7.2 tt -99.05 -23.91 15.1 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.152 0.501 . . . . 0.0 110.214 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.9 mmmt -75.11 99.07 3.83 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -178.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -126.48 -24.88 3.54 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 175.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -171.63 -166.03 0.42 Allowed 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 112.235 -2.257 . . . . 0.0 105.612 178.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -70.15 -59.96 2.58 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 119.92 -0.712 . . . . 0.0 110.258 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 56.45 -118.45 11.57 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 121.133 -0.556 . . . . 0.0 112.59 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 10.5 t -96.64 -94.12 0.21 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 66.93 -51.54 0.47 Allowed 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.1 p -54.84 -22.28 14.02 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 113.715 1.005 . . . . 0.0 113.715 -178.315 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.1 t -66.75 -49.98 64.23 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.494 0.664 . . . . 0.0 109.924 178.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.609 ' CD2' HG12 ' A' ' 17' ' ' ILE . 0.8 OUTLIER -72.2 -43.57 64.28 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 178.271 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.429 ' O ' ' HB3' ' A' ' 61' ' ' CYS . 86.1 m -94.14 67.58 3.62 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.832 -1.077 . . . . 0.0 109.611 178.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -92.9 -105.33 0.12 Allowed 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.2 p30 -72.85 -10.57 59.94 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 121.934 0.873 . . . . 0.0 108.972 177.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -103.35 99.06 8.89 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 113.687 -1.597 . . . . 0.0 106.793 177.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 44.9 t -169.07 79.92 0.13 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -177.086 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.514 ' CE1' ' HB2' ' B' ' 89' ' ' ASP . 3.5 p80 -138.93 18.03 2.65 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.415 0.626 . . . . 0.0 110.454 176.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.705 ' HA3' ' HG2' ' B' ' 91' ' ' PRO . . . -119.33 -135.36 5.08 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.657 -0.702 . . . . 0.0 112.337 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.568 ' CG2' ' HG ' ' A' ' 29' ' ' LEU . 16.1 m -55.54 -27.94 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.689 ' HB2' HD21 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -74.38 -38.23 63.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.448 -179.26 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.598 ' HD3' ' O ' ' A' ' 53' ' ' GLY . 0.0 OUTLIER -65.61 -24.91 67.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.697 0.284 . . . . 0.0 111.062 -179.773 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -58.36 -26.09 62.75 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.441 -179.276 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.552 ' HB2' HD22 ' A' ' 60' ' ' LEU . 3.2 mm? -90.72 -23.66 20.64 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.501 ' HB2' ' O ' ' A' ' 58' ' ' LEU . 39.3 m-70 74.72 63.83 0.07 Allowed 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.144 0.578 . . . . 0.0 111.994 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.552 HD22 ' HB2' ' A' ' 58' ' ' LEU . 1.9 pt? -140.48 14.98 2.37 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.947 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.429 ' HB3' ' O ' ' A' ' 47' ' ' CYS . 1.5 p . . . . . 0 C--O 1.245 0.829 0 CA-C-O 118.136 -0.935 . . . . 0.0 111.287 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 74' ' ' CYS . . . . . 0.646 ' HB3' ' SG ' ' B' ' 103' ' ' CYS . 15.0 p . . . . . 0 C--O 1.225 -0.213 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -69.8 -3.69 16.73 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -105.15 -46.91 4.12 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.172 0.511 . . . . 0.0 109.741 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.6 -39.97 70.16 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.32 -0.855 . . . . 0.0 112.079 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.789 HD13 HD12 ' B' ' 97' ' ' LEU . 6.0 tp -73.23 -37.37 51.96 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 CA-C-O 121.323 0.582 . . . . 0.0 109.706 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.32 -33.09 74.76 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.915 -1.038 . . . . 0.0 110.713 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -74.96 -30.96 58.52 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.646 -0.787 . . . . 0.0 111.699 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.76 -21.43 61.74 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.206 0.527 . . . . 0.0 110.47 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 82' ' ' VAL . . . . . 0.455 HG23 ' O ' ' B' ' 78' ' ' ILE . 44.4 t -64.46 -51.72 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.081 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.45 -19.72 63.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.126 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.65 -39.64 57.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.737 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 1.4 t -88.36 -30.8 19.27 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.804 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 114.66 40.37 0.93 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.299 -0.953 . . . . 0.0 113.806 178.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 136.15 175.05 13.61 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.072 -1.061 . . . . 0.0 112.936 179.324 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 6.1 tp -91.3 134.3 30.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.183 0.516 . . . . 0.0 111.098 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 89' ' ' ASP . . . . . 0.514 ' HB2' ' CE1' ' A' ' 52' ' ' HIS . 2.6 t0 -156.46 -119.01 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 90' ' ' LEU . . . . . 0.553 ' N ' ' HD2' ' B' ' 91' ' ' PRO . 47.1 tp -177.66 -53.63 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.461 0 C-N-CA 123.077 0.551 . . . . 0.0 111.121 177.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 91' ' ' PRO . . . . . 0.815 ' HA ' HG21 ' B' ' 115' ' ' VAL . 2.9 Cg_endo -48.36 -48.96 15.46 Favored 'Trans proline' 0 C--N 1.359 1.093 0 C-N-CA 123.018 2.479 . . . . 0.0 113.634 -179.257 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 4.2 t -81.64 -40.34 23.06 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.935 0.398 . . . . 0.0 111.583 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 93' ' ' VAL . . . . . 0.437 ' H ' HG23 ' B' ' 93' ' ' VAL . 2.2 t -62.3 -24.49 35.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.409 -179.07 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 94' ' ' LEU . . . . . 0.74 HD22 HG23 ' B' ' 115' ' ' VAL . 22.5 tp -63.48 -26.72 68.85 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.27 0.471 . . . . 0.0 112.27 -179.316 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.05 -31.89 61.47 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -178.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -83.59 -1.85 54.78 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 97' ' ' LEU . . . . . 0.789 HD12 HD13 ' B' ' 78' ' ' ILE . 21.0 mt -136.75 14.88 3.13 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -178.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 98' ' ' LYS . . . . . 0.728 ' HG3' ' HG ' ' B' ' 94' ' ' LEU . 12.6 mtpt . . . . . 0 C--N 1.322 -0.621 0 C-N-CA 119.554 -0.859 . . . . 0.0 111.73 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 103' ' ' CYS . . . . . 0.646 ' SG ' ' HB3' ' B' ' 74' ' ' CYS . 45.9 t . . . . . 0 N--CA 1.454 -0.266 0 CA-C-O 119.757 -0.163 . . . . 0.0 110.616 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 104' ' ' ALA . . . . . 0.418 ' N ' ' SG ' ' B' ' 103' ' ' CYS . . . 67.82 -59.06 0.43 Allowed 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.682 0.793 . . . . 0.0 112.4 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 105' ' ' SER . . . . . 0.523 ' HA ' ' HB2' ' B' ' 108' ' ' CYS . 5.0 p -63.94 2.8 0.46 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -178.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 8.7 t -72.81 -47.27 47.86 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 107' ' ' PHE . . . . . 0.619 ' CD2' HG12 ' B' ' 78' ' ' ILE . 1.0 OUTLIER -74.24 -25.93 59.93 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 177.216 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 108' ' ' CYS . . . . . 0.594 ' O ' ' HB3' ' B' ' 122' ' ' CYS . 2.5 m -103.36 67.35 0.92 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.42 -1.263 . . . . 0.0 110.279 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 109' ' ' GLU . . . . . 0.408 ' HB3' ' H ' ' B' ' 110' ' ' ASP . 9.3 tp10 -96.53 -108.04 0.16 Allowed 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 110' ' ' ASP . . . . . 0.408 ' H ' ' HB3' ' B' ' 109' ' ' GLU . 45.8 p30 -72.95 -11.45 60.58 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 177.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -103.03 99.12 8.98 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 113.087 -1.87 . . . . 0.0 106.877 177.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 42.6 t -144.96 83.06 1.68 Allowed 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.791 -176.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 113' ' ' HIS . . . . . 0.725 ' HA ' ' HD2' ' B' ' 117' ' ' LYS . 1.5 p-80 -150.01 2.41 0.51 Allowed 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.8 0.666 . . . . 0.0 112.8 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 114' ' ' GLY . . . . . 0.589 ' HA2' ' HB2' ' A' ' 30' ' ' PRO . . . -98.72 -156.48 29.34 Favored Glycine 0 C--O 1.227 -0.293 0 C-N-CA 120.048 -1.072 . . . . 0.0 112.728 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 115' ' ' VAL . . . . . 0.815 HG21 ' HA ' ' B' ' 91' ' ' PRO . 19.6 m -56.63 -11.19 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 122.959 0.504 . . . . 0.0 112.35 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 116' ' ' CYS . . . . . . . . . . . . . 35.7 t -84.25 -39.75 18.89 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.377 -178.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 117' ' ' LYS . . . . . 0.725 ' HD2' ' HA ' ' B' ' 113' ' ' HIS . 6.3 ptmm? -64.99 -14.37 60.12 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.71 0.291 . . . . 0.0 110.737 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -57.08 -25.33 58.56 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.138 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 119' ' ' LEU . . . . . 0.565 ' HB2' HD22 ' B' ' 121' ' ' LEU . 3.1 mm? -99.26 -13.18 19.8 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 122.072 -0.392 . . . . 0.0 111.483 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 22.2 m-70 67.34 76.03 0.29 Allowed 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 122.943 0.497 . . . . 0.0 111.365 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 121' ' ' LEU . . . . . 0.565 HD22 ' HB2' ' B' ' 119' ' ' LEU . 1.0 OUTLIER -140.02 18.56 2.46 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.487 -179.334 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 122' ' ' CYS . . . . . 0.594 ' HB3' ' O ' ' B' ' 108' ' ' CYS . 0.9 OUTLIER . . . . . 0 C--O 1.246 0.889 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.767 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.999 ' HB2' HD12 ' A' ' 17' ' ' ILE . 1.8 p . . . . . 0 N--CA 1.47 0.56 0 CA-C-O 121.847 0.832 . . . . 0.0 110.737 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.62 65.23 8.43 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 114.258 -1.337 . . . . 0.0 110.545 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -145.61 -88.6 0.1 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.765 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.59 -21.74 44.63 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.325 0.584 . . . . 0.0 111.732 -178.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.999 HD12 ' HB2' ' A' ' 13' ' ' CYS . 64.5 mt -80.76 -8.79 11.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-O 121.836 0.827 . . . . 0.0 110.808 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -111.01 -9.9 14.39 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.529 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -115.18 -53.69 0.39 Allowed Glycine 0 C--O 1.228 -0.264 0 C-N-CA 120.568 -0.825 . . . . 0.0 113.013 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.88 -22.9 65.08 Favored 'General case' 0 C--O 1.226 -0.172 0 CA-C-N 117.207 0.504 . . . . 0.0 111.469 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.6 t -66.7 -41.9 88.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 O-C-N 122.09 -0.381 . . . . 0.0 110.824 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.03 -30.08 69.22 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.456 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.86 -30.82 71.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.092 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.0 t -87.09 -23.35 24.93 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.787 0.327 . . . . 0.0 110.664 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.64 39.32 4.19 Favored Glycine 0 N--CA 1.453 -0.177 0 C-N-CA 120.51 -0.852 . . . . 0.0 113.115 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 135.14 174.25 13.36 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.188 -1.006 . . . . 0.0 112.782 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 23.0 mm -72.73 125.85 32.28 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 CA-C-O 121.261 0.553 . . . . 0.0 111.412 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.417 ' HB2' ' CD2' ' B' ' 113' ' ' HIS . 35.5 t70 -144.31 -122.01 0.08 Allowed 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.737 -1.12 . . . . 0.0 108.421 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.743 ' HG ' HG21 ' A' ' 54' ' ' VAL . 12.1 tp 165.65 -61.02 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.407 0 C-N-CA 124.134 0.973 . . . . 0.0 109.645 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 1.033 ' HA ' HG11 ' A' ' 54' ' ' VAL . 9.5 Cg_endo -54.32 -41.22 78.31 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.044 1.83 . . . . 0.0 113.216 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.755 ' HB3' ' HA2' ' B' ' 114' ' ' GLY . 23.4 p -81.2 -38.07 27.64 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.552 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.1 t -67.51 -25.11 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.74 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.726 ' HA ' ' HB3' ' A' ' 36' ' ' LEU . 22.2 tp -52.35 -32.43 38.21 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.563 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -45.36 -43.98 11.41 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -115.83 22.41 13.08 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.104 0.478 . . . . 0.0 109.873 178.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.726 ' HB3' ' HA ' ' A' ' 33' ' ' LEU . 27.9 tp -114.81 -14.2 11.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.898 -178.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.611 ' HD3' ' O ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -69.36 85.11 0.4 Allowed 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.794 0.807 . . . . 0.0 111.674 -179.143 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.37 -159.06 0.98 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.047 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.412 ' HA ' ' HB2' ' A' ' 43' ' ' ALA . . . -125.06 -162.78 1.13 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.799 0.333 . . . . 0.0 111.539 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 58.11 -129.46 1.46 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.331 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.532 ' O ' ' HB3' ' A' ' 13' ' ' CYS . . . -62.12 -25.41 66.29 Favored Glycine 0 C--N 1.332 0.341 0 CA-C-N 115.892 -0.595 . . . . 0.0 114.429 -178.56 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 98.1 m -86.48 -0.45 56.08 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 117.711 0.755 . . . . 0.0 111.579 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' A' ' 47' ' ' CYS . . . -113.61 -61.15 1.78 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.679 0.276 . . . . 0.0 111.534 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 18.4 m -89.22 50.95 2.02 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -178.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.431 ' HB3' ' HB3' ' A' ' 13' ' ' CYS . 11.2 t -150.83 -56.28 0.16 Allowed 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.104 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.753 ' HB2' HD13 ' A' ' 17' ' ' ILE . 0.9 OUTLIER -87.99 -47.61 8.41 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.866 178.808 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 43' ' ' ALA . 95.5 m -81.98 47.82 1.16 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.102 -0.954 . . . . 0.0 112.144 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -84.79 -74.94 0.37 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 178.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -100.63 -21.46 15.25 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.356 178.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.402 ' HB3' HD22 ' A' ' 29' ' ' LEU . 55.2 m-70 -84.82 98.43 10.29 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 177.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.672 ' HB3' ' HG2' ' A' ' 56' ' ' LYS . 81.1 m -142.86 -10.28 0.79 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -177.376 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.651 ' O ' ' HB2' ' B' ' 91' ' ' PRO . 45.6 m80 -30.15 95.9 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 115.459 1.652 . . . . 0.0 115.459 -178.38 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 64.44 -6.71 0.74 Allowed Glycine 0 CA--C 1.526 0.753 0 N-CA-C 116.287 1.275 . . . . 0.0 116.287 176.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 1.033 HG11 ' HA ' ' A' ' 30' ' ' PRO . 0.1 OUTLIER -106.59 -72.62 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 118.359 1.08 . . . . 0.0 110.896 -179.806 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.624 ' SG ' HD11 ' A' ' 29' ' ' LEU . 57.5 m -71.23 -23.3 61.98 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.406 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.672 ' HG2' ' HB3' ' A' ' 51' ' ' CYS . 53.3 mmtt -72.19 -32.65 66.99 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.084 177.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -62.65 -39.2 93.12 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.654 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 38.9 mt -77.45 -16.03 59.0 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.397 178.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 12.4 t-160 58.78 65.19 1.27 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.112 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.1 mt -131.61 13.8 4.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.389 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 7.9 p . . . . . 0 C--O 1.245 0.851 0 CA-C-O 117.793 -1.099 . . . . 0.0 109.573 -179.823 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 74' ' ' CYS . . . . . 0.815 ' HB3' HD12 ' B' ' 78' ' ' ILE . 2.7 m . . . . . 0 C--O 1.233 0.222 0 CA-C-O 121.275 0.559 . . . . 0.0 109.893 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 75' ' ' ALA . . . . . 0.643 ' HA ' ' HB3' ' B' ' 79' ' ' ALA . . . -78.98 64.47 3.92 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -177.114 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -163.04 -77.07 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.923 0.392 . . . . 0.0 111.127 178.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 77' ' ' ALA . . . . . 0.494 ' HB1' ' HA ' ' B' ' 97' ' ' LEU . . . -86.51 -2.52 58.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.211 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.815 HD12 ' HB3' ' B' ' 74' ' ' CYS . 44.8 mt -119.03 -68.09 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.637 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 79' ' ' ALA . . . . . 0.643 ' HB3' ' HA ' ' B' ' 75' ' ' ALA . . . -84.57 52.46 2.38 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.563 0.697 . . . . 0.0 109.472 177.233 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -165.21 -38.68 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 110.306 -1.117 . . . . 0.0 110.306 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.15 -11.44 59.93 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-O 121.253 0.549 . . . . 0.0 109.724 178.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 82' ' ' VAL . . . . . 0.574 HG22 ' HB ' ' B' ' 88' ' ' ILE . 15.3 t -65.43 -36.98 78.97 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.272 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -77.07 -8.77 58.04 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.593 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -103.88 -17.94 14.83 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.779 0.323 . . . . 0.0 111.251 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -109.42 -7.57 15.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.375 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 69.44 56.37 8.74 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.569 -0.824 . . . . 0.0 111.858 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 120.79 152.58 8.88 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.85 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 88' ' ' ILE . . . . . 0.574 ' HB ' HG22 ' B' ' 82' ' ' VAL . 4.3 tp -98.64 137.2 26.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.946 0.403 . . . . 0.0 112.042 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 89' ' ' ASP . . . . . 0.495 ' H ' HG21 ' B' ' 93' ' ' VAL . 7.0 t70 -161.65 -96.3 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.591 -0.732 . . . . 0.0 109.324 178.227 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 90' ' ' LEU . . . . . 0.557 ' N ' ' HD2' ' B' ' 91' ' ' PRO . 52.6 tp -179.29 -54.42 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.586 0 CA-C-O 119.514 -0.279 . . . . 0.0 111.686 178.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 91' ' ' PRO . . . . . 0.672 ' HA ' HG21 ' B' ' 115' ' ' VAL . 2.7 Cg_endo -41.44 -58.36 1.13 Allowed 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 123.522 2.815 . . . . 0.0 114.486 -178.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 8.8 p -86.91 -34.01 19.53 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.4 -0.52 . . . . 0.0 111.408 -179.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 93' ' ' VAL . . . . . 0.495 HG21 ' H ' ' B' ' 89' ' ' ASP . 2.8 t -58.86 -22.16 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.515 -179.146 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 94' ' ' LEU . . . . . 1.015 HD22 ' HB ' ' B' ' 115' ' ' VAL . 15.1 tp -54.43 -34.54 61.58 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.527 179.218 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.82 -46.3 81.73 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -102.83 10.81 38.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.558 0.218 . . . . 0.0 111.504 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 97' ' ' LEU . . . . . 0.494 ' HA ' ' HB1' ' B' ' 77' ' ' ALA . 23.0 tp -81.84 -9.54 59.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.1 0.476 . . . . 0.0 110.294 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.037 179.249 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 13.3 m . . . . . 0 CA--C 1.524 -0.035 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -74.1 -33.61 63.68 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.922 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 13.3 m -85.61 4.28 36.97 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -178.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 32.1 p -110.04 -37.45 5.59 Favored 'General case' 0 C--N 1.327 -0.383 0 O-C-N 121.494 -0.754 . . . . 0.0 110.498 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 107' ' ' PHE . . . . . 0.721 ' HB2' HD13 ' B' ' 78' ' ' ILE . 0.6 OUTLIER -88.65 -74.28 0.47 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.133 -179.54 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 108' ' ' CYS . . . . . 0.663 ' HB3' ' SG ' ' B' ' 122' ' ' CYS . 13.4 m -66.49 15.19 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 109' ' ' GLU . . . . . 0.541 ' H ' ' C ' ' B' ' 107' ' ' PHE . 19.4 tp10 -71.86 -69.6 0.38 Allowed 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.925 -179.381 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -59.93 -45.65 91.92 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.72 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -111.32 100.28 8.92 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.994 177.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 112' ' ' CYS . . . . . 0.485 ' O ' ' HD2' ' B' ' 117' ' ' LYS . 35.9 t -114.63 63.35 0.67 Allowed 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.394 -178.469 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 113' ' ' HIS . . . . . 0.417 ' CD2' ' HB2' ' A' ' 28' ' ' ASP . 13.6 p-80 -146.61 -172.35 3.95 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.326 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 114' ' ' GLY . . . . . 0.755 ' HA2' ' HB3' ' A' ' 31' ' ' CYS . . . 72.57 -144.29 35.33 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.747 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 115' ' ' VAL . . . . . 1.015 ' HB ' HD22 ' B' ' 94' ' ' LEU . 1.4 m -62.77 -22.28 29.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 116' ' ' CYS . . . . . 0.5 ' SG ' ' HB2' ' B' ' 121' ' ' LEU . 4.6 t -65.03 -31.86 73.3 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.304 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 117' ' ' LYS . . . . . 0.485 ' HD2' ' O ' ' B' ' 112' ' ' CYS . 8.8 mtpm? -89.31 -22.81 22.48 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.318 -0.401 . . . . 0.0 109.963 178.109 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -57.19 -42.86 82.03 Favored 'General case' 0 CA--C 1.522 -0.109 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 119' ' ' LEU . . . . . 0.557 ' O ' ' HB2' ' B' ' 120' ' ' HIS . 5.3 tt -89.54 -72.82 0.54 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 177.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 120' ' ' HIS . . . . . 0.557 ' HB2' ' O ' ' B' ' 119' ' ' LEU . 14.2 t-160 134.02 91.18 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 125.829 1.652 . . . . 0.0 109.733 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 121' ' ' LEU . . . . . 0.5 ' HB2' ' SG ' ' B' ' 116' ' ' CYS . 88.2 mt -117.14 -53.53 2.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.935 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 122' ' ' CYS . . . . . 0.663 ' SG ' ' HB3' ' B' ' 108' ' ' CYS . 1.8 p . . . . . 0 C--O 1.244 0.812 0 CA-C-O 118.607 -0.711 . . . . 0.0 109.398 178.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.435 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 0.5 OUTLIER . . . . . 0 N--CA 1.475 0.824 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -44.89 -81.7 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 115.588 1.699 . . . . 0.0 115.588 -177.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -49.75 -35.43 22.27 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -177.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.82 -28.6 44.48 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -178.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.695 HG12 ' CD1' ' A' ' 46' ' ' PHE . 7.2 tp -86.4 -43.04 16.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.27 0.557 . . . . 0.0 110.883 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.5 -38.08 86.03 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.824 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.19 -17.7 79.64 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.052 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.79 -25.52 32.67 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.857 0.361 . . . . 0.0 111.0 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 93.7 t -62.04 -47.76 91.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.569 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.82 -41.21 97.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.665 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.78 -29.4 67.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.453 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.2 t -85.63 -7.21 58.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.266 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.06 24.12 72.54 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.52 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 146.2 176.93 20.46 Favored Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.589 HG12 ' N ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -79.53 151.14 4.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.564 0.697 . . . . 0.0 110.598 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.776 ' HB3' HG23 ' A' ' 32' ' ' VAL . 44.8 t0 -158.85 -122.94 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.294 -178.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.57 ' O ' ' HB2' ' A' ' 33' ' ' LEU . 23.1 tp 174.0 -62.93 0.0 OUTLIER Pre-proline 0 C--O 1.214 -0.77 0 C-N-CA 124.836 1.254 . . . . 0.0 108.905 178.468 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.689 ' HG2' ' HA2' ' B' ' 114' ' ' GLY . 9.3 Cg_endo -54.91 -37.16 93.24 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 121.687 1.592 . . . . 0.0 112.155 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.478 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 0.1 OUTLIER -87.37 -43.34 12.19 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.656 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.776 HG23 ' HB3' ' A' ' 28' ' ' ASP . 10.6 t -70.11 -34.77 60.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -178.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.57 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 0.8 OUTLIER -60.52 -35.6 76.37 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.098 0.475 . . . . 0.0 110.273 179.792 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -54.61 -31.48 57.19 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.467 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -72.57 -24.91 61.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.814 0.34 . . . . 0.0 110.843 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.452 HD13 ' HA ' ' A' ' 43' ' ' ALA . 11.8 mt -92.25 9.5 33.55 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.794 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.402 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 18.8 mmtp -68.58 -175.23 0.64 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.834 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 37' ' ' LYS . . . 76.61 -42.9 0.44 Allowed 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.676 0.79 . . . . 0.0 110.318 -178.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -131.22 63.93 1.59 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 178.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -63.37 -8.77 9.66 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -177.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -59.29 -32.64 72.63 Favored Glycine 0 CA--C 1.518 0.244 0 C-N-CA 121.01 -0.614 . . . . 0.0 113.632 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 64.5 m -107.54 24.91 12.15 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 122.385 -0.479 . . . . 0.0 111.321 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.452 ' HA ' HD13 ' A' ' 36' ' ' LEU . . . -88.99 -19.81 25.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.531 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.7 p -56.36 -33.43 65.68 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.331 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.435 ' HB3' ' HB3' ' A' ' 13' ' ' CYS . 7.6 t -47.7 -46.53 29.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.693 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.695 ' CD1' HG12 ' A' ' 17' ' ' ILE . 72.4 t80 -71.31 -50.82 28.65 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -179.4 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.628 ' HA ' ' HB2' ' A' ' 50' ' ' HIS . 0.1 OUTLIER -86.76 26.8 1.06 Allowed 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 -177.202 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -53.12 -53.68 46.84 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 119.428 1.013 . . . . 0.0 110.48 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -103.77 20.11 18.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.225 0.536 . . . . 0.0 109.789 178.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.628 ' HB2' ' HA ' ' A' ' 47' ' ' CYS . 41.3 m80 -126.29 62.22 1.27 Allowed 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.278 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 64.6 m -92.49 49.4 1.48 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.632 0.729 . . . . 0.0 109.758 178.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.604 ' CE1' ' HB3' ' B' ' 92' ' ' CYS . 49.7 t-80 -132.33 94.19 3.39 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.551 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.584 ' HA3' ' HB2' ' B' ' 91' ' ' PRO . . . 130.89 -144.91 16.4 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 119.485 -1.341 . . . . 0.0 114.839 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.522 HG21 ' HA ' ' A' ' 30' ' ' PRO . 14.3 m -60.4 -25.97 35.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -177.399 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.545 ' SG ' ' HB2' ' A' ' 60' ' ' LEU . 34.9 t -76.83 -44.08 33.84 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.044 -0.662 . . . . 0.0 111.826 -178.5 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.48 -13.45 61.06 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.062 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -66.99 -40.84 87.47 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.988 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.6 mt -93.48 2.7 56.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.517 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 58.98 54.16 5.19 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.619 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.545 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 87.1 mt -94.48 -39.91 10.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.741 -179.139 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 26.3 p . . . . . 0 C--O 1.245 0.866 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.302 179.751 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 3.2 m . . . . . 0 N--CA 1.469 0.506 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.66 -45.88 88.4 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -177.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.81 -3.06 11.01 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -123.49 -20.11 5.67 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.561 ' O ' HG23 ' B' ' 82' ' ' VAL . 4.0 tp -112.0 -44.95 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.722 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.64 -32.83 74.4 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.186 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.02 -24.01 60.5 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.366 -0.921 . . . . 0.0 111.724 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.4 -19.69 57.87 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.586 0.231 . . . . 0.0 111.332 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 82' ' ' VAL . . . . . 0.561 HG23 ' O ' ' B' ' 78' ' ' ILE . 80.9 t -65.1 -52.51 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.691 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.89 -34.46 77.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.736 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.64 -38.51 89.59 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.44 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 16.0 t -85.84 -26.21 25.82 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.344 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.76 46.04 7.45 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.02 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 152.94 132.71 1.79 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.986 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 4.7 tp -93.19 135.89 26.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.312 0.577 . . . . 0.0 111.261 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 89' ' ' ASP . . . . . 0.517 ' H ' HG21 ' B' ' 93' ' ' VAL . 47.2 t0 -163.85 -98.82 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 90' ' ' LEU . . . . . 0.774 HD12 ' HB2' ' B' ' 94' ' ' LEU . 59.8 tp -170.11 -58.93 0.0 OUTLIER Pre-proline 0 C--O 1.223 -0.332 0 CA-C-O 119.187 -0.435 . . . . 0.0 111.03 178.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 91' ' ' PRO . . . . . 0.584 ' HB2' ' HA3' ' A' ' 53' ' ' GLY . 2.0 Cg_endo -39.59 -58.79 0.77 Allowed 'Trans proline' 0 C--N 1.363 1.301 0 C-N-CA 123.623 2.882 . . . . 0.0 114.705 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 92' ' ' CYS . . . . . 0.604 ' HB3' ' CE1' ' A' ' 52' ' ' HIS . 8.6 t -84.2 -30.71 25.56 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -178.371 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 93' ' ' VAL . . . . . 0.517 HG21 ' H ' ' B' ' 89' ' ' ASP . 2.6 t -71.69 -49.62 44.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -178.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 94' ' ' LEU . . . . . 0.774 ' HB2' HD12 ' B' ' 90' ' ' LEU . 2.1 tm? -63.43 -35.16 79.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.955 0.407 . . . . 0.0 110.91 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -53.83 -33.28 55.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.431 -179.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -82.61 -16.96 46.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.95 0.405 . . . . 0.0 111.37 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 97' ' ' LEU . . . . . 0.411 HD13 HD13 ' B' ' 78' ' ' ILE . 6.6 tt -81.69 -10.16 59.46 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.732 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 42.5 mtpt . . . . . 0 CA--C 1.535 0.379 0 CA-C-O 121.063 0.459 . . . . 0.0 111.924 -179.61 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 71.6 m . . . . . 0 C--O 1.224 -0.284 0 N-CA-C 111.537 0.199 . . . . 0.0 111.537 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.16 -13.62 13.07 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 13.0 m -64.94 -27.25 68.71 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.517 0.192 . . . . 0.0 111.517 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 106' ' ' CYS . . . . . 0.429 ' SG ' ' N ' ' B' ' 107' ' ' PHE . 16.6 p -48.9 -57.42 6.48 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.276 0.56 . . . . 0.0 111.415 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 107' ' ' PHE . . . . . 0.536 ' CD2' HG12 ' B' ' 78' ' ' ILE . 0.5 OUTLIER -80.27 -54.21 5.94 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.574 -179.693 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 76.1 m -82.27 42.84 0.76 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -178.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -77.11 -62.36 1.68 Allowed 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -90.92 7.35 40.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.876 178.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 14.1 m80 -126.58 79.55 1.87 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.976 -1.011 . . . . 0.0 108.294 178.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 112' ' ' CYS . . . . . 0.411 ' O ' ' HB3' ' B' ' 117' ' ' LYS . 4.0 t -98.28 32.59 2.42 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -177.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 113' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -121.87 -160.38 0.86 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 178.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 114' ' ' GLY . . . . . 0.689 ' HA2' ' HG2' ' A' ' 30' ' ' PRO . . . 66.86 -145.13 46.25 Favored Glycine 0 C--O 1.226 -0.346 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.364 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 115' ' ' VAL . . . . . 0.507 HG23 ' HB3' ' B' ' 94' ' ' LEU . 8.2 m -78.56 -2.82 5.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 117.228 0.514 . . . . 0.0 110.518 178.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 116' ' ' CYS . . . . . 0.462 ' SG ' ' HG ' ' B' ' 94' ' ' LEU . 0.5 OUTLIER -82.56 -26.86 32.01 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.709 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 117' ' ' LYS . . . . . 0.561 ' HG2' ' O ' ' B' ' 114' ' ' GLY . 14.0 ptmm? -84.33 -6.67 59.42 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 177.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -65.17 -45.77 83.55 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 178.158 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 66.0 mt -87.13 -33.62 19.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.974 -1.012 . . . . 0.0 108.585 177.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 58.75 75.28 0.4 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 114.464 -1.243 . . . . 0.0 111.866 179.233 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.97 21.75 4.15 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.856 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 122' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.243 0.759 0 CA-C-O 118.426 -0.797 . . . . 0.0 110.753 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.488 ' O ' HG22 ' A' ' 17' ' ' ILE . 18.1 p . . . . . 0 N--CA 1.476 0.869 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.412 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -70.76 -34.77 72.18 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 118.213 0.46 . . . . 0.0 112.134 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.83 -6.25 36.53 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.97 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -114.34 -35.18 5.05 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.5 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.812 HG12 ' CD2' ' A' ' 46' ' ' PHE . 5.3 tp -93.53 -50.81 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.114 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.619 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.436 ' N ' HG23 ' A' ' 17' ' ' ILE . . . -63.71 -31.64 72.88 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.119 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.53 -24.67 74.34 Favored Glycine 0 N--CA 1.451 -0.357 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 177.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.503 ' CB ' ' HB3' ' A' ' 35' ' ' ALA . . . -76.31 -26.58 55.98 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.114 0.483 . . . . 0.0 110.392 178.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 17' ' ' ILE . 57.9 t -63.46 -50.08 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.473 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.51 -31.64 71.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.93 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.7 -41.67 78.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.759 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.6 t -84.77 -22.97 29.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.861 0.363 . . . . 0.0 110.74 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 111.1 -38.38 3.31 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.683 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -137.19 167.25 24.75 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.236 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.8 tp -96.2 133.86 35.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.071 0.463 . . . . 0.0 111.061 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.515 ' OD2' ' HD2' ' A' ' 30' ' ' PRO . 9.2 t70 -163.82 -111.16 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.699 HD11 ' HB2' ' A' ' 55' ' ' CYS . 38.8 tp -168.16 -54.01 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 178.04 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.744 ' HB2' ' HA3' ' B' ' 114' ' ' GLY . 86.5 Cg_exo -46.7 -53.03 6.65 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 122.596 2.197 . . . . 0.0 113.887 -179.012 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.635 ' HB3' ' CE1' ' B' ' 113' ' ' HIS . 7.7 t -81.33 -33.11 32.71 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.555 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.465 HG23 ' HE1' ' B' ' 113' ' ' HIS . 2.8 t -65.14 -28.72 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-O 121.055 0.455 . . . . 0.0 110.895 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.423 HD13 ' O ' ' A' ' 33' ' ' LEU . 1.9 tm? -61.98 -39.0 90.67 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.641 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.33 -46.23 89.18 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.503 ' HB3' ' CB ' ' A' ' 20' ' ' ALA . . . -78.84 -13.61 59.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.785 0.326 . . . . 0.0 111.402 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 23.0 tp -73.76 -53.05 11.18 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -167.11 -21.99 0.02 OUTLIER 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.251 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 66.61 25.78 9.88 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.118 -179.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -166.57 -170.64 1.67 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.79 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.424 ' HG2' HD11 ' A' ' 60' ' ' LEU . 48.2 mt-10 -64.22 131.37 47.19 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 123.064 0.228 . . . . 0.0 111.249 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 145.7 140.59 3.53 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 119.945 -1.122 . . . . 0.0 113.371 179.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 90.2 m 61.64 31.85 18.61 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.624 ' CB ' ' HB3' ' A' ' 60' ' ' LEU . . . -80.59 -44.36 19.07 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.384 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 12.2 m -68.8 -16.11 63.69 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.903 0.383 . . . . 0.0 111.268 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 42.5 t -78.09 -54.91 5.73 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.944 0.402 . . . . 0.0 111.276 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.812 ' CD2' HG12 ' A' ' 17' ' ' ILE . 3.6 t80 -102.18 -49.75 3.82 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -178.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.417 ' SG ' ' HD1' ' A' ' 46' ' ' PHE . 21.2 m -72.96 13.56 0.38 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -177.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 44' ' ' SER . 16.5 tp10 -69.6 -53.66 17.72 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.142 0.496 . . . . 0.0 111.185 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -66.38 -23.95 66.41 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.079 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -135.23 103.78 5.65 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 96.0 m -112.65 81.07 1.42 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 177.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.547 ' O ' ' HB2' ' B' ' 92' ' ' CYS . 3.1 t60 -142.16 -34.52 0.46 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -177.028 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.807 ' HA2' ' HB2' ' B' ' 91' ' ' PRO . . . -87.16 -162.45 37.7 Favored Glycine 0 CA--C 1.518 0.266 0 N-CA-C 115.587 0.995 . . . . 0.0 115.587 -178.097 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.4 ' CG1' ' HA ' ' A' ' 30' ' ' PRO . 7.7 p -58.44 -10.49 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 124.409 1.084 . . . . 0.0 112.575 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.699 ' HB2' HD11 ' A' ' 29' ' ' LEU . 18.0 t -77.99 -31.49 50.73 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 121.999 -0.438 . . . . 0.0 111.071 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.607 ' HG3' ' O ' ' A' ' 53' ' ' GLY . 0.1 OUTLIER -90.34 -2.35 57.98 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.466 179.819 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.424 ' O ' ' HB3' ' A' ' 58' ' ' LEU . 52.9 t0 -56.46 122.47 12.0 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.647 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.685 ' O ' ' HB2' ' A' ' 59' ' ' HIS . 45.2 tp 90.24 -64.94 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.029 1.332 . . . . 0.0 108.699 -177.137 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.685 ' HB2' ' O ' ' A' ' 58' ' ' LEU . 26.5 t-80 153.03 121.13 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.911 0 O-C-N 124.763 1.289 . . . . 0.0 109.303 178.24 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.624 ' HB3' ' CB ' ' A' ' 43' ' ' ALA . 22.1 mt -147.3 -55.85 0.24 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 19.1 p . . . . . 0 C--O 1.246 0.906 0 CA-C-O 118.435 -0.793 . . . . 0.0 110.747 -179.812 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 74' ' ' CYS . . . . . 0.501 ' O ' HG22 ' B' ' 78' ' ' ILE . 9.7 p . . . . . 0 N--CA 1.478 0.936 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 75' ' ' ALA . . . . . 0.487 ' HA ' HG22 ' B' ' 78' ' ' ILE . . . -67.13 -26.32 66.62 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.82 -9.09 25.65 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -120.75 -34.28 3.61 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.606 HG12 ' CD1' ' B' ' 107' ' ' PHE . 7.8 tp -82.79 -48.5 17.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.118 0.485 . . . . 0.0 111.683 -179.021 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.81 -24.9 59.54 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.106 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.18 -22.85 70.0 Favored Glycine 0 C--N 1.329 0.183 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.12 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -80.65 -17.81 50.04 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.092 0.472 . . . . 0.0 110.623 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 82' ' ' VAL . . . . . 0.469 HG22 HD13 ' B' ' 88' ' ' ILE . 60.4 t -66.78 -43.44 89.86 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.453 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.24 6.48 11.76 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.917 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -110.26 -19.68 12.92 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 3.0 t -120.03 12.23 11.9 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.515 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 71.06 33.82 65.08 Favored Glycine 0 CA--C 1.519 0.285 0 N-CA-C 114.693 0.637 . . . . 0.0 114.693 178.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 148.36 -177.05 26.87 Favored Glycine 0 CA--C 1.51 -0.269 0 C-N-CA 119.864 -1.16 . . . . 0.0 112.543 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 88' ' ' ILE . . . . . 0.469 HD13 HG22 ' B' ' 82' ' ' VAL . 4.4 tp -123.23 134.7 65.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.994 0.426 . . . . 0.0 111.043 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 89' ' ' ASP . . . . . 0.565 ' H ' HG21 ' B' ' 93' ' ' VAL . 28.7 t70 -156.47 -102.38 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 90' ' ' LEU . . . . . 0.598 HD11 ' HB2' ' B' ' 116' ' ' CYS . 22.1 tp -167.09 -59.06 0.01 OUTLIER Pre-proline 0 N--CA 1.469 0.488 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 177.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 91' ' ' PRO . . . . . 0.998 ' HA ' HG11 ' B' ' 115' ' ' VAL . 2.1 Cg_endo -43.87 -56.2 2.58 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 123.049 2.499 . . . . 0.0 114.631 -178.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 92' ' ' CYS . . . . . 0.547 ' HB2' ' O ' ' A' ' 52' ' ' HIS . 12.3 t -81.22 -32.85 33.25 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 93' ' ' VAL . . . . . 0.565 HG21 ' H ' ' B' ' 89' ' ' ASP . 0.2 OUTLIER -68.02 -29.2 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-O 120.668 0.27 . . . . 0.0 111.217 -179.197 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -62.21 -39.15 91.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.222 0.534 . . . . 0.0 110.252 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.35 -43.53 85.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.206 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.6 19.51 4.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.68 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 97' ' ' LEU . . . . . 0.44 HD13 HD13 ' B' ' 78' ' ' ILE . 35.8 tp -77.04 -52.62 9.01 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.17 0.509 . . . . 0.0 109.708 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.181 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 87.7 m . . . . . 0 N--CA 1.468 0.429 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -90.1 -24.92 20.99 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 18.0 t -64.45 -47.2 79.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.72 0.295 . . . . 0.0 110.863 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 37.0 t -60.16 -50.24 74.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.917 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 107' ' ' PHE . . . . . 0.606 ' CD1' HG12 ' B' ' 78' ' ' ILE . 52.9 t80 -73.09 -58.55 3.23 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -178.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 21.7 m -79.03 34.14 0.23 Allowed 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -177.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 19.1 tp10 -63.31 -80.99 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 118.154 0.433 . . . . 0.0 110.373 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -76.32 -30.55 57.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.505 0.669 . . . . 0.0 109.294 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -81.87 71.07 8.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.647 179.162 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 9.8 t -128.84 84.47 2.23 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.116 0.484 . . . . 0.0 110.057 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 113' ' ' HIS . . . . . 0.635 ' CE1' ' HB3' ' A' ' 31' ' ' CYS . 9.3 t-80 -126.08 -47.48 1.63 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.289 -178.523 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 114' ' ' GLY . . . . . 0.744 ' HA3' ' HB2' ' A' ' 30' ' ' PRO . . . -147.41 164.68 28.71 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 119.997 -1.097 . . . . 0.0 113.401 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 115' ' ' VAL . . . . . 0.998 HG11 ' HA ' ' B' ' 91' ' ' PRO . 0.5 OUTLIER 61.88 -45.0 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 125.581 1.552 . . . . 0.0 113.253 179.626 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 116' ' ' CYS . . . . . 0.598 ' HB2' HD11 ' B' ' 90' ' ' LEU . 6.9 t -87.2 -30.23 21.14 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -90.74 4.47 51.47 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.375 178.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -63.01 -32.44 73.8 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.352 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 25.5 tp -112.78 -114.71 0.33 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -141.51 59.13 1.51 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 86.2 mt -99.24 -35.93 9.81 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 122' ' ' CYS . . . . . . . . . . . . . 3.4 p . . . . . 0 C--O 1.245 0.824 0 CA-C-O 118.345 -0.836 . . . . 0.0 110.286 179.339 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.83 ' HB3' HD12 ' A' ' 17' ' ' ILE . 76.4 m . . . . . 0 N--CA 1.471 0.605 0 N-CA-C 112.97 0.729 . . . . 0.0 112.97 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.673 ' HA ' ' HB3' ' A' ' 18' ' ' ALA . . . -73.7 16.99 0.17 Allowed 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.042 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -104.44 -31.46 9.48 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.733 0.302 . . . . 0.0 111.109 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -123.37 -48.84 1.94 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.476 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.83 HD12 ' HB3' ' A' ' 13' ' ' CYS . 69.3 mt -64.19 -45.92 94.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-O 121.42 0.629 . . . . 0.0 109.569 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.673 ' HB3' ' HA ' ' A' ' 14' ' ' ALA . . . -110.44 31.71 5.73 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.156 178.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -129.63 -43.23 0.21 Allowed Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.73 -0.747 . . . . 0.0 111.968 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.669 ' HB3' HG13 ' A' ' 32' ' ' VAL . . . -87.35 19.92 3.05 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.997 0.427 . . . . 0.0 111.343 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.452 HG13 ' N ' ' A' ' 22' ' ' ALA . 12.5 p -65.92 -45.57 90.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.974 0.892 . . . . 0.0 110.286 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.452 ' N ' HG13 ' A' ' 21' ' ' VAL . . . -64.46 -26.42 68.44 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.555 -1.202 . . . . 0.0 111.629 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.8 -40.06 95.73 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.587 ' SG ' ' HA3' ' B' ' 114' ' ' GLY . 4.5 t -97.07 1.6 50.27 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.768 0.318 . . . . 0.0 110.801 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.42 42.43 82.02 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.519 -0.848 . . . . 0.0 111.426 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 144.35 156.03 6.66 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.403 ' HB ' HG23 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -87.19 133.92 28.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 117.595 0.697 . . . . 0.0 111.389 -179.035 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.632 ' OD1' ' HB3' ' A' ' 31' ' ' CYS . 1.2 p30 -143.55 -112.25 0.11 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.308 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.785 HD21 ' HB3' ' A' ' 55' ' ' CYS . 12.5 tp -179.28 -56.56 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.449 0 C-N-CA 122.358 0.263 . . . . 0.0 111.7 178.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.916 ' HB3' HG13 ' A' ' 54' ' ' VAL . 8.7 Cg_exo -76.05 -4.12 14.73 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 121.874 1.716 . . . . 0.0 113.177 -178.367 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.707 ' HB2' HG13 ' B' ' 115' ' ' VAL . 21.6 t -104.88 -38.95 6.45 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 177.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.669 HG13 ' HB3' ' A' ' 20' ' ' ALA . 42.3 t -78.64 -10.77 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.221 178.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.581 ' HG ' ' HB2' ' A' ' 37' ' ' LYS . 6.3 tp -54.21 -29.17 45.23 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.945 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -46.95 -45.82 21.04 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -178.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -102.88 33.23 3.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.982 0.42 . . . . 0.0 111.16 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.411 ' HG ' ' HA2' ' A' ' 41' ' ' GLY . 5.5 tp -137.14 -41.59 0.58 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.761 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.581 ' HB2' ' HG ' ' A' ' 33' ' ' LEU . 1.8 tmtp? -59.96 -35.11 74.25 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -177.526 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.23 -64.18 1.04 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -178.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -93.81 55.01 2.07 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -178.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.854 ' HG2' ' H ' ' A' ' 42' ' ' CYS . 85.0 tt0 70.83 137.63 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.337 0.589 . . . . 0.0 111.517 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.562 ' HA3' HD11 ' A' ' 60' ' ' LEU . . . -79.32 -11.23 85.19 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.715 -0.755 . . . . 0.0 113.186 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.854 ' H ' ' HG2' ' A' ' 40' ' ' GLU . 33.9 m 69.75 94.61 0.07 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 122.96 0.504 . . . . 0.0 111.193 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.44 ' C ' ' H ' ' A' ' 45' ' ' CYS . . . -65.96 153.43 42.11 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.902 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.6 p 66.76 -29.09 0.13 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.624 1.169 . . . . 0.0 112.365 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.44 ' H ' ' C ' ' A' ' 43' ' ' ALA . 6.0 t -78.15 -70.13 0.51 Allowed 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.56 ' HD1' ' CE1' ' A' ' 50' ' ' HIS . 0.1 OUTLIER -90.18 165.31 14.03 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 175.514 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.788 ' HB3' ' SG ' ' A' ' 61' ' ' CYS . 73.4 m 72.66 -0.68 3.24 Favored 'General case' 0 C--O 1.216 -0.68 0 O-C-N 123.364 0.415 . . . . 0.0 111.642 -178.039 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.549 ' HA ' ' OE1' ' A' ' 48' ' ' GLU . 5.1 tp10 -61.35 -93.32 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.274 0.559 . . . . 0.0 111.187 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.458 ' H ' ' HB3' ' A' ' 48' ' ' GLU . 17.8 t70 -70.35 -33.33 71.33 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 178.288 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.56 ' CE1' ' HD1' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -88.61 56.95 3.97 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 112.466 -2.152 . . . . 0.0 109.535 178.463 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 14.8 t -93.63 63.77 3.46 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 17.2 t-160 -163.49 136.25 5.35 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.06 -177.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 117.0 -157.7 14.91 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 119.864 -1.16 . . . . 0.0 113.78 178.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.916 HG13 ' HB3' ' A' ' 30' ' ' PRO . 3.5 m -70.73 -5.13 5.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.39 -0.405 . . . . 0.0 112.001 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.785 ' HB3' HD21 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -76.79 -40.94 46.46 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.119 0.485 . . . . 0.0 110.573 -178.98 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.404 ' HE2' ' HB3' ' A' ' 56' ' ' LYS . 31.6 mtpt -67.46 -10.75 54.45 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.818 179.142 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -65.59 -33.03 74.96 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.497 ' O ' HD23 ' A' ' 58' ' ' LEU . 2.4 tt -90.19 -21.16 22.31 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.937 178.4 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 75.06 97.87 0.07 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.377 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.643 ' HB2' ' SG ' ' A' ' 47' ' ' CYS . 26.3 mt -136.84 2.37 2.61 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.144 -179.379 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.788 ' SG ' ' HB3' ' A' ' 47' ' ' CYS . 29.2 p . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.107 -0.949 . . . . 0.0 109.707 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 74' ' ' CYS . . . . . 0.856 ' HB3' HD12 ' B' ' 78' ' ' ILE . 12.2 m . . . . . 0 N--CA 1.466 0.34 0 N-CA-C 112.854 0.686 . . . . 0.0 112.854 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 75' ' ' ALA . . . . . 0.954 ' HA ' ' HB3' ' B' ' 79' ' ' ALA . . . -82.6 6.62 17.11 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 76' ' ' ALA . . . . . 0.408 ' O ' ' HA3' ' B' ' 80' ' ' GLY . . . -99.17 -57.52 2.14 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.733 0.302 . . . . 0.0 111.789 -179.544 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.19 -38.66 12.57 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.856 HD12 ' HB3' ' B' ' 74' ' ' CYS . 71.9 mt -81.71 -55.5 7.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.979 0.419 . . . . 0.0 110.383 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 79' ' ' ALA . . . . . 0.954 ' HB3' ' HA ' ' B' ' 75' ' ' ALA . . . -83.39 14.47 3.61 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.276 0.56 . . . . 0.0 110.853 178.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 80' ' ' GLY . . . . . 0.408 ' HA3' ' O ' ' B' ' 76' ' ' ALA . . . -114.24 -41.22 0.9 Allowed Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 178.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 81' ' ' ALA . . . . . 0.685 ' HB3' HG13 ' B' ' 93' ' ' VAL . . . -73.51 -7.31 51.31 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-O 120.976 0.417 . . . . 0.0 110.358 178.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 82' ' ' VAL . . . . . 0.409 HG13 ' N ' ' B' ' 83' ' ' ALA . 13.0 p -60.14 -42.16 89.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-O 121.619 0.723 . . . . 0.0 109.445 178.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 83' ' ' ALA . . . . . 0.409 ' N ' HG13 ' B' ' 82' ' ' VAL . . . -70.36 -27.29 64.22 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.429 -1.26 . . . . 0.0 111.467 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.69 -46.06 14.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.84 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 38.0 t -79.33 -48.33 14.27 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.903 0.382 . . . . 0.0 110.85 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 117.98 41.09 0.67 Allowed Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.908 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 140.1 176.19 14.89 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.525 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 18.1 mm -104.65 118.85 52.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.158 0.504 . . . . 0.0 111.232 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 89' ' ' ASP . . . . . 0.458 ' CG ' ' H ' ' B' ' 90' ' ' LEU . 7.7 p-10 -138.24 -108.5 0.18 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.029 178.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 90' ' ' LEU . . . . . 0.732 HD11 ' SG ' ' B' ' 108' ' ' CYS . 0.1 OUTLIER -174.87 -53.76 0.0 OUTLIER Pre-proline 0 N--CA 1.451 -0.402 0 C-N-CA 122.367 0.267 . . . . 0.0 111.105 179.621 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 91' ' ' PRO . . . . . 0.947 ' HB3' HG11 ' B' ' 115' ' ' VAL . 27.1 Cg_exo -63.97 -29.9 66.76 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.212 1.941 . . . . 0.0 115.293 -176.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 14.3 p -92.07 -40.5 11.04 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 119.695 -0.802 . . . . 0.0 110.042 179.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 93' ' ' VAL . . . . . 0.685 HG13 ' HB3' ' B' ' 81' ' ' ALA . 2.5 t -65.83 -27.76 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.699 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 26.1 tp -55.43 -45.3 76.81 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.355 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.8 -45.66 91.63 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.245 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.25 -21.27 59.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.178 0.514 . . . . 0.0 110.787 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 97' ' ' LEU . . . . . 0.652 HD21 ' HB2' ' B' ' 103' ' ' CYS . 10.2 tt -78.66 -29.02 45.48 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.086 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 29.5 tttm . . . . . 0 C--O 1.235 0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 112.115 -179.463 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 103' ' ' CYS . . . . . 0.652 ' HB2' HD21 ' B' ' 97' ' ' LEU . 82.5 m . . . . . 0 N--CA 1.466 0.329 0 CA-C-O 121.7 0.762 . . . . 0.0 110.711 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 104' ' ' ALA . . . . . 0.518 ' HB2' HD12 ' B' ' 121' ' ' LEU . . . -114.64 -160.28 0.73 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 177.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 105' ' ' SER . . . . . 0.525 ' O ' ' HB2' ' B' ' 109' ' ' GLU . 15.0 m 68.37 -56.15 0.51 Allowed 'General case' 0 N--CA 1.467 0.418 0 O-C-N 123.584 0.553 . . . . 0.0 112.317 178.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 29.9 p -80.04 -35.74 36.74 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 122.001 -0.437 . . . . 0.0 110.566 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 107' ' ' PHE . . . . . 0.584 ' CE1' HD22 ' B' ' 90' ' ' LEU . 0.7 OUTLIER -88.63 -97.78 0.09 Allowed 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.248 -178.536 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 108' ' ' CYS . . . . . 0.732 ' SG ' HD11 ' B' ' 90' ' ' LEU . 33.7 m -63.43 33.75 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 115.011 1.486 . . . . 0.0 115.011 -177.355 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 109' ' ' GLU . . . . . 0.525 ' HB2' ' O ' ' B' ' 105' ' ' SER . 44.3 tp10 -59.92 -70.44 0.17 Allowed 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 119.301 0.955 . . . . 0.0 110.709 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -92.53 -20.31 21.07 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.082 0.468 . . . . 0.0 110.137 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -86.88 86.63 7.33 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.034 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 112' ' ' CYS . . . . . 0.427 ' O ' ' HE2' ' B' ' 117' ' ' LYS . 1.6 t -121.05 43.03 2.9 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.942 0.401 . . . . 0.0 110.416 -178.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 113' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -88.37 121.03 30.31 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.556 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 114' ' ' GLY . . . . . 0.587 ' HA3' ' SG ' ' A' ' 24' ' ' CYS . . . 45.45 -99.86 0.02 OUTLIER Glycine 0 C--O 1.223 -0.566 0 N-CA-C 115.681 1.032 . . . . 0.0 115.681 177.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 115' ' ' VAL . . . . . 0.947 HG11 ' HB3' ' B' ' 91' ' ' PRO . 12.5 m -29.57 -60.54 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 -177.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 116' ' ' CYS . . . . . 0.524 ' H ' HG23 ' B' ' 115' ' ' VAL . 0.9 OUTLIER -73.34 -30.5 63.38 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.102 -0.639 . . . . 0.0 112.019 -177.755 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 117' ' ' LYS . . . . . 0.427 ' HE2' ' O ' ' B' ' 112' ' ' CYS . 11.9 ttmm -76.08 -11.05 59.87 Favored 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 122.024 -0.422 . . . . 0.0 110.09 178.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -67.83 -43.29 79.89 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 178.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 119' ' ' LEU . . . . . 0.581 ' HB3' ' CD2' ' B' ' 121' ' ' LEU . 5.1 tt -78.28 -36.47 46.68 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 177.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 14.1 t-80 78.82 75.58 0.05 Allowed 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 114.693 -1.14 . . . . 0.0 111.656 178.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 121' ' ' LEU . . . . . 0.581 ' CD2' ' HB3' ' B' ' 119' ' ' LEU . 0.4 OUTLIER -128.16 13.39 6.68 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.378 179.47 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 122' ' ' CYS . . . . . . . . . . . . . 3.6 p . . . . . 0 C--O 1.246 0.869 0 CA-C-O 118.293 -0.861 . . . . 0.0 110.478 179.212 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.434 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 95.7 m . . . . . 0 N--CA 1.475 0.803 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -99.31 14.86 28.13 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.41 -68.97 0.79 Allowed 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -87.65 -3.15 58.98 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -178.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.744 HD13 ' HB2' ' A' ' 46' ' ' PHE . 45.3 mt -112.64 -62.86 2.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.548 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.27 -34.72 72.6 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.86 -37.84 18.03 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.689 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.04 -28.21 60.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.021 0.439 . . . . 0.0 111.677 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.462 HG13 ' N ' ' A' ' 27' ' ' ILE . 1.9 t -66.36 -43.17 91.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.617 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.64 -25.66 64.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.149 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.75 -24.39 63.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.651 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 12.4 t -89.17 -31.93 17.71 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.755 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 128.55 17.23 1.95 Allowed Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.093 -1.051 . . . . 0.0 113.88 178.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 116.14 114.65 2.86 Favored Glycine 0 C--O 1.227 -0.309 0 C-N-CA 120.24 -0.981 . . . . 0.0 112.29 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.462 ' N ' HG13 ' A' ' 21' ' ' VAL . 1.4 tt 19.13 94.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.621 ' HB3' HG23 ' A' ' 32' ' ' VAL . 6.8 t0 -127.73 143.34 51.15 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 114.18 -1.373 . . . . 0.0 107.616 177.458 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.781 ' HB3' ' HD3' ' A' ' 30' ' ' PRO . 36.7 tp -106.88 -58.49 0.05 OUTLIER Pre-proline 0 C--N 1.303 -1.429 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.232 -179.266 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.781 ' HD3' ' HB3' ' A' ' 29' ' ' LEU . 25.9 Cg_exo -62.59 -28.22 77.0 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 121.93 1.753 . . . . 0.0 112.594 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.602 ' HB3' ' CG ' ' A' ' 28' ' ' ASP . 0.1 OUTLIER -84.46 -41.31 16.73 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.764 -179.147 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.621 HG23 ' HB3' ' A' ' 28' ' ' ASP . 45.1 t -84.91 -6.22 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-O 121.174 0.511 . . . . 0.0 111.021 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.461 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 2.4 tm? -54.37 -45.46 72.79 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.326 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.77 -36.86 80.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.529 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.08 2.02 52.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.805 0.336 . . . . 0.0 111.493 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 57.4 tp -97.3 -32.32 11.95 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.322 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -75.93 -26.5 56.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.19 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -106.9 -179.71 4.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.628 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 57.49 31.91 20.99 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 123.568 0.542 . . . . 0.0 112.286 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 53.69 67.91 0.93 Allowed 'General case' 0 CA--C 1.534 0.348 0 O-C-N 123.611 0.569 . . . . 0.0 110.509 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -79.5 -166.07 31.67 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.73 -0.668 . . . . 0.0 113.493 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 47.0 t -160.31 88.83 0.82 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.635 ' CB ' ' HB3' ' A' ' 60' ' ' LEU . . . -68.44 -42.03 79.46 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -178.184 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.4 p -75.56 28.4 0.1 Allowed 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.363 0.602 . . . . 0.0 112.438 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.445 ' H ' ' C ' ' A' ' 43' ' ' ALA . 20.1 t -139.6 -18.21 0.97 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.748 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.744 ' HB2' HD13 ' A' ' 17' ' ' ILE . 0.8 OUTLIER -111.0 -63.17 1.43 Allowed 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.785 -179.311 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 19.8 m -79.12 25.34 0.29 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.473 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -52.94 -62.31 1.74 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.642 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -92.74 -31.8 14.93 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 8.0 m80 -79.47 76.05 6.07 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.432 ' SG ' ' HB3' ' A' ' 56' ' ' LYS . 4.0 t -128.31 52.45 1.9 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -177.15 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 15.9 p-80 -122.46 82.64 2.0 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.637 0.732 . . . . 0.0 110.712 178.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.75 172.77 44.21 Favored Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.479 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.768 HG11 ' HA ' ' A' ' 30' ' ' PRO . 44.9 t 63.61 -73.32 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 123.297 0.639 . . . . 0.0 112.59 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.735 ' HB2' HD11 ' A' ' 29' ' ' LEU . 38.9 t -71.72 -44.38 64.23 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.407 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.432 ' HB3' ' SG ' ' A' ' 51' ' ' CYS . 0.1 OUTLIER -88.05 13.31 11.4 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 119.899 -0.72 . . . . 0.0 110.603 179.17 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -69.14 -35.35 76.26 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 177.049 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -95.58 -4.13 45.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 113.972 -1.467 . . . . 0.0 108.521 177.595 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.402 ' H ' ' C ' ' A' ' 56' ' ' LYS . 75.1 m-70 65.91 75.25 0.35 Allowed 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 114.414 -1.266 . . . . 0.0 110.912 -178.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.635 ' HB3' ' CB ' ' A' ' 43' ' ' ALA . 88.6 mt -106.06 -31.29 8.79 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.36 -179.301 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.7 p . . . . . 0 C--O 1.245 0.845 0 CA-C-O 118.304 -0.855 . . . . 0.0 110.179 179.059 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 74' ' ' CYS . . . . . 0.711 ' HB3' HD12 ' B' ' 78' ' ' ILE . 30.3 m . . . . . 0 N--CA 1.475 0.788 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -90.64 -31.23 16.72 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -178.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -71.15 -75.16 0.13 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -178.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.01 29.67 0.13 Allowed 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -177.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.711 HD12 ' HB3' ' B' ' 74' ' ' CYS . 23.2 mt -142.2 -58.3 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 O-C-N 122.246 -0.284 . . . . 0.0 110.408 178.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.79 -35.58 77.21 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.927 0.394 . . . . 0.0 110.65 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -75.34 -23.82 72.61 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.363 178.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.78 -28.32 63.54 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.783 0.325 . . . . 0.0 110.747 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 82' ' ' VAL . . . . . 0.516 HG23 ' O ' ' B' ' 78' ' ' ILE . 52.8 t -70.72 -28.11 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.031 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.44 -32.81 72.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.089 0.471 . . . . 0.0 109.883 178.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -87.12 1.3 53.43 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.754 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 64.3 m -148.49 64.97 1.07 Allowed 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -28.72 -48.09 0.08 OUTLIER Glycine 0 N--CA 1.469 0.899 0 O-C-N 124.881 1.363 . . . . 0.0 114.414 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . -96.36 86.41 0.91 Allowed Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 177.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 88' ' ' ILE . . . . . 0.502 ' HB ' HG13 ' B' ' 82' ' ' VAL . 0.0 OUTLIER -62.08 135.77 26.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.637 0.732 . . . . 0.0 112.406 -177.551 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 89' ' ' ASP . . . . . 0.477 ' O ' ' HB2' ' B' ' 90' ' ' LEU . 10.3 t70 -146.92 -71.47 0.23 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.146 178.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 90' ' ' LEU . . . . . 0.653 ' N ' ' HD2' ' B' ' 91' ' ' PRO . 29.1 tp 172.37 -49.54 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.434 0 O-C-N 123.995 0.81 . . . . 0.0 109.844 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 91' ' ' PRO . . . . . 0.653 ' HD2' ' N ' ' B' ' 90' ' ' LEU . 5.4 Cg_exo -31.9 -70.11 0.05 OUTLIER 'Trans proline' 0 C--N 1.367 1.505 0 C-N-CA 124.842 3.695 . . . . 0.0 115.341 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 26.8 p -83.81 -31.84 25.64 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -177.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 93' ' ' VAL . . . . . 0.452 ' H ' HG23 ' B' ' 93' ' ' VAL . 1.1 t -62.02 -22.49 28.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.943 0.401 . . . . 0.0 111.002 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 94' ' ' LEU . . . . . 0.691 ' HG ' HG12 ' B' ' 115' ' ' VAL . 2.8 tm? -67.97 -37.12 81.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.663 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.53 -47.32 79.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.978 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -83.48 -2.52 56.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.684 0.278 . . . . 0.0 111.717 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 97' ' ' LEU . . . . . 0.449 HD13 ' HE2' ' B' ' 107' ' ' PHE . 27.1 tp -86.84 -21.66 26.28 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.27 0.557 . . . . 0.0 110.055 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.442 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 103' ' ' CYS . . . . . 0.667 ' SG ' ' HB2' ' B' ' 106' ' ' CYS . 35.3 t . . . . . 0 C--O 1.234 0.279 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 104' ' ' ALA . . . . . 0.572 ' CB ' ' HB3' ' B' ' 121' ' ' LEU . . . -67.0 -40.14 87.26 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -178.17 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 8.0 t -75.94 29.94 0.11 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.168 0.508 . . . . 0.0 111.488 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 106' ' ' CYS . . . . . 0.667 ' HB2' ' SG ' ' B' ' 103' ' ' CYS . 44.6 t -118.73 -50.17 2.42 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.756 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 107' ' ' PHE . . . . . 0.47 ' HB3' HD13 ' B' ' 78' ' ' ILE . 0.1 OUTLIER -102.41 -46.0 4.92 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.35 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -70.26 30.13 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.487 -0.778 . . . . 0.0 112.727 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 109' ' ' GLU . . . . . 0.423 ' H ' ' C ' ' B' ' 107' ' ' PHE . 23.5 tt0 -69.06 -64.2 0.91 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.49 0.186 . . . . 0.0 110.581 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -76.15 -31.68 58.71 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 20.9 m80 -74.16 85.67 1.87 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.97 -1.014 . . . . 0.0 108.826 178.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 112' ' ' CYS . . . . . 0.473 ' SG ' ' HG3' ' B' ' 117' ' ' LYS . 4.5 t -151.0 71.58 1.03 Allowed 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.264 -0.574 . . . . 0.0 112.097 -177.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 113' ' ' HIS . . . . . . . . . . . . . 49.4 p-80 -128.64 -17.4 4.09 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 179.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -155.25 -73.18 0.01 OUTLIER Glycine 0 C--O 1.226 -0.396 0 C-N-CA 119.06 -1.543 . . . . 0.0 114.713 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 115' ' ' VAL . . . . . 0.691 HG12 ' HG ' ' B' ' 94' ' ' LEU . 2.8 t -58.42 -55.6 21.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -177.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 116' ' ' CYS . . . . . 0.446 ' SG ' HD11 ' B' ' 90' ' ' LEU . 1.0 OUTLIER -73.07 -19.86 61.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.831 0.348 . . . . 0.0 111.675 -179.607 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 117' ' ' LYS . . . . . 0.473 ' HG3' ' SG ' ' B' ' 112' ' ' CYS . 15.5 mttm -82.72 -24.44 33.58 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.877 178.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -63.43 -45.42 91.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.93 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -90.24 7.66 37.08 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.23 -0.441 . . . . 0.0 112.053 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 53.3 62.52 2.62 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.022 0.439 . . . . 0.0 110.683 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 121' ' ' LEU . . . . . 0.572 ' HB3' ' CB ' ' B' ' 104' ' ' ALA . 96.3 mt -110.13 -12.55 14.49 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -178.167 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 122' ' ' CYS . . . . . 0.438 ' SG ' ' HB3' ' B' ' 116' ' ' CYS . 1.8 p . . . . . 0 C--O 1.245 0.848 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.402 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 6.1 p . . . . . 0 CA--C 1.515 -0.387 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.21 -38.87 92.62 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.12 -12.69 60.01 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.438 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . . . -101.79 -38.57 7.8 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -179.511 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.924 HD13 HD13 ' A' ' 36' ' ' LEU . 10.9 tp -73.28 -35.06 45.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.42 0.628 . . . . 0.0 111.017 -179.244 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.34 -22.39 53.1 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.973 -1.012 . . . . 0.0 112.806 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -77.79 -29.38 54.93 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.349 -179.135 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.14 -17.37 52.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.65 0.262 . . . . 0.0 111.143 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.1 t -63.07 -46.34 96.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 CA-C-O 120.898 0.38 . . . . 0.0 110.733 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.7 -23.75 64.41 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.165 -0.471 . . . . 0.0 112.201 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -85.71 -23.91 27.19 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.551 0.691 . . . . 0.0 110.947 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.554 ' SG ' ' CD2' ' B' ' 113' ' ' HIS . 0.7 OUTLIER -86.17 -28.1 24.14 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.151 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.21 39.62 9.08 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.131 -1.033 . . . . 0.0 110.684 -179.042 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 143.63 178.16 19.17 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 -178.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.593 HD12 HG21 ' A' ' 32' ' ' VAL . 3.0 tp -129.47 121.81 54.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 117.871 0.836 . . . . 0.0 112.117 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.595 ' HB3' ' HD2' ' A' ' 30' ' ' PRO . 2.1 m-20 -140.45 -75.83 0.33 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.051 178.464 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.678 ' HG ' ' CG2' ' A' ' 54' ' ' VAL . 26.6 tp 172.26 -49.63 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.411 0 O-C-N 124.136 0.898 . . . . 0.0 111.354 179.303 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.723 ' HA ' HG11 ' A' ' 54' ' ' VAL . 5.4 Cg_endo -48.23 -63.66 0.3 Allowed 'Trans proline' 0 C--N 1.359 1.11 0 C-N-CA 123.093 2.529 . . . . 0.0 114.31 -179.206 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.424 ' HB3' ' O ' ' B' ' 113' ' ' HIS . 4.4 p -66.93 -37.87 85.12 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.41 -178.444 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.593 HG21 HD12 ' A' ' 27' ' ' ILE . 0.2 OUTLIER -70.57 -18.29 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.722 -178.486 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.554 HD22 ' HB ' ' A' ' 54' ' ' VAL . 58.9 tp -64.88 -21.7 66.86 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.722 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.34 -31.86 35.45 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -178.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -121.43 43.56 2.79 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.838 0.352 . . . . 0.0 110.744 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.924 HD13 HD13 ' A' ' 17' ' ' ILE . 14.3 tp -133.91 -6.2 2.77 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -178.575 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.412 ' O ' ' HB2' ' A' ' 38' ' ' ALA . 77.9 tttt -85.49 74.42 10.33 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 122.032 -0.418 . . . . 0.0 111.989 -179.289 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.412 ' HB2' ' O ' ' A' ' 37' ' ' LYS . . . 171.79 169.82 0.1 Allowed 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.124 0.569 . . . . 0.0 110.523 179.061 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.96 -39.32 87.21 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.456 ' H ' ' HG2' ' A' ' 40' ' ' GLU . 3.2 pt-20 -78.03 88.59 4.17 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 176.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.438 ' HA2' ' HB3' ' A' ' 16' ' ' ALA . . . 137.94 -39.53 1.59 Allowed Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 108.05 -2.02 . . . . 0.0 108.05 -176.125 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 1.1 m 55.07 93.38 0.02 OUTLIER 'General case' 0 C--O 1.235 0.325 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 176.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.5 ' HA ' ' HG ' ' A' ' 36' ' ' LEU . . . -70.59 -24.99 62.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.476 176.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.8 p -76.15 12.9 1.01 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.925 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 37.8 t -113.14 -56.35 2.42 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.08 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.616 ' CD2' HG12 ' A' ' 17' ' ' ILE . 1.1 t80 -77.03 -54.65 6.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.755 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.576 ' O ' ' HB2' ' A' ' 51' ' ' CYS . 53.9 m -68.49 6.23 0.86 Allowed 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -178.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -66.98 -71.02 0.22 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.279 0.561 . . . . 0.0 110.685 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.06 -17.56 58.67 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.372 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 21.9 m80 -113.08 83.26 1.8 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.481 -0.782 . . . . 0.0 109.943 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.576 ' HB2' ' O ' ' A' ' 47' ' ' CYS . 22.2 t -140.03 86.94 2.12 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.158 -0.617 . . . . 0.0 112.526 -178.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.699 ' O ' ' HB3' ' B' ' 92' ' ' CYS . 0.0 OUTLIER -144.11 -3.02 0.87 Allowed 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.022 0.439 . . . . 0.0 110.444 177.742 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.868 ' HA3' ' HB2' ' B' ' 91' ' ' PRO . . . -157.42 163.97 32.76 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-O 118.914 -0.936 . . . . 0.0 111.695 178.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.723 HG11 ' HA ' ' A' ' 30' ' ' PRO . 6.0 m 46.55 -64.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 115.377 1.621 . . . . 0.0 115.377 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.462 ' N ' ' O ' ' A' ' 53' ' ' GLY . 0.6 OUTLIER -63.04 -34.13 76.91 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 122.111 -0.368 . . . . 0.0 111.16 -178.676 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.0 pttp -70.58 -28.53 64.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.009 0.433 . . . . 0.0 110.321 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -65.83 -39.34 90.73 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.395 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.439 HD12 HD21 ' A' ' 33' ' ' LEU . 91.3 mt -87.24 4.21 43.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.74 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 58.5 m170 59.5 57.65 3.22 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 123.425 0.453 . . . . 0.0 111.809 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.412 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 80.4 mt -112.55 -2.68 14.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.02 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.452 ' SG ' ' HB3' ' A' ' 47' ' ' CYS . 6.3 p . . . . . 0 C--O 1.247 0.946 0 CA-C-O 117.907 -1.044 . . . . 0.0 109.513 179.171 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 74' ' ' CYS . . . . . 0.484 ' HB3' ' HB3' ' B' ' 106' ' ' CYS . 4.6 p . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.937 0.399 . . . . 0.0 110.774 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 75' ' ' ALA . . . . . 0.475 ' HA ' HG22 ' B' ' 78' ' ' ILE . . . -68.4 -5.67 20.32 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.539 -179.304 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.77 -27.39 63.89 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.359 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -128.79 -29.99 2.31 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 1.016 HD13 HD13 ' B' ' 97' ' ' LEU . 6.4 tp -73.68 -36.22 46.23 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 C-N-CA 120.634 -0.426 . . . . 0.0 111.309 -178.77 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.05 -34.02 71.45 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.869 -178.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -76.69 -33.83 45.78 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.381 -0.914 . . . . 0.0 111.297 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 81' ' ' ALA . . . . . 0.485 ' HB2' ' HB3' ' B' ' 96' ' ' ALA . . . -66.65 -24.81 66.34 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.687 0.28 . . . . 0.0 111.478 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 82' ' ' VAL . . . . . 0.576 HG22 HD13 ' B' ' 88' ' ' ILE . 91.6 t -58.23 -38.5 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-O 121.156 0.503 . . . . 0.0 110.663 179.452 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.79 -33.25 12.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.373 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.78 -19.15 64.3 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -179.122 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 85' ' ' CYS . . . . . 0.418 ' HB2' ' O ' ' B' ' 81' ' ' ALA . 0.8 OUTLIER -98.94 -1.01 41.03 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 121.21 -0.196 . . . . 0.0 111.506 -179.858 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 59.68 37.03 91.73 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.298 -179.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 143.35 137.81 3.33 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 110.106 -1.197 . . . . 0.0 110.106 -178.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 88' ' ' ILE . . . . . 0.576 HD13 HG22 ' B' ' 82' ' ' VAL . 3.4 tp -103.25 118.54 50.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 121.493 0.663 . . . . 0.0 112.639 -178.349 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -133.52 -83.54 0.46 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.261 -0.882 . . . . 0.0 108.876 178.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 90' ' ' LEU . . . . . 0.632 HD11 ' HB2' ' B' ' 116' ' ' CYS . 38.0 tp 176.85 -51.79 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.94 179.193 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 91' ' ' PRO . . . . . 0.868 ' HB2' ' HA3' ' A' ' 53' ' ' GLY . 4.0 Cg_exo -38.93 -60.99 0.43 Allowed 'Trans proline' 0 C--N 1.363 1.334 0 C-N-CA 123.66 2.907 . . . . 0.0 114.587 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 92' ' ' CYS . . . . . 0.699 ' HB3' ' O ' ' A' ' 52' ' ' HIS . 24.5 p -83.15 -33.02 26.34 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -178.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 93' ' ' VAL . . . . . 0.433 ' H ' HG23 ' B' ' 93' ' ' VAL . 1.8 t -59.24 -21.44 20.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.881 -178.382 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 94' ' ' LEU . . . . . 0.834 HD22 ' HB ' ' B' ' 115' ' ' VAL . 15.9 tp -63.17 -35.19 79.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.654 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.35 -28.91 70.09 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 96' ' ' ALA . . . . . 0.485 ' HB3' ' HB2' ' B' ' 81' ' ' ALA . . . -103.58 10.0 37.17 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.93 0.395 . . . . 0.0 111.375 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 97' ' ' LEU . . . . . 1.016 HD13 HD13 ' B' ' 78' ' ' ILE . 40.9 tp -93.81 -28.89 15.63 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.571 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 81.4 tttt . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.472 179.693 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.68 0 N-CA-C 110.892 -0.04 . . . . 0.0 110.892 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 104' ' ' ALA . . . . . 0.759 ' HB1' ' HB3' ' B' ' 121' ' ' LEU . . . 70.51 -59.69 0.52 Allowed 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 178.238 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 12.8 p -50.07 -43.84 51.49 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -178.482 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 106' ' ' CYS . . . . . 0.484 ' HB3' ' HB3' ' B' ' 74' ' ' CYS . 0.0 OUTLIER -52.35 -45.71 65.81 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.108 0.48 . . . . 0.0 111.711 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 107' ' ' PHE . . . . . 0.696 ' CD2' HG12 ' B' ' 78' ' ' ILE . 20.3 t80 -75.57 -60.88 2.11 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.339 -179.266 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 108' ' ' CYS . . . . . 0.65 ' HA ' ' HB2' ' B' ' 111' ' ' HIS . 38.1 m -78.84 43.54 0.5 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -178.103 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -74.99 -52.39 11.24 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -102.84 12.84 35.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.894 0.854 . . . . 0.0 108.737 178.268 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 111' ' ' HIS . . . . . 0.65 ' HB2' ' HA ' ' B' ' 108' ' ' CYS . 36.3 m80 -119.68 58.45 0.89 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.684 -179.057 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 72.0 m -110.61 61.73 0.61 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.02 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 113' ' ' HIS . . . . . 0.554 ' CD2' ' SG ' ' A' ' 24' ' ' CYS . 0.2 OUTLIER -138.24 -15.68 1.27 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.219 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 114' ' ' GLY . . . . . 0.418 ' O ' ' HG3' ' B' ' 117' ' ' LYS . . . -120.17 -145.08 7.34 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 119.8 -1.19 . . . . 0.0 113.86 -179.124 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 115' ' ' VAL . . . . . 0.834 ' HB ' HD22 ' B' ' 94' ' ' LEU . 20.2 m -46.16 -28.76 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -179.09 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 116' ' ' CYS . . . . . 0.632 ' HB2' HD11 ' B' ' 90' ' ' LEU . 2.8 t -71.23 -39.3 71.78 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -177.745 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 117' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' B' ' 114' ' ' GLY . 0.0 OUTLIER -77.28 -14.72 59.7 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.214 -179.949 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 118' ' ' ASP . . . . . 0.416 ' N ' ' HD3' ' B' ' 117' ' ' LYS . 12.3 t70 -70.0 -37.61 75.75 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.653 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 89.0 mt -94.89 6.95 47.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.417 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 56.5 m170 60.36 69.02 0.72 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.341 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 121' ' ' LEU . . . . . 0.759 ' HB3' ' HB1' ' B' ' 104' ' ' ALA . 98.3 mt -112.7 3.19 16.42 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 122' ' ' CYS . . . . . . . . . . . . . 25.3 p . . . . . 0 C--O 1.246 0.906 0 CA-C-O 118.028 -0.986 . . . . 0.0 109.874 178.078 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.914 ' HB3' HD12 ' A' ' 17' ' ' ILE . 24.0 m . . . . . 0 N--CA 1.467 0.401 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.67 -66.92 0.49 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.65 38.32 0.19 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -147.46 -52.02 0.2 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.102 0.477 . . . . 0.0 110.497 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.914 HD12 ' HB3' ' A' ' 13' ' ' CYS . 5.3 mt -83.81 -46.8 18.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.343 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.22 -20.09 60.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.137 0.494 . . . . 0.0 109.838 177.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -82.01 -34.94 22.81 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 111.291 -0.724 . . . . 0.0 111.291 178.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.91 -26.71 68.72 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 121.085 0.469 . . . . 0.0 110.881 179.161 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 17' ' ' ILE . 57.0 t -63.76 -45.24 97.8 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.299 179.115 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.42 -18.99 62.31 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.461 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.14 -47.07 15.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.775 0.322 . . . . 0.0 111.844 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.7 t -88.33 -15.31 36.03 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.93 -179.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 108.51 -63.15 0.28 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.216 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -122.53 155.36 17.0 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.334 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -86.38 141.89 13.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.06 0.457 . . . . 0.0 111.15 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.528 ' H ' HG21 ' A' ' 32' ' ' VAL . 26.6 t70 -163.97 -98.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 178.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.791 HD11 ' SG ' ' A' ' 55' ' ' CYS . 32.8 tp -174.07 -55.32 0.0 OUTLIER Pre-proline 0 C--O 1.222 -0.363 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 178.485 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.571 ' HA ' HG11 ' A' ' 54' ' ' VAL . 3.4 Cg_endo -47.74 -61.71 0.56 Allowed 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 122.786 2.324 . . . . 0.0 114.262 -178.397 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 13.0 p -76.6 -33.11 58.43 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.459 -178.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.528 HG21 ' H ' ' A' ' 28' ' ' ASP . 13.0 t -63.09 -26.22 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.727 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.578 ' HG ' HG22 ' A' ' 54' ' ' VAL . 3.1 tm? -55.56 -38.59 69.52 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.767 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -57.45 -41.92 81.46 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.284 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -98.35 12.28 35.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.263 0.554 . . . . 0.0 110.743 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.447 HD21 ' SG ' ' A' ' 47' ' ' CYS . 46.5 tp -99.34 -61.91 1.31 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.654 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.437 ' HB2' ' HE2' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -110.16 167.24 10.33 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.372 0.606 . . . . 0.0 111.539 -179.28 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -172.56 -112.05 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' A' ' 40' ' ' GLU . . . -92.26 73.08 5.37 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 176.192 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.405 ' HB2' ' O ' ' A' ' 39' ' ' ALA . 93.0 mt-10 71.22 92.16 0.09 Allowed 'General case' 0 N--CA 1.464 0.272 0 O-C-N 124.084 0.865 . . . . 0.0 109.707 -177.121 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -115.43 -173.73 17.67 Favored Glycine 0 C--N 1.33 0.209 0 C-N-CA 120.556 -0.831 . . . . 0.0 113.063 -179.008 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.423 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 57.3 m -82.56 62.41 6.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.751 0.31 . . . . 0.0 111.714 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -96.56 -7.59 34.1 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.809 0.338 . . . . 0.0 110.829 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.4 m -81.54 -16.27 52.24 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.886 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.423 ' SG ' ' HB3' ' A' ' 42' ' ' CYS . 6.3 p -98.48 -33.47 11.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.296 0.569 . . . . 0.0 111.131 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.736 ' HB2' ' CD1' ' A' ' 17' ' ' ILE . 0.9 OUTLIER -86.13 -60.99 1.85 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.665 -178.511 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.447 ' SG ' HD21 ' A' ' 36' ' ' LEU . 4.5 m -72.61 14.08 0.3 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.637 -177.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -51.84 -74.98 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 121.179 0.514 . . . . 0.0 110.457 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -84.86 -27.01 27.01 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 18.3 m80 -86.71 56.58 4.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.019 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.403 ' O ' ' HB2' ' A' ' 56' ' ' LYS . 7.6 t -108.37 39.62 1.94 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.243 0.544 . . . . 0.0 110.126 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.607 ' CD2' ' HB2' ' B' ' 89' ' ' ASP . 7.8 p-80 -117.82 -12.91 10.14 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.55 -179.19 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.529 ' HA3' HD23 ' A' ' 29' ' ' LEU . . . -95.32 -136.14 8.46 Favored Glycine 0 C--O 1.228 -0.226 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.812 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.578 HG22 ' HG ' ' A' ' 33' ' ' LEU . 2.2 p -70.19 -16.11 19.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 120.747 0.308 . . . . 0.0 111.561 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.791 ' SG ' HD11 ' A' ' 29' ' ' LEU . 89.2 m -72.21 -21.17 61.45 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.603 0.716 . . . . 0.0 109.112 176.566 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.519 ' HB3' ' O ' ' A' ' 53' ' ' GLY . 22.7 tptm -79.6 -20.38 47.04 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.474 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -59.44 -50.25 74.65 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.291 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.512 ' O ' HD23 ' A' ' 58' ' ' LEU . 5.7 tt -83.26 -29.37 28.47 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 9.6 t-160 64.26 55.86 1.4 Allowed 'General case' 0 C--O 1.235 0.301 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.04 179.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.52 20.4 16.13 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.473 179.078 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.244 0.805 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.541 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 74' ' ' CYS . . . . . 0.734 ' O ' ' HB ' ' B' ' 78' ' ' ILE . 8.5 p . . . . . 0 N--CA 1.475 0.818 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -88.87 -3.14 58.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.741 0.305 . . . . 0.0 110.86 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -98.74 22.76 9.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.214 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -163.58 -38.17 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.378 0.608 . . . . 0.0 110.285 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.734 ' HB ' ' O ' ' B' ' 74' ' ' CYS . 1.4 mt -83.66 -46.69 18.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.741 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.8 -29.27 68.41 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.883 0.373 . . . . 0.0 110.682 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.4 -35.71 28.79 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.045 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 81' ' ' ALA . . . . . 0.416 ' CB ' HG13 ' B' ' 93' ' ' VAL . . . -69.61 -26.57 64.5 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.181 0.515 . . . . 0.0 110.626 179.225 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 82' ' ' VAL . . . . . 0.498 HG23 ' O ' ' B' ' 78' ' ' ILE . 25.5 t -65.82 -43.14 93.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.567 178.457 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.38 -27.4 67.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.063 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.05 -44.57 46.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.651 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 73.0 m -83.43 -11.83 57.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.762 0.315 . . . . 0.0 110.725 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.3 42.6 10.34 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.605 -0.807 . . . . 0.0 113.171 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.05 176.71 14.51 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.56 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 7.4 tp -74.87 132.93 32.54 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 CA-C-O 121.388 0.613 . . . . 0.0 110.191 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 89' ' ' ASP . . . . . 0.607 ' HB2' ' CD2' ' A' ' 52' ' ' HIS . 32.5 t70 -152.9 -133.85 0.05 OUTLIER 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.479 -178.477 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 90' ' ' LEU . . . . . 0.874 HD11 ' HB2' ' B' ' 116' ' ' CYS . 31.9 tp 179.61 -57.4 0.0 OUTLIER Pre-proline 0 C--N 1.317 -0.826 0 C-N-CA 123.804 0.841 . . . . 0.0 110.129 179.151 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 91' ' ' PRO . . . . . 0.727 ' HD3' ' HB3' ' B' ' 90' ' ' LEU . 74.2 Cg_exo -51.77 -38.63 67.49 Favored 'Trans proline' 0 C--N 1.363 1.321 0 C-N-CA 122.347 2.031 . . . . 0.0 112.225 179.068 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 9.4 t -88.83 -40.43 13.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.676 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 93' ' ' VAL . . . . . 0.508 HG11 ' HE2' ' B' ' 107' ' ' PHE . 7.3 t -66.6 -23.4 31.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.779 -179.204 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 94' ' ' LEU . . . . . 0.586 ' HG ' HG22 ' B' ' 115' ' ' VAL . 2.7 tm? -50.35 -38.76 43.81 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 123.19 0.596 . . . . 0.0 111.929 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -42.67 -51.32 5.3 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -179.278 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -108.79 21.66 16.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.021 0.438 . . . . 0.0 111.07 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 97' ' ' LEU . . . . . 0.467 ' HB3' ' HA ' ' B' ' 94' ' ' LEU . 32.4 tp -105.25 -49.31 3.49 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.476 -179.073 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 98' ' ' LYS . . . . . 0.525 ' HG2' HD13 ' B' ' 94' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.275 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -178.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 103' ' ' CYS . . . . . 0.454 ' HA ' ' HB3' ' B' ' 74' ' ' CYS . 58.5 m . . . . . 0 N--CA 1.451 -0.415 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -66.65 -16.24 64.06 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.445 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 19.8 m -72.95 -39.45 66.17 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.623 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 13.4 p -63.6 -24.77 67.93 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 122.077 0.941 . . . . 0.0 109.679 179.049 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 107' ' ' PHE . . . . . 0.648 ' HB2' HD13 ' B' ' 78' ' ' ILE . 0.8 OUTLIER -88.81 -69.94 0.68 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.099 -1.41 . . . . 0.0 111.959 -178.87 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 108' ' ' CYS . . . . . 0.401 ' O ' ' HB2' ' B' ' 112' ' ' CYS . 82.5 m -74.27 28.42 0.08 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -177.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -53.69 -69.73 0.11 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.17 0.51 . . . . 0.0 110.266 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -89.93 -35.16 15.74 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.499 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -79.51 70.71 6.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.763 179.32 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 112' ' ' CYS . . . . . 0.401 ' HB2' ' O ' ' B' ' 108' ' ' CYS . 13.0 t -127.46 54.68 1.65 Allowed 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.924 -178.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 113' ' ' HIS . . . . . 0.428 ' HE1' ' HB3' ' A' ' 28' ' ' ASP . 0.1 OUTLIER -129.95 -12.38 4.2 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -179.843 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -94.69 -142.95 13.15 Favored Glycine 0 C--O 1.228 -0.272 0 C-N-CA 120.442 -0.885 . . . . 0.0 113.333 -179.182 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 115' ' ' VAL . . . . . 0.706 HG11 ' HA ' ' B' ' 91' ' ' PRO . 14.6 p -62.86 -15.46 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-O 121.142 0.496 . . . . 0.0 111.605 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 116' ' ' CYS . . . . . 0.874 ' HB2' HD11 ' B' ' 90' ' ' LEU . 6.8 t -76.19 -22.83 54.84 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.408 0.623 . . . . 0.0 109.76 178.385 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 117' ' ' LYS . . . . . 0.463 ' O ' ' HG3' ' B' ' 117' ' ' LYS . 13.5 tptt -79.16 -19.33 51.25 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.134 179.33 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -57.01 -41.55 78.69 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.2 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 119' ' ' LEU . . . . . 0.525 HD22 HD23 ' B' ' 121' ' ' LEU . 5.7 tt -86.19 -29.58 23.09 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 65.51 75.03 0.36 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.721 179.039 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 121' ' ' LEU . . . . . 0.525 HD23 HD22 ' B' ' 119' ' ' LEU . 0.4 OUTLIER -124.33 7.59 8.42 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.586 -0.733 . . . . 0.0 111.522 -179.701 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 122' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.244 0.803 0 CA-C-O 118.545 -0.741 . . . . 0.0 110.461 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.882 ' HB2' HD12 ' A' ' 17' ' ' ILE . 8.4 p . . . . . 0 N--CA 1.47 0.537 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -112.09 16.45 20.19 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 120.934 0.397 . . . . 0.0 110.547 178.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -91.46 -82.61 0.3 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.028 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.99 -27.72 60.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.945 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.882 HD12 ' HB2' ' A' ' 13' ' ' CYS . 49.2 mt -74.08 -46.84 44.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.69 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' A' ' 14' ' ' ALA . . . -82.18 -15.89 51.64 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.197 179.504 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -82.79 -33.64 23.92 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.115 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.531 ' HB3' HG13 ' A' ' 32' ' ' VAL . . . -74.28 -13.5 60.78 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.831 0.348 . . . . 0.0 110.914 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 17' ' ' ILE . 78.7 t -64.34 -39.46 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.043 179.03 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.92 -31.18 67.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.112 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.13 -43.76 66.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.688 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.431 ' HB3' ' CG ' ' B' ' 113' ' ' HIS . 56.6 m -82.42 -19.34 39.21 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.099 -179.588 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.14 59.1 3.01 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 -179.054 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 122.0 156.63 9.75 Favored Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -177.554 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.516 HG12 ' N ' ' A' ' 28' ' ' ASP . 5.0 tt -98.87 147.08 7.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 118.125 0.963 . . . . 0.0 112.484 -178.601 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.516 ' N ' HG12 ' A' ' 27' ' ' ILE . 34.4 t0 -161.42 -106.13 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.48 -1.236 . . . . 0.0 107.967 179.133 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.717 HD11 ' HB2' ' A' ' 55' ' ' CYS . 40.2 tp -174.5 -47.94 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 178.423 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.63 ' HD2' ' H ' ' A' ' 29' ' ' LEU . 11.1 Cg_endo -54.52 -15.3 8.6 Favored 'Trans proline' 0 C--N 1.358 1.031 0 C-N-CA 122.959 2.44 . . . . 0.0 114.593 -178.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.553 ' HB2' ' O ' ' B' ' 113' ' ' HIS . 11.0 t -117.89 -31.72 5.01 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.275 0.56 . . . . 0.0 110.744 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.531 HG13 ' HB3' ' A' ' 20' ' ' ALA . 1.7 t -73.26 -9.17 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-N 115.74 -0.663 . . . . 0.0 112.375 -178.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.781 HD13 ' HB ' ' A' ' 54' ' ' VAL . 1.5 pt? -71.87 -14.82 62.06 Favored 'General case' 0 CA--C 1.531 0.25 0 O-C-N 122.221 -0.299 . . . . 0.0 111.64 -179.541 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -56.72 -55.09 38.62 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.876 0.37 . . . . 0.0 111.844 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -89.26 16.72 6.91 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.651 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.0 tp -112.69 -0.25 15.12 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.708 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.563 ' HD3' HD21 ' A' ' 58' ' ' LEU . 26.6 ttpt -98.55 154.52 17.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.256 -179.396 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 71.89 63.12 0.14 Allowed 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.587 0.755 . . . . 0.0 111.607 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -163.39 163.05 25.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.639 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -84.31 70.52 10.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.025 0.44 . . . . 0.0 110.025 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.715 ' HA2' HD22 ' A' ' 60' ' ' LEU . . . 89.34 -111.18 3.8 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.493 -0.861 . . . . 0.0 111.887 -179.439 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 81.1 m 73.09 -34.93 0.31 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.237 0.615 . . . . 0.0 112.318 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.435 ' HB1' ' SG ' ' A' ' 47' ' ' CYS . . . -79.49 17.16 0.9 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.426 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.4 m -66.82 -59.12 3.81 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.768 0.318 . . . . 0.0 110.763 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -66.91 -24.98 66.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.662 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.786 ' HB2' HD13 ' A' ' 17' ' ' ILE . 1.0 OUTLIER -81.4 -72.75 0.41 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.523 -178.948 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.449 ' HB3' ' O ' ' A' ' 50' ' ' HIS . 23.7 m -78.44 39.88 0.34 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.4 -178.303 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -73.05 -54.23 9.07 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.979 0.895 . . . . 0.0 109.161 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -87.84 -9.31 54.19 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.364 -1.289 . . . . 0.0 109.682 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.449 ' O ' ' HB3' ' A' ' 47' ' ' CYS . 15.6 m80 -109.98 90.97 3.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.314 -178.499 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 72.9 m -136.4 55.28 1.85 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.65 ' HB2' ' OD2' ' B' ' 89' ' ' ASP . 40.8 m80 -115.68 -54.73 2.49 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.356 178.385 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 55' ' ' CYS . . . -134.63 -171.62 12.56 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-O 119.171 -0.794 . . . . 0.0 112.059 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.781 ' HB ' HD13 ' A' ' 33' ' ' LEU . 14.2 m 43.75 -62.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 N-CA-C 115.97 1.841 . . . . 0.0 115.97 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.717 ' HB2' HD11 ' A' ' 29' ' ' LEU . 15.7 t -70.16 -44.56 68.56 Favored 'General case' 0 C--N 1.322 -0.601 0 O-C-N 121.641 -0.662 . . . . 0.0 111.457 -179.032 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.526 ' HE3' ' HB2' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -81.13 12.68 3.26 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.958 179.403 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -76.94 -27.57 54.89 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 175.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.563 HD21 ' HD3' ' A' ' 37' ' ' LYS . 32.3 mt -98.51 -16.49 19.15 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 113.596 -1.638 . . . . 0.0 108.981 177.423 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 64.89 82.45 0.19 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.91 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.715 HD22 ' HA2' ' A' ' 41' ' ' GLY . 87.2 mt -125.15 -7.42 7.11 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -178.662 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 26.3 p . . . . . 0 C--O 1.245 0.836 0 CA-C-O 118.41 -0.805 . . . . 0.0 110.591 178.67 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 74' ' ' CYS . . . . . 0.525 ' HB2' HD12 ' B' ' 78' ' ' ILE . 18.1 p . . . . . 0 N--CA 1.47 0.55 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.97 4.3 23.13 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 120.997 0.427 . . . . 0.0 110.897 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.8 -76.33 0.09 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.426 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 77' ' ' ALA . . . . . 0.527 ' HB1' ' O ' ' B' ' 96' ' ' ALA . . . -93.85 -10.06 35.22 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -178.621 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.67 HD13 ' HB2' ' B' ' 107' ' ' PHE . 40.8 mt -89.17 -47.38 15.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.661 -179.176 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.83 -18.27 38.18 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.923 0.392 . . . . 0.0 111.229 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.8 -25.69 62.05 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.336 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 81' ' ' ALA . . . . . 0.779 ' HB2' ' HB3' ' B' ' 96' ' ' ALA . . . -82.93 -9.99 59.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.972 0.415 . . . . 0.0 111.027 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 69.2 t -68.31 -37.16 77.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.998 179.199 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -79.79 10.17 4.41 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.444 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -109.73 -48.2 3.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.968 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 63.1 m -88.94 -9.57 51.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.329 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.78 44.39 6.09 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.686 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 132.6 173.81 13.42 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.056 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 88' ' ' ILE . . . . . 0.519 HG12 ' N ' ' B' ' 89' ' ' ASP . 0.0 OUTLIER -77.05 136.86 23.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.049 0.452 . . . . 0.0 110.936 179.714 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 89' ' ' ASP . . . . . 0.65 ' OD2' ' HB2' ' A' ' 52' ' ' HIS . 40.5 t0 -153.87 -122.96 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.525 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 90' ' ' LEU . . . . . 0.728 ' HB3' ' HD3' ' B' ' 91' ' ' PRO . 41.5 tp 173.02 -57.81 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 124.318 1.047 . . . . 0.0 109.6 179.202 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 91' ' ' PRO . . . . . 0.728 ' HD3' ' HB3' ' B' ' 90' ' ' LEU . 51.8 Cg_exo -54.19 -25.52 38.34 Favored 'Trans proline' 0 C--N 1.363 1.323 0 C-N-CA 122.684 2.256 . . . . 0.0 112.992 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 29.9 t -107.94 -34.61 6.86 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.18 0.514 . . . . 0.0 110.329 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 93' ' ' VAL . . . . . 0.673 HG13 ' HB3' ' B' ' 81' ' ' ALA . 38.6 t -70.42 -16.62 20.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.821 -179.043 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 94' ' ' LEU . . . . . 0.793 HD13 ' HB ' ' B' ' 115' ' ' VAL . 1.2 pt? -61.45 -18.02 57.03 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 122.25 -0.281 . . . . 0.0 111.743 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.53 -34.2 73.78 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 96' ' ' ALA . . . . . 0.779 ' HB3' ' HB2' ' B' ' 81' ' ' ALA . . . -100.64 -3.49 30.27 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.862 0.363 . . . . 0.0 110.643 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 23.6 tp -92.99 3.07 56.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.379 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt . . . . . 0 C--O 1.235 0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.405 179.574 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 79.0 m . . . . . 0 N--CA 1.466 0.347 0 CA-C-O 120.732 0.301 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 104' ' ' ALA . . . . . 0.549 ' HB1' ' HB2' ' B' ' 108' ' ' CYS . . . -102.68 20.38 17.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.409 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -69.36 -31.77 70.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.83 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 4.2 p -101.97 -29.37 11.84 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.255 0.55 . . . . 0.0 110.29 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 107' ' ' PHE . . . . . 0.67 ' HB2' HD13 ' B' ' 78' ' ' ILE . 1.0 OUTLIER -81.99 -90.86 0.07 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.985 -178.228 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 108' ' ' CYS . . . . . 0.549 ' HB2' ' HB1' ' B' ' 104' ' ' ALA . 36.2 m -70.44 40.99 0.05 Allowed 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 -178.58 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 109' ' ' GLU . . . . . 0.4 ' HA ' ' OE1' ' B' ' 109' ' ' GLU . 4.9 tp10 -77.23 -53.51 7.65 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.48 0.657 . . . . 0.0 109.455 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -97.96 1.08 47.55 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.744 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 10.0 m80 -112.33 88.89 2.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.47 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 71.0 m -135.78 46.79 2.31 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 114.665 1.358 . . . . 0.0 114.665 -177.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 113' ' ' HIS . . . . . 0.553 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 2.9 p80 -135.24 -0.46 2.72 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 118.994 -1.082 . . . . 0.0 111.982 177.416 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 114' ' ' GLY . . . . . 0.453 ' HA3' ' HB2' ' A' ' 30' ' ' PRO . . . -154.64 145.9 13.47 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 119.914 -1.136 . . . . 0.0 112.664 179.06 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 115' ' ' VAL . . . . . 0.793 ' HB ' HD13 ' B' ' 94' ' ' LEU . 27.6 m 50.28 -48.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 C-N-CA 126.648 1.979 . . . . 0.0 115.936 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 116' ' ' CYS . . . . . 0.617 ' HB2' HD11 ' B' ' 90' ' ' LEU . 3.9 t -73.84 -25.65 60.18 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 121.543 -0.723 . . . . 0.0 110.094 -179.355 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 19.3 ttmt -77.58 -22.89 50.25 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.422 178.262 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -64.2 -40.16 95.5 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.043 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 43.1 mt -81.84 -22.6 36.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.14 178.126 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 64.91 79.89 0.24 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.226 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 86.5 mt -123.82 -6.59 7.94 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -178.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 122' ' ' CYS . . . . . . . . . . . . . 26.1 p . . . . . 0 C--O 1.245 0.818 0 CA-C-O 118.473 -0.775 . . . . 0.0 110.59 179.111 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.747 ' HB2' HD12 ' A' ' 17' ' ' ILE . 11.7 p . . . . . 0 N--CA 1.467 0.394 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.84 -26.85 62.6 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -177.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -109.4 29.03 7.93 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.387 -0.525 . . . . 0.0 112.019 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -151.03 -53.12 0.14 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.222 0.534 . . . . 0.0 110.93 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.747 HD12 ' HB2' ' A' ' 13' ' ' CYS . 73.6 mt -74.69 -42.64 47.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.329 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.79 -30.99 72.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.458 178.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.9 -30.83 37.37 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.649 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.28 -24.18 63.0 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 121.031 0.443 . . . . 0.0 110.381 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 17' ' ' ILE . 49.7 t -65.26 -46.55 90.34 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.669 178.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.69 -18.12 62.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.16 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -81.17 -51.04 8.86 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.165 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 49.1 t -76.01 -33.79 59.69 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.913 0.387 . . . . 0.0 110.132 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.18 36.29 2.54 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.47 -0.872 . . . . 0.0 112.532 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 147.73 152.57 5.71 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.127 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -81.9 132.58 31.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.288 0.566 . . . . 0.0 109.767 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.414 ' HB2' ' NE2' ' B' ' 113' ' ' HIS . 46.8 t0 -158.85 -115.45 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.41 -178.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.661 HD21 ' HB2' ' A' ' 55' ' ' CYS . 35.0 tp -174.95 -57.47 0.0 OUTLIER Pre-proline 0 C--O 1.22 -0.48 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.16 178.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.908 ' HA ' HG11 ' A' ' 54' ' ' VAL . 1.0 OUTLIER -45.42 -52.71 6.3 Favored 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 122.959 2.439 . . . . 0.0 114.117 -178.971 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 19.7 p -84.08 -35.7 23.56 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.087 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.425 HG23 ' H ' ' A' ' 32' ' ' VAL . 3.5 t -63.45 -29.78 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.161 -179.33 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.425 HD22 HG13 ' A' ' 54' ' ' VAL . 29.9 tp -63.53 -32.28 73.69 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.086 0.469 . . . . 0.0 110.515 179.415 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.83 -37.55 79.24 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.07 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.53 -9.25 58.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.115 0.484 . . . . 0.0 110.601 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 23.8 tp -76.09 -6.93 53.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.453 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -86.01 5.37 33.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.102 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.66 -4.77 47.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.967 0.413 . . . . 0.0 110.354 178.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -147.17 175.46 10.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.703 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -87.14 120.05 28.01 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.53 0.205 . . . . 0.0 110.866 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.71 -105.79 1.27 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.988 179.154 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER 64.04 15.72 9.44 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.082 0.553 . . . . 0.0 111.175 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -97.05 -6.81 34.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.048 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 40.7 t -66.12 -9.44 31.4 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.22 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.535 ' HB3' ' HB3' ' A' ' 13' ' ' CYS . 33.6 t -118.95 -31.8 4.66 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.309 0.575 . . . . 0.0 110.151 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.572 ' HB2' ' CD1' ' A' ' 17' ' ' ILE . 0.6 OUTLIER -73.88 -78.55 0.09 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.327 -0.851 . . . . 0.0 113.228 -178.496 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.549 ' HA ' ' HB2' ' A' ' 50' ' ' HIS . 84.9 m -72.99 27.29 0.06 Allowed 'General case' 0 C--O 1.219 -0.505 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -176.278 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -67.61 -61.82 1.71 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 118.953 0.797 . . . . 0.0 109.762 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -91.14 -7.46 51.49 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.398 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.549 ' HB2' ' HA ' ' A' ' 47' ' ' CYS . 62.2 m-70 -107.73 62.24 0.62 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.497 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.517 ' O ' ' HB3' ' A' ' 56' ' ' LYS . 62.6 m -95.95 33.56 1.68 Allowed 'General case' 0 C--N 1.327 -0.393 0 O-C-N 122.031 -0.418 . . . . 0.0 110.908 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.69 ' ND1' ' HB3' ' B' ' 92' ' ' CYS . 27.6 p80 -129.82 157.71 41.47 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.732 0.301 . . . . 0.0 110.782 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.893 ' HA3' ' HB2' ' B' ' 91' ' ' PRO . . . 92.43 -132.99 11.52 Favored Glycine 0 C--O 1.227 -0.34 0 C-N-CA 120.494 -0.86 . . . . 0.0 113.267 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.908 HG11 ' HA ' ' A' ' 30' ' ' PRO . 8.9 p -78.01 -21.74 13.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 122.562 -0.375 . . . . 0.0 111.881 -178.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.661 ' HB2' HD21 ' A' ' 29' ' ' LEU . 7.5 t -77.03 -28.86 55.04 Favored 'General case' 0 C--O 1.224 -0.285 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.747 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.55 ' HG3' ' O ' ' A' ' 53' ' ' GLY . 0.0 OUTLIER -73.96 -31.19 62.91 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.0 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -69.61 -56.33 7.58 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.037 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.453 HD22 ' HA ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -94.7 65.6 3.09 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 106.579 -1.638 . . . . 0.0 106.579 176.363 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 20.3 t60 -35.42 124.44 0.64 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 114.238 -1.347 . . . . 0.0 113.968 -176.497 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 13.7 mt -146.37 21.84 1.34 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.793 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 8.9 p . . . . . 0 C--O 1.245 0.825 0 CA-C-O 118.124 -0.941 . . . . 0.0 110.756 178.425 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 74' ' ' CYS . . . . . 0.928 ' HB3' HD12 ' B' ' 78' ' ' ILE . 21.9 m . . . . . 0 N--CA 1.468 0.473 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -73.23 -59.98 2.45 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -80.46 48.03 0.99 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.945 0.402 . . . . 0.0 111.509 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -162.18 -53.74 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.877 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.928 HD12 ' HB3' ' B' ' 74' ' ' CYS . 51.7 mt -92.94 -49.15 13.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.395 -179.305 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.48 -19.36 65.53 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.669 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -75.66 -24.32 70.39 Favored Glycine 0 N--CA 1.452 -0.28 0 N-CA-C 111.53 -0.628 . . . . 0.0 111.53 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 81' ' ' ALA . . . . . 0.83 ' HB2' ' HB3' ' B' ' 96' ' ' ALA . . . -80.94 -30.22 35.28 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.021 0.439 . . . . 0.0 110.469 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 32.0 t -56.76 -40.86 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.904 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.54 -34.62 78.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.543 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.61 -28.23 56.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.997 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 15.7 m -94.15 -14.9 25.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.745 -178.738 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.67 31.43 60.54 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.246 -178.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 152.46 151.7 5.74 Favored Glycine 0 N--CA 1.449 -0.47 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.76 129.76 55.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.726 0.774 . . . . 0.0 111.786 -178.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 89' ' ' ASP . . . . . 0.666 ' H ' HG21 ' B' ' 93' ' ' VAL . 28.4 m-20 -144.8 -82.73 0.15 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.462 -1.245 . . . . 0.0 108.526 178.551 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 90' ' ' LEU . . . . . 0.688 HD11 ' HB2' ' B' ' 116' ' ' CYS . 51.9 tp 179.44 -54.38 0.0 OUTLIER Pre-proline 0 C--O 1.227 -0.13 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.292 178.64 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 91' ' ' PRO . . . . . 0.893 ' HB2' ' HA3' ' A' ' 53' ' ' GLY . 4.9 Cg_exo -38.53 -65.94 0.15 Allowed 'Trans proline' 0 C--N 1.361 1.225 0 C-N-CA 123.487 2.792 . . . . 0.0 114.31 -179.014 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 92' ' ' CYS . . . . . 0.69 ' HB3' ' ND1' ' A' ' 52' ' ' HIS . 1.5 t -82.04 -31.42 30.93 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -179.066 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 93' ' ' VAL . . . . . 0.666 HG21 ' H ' ' B' ' 89' ' ' ASP . 1.5 t -64.81 -16.31 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-O 120.804 0.335 . . . . 0.0 111.761 -179.285 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 94' ' ' LEU . . . . . 0.564 HD22 HG13 ' B' ' 115' ' ' VAL . 22.7 tp -73.5 -19.12 61.01 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.859 0.361 . . . . 0.0 111.008 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.07 -53.21 60.84 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.114 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 96' ' ' ALA . . . . . 0.83 ' HB3' ' HB2' ' B' ' 81' ' ' ALA . . . -75.96 -14.15 60.24 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 111.617 0.228 . . . . 0.0 111.617 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 97' ' ' LEU . . . . . 0.423 HD23 HD12 ' B' ' 94' ' ' LEU . 17.6 tp -72.69 -28.74 62.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.979 0.419 . . . . 0.0 110.051 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp . . . . . 0 C--N 1.332 -0.195 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.216 178.881 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 36.3 m . . . . . 0 N--CA 1.465 0.286 0 CA-C-O 121.407 0.623 . . . . 0.0 110.502 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 104' ' ' ALA . . . . . 0.729 ' HB1' ' HB2' ' B' ' 108' ' ' CYS . . . -95.63 -6.55 39.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.451 -179.578 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 26.6 p -63.26 -20.3 65.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.998 0.428 . . . . 0.0 111.797 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 24.7 p -106.8 -29.2 9.67 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.294 0.569 . . . . 0.0 111.101 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 107' ' ' PHE . . . . . 0.77 ' HB2' HD13 ' B' ' 78' ' ' ILE . 1.0 OUTLIER -100.88 -79.72 0.5 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -177.518 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 108' ' ' CYS . . . . . 0.729 ' HB2' ' HB1' ' B' ' 104' ' ' ALA . 1.8 m -67.45 24.19 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -177.117 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -81.36 -68.31 0.7 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 118.583 0.629 . . . . 0.0 109.715 178.234 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -73.36 -15.02 61.39 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 177.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 111' ' ' HIS . . . . . 0.447 ' HB3' HD22 ' B' ' 90' ' ' LEU . 21.1 m80 -110.07 65.88 0.62 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.421 -1.263 . . . . 0.0 107.973 178.311 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 36.6 t -106.45 49.46 0.8 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.95 0.405 . . . . 0.0 111.757 -177.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 113' ' ' HIS . . . . . 0.483 ' HA ' ' HG2' ' B' ' 117' ' ' LYS . 18.1 p-80 -156.55 -165.74 1.96 Allowed 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.172 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . 64.64 -137.73 39.69 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.977 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 115' ' ' VAL . . . . . 0.564 HG13 HD22 ' B' ' 94' ' ' LEU . 11.3 p -79.66 -16.71 13.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.814 0.34 . . . . 0.0 111.076 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 116' ' ' CYS . . . . . 0.688 ' HB2' HD11 ' B' ' 90' ' ' LEU . 2.1 t -57.92 -59.75 4.77 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 120.808 0.337 . . . . 0.0 110.716 178.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 117' ' ' LYS . . . . . 0.483 ' HG2' ' HA ' ' B' ' 113' ' ' HIS . 45.3 pttt -101.4 31.94 3.52 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.742 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 118' ' ' ASP . . . . . 0.475 ' HB2' ' HA ' ' B' ' 115' ' ' VAL . 10.3 t70 -54.44 -39.16 67.11 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 178.146 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 119' ' ' LEU . . . . . 0.608 ' O ' ' HB2' ' B' ' 120' ' ' HIS . 3.3 mm? -103.32 -52.66 2.97 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 174.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 120' ' ' HIS . . . . . 0.608 ' HB2' ' O ' ' B' ' 119' ' ' LEU . 42.3 t60 153.6 129.26 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.862 0 O-C-N 124.951 1.407 . . . . 0.0 110.422 176.821 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 121' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' B' ' 120' ' ' HIS . 14.4 mt -160.33 41.26 0.18 Allowed 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 122' ' ' CYS . . . . . 0.426 ' HB3' ' O ' ' B' ' 108' ' ' CYS . 1.4 p . . . . . 0 C--O 1.246 0.9 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.711 178.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 13.0 p . . . . . 0 CA--C 1.528 0.101 0 CA-C-O 120.836 0.35 . . . . 0.0 111.409 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.676 ' HA ' HG22 ' A' ' 17' ' ' ILE . . . -64.85 -19.49 65.91 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.228 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.09 0.82 23.2 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -132.19 -22.48 2.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.777 0.322 . . . . 0.0 111.76 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.676 HG22 ' HA ' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -92.93 -44.58 13.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.945 0.403 . . . . 0.0 111.484 -178.923 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.18 -32.38 66.39 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.769 -178.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.98 -24.04 74.86 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.313 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.798 ' HB2' ' HB3' ' A' ' 35' ' ' ALA . . . -83.92 -24.79 30.6 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 120.821 0.343 . . . . 0.0 111.039 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 17' ' ' ILE . 86.8 t -66.36 -46.65 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.551 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.34 -28.38 65.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.462 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -75.84 -44.9 38.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 112.061 -179.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.8 t -84.87 -37.28 20.84 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.729 0.299 . . . . 0.0 110.869 -179.173 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.99 48.9 1.3 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.405 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 143.67 -179.51 21.03 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.217 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.547 HD13 HD11 ' A' ' 17' ' ' ILE . 6.0 tp -113.23 117.23 54.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.489 0.661 . . . . 0.0 111.988 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.63 ' H ' HG21 ' A' ' 32' ' ' VAL . 30.6 t0 -134.28 -108.89 0.22 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.784 ' HG ' HG22 ' A' ' 54' ' ' VAL . 41.0 tp -175.01 -57.03 0.0 OUTLIER Pre-proline 0 C--O 1.223 -0.326 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.291 178.672 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.717 ' HA ' HG21 ' A' ' 54' ' ' VAL . 2.3 Cg_endo -46.24 -60.18 0.95 Allowed 'Trans proline' 0 C--N 1.361 1.231 0 C-N-CA 123.005 2.47 . . . . 0.0 114.357 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 19.9 p -79.41 -33.84 42.29 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.655 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.63 HG21 ' H ' ' A' ' 28' ' ' ASP . 2.4 t -67.1 -17.62 22.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.552 -179.379 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 30.0 tp -64.26 -26.13 68.36 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.495 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.37 -59.73 4.2 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -178.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.798 ' HB3' ' HB2' ' A' ' 20' ' ' ALA . . . -75.15 -17.0 60.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.747 0.308 . . . . 0.0 111.791 -179.107 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.507 HD22 ' CD2' ' A' ' 46' ' ' PHE . 32.8 tp -75.16 -10.33 59.37 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.931 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -74.4 93.13 2.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.894 0.378 . . . . 0.0 110.363 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -111.22 -5.55 14.69 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.698 -179.094 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 72.69 -61.92 0.48 Allowed 'General case' 0 N--CA 1.473 0.694 0 O-C-N 123.989 0.806 . . . . 0.0 113.02 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -60.67 -69.11 0.24 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.834 0.35 . . . . 0.0 111.826 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 42' ' ' CYS . . . -156.16 -139.63 2.79 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.146 -1.026 . . . . 0.0 112.779 -179.438 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 41' ' ' GLY . 96.5 m 73.17 8.81 5.31 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.16 0.584 . . . . 0.0 111.197 -179.581 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -95.51 -21.76 18.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.869 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.7 p -79.89 11.51 3.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.488 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 46.8 t -109.65 -62.29 1.52 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.507 ' CD2' HD22 ' A' ' 36' ' ' LEU . 0.8 OUTLIER -67.48 -59.28 3.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.713 178.697 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.622 ' HA ' ' HB2' ' A' ' 50' ' ' HIS . 87.9 m -74.6 15.54 0.35 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -55.86 -52.55 63.67 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.334 0.587 . . . . 0.0 110.386 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -94.79 -20.07 19.8 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.914 178.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.622 ' HB2' ' HA ' ' A' ' 47' ' ' CYS . 39.8 m80 -98.56 72.56 2.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.443 -179.506 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 97.0 m -92.16 -2.16 56.73 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -178.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 1.015 ' HA ' ' HB3' ' A' ' 56' ' ' LYS . 9.6 p80 -117.2 -160.16 0.76 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 119.808 -0.757 . . . . 0.0 111.112 179.243 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 68.47 -130.99 26.58 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.571 -0.823 . . . . 0.0 111.794 -178.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.784 HG22 ' HG ' ' A' ' 29' ' ' LEU . 30.0 m -75.97 -18.99 15.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.858 0.329 . . . . 0.0 111.633 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.499 ' HB2' HD11 ' A' ' 29' ' ' LEU . 1.4 t -82.57 -23.29 34.53 Favored 'General case' 0 C--O 1.216 -0.691 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.184 -179.08 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 1.015 ' HB3' ' HA ' ' A' ' 52' ' ' HIS . 0.0 OUTLIER -77.58 -13.39 59.92 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.352 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -90.45 -59.86 2.07 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.749 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 20.6 tp -80.12 -75.58 0.25 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.592 0.234 . . . . 0.0 111.316 -179.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 58.1 m-70 -90.28 -129.5 0.09 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 60' ' ' LEU . 8.1 tp -169.83 -87.56 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 177.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.592 ' HB3' ' O ' ' A' ' 47' ' ' CYS . 1.8 p . . . . . 0 C--O 1.245 0.82 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.651 178.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 31.7 p . . . . . 0 CA--C 1.515 -0.404 0 N-CA-C 111.634 0.235 . . . . 0.0 111.634 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 75' ' ' ALA . . . . . 0.476 ' HA ' HG22 ' B' ' 78' ' ' ILE . . . -59.21 -35.66 74.0 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 123.253 0.345 . . . . 0.0 111.209 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -74.11 -0.53 16.87 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 77' ' ' ALA . . . . . 0.463 ' O ' ' HA ' ' B' ' 97' ' ' LEU . . . -124.66 -12.73 7.13 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.539 HG13 ' CD2' ' B' ' 107' ' ' PHE . 0.0 OUTLIER -106.5 -46.54 8.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.097 0.475 . . . . 0.0 110.91 -179.238 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -56.91 -23.47 45.17 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.947 -179.049 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -75.39 -25.26 68.62 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.403 -0.904 . . . . 0.0 112.151 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -82.21 -16.9 48.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.763 0.316 . . . . 0.0 111.348 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 82' ' ' VAL . . . . . 0.401 HG22 HD13 ' B' ' 88' ' ' ILE . 59.6 t -62.46 -45.78 97.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-O 121.033 0.444 . . . . 0.0 110.77 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.87 -31.19 70.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.473 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.19 -36.27 79.3 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.516 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 26.6 m -92.99 -12.27 31.1 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 69.55 42.27 73.2 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.488 -0.863 . . . . 0.0 111.319 -178.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 151.81 137.66 2.65 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 88' ' ' ILE . . . . . 0.401 HD13 HG22 ' B' ' 82' ' ' VAL . 2.9 tp -91.23 114.1 27.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.34 0.59 . . . . 0.0 111.944 -179.252 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 89' ' ' ASP . . . . . 0.588 ' H ' HG21 ' B' ' 93' ' ' VAL . 0.9 OUTLIER -130.44 -91.91 0.44 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.641 179.038 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 90' ' ' LEU . . . . . 0.456 ' HG ' ' CG2' ' B' ' 115' ' ' VAL . 10.8 tp 175.93 -54.4 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.481 0 C-N-CA 123.484 0.714 . . . . 0.0 110.357 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 91' ' ' PRO . . . . . 0.85 ' HA ' HG21 ' B' ' 115' ' ' VAL . 60.9 Cg_exo -35.67 -63.11 0.2 Allowed 'Trans proline' 0 C--N 1.365 1.438 0 C-N-CA 123.492 2.795 . . . . 0.0 115.009 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 29.3 p -90.94 -31.32 16.42 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -178.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 93' ' ' VAL . . . . . 0.588 HG21 ' H ' ' B' ' 89' ' ' ASP . 3.2 t -57.58 -29.5 34.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.079 0.466 . . . . 0.0 111.561 -179.254 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 5.5 tp -62.46 -33.46 74.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.834 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.92 -15.16 54.39 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -177.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -129.07 20.81 5.83 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.667 0.618 . . . . 0.0 112.667 -179.288 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 97' ' ' LEU . . . . . 0.53 ' O ' ' HG ' ' B' ' 97' ' ' LEU . 0.0 OUTLIER -106.21 -9.12 17.02 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.431 179.827 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 60.4 tttm . . . . . 0 N--CA 1.47 0.532 0 O-C-N 123.994 0.809 . . . . 0.0 112.044 -179.457 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 5.5 m . . . . . 0 N--CA 1.466 0.342 0 CA-C-O 120.657 0.265 . . . . 0.0 111.28 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -112.07 -9.48 13.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.038 0.447 . . . . 0.0 110.215 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 8.4 p -79.18 -17.89 54.05 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.603 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 4.0 p -78.3 -62.02 1.82 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.287 0.565 . . . . 0.0 110.511 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 107' ' ' PHE . . . . . 0.539 ' CD2' HG13 ' B' ' 78' ' ' ILE . 0.9 OUTLIER -61.62 -61.03 2.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.168 -0.923 . . . . 0.0 110.75 -179.839 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 108' ' ' CYS . . . . . 0.749 ' O ' ' HB3' ' B' ' 122' ' ' CYS . 61.0 m -90.11 54.12 2.71 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.9 -179.039 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -74.24 -62.89 1.36 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.204 0.526 . . . . 0.0 110.125 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -86.13 -8.74 57.64 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.007 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 111' ' ' HIS . . . . . 0.701 ' O ' ' HB3' ' B' ' 108' ' ' CYS . 3.5 m-70 -106.99 88.26 2.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.554 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 90.3 m -114.48 37.66 3.33 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.381 -0.528 . . . . 0.0 112.101 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 113' ' ' HIS . . . . . 0.74 ' HA ' ' HB3' ' B' ' 117' ' ' LYS . 2.1 p80 -144.38 -149.69 0.29 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 110.202 -0.295 . . . . 0.0 110.202 178.278 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 114' ' ' GLY . . . . . 0.458 ' HA3' ' HG2' ' A' ' 30' ' ' PRO . . . 58.04 -106.37 0.8 Allowed Glycine 0 C--N 1.332 0.34 0 C-N-CA 121.205 -0.522 . . . . 0.0 112.973 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 115' ' ' VAL . . . . . 0.85 HG21 ' HA ' ' B' ' 91' ' ' PRO . 5.4 m -106.36 -23.76 4.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.582 0.23 . . . . 0.0 111.064 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 116' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -76.22 1.83 14.83 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 121.274 0.559 . . . . 0.0 110.966 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 117' ' ' LYS . . . . . 0.74 ' HB3' ' HA ' ' B' ' 113' ' ' HIS . 0.1 OUTLIER -100.27 -3.2 31.88 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.181 178.058 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -102.48 110.58 22.56 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.219 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 39.7 tp 77.55 -51.48 0.53 Allowed 'General case' 0 N--CA 1.474 0.729 0 O-C-N 124.108 0.88 . . . . 0.0 110.666 -178.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 28.5 m80 -94.82 169.06 10.42 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 11.4 tp -167.95 64.79 0.07 Allowed 'General case' 0 C--O 1.233 0.203 0 C-N-CA 120.068 -0.653 . . . . 0.0 112.542 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 122' ' ' CYS . . . . . 0.749 ' HB3' ' O ' ' B' ' 108' ' ' CYS . 0.8 OUTLIER . . . . . 0 C--O 1.248 0.996 0 O-C-N 124.043 0.839 . . . . 0.0 113.162 179.069 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.599 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 18.9 m . . . . . 0 N--CA 1.468 0.47 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -89.88 28.38 1.37 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -108.39 -94.81 0.4 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.807 0.337 . . . . 0.0 110.997 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.16 -0.21 16.02 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.642 HD13 ' HB2' ' A' ' 46' ' ' PHE . 60.5 mt -107.99 -61.64 2.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.787 -0.188 . . . . 0.0 111.206 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.58 -31.36 71.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.999 0.428 . . . . 0.0 110.535 179.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.33 -20.48 72.11 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.638 179.215 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.3 -22.63 51.71 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.161 0.505 . . . . 0.0 110.016 179.101 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 75.3 t -64.55 -44.19 96.82 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.594 178.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.78 -16.44 61.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.349 179.101 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.88 -44.38 32.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.121 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.517 ' SG ' ' HB2' ' B' ' 113' ' ' HIS . 24.8 t -85.67 -28.98 24.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.032 0.444 . . . . 0.0 110.831 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 103.52 38.14 2.87 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.432 -0.89 . . . . 0.0 112.198 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 145.62 165.68 11.47 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.916 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.9 tp -95.81 109.59 22.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.256 0.551 . . . . 0.0 110.362 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.732 ' C ' ' HD2' ' A' ' 30' ' ' PRO . 15.9 p-10 -128.73 -50.3 1.25 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 118.963 -0.541 . . . . 0.0 111.27 -179.463 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.664 ' HB3' ' O ' ' A' ' 28' ' ' ASP . 17.0 tp 107.14 -54.39 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 124.913 1.383 . . . . 0.0 111.794 -179.034 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.851 ' HA ' HG21 ' A' ' 54' ' ' VAL . 10.6 Cg_endo -53.75 -36.55 82.5 Favored 'Trans proline' 0 C--N 1.364 1.38 0 C-N-CA 122.325 2.017 . . . . 0.0 112.869 179.368 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 2.4 t -93.9 -36.43 12.21 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.109 0.48 . . . . 0.0 110.711 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.588 HG23 ' OD1' ' A' ' 28' ' ' ASP . 94.0 t -64.25 -25.93 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.359 -179.606 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.418 HD23 HG21 ' A' ' 54' ' ' VAL . 2.9 pp -57.69 -33.27 68.2 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.789 0.328 . . . . 0.0 111.139 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.61 -38.13 62.65 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.67 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.28 -13.46 60.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.47 -179.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -93.11 -41.54 9.89 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.362 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.9 ttmm 55.1 77.42 0.22 Allowed 'General case' 0 N--CA 1.47 0.546 0 O-C-N 123.464 0.478 . . . . 0.0 110.281 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -99.59 138.44 36.67 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.117 0.485 . . . . 0.0 111.972 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -115.71 -99.96 0.44 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.3 178.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -86.42 78.28 9.29 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.463 0.649 . . . . 0.0 110.23 178.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 102.77 -128.94 9.71 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.482 -179.12 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 3.9 m 70.29 -57.49 0.57 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.336 0.654 . . . . 0.0 111.657 179.491 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -87.7 13.63 10.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.529 0.204 . . . . 0.0 111.116 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.24 -44.89 96.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.863 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 8.0 p -80.01 -32.5 39.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.17 0.51 . . . . 0.0 110.514 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.642 ' HB2' HD13 ' A' ' 17' ' ' ILE . 0.9 OUTLIER -59.68 -61.12 2.86 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.554 -179.801 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 62.6 m -80.32 52.59 1.62 Allowed 'General case' 0 C--O 1.211 -0.94 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.137 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -78.3 -59.58 2.72 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -101.08 -13.3 18.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.239 179.009 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -96.88 76.21 2.73 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.198 -0.91 . . . . 0.0 108.955 179.378 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 88.9 m -117.7 19.64 13.76 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -177.326 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 9.0 p-80 -123.31 -20.98 5.48 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 119.439 -0.904 . . . . 0.0 113.192 -179.023 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.493 ' HA3' ' HG2' ' B' ' 91' ' ' PRO . . . -106.21 119.57 6.06 Favored Glycine 0 C--O 1.221 -0.682 0 C-N-CA 120.034 -1.079 . . . . 0.0 112.606 179.465 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.851 HG21 ' HA ' ' A' ' 30' ' ' PRO . 14.3 m 54.54 -33.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 13.4 t -72.87 -37.75 67.23 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 121.471 -0.768 . . . . 0.0 110.938 -178.385 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 35.7 tttp -67.29 -8.62 33.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.703 179.377 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -71.97 -22.86 61.38 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 178.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.4 mp -114.4 -21.56 10.31 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.854 178.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 67.18 87.51 0.12 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.05 0.54 . . . . 0.0 111.059 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.7 mt -125.31 19.58 8.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.707 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 10.6 p . . . . . 0 C--O 1.245 0.817 0 CA-C-O 118.063 -0.97 . . . . 0.0 109.786 179.385 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 74' ' ' CYS . . . . . 0.942 ' HB3' HD12 ' B' ' 78' ' ' ILE . 51.6 m . . . . . 0 N--CA 1.465 0.322 0 CA-C-O 120.608 0.242 . . . . 0.0 111.564 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -90.45 -43.24 10.4 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -178.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.89 -66.55 0.53 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -177.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.89 10.48 2.78 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -177.503 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.942 HD12 ' HB3' ' B' ' 74' ' ' CYS . 20.8 mt -130.8 -55.37 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 O-C-N 121.778 -0.576 . . . . 0.0 111.432 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.78 -36.22 70.28 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.282 178.401 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -75.53 -23.7 72.41 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.281 178.485 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.63 -22.59 63.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.029 0.442 . . . . 0.0 110.693 179.368 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 54.7 t -65.84 -38.83 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.574 179.282 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -76.52 -13.98 60.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.805 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.53 -35.01 30.85 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.519 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 54.0 t -92.61 -40.26 10.87 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 121.005 -0.278 . . . . 0.0 111.508 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.02 37.27 1.54 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.502 -0.856 . . . . 0.0 111.628 -179.116 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 158.4 167.11 18.77 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 121.028 -0.606 . . . . 0.0 111.687 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 3.1 tp -102.48 123.45 55.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.915 0.388 . . . . 0.0 111.363 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 89' ' ' ASP . . . . . 0.49 ' CG ' ' H ' ' B' ' 90' ' ' LEU . 9.9 p-10 -163.7 -111.89 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.581 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 90' ' ' LEU . . . . . 0.682 ' HG ' HG22 ' B' ' 115' ' ' VAL . 37.1 tp -179.32 -49.99 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.404 0 C-N-CA 123.843 0.857 . . . . 0.0 110.454 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 91' ' ' PRO . . . . . 0.719 ' HG3' ' HD3' ' A' ' 30' ' ' PRO . 5.4 Cg_endo -46.9 -34.28 15.98 Favored 'Trans proline' 0 C--N 1.366 1.465 0 C-N-CA 123.39 2.727 . . . . 0.0 114.575 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 15.2 p -108.64 -27.99 9.52 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.161 0.505 . . . . 0.0 110.755 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 48.2 t -60.67 -20.15 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.705 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 94' ' ' LEU . . . . . 0.64 HD12 ' N ' ' B' ' 95' ' ' ALA . 0.8 OUTLIER -53.77 -24.33 14.8 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 179.953 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 95' ' ' ALA . . . . . 0.64 ' N ' HD12 ' B' ' 94' ' ' LEU . . . -60.5 -55.36 34.36 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -178.559 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -82.75 -21.57 34.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.783 0.325 . . . . 0.0 110.705 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 97' ' ' LEU . . . . . 0.429 ' HB3' ' HA ' ' B' ' 94' ' ' LEU . 44.1 tp -62.22 -51.83 66.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.292 178.74 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 51.1 tttm . . . . . 0 N--CA 1.465 0.277 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.697 177.957 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 39.9 m . . . . . 0 N--CA 1.469 0.525 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -79.37 -9.66 59.64 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 54.4 p -52.46 -52.43 54.22 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.126 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 4.8 p -62.37 -30.49 71.22 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.031 0.444 . . . . 0.0 111.179 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 107' ' ' PHE . . . . . 0.445 ' HB2' HD11 ' B' ' 78' ' ' ILE . 0.5 OUTLIER -69.18 -56.7 6.84 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.31 -179.189 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 108' ' ' CYS . . . . . 0.623 ' SG ' ' HB3' ' B' ' 122' ' ' CYS . 0.8 OUTLIER -79.57 18.21 0.77 Allowed 'General case' 0 CA--C 1.514 -0.407 0 C-N-CA 120.631 -0.427 . . . . 0.0 111.973 179.914 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -55.22 -65.11 0.64 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.378 0.609 . . . . 0.0 110.201 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -89.13 -10.36 47.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.254 178.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 16.3 m80 -110.69 64.95 0.61 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.928 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 1.7 m -91.2 39.54 1.0 Allowed 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 112.046 0.388 . . . . 0.0 112.046 -178.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 113' ' ' HIS . . . . . 0.517 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 14.1 p-80 -143.22 -15.39 0.68 Allowed 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.341 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -77.25 -159.97 11.4 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.762 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 115' ' ' VAL . . . . . 0.682 HG22 ' HG ' ' B' ' 90' ' ' LEU . 24.4 m -64.39 -4.96 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -179.402 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 116' ' ' CYS . . . . . 0.512 ' SG ' ' HB2' ' B' ' 121' ' ' LEU . 7.0 t -78.77 -23.45 45.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.685 0.755 . . . . 0.0 109.115 178.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 4.0 ttmt -81.79 -7.57 59.61 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.146 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -65.01 -31.92 73.39 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.096 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 16.6 tp -114.23 -8.13 12.95 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.188 178.289 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 66.51 79.52 0.24 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.024 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 121' ' ' LEU . . . . . 0.512 ' HB2' ' SG ' ' B' ' 116' ' ' CYS . 96.6 mt -116.5 4.64 13.29 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 122' ' ' CYS . . . . . 0.623 ' HB3' ' SG ' ' B' ' 108' ' ' CYS . 21.2 p . . . . . 0 C--O 1.248 0.977 0 CA-C-O 118.177 -0.915 . . . . 0.0 109.335 178.098 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.807 ' HA ' HD12 ' A' ' 17' ' ' ILE . 26.7 m . . . . . 0 C--O 1.227 -0.099 0 CA-C-O 120.941 0.401 . . . . 0.0 111.122 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.591 ' HA ' ' HB3' ' A' ' 18' ' ' ALA . . . -106.56 -13.99 15.17 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.789 0.328 . . . . 0.0 111.261 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -88.23 -69.27 0.71 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.151 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.669 ' HB1' ' HA ' ' A' ' 36' ' ' LEU . . . -88.87 2.87 53.01 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.598 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.807 HD12 ' HA ' ' A' ' 13' ' ' CYS . 66.9 mt -119.0 -64.79 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 121.218 -0.193 . . . . 0.0 110.932 -179.584 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.591 ' HB3' ' HA ' ' A' ' 14' ' ' ALA . . . -68.27 -26.68 65.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.126 0.489 . . . . 0.0 110.057 178.534 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -87.47 10.35 69.77 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 178.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -125.12 -2.21 7.65 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 122.801 0.44 . . . . 0.0 110.456 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.566 HG13 ' HA2' ' A' ' 26' ' ' GLY . 64.3 t -66.5 -43.51 90.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.22 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.19 -4.57 30.09 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -84.17 -13.87 51.64 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -149.03 40.85 0.89 Allowed 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.47 -48.27 2.52 Favored Glycine 0 C--O 1.227 -0.336 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.882 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.566 ' HA2' HG13 ' A' ' 21' ' ' VAL . . . -168.57 176.49 42.88 Favored Glycine 0 N--CA 1.442 -0.907 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.44 HG23 HG22 ' A' ' 21' ' ' VAL . 0.9 OUTLIER -49.86 110.83 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.607 0.718 . . . . 0.0 112.18 179.972 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.645 ' HB3' HG23 ' A' ' 32' ' ' VAL . 49.2 t0 -121.47 -118.82 0.3 Allowed 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.448 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.805 HD11 ' HB2' ' A' ' 55' ' ' CYS . 16.1 tp 173.01 -57.94 0.0 OUTLIER Pre-proline 0 C--O 1.223 -0.296 0 O-C-N 123.612 0.57 . . . . 0.0 111.429 178.371 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.722 ' HD3' ' HB3' ' A' ' 29' ' ' LEU . 54.3 Cg_exo -52.06 -49.21 18.1 Favored 'Trans proline' 0 C--N 1.358 1.048 0 C-N-CA 122.268 1.979 . . . . 0.0 113.225 -179.517 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 25.5 p -92.42 -35.15 13.83 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.238 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.645 HG23 ' HB3' ' A' ' 28' ' ' ASP . 65.4 t -65.06 -18.92 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.241 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 25.9 tp -57.93 -25.78 61.36 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.893 178.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.05 -41.13 99.42 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.648 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -86.36 -8.87 57.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.971 0.415 . . . . 0.0 111.057 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.669 ' HA ' ' HB1' ' A' ' 16' ' ' ALA . 33.5 tp -89.17 62.11 6.05 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 178.356 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.647 ' HD3' ' H ' ' A' ' 37' ' ' LYS . 0.3 OUTLIER -75.27 45.08 0.27 Allowed 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -177.1 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.61 156.83 16.61 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 122.189 -0.319 . . . . 0.0 110.386 178.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.416 ' HA ' HD21 ' A' ' 58' ' ' LEU . . . -115.23 -40.97 3.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.983 0.421 . . . . 0.0 110.583 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -93.53 -169.1 2.04 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.069 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -75.31 56.65 2.83 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 121.015 -0.612 . . . . 0.0 113.851 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 19.7 m -97.66 5.0 49.94 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 122.466 -0.432 . . . . 0.0 110.396 179.146 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.581 ' HB2' HD11 ' A' ' 36' ' ' LEU . . . -126.07 16.56 7.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.193 179.034 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.567 ' O ' ' HG2' ' A' ' 48' ' ' GLU . 5.9 m -61.86 -32.08 72.4 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.704 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 12.7 p -66.25 -26.74 67.5 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.124 0.488 . . . . 0.0 111.058 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.772 ' HB2' HD13 ' A' ' 17' ' ' ILE . 1.0 OUTLIER -93.29 -63.89 1.16 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.843 -178.67 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.493 ' HA ' ' HB2' ' A' ' 50' ' ' HIS . 72.9 m -82.84 45.44 1.0 Allowed 'General case' 0 C--O 1.217 -0.621 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -177.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.567 ' HG2' ' O ' ' A' ' 44' ' ' SER . 0.9 OUTLIER -72.81 -71.15 0.31 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 119.147 0.885 . . . . 0.0 110.401 179.406 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -78.36 -5.92 53.66 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.606 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.493 ' HB2' ' HA ' ' A' ' 47' ' ' CYS . 36.2 m-70 -104.29 66.17 0.81 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.924 -179.203 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.414 ' O ' ' HD2' ' A' ' 56' ' ' LYS . 72.4 m -120.41 50.08 1.36 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 178.389 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.436 ' HB3' ' SG ' ' B' ' 85' ' ' CYS . 13.1 m80 -96.92 -77.01 0.5 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.594 0.712 . . . . 0.0 110.185 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 55' ' ' CYS . . . -120.86 -174.99 15.15 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 179.05 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.646 HG11 ' HA ' ' A' ' 30' ' ' PRO . 9.3 m 47.02 -64.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.805 ' HB2' HD11 ' A' ' 29' ' ' LEU . 8.8 t -64.78 -48.89 72.84 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 121.664 -0.647 . . . . 0.0 111.836 -178.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.414 ' HD2' ' O ' ' A' ' 51' ' ' CYS . 17.0 ptmt -75.23 -2.01 26.02 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 119.42 -0.912 . . . . 0.0 111.296 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -65.97 -35.52 80.8 Favored 'General case' 0 N--CA 1.461 0.114 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 177.4 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.483 HD22 HD22 ' A' ' 60' ' ' LEU . 7.9 tt -90.26 -33.13 16.26 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 114.58 -1.191 . . . . 0.0 108.011 177.366 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 22.5 t-160 77.25 86.6 0.08 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.274 178.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.541 HD23 ' N ' ' A' ' 60' ' ' LEU . 0.7 OUTLIER -140.57 25.45 2.19 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -179.932 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 6.0 p . . . . . 0 C--O 1.244 0.791 0 CA-C-O 118.17 -0.919 . . . . 0.0 109.856 176.853 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 74' ' ' CYS . . . . . 0.615 ' HA ' HD12 ' B' ' 78' ' ' ILE . 13.0 p . . . . . 0 CA--C 1.521 -0.137 0 CA-C-O 120.85 0.357 . . . . 0.0 111.285 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -115.61 13.16 16.26 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 120.906 0.384 . . . . 0.0 110.661 178.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -128.48 -76.36 0.56 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.391 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.45 -39.44 90.84 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.884 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.881 HD13 ' HB2' ' B' ' 107' ' ' PHE . 13.5 mt -74.01 -41.2 52.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.03 0.443 . . . . 0.0 110.995 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.53 -32.75 71.77 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.161 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.63 -35.64 9.18 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.872 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.25 -26.51 61.14 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -178.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 82' ' ' VAL . . . . . 0.46 ' CG1' HG22 ' B' ' 88' ' ' ILE . 3.2 t -66.76 -50.51 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.298 179.491 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.34 -26.11 67.13 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.006 0.431 . . . . 0.0 111.34 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.69 -25.14 64.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.033 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 85' ' ' CYS . . . . . 0.436 ' SG ' ' HB3' ' A' ' 52' ' ' HIS . 1.5 t -88.92 -22.62 23.01 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.962 -179.46 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 99.66 43.99 2.38 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.166 -1.016 . . . . 0.0 113.804 179.044 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 114.87 52.01 0.44 Allowed Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.05 -1.072 . . . . 0.0 113.893 178.463 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 88' ' ' ILE . . . . . 0.479 ' O ' ' HB2' ' B' ' 89' ' ' ASP . 0.5 OUTLIER 56.04 174.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 124.29 1.036 . . . . 0.0 113.184 179.142 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 89' ' ' ASP . . . . . 0.59 ' CG ' ' HD2' ' B' ' 91' ' ' PRO . 39.2 t0 170.41 -124.62 0.0 OUTLIER 'General case' 0 C--O 1.233 0.212 0 CA-C-N 114.348 -1.296 . . . . 0.0 108.403 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 90' ' ' LEU . . . . . 0.801 HD11 ' SG ' ' B' ' 116' ' ' CYS . 21.1 tp 172.46 -58.5 0.0 OUTLIER Pre-proline 0 C--N 1.324 -0.542 0 C-N-CA 124.364 1.066 . . . . 0.0 109.34 178.481 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 91' ' ' PRO . . . . . 1.008 ' HA ' HG11 ' B' ' 115' ' ' VAL . 50.8 Cg_exo -54.07 -43.25 59.99 Favored 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 122.031 1.821 . . . . 0.0 112.281 179.11 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 24.7 p -79.85 -35.82 37.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.055 0.455 . . . . 0.0 110.87 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 93' ' ' VAL . . . . . 0.443 HG23 ' HB3' ' B' ' 89' ' ' ASP . 5.8 t -71.02 -25.4 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.481 -178.726 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 94' ' ' LEU . . . . . 0.554 HD22 ' HB ' ' B' ' 115' ' ' VAL . 30.8 tp -60.16 -28.33 67.83 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 120.828 0.347 . . . . 0.0 110.934 -179.547 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.86 -36.62 81.76 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.408 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -99.37 9.86 42.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.297 0.57 . . . . 0.0 110.089 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 97' ' ' LEU . . . . . 0.514 HD21 ' HB1' ' B' ' 104' ' ' ALA . 24.3 tp -107.55 68.24 0.71 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.167 -0.924 . . . . 0.0 108.708 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 98' ' ' LYS . . . . . 0.413 ' NZ ' ' HB2' ' B' ' 98' ' ' LYS . 8.1 mtmp? . . . . . 0 N--CA 1.468 0.469 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.426 -178.282 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 79.4 m . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 120.976 0.417 . . . . 0.0 109.932 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 104' ' ' ALA . . . . . 0.514 ' HB1' HD21 ' B' ' 97' ' ' LEU . . . -109.74 -25.63 10.28 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.843 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 22.0 p -60.58 -25.93 66.57 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.754 0.312 . . . . 0.0 111.21 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 106' ' ' CYS . . . . . 0.497 ' HB3' ' HB3' ' B' ' 74' ' ' CYS . 43.5 t -60.33 -18.73 51.81 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.382 0.611 . . . . 0.0 110.389 178.654 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 107' ' ' PHE . . . . . 0.881 ' HB2' HD13 ' B' ' 78' ' ' ILE . 0.6 OUTLIER -104.16 -65.06 1.05 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.519 -179.535 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 108' ' ' CYS . . . . . 0.444 ' HB2' ' HB3' ' B' ' 122' ' ' CYS . 0.0 OUTLIER -73.69 15.77 0.25 Allowed 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -178.504 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -37.49 -73.23 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.181 0.592 . . . . 0.0 112.364 -178.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -98.71 -33.91 10.74 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -70.63 87.07 0.66 Allowed 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.026 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 112' ' ' CYS . . . . . 0.596 ' HB3' ' HG2' ' B' ' 117' ' ' LYS . 0.5 OUTLIER -154.21 136.63 14.99 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -178.622 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 113' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -153.22 -49.63 0.1 Allowed 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 178.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 114' ' ' GLY . . . . . 0.405 ' HA3' ' HB2' ' A' ' 30' ' ' PRO . . . -127.14 -159.38 10.14 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 177.468 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 115' ' ' VAL . . . . . 1.008 HG11 ' HA ' ' B' ' 91' ' ' PRO . 0.4 OUTLIER 41.45 -86.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 123.903 0.881 . . . . 0.0 113.31 179.644 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 116' ' ' CYS . . . . . 0.801 ' SG ' HD11 ' B' ' 90' ' ' LEU . 36.5 m -61.36 -33.13 73.13 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 118.431 0.56 . . . . 0.0 109.831 178.335 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 117' ' ' LYS . . . . . 0.596 ' HG2' ' HB3' ' B' ' 112' ' ' CYS . 3.9 mmmm -77.53 -21.0 53.31 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.244 178.469 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -62.38 -47.86 82.28 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.332 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 7.9 tt -79.77 -29.28 40.39 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 177.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 8.5 t-160 76.01 67.67 0.06 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.529 178.15 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -126.81 8.97 6.91 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.475 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 122' ' ' CYS . . . . . 0.444 ' HB3' ' HB2' ' B' ' 108' ' ' CYS . 0.8 OUTLIER . . . . . 0 C--O 1.245 0.852 0 CA-C-O 118.173 -0.918 . . . . 0.0 110.208 178.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 120.704 0.288 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 51.7 mtt -107.67 116.75 32.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.505 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -162.36 45.95 0.35 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 119.836 -1.174 . . . . 0.0 113.63 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.437 ' HD2' ' O ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -71.3 99.72 1.99 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.113 0.482 . . . . 0.0 110.261 178.911 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.469 ' H ' ' CB ' ' A' ' 40' ' ' GLU . 13.9 t 63.07 56.6 1.75 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.216 -178.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.0 t -94.35 -159.01 0.67 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.401 -178.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.713 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 0.2 OUTLIER -90.31 -173.76 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.545 -178.588 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.713 ' HG ' ' O ' ' A' ' 7' ' ' VAL . 2.8 pp 62.17 -59.36 0.12 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.582 1.553 . . . . 0.0 113.358 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.425 ' N ' HD12 ' A' ' 8' ' ' LEU . 19.7 ptmt -87.08 17.9 3.94 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 121.817 -0.552 . . . . 0.0 110.481 179.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.477 ' HB2' ' HB3' ' A' ' 43' ' ' ALA . 19.1 pttp -76.97 -8.85 58.12 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.225 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.427 ' C ' ' H ' ' A' ' 13' ' ' CYS . 2.5 t -78.83 -3.96 6.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.938 179.227 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.69 7.03 4.13 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.672 0.748 . . . . 0.0 109.65 177.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.687 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 1.3 p -58.23 -35.3 71.48 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.072 179.104 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.49 28.3 0.08 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.409 ' H ' ' C ' ' A' ' 13' ' ' CYS . . . -138.38 -64.34 0.53 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.929 0.395 . . . . 0.0 110.27 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.42 -43.83 47.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.943 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.838 HD13 ' HB2' ' A' ' 46' ' ' PHE . 10.6 mt -70.28 -38.2 73.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.117 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.1 -39.01 88.33 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.823 178.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.6 -31.52 44.93 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.966 -0.635 . . . . 0.0 111.886 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.59 -28.84 61.09 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.302 0.573 . . . . 0.0 110.293 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.724 HG13 ' H ' ' A' ' 27' ' ' ILE . 1.2 t -68.3 -37.36 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.235 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.82 -6.27 40.35 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.616 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.84 -2.33 58.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.491 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.6 t -147.05 55.23 1.1 Allowed 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.977 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.38 -53.41 4.21 Favored Glycine 0 N--CA 1.455 -0.088 0 C-N-CA 121.2 -0.524 . . . . 0.0 113.936 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.695 ' HA2' HG13 ' A' ' 21' ' ' VAL . . . 131.79 116.66 1.8 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.969 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.724 ' H ' HG13 ' A' ' 21' ' ' VAL . 43.9 mm 72.83 78.62 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.505 -0.773 0 CA-C-O 122.787 1.279 . . . . 0.0 111.58 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.705 ' OD2' ' HB3' ' A' ' 31' ' ' CYS . 40.1 t0 -148.63 161.61 41.37 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-N 112.683 -2.053 . . . . 0.0 107.298 177.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.613 ' HB3' ' HD3' ' A' ' 30' ' ' PRO . 36.0 tp -126.12 -52.63 0.03 OUTLIER Pre-proline 0 C--N 1.296 -1.729 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.026 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.838 ' HB3' HG13 ' B' ' 115' ' ' VAL . 47.2 Cg_exo -54.84 -41.7 75.76 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 121.907 1.738 . . . . 0.0 112.632 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.705 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 5.6 t -85.82 -38.96 17.59 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.187 -178.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.675 HG23 ' HB3' ' A' ' 28' ' ' ASP . 93.0 t -73.44 -16.23 17.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.799 HD22 ' HB ' ' A' ' 54' ' ' VAL . 44.8 tp -55.27 -31.08 61.28 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -56.67 -37.05 70.28 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -104.44 4.37 33.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.808 0.337 . . . . 0.0 111.112 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 52.3 tp -85.87 -25.55 26.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.869 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.82 46.47 1.18 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.451 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -136.59 134.87 37.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.802 -0.181 . . . . 0.0 111.336 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 65.37 -165.54 0.23 Allowed 'General case' 0 N--CA 1.468 0.474 0 O-C-N 123.968 0.793 . . . . 0.0 111.838 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.469 ' CB ' ' H ' ' A' ' 5' ' ' CYS . 6.0 pt-20 -124.14 53.88 1.38 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.189 0.518 . . . . 0.0 112.005 -179.157 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -134.39 52.54 0.81 Allowed Glycine 0 CA--C 1.517 0.17 0 C-N-CA 121.062 -0.589 . . . . 0.0 111.881 178.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -127.09 -104.74 0.33 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.733 -0.234 . . . . 0.0 111.089 -179.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.477 ' HB3' ' HB2' ' A' ' 10' ' ' LYS . . . 57.99 -154.1 0.36 Allowed 'General case' 0 C--O 1.239 0.503 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 178.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.8 p -66.82 32.88 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -176.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 43.8 t -107.87 -31.56 7.96 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 176.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.838 ' HB2' HD13 ' A' ' 17' ' ' ILE . 1.1 t80 -103.52 -65.53 1.0 Allowed 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.299 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.456 ' HA ' ' HB2' ' A' ' 50' ' ' HIS . 7.6 m -75.77 23.6 0.13 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -177.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.582 ' HA ' ' OE1' ' A' ' 48' ' ' GLU . 7.3 tp10 -69.1 -68.02 0.43 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.95 0.405 . . . . 0.0 110.581 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -79.79 -14.49 58.66 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.456 ' HB2' ' HA ' ' A' ' 47' ' ' CYS . 32.5 m80 -100.44 63.43 1.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.669 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -115.02 68.42 0.7 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.876 0.37 . . . . 0.0 110.595 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -107.82 -64.07 1.25 Allowed 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.276 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.508 ' HA3' ' HB2' ' B' ' 92' ' ' CYS . . . -134.12 -107.54 0.98 Allowed Glycine 0 C--O 1.219 -0.835 0 C-N-CA 120.031 -1.08 . . . . 0.0 113.799 -178.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.799 ' HB ' HD22 ' A' ' 33' ' ' LEU . 2.9 m -12.51 -67.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 N-CA-C 116.496 2.036 . . . . 0.0 116.496 -178.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.595 ' H ' HG23 ' A' ' 54' ' ' VAL . 32.4 t -73.38 -39.79 64.84 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -177.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.7 tttm -63.46 -24.75 67.96 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.02 0.438 . . . . 0.0 109.941 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -62.18 -32.68 73.33 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.213 178.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 60.5 mt -94.36 -4.69 48.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.44 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 66.2 t-80 64.79 84.04 0.16 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.851 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.503 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 8.1 mp -126.98 27.35 5.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.026 178.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.903 0 CA-C-O 118.213 -0.898 . . . . 0.0 109.462 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.082 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 63' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -96.73 70.76 2.55 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.189 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -149.08 78.11 0.23 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 119.861 -1.161 . . . . 0.0 113.743 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -88.04 125.11 34.38 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 66' ' ' CYS . . . . . . . . . . . . . 43.9 t 55.91 52.86 10.01 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.322 0.582 . . . . 0.0 109.778 -178.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 9.9 p -105.27 169.37 8.49 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.579 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 14.8 t -75.5 85.78 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.577 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.428 ' C ' ' H ' ' B' ' 71' ' ' LYS . 42.4 tp -178.45 -53.21 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 70' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -87.5 31.52 0.74 Allowed 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 71' ' ' LYS . . . . . 0.428 ' H ' ' C ' ' B' ' 69' ' ' LEU . 3.1 tmmm? -71.34 -30.28 66.0 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 113.957 -1.474 . . . . 0.0 110.215 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 12.5 t -62.88 -24.77 36.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.275 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.61 11.04 1.43 Allowed 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 74' ' ' CYS . . . . . 1.114 ' HB2' HD12 ' B' ' 78' ' ' ILE . 31.2 p -73.56 -15.08 61.3 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.788 0.327 . . . . 0.0 111.305 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 75' ' ' ALA . . . . . 0.45 ' O ' ' HB3' ' B' ' 79' ' ' ALA . . . -69.53 -6.34 30.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.89 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -102.25 -47.91 4.36 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.65 -41.42 13.4 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -178.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 1.114 HD12 ' HB2' ' B' ' 74' ' ' CYS . 84.3 mt -76.27 -43.01 37.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.646 0.26 . . . . 0.0 110.713 -179.193 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 79' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' B' ' 75' ' ' ALA . . . -78.74 -16.99 56.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.925 0.393 . . . . 0.0 110.906 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -86.62 -34.29 11.92 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.591 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.69 -19.58 65.19 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.652 0.263 . . . . 0.0 111.354 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 77.4 t -62.13 -54.75 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.121 178.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.41 -26.47 65.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.225 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.54 -40.89 96.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.84 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 7.2 t -110.75 25.38 11.84 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.411 -0.516 . . . . 0.0 111.668 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.73 -51.48 4.58 Favored Glycine 0 CA--C 1.518 0.245 0 N-CA-C 114.858 0.703 . . . . 0.0 114.858 178.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . -138.25 -177.4 15.24 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.036 -1.078 . . . . 0.0 113.837 -178.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 3.9 tp -102.11 137.0 31.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.217 0.532 . . . . 0.0 111.187 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 89' ' ' ASP . . . . . 0.428 ' H ' HG21 ' B' ' 93' ' ' VAL . 38.9 t0 -171.2 -104.64 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.226 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 90' ' ' LEU . . . . . 0.675 HD21 ' HB2' ' B' ' 116' ' ' CYS . 56.0 tp -176.16 -50.61 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.388 0 CA-C-O 119.476 -0.297 . . . . 0.0 111.494 178.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 91' ' ' PRO . . . . . 0.625 ' HD2' ' N ' ' B' ' 90' ' ' LEU . 3.4 Cg_exo -40.73 -39.83 3.23 Favored 'Trans proline' 0 C--N 1.364 1.344 0 C-N-CA 124.051 3.167 . . . . 0.0 114.67 -179.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 92' ' ' CYS . . . . . 0.508 ' HB2' ' HA3' ' A' ' 53' ' ' GLY . 19.6 t -113.16 -14.8 12.86 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.067 0.461 . . . . 0.0 111.726 -178.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 93' ' ' VAL . . . . . 0.428 HG21 ' H ' ' B' ' 89' ' ' ASP . 12.3 t -72.62 -17.68 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.395 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 94' ' ' LEU . . . . . 0.954 HD22 ' HB ' ' B' ' 115' ' ' VAL . 23.8 tp -62.22 -35.58 79.34 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.46 -54.89 26.33 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 -178.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -87.38 7.97 26.6 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 97' ' ' LEU . . . . . 0.495 HD23 HD12 ' B' ' 94' ' ' LEU . 59.8 tp -79.0 -31.02 44.63 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.288 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 98' ' ' LYS . . . . . 0.641 ' HE3' HD11 ' B' ' 119' ' ' LEU . 39.0 ttmt -88.53 66.92 8.39 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.551 0.691 . . . . 0.0 110.743 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -104.99 64.53 0.72 Allowed 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . 77.03 -66.69 0.24 Allowed 'General case' 0 N--CA 1.467 0.414 0 O-C-N 124.439 1.087 . . . . 0.0 109.074 -176.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -160.71 -138.19 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.761 177.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 102' ' ' GLY . . . . . 0.584 ' O ' ' HA ' ' B' ' 74' ' ' CYS . . . 73.8 25.05 72.87 Favored Glycine 0 N--CA 1.453 -0.18 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.068 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 103' ' ' CYS . . . . . 0.826 ' HB2' HD21 ' B' ' 121' ' ' LEU . 0.5 OUTLIER -106.55 -84.73 0.51 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.559 0.219 . . . . 0.0 110.49 -179.737 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 104' ' ' ALA . . . . . 0.415 ' HB3' ' HA ' ' B' ' 71' ' ' LYS . . . 53.87 -155.24 0.23 Allowed 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 178.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.66 33.97 0.05 Allowed 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 115.18 -0.918 . . . . 0.0 113.47 -178.032 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 38.8 t -105.86 -28.68 10.47 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 177.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 107' ' ' PHE . . . . . 0.57 ' HB2' HD11 ' B' ' 78' ' ' ILE . 0.0 OUTLIER -123.48 162.4 22.94 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 113.94 -1.482 . . . . 0.0 107.055 176.24 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 66.9 m 68.2 -3.94 1.17 Allowed 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -62.08 -85.41 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 118.563 0.62 . . . . 0.0 111.043 179.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -86.62 -7.96 57.89 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 178.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -101.16 36.17 2.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.324 -1.307 . . . . 0.0 111.158 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.79 63.77 3.37 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 113' ' ' HIS . . . . . 0.484 ' NE2' ' HB2' ' A' ' 28' ' ' ASP . 9.5 t-160 -122.57 -54.48 1.86 Allowed 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.549 -178.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 114' ' ' GLY . . . . . 0.548 ' O ' ' HG3' ' B' ' 117' ' ' LYS . . . -84.01 -137.24 3.37 Favored Glycine 0 C--O 1.227 -0.295 0 C-N-CA 120.511 -0.852 . . . . 0.0 113.452 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 115' ' ' VAL . . . . . 0.954 ' HB ' HD22 ' B' ' 94' ' ' LEU . 16.8 m -58.96 -10.76 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 116' ' ' CYS . . . . . 0.675 ' HB2' HD21 ' B' ' 90' ' ' LEU . 0.0 OUTLIER -65.21 -32.0 73.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.707 0.289 . . . . 0.0 111.469 -179.714 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 117' ' ' LYS . . . . . 0.548 ' HG3' ' O ' ' B' ' 114' ' ' GLY . 0.3 OUTLIER -87.23 -26.21 23.61 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.272 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.2 -42.62 96.54 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.5 178.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 119' ' ' LEU . . . . . 0.641 HD11 ' HE3' ' B' ' 98' ' ' LYS . 1.8 tt -101.41 63.13 0.96 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 176.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 65.0 t-80 -20.38 114.57 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 113.732 -1.576 . . . . 0.0 114.725 -176.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 121' ' ' LEU . . . . . 0.826 HD21 ' HB2' ' B' ' 103' ' ' CYS . 1.0 OUTLIER -134.03 -33.46 1.03 Allowed 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.451 -1.25 . . . . 0.0 109.293 178.372 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 122' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.247 0.923 0 CA-C-O 118.405 -0.807 . . . . 0.0 109.94 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.307 0 CA-C-O 120.553 0.216 . . . . 0.0 110.618 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -75.18 95.39 3.11 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 97.76 -135.51 12.23 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.236 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.2 mtpp 58.73 -112.23 0.61 Allowed 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 122.624 0.37 . . . . 0.0 110.63 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 8.7 m -108.77 7.48 26.32 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 45.1 t -66.67 104.59 1.33 Allowed 'General case' 0 C--O 1.224 -0.27 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 32.8 t -45.44 -60.44 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -177.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 44.2 tp -64.47 -38.13 89.96 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 36.2 mtpt -88.95 27.15 1.39 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.661 0.743 . . . . 0.0 111.529 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.4 tptm -137.55 38.87 2.44 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.8 t 55.77 44.04 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.749 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 55.91 46.17 22.59 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.352 -178.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 17.0 p 52.51 12.24 0.23 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.201 1.401 . . . . 0.0 113.956 -178.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.07 178.12 7.01 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 178.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 72.2 -50.35 0.7 Allowed 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.692 0.62 . . . . 0.0 110.161 -178.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.07 -34.34 73.06 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.586 HG12 ' CD1' ' A' ' 46' ' ' PHE . 6.2 tp -89.43 -58.36 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-O 121.022 0.439 . . . . 0.0 110.607 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.489 ' H ' HG23 ' A' ' 17' ' ' ILE . . . -54.75 -34.12 62.11 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.231 -0.895 . . . . 0.0 112.024 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.31 -27.94 50.35 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.231 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.24 -15.83 59.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.845 0.355 . . . . 0.0 110.838 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 17' ' ' ILE . 66.9 t -63.57 -40.46 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.483 179.177 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.32 -18.65 63.09 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.889 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -72.32 -35.24 68.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.835 0.35 . . . . 0.0 111.442 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.537 ' HB3' ' CG ' ' B' ' 113' ' ' HIS . 71.0 m -99.48 -29.29 12.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.685 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.32 80.02 1.47 Allowed Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.249 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.85 166.08 16.72 Favored Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.407 ' O ' HG23 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -105.94 96.91 4.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.922 0.868 . . . . 0.0 111.283 -179.626 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.649 ' HB2' ' CE1' ' B' ' 113' ' ' HIS . 33.5 m-20 -115.81 -105.72 0.39 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.685 ' HB3' ' HD3' ' A' ' 30' ' ' PRO . 60.2 tp -177.86 -53.7 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.362 0 N-CA-C 111.911 0.338 . . . . 0.0 111.911 178.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.695 ' HA ' HG21 ' A' ' 54' ' ' VAL . 15.2 Cg_exo -70.9 49.07 0.9 Allowed 'Trans proline' 0 C--N 1.362 1.25 0 C-N-CA 122.97 2.447 . . . . 0.0 114.624 -178.235 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.594 ' HB2' ' O ' ' B' ' 113' ' ' HIS . 50.5 t -168.29 -49.27 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.8 t -73.91 -29.76 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.679 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -55.66 -45.36 77.71 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.112 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.06 3.88 3.1 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -101.46 -38.78 7.85 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.64 0.257 . . . . 0.0 111.239 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.553 ' H ' HD23 ' A' ' 36' ' ' LEU . 2.5 pt? -104.63 6.33 34.35 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.454 -179.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -62.72 -47.8 82.03 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 119.431 -0.319 . . . . 0.0 111.625 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 45.32 -101.59 0.05 Allowed 'General case' 0 N--CA 1.469 0.494 0 O-C-N 123.812 0.695 . . . . 0.0 111.194 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -99.05 -106.66 0.2 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -145.79 155.06 42.68 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.787 0.327 . . . . 0.0 110.598 178.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.428 ' H ' HD21 ' A' ' 60' ' ' LEU . . . 71.13 37.94 63.64 Favored Glycine 0 C--O 1.229 -0.165 0 C-N-CA 121.101 -0.571 . . . . 0.0 113.516 179.033 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -126.16 -16.46 5.5 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 122.447 -0.443 . . . . 0.0 111.924 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -109.32 15.36 23.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.931 0.396 . . . . 0.0 111.155 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.5 p -66.4 -53.57 34.34 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.713 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.602 ' O ' ' HG2' ' A' ' 48' ' ' GLU . 1.6 p -55.11 -44.94 75.44 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.725 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.586 ' CD1' HG12 ' A' ' 17' ' ' ILE . 65.2 t80 -63.26 -45.48 91.33 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.591 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.432 ' CB ' ' SG ' ' A' ' 61' ' ' CYS . 98.4 m -94.92 37.98 1.13 Allowed 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -177.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.602 ' HG2' ' O ' ' A' ' 45' ' ' CYS . 62.6 mm-40 -44.69 -76.27 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 118.742 0.701 . . . . 0.0 112.499 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -99.03 -14.04 19.61 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.693 0.758 . . . . 0.0 109.461 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.433 ' CD2' ' N ' ' A' ' 50' ' ' HIS . 0.0 OUTLIER -90.36 68.73 6.91 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.703 179.457 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 5.8 t -132.53 60.24 1.7 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.958 -177.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.601 ' ND1' ' HB3' ' B' ' 92' ' ' CYS . 5.8 p80 -131.35 17.69 4.91 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.795 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.625 ' O ' ' HG3' ' A' ' 56' ' ' LYS . . . -128.27 -137.89 4.48 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.485 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.695 HG21 ' HA ' ' A' ' 30' ' ' PRO . 35.6 m -58.98 -17.29 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-O 120.892 0.377 . . . . 0.0 111.807 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.586 ' HB2' HD11 ' A' ' 29' ' ' LEU . 3.9 t -78.54 -36.37 44.81 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.134 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.625 ' HG3' ' O ' ' A' ' 53' ' ' GLY . 0.0 OUTLIER -81.08 -5.57 57.79 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.158 0.504 . . . . 0.0 110.373 179.364 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -66.38 -27.42 67.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.705 178.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.474 ' HB2' HD13 ' A' ' 60' ' ' LEU . 45.0 mt -100.6 -19.15 16.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.502 179.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 66.4 78.03 0.27 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.669 0.788 . . . . 0.0 111.021 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.474 HD13 ' HB2' ' A' ' 58' ' ' LEU . 11.0 mp -123.48 -20.81 5.46 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.398 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.432 ' SG ' ' CB ' ' A' ' 47' ' ' CYS . 0.6 OUTLIER . . . . . 0 C--O 1.246 0.873 0 CA-C-O 118.391 -0.814 . . . . 0.0 111.511 -177.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.273 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 63' ' ' MET . . . . . . . . . . . . . 2.2 tmt? -129.12 132.97 47.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.865 0.364 . . . . 0.0 111.508 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 97.06 -116.83 5.6 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.585 -0.817 . . . . 0.0 114.17 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp 64.95 -109.09 0.18 Allowed 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 122.895 0.478 . . . . 0.0 109.996 -177.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 66' ' ' CYS . . . . . . . . . . . . . 3.2 t -167.03 91.36 0.4 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.771 0.32 . . . . 0.0 110.443 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.467 ' HB3' ' HB2' ' B' ' 70' ' ' LYS . 33.7 t -124.56 164.74 19.16 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.192 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 21.8 t -98.52 -56.55 5.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.922 0.391 . . . . 0.0 110.726 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 52.5 tp -67.11 -47.44 71.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.236 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 70' ' ' LYS . . . . . 0.467 ' HB2' ' HB3' ' B' ' 67' ' ' SER . 97.2 mttt -61.76 -19.94 63.01 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 120.848 0.356 . . . . 0.0 111.832 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 71' ' ' LYS . . . . . 0.451 ' HB3' ' HA ' ' B' ' 74' ' ' CYS . 6.3 mmtp -86.94 30.47 0.75 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.694 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 17.0 t 56.5 47.44 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . 58.13 38.43 26.43 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.236 -0.893 . . . . 0.0 108.782 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 74' ' ' CYS . . . . . 0.451 ' HA ' ' HB3' ' B' ' 71' ' ' LYS . 20.9 p 48.66 26.66 1.28 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 114.076 -1.42 . . . . 0.0 112.94 -178.093 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -89.9 -175.56 4.64 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . 71.46 -50.08 0.69 Allowed 'General case' 0 N--CA 1.474 0.744 0 O-C-N 123.713 0.633 . . . . 0.0 110.514 -178.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -76.5 -50.39 14.11 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.085 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.723 ' HB ' HD13 ' B' ' 97' ' ' LEU . 8.9 tp -80.26 -42.25 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-O 121.215 0.531 . . . . 0.0 110.094 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.59 -29.69 70.33 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.616 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -82.44 -33.21 25.99 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.772 -0.728 . . . . 0.0 111.581 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.13 -19.53 64.03 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.82 0.343 . . . . 0.0 110.898 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 82' ' ' VAL . . . . . 0.653 HG23 ' O ' ' B' ' 78' ' ' ILE . 75.4 t -60.76 -52.32 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.054 178.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.9 -36.36 62.23 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.999 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.34 -43.02 96.84 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.006 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 2.3 t -90.94 -8.93 47.94 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.3 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 74.47 48.49 13.64 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.95 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 143.5 135.98 3.07 Favored Glycine 0 CA--C 1.509 -0.288 0 C-N-CA 120.896 -0.668 . . . . 0.0 111.777 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 88' ' ' ILE . . . . . 0.591 ' HB ' HG22 ' B' ' 82' ' ' VAL . 0.0 OUTLIER -100.9 107.99 22.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.682 0.753 . . . . 0.0 110.645 -179.806 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 89' ' ' ASP . . . . . 0.568 ' HB2' ' HE1' ' A' ' 52' ' ' HIS . 44.0 m-20 -120.9 -86.43 0.65 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 90' ' ' LEU . . . . . 0.659 ' O ' ' HB2' ' B' ' 94' ' ' LEU . 59.3 tp 179.09 -52.43 0.0 OUTLIER Pre-proline 0 C--O 1.217 -0.655 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.108 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 91' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' B' ' 90' ' ' LEU . 1.0 OUTLIER -43.17 -70.49 0.07 OUTLIER 'Trans proline' 0 C--N 1.36 1.177 0 C-N-CA 123.351 2.701 . . . . 0.0 114.767 -179.413 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 92' ' ' CYS . . . . . 0.601 ' HB3' ' ND1' ' A' ' 52' ' ' HIS . 0.8 OUTLIER -72.83 -38.62 67.06 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -178.17 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 93' ' ' VAL . . . . . 0.579 HG12 HD12 ' B' ' 78' ' ' ILE . 0.6 OUTLIER -66.41 -24.5 33.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -178.199 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 94' ' ' LEU . . . . . 0.659 ' HB2' ' O ' ' B' ' 90' ' ' LEU . 1.3 tm? -67.96 -41.94 81.66 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.52 -9.45 8.7 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -178.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -87.67 -37.43 16.74 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 97' ' ' LEU . . . . . 0.723 HD13 ' HB ' ' B' ' 78' ' ' ILE . 1.7 pt? -115.03 17.56 16.76 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -178.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -70.67 -83.95 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.801 -0.36 . . . . 0.0 111.408 -178.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . 65.6 -84.05 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 O-C-N 123.562 0.539 . . . . 0.0 111.186 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.86 -163.65 1.43 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.396 -0.224 . . . . 0.0 110.396 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -84.11 131.68 34.77 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.655 0.264 . . . . 0.0 110.923 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 110.07 6.89 27.58 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.38 -0.914 . . . . 0.0 113.767 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 92.6 m -110.56 -43.26 3.89 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 117.405 0.603 . . . . 0.0 111.416 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -96.08 2.71 53.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.187 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 4.3 m -54.43 -42.78 70.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.117 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 1.8 p -55.42 -61.49 2.31 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.045 0.45 . . . . 0.0 111.216 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 107' ' ' PHE . . . . . 0.447 ' CD2' HG12 ' B' ' 78' ' ' ILE . 0.8 OUTLIER -58.49 -55.31 36.73 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.342 -179.652 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 12.4 m -76.29 22.63 0.16 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -178.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -63.4 -58.24 7.72 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 118.296 0.498 . . . . 0.0 111.155 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -93.93 -21.48 19.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.293 0.568 . . . . 0.0 109.998 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 18.1 m80 -92.6 89.9 6.9 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.588 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 96.1 m -123.1 46.36 2.2 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -177.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 113' ' ' HIS . . . . . 0.854 ' HA ' ' HG2' ' B' ' 117' ' ' LYS . 23.1 p80 -140.74 5.96 2.01 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 119.608 -0.837 . . . . 0.0 111.798 177.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 114' ' ' GLY . . . . . 0.59 ' O ' ' HG3' ' B' ' 117' ' ' LYS . . . -98.1 -152.6 28.23 Favored Glycine 0 C--O 1.226 -0.348 0 C-N-CA 120.489 -0.862 . . . . 0.0 111.393 177.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 115' ' ' VAL . . . . . 0.549 ' CG2' ' HA ' ' B' ' 91' ' ' PRO . 35.1 m -66.17 -5.92 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 117.411 0.606 . . . . 0.0 111.701 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 116' ' ' CYS . . . . . 0.436 ' SG ' HD21 ' B' ' 94' ' ' LEU . 0.9 OUTLIER -79.79 -25.28 40.97 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.294 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 117' ' ' LYS . . . . . 0.854 ' HG2' ' HA ' ' B' ' 113' ' ' HIS . 0.0 OUTLIER -96.03 3.51 53.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.359 178.19 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -44.97 -42.46 8.23 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 119' ' ' LEU . . . . . 0.704 ' O ' ' HB2' ' B' ' 120' ' ' HIS . 87.9 mt -106.66 -64.77 1.14 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 174.244 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 120' ' ' HIS . . . . . 0.704 ' HB2' ' O ' ' B' ' 119' ' ' LEU . 11.4 t-80 145.16 91.57 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.881 1.672 . . . . 0.0 108.883 177.218 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 62.1 mt -114.98 31.78 6.46 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -177.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 122' ' ' CYS . . . . . . . . . . . . . 6.3 p . . . . . 0 C--O 1.242 0.699 0 CA-C-O 118.408 -0.806 . . . . 0.0 110.965 178.653 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.197 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -100.02 144.55 28.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.747 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -77.79 99.41 1.5 Allowed Glycine 0 CA--C 1.509 -0.339 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.484 ' HD3' ' OG ' ' A' ' 44' ' ' SER . 64.2 mttp 67.77 -84.01 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -177.299 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.436 ' HB3' ' O ' ' A' ' 40' ' ' GLU . 13.7 p -159.81 20.18 0.17 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 177.111 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.563 ' HB3' ' HD3' ' A' ' 9' ' ' LYS . 14.5 m 64.79 55.5 1.23 Allowed 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.106 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -87.0 -16.1 9.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.349 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.509 HD12 ' N ' ' A' ' 9' ' ' LYS . 3.3 pp -68.61 -35.16 76.94 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.333 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.563 ' HD3' ' HB3' ' A' ' 6' ' ' SER . 0.0 OUTLIER -88.51 3.28 50.8 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 121.304 0.573 . . . . 0.0 110.408 178.783 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.4 tptt -98.42 37.65 1.44 Allowed 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 177.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.411 ' O ' HG12 ' A' ' 11' ' ' VAL . 20.7 t 58.79 41.84 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.972 -178.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 55.71 48.89 17.43 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.035 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.422 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 55.9 m 71.58 -4.82 1.78 Allowed 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 179.142 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.458 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -70.86 -34.55 71.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.742 0.306 . . . . 0.0 111.736 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.82 38.81 0.66 Allowed 'General case' 0 C--N 1.326 -0.443 0 O-C-N 122.103 -0.373 . . . . 0.0 111.95 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -167.66 -53.06 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.1 0.476 . . . . 0.0 111.017 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.732 HD13 ' HB2' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -78.04 -42.4 27.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.036 -179.748 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' A' ' 14' ' ' ALA . . . -67.97 -31.3 70.93 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.962 0.41 . . . . 0.0 110.721 178.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -76.11 -26.19 64.77 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.663 -0.779 . . . . 0.0 111.84 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.44 -24.44 60.24 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 120.882 0.372 . . . . 0.0 110.743 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 17' ' ' ILE . 98.9 t -66.35 -47.02 85.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.641 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.43 -22.06 66.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.722 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.11 -40.13 86.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.462 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.5 t -99.78 -12.86 19.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.009 0.433 . . . . 0.0 111.207 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.84 -61.76 0.35 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.097 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -105.74 170.23 16.88 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.249 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.456 HD13 HG22 ' A' ' 21' ' ' VAL . 2.6 tp -98.04 104.98 16.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.57 0.7 . . . . 0.0 111.581 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.558 ' OD1' HG23 ' A' ' 32' ' ' VAL . 18.1 p-10 -129.2 -111.33 0.27 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.726 178.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.62 ' HG ' ' CG2' ' A' ' 54' ' ' VAL . 43.3 tp -178.72 -47.03 0.0 OUTLIER Pre-proline 0 C--N 1.324 -0.505 0 C-N-CA 123.575 0.75 . . . . 0.0 110.682 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.832 ' HA ' HG21 ' A' ' 54' ' ' VAL . 32.5 Cg_exo -55.37 -31.59 77.94 Favored 'Trans proline' 0 C--N 1.367 1.528 0 C-N-CA 122.455 2.103 . . . . 0.0 113.227 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 19.5 t -106.93 -25.98 11.41 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.383 -178.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.558 HG23 ' OD1' ' A' ' 28' ' ' ASP . 65.8 t -72.13 -14.28 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.736 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.722 ' HA ' ' HB3' ' A' ' 36' ' ' LEU . 1.0 OUTLIER -59.19 -15.3 14.13 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.896 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.514 ' N ' HD12 ' A' ' 33' ' ' LEU . . . -54.3 -53.92 47.26 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.935 0.398 . . . . 0.0 111.66 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -103.3 28.29 6.51 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.222 0.534 . . . . 0.0 109.851 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.722 ' HB3' ' HA ' ' A' ' 33' ' ' LEU . 42.6 tp -122.67 -48.88 2.02 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.791 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.509 ' HE3' ' HB2' ' A' ' 58' ' ' LEU . 84.3 tttt -73.71 96.01 2.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.868 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -144.93 -80.14 0.17 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.66 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -113.27 150.74 32.02 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.497 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.436 ' O ' ' HB3' ' A' ' 5' ' ' CYS . 4.7 mp0 -67.45 143.03 56.45 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.562 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.43 -9.36 77.78 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.506 -0.854 . . . . 0.0 113.572 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 85.6 m -86.34 -23.15 26.33 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 117.331 0.565 . . . . 0.0 110.952 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.469 ' HB3' ' CD2' ' A' ' 60' ' ' LEU . . . -111.54 23.76 13.56 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.681 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.484 ' OG ' ' HD3' ' A' ' 4' ' ' LYS . 34.7 p -78.95 -49.71 12.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.552 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.7 p -54.55 -36.13 63.98 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.547 0.689 . . . . 0.0 111.103 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.732 ' HB2' HD13 ' A' ' 17' ' ' ILE . 0.8 OUTLIER -83.6 -68.62 0.7 Allowed 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.652 -1.158 . . . . 0.0 111.441 -178.982 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.483 ' HA ' ' HB2' ' A' ' 50' ' ' HIS . 37.4 m -77.57 32.16 0.16 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.218 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -65.35 -57.61 7.96 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.363 0.601 . . . . 0.0 109.385 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -90.4 -10.83 42.44 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.117 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.483 ' HB2' ' HA ' ' A' ' 47' ' ' CYS . 12.9 m80 -106.23 60.43 0.65 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.119 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 5.2 t -111.18 50.22 0.83 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.033 0.444 . . . . 0.0 111.108 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.501 ' HA ' ' HD2' ' A' ' 56' ' ' LYS . 20.6 p-80 -140.92 -7.46 1.07 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 0.0 112.05 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.427 ' O ' ' HG2' ' A' ' 56' ' ' LYS . . . -104.05 -151.71 22.11 Favored Glycine 0 CA--C 1.521 0.428 0 C-N-CA 120.519 -0.848 . . . . 0.0 113.01 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.832 HG21 ' HA ' ' A' ' 30' ' ' PRO . 31.1 m -55.03 -17.23 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.581 ' HB2' HD21 ' A' ' 29' ' ' LEU . 1.8 t -70.61 -24.52 62.75 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.71 -179.196 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.546 ' C ' ' H ' ' A' ' 58' ' ' LEU . 10.0 ptmt -94.19 17.17 13.11 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.373 178.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -83.99 29.59 0.55 Allowed 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 123.057 1.408 . . . . 0.0 107.926 177.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.546 ' H ' ' C ' ' A' ' 56' ' ' LYS . 6.9 tt -170.16 -37.3 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 32.6 t60 71.07 91.37 0.09 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 113.88 -1.509 . . . . 0.0 111.834 178.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.546 HD12 HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -131.09 16.07 5.12 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.377 179.927 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.879 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.131 0 CA-C-O 120.733 0.302 . . . . 0.0 110.373 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 63' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -81.31 114.92 20.41 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.715 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -78.93 80.35 1.5 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.615 -0.802 . . . . 0.0 111.651 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 65' ' ' LYS . . . . . 0.432 ' HE2' ' HB3' ' B' ' 65' ' ' LYS . 6.1 ptpt 46.93 -80.92 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.638 1.175 . . . . 0.0 113.414 -179.014 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 66' ' ' CYS . . . . . . . . . . . . . 29.5 p -154.75 17.33 0.45 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.595 ' HB3' ' HG2' ' B' ' 70' ' ' LYS . 18.9 m 55.59 70.2 0.66 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.347 0.594 . . . . 0.0 110.116 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.468 HG13 ' HB3' ' B' ' 74' ' ' CYS . 42.5 t -65.73 -37.26 79.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -177.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.439 ' HG ' ' N ' ' B' ' 70' ' ' LYS . 0.7 OUTLIER -65.88 -44.48 85.24 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -178.629 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 70' ' ' LYS . . . . . 0.595 ' HG2' ' HB3' ' B' ' 67' ' ' SER . 18.7 pttp -77.96 -1.54 32.47 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.126 0.488 . . . . 0.0 110.861 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 10.9 tttt -96.57 41.07 1.12 Allowed 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 177.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 12.5 t 59.73 39.78 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 114.499 -1.228 . . . . 0.0 110.422 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . 51.55 51.47 16.66 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.997 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 74' ' ' CYS . . . . . 0.753 ' HB2' HD12 ' B' ' 78' ' ' ILE . 2.0 p 48.14 37.5 8.18 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 114.506 -1.225 . . . . 0.0 113.638 -178.196 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -100.4 7.75 44.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.156 0.503 . . . . 0.0 110.575 178.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -89.61 -64.5 1.13 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.342 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.67 -24.71 23.81 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.812 HD13 ' HB2' ' B' ' 107' ' ' PHE . 23.9 mt -89.13 -55.18 6.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.553 0.216 . . . . 0.0 111.082 -179.167 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.17 -21.19 46.78 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.391 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.03 -34.16 42.95 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.705 -0.76 . . . . 0.0 111.626 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 81' ' ' ALA . . . . . 0.523 ' HB2' ' HB3' ' B' ' 96' ' ' ALA . . . -71.29 -18.15 62.43 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 120.956 0.408 . . . . 0.0 110.702 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 82' ' ' VAL . . . . . 0.463 HG23 ' O ' ' B' ' 78' ' ' ILE . 69.9 t -64.07 -41.73 93.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.857 178.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.02 -22.57 60.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.057 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.82 -39.54 30.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.547 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 22.7 t -89.5 -25.37 21.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.757 0.313 . . . . 0.0 110.865 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 96.46 34.5 5.79 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.367 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 147.6 163.8 10.86 Favored Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 111.399 -0.68 . . . . 0.0 111.399 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.36 127.42 63.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 117.199 0.5 . . . . 0.0 110.666 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 89' ' ' ASP . . . . . 0.558 ' OD2' ' HG2' ' B' ' 91' ' ' PRO . 30.2 p-10 -144.67 -59.22 0.37 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.449 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 90' ' ' LEU . . . . . 0.679 HD11 ' HB2' ' B' ' 116' ' ' CYS . 61.0 tp 133.55 -51.63 0.0 OUTLIER Pre-proline 0 N--CA 1.484 1.269 0 C-N-CA 126.2 1.8 . . . . 0.0 110.337 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 91' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' B' ' 90' ' ' LEU . 4.5 Cg_exo -44.06 -38.41 10.5 Favored 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 123.539 2.826 . . . . 0.0 114.686 -179.235 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 31.5 p -104.98 -31.14 9.36 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 120.241 -0.583 . . . . 0.0 111.581 -179.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 93' ' ' VAL . . . . . 0.493 HG13 ' HB3' ' B' ' 81' ' ' ALA . 3.9 t -63.29 -7.37 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.43 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 94' ' ' LEU . . . . . 0.447 HD22 ' HB ' ' B' ' 115' ' ' VAL . 4.3 pp -61.66 -22.61 65.45 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 122.343 -0.223 . . . . 0.0 111.2 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -53.2 -60.46 3.26 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -178.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 96' ' ' ALA . . . . . 0.523 ' HB3' ' HB2' ' B' ' 81' ' ' ALA . . . -78.11 -15.58 58.75 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.223 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 18.1 tp -74.61 -41.38 60.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.898 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 98' ' ' LYS . . . . . 0.746 ' HA ' HD11 ' B' ' 119' ' ' LEU . 43.9 mtpt -67.74 -20.26 65.22 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.777 0.323 . . . . 0.0 111.195 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -78.91 -11.1 59.99 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.617 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 100' ' ' ALA . . . . . 0.652 ' HB1' ' SG ' ' B' ' 103' ' ' CYS . . . -108.43 111.5 23.42 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.816 0.341 . . . . 0.0 110.951 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 12.0 mp0 -67.17 99.24 0.66 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.46 -178.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 70.77 35.45 66.33 Favored Glycine 0 CA--C 1.517 0.194 0 N-CA-C 114.396 0.518 . . . . 0.0 114.396 177.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 103' ' ' CYS . . . . . 0.652 ' SG ' ' HB1' ' B' ' 100' ' ' ALA . 60.8 m -107.38 13.88 26.55 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 117.567 0.683 . . . . 0.0 111.178 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 104' ' ' ALA . . . . . 0.563 ' HB3' HD21 ' B' ' 121' ' ' LEU . . . -100.46 27.17 5.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.227 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 3.0 p -73.96 -61.07 1.98 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.952 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 4.5 p -55.63 -37.74 68.58 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.556 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 107' ' ' PHE . . . . . 0.812 ' HB2' HD13 ' B' ' 78' ' ' ILE . 1.1 t80 -79.38 -75.71 0.24 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.069 -0.969 . . . . 0.0 112.514 -177.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 74.3 m -73.12 33.57 0.07 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -177.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -59.53 -57.92 10.84 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.332 0.587 . . . . 0.0 109.531 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -98.15 -19.65 17.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.483 178.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 7.3 m80 -93.77 65.34 3.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.722 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 4.6 t -123.53 58.91 1.12 Allowed 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.466 -0.493 . . . . 0.0 111.0 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 113' ' ' HIS . . . . . 0.57 ' O ' ' HE2' ' B' ' 117' ' ' LYS . 20.7 p-80 -139.96 -25.34 0.81 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 114' ' ' GLY . . . . . 0.447 ' O ' HG22 ' B' ' 115' ' ' VAL . . . -127.8 129.85 6.52 Favored Glycine 0 C--O 1.226 -0.396 0 C-N-CA 120.184 -1.008 . . . . 0.0 112.695 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 115' ' ' VAL . . . . . 0.447 HG22 ' O ' ' B' ' 114' ' ' GLY . 24.4 m 54.82 -31.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 C-N-CA 126.164 1.786 . . . . 0.0 115.204 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 116' ' ' CYS . . . . . 0.679 ' HB2' HD11 ' B' ' 90' ' ' LEU . 35.2 t -81.18 -37.69 28.3 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 121.807 -0.558 . . . . 0.0 111.291 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 117' ' ' LYS . . . . . 0.57 ' HE2' ' O ' ' B' ' 113' ' ' HIS . 52.1 pttt -77.7 15.05 0.89 Allowed 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 119.697 -0.801 . . . . 0.0 110.957 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -75.38 -24.1 57.18 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 106.824 -1.546 . . . . 0.0 106.824 175.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 119' ' ' LEU . . . . . 0.746 HD11 ' HA ' ' B' ' 98' ' ' LYS . 53.1 mt -94.75 -31.7 13.66 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 114.137 -1.392 . . . . 0.0 107.704 176.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 12.7 t60 55.9 76.28 0.29 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 113.886 -1.507 . . . . 0.0 112.437 178.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 121' ' ' LEU . . . . . 0.609 HD13 ' H ' ' B' ' 121' ' ' LEU . 0.0 OUTLIER -131.69 -3.34 3.71 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-O 120.959 0.409 . . . . 0.0 110.821 179.885 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 122' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.246 0.882 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.39 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.601 ' O ' ' HE2' ' A' ' 9' ' ' LYS . . . . . . . . 0 N--CA 1.484 1.259 0 CA-C-O 120.663 0.268 . . . . 0.0 110.549 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 7.7 mtp -101.54 114.52 28.62 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -105.49 176.55 22.45 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.466 -0.873 . . . . 0.0 113.552 -178.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.0 ptmm? -95.14 -27.03 15.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.836 0.351 . . . . 0.0 110.337 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 9.3 t -176.46 65.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.699 ' HB2' ' HB2' ' A' ' 9' ' ' LYS . 16.6 m -70.99 168.57 16.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.336 -178.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.0 m -75.56 -46.79 36.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -178.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.5 pp -89.48 -22.15 22.61 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 119.879 -0.728 . . . . 0.0 109.582 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.699 ' HB2' ' HB2' ' A' ' 6' ' ' SER . 19.1 mtpp -96.29 30.82 2.38 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 177.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -73.78 -6.35 46.48 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.697 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.442 ' O ' HG12 ' A' ' 11' ' ' VAL . 22.6 t 58.45 41.44 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.355 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 51.57 28.72 4.86 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 114.569 -1.196 . . . . 0.0 112.791 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.529 ' HB3' HD12 ' A' ' 17' ' ' ILE . 6.5 m 66.74 5.58 4.02 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.47 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -79.51 -13.47 59.53 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -178.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -98.04 15.62 23.58 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.912 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.47 -59.53 0.24 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.135 0.493 . . . . 0.0 111.3 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.723 HD13 ' HB3' ' A' ' 46' ' ' PHE . 80.6 mt -75.17 -42.77 44.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.354 -179.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 14' ' ' ALA . . . -59.54 -34.06 72.18 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -179.151 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -85.99 -33.1 15.9 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.646 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.811 ' HB1' HG13 ' A' ' 32' ' ' VAL . . . -69.6 -34.78 74.6 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.011 0.434 . . . . 0.0 111.343 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.4 t -64.07 -44.36 97.7 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.784 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.15 -22.53 66.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.648 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.65 -43.2 66.52 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 60.3 m -104.03 0.64 30.08 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 -178.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.18 42.95 10.06 Favored Glycine 0 CA--C 1.517 0.197 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.884 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 130.32 -178.88 17.28 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 121.062 -0.589 . . . . 0.0 111.634 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.2 pp -74.18 134.35 29.73 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 CA-C-O 121.748 0.785 . . . . 0.0 110.343 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.532 ' HB3' HG23 ' A' ' 32' ' ' VAL . 32.9 t70 -148.59 -127.7 0.05 Allowed 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.564 -1.198 . . . . 0.0 108.007 -178.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.869 HD21 ' HB2' ' A' ' 55' ' ' CYS . 20.6 tp 175.27 -56.3 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.461 0 O-C-N 123.418 0.449 . . . . 0.0 112.042 178.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.589 ' HA ' HG11 ' A' ' 54' ' ' VAL . 3.8 Cg_endo -49.92 -34.78 38.37 Favored 'Trans proline' 0 C--N 1.364 1.353 0 C-N-CA 122.752 2.301 . . . . 0.0 113.308 -179.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 17.3 p -110.59 -28.85 8.3 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.216 0.531 . . . . 0.0 110.979 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.811 HG13 ' HB1' ' A' ' 20' ' ' ALA . 51.6 t -67.72 -23.91 30.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.44 -179.38 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.8 pp -54.9 -26.56 36.66 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.95 -61.04 2.66 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -178.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.471 ' HB3' ' HB2' ' A' ' 20' ' ' ALA . . . -77.46 -21.64 52.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.74 0.305 . . . . 0.0 111.389 -179.354 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 52.6 tp -68.05 -36.47 79.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.498 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -66.12 -39.74 90.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.457 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 58.12 -100.25 0.11 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.577 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -132.64 18.81 4.27 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.715 -0.221 . . . . 0.0 111.396 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -168.26 -110.49 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -110.98 -64.32 0.51 Allowed Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 178.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 12.0 m 48.71 29.4 2.19 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.485 0.714 . . . . 0.0 112.916 177.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.572 ' CB ' ' HG ' ' A' ' 60' ' ' LEU . . . -115.35 -15.99 11.5 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.457 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 2.5 m -58.02 -19.18 29.2 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.013 0.435 . . . . 0.0 111.812 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 42.5 t -64.99 -53.38 47.16 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.723 ' HB3' HD13 ' A' ' 17' ' ' ILE . 0.3 OUTLIER -107.92 -46.63 3.74 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.294 -179.641 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.58 ' O ' ' HB3' ' A' ' 51' ' ' CYS . 0.1 OUTLIER -68.31 21.0 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.634 179.737 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.508 ' H ' ' C ' ' A' ' 46' ' ' PHE . 38.9 tp10 -63.52 -76.2 0.07 Allowed 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 123.246 0.618 . . . . 0.0 111.903 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -69.86 -44.69 69.34 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.858 -178.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -103.3 111.52 23.97 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.168 0.509 . . . . 0.0 111.901 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.695 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 13.5 p -164.99 35.33 0.06 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.613 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.492 ' HA ' ' HE3' ' A' ' 56' ' ' LYS . 3.7 p-80 -82.81 -16.33 48.19 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.541 ' HA3' ' HG2' ' B' ' 91' ' ' PRO . . . -76.86 -123.89 0.21 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.384 -0.913 . . . . 0.0 112.04 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.589 HG11 ' HA ' ' A' ' 30' ' ' PRO . 8.9 p -85.9 18.84 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.745 0.783 . . . . 0.0 110.265 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.869 ' HB2' HD21 ' A' ' 29' ' ' LEU . 5.3 t -91.64 -48.43 6.84 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.295 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.492 ' HE3' ' HA ' ' A' ' 52' ' ' HIS . 19.8 pttp -89.27 14.07 11.91 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 120.976 -0.289 . . . . 0.0 110.662 178.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -56.13 -41.63 75.62 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.259 0.552 . . . . 0.0 109.727 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.5 tt -135.67 -79.16 0.43 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 177.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -155.1 118.25 4.41 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.977 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.572 ' HG ' ' CB ' ' A' ' 43' ' ' ALA . 8.1 tp -153.87 -50.97 0.1 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.92 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.533 ' HB3' ' O ' ' A' ' 47' ' ' CYS . 0.8 OUTLIER . . . . . 0 C--O 1.243 0.759 0 CA-C-O 118.474 -0.774 . . . . 0.0 110.518 178.445 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.044 0 CA-C-O 120.771 0.319 . . . . 0.0 110.945 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 63' ' ' MET . . . . . . . . . . . . . 23.7 mmt -73.67 134.46 43.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.48 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -80.78 118.03 4.56 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.897 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 65' ' ' LYS . . . . . 0.623 ' HE2' ' O ' ' B' ' 100' ' ' ALA . 69.6 tttt -73.25 -63.03 1.27 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.869 0.366 . . . . 0.0 110.052 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 66' ' ' CYS . . . . . 0.939 ' HB3' ' HB3' ' B' ' 101' ' ' GLU . 32.1 t 177.6 152.94 0.26 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.406 ' O ' ' HB3' ' B' ' 71' ' ' LYS . 15.8 t -162.06 -170.55 2.54 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 27.5 m -94.25 -13.03 8.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.012 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.407 ' HG ' ' N ' ' B' ' 70' ' ' LYS . 0.7 OUTLIER -108.5 -45.68 3.83 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 121.281 -0.168 . . . . 0.0 111.228 179.811 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 70' ' ' LYS . . . . . 0.505 ' HE3' ' HB2' ' B' ' 70' ' ' LYS . 14.9 ptmt -96.24 38.29 1.2 Allowed 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 122.05 0.928 . . . . 0.0 109.075 178.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 71' ' ' LYS . . . . . 0.406 ' HB3' ' O ' ' B' ' 67' ' ' SER . 60.9 pttt -74.23 -11.42 60.28 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 114.113 -1.403 . . . . 0.0 107.726 177.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 6.7 t 58.33 43.09 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 113.981 -1.463 . . . . 0.0 110.435 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . 51.25 24.99 2.26 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.171 -178.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 74' ' ' CYS . . . . . 0.521 ' HB3' HD12 ' B' ' 78' ' ' ILE . 0.0 OUTLIER 53.49 27.25 6.29 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.603 -178.714 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.68 -53.79 8.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.858 0.361 . . . . 0.0 110.965 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.85 42.68 0.72 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.973 0.416 . . . . 0.0 111.381 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -159.21 -44.87 0.05 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.582 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.674 HD13 ' HB2' ' B' ' 107' ' ' PHE . 12.5 mt -100.79 -52.44 8.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.203 -179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.88 -33.63 73.38 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.15 -37.62 17.84 Favored Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.645 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.78 -29.54 63.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.052 0.453 . . . . 0.0 111.49 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 82' ' ' VAL . . . . . 0.478 HG22 ' HA ' ' B' ' 88' ' ' ILE . 2.6 t -66.13 -40.17 86.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.607 179.368 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.4 -24.05 66.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.261 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.9 -39.08 44.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.319 -0.401 . . . . 0.0 112.049 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 4.8 t -85.52 -25.51 26.78 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.871 -0.331 . . . . 0.0 111.123 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 104.71 39.79 2.29 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.474 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 87' ' ' GLY . . . . . 0.434 ' C ' HG13 ' B' ' 82' ' ' VAL . . . 124.45 170.99 13.31 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.025 -0.607 . . . . 0.0 111.613 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 88' ' ' ILE . . . . . 0.478 ' HA ' HG22 ' B' ' 82' ' ' VAL . 1.2 pt -66.12 143.14 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.438 0 CA-C-O 121.416 0.627 . . . . 0.0 110.436 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 89' ' ' ASP . . . . . 0.484 ' O ' ' HB2' ' B' ' 90' ' ' LEU . 29.6 t70 -157.26 -127.4 0.03 OUTLIER 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.728 -178.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 90' ' ' LEU . . . . . 0.555 HD21 ' HB2' ' B' ' 116' ' ' CYS . 36.5 tp 170.73 -58.14 0.0 OUTLIER Pre-proline 0 C--N 1.323 -0.558 0 O-C-N 123.867 0.73 . . . . 0.0 110.563 178.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 91' ' ' PRO . . . . . 0.541 ' HG2' ' HA3' ' A' ' 53' ' ' GLY . 14.3 Cg_endo -57.8 -16.11 24.14 Favored 'Trans proline' 0 C--N 1.365 1.409 0 C-N-CA 122.681 2.254 . . . . 0.0 113.585 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 20.3 p -110.23 -34.02 6.49 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.217 0.532 . . . . 0.0 110.37 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 93' ' ' VAL . . . . . 0.41 HG12 ' HB2' ' B' ' 97' ' ' LEU . 3.0 t -74.26 -18.05 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.141 -178.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 94' ' ' LEU . . . . . 0.654 HD23 HG11 ' B' ' 115' ' ' VAL . 0.6 OUTLIER -40.95 -31.74 0.19 Allowed 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 -178.206 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 95' ' ' ALA . . . . . 0.555 ' N ' HD12 ' B' ' 94' ' ' LEU . . . -84.28 -54.53 4.73 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 118.442 0.564 . . . . 0.0 112.257 -178.309 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.8 -17.48 62.16 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.6 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 97' ' ' LEU . . . . . 0.41 ' HB2' HG12 ' B' ' 93' ' ' VAL . 20.0 tp -67.97 -38.12 82.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.478 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 44.5 mttm -56.69 -51.86 67.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.757 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . 72.01 -54.94 0.67 Allowed 'General case' 0 N--CA 1.471 0.612 0 O-C-N 124.024 0.828 . . . . 0.0 110.68 -178.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 100' ' ' ALA . . . . . 0.623 ' O ' ' HE2' ' B' ' 65' ' ' LYS . . . -163.39 -27.11 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.547 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 101' ' ' GLU . . . . . 0.939 ' HB3' ' HB3' ' B' ' 66' ' ' CYS . 32.1 tt0 -141.79 -85.28 0.18 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.043 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.99 -85.06 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 58.2 m 59.37 24.85 13.45 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 178.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -113.22 16.31 19.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.864 0.364 . . . . 0.0 110.693 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 105' ' ' SER . . . . . 0.648 ' O ' ' HG2' ' B' ' 109' ' ' GLU . 3.9 p -58.67 -52.05 67.33 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.142 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 18.7 p -53.95 -41.28 67.61 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.78 0.8 . . . . 0.0 111.517 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 107' ' ' PHE . . . . . 0.674 ' HB2' HD13 ' B' ' 78' ' ' ILE . 0.9 OUTLIER -69.36 -72.32 0.19 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.27 -1.332 . . . . 0.0 112.908 -177.928 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 108' ' ' CYS . . . . . 0.813 ' HA ' ' HB2' ' B' ' 111' ' ' HIS . 36.3 m -81.11 34.8 0.37 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -176.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 109' ' ' GLU . . . . . 0.648 ' HG2' ' O ' ' B' ' 105' ' ' SER . 13.1 mm-40 -60.59 -60.89 3.09 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 177.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -96.69 -0.18 48.74 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 111' ' ' HIS . . . . . 0.813 ' HB2' ' HA ' ' B' ' 108' ' ' CYS . 55.4 m-70 -108.59 39.48 1.99 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.962 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 2.1 t -98.0 49.31 1.01 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 113' ' ' HIS . . . . . . . . . . . . . 22.3 p-80 -123.24 -33.18 3.32 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.097 -178.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 114' ' ' GLY . . . . . 0.427 ' C ' ' H ' ' B' ' 116' ' ' CYS . . . -85.15 -146.33 8.29 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.857 -0.687 . . . . 0.0 113.425 -179.052 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 115' ' ' VAL . . . . . 0.654 HG11 HD23 ' B' ' 94' ' ' LEU . 7.7 p -74.65 37.34 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 122.331 1.062 . . . . 0.0 111.436 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 116' ' ' CYS . . . . . 0.555 ' HB2' HD21 ' B' ' 90' ' ' LEU . 2.5 t -120.31 -25.88 5.56 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.527 -0.76 . . . . 0.0 108.986 178.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.78 -9.83 39.11 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.909 178.305 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -49.54 -52.2 31.52 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.636 -179.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 73.1 mt -107.4 -104.34 0.35 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 177.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -151.18 93.33 1.9 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.228 0.537 . . . . 0.0 109.9 177.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 121' ' ' LEU . . . . . 0.411 ' HB2' ' O ' ' B' ' 116' ' ' CYS . 9.4 mp -121.58 -28.01 4.65 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.982 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 122' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.245 0.859 0 CA-C-O 118.437 -0.792 . . . . 0.0 110.802 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.243 0 CA-C-O 120.624 0.249 . . . . 0.0 110.74 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 54.1 mtm -80.8 178.44 8.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.03 0.443 . . . . 0.0 110.943 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -95.19 80.49 0.86 Allowed Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.01 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.41 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 0.9 OUTLIER -78.55 53.35 1.3 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.47 0.176 . . . . 0.0 111.41 -179.746 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.768 ' HA ' ' HB3' ' A' ' 9' ' ' LYS . 28.5 m 56.78 45.2 22.14 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.169 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.8 m -97.22 123.21 40.94 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 22.0 t 49.19 -83.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 O-C-N 124.318 1.011 . . . . 0.0 113.59 178.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.7 tp -65.06 -48.29 74.29 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.712 0.291 . . . . 0.0 110.519 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.768 ' HB3' ' HA ' ' A' ' 5' ' ' CYS . 0.0 OUTLIER -73.46 10.73 0.95 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.191 178.904 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -97.0 -19.39 18.79 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.4 t -119.66 -43.1 2.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.044 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.4 16.86 1.19 Allowed 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -80.02 -17.11 53.66 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.832 0.348 . . . . 0.0 111.125 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -81.21 21.41 0.74 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.619 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -109.75 -42.74 4.19 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.283 0.563 . . . . 0.0 109.838 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.27 -40.8 43.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.979 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.609 HG12 ' CD2' ' A' ' 46' ' ' PHE . 10.9 tp -72.38 -32.16 41.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.517 0.675 . . . . 0.0 110.194 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.404 ' HB2' ' O ' ' A' ' 14' ' ' ALA . . . -56.3 -27.66 56.21 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.527 -1.215 . . . . 0.0 111.595 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.48 -29.67 51.97 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.437 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.92 -28.83 62.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.064 0.459 . . . . 0.0 110.477 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 96.5 t -66.04 -48.88 80.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.297 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.96 -33.91 76.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.179 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.61 -34.66 78.75 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.783 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.545 ' SG ' ' HB2' ' B' ' 113' ' ' HIS . 3.9 t -89.21 -28.93 19.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.772 0.32 . . . . 0.0 111.109 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.6 40.8 3.54 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.362 -0.923 . . . . 0.0 112.209 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 148.11 163.03 10.49 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.761 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -108.18 135.58 46.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.255 0.55 . . . . 0.0 111.938 -179.268 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.465 ' HB3' ' H ' ' A' ' 29' ' ' LEU . 7.9 t70 -160.59 -97.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.047 -0.979 . . . . 0.0 108.798 178.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.689 HD21 ' HB2' ' A' ' 55' ' ' CYS . 49.4 tp -178.85 -53.86 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.254 0 CA-C-O 119.263 -0.399 . . . . 0.0 111.484 178.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.664 ' HG3' ' HD3' ' B' ' 91' ' ' PRO . 96.3 Cg_exo -41.35 -65.47 0.19 Allowed 'Trans proline' 0 C--N 1.36 1.183 0 C-N-CA 123.203 2.602 . . . . 0.0 114.463 -178.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.503 ' HB3' ' O ' ' B' ' 113' ' ' HIS . 14.0 p -79.2 -32.49 44.1 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.878 -178.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.519 HG12 HD11 ' A' ' 17' ' ' ILE . 2.6 t -62.57 -31.05 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.988 -179.305 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 23.6 tp -65.76 -45.57 82.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.306 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.38 -43.76 68.07 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -178.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.57 -20.22 65.36 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -179.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.406 HD13 HD13 ' A' ' 17' ' ' ILE . 7.2 tt -99.05 -23.91 15.1 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.152 0.501 . . . . 0.0 110.214 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.9 mmmt -75.11 99.07 3.83 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -178.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -126.48 -24.88 3.54 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 175.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -171.63 -166.03 0.42 Allowed 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 112.235 -2.257 . . . . 0.0 105.612 178.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -70.15 -59.96 2.58 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 119.92 -0.712 . . . . 0.0 110.258 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 4' ' ' LYS . . . 56.45 -118.45 11.57 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 121.133 -0.556 . . . . 0.0 112.59 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 10.5 t -96.64 -94.12 0.21 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 66.93 -51.54 0.47 Allowed 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.1 p -54.84 -22.28 14.02 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 113.715 1.005 . . . . 0.0 113.715 -178.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.1 t -66.75 -49.98 64.23 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.494 0.664 . . . . 0.0 109.924 178.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.609 ' CD2' HG12 ' A' ' 17' ' ' ILE . 0.8 OUTLIER -72.2 -43.57 64.28 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 178.271 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.429 ' O ' ' HB3' ' A' ' 61' ' ' CYS . 86.1 m -94.14 67.58 3.62 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.832 -1.077 . . . . 0.0 109.611 178.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -92.9 -105.33 0.12 Allowed 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.2 p30 -72.85 -10.57 59.94 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 121.934 0.873 . . . . 0.0 108.972 177.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -103.35 99.06 8.89 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 113.687 -1.597 . . . . 0.0 106.793 177.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 44.9 t -169.07 79.92 0.13 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -177.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.514 ' CE1' ' HB2' ' B' ' 89' ' ' ASP . 3.5 p80 -138.93 18.03 2.65 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.415 0.626 . . . . 0.0 110.454 176.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.705 ' HA3' ' HG2' ' B' ' 91' ' ' PRO . . . -119.33 -135.36 5.08 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.657 -0.702 . . . . 0.0 112.337 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.568 ' CG2' ' HG ' ' A' ' 29' ' ' LEU . 16.1 m -55.54 -27.94 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.689 ' HB2' HD21 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -74.38 -38.23 63.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.448 -179.26 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.598 ' HD3' ' O ' ' A' ' 53' ' ' GLY . 0.0 OUTLIER -65.61 -24.91 67.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.697 0.284 . . . . 0.0 111.062 -179.773 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -58.36 -26.09 62.75 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.441 -179.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.552 ' HB2' HD22 ' A' ' 60' ' ' LEU . 3.2 mm? -90.72 -23.66 20.64 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.501 ' HB2' ' O ' ' A' ' 58' ' ' LEU . 39.3 m-70 74.72 63.83 0.07 Allowed 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.144 0.578 . . . . 0.0 111.994 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.552 HD22 ' HB2' ' A' ' 58' ' ' LEU . 1.9 pt? -140.48 14.98 2.37 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.947 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.429 ' HB3' ' O ' ' A' ' 47' ' ' CYS . 1.5 p . . . . . 0 C--O 1.245 0.829 0 CA-C-O 118.136 -0.935 . . . . 0.0 111.287 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.286 0 CA-C-O 120.763 0.316 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 63' ' ' MET . . . . . 0.558 ' HG3' ' H ' ' B' ' 64' ' ' GLY . 6.0 ptt? -89.69 -85.47 0.21 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.533 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 64' ' ' GLY . . . . . 0.558 ' H ' ' HG3' ' B' ' 63' ' ' MET . . . 79.16 175.65 47.36 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.608 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 21.8 mttp -111.16 94.27 4.9 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 122.619 -0.342 . . . . 0.0 110.972 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 66' ' ' CYS . . . . . 0.727 ' HA ' ' CB ' ' B' ' 70' ' ' LYS . 0.0 OUTLIER 56.39 60.37 3.17 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.328 178.964 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 1.7 p -102.24 131.18 48.95 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.289 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.52 ' O ' ' HB2' ' B' ' 71' ' ' LYS . 12.0 t 51.14 -95.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 123.984 0.914 . . . . 0.0 113.411 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.4 ' H ' ' HB ' ' B' ' 68' ' ' VAL . 46.1 tp -60.29 -42.25 95.09 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 120.836 0.351 . . . . 0.0 111.341 -178.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 70' ' ' LYS . . . . . 0.727 ' CB ' ' HA ' ' B' ' 66' ' ' CYS . 17.9 mmtm -64.45 -23.35 67.25 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.614 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 71' ' ' LYS . . . . . 0.52 ' HB2' ' O ' ' B' ' 68' ' ' VAL . 0.0 OUTLIER -65.64 -25.88 67.56 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.009 179.85 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 4.9 t -94.38 -16.95 7.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.43 0.633 . . . . 0.0 109.755 179.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.65 -33.96 40.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.761 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 74' ' ' CYS . . . . . 0.646 ' HB3' ' SG ' ' B' ' 103' ' ' CYS . 15.0 p -64.67 -43.28 94.08 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.772 -179.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -69.8 -3.69 16.73 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -105.15 -46.91 4.12 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.172 0.511 . . . . 0.0 109.741 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.6 -39.97 70.16 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.32 -0.855 . . . . 0.0 112.079 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.789 HD13 HD12 ' B' ' 97' ' ' LEU . 6.0 tp -73.23 -37.37 51.96 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 CA-C-O 121.323 0.582 . . . . 0.0 109.706 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.32 -33.09 74.76 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.915 -1.038 . . . . 0.0 110.713 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -74.96 -30.96 58.52 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.646 -0.787 . . . . 0.0 111.699 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.76 -21.43 61.74 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.206 0.527 . . . . 0.0 110.47 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 82' ' ' VAL . . . . . 0.455 HG23 ' O ' ' B' ' 78' ' ' ILE . 44.4 t -64.46 -51.72 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.081 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.45 -19.72 63.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.126 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.65 -39.64 57.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.737 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 1.4 t -88.36 -30.8 19.27 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.804 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 114.66 40.37 0.93 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.299 -0.953 . . . . 0.0 113.806 178.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 136.15 175.05 13.61 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.072 -1.061 . . . . 0.0 112.936 179.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 6.1 tp -91.3 134.3 30.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.183 0.516 . . . . 0.0 111.098 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 89' ' ' ASP . . . . . 0.514 ' HB2' ' CE1' ' A' ' 52' ' ' HIS . 2.6 t0 -156.46 -119.01 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 90' ' ' LEU . . . . . 0.553 ' N ' ' HD2' ' B' ' 91' ' ' PRO . 47.1 tp -177.66 -53.63 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.461 0 C-N-CA 123.077 0.551 . . . . 0.0 111.121 177.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 91' ' ' PRO . . . . . 0.815 ' HA ' HG21 ' B' ' 115' ' ' VAL . 2.9 Cg_endo -48.36 -48.96 15.46 Favored 'Trans proline' 0 C--N 1.359 1.093 0 C-N-CA 123.018 2.479 . . . . 0.0 113.634 -179.257 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 4.2 t -81.64 -40.34 23.06 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.935 0.398 . . . . 0.0 111.583 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 93' ' ' VAL . . . . . 0.437 ' H ' HG23 ' B' ' 93' ' ' VAL . 2.2 t -62.3 -24.49 35.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.409 -179.07 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 94' ' ' LEU . . . . . 0.74 HD22 HG23 ' B' ' 115' ' ' VAL . 22.5 tp -63.48 -26.72 68.85 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.27 0.471 . . . . 0.0 112.27 -179.316 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.05 -31.89 61.47 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -178.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -83.59 -1.85 54.78 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 97' ' ' LEU . . . . . 0.789 HD12 HD13 ' B' ' 78' ' ' ILE . 21.0 mt -136.75 14.88 3.13 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -178.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 98' ' ' LYS . . . . . 0.728 ' HG3' ' HG ' ' B' ' 94' ' ' LEU . 12.6 mtpt -84.68 102.54 13.04 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 119.554 -0.859 . . . . 0.0 111.73 -179.229 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -162.16 170.9 18.3 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.35 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -80.09 127.38 32.23 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 58.23 -143.75 0.63 Allowed 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -178.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.37 -72.45 1.19 Allowed Glycine 0 C--N 1.329 0.189 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.676 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 103' ' ' CYS . . . . . 0.646 ' SG ' ' HB3' ' B' ' 74' ' ' CYS . 45.9 t -164.56 -109.63 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 119.757 -0.163 . . . . 0.0 110.616 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 104' ' ' ALA . . . . . 0.418 ' N ' ' SG ' ' B' ' 103' ' ' CYS . . . 67.82 -59.06 0.43 Allowed 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.682 0.793 . . . . 0.0 112.4 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 105' ' ' SER . . . . . 0.523 ' HA ' ' HB2' ' B' ' 108' ' ' CYS . 5.0 p -63.94 2.8 0.46 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -178.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 106' ' ' CYS . . . . . 0.453 ' HB2' ' SG ' ' B' ' 66' ' ' CYS . 8.7 t -72.81 -47.27 47.86 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.023 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 107' ' ' PHE . . . . . 0.619 ' CD2' HG12 ' B' ' 78' ' ' ILE . 1.0 OUTLIER -74.24 -25.93 59.93 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 177.216 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 108' ' ' CYS . . . . . 0.594 ' O ' ' HB3' ' B' ' 122' ' ' CYS . 2.5 m -103.36 67.35 0.92 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.42 -1.263 . . . . 0.0 110.279 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 109' ' ' GLU . . . . . 0.408 ' HB3' ' H ' ' B' ' 110' ' ' ASP . 9.3 tp10 -96.53 -108.04 0.16 Allowed 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 110' ' ' ASP . . . . . 0.408 ' H ' ' HB3' ' B' ' 109' ' ' GLU . 45.8 p30 -72.95 -11.45 60.58 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 177.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -103.03 99.12 8.98 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 113.087 -1.87 . . . . 0.0 106.877 177.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 42.6 t -144.96 83.06 1.68 Allowed 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.791 -176.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 113' ' ' HIS . . . . . 0.725 ' HA ' ' HD2' ' B' ' 117' ' ' LYS . 1.5 p-80 -150.01 2.41 0.51 Allowed 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.8 0.666 . . . . 0.0 112.8 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 114' ' ' GLY . . . . . 0.589 ' HA2' ' HB2' ' A' ' 30' ' ' PRO . . . -98.72 -156.48 29.34 Favored Glycine 0 C--O 1.227 -0.293 0 C-N-CA 120.048 -1.072 . . . . 0.0 112.728 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 115' ' ' VAL . . . . . 0.815 HG21 ' HA ' ' B' ' 91' ' ' PRO . 19.6 m -56.63 -11.19 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 122.959 0.504 . . . . 0.0 112.35 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 116' ' ' CYS . . . . . . . . . . . . . 35.7 t -84.25 -39.75 18.89 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.377 -178.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 117' ' ' LYS . . . . . 0.725 ' HD2' ' HA ' ' B' ' 113' ' ' HIS . 6.3 ptmm? -64.99 -14.37 60.12 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.71 0.291 . . . . 0.0 110.737 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -57.08 -25.33 58.56 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.138 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 119' ' ' LEU . . . . . 0.565 ' HB2' HD22 ' B' ' 121' ' ' LEU . 3.1 mm? -99.26 -13.18 19.8 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 122.072 -0.392 . . . . 0.0 111.483 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 22.2 m-70 67.34 76.03 0.29 Allowed 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 122.943 0.497 . . . . 0.0 111.365 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 121' ' ' LEU . . . . . 0.565 HD22 ' HB2' ' B' ' 119' ' ' LEU . 1.0 OUTLIER -140.02 18.56 2.46 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.487 -179.334 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 122' ' ' CYS . . . . . 0.594 ' HB3' ' O ' ' B' ' 108' ' ' CYS . 0.9 OUTLIER . . . . . 0 C--O 1.246 0.889 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.767 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.191 0 CA-C-O 120.801 0.334 . . . . 0.0 110.762 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 4.6 ptm -148.18 172.84 13.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.306 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 144.67 178.28 20.18 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.646 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 27.3 mtmm -89.42 144.94 25.67 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.521 0.201 . . . . 0.0 110.87 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 34.6 m 64.85 29.93 12.35 Favored 'General case' 0 N--CA 1.463 0.203 0 O-C-N 123.852 0.72 . . . . 0.0 110.883 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 27.2 m -99.57 164.97 11.85 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -179.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.838 HG13 ' H ' ' A' ' 8' ' ' LEU . 5.7 p 36.76 -92.25 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 179.307 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.838 ' H ' HG13 ' A' ' 7' ' ' VAL . 22.0 tp -66.74 -31.41 72.04 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 117.957 0.344 . . . . 0.0 111.63 -177.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.2 mmmm -91.71 12.59 20.74 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.491 ' O ' ' HG3' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -111.47 11.56 21.4 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.609 -179.84 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 8' ' ' LEU . 95.0 t -51.31 -55.14 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 121.243 0.544 . . . . 0.0 110.624 178.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -167.32 62.49 0.08 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.975 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.999 ' HB2' HD12 ' A' ' 17' ' ' ILE . 1.8 p 46.98 33.1 2.11 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 124.129 0.893 . . . . 0.0 110.737 -177.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.62 65.23 8.43 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 114.258 -1.337 . . . . 0.0 110.545 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -145.61 -88.6 0.1 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.765 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.59 -21.74 44.63 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.325 0.584 . . . . 0.0 111.732 -178.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.999 HD12 ' HB2' ' A' ' 13' ' ' CYS . 64.5 mt -80.76 -8.79 11.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-O 121.836 0.827 . . . . 0.0 110.808 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -111.01 -9.9 14.39 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.529 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -115.18 -53.69 0.39 Allowed Glycine 0 C--O 1.228 -0.264 0 C-N-CA 120.568 -0.825 . . . . 0.0 113.013 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.88 -22.9 65.08 Favored 'General case' 0 C--O 1.226 -0.172 0 CA-C-N 117.207 0.504 . . . . 0.0 111.469 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.6 t -66.7 -41.9 88.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 O-C-N 122.09 -0.381 . . . . 0.0 110.824 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.03 -30.08 69.22 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.456 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.86 -30.82 71.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.092 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.0 t -87.09 -23.35 24.93 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.787 0.327 . . . . 0.0 110.664 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.64 39.32 4.19 Favored Glycine 0 N--CA 1.453 -0.177 0 C-N-CA 120.51 -0.852 . . . . 0.0 113.115 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 135.14 174.25 13.36 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.188 -1.006 . . . . 0.0 112.782 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 23.0 mm -72.73 125.85 32.28 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 CA-C-O 121.261 0.553 . . . . 0.0 111.412 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.417 ' HB2' ' CD2' ' B' ' 113' ' ' HIS . 35.5 t70 -144.31 -122.01 0.08 Allowed 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.737 -1.12 . . . . 0.0 108.421 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.743 ' HG ' HG21 ' A' ' 54' ' ' VAL . 12.1 tp 165.65 -61.02 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.407 0 C-N-CA 124.134 0.973 . . . . 0.0 109.645 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 1.033 ' HA ' HG11 ' A' ' 54' ' ' VAL . 9.5 Cg_endo -54.32 -41.22 78.31 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.044 1.83 . . . . 0.0 113.216 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.755 ' HB3' ' HA2' ' B' ' 114' ' ' GLY . 23.4 p -81.2 -38.07 27.64 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.552 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.1 t -67.51 -25.11 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.74 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.726 ' HA ' ' HB3' ' A' ' 36' ' ' LEU . 22.2 tp -52.35 -32.43 38.21 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.563 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -45.36 -43.98 11.41 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -115.83 22.41 13.08 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.104 0.478 . . . . 0.0 109.873 178.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.726 ' HB3' ' HA ' ' A' ' 33' ' ' LEU . 27.9 tp -114.81 -14.2 11.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.898 -178.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.611 ' HD3' ' O ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -69.36 85.11 0.4 Allowed 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.794 0.807 . . . . 0.0 111.674 -179.143 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.37 -159.06 0.98 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.047 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.412 ' HA ' ' HB2' ' A' ' 43' ' ' ALA . . . -125.06 -162.78 1.13 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.799 0.333 . . . . 0.0 111.539 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 58.11 -129.46 1.46 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.331 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.532 ' O ' ' HB3' ' A' ' 13' ' ' CYS . . . -62.12 -25.41 66.29 Favored Glycine 0 C--N 1.332 0.341 0 CA-C-N 115.892 -0.595 . . . . 0.0 114.429 -178.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 98.1 m -86.48 -0.45 56.08 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 117.711 0.755 . . . . 0.0 111.579 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' A' ' 47' ' ' CYS . . . -113.61 -61.15 1.78 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.679 0.276 . . . . 0.0 111.534 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 18.4 m -89.22 50.95 2.02 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -178.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.431 ' HB3' ' HB3' ' A' ' 13' ' ' CYS . 11.2 t -150.83 -56.28 0.16 Allowed 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.104 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.753 ' HB2' HD13 ' A' ' 17' ' ' ILE . 0.9 OUTLIER -87.99 -47.61 8.41 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.866 178.808 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 43' ' ' ALA . 95.5 m -81.98 47.82 1.16 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.102 -0.954 . . . . 0.0 112.144 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -84.79 -74.94 0.37 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 178.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -100.63 -21.46 15.25 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.356 178.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.402 ' HB3' HD22 ' A' ' 29' ' ' LEU . 55.2 m-70 -84.82 98.43 10.29 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 177.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.672 ' HB3' ' HG2' ' A' ' 56' ' ' LYS . 81.1 m -142.86 -10.28 0.79 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -177.376 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.651 ' O ' ' HB2' ' B' ' 91' ' ' PRO . 45.6 m80 -30.15 95.9 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 115.459 1.652 . . . . 0.0 115.459 -178.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 64.44 -6.71 0.74 Allowed Glycine 0 CA--C 1.526 0.753 0 N-CA-C 116.287 1.275 . . . . 0.0 116.287 176.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 1.033 HG11 ' HA ' ' A' ' 30' ' ' PRO . 0.1 OUTLIER -106.59 -72.62 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 118.359 1.08 . . . . 0.0 110.896 -179.806 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.624 ' SG ' HD11 ' A' ' 29' ' ' LEU . 57.5 m -71.23 -23.3 61.98 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.406 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.672 ' HG2' ' HB3' ' A' ' 51' ' ' CYS . 53.3 mmtt -72.19 -32.65 66.99 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.084 177.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -62.65 -39.2 93.12 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.654 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 38.9 mt -77.45 -16.03 59.0 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.397 178.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 12.4 t-160 58.78 65.19 1.27 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.112 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.1 mt -131.61 13.8 4.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.389 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 7.9 p . . . . . 0 C--O 1.245 0.851 0 CA-C-O 117.793 -1.099 . . . . 0.0 109.573 -179.823 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.264 0 CA-C-O 120.7 0.286 . . . . 0.0 110.831 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 63' ' ' MET . . . . . . . . . . . . . 16.1 ptp -93.69 164.74 13.03 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 140.74 166.75 10.81 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.185 -1.007 . . . . 0.0 113.153 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 29.7 mttm -69.27 120.61 15.37 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.516 0.198 . . . . 0.0 111.084 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 66' ' ' CYS . . . . . 0.571 ' SG ' ' HB3' ' B' ' 76' ' ' ALA . 30.9 m 65.38 55.95 1.02 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.407 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 71.0 m -79.46 -85.84 0.08 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.676 -0.238 . . . . 0.0 110.992 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.466 HG13 ' H ' ' B' ' 69' ' ' LEU . 4.2 p -122.6 -58.68 2.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.679 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.466 ' H ' HG13 ' B' ' 68' ' ' VAL . 31.5 tp -73.73 -23.84 59.82 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.247 0.546 . . . . 0.0 110.135 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 70' ' ' LYS . . . . . 0.776 ' HB3' ' HB2' ' B' ' 76' ' ' ALA . 1.0 OUTLIER -88.38 11.18 17.52 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.912 178.789 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 71' ' ' LYS . . . . . 0.573 ' HG3' ' HA3' ' B' ' 102' ' ' GLY . 25.1 ttpp -114.78 17.73 16.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.611 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.413 HG23 ' O ' ' B' ' 69' ' ' LEU . 63.1 t -71.92 -59.81 3.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 120.836 0.351 . . . . 0.0 110.755 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -141.61 55.62 1.51 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.874 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 74' ' ' CYS . . . . . 0.815 ' HB3' HD12 ' B' ' 78' ' ' ILE . 2.7 m 58.56 29.68 18.77 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.893 -179.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 75' ' ' ALA . . . . . 0.643 ' HA ' ' HB3' ' B' ' 79' ' ' ALA . . . -78.98 64.47 3.92 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -177.114 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 76' ' ' ALA . . . . . 0.776 ' HB2' ' HB3' ' B' ' 70' ' ' LYS . . . -163.04 -77.07 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.923 0.392 . . . . 0.0 111.127 178.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 77' ' ' ALA . . . . . 0.494 ' HB1' ' HA ' ' B' ' 97' ' ' LEU . . . -86.51 -2.52 58.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.211 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.815 HD12 ' HB3' ' B' ' 74' ' ' CYS . 44.8 mt -119.03 -68.09 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.637 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 79' ' ' ALA . . . . . 0.643 ' HB3' ' HA ' ' B' ' 75' ' ' ALA . . . -84.57 52.46 2.38 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.563 0.697 . . . . 0.0 109.472 177.233 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -165.21 -38.68 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 110.306 -1.117 . . . . 0.0 110.306 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.15 -11.44 59.93 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-O 121.253 0.549 . . . . 0.0 109.724 178.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 82' ' ' VAL . . . . . 0.574 HG22 ' HB ' ' B' ' 88' ' ' ILE . 15.3 t -65.43 -36.98 78.97 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.272 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -77.07 -8.77 58.04 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.593 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -103.88 -17.94 14.83 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.779 0.323 . . . . 0.0 111.251 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -109.42 -7.57 15.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.375 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 69.44 56.37 8.74 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.569 -0.824 . . . . 0.0 111.858 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 120.79 152.58 8.88 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.85 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 88' ' ' ILE . . . . . 0.574 ' HB ' HG22 ' B' ' 82' ' ' VAL . 4.3 tp -98.64 137.2 26.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.946 0.403 . . . . 0.0 112.042 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 89' ' ' ASP . . . . . 0.495 ' H ' HG21 ' B' ' 93' ' ' VAL . 7.0 t70 -161.65 -96.3 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.591 -0.732 . . . . 0.0 109.324 178.227 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 90' ' ' LEU . . . . . 0.557 ' N ' ' HD2' ' B' ' 91' ' ' PRO . 52.6 tp -179.29 -54.42 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.586 0 CA-C-O 119.514 -0.279 . . . . 0.0 111.686 178.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 91' ' ' PRO . . . . . 0.672 ' HA ' HG21 ' B' ' 115' ' ' VAL . 2.7 Cg_endo -41.44 -58.36 1.13 Allowed 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 123.522 2.815 . . . . 0.0 114.486 -178.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 8.8 p -86.91 -34.01 19.53 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.4 -0.52 . . . . 0.0 111.408 -179.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 93' ' ' VAL . . . . . 0.495 HG21 ' H ' ' B' ' 89' ' ' ASP . 2.8 t -58.86 -22.16 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.515 -179.146 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 94' ' ' LEU . . . . . 1.015 HD22 ' HB ' ' B' ' 115' ' ' VAL . 15.1 tp -54.43 -34.54 61.58 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.527 179.218 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.82 -46.3 81.73 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -102.83 10.81 38.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.558 0.218 . . . . 0.0 111.504 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 97' ' ' LEU . . . . . 0.494 ' HA ' ' HB1' ' B' ' 77' ' ' ALA . 23.0 tp -81.84 -9.54 59.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.1 0.476 . . . . 0.0 110.294 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -62.89 101.24 0.25 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.037 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -130.46 -179.68 5.41 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.987 0.422 . . . . 0.0 111.867 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -92.04 -87.52 0.21 Allowed 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.041 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -119.83 155.85 31.81 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -178.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 102' ' ' GLY . . . . . 0.573 ' HA3' ' HG3' ' B' ' 71' ' ' LYS . . . 63.4 30.05 76.39 Favored Glycine 0 C--N 1.332 0.336 0 N-CA-C 115.559 0.983 . . . . 0.0 115.559 177.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 13.3 m -138.25 -42.56 0.51 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 118.053 0.926 . . . . 0.0 111.897 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -74.1 -33.61 63.68 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.922 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 13.3 m -85.61 4.28 36.97 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -178.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 32.1 p -110.04 -37.45 5.59 Favored 'General case' 0 C--N 1.327 -0.383 0 O-C-N 121.494 -0.754 . . . . 0.0 110.498 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 107' ' ' PHE . . . . . 0.721 ' HB2' HD13 ' B' ' 78' ' ' ILE . 0.6 OUTLIER -88.65 -74.28 0.47 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.133 -179.54 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 108' ' ' CYS . . . . . 0.663 ' HB3' ' SG ' ' B' ' 122' ' ' CYS . 13.4 m -66.49 15.19 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 109' ' ' GLU . . . . . 0.541 ' H ' ' C ' ' B' ' 107' ' ' PHE . 19.4 tp10 -71.86 -69.6 0.38 Allowed 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.925 -179.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -59.93 -45.65 91.92 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.72 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -111.32 100.28 8.92 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.994 177.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 112' ' ' CYS . . . . . 0.485 ' O ' ' HD2' ' B' ' 117' ' ' LYS . 35.9 t -114.63 63.35 0.67 Allowed 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.394 -178.469 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 113' ' ' HIS . . . . . 0.417 ' CD2' ' HB2' ' A' ' 28' ' ' ASP . 13.6 p-80 -146.61 -172.35 3.95 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.326 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 114' ' ' GLY . . . . . 0.755 ' HA2' ' HB3' ' A' ' 31' ' ' CYS . . . 72.57 -144.29 35.33 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.747 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 115' ' ' VAL . . . . . 1.015 ' HB ' HD22 ' B' ' 94' ' ' LEU . 1.4 m -62.77 -22.28 29.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 116' ' ' CYS . . . . . 0.5 ' SG ' ' HB2' ' B' ' 121' ' ' LEU . 4.6 t -65.03 -31.86 73.3 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.304 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 117' ' ' LYS . . . . . 0.485 ' HD2' ' O ' ' B' ' 112' ' ' CYS . 8.8 mtpm? -89.31 -22.81 22.48 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.318 -0.401 . . . . 0.0 109.963 178.109 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -57.19 -42.86 82.03 Favored 'General case' 0 CA--C 1.522 -0.109 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 119' ' ' LEU . . . . . 0.557 ' O ' ' HB2' ' B' ' 120' ' ' HIS . 5.3 tt -89.54 -72.82 0.54 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 177.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 120' ' ' HIS . . . . . 0.557 ' HB2' ' O ' ' B' ' 119' ' ' LEU . 14.2 t-160 134.02 91.18 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 125.829 1.652 . . . . 0.0 109.733 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 121' ' ' LEU . . . . . 0.5 ' HB2' ' SG ' ' B' ' 116' ' ' CYS . 88.2 mt -117.14 -53.53 2.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.935 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 122' ' ' CYS . . . . . 0.663 ' SG ' ' HB3' ' B' ' 108' ' ' CYS . 1.8 p . . . . . 0 C--O 1.244 0.812 0 CA-C-O 118.607 -0.711 . . . . 0.0 109.398 178.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.595 0.236 . . . . 0.0 110.407 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 15.1 mmt -126.14 64.46 1.23 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.882 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -125.82 29.37 4.69 Favored Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.209 -0.996 . . . . 0.0 114.047 -178.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.484 ' O ' ' HB2' ' A' ' 5' ' ' CYS . 0.0 OUTLIER -77.43 134.58 38.36 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.281 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.619 ' O ' ' HG3' ' A' ' 9' ' ' LYS . 52.8 m 73.62 23.19 2.45 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.3 m 37.45 -113.8 0.11 Allowed 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 178.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.411 HG23 HD23 ' A' ' 8' ' ' LEU . 9.2 m -123.34 -54.3 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -177.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.483 ' H ' HD23 ' A' ' 8' ' ' LEU . 0.3 OUTLIER -67.08 -47.2 71.97 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 120.726 0.298 . . . . 0.0 111.743 -178.799 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.619 ' HG3' ' O ' ' A' ' 5' ' ' CYS . 0.4 OUTLIER -83.98 11.75 7.34 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.058 0.456 . . . . 0.0 109.93 179.131 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 51.1 tptt -81.38 13.85 2.75 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.436 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 18.7 t -60.61 -11.54 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 176.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.426 ' C ' ' H ' ' A' ' 14' ' ' ALA . . . 60.04 29.51 19.07 Favored 'General case' 0 C--N 1.344 0.351 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.529 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.435 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 0.5 OUTLIER 66.22 -30.58 0.14 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 114.318 -1.31 . . . . 0.0 113.543 179.774 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.426 ' H ' ' C ' ' A' ' 12' ' ' ALA . . . -44.89 -81.7 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 115.588 1.699 . . . . 0.0 115.588 -177.109 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -49.75 -35.43 22.27 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -177.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.82 -28.6 44.48 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -178.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.695 HG12 ' CD1' ' A' ' 46' ' ' PHE . 7.2 tp -86.4 -43.04 16.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.27 0.557 . . . . 0.0 110.883 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.5 -38.08 86.03 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.824 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.19 -17.7 79.64 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.052 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.79 -25.52 32.67 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.857 0.361 . . . . 0.0 111.0 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 93.7 t -62.04 -47.76 91.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.569 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.82 -41.21 97.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.665 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.78 -29.4 67.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.453 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.2 t -85.63 -7.21 58.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.266 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.06 24.12 72.54 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.52 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 146.2 176.93 20.46 Favored Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.589 HG12 ' N ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -79.53 151.14 4.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.564 0.697 . . . . 0.0 110.598 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.776 ' HB3' HG23 ' A' ' 32' ' ' VAL . 44.8 t0 -158.85 -122.94 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.294 -178.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.57 ' O ' ' HB2' ' A' ' 33' ' ' LEU . 23.1 tp 174.0 -62.93 0.0 OUTLIER Pre-proline 0 C--O 1.214 -0.77 0 C-N-CA 124.836 1.254 . . . . 0.0 108.905 178.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.689 ' HG2' ' HA2' ' B' ' 114' ' ' GLY . 9.3 Cg_endo -54.91 -37.16 93.24 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 121.687 1.592 . . . . 0.0 112.155 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.478 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 0.1 OUTLIER -87.37 -43.34 12.19 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.656 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.776 HG23 ' HB3' ' A' ' 28' ' ' ASP . 10.6 t -70.11 -34.77 60.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -178.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.57 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 0.8 OUTLIER -60.52 -35.6 76.37 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.098 0.475 . . . . 0.0 110.273 179.792 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -54.61 -31.48 57.19 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.467 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -72.57 -24.91 61.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.814 0.34 . . . . 0.0 110.843 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.452 HD13 ' HA ' ' A' ' 43' ' ' ALA . 11.8 mt -92.25 9.5 33.55 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.794 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.402 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 18.8 mmtp -68.58 -175.23 0.64 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.834 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 37' ' ' LYS . . . 76.61 -42.9 0.44 Allowed 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.676 0.79 . . . . 0.0 110.318 -178.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -131.22 63.93 1.59 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 178.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -63.37 -8.77 9.66 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -177.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -59.29 -32.64 72.63 Favored Glycine 0 CA--C 1.518 0.244 0 C-N-CA 121.01 -0.614 . . . . 0.0 113.632 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.513 ' SG ' ' HB2' ' A' ' 9' ' ' LYS . 64.5 m -107.54 24.91 12.15 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 122.385 -0.479 . . . . 0.0 111.321 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.452 ' HA ' HD13 ' A' ' 36' ' ' LEU . . . -88.99 -19.81 25.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.531 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.7 p -56.36 -33.43 65.68 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.331 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.435 ' HB3' ' HB3' ' A' ' 13' ' ' CYS . 7.6 t -47.7 -46.53 29.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.693 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.695 ' CD1' HG12 ' A' ' 17' ' ' ILE . 72.4 t80 -71.31 -50.82 28.65 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -179.4 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.628 ' HA ' ' HB2' ' A' ' 50' ' ' HIS . 0.1 OUTLIER -86.76 26.8 1.06 Allowed 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 -177.202 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -53.12 -53.68 46.84 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 119.428 1.013 . . . . 0.0 110.48 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -103.77 20.11 18.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.225 0.536 . . . . 0.0 109.789 178.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.628 ' HB2' ' HA ' ' A' ' 47' ' ' CYS . 41.3 m80 -126.29 62.22 1.27 Allowed 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.278 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 64.6 m -92.49 49.4 1.48 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.632 0.729 . . . . 0.0 109.758 178.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.604 ' CE1' ' HB3' ' B' ' 92' ' ' CYS . 49.7 t-80 -132.33 94.19 3.39 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.551 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.584 ' HA3' ' HB2' ' B' ' 91' ' ' PRO . . . 130.89 -144.91 16.4 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 119.485 -1.341 . . . . 0.0 114.839 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.522 HG21 ' HA ' ' A' ' 30' ' ' PRO . 14.3 m -60.4 -25.97 35.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -177.399 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.545 ' SG ' ' HB2' ' A' ' 60' ' ' LEU . 34.9 t -76.83 -44.08 33.84 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.044 -0.662 . . . . 0.0 111.826 -178.5 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.48 -13.45 61.06 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.062 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -66.99 -40.84 87.47 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.988 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.6 mt -93.48 2.7 56.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.517 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 58.98 54.16 5.19 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.619 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.545 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 87.1 mt -94.48 -39.91 10.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.741 -179.139 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 26.3 p . . . . . 0 C--O 1.245 0.866 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.302 179.751 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.261 0 CA-C-O 120.597 0.237 . . . . 0.0 110.468 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 63' ' ' MET . . . . . . . . . . . . . 15.4 ptp -132.88 -22.02 2.11 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.751 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -164.38 -161.64 13.83 Favored Glycine 0 CA--C 1.507 -0.439 0 C-N-CA 120.387 -0.911 . . . . 0.0 112.458 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -115.38 -53.54 2.6 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 121.005 -0.278 . . . . 0.0 111.255 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 66' ' ' CYS . . . . . . . . . . . . . 46.0 t -111.64 105.22 13.69 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -178.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.572 ' OG ' ' HE2' ' B' ' 70' ' ' LYS . 49.1 m 53.59 -160.96 0.13 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.258 -0.883 . . . . 0.0 113.377 178.066 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 13.3 m -120.62 -50.29 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.995 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 3.9 pp -86.22 -18.51 31.94 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.479 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 70' ' ' LYS . . . . . 0.572 ' HE2' ' OG ' ' B' ' 67' ' ' SER . 37.1 mtmt -91.87 14.87 14.32 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 177.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 71' ' ' LYS . . . . . 0.416 ' C ' ' H ' ' B' ' 73' ' ' ALA . 70.0 tttt -89.11 22.22 2.87 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.026 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 2.4 t -68.66 0.01 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-O 121.252 0.549 . . . . 0.0 109.816 178.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.416 ' H ' ' C ' ' B' ' 71' ' ' LYS . . . 72.29 25.82 2.79 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.558 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 3.2 m 64.04 -5.97 0.28 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.378 -0.828 . . . . 0.0 113.182 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.66 -45.88 88.4 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -177.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.81 -3.06 11.01 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -123.49 -20.11 5.67 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.561 ' O ' HG23 ' B' ' 82' ' ' VAL . 4.0 tp -112.0 -44.95 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.722 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.64 -32.83 74.4 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.186 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.02 -24.01 60.5 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.366 -0.921 . . . . 0.0 111.724 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.4 -19.69 57.87 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.586 0.231 . . . . 0.0 111.332 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 82' ' ' VAL . . . . . 0.561 HG23 ' O ' ' B' ' 78' ' ' ILE . 80.9 t -65.1 -52.51 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.691 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.89 -34.46 77.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.736 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.64 -38.51 89.59 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.44 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 16.0 t -85.84 -26.21 25.82 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.344 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.76 46.04 7.45 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.02 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 152.94 132.71 1.79 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.986 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 4.7 tp -93.19 135.89 26.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.312 0.577 . . . . 0.0 111.261 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 89' ' ' ASP . . . . . 0.517 ' H ' HG21 ' B' ' 93' ' ' VAL . 47.2 t0 -163.85 -98.82 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 90' ' ' LEU . . . . . 0.774 HD12 ' HB2' ' B' ' 94' ' ' LEU . 59.8 tp -170.11 -58.93 0.0 OUTLIER Pre-proline 0 C--O 1.223 -0.332 0 CA-C-O 119.187 -0.435 . . . . 0.0 111.03 178.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 91' ' ' PRO . . . . . 0.584 ' HB2' ' HA3' ' A' ' 53' ' ' GLY . 2.0 Cg_endo -39.59 -58.79 0.77 Allowed 'Trans proline' 0 C--N 1.363 1.301 0 C-N-CA 123.623 2.882 . . . . 0.0 114.705 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 92' ' ' CYS . . . . . 0.604 ' HB3' ' CE1' ' A' ' 52' ' ' HIS . 8.6 t -84.2 -30.71 25.56 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -178.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 93' ' ' VAL . . . . . 0.517 HG21 ' H ' ' B' ' 89' ' ' ASP . 2.6 t -71.69 -49.62 44.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -178.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 94' ' ' LEU . . . . . 0.774 ' HB2' HD12 ' B' ' 90' ' ' LEU . 2.1 tm? -63.43 -35.16 79.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.955 0.407 . . . . 0.0 110.91 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -53.83 -33.28 55.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.431 -179.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -82.61 -16.96 46.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.95 0.405 . . . . 0.0 111.37 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 97' ' ' LEU . . . . . 0.411 HD13 HD13 ' B' ' 78' ' ' ILE . 6.6 tt -81.69 -10.16 59.46 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.732 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 42.5 mtpt -67.16 72.17 0.11 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.063 0.459 . . . . 0.0 111.924 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -156.67 -40.18 0.07 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -110.25 63.72 0.61 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.874 178.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -59.22 162.42 4.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.06 -178.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 88.05 -45.55 3.31 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.312 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 71.6 m -78.38 -6.26 54.66 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 111.537 0.199 . . . . 0.0 111.537 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.16 -13.62 13.07 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 13.0 m -64.94 -27.25 68.71 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.517 0.192 . . . . 0.0 111.517 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 106' ' ' CYS . . . . . 0.429 ' SG ' ' N ' ' B' ' 107' ' ' PHE . 16.6 p -48.9 -57.42 6.48 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.276 0.56 . . . . 0.0 111.415 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 107' ' ' PHE . . . . . 0.536 ' CD2' HG12 ' B' ' 78' ' ' ILE . 0.5 OUTLIER -80.27 -54.21 5.94 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.574 -179.693 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 76.1 m -82.27 42.84 0.76 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -178.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -77.11 -62.36 1.68 Allowed 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -90.92 7.35 40.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.876 178.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 14.1 m80 -126.58 79.55 1.87 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.976 -1.011 . . . . 0.0 108.294 178.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 112' ' ' CYS . . . . . 0.411 ' O ' ' HB3' ' B' ' 117' ' ' LYS . 4.0 t -98.28 32.59 2.42 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -177.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 113' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -121.87 -160.38 0.86 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 178.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 114' ' ' GLY . . . . . 0.689 ' HA2' ' HG2' ' A' ' 30' ' ' PRO . . . 66.86 -145.13 46.25 Favored Glycine 0 C--O 1.226 -0.346 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.364 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 115' ' ' VAL . . . . . 0.507 HG23 ' HB3' ' B' ' 94' ' ' LEU . 8.2 m -78.56 -2.82 5.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 117.228 0.514 . . . . 0.0 110.518 178.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 116' ' ' CYS . . . . . 0.462 ' SG ' ' HG ' ' B' ' 94' ' ' LEU . 0.5 OUTLIER -82.56 -26.86 32.01 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.709 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 117' ' ' LYS . . . . . 0.561 ' HG2' ' O ' ' B' ' 114' ' ' GLY . 14.0 ptmm? -84.33 -6.67 59.42 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 177.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -65.17 -45.77 83.55 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 178.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 66.0 mt -87.13 -33.62 19.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.974 -1.012 . . . . 0.0 108.585 177.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 58.75 75.28 0.4 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 114.464 -1.243 . . . . 0.0 111.866 179.233 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.97 21.75 4.15 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.856 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 122' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.243 0.759 0 CA-C-O 118.426 -0.797 . . . . 0.0 110.753 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.291 0 CA-C-O 120.88 0.371 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 85.8 mtp -127.74 168.18 15.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.826 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -166.72 159.95 33.44 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.321 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -76.49 -61.43 1.96 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.997 0.427 . . . . 0.0 110.078 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 14.4 t -122.86 26.82 8.0 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.513 0.673 . . . . 0.0 109.375 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.1 p -131.5 -175.92 3.86 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.29 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 49.5 t 66.56 -74.99 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 O-C-N 123.649 0.593 . . . . 0.0 111.327 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 28.7 tp -82.52 -32.94 28.45 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.5 mptt -88.34 19.83 3.6 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.906 177.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.41 ' HB3' ' HE2' ' A' ' 10' ' ' LYS . 32.6 ttpt -66.68 -15.19 63.32 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.681 179.375 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.3 t -90.96 35.02 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.883 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 60.32 46.57 9.95 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.319 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.488 ' O ' HG22 ' A' ' 17' ' ' ILE . 18.1 p 50.38 9.31 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.412 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -70.76 -34.77 72.18 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 118.213 0.46 . . . . 0.0 112.134 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.83 -6.25 36.53 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.97 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -114.34 -35.18 5.05 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.5 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.812 HG12 ' CD2' ' A' ' 46' ' ' PHE . 5.3 tp -93.53 -50.81 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.114 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.619 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.436 ' N ' HG23 ' A' ' 17' ' ' ILE . . . -63.71 -31.64 72.88 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.119 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.53 -24.67 74.34 Favored Glycine 0 N--CA 1.451 -0.357 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 177.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.503 ' CB ' ' HB3' ' A' ' 35' ' ' ALA . . . -76.31 -26.58 55.98 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.114 0.483 . . . . 0.0 110.392 178.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 17' ' ' ILE . 57.9 t -63.46 -50.08 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.473 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.51 -31.64 71.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.93 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.7 -41.67 78.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.759 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.6 t -84.77 -22.97 29.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.861 0.363 . . . . 0.0 110.74 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 111.1 -38.38 3.31 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.683 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -137.19 167.25 24.75 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.236 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.8 tp -96.2 133.86 35.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.071 0.463 . . . . 0.0 111.061 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.515 ' OD2' ' HD2' ' A' ' 30' ' ' PRO . 9.2 t70 -163.82 -111.16 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.699 HD11 ' HB2' ' A' ' 55' ' ' CYS . 38.8 tp -168.16 -54.01 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 178.04 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.744 ' HB2' ' HA3' ' B' ' 114' ' ' GLY . 86.5 Cg_exo -46.7 -53.03 6.65 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 122.596 2.197 . . . . 0.0 113.887 -179.012 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.635 ' HB3' ' CE1' ' B' ' 113' ' ' HIS . 7.7 t -81.33 -33.11 32.71 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.555 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.465 HG23 ' HE1' ' B' ' 113' ' ' HIS . 2.8 t -65.14 -28.72 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-O 121.055 0.455 . . . . 0.0 110.895 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.423 HD13 ' O ' ' A' ' 33' ' ' LEU . 1.9 tm? -61.98 -39.0 90.67 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.641 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.33 -46.23 89.18 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.503 ' HB3' ' CB ' ' A' ' 20' ' ' ALA . . . -78.84 -13.61 59.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.785 0.326 . . . . 0.0 111.402 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 23.0 tp -73.76 -53.05 11.18 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -167.11 -21.99 0.02 OUTLIER 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.251 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 66.61 25.78 9.88 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.118 -179.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -166.57 -170.64 1.67 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.79 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.424 ' HG2' HD11 ' A' ' 60' ' ' LEU . 48.2 mt-10 -64.22 131.37 47.19 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 123.064 0.228 . . . . 0.0 111.249 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 145.7 140.59 3.53 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 119.945 -1.122 . . . . 0.0 113.371 179.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 90.2 m 61.64 31.85 18.61 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.624 ' CB ' ' HB3' ' A' ' 60' ' ' LEU . . . -80.59 -44.36 19.07 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.384 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 12.2 m -68.8 -16.11 63.69 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.903 0.383 . . . . 0.0 111.268 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 42.5 t -78.09 -54.91 5.73 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.944 0.402 . . . . 0.0 111.276 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.812 ' CD2' HG12 ' A' ' 17' ' ' ILE . 3.6 t80 -102.18 -49.75 3.82 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -178.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.417 ' SG ' ' HD1' ' A' ' 46' ' ' PHE . 21.2 m -72.96 13.56 0.38 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -177.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 44' ' ' SER . 16.5 tp10 -69.6 -53.66 17.72 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.142 0.496 . . . . 0.0 111.185 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -66.38 -23.95 66.41 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.079 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -135.23 103.78 5.65 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 96.0 m -112.65 81.07 1.42 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 177.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.547 ' O ' ' HB2' ' B' ' 92' ' ' CYS . 3.1 t60 -142.16 -34.52 0.46 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -177.028 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.807 ' HA2' ' HB2' ' B' ' 91' ' ' PRO . . . -87.16 -162.45 37.7 Favored Glycine 0 CA--C 1.518 0.266 0 N-CA-C 115.587 0.995 . . . . 0.0 115.587 -178.097 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.4 ' CG1' ' HA ' ' A' ' 30' ' ' PRO . 7.7 p -58.44 -10.49 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 124.409 1.084 . . . . 0.0 112.575 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.699 ' HB2' HD11 ' A' ' 29' ' ' LEU . 18.0 t -77.99 -31.49 50.73 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 121.999 -0.438 . . . . 0.0 111.071 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.607 ' HG3' ' O ' ' A' ' 53' ' ' GLY . 0.1 OUTLIER -90.34 -2.35 57.98 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.466 179.819 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.424 ' O ' ' HB3' ' A' ' 58' ' ' LEU . 52.9 t0 -56.46 122.47 12.0 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.647 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.685 ' O ' ' HB2' ' A' ' 59' ' ' HIS . 45.2 tp 90.24 -64.94 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.029 1.332 . . . . 0.0 108.699 -177.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.685 ' HB2' ' O ' ' A' ' 58' ' ' LEU . 26.5 t-80 153.03 121.13 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.911 0 O-C-N 124.763 1.289 . . . . 0.0 109.303 178.24 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.624 ' HB3' ' CB ' ' A' ' 43' ' ' ALA . 22.1 mt -147.3 -55.85 0.24 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 19.1 p . . . . . 0 C--O 1.246 0.906 0 CA-C-O 118.435 -0.793 . . . . 0.0 110.747 -179.812 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.199 0 CA-C-O 120.738 0.304 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 63' ' ' MET . . . . . . . . . . . . . 9.9 ptm -149.33 -37.49 0.16 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.074 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 48.11 -144.47 6.36 Favored Glycine 0 C--N 1.334 0.446 0 N-CA-C 115.05 0.78 . . . . 0.0 115.05 178.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 65' ' ' LYS . . . . . 0.444 ' O ' ' HD3' ' B' ' 70' ' ' LYS . 33.9 ttmt -89.41 -98.83 0.1 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.201 -0.5 . . . . 0.0 110.017 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 66' ' ' CYS . . . . . . . . . . . . . 66.0 m -119.47 19.87 12.58 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.342 0.591 . . . . 0.0 109.872 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 10.3 p -127.05 -176.99 3.88 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.225 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 22.7 t 64.68 -80.64 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 O-C-N 123.704 0.627 . . . . 0.0 111.519 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 44.2 tp -78.75 -38.48 38.67 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 70' ' ' LYS . . . . . 0.444 ' HD3' ' O ' ' B' ' 65' ' ' LYS . 6.6 mptt -87.15 22.27 2.13 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.258 178.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 71' ' ' LYS . . . . . 0.45 ' C ' ' H ' ' B' ' 73' ' ' ALA . 33.0 ttmt -66.41 -15.18 63.11 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.863 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 2.3 t -80.54 33.55 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.015 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.45 ' H ' ' C ' ' B' ' 71' ' ' LYS . . . 62.03 55.45 2.51 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.863 -1.062 . . . . 0.0 112.048 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 74' ' ' CYS . . . . . 0.501 ' O ' HG22 ' B' ' 78' ' ' ILE . 9.7 p 57.58 -4.18 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.624 1.169 . . . . 0.0 114.138 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 75' ' ' ALA . . . . . 0.487 ' HA ' HG22 ' B' ' 78' ' ' ILE . . . -67.13 -26.32 66.62 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.82 -9.09 25.65 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -120.75 -34.28 3.61 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.606 HG12 ' CD1' ' B' ' 107' ' ' PHE . 7.8 tp -82.79 -48.5 17.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.118 0.485 . . . . 0.0 111.683 -179.021 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.81 -24.9 59.54 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.106 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.18 -22.85 70.0 Favored Glycine 0 C--N 1.329 0.183 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.12 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -80.65 -17.81 50.04 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.092 0.472 . . . . 0.0 110.623 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 82' ' ' VAL . . . . . 0.469 HG22 HD13 ' B' ' 88' ' ' ILE . 60.4 t -66.78 -43.44 89.86 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.453 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.24 6.48 11.76 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.917 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -110.26 -19.68 12.92 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 3.0 t -120.03 12.23 11.9 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.515 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 71.06 33.82 65.08 Favored Glycine 0 CA--C 1.519 0.285 0 N-CA-C 114.693 0.637 . . . . 0.0 114.693 178.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 148.36 -177.05 26.87 Favored Glycine 0 CA--C 1.51 -0.269 0 C-N-CA 119.864 -1.16 . . . . 0.0 112.543 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 88' ' ' ILE . . . . . 0.469 HD13 HG22 ' B' ' 82' ' ' VAL . 4.4 tp -123.23 134.7 65.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.994 0.426 . . . . 0.0 111.043 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 89' ' ' ASP . . . . . 0.565 ' H ' HG21 ' B' ' 93' ' ' VAL . 28.7 t70 -156.47 -102.38 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 90' ' ' LEU . . . . . 0.598 HD11 ' HB2' ' B' ' 116' ' ' CYS . 22.1 tp -167.09 -59.06 0.01 OUTLIER Pre-proline 0 N--CA 1.469 0.488 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 177.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 91' ' ' PRO . . . . . 0.998 ' HA ' HG11 ' B' ' 115' ' ' VAL . 2.1 Cg_endo -43.87 -56.2 2.58 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 123.049 2.499 . . . . 0.0 114.631 -178.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 92' ' ' CYS . . . . . 0.547 ' HB2' ' O ' ' A' ' 52' ' ' HIS . 12.3 t -81.22 -32.85 33.25 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 93' ' ' VAL . . . . . 0.565 HG21 ' H ' ' B' ' 89' ' ' ASP . 0.2 OUTLIER -68.02 -29.2 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-O 120.668 0.27 . . . . 0.0 111.217 -179.197 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -62.21 -39.15 91.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.222 0.534 . . . . 0.0 110.252 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.35 -43.53 85.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.206 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.6 19.51 4.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.68 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 97' ' ' LEU . . . . . 0.44 HD13 HD13 ' B' ' 78' ' ' ILE . 35.8 tp -77.04 -52.62 9.01 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.17 0.509 . . . . 0.0 109.708 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -140.82 -64.33 0.46 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.181 179.22 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -176.35 -60.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.893 -1.049 . . . . 0.0 108.578 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -131.89 -56.28 0.99 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.116 178.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -130.56 156.46 44.8 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.883 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 128.91 127.12 2.93 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 119.86 -1.162 . . . . 0.0 114.002 178.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 87.7 m 58.43 31.81 21.38 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -90.1 -24.92 20.99 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 18.0 t -64.45 -47.2 79.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.72 0.295 . . . . 0.0 110.863 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 37.0 t -60.16 -50.24 74.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.917 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 107' ' ' PHE . . . . . 0.606 ' CD1' HG12 ' B' ' 78' ' ' ILE . 52.9 t80 -73.09 -58.55 3.23 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -178.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 21.7 m -79.03 34.14 0.23 Allowed 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -177.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 19.1 tp10 -63.31 -80.99 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 118.154 0.433 . . . . 0.0 110.373 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -76.32 -30.55 57.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.505 0.669 . . . . 0.0 109.294 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -81.87 71.07 8.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.647 179.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 9.8 t -128.84 84.47 2.23 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.116 0.484 . . . . 0.0 110.057 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 113' ' ' HIS . . . . . 0.635 ' CE1' ' HB3' ' A' ' 31' ' ' CYS . 9.3 t-80 -126.08 -47.48 1.63 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.289 -178.523 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 114' ' ' GLY . . . . . 0.744 ' HA3' ' HB2' ' A' ' 30' ' ' PRO . . . -147.41 164.68 28.71 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 119.997 -1.097 . . . . 0.0 113.401 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 115' ' ' VAL . . . . . 0.998 HG11 ' HA ' ' B' ' 91' ' ' PRO . 0.5 OUTLIER 61.88 -45.0 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 125.581 1.552 . . . . 0.0 113.253 179.626 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 116' ' ' CYS . . . . . 0.598 ' HB2' HD11 ' B' ' 90' ' ' LEU . 6.9 t -87.2 -30.23 21.14 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -90.74 4.47 51.47 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.375 178.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -63.01 -32.44 73.8 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.352 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 25.5 tp -112.78 -114.71 0.33 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -141.51 59.13 1.51 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 86.2 mt -99.24 -35.93 9.81 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 122' ' ' CYS . . . . . . . . . . . . . 3.4 p . . . . . 0 C--O 1.245 0.824 0 CA-C-O 118.345 -0.836 . . . . 0.0 110.286 179.339 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.231 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 18.9 ptm -72.18 125.35 27.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.947 0.403 . . . . 0.0 110.54 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 128.85 128.31 3.05 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.77 -0.728 . . . . 0.0 111.904 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.4 ttmm -67.02 -30.09 70.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.175 0.512 . . . . 0.0 110.747 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 52.3 t -67.19 -40.47 86.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.338 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.1 p -76.79 29.88 0.13 Allowed 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 46.2 t -120.78 -55.98 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 178.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 34.9 tp -98.99 -39.11 8.7 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.506 ' N ' ' HD3' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -92.24 26.15 2.65 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 176.915 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.51 ' C ' ' H ' ' A' ' 12' ' ' ALA . 46.7 pttt -59.64 -17.79 36.52 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.098 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.5 t -75.2 26.38 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.043 179.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.51 ' H ' ' C ' ' A' ' 10' ' ' LYS . . . 60.36 51.07 5.58 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.709 0.804 . . . . 0.0 111.9 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.83 ' HB3' HD12 ' A' ' 17' ' ' ILE . 76.4 m 73.21 -17.97 0.39 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.97 0.729 . . . . 0.0 112.97 179.126 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.673 ' HA ' ' HB3' ' A' ' 18' ' ' ALA . . . -73.7 16.99 0.17 Allowed 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.042 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.454 ' HB3' ' HA ' ' A' ' 9' ' ' LYS . . . -104.44 -31.46 9.48 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.733 0.302 . . . . 0.0 111.109 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -123.37 -48.84 1.94 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.476 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.83 HD12 ' HB3' ' A' ' 13' ' ' CYS . 69.3 mt -64.19 -45.92 94.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-O 121.42 0.629 . . . . 0.0 109.569 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.673 ' HB3' ' HA ' ' A' ' 14' ' ' ALA . . . -110.44 31.71 5.73 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.156 178.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -129.63 -43.23 0.21 Allowed Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.73 -0.747 . . . . 0.0 111.968 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.669 ' HB3' HG13 ' A' ' 32' ' ' VAL . . . -87.35 19.92 3.05 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.997 0.427 . . . . 0.0 111.343 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.452 HG13 ' N ' ' A' ' 22' ' ' ALA . 12.5 p -65.92 -45.57 90.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.974 0.892 . . . . 0.0 110.286 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.452 ' N ' HG13 ' A' ' 21' ' ' VAL . . . -64.46 -26.42 68.44 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.555 -1.202 . . . . 0.0 111.629 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.8 -40.06 95.73 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.587 ' SG ' ' HA3' ' B' ' 114' ' ' GLY . 4.5 t -97.07 1.6 50.27 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.768 0.318 . . . . 0.0 110.801 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.42 42.43 82.02 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.519 -0.848 . . . . 0.0 111.426 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 144.35 156.03 6.66 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.403 ' HB ' HG23 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -87.19 133.92 28.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 117.595 0.697 . . . . 0.0 111.389 -179.035 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.632 ' OD1' ' HB3' ' A' ' 31' ' ' CYS . 1.2 p30 -143.55 -112.25 0.11 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.308 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.785 HD21 ' HB3' ' A' ' 55' ' ' CYS . 12.5 tp -179.28 -56.56 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.449 0 C-N-CA 122.358 0.263 . . . . 0.0 111.7 178.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.916 ' HB3' HG13 ' A' ' 54' ' ' VAL . 8.7 Cg_exo -76.05 -4.12 14.73 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 121.874 1.716 . . . . 0.0 113.177 -178.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.707 ' HB2' HG13 ' B' ' 115' ' ' VAL . 21.6 t -104.88 -38.95 6.45 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 177.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.669 HG13 ' HB3' ' A' ' 20' ' ' ALA . 42.3 t -78.64 -10.77 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.221 178.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.581 ' HG ' ' HB2' ' A' ' 37' ' ' LYS . 6.3 tp -54.21 -29.17 45.23 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.945 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -46.95 -45.82 21.04 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -178.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -102.88 33.23 3.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.982 0.42 . . . . 0.0 111.16 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.411 ' HG ' ' HA2' ' A' ' 41' ' ' GLY . 5.5 tp -137.14 -41.59 0.58 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.761 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.581 ' HB2' ' HG ' ' A' ' 33' ' ' LEU . 1.8 tmtp? -59.96 -35.11 74.25 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -177.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.23 -64.18 1.04 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -178.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.487 ' O ' ' HE2' ' A' ' 9' ' ' LYS . . . -93.81 55.01 2.07 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -178.105 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.854 ' HG2' ' H ' ' A' ' 42' ' ' CYS . 85.0 tt0 70.83 137.63 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.337 0.589 . . . . 0.0 111.517 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.562 ' HA3' HD11 ' A' ' 60' ' ' LEU . . . -79.32 -11.23 85.19 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.715 -0.755 . . . . 0.0 113.186 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.854 ' H ' ' HG2' ' A' ' 40' ' ' GLU . 33.9 m 69.75 94.61 0.07 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 122.96 0.504 . . . . 0.0 111.193 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.44 ' C ' ' H ' ' A' ' 45' ' ' CYS . . . -65.96 153.43 42.11 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.902 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.6 p 66.76 -29.09 0.13 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.624 1.169 . . . . 0.0 112.365 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.44 ' H ' ' C ' ' A' ' 43' ' ' ALA . 6.0 t -78.15 -70.13 0.51 Allowed 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.56 ' HD1' ' CE1' ' A' ' 50' ' ' HIS . 0.1 OUTLIER -90.18 165.31 14.03 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 175.514 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.788 ' HB3' ' SG ' ' A' ' 61' ' ' CYS . 73.4 m 72.66 -0.68 3.24 Favored 'General case' 0 C--O 1.216 -0.68 0 O-C-N 123.364 0.415 . . . . 0.0 111.642 -178.039 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.549 ' HA ' ' OE1' ' A' ' 48' ' ' GLU . 5.1 tp10 -61.35 -93.32 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.274 0.559 . . . . 0.0 111.187 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.458 ' H ' ' HB3' ' A' ' 48' ' ' GLU . 17.8 t70 -70.35 -33.33 71.33 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 178.288 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.56 ' CE1' ' HD1' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -88.61 56.95 3.97 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 112.466 -2.152 . . . . 0.0 109.535 178.463 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 14.8 t -93.63 63.77 3.46 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 17.2 t-160 -163.49 136.25 5.35 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.06 -177.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 117.0 -157.7 14.91 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 119.864 -1.16 . . . . 0.0 113.78 178.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.916 HG13 ' HB3' ' A' ' 30' ' ' PRO . 3.5 m -70.73 -5.13 5.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.39 -0.405 . . . . 0.0 112.001 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.785 ' HB3' HD21 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -76.79 -40.94 46.46 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.119 0.485 . . . . 0.0 110.573 -178.98 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.404 ' HE2' ' HB3' ' A' ' 56' ' ' LYS . 31.6 mtpt -67.46 -10.75 54.45 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.818 179.142 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -65.59 -33.03 74.96 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.497 ' O ' HD23 ' A' ' 58' ' ' LEU . 2.4 tt -90.19 -21.16 22.31 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.937 178.4 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 75.06 97.87 0.07 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.377 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.643 ' HB2' ' SG ' ' A' ' 47' ' ' CYS . 26.3 mt -136.84 2.37 2.61 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.144 -179.379 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.788 ' SG ' ' HB3' ' A' ' 47' ' ' CYS . 29.2 p . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.107 -0.949 . . . . 0.0 109.707 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.169 0 CA-C-O 120.707 0.289 . . . . 0.0 110.399 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 63' ' ' MET . . . . . . . . . . . . . 22.9 ptm -111.01 151.87 27.49 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.395 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.65 173.16 26.87 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.077 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 3.4 ttpm? -131.84 44.59 2.89 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.346 0.593 . . . . 0.0 109.832 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 66' ' ' CYS . . . . . 0.577 ' HB2' ' O ' ' B' ' 101' ' ' GLU . 48.9 t -120.38 -40.89 2.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.274 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 35.1 m -74.17 34.31 0.09 Allowed 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 22.8 t -122.69 -59.01 2.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.407 ' C ' ' H ' ' B' ' 71' ' ' LYS . 52.3 tp -96.04 -40.3 9.32 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.187 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 70' ' ' LYS . . . . . 0.407 ' HA ' ' HB3' ' B' ' 76' ' ' ALA . 0.8 OUTLIER -85.26 24.68 1.1 Allowed 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 177.227 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 71' ' ' LYS . . . . . 0.549 ' C ' ' H ' ' B' ' 73' ' ' ALA . 0.0 OUTLIER -65.51 -10.09 31.62 Favored 'General case' 0 C--N 1.341 0.223 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.558 179.819 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 2.4 t -70.76 21.58 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.868 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.549 ' H ' ' C ' ' B' ' 71' ' ' LYS . . . 63.79 56.98 1.43 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.844 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 74' ' ' CYS . . . . . 0.856 ' HB3' HD12 ' B' ' 78' ' ' ILE . 12.2 m 67.45 0.74 2.26 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.854 0.686 . . . . 0.0 112.854 178.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 75' ' ' ALA . . . . . 0.954 ' HA ' ' HB3' ' B' ' 79' ' ' ALA . . . -82.6 6.62 17.11 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 76' ' ' ALA . . . . . 0.408 ' O ' ' HA3' ' B' ' 80' ' ' GLY . . . -99.17 -57.52 2.14 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.733 0.302 . . . . 0.0 111.789 -179.544 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.19 -38.66 12.57 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.856 HD12 ' HB3' ' B' ' 74' ' ' CYS . 71.9 mt -81.71 -55.5 7.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.979 0.419 . . . . 0.0 110.383 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 79' ' ' ALA . . . . . 0.954 ' HB3' ' HA ' ' B' ' 75' ' ' ALA . . . -83.39 14.47 3.61 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.276 0.56 . . . . 0.0 110.853 178.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 80' ' ' GLY . . . . . 0.408 ' HA3' ' O ' ' B' ' 76' ' ' ALA . . . -114.24 -41.22 0.9 Allowed Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 178.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 81' ' ' ALA . . . . . 0.685 ' HB3' HG13 ' B' ' 93' ' ' VAL . . . -73.51 -7.31 51.31 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-O 120.976 0.417 . . . . 0.0 110.358 178.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 82' ' ' VAL . . . . . 0.409 HG13 ' N ' ' B' ' 83' ' ' ALA . 13.0 p -60.14 -42.16 89.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-O 121.619 0.723 . . . . 0.0 109.445 178.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 83' ' ' ALA . . . . . 0.409 ' N ' HG13 ' B' ' 82' ' ' VAL . . . -70.36 -27.29 64.22 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.429 -1.26 . . . . 0.0 111.467 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.69 -46.06 14.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.84 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 38.0 t -79.33 -48.33 14.27 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.903 0.382 . . . . 0.0 110.85 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 117.98 41.09 0.67 Allowed Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.908 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 140.1 176.19 14.89 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.525 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 18.1 mm -104.65 118.85 52.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.158 0.504 . . . . 0.0 111.232 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 89' ' ' ASP . . . . . 0.458 ' CG ' ' H ' ' B' ' 90' ' ' LEU . 7.7 p-10 -138.24 -108.5 0.18 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.029 178.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 90' ' ' LEU . . . . . 0.732 HD11 ' SG ' ' B' ' 108' ' ' CYS . 0.1 OUTLIER -174.87 -53.76 0.0 OUTLIER Pre-proline 0 N--CA 1.451 -0.402 0 C-N-CA 122.367 0.267 . . . . 0.0 111.105 179.621 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 91' ' ' PRO . . . . . 0.947 ' HB3' HG11 ' B' ' 115' ' ' VAL . 27.1 Cg_exo -63.97 -29.9 66.76 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.212 1.941 . . . . 0.0 115.293 -176.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 14.3 p -92.07 -40.5 11.04 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 119.695 -0.802 . . . . 0.0 110.042 179.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 93' ' ' VAL . . . . . 0.685 HG13 ' HB3' ' B' ' 81' ' ' ALA . 2.5 t -65.83 -27.76 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.699 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 26.1 tp -55.43 -45.3 76.81 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.355 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.8 -45.66 91.63 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.245 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.25 -21.27 59.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.178 0.514 . . . . 0.0 110.787 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 97' ' ' LEU . . . . . 0.652 HD21 ' HB2' ' B' ' 103' ' ' CYS . 10.2 tt -78.66 -29.02 45.48 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.086 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 29.5 tttm -74.7 45.8 0.26 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 112.115 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -98.87 -12.4 20.81 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -151.37 -150.33 0.34 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.504 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 101' ' ' GLU . . . . . 0.577 ' O ' ' HB2' ' B' ' 66' ' ' CYS . 47.1 mt-10 -112.33 160.64 17.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.765 0.317 . . . . 0.0 111.461 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.35 -141.29 29.69 Favored Glycine 0 N--CA 1.452 -0.285 0 CA-C-N 115.801 -0.636 . . . . 0.0 113.724 178.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 103' ' ' CYS . . . . . 0.652 ' HB2' HD21 ' B' ' 97' ' ' LEU . 82.5 m 72.79 40.13 0.62 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.7 0.762 . . . . 0.0 110.711 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 104' ' ' ALA . . . . . 0.518 ' HB2' HD12 ' B' ' 121' ' ' LEU . . . -114.64 -160.28 0.73 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 177.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 105' ' ' SER . . . . . 0.525 ' O ' ' HB2' ' B' ' 109' ' ' GLU . 15.0 m 68.37 -56.15 0.51 Allowed 'General case' 0 N--CA 1.467 0.418 0 O-C-N 123.584 0.553 . . . . 0.0 112.317 178.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 29.9 p -80.04 -35.74 36.74 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 122.001 -0.437 . . . . 0.0 110.566 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 107' ' ' PHE . . . . . 0.584 ' CE1' HD22 ' B' ' 90' ' ' LEU . 0.7 OUTLIER -88.63 -97.78 0.09 Allowed 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.248 -178.536 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 108' ' ' CYS . . . . . 0.732 ' SG ' HD11 ' B' ' 90' ' ' LEU . 33.7 m -63.43 33.75 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 115.011 1.486 . . . . 0.0 115.011 -177.355 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 109' ' ' GLU . . . . . 0.525 ' HB2' ' O ' ' B' ' 105' ' ' SER . 44.3 tp10 -59.92 -70.44 0.17 Allowed 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 119.301 0.955 . . . . 0.0 110.709 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -92.53 -20.31 21.07 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.082 0.468 . . . . 0.0 110.137 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -86.88 86.63 7.33 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.034 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 112' ' ' CYS . . . . . 0.427 ' O ' ' HE2' ' B' ' 117' ' ' LYS . 1.6 t -121.05 43.03 2.9 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.942 0.401 . . . . 0.0 110.416 -178.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 113' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -88.37 121.03 30.31 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.556 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 114' ' ' GLY . . . . . 0.587 ' HA3' ' SG ' ' A' ' 24' ' ' CYS . . . 45.45 -99.86 0.02 OUTLIER Glycine 0 C--O 1.223 -0.566 0 N-CA-C 115.681 1.032 . . . . 0.0 115.681 177.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 115' ' ' VAL . . . . . 0.947 HG11 ' HB3' ' B' ' 91' ' ' PRO . 12.5 m -29.57 -60.54 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 -177.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 116' ' ' CYS . . . . . 0.524 ' H ' HG23 ' B' ' 115' ' ' VAL . 0.9 OUTLIER -73.34 -30.5 63.38 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.102 -0.639 . . . . 0.0 112.019 -177.755 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 117' ' ' LYS . . . . . 0.427 ' HE2' ' O ' ' B' ' 112' ' ' CYS . 11.9 ttmm -76.08 -11.05 59.87 Favored 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 122.024 -0.422 . . . . 0.0 110.09 178.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -67.83 -43.29 79.89 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 178.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 119' ' ' LEU . . . . . 0.581 ' HB3' ' CD2' ' B' ' 121' ' ' LEU . 5.1 tt -78.28 -36.47 46.68 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 177.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 14.1 t-80 78.82 75.58 0.05 Allowed 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 114.693 -1.14 . . . . 0.0 111.656 178.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 121' ' ' LEU . . . . . 0.581 ' CD2' ' HB3' ' B' ' 119' ' ' LEU . 0.4 OUTLIER -128.16 13.39 6.68 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.378 179.47 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 122' ' ' CYS . . . . . . . . . . . . . 3.6 p . . . . . 0 C--O 1.246 0.869 0 CA-C-O 118.293 -0.861 . . . . 0.0 110.478 179.212 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.242 0 CA-C-O 120.527 0.203 . . . . 0.0 111.012 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 73.8 mtp -124.06 -11.71 7.53 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -71.17 92.27 0.48 Allowed Glycine 0 CA--C 1.516 0.128 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.872 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.45 ' HB3' ' H ' ' A' ' 5' ' ' CYS . 19.4 tptm 57.45 -93.62 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.422 0.689 . . . . 0.0 110.575 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.605 ' HB2' ' OG ' ' A' ' 44' ' ' SER . 49.5 t -141.75 143.05 33.3 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.518 ' HB2' ' HE2' ' A' ' 10' ' ' LYS . 6.2 m -66.17 117.57 8.66 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.414 HG12 ' SG ' ' A' ' 13' ' ' CYS . 18.8 m -119.71 -27.2 2.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -178.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.757 ' H ' HD23 ' A' ' 8' ' ' LEU . 0.4 OUTLIER -73.2 -51.07 19.13 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 -178.826 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.7 mmtt -83.79 -12.96 54.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.716 0.293 . . . . 0.0 111.333 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.656 ' NZ ' ' HG3' ' A' ' 40' ' ' GLU . 16.7 ttmm -91.81 33.8 1.02 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.703 0.287 . . . . 0.0 111.335 -178.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.3 t 53.15 41.33 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 123.514 0.726 . . . . 0.0 112.138 178.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.414 ' HA ' ' O ' ' A' ' 7' ' ' VAL . . . 51.68 36.18 16.86 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.973 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.434 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 95.7 m 64.89 14.14 9.05 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -99.31 14.86 28.13 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.41 -68.97 0.79 Allowed 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -87.65 -3.15 58.98 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -178.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.744 HD13 ' HB2' ' A' ' 46' ' ' PHE . 45.3 mt -112.64 -62.86 2.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.548 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.27 -34.72 72.6 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.86 -37.84 18.03 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.689 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.04 -28.21 60.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.021 0.439 . . . . 0.0 111.677 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.462 HG13 ' N ' ' A' ' 27' ' ' ILE . 1.9 t -66.36 -43.17 91.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.617 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.64 -25.66 64.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.149 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.75 -24.39 63.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.651 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 12.4 t -89.17 -31.93 17.71 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.755 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 128.55 17.23 1.95 Allowed Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.093 -1.051 . . . . 0.0 113.88 178.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 116.14 114.65 2.86 Favored Glycine 0 C--O 1.227 -0.309 0 C-N-CA 120.24 -0.981 . . . . 0.0 112.29 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.462 ' N ' HG13 ' A' ' 21' ' ' VAL . 1.4 tt 19.13 94.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.621 ' HB3' HG23 ' A' ' 32' ' ' VAL . 6.8 t0 -127.73 143.34 51.15 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 114.18 -1.373 . . . . 0.0 107.616 177.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.781 ' HB3' ' HD3' ' A' ' 30' ' ' PRO . 36.7 tp -106.88 -58.49 0.05 OUTLIER Pre-proline 0 C--N 1.303 -1.429 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.232 -179.266 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.781 ' HD3' ' HB3' ' A' ' 29' ' ' LEU . 25.9 Cg_exo -62.59 -28.22 77.0 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 121.93 1.753 . . . . 0.0 112.594 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.602 ' HB3' ' CG ' ' A' ' 28' ' ' ASP . 0.1 OUTLIER -84.46 -41.31 16.73 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.764 -179.147 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.621 HG23 ' HB3' ' A' ' 28' ' ' ASP . 45.1 t -84.91 -6.22 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-O 121.174 0.511 . . . . 0.0 111.021 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.461 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 2.4 tm? -54.37 -45.46 72.79 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.326 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.77 -36.86 80.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.529 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.08 2.02 52.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.805 0.336 . . . . 0.0 111.493 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 57.4 tp -97.3 -32.32 11.95 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.322 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -75.93 -26.5 56.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.19 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -106.9 -179.71 4.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.628 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 57.49 31.91 20.99 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 123.568 0.542 . . . . 0.0 112.286 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.656 ' HG3' ' NZ ' ' A' ' 10' ' ' LYS . 11.6 tp10 53.69 67.91 0.93 Allowed 'General case' 0 CA--C 1.534 0.348 0 O-C-N 123.611 0.569 . . . . 0.0 110.509 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -79.5 -166.07 31.67 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.73 -0.668 . . . . 0.0 113.493 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.488 ' HB2' ' CD ' ' A' ' 10' ' ' LYS . 47.0 t -160.31 88.83 0.82 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.635 ' CB ' ' HB3' ' A' ' 60' ' ' LEU . . . -68.44 -42.03 79.46 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -178.184 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.605 ' OG ' ' HB2' ' A' ' 5' ' ' CYS . 2.4 p -75.56 28.4 0.1 Allowed 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.363 0.602 . . . . 0.0 112.438 -179.222 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.445 ' H ' ' C ' ' A' ' 43' ' ' ALA . 20.1 t -139.6 -18.21 0.97 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.744 ' HB2' HD13 ' A' ' 17' ' ' ILE . 0.8 OUTLIER -111.0 -63.17 1.43 Allowed 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.785 -179.311 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 19.8 m -79.12 25.34 0.29 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.473 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -52.94 -62.31 1.74 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.642 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -92.74 -31.8 14.93 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 8.0 m80 -79.47 76.05 6.07 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.432 ' SG ' ' HB3' ' A' ' 56' ' ' LYS . 4.0 t -128.31 52.45 1.9 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -177.15 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 15.9 p-80 -122.46 82.64 2.0 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.637 0.732 . . . . 0.0 110.712 178.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.75 172.77 44.21 Favored Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.479 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.768 HG11 ' HA ' ' A' ' 30' ' ' PRO . 44.9 t 63.61 -73.32 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 123.297 0.639 . . . . 0.0 112.59 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.735 ' HB2' HD11 ' A' ' 29' ' ' LEU . 38.9 t -71.72 -44.38 64.23 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.407 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.432 ' HB3' ' SG ' ' A' ' 51' ' ' CYS . 0.1 OUTLIER -88.05 13.31 11.4 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 119.899 -0.72 . . . . 0.0 110.603 179.17 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -69.14 -35.35 76.26 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 177.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -95.58 -4.13 45.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 113.972 -1.467 . . . . 0.0 108.521 177.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.402 ' H ' ' C ' ' A' ' 56' ' ' LYS . 75.1 m-70 65.91 75.25 0.35 Allowed 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 114.414 -1.266 . . . . 0.0 110.912 -178.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.635 ' HB3' ' CB ' ' A' ' 43' ' ' ALA . 88.6 mt -106.06 -31.29 8.79 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.36 -179.301 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.7 p . . . . . 0 C--O 1.245 0.845 0 CA-C-O 118.304 -0.855 . . . . 0.0 110.179 179.059 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 62' ' ' ALA . . . . . 0.416 ' O ' ' HB2' ' B' ' 63' ' ' MET . . . . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 120.454 0.169 . . . . 0.0 111.017 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 63' ' ' MET . . . . . 0.416 ' HB2' ' O ' ' B' ' 62' ' ' ALA . 56.9 mtp 73.03 -76.17 0.07 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.577 0.751 . . . . 0.0 112.434 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -153.61 173.28 32.36 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 119.871 -1.157 . . . . 0.0 113.361 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 38.6 mtpt 53.09 -104.15 0.19 Allowed 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.435 0.694 . . . . 0.0 111.81 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 66' ' ' CYS . . . . . 0.464 ' SG ' ' HE3' ' B' ' 71' ' ' LYS . 42.2 t -161.02 133.27 5.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.562 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 31.1 m -80.94 86.06 6.14 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.406 HG12 ' SG ' ' B' ' 74' ' ' CYS . 27.7 m -63.37 -38.94 83.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -176.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.71 -43.93 93.91 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -177.542 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 70' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -91.29 12.51 20.1 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.712 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 71' ' ' LYS . . . . . 0.797 ' HD2' ' HB2' ' B' ' 103' ' ' CYS . 13.0 ttmm -122.64 38.67 4.11 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.87 0.367 . . . . 0.0 110.824 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.436 ' O ' HG12 ' B' ' 72' ' ' VAL . 9.7 t 56.1 32.91 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 123.57 0.748 . . . . 0.0 112.087 179.114 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . 50.58 34.41 9.58 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 178.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 74' ' ' CYS . . . . . 0.711 ' HB3' HD12 ' B' ' 78' ' ' ILE . 30.3 m 66.15 23.65 10.93 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 178.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -90.64 -31.23 16.72 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -178.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -71.15 -75.16 0.13 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -178.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.01 29.67 0.13 Allowed 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -177.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.711 HD12 ' HB3' ' B' ' 74' ' ' CYS . 23.2 mt -142.2 -58.3 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 O-C-N 122.246 -0.284 . . . . 0.0 110.408 178.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.79 -35.58 77.21 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.927 0.394 . . . . 0.0 110.65 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -75.34 -23.82 72.61 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.363 178.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.78 -28.32 63.54 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.783 0.325 . . . . 0.0 110.747 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 82' ' ' VAL . . . . . 0.516 HG23 ' O ' ' B' ' 78' ' ' ILE . 52.8 t -70.72 -28.11 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.031 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.44 -32.81 72.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.089 0.471 . . . . 0.0 109.883 178.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -87.12 1.3 53.43 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.754 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 64.3 m -148.49 64.97 1.07 Allowed 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -28.72 -48.09 0.08 OUTLIER Glycine 0 N--CA 1.469 0.899 0 O-C-N 124.881 1.363 . . . . 0.0 114.414 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . -96.36 86.41 0.91 Allowed Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 177.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 88' ' ' ILE . . . . . 0.502 ' HB ' HG13 ' B' ' 82' ' ' VAL . 0.0 OUTLIER -62.08 135.77 26.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.637 0.732 . . . . 0.0 112.406 -177.551 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 89' ' ' ASP . . . . . 0.477 ' O ' ' HB2' ' B' ' 90' ' ' LEU . 10.3 t70 -146.92 -71.47 0.23 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.146 178.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 90' ' ' LEU . . . . . 0.653 ' N ' ' HD2' ' B' ' 91' ' ' PRO . 29.1 tp 172.37 -49.54 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.434 0 O-C-N 123.995 0.81 . . . . 0.0 109.844 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 91' ' ' PRO . . . . . 0.653 ' HD2' ' N ' ' B' ' 90' ' ' LEU . 5.4 Cg_exo -31.9 -70.11 0.05 OUTLIER 'Trans proline' 0 C--N 1.367 1.505 0 C-N-CA 124.842 3.695 . . . . 0.0 115.341 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 26.8 p -83.81 -31.84 25.64 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -177.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 93' ' ' VAL . . . . . 0.452 ' H ' HG23 ' B' ' 93' ' ' VAL . 1.1 t -62.02 -22.49 28.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.943 0.401 . . . . 0.0 111.002 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 94' ' ' LEU . . . . . 0.691 ' HG ' HG12 ' B' ' 115' ' ' VAL . 2.8 tm? -67.97 -37.12 81.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.663 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.53 -47.32 79.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.978 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -83.48 -2.52 56.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.684 0.278 . . . . 0.0 111.717 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 97' ' ' LEU . . . . . 0.449 HD13 ' HE2' ' B' ' 107' ' ' PHE . 27.1 tp -86.84 -21.66 26.28 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.27 0.557 . . . . 0.0 110.055 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.25 -3.02 27.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.442 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -121.84 160.7 24.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.651 0.262 . . . . 0.0 111.457 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . 55.92 56.61 5.85 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.161 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 52.53 60.45 3.8 Favored 'General case' 0 N--CA 1.465 0.277 0 O-C-N 123.728 0.642 . . . . 0.0 110.533 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 102' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' B' ' 97' ' ' LEU . . . -77.66 164.89 52.31 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.847 -0.692 . . . . 0.0 113.328 -178.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 103' ' ' CYS . . . . . 0.797 ' HB2' ' HD2' ' B' ' 71' ' ' LYS . 35.3 t -136.44 77.73 1.67 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 104' ' ' ALA . . . . . 0.572 ' CB ' ' HB3' ' B' ' 121' ' ' LEU . . . -67.0 -40.14 87.26 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -178.17 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 8.0 t -75.94 29.94 0.11 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.168 0.508 . . . . 0.0 111.488 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 106' ' ' CYS . . . . . 0.667 ' HB2' ' SG ' ' B' ' 103' ' ' CYS . 44.6 t -118.73 -50.17 2.42 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.756 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 107' ' ' PHE . . . . . 0.47 ' HB3' HD13 ' B' ' 78' ' ' ILE . 0.1 OUTLIER -102.41 -46.0 4.92 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.35 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -70.26 30.13 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.487 -0.778 . . . . 0.0 112.727 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 109' ' ' GLU . . . . . 0.423 ' H ' ' C ' ' B' ' 107' ' ' PHE . 23.5 tt0 -69.06 -64.2 0.91 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.49 0.186 . . . . 0.0 110.581 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -76.15 -31.68 58.71 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 20.9 m80 -74.16 85.67 1.87 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.97 -1.014 . . . . 0.0 108.826 178.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 112' ' ' CYS . . . . . 0.473 ' SG ' ' HG3' ' B' ' 117' ' ' LYS . 4.5 t -151.0 71.58 1.03 Allowed 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.264 -0.574 . . . . 0.0 112.097 -177.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 113' ' ' HIS . . . . . . . . . . . . . 49.4 p-80 -128.64 -17.4 4.09 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 179.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -155.25 -73.18 0.01 OUTLIER Glycine 0 C--O 1.226 -0.396 0 C-N-CA 119.06 -1.543 . . . . 0.0 114.713 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 115' ' ' VAL . . . . . 0.691 HG12 ' HG ' ' B' ' 94' ' ' LEU . 2.8 t -58.42 -55.6 21.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -177.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 116' ' ' CYS . . . . . 0.446 ' SG ' HD11 ' B' ' 90' ' ' LEU . 1.0 OUTLIER -73.07 -19.86 61.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.831 0.348 . . . . 0.0 111.675 -179.607 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 117' ' ' LYS . . . . . 0.473 ' HG3' ' SG ' ' B' ' 112' ' ' CYS . 15.5 mttm -82.72 -24.44 33.58 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.877 178.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -63.43 -45.42 91.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.93 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -90.24 7.66 37.08 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.23 -0.441 . . . . 0.0 112.053 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 53.3 62.52 2.62 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.022 0.439 . . . . 0.0 110.683 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 121' ' ' LEU . . . . . 0.572 ' HB3' ' CB ' ' B' ' 104' ' ' ALA . 96.3 mt -110.13 -12.55 14.49 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -178.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 122' ' ' CYS . . . . . 0.438 ' SG ' ' HB3' ' B' ' 116' ' ' CYS . 1.8 p . . . . . 0 C--O 1.245 0.848 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.402 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.169 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 4.0 ptm 46.48 -170.22 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.193 0.997 . . . . 0.0 113.553 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -122.19 58.33 0.6 Allowed Glycine 0 CA--C 1.505 -0.549 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.547 -179.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 67.0 mttm 57.03 -122.51 1.62 Allowed 'General case' 0 C--N 1.328 -0.328 0 O-C-N 123.882 0.401 . . . . 0.0 109.991 -179.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 59.2 m -137.47 139.59 40.69 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.311 -0.556 . . . . 0.0 111.989 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.5 p -106.99 -164.45 0.99 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.284 -0.871 . . . . 0.0 108.919 178.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.5 p -78.39 -19.6 13.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.558 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.631 ' H ' HD23 ' A' ' 8' ' ' LEU . 1.0 OUTLIER -96.8 -35.46 10.95 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 121.052 -0.259 . . . . 0.0 110.408 178.728 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.532 ' HD2' ' HG ' ' A' ' 8' ' ' LEU . 1.7 mptm? -84.18 22.96 1.12 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.811 0.339 . . . . 0.0 110.322 178.076 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.7 -9.46 58.61 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 121.433 0.635 . . . . 0.0 110.299 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.6 t -67.27 -22.62 29.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.783 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -81.76 -10.26 59.4 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -178.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 6.1 p -104.36 -47.78 4.02 Favored 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 119.806 -0.757 . . . . 0.0 112.326 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.21 -38.87 92.62 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.12 -12.69 60.01 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.438 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . . . -101.79 -38.57 7.8 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -179.511 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.924 HD13 HD13 ' A' ' 36' ' ' LEU . 10.9 tp -73.28 -35.06 45.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.42 0.628 . . . . 0.0 111.017 -179.244 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.34 -22.39 53.1 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.973 -1.012 . . . . 0.0 112.806 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -77.79 -29.38 54.93 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.349 -179.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.14 -17.37 52.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.65 0.262 . . . . 0.0 111.143 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.1 t -63.07 -46.34 96.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 CA-C-O 120.898 0.38 . . . . 0.0 110.733 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.7 -23.75 64.41 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.165 -0.471 . . . . 0.0 112.201 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -85.71 -23.91 27.19 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.551 0.691 . . . . 0.0 110.947 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.554 ' SG ' ' CD2' ' B' ' 113' ' ' HIS . 0.7 OUTLIER -86.17 -28.1 24.14 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.151 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.21 39.62 9.08 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.131 -1.033 . . . . 0.0 110.684 -179.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 143.63 178.16 19.17 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 -178.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.593 HD12 HG21 ' A' ' 32' ' ' VAL . 3.0 tp -129.47 121.81 54.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 117.871 0.836 . . . . 0.0 112.117 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.595 ' HB3' ' HD2' ' A' ' 30' ' ' PRO . 2.1 m-20 -140.45 -75.83 0.33 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.051 178.464 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.678 ' HG ' ' CG2' ' A' ' 54' ' ' VAL . 26.6 tp 172.26 -49.63 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.411 0 O-C-N 124.136 0.898 . . . . 0.0 111.354 179.303 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.723 ' HA ' HG11 ' A' ' 54' ' ' VAL . 5.4 Cg_endo -48.23 -63.66 0.3 Allowed 'Trans proline' 0 C--N 1.359 1.11 0 C-N-CA 123.093 2.529 . . . . 0.0 114.31 -179.206 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.424 ' HB3' ' O ' ' B' ' 113' ' ' HIS . 4.4 p -66.93 -37.87 85.12 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.41 -178.444 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.593 HG21 HD12 ' A' ' 27' ' ' ILE . 0.2 OUTLIER -70.57 -18.29 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.722 -178.486 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.554 HD22 ' HB ' ' A' ' 54' ' ' VAL . 58.9 tp -64.88 -21.7 66.86 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.722 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.34 -31.86 35.45 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -178.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -121.43 43.56 2.79 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.838 0.352 . . . . 0.0 110.744 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.924 HD13 HD13 ' A' ' 17' ' ' ILE . 14.3 tp -133.91 -6.2 2.77 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -178.575 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.412 ' O ' ' HB2' ' A' ' 38' ' ' ALA . 77.9 tttt -85.49 74.42 10.33 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 122.032 -0.418 . . . . 0.0 111.989 -179.289 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.412 ' HB2' ' O ' ' A' ' 37' ' ' LYS . . . 171.79 169.82 0.1 Allowed 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.124 0.569 . . . . 0.0 110.523 179.061 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.96 -39.32 87.21 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.456 ' H ' ' HG2' ' A' ' 40' ' ' GLU . 3.2 pt-20 -78.03 88.59 4.17 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 176.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.438 ' HA2' ' HB3' ' A' ' 16' ' ' ALA . . . 137.94 -39.53 1.59 Allowed Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 108.05 -2.02 . . . . 0.0 108.05 -176.125 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 1.1 m 55.07 93.38 0.02 OUTLIER 'General case' 0 C--O 1.235 0.325 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 176.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.5 ' HA ' ' HG ' ' A' ' 36' ' ' LEU . . . -70.59 -24.99 62.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.476 176.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.8 p -76.15 12.9 1.01 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.925 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 37.8 t -113.14 -56.35 2.42 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.08 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.616 ' CD2' HG12 ' A' ' 17' ' ' ILE . 1.1 t80 -77.03 -54.65 6.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.755 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.576 ' O ' ' HB2' ' A' ' 51' ' ' CYS . 53.9 m -68.49 6.23 0.86 Allowed 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -178.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -66.98 -71.02 0.22 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.279 0.561 . . . . 0.0 110.685 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.06 -17.56 58.67 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.372 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 21.9 m80 -113.08 83.26 1.8 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.481 -0.782 . . . . 0.0 109.943 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.576 ' HB2' ' O ' ' A' ' 47' ' ' CYS . 22.2 t -140.03 86.94 2.12 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.158 -0.617 . . . . 0.0 112.526 -178.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.699 ' O ' ' HB3' ' B' ' 92' ' ' CYS . 0.0 OUTLIER -144.11 -3.02 0.87 Allowed 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.022 0.439 . . . . 0.0 110.444 177.742 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.868 ' HA3' ' HB2' ' B' ' 91' ' ' PRO . . . -157.42 163.97 32.76 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-O 118.914 -0.936 . . . . 0.0 111.695 178.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.723 HG11 ' HA ' ' A' ' 30' ' ' PRO . 6.0 m 46.55 -64.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 115.377 1.621 . . . . 0.0 115.377 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.462 ' N ' ' O ' ' A' ' 53' ' ' GLY . 0.6 OUTLIER -63.04 -34.13 76.91 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 122.111 -0.368 . . . . 0.0 111.16 -178.676 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.0 pttp -70.58 -28.53 64.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.009 0.433 . . . . 0.0 110.321 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -65.83 -39.34 90.73 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.395 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.439 HD12 HD21 ' A' ' 33' ' ' LEU . 91.3 mt -87.24 4.21 43.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.74 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 58.5 m170 59.5 57.65 3.22 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 123.425 0.453 . . . . 0.0 111.809 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.412 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 80.4 mt -112.55 -2.68 14.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.02 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.452 ' SG ' ' HB3' ' A' ' 47' ' ' CYS . 6.3 p . . . . . 0 C--O 1.247 0.946 0 CA-C-O 117.907 -1.044 . . . . 0.0 109.513 179.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 120.587 0.232 . . . . 0.0 110.602 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 63' ' ' MET . . . . . . . . . . . . . 4.9 mtm 71.86 -40.89 0.49 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.125 0.97 . . . . 0.0 112.369 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.23 -36.56 4.21 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.711 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 45.2 mttp 56.24 -154.7 0.32 Allowed 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 122.893 0.477 . . . . 0.0 111.15 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -96.19 71.86 2.85 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.429 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 14.5 p -87.81 -131.04 0.07 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.16 -179.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 6.0 p -103.12 -41.96 7.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.657 0.265 . . . . 0.0 111.239 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.758 HD23 ' H ' ' B' ' 69' ' ' LEU . 2.4 pt? -86.56 -39.75 15.89 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.349 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 70' ' ' LYS . . . . . . . . . . . . . 7.5 mtpm? -89.03 24.81 1.99 Allowed 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.257 0.551 . . . . 0.0 110.572 179.064 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.55 -27.24 63.03 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.28 178.176 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 2.7 t -82.48 6.71 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.448 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.11 -8.59 31.89 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.483 0.659 . . . . 0.0 110.456 178.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 74' ' ' CYS . . . . . 0.484 ' HB3' ' HB3' ' B' ' 106' ' ' CYS . 4.6 p -71.42 -30.69 66.37 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.774 179.228 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 75' ' ' ALA . . . . . 0.475 ' HA ' HG22 ' B' ' 78' ' ' ILE . . . -68.4 -5.67 20.32 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.539 -179.304 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.77 -27.39 63.89 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.359 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -128.79 -29.99 2.31 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 1.016 HD13 HD13 ' B' ' 97' ' ' LEU . 6.4 tp -73.68 -36.22 46.23 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 C-N-CA 120.634 -0.426 . . . . 0.0 111.309 -178.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.05 -34.02 71.45 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.869 -178.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -76.69 -33.83 45.78 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.381 -0.914 . . . . 0.0 111.297 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 81' ' ' ALA . . . . . 0.485 ' HB2' ' HB3' ' B' ' 96' ' ' ALA . . . -66.65 -24.81 66.34 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.687 0.28 . . . . 0.0 111.478 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 82' ' ' VAL . . . . . 0.576 HG22 HD13 ' B' ' 88' ' ' ILE . 91.6 t -58.23 -38.5 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-O 121.156 0.503 . . . . 0.0 110.663 179.452 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.79 -33.25 12.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.373 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.78 -19.15 64.3 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -179.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 85' ' ' CYS . . . . . 0.418 ' HB2' ' O ' ' B' ' 81' ' ' ALA . 0.8 OUTLIER -98.94 -1.01 41.03 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 121.21 -0.196 . . . . 0.0 111.506 -179.858 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 59.68 37.03 91.73 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.298 -179.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 143.35 137.81 3.33 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 110.106 -1.197 . . . . 0.0 110.106 -178.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 88' ' ' ILE . . . . . 0.576 HD13 HG22 ' B' ' 82' ' ' VAL . 3.4 tp -103.25 118.54 50.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 121.493 0.663 . . . . 0.0 112.639 -178.349 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -133.52 -83.54 0.46 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.261 -0.882 . . . . 0.0 108.876 178.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 90' ' ' LEU . . . . . 0.632 HD11 ' HB2' ' B' ' 116' ' ' CYS . 38.0 tp 176.85 -51.79 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.94 179.193 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 91' ' ' PRO . . . . . 0.868 ' HB2' ' HA3' ' A' ' 53' ' ' GLY . 4.0 Cg_exo -38.93 -60.99 0.43 Allowed 'Trans proline' 0 C--N 1.363 1.334 0 C-N-CA 123.66 2.907 . . . . 0.0 114.587 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 92' ' ' CYS . . . . . 0.699 ' HB3' ' O ' ' A' ' 52' ' ' HIS . 24.5 p -83.15 -33.02 26.34 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -178.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 93' ' ' VAL . . . . . 0.433 ' H ' HG23 ' B' ' 93' ' ' VAL . 1.8 t -59.24 -21.44 20.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.881 -178.382 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 94' ' ' LEU . . . . . 0.834 HD22 ' HB ' ' B' ' 115' ' ' VAL . 15.9 tp -63.17 -35.19 79.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.654 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.35 -28.91 70.09 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 96' ' ' ALA . . . . . 0.485 ' HB3' ' HB2' ' B' ' 81' ' ' ALA . . . -103.58 10.0 37.17 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.93 0.395 . . . . 0.0 111.375 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 97' ' ' LEU . . . . . 1.016 HD13 HD13 ' B' ' 78' ' ' ILE . 40.9 tp -93.81 -28.89 15.63 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.571 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -81.8 103.04 11.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.472 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -158.56 -175.34 5.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.302 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -80.25 -0.21 35.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.231 0.538 . . . . 0.0 110.3 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -147.36 47.09 1.13 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.217 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 102' ' ' GLY . . . . . 0.479 ' O ' ' HA ' ' B' ' 74' ' ' CYS . . . -103.9 -44.68 1.6 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.303 -0.951 . . . . 0.0 113.426 -178.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 75.74 -51.25 0.63 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.136 0.574 . . . . 0.0 110.892 -179.126 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 104' ' ' ALA . . . . . 0.759 ' HB1' ' HB3' ' B' ' 121' ' ' LEU . . . 70.51 -59.69 0.52 Allowed 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 178.238 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 12.8 p -50.07 -43.84 51.49 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -178.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 106' ' ' CYS . . . . . 0.484 ' HB3' ' HB3' ' B' ' 74' ' ' CYS . 0.0 OUTLIER -52.35 -45.71 65.81 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.108 0.48 . . . . 0.0 111.711 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 107' ' ' PHE . . . . . 0.696 ' CD2' HG12 ' B' ' 78' ' ' ILE . 20.3 t80 -75.57 -60.88 2.11 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.339 -179.266 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 108' ' ' CYS . . . . . 0.65 ' HA ' ' HB2' ' B' ' 111' ' ' HIS . 38.1 m -78.84 43.54 0.5 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -178.103 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -74.99 -52.39 11.24 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -102.84 12.84 35.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.894 0.854 . . . . 0.0 108.737 178.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 111' ' ' HIS . . . . . 0.65 ' HB2' ' HA ' ' B' ' 108' ' ' CYS . 36.3 m80 -119.68 58.45 0.89 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.684 -179.057 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 72.0 m -110.61 61.73 0.61 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.02 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 113' ' ' HIS . . . . . 0.554 ' CD2' ' SG ' ' A' ' 24' ' ' CYS . 0.2 OUTLIER -138.24 -15.68 1.27 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.219 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 114' ' ' GLY . . . . . 0.418 ' O ' ' HG3' ' B' ' 117' ' ' LYS . . . -120.17 -145.08 7.34 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 119.8 -1.19 . . . . 0.0 113.86 -179.124 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 115' ' ' VAL . . . . . 0.834 ' HB ' HD22 ' B' ' 94' ' ' LEU . 20.2 m -46.16 -28.76 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -179.09 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 116' ' ' CYS . . . . . 0.632 ' HB2' HD11 ' B' ' 90' ' ' LEU . 2.8 t -71.23 -39.3 71.78 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -177.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 117' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' B' ' 114' ' ' GLY . 0.0 OUTLIER -77.28 -14.72 59.7 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.214 -179.949 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 118' ' ' ASP . . . . . 0.416 ' N ' ' HD3' ' B' ' 117' ' ' LYS . 12.3 t70 -70.0 -37.61 75.75 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.653 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 89.0 mt -94.89 6.95 47.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.417 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 56.5 m170 60.36 69.02 0.72 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.341 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 121' ' ' LEU . . . . . 0.759 ' HB3' ' HB1' ' B' ' 104' ' ' ALA . 98.3 mt -112.7 3.19 16.42 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 122' ' ' CYS . . . . . . . . . . . . . 25.3 p . . . . . 0 C--O 1.246 0.906 0 CA-C-O 118.028 -0.986 . . . . 0.0 109.874 178.078 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.854 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 21.2 ptp -81.45 167.62 19.19 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.212 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 145.82 82.05 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.408 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -62.63 -50.0 72.95 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.839 0.352 . . . . 0.0 110.349 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 75.1 m -81.9 -64.1 1.25 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.228 0.537 . . . . 0.0 110.677 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.506 ' HB3' ' HB2' ' A' ' 9' ' ' LYS . 34.6 t -160.71 -176.89 5.81 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.838 -178.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.1 p -79.27 -28.66 13.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.783 0.325 . . . . 0.0 110.794 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.649 ' H ' HD23 ' A' ' 8' ' ' LEU . 1.1 pt? -94.04 -27.66 16.17 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 121.162 0.506 . . . . 0.0 109.828 178.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.506 ' HB2' ' HB3' ' A' ' 6' ' ' SER . 10.4 mtmt -91.74 29.0 1.62 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 177.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.465 ' C ' ' H ' ' A' ' 12' ' ' ALA . 32.5 tttm -81.11 -4.59 55.79 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 114.071 -1.422 . . . . 0.0 110.227 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.483 HG12 ' HB3' ' A' ' 14' ' ' ALA . 2.3 t -69.75 13.14 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.64 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.465 ' H ' ' C ' ' A' ' 10' ' ' LYS . . . 59.11 48.65 10.3 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 123.429 0.692 . . . . 0.0 112.55 178.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.914 ' HB3' HD12 ' A' ' 17' ' ' ILE . 24.0 m 67.02 1.75 2.45 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 178.196 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.483 ' HB3' HG12 ' A' ' 11' ' ' VAL . . . -66.67 -66.92 0.49 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.192 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.65 38.32 0.19 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -147.46 -52.02 0.2 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.102 0.477 . . . . 0.0 110.497 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.914 HD12 ' HB3' ' A' ' 13' ' ' CYS . 5.3 mt -83.81 -46.8 18.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.343 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.22 -20.09 60.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.137 0.494 . . . . 0.0 109.838 177.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -82.01 -34.94 22.81 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 111.291 -0.724 . . . . 0.0 111.291 178.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.91 -26.71 68.72 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 121.085 0.469 . . . . 0.0 110.881 179.161 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 17' ' ' ILE . 57.0 t -63.76 -45.24 97.8 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.299 179.115 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.42 -18.99 62.31 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.461 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.14 -47.07 15.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.775 0.322 . . . . 0.0 111.844 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.7 t -88.33 -15.31 36.03 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.93 -179.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 108.51 -63.15 0.28 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.216 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -122.53 155.36 17.0 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.334 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -86.38 141.89 13.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.06 0.457 . . . . 0.0 111.15 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.528 ' H ' HG21 ' A' ' 32' ' ' VAL . 26.6 t70 -163.97 -98.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 178.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.791 HD11 ' SG ' ' A' ' 55' ' ' CYS . 32.8 tp -174.07 -55.32 0.0 OUTLIER Pre-proline 0 C--O 1.222 -0.363 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 178.485 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.571 ' HA ' HG11 ' A' ' 54' ' ' VAL . 3.4 Cg_endo -47.74 -61.71 0.56 Allowed 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 122.786 2.324 . . . . 0.0 114.262 -178.397 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 13.0 p -76.6 -33.11 58.43 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.459 -178.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.528 HG21 ' H ' ' A' ' 28' ' ' ASP . 13.0 t -63.09 -26.22 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.727 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.578 ' HG ' HG22 ' A' ' 54' ' ' VAL . 3.1 tm? -55.56 -38.59 69.52 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.767 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -57.45 -41.92 81.46 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.284 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -98.35 12.28 35.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.263 0.554 . . . . 0.0 110.743 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.447 HD21 ' SG ' ' A' ' 47' ' ' CYS . 46.5 tp -99.34 -61.91 1.31 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.654 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.437 ' HB2' ' HE2' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -110.16 167.24 10.33 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.372 0.606 . . . . 0.0 111.539 -179.28 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -172.56 -112.05 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' A' ' 40' ' ' GLU . . . -92.26 73.08 5.37 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 176.192 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.405 ' HB2' ' O ' ' A' ' 39' ' ' ALA . 93.0 mt-10 71.22 92.16 0.09 Allowed 'General case' 0 N--CA 1.464 0.272 0 O-C-N 124.084 0.865 . . . . 0.0 109.707 -177.121 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -115.43 -173.73 17.67 Favored Glycine 0 C--N 1.33 0.209 0 C-N-CA 120.556 -0.831 . . . . 0.0 113.063 -179.008 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.423 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 57.3 m -82.56 62.41 6.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.751 0.31 . . . . 0.0 111.714 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -96.56 -7.59 34.1 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.809 0.338 . . . . 0.0 110.829 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.4 m -81.54 -16.27 52.24 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.886 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.423 ' SG ' ' HB3' ' A' ' 42' ' ' CYS . 6.3 p -98.48 -33.47 11.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.296 0.569 . . . . 0.0 111.131 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.736 ' HB2' ' CD1' ' A' ' 17' ' ' ILE . 0.9 OUTLIER -86.13 -60.99 1.85 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.665 -178.511 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.447 ' SG ' HD21 ' A' ' 36' ' ' LEU . 4.5 m -72.61 14.08 0.3 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.637 -177.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -51.84 -74.98 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 121.179 0.514 . . . . 0.0 110.457 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -84.86 -27.01 27.01 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 18.3 m80 -86.71 56.58 4.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.019 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.403 ' O ' ' HB2' ' A' ' 56' ' ' LYS . 7.6 t -108.37 39.62 1.94 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.243 0.544 . . . . 0.0 110.126 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.607 ' CD2' ' HB2' ' B' ' 89' ' ' ASP . 7.8 p-80 -117.82 -12.91 10.14 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.55 -179.19 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.529 ' HA3' HD23 ' A' ' 29' ' ' LEU . . . -95.32 -136.14 8.46 Favored Glycine 0 C--O 1.228 -0.226 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.812 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.578 HG22 ' HG ' ' A' ' 33' ' ' LEU . 2.2 p -70.19 -16.11 19.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 120.747 0.308 . . . . 0.0 111.561 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.791 ' SG ' HD11 ' A' ' 29' ' ' LEU . 89.2 m -72.21 -21.17 61.45 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.603 0.716 . . . . 0.0 109.112 176.566 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.519 ' HB3' ' O ' ' A' ' 53' ' ' GLY . 22.7 tptm -79.6 -20.38 47.04 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.474 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -59.44 -50.25 74.65 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.291 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.512 ' O ' HD23 ' A' ' 58' ' ' LEU . 5.7 tt -83.26 -29.37 28.47 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 9.6 t-160 64.26 55.86 1.4 Allowed 'General case' 0 C--O 1.235 0.301 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.04 179.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.52 20.4 16.13 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.473 179.078 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.244 0.805 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.541 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.272 0 CA-C-O 120.867 0.365 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 63' ' ' MET . . . . . . . . . . . . . 8.9 ptp -136.13 131.45 34.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.98 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -99.29 49.46 1.22 Allowed Glycine 0 C--O 1.229 -0.209 0 C-N-CA 120.542 -0.837 . . . . 0.0 114.734 -177.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 12.2 mtmt -133.36 -35.98 1.0 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 117.245 0.522 . . . . 0.0 110.427 178.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 66' ' ' CYS . . . . . 0.494 ' HB3' ' HB2' ' B' ' 70' ' ' LYS . 10.4 m -153.71 -108.25 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.656 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 30.0 t -142.65 -179.6 6.41 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 14.0 p -68.61 -28.07 38.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 CA-C-O 120.554 0.216 . . . . 0.0 111.307 -179.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.73 HD23 ' H ' ' B' ' 69' ' ' LEU . 1.4 pt? -98.38 -26.74 14.38 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.089 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 70' ' ' LYS . . . . . 0.494 ' HB2' ' HB3' ' B' ' 66' ' ' CYS . 25.2 mmtp -87.16 21.46 2.37 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 177.477 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -66.83 -6.23 15.42 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.592 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 2.7 t -71.84 12.82 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.654 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . 62.76 67.02 0.72 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.009 0.523 . . . . 0.0 111.763 179.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 74' ' ' CYS . . . . . 0.734 ' O ' ' HB ' ' B' ' 78' ' ' ILE . 8.5 p 52.77 7.99 0.08 Allowed 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 114.381 -1.282 . . . . 0.0 113.593 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -88.87 -3.14 58.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.741 0.305 . . . . 0.0 110.86 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -98.74 22.76 9.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.214 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -163.58 -38.17 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.378 0.608 . . . . 0.0 110.285 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.734 ' HB ' ' O ' ' B' ' 74' ' ' CYS . 1.4 mt -83.66 -46.69 18.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.741 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.8 -29.27 68.41 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.883 0.373 . . . . 0.0 110.682 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.4 -35.71 28.79 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.045 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 81' ' ' ALA . . . . . 0.416 ' CB ' HG13 ' B' ' 93' ' ' VAL . . . -69.61 -26.57 64.5 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.181 0.515 . . . . 0.0 110.626 179.225 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 82' ' ' VAL . . . . . 0.498 HG23 ' O ' ' B' ' 78' ' ' ILE . 25.5 t -65.82 -43.14 93.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.567 178.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.38 -27.4 67.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.063 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.05 -44.57 46.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.651 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 73.0 m -83.43 -11.83 57.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.762 0.315 . . . . 0.0 110.725 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.3 42.6 10.34 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.605 -0.807 . . . . 0.0 113.171 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.05 176.71 14.51 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.56 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 7.4 tp -74.87 132.93 32.54 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 CA-C-O 121.388 0.613 . . . . 0.0 110.191 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 89' ' ' ASP . . . . . 0.607 ' HB2' ' CD2' ' A' ' 52' ' ' HIS . 32.5 t70 -152.9 -133.85 0.05 OUTLIER 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.479 -178.477 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 90' ' ' LEU . . . . . 0.874 HD11 ' HB2' ' B' ' 116' ' ' CYS . 31.9 tp 179.61 -57.4 0.0 OUTLIER Pre-proline 0 C--N 1.317 -0.826 0 C-N-CA 123.804 0.841 . . . . 0.0 110.129 179.151 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 91' ' ' PRO . . . . . 0.727 ' HD3' ' HB3' ' B' ' 90' ' ' LEU . 74.2 Cg_exo -51.77 -38.63 67.49 Favored 'Trans proline' 0 C--N 1.363 1.321 0 C-N-CA 122.347 2.031 . . . . 0.0 112.225 179.068 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 9.4 t -88.83 -40.43 13.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.676 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 93' ' ' VAL . . . . . 0.508 HG11 ' HE2' ' B' ' 107' ' ' PHE . 7.3 t -66.6 -23.4 31.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.779 -179.204 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 94' ' ' LEU . . . . . 0.586 ' HG ' HG22 ' B' ' 115' ' ' VAL . 2.7 tm? -50.35 -38.76 43.81 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 123.19 0.596 . . . . 0.0 111.929 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -42.67 -51.32 5.3 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -179.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -108.79 21.66 16.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.021 0.438 . . . . 0.0 111.07 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 97' ' ' LEU . . . . . 0.467 ' HB3' ' HA ' ' B' ' 94' ' ' LEU . 32.4 tp -105.25 -49.31 3.49 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.476 -179.073 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 98' ' ' LYS . . . . . 0.525 ' HG2' HD13 ' B' ' 94' ' ' LEU . 0.0 OUTLIER -63.45 -19.56 64.83 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -178.989 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.74 -23.87 41.99 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -179.12 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -109.33 93.1 4.33 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -66.69 148.79 51.43 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 83.39 -46.98 3.74 Favored Glycine 0 N--CA 1.451 -0.345 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 -178.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 103' ' ' CYS . . . . . 0.454 ' HA ' ' HB3' ' B' ' 74' ' ' CYS . 58.5 m -66.75 -45.48 78.47 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.299 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -66.65 -16.24 64.06 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.445 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 19.8 m -72.95 -39.45 66.17 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.623 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 13.4 p -63.6 -24.77 67.93 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 122.077 0.941 . . . . 0.0 109.679 179.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 107' ' ' PHE . . . . . 0.648 ' HB2' HD13 ' B' ' 78' ' ' ILE . 0.8 OUTLIER -88.81 -69.94 0.68 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.099 -1.41 . . . . 0.0 111.959 -178.87 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 108' ' ' CYS . . . . . 0.401 ' O ' ' HB2' ' B' ' 112' ' ' CYS . 82.5 m -74.27 28.42 0.08 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -177.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -53.69 -69.73 0.11 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.17 0.51 . . . . 0.0 110.266 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -89.93 -35.16 15.74 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -79.51 70.71 6.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.763 179.32 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 112' ' ' CYS . . . . . 0.401 ' HB2' ' O ' ' B' ' 108' ' ' CYS . 13.0 t -127.46 54.68 1.65 Allowed 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.924 -178.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 113' ' ' HIS . . . . . 0.428 ' HE1' ' HB3' ' A' ' 28' ' ' ASP . 0.1 OUTLIER -129.95 -12.38 4.2 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -179.843 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -94.69 -142.95 13.15 Favored Glycine 0 C--O 1.228 -0.272 0 C-N-CA 120.442 -0.885 . . . . 0.0 113.333 -179.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 115' ' ' VAL . . . . . 0.706 HG11 ' HA ' ' B' ' 91' ' ' PRO . 14.6 p -62.86 -15.46 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-O 121.142 0.496 . . . . 0.0 111.605 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 116' ' ' CYS . . . . . 0.874 ' HB2' HD11 ' B' ' 90' ' ' LEU . 6.8 t -76.19 -22.83 54.84 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.408 0.623 . . . . 0.0 109.76 178.385 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 117' ' ' LYS . . . . . 0.463 ' O ' ' HG3' ' B' ' 117' ' ' LYS . 13.5 tptt -79.16 -19.33 51.25 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.134 179.33 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -57.01 -41.55 78.69 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.2 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 119' ' ' LEU . . . . . 0.525 HD22 HD23 ' B' ' 121' ' ' LEU . 5.7 tt -86.19 -29.58 23.09 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 65.51 75.03 0.36 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.721 179.039 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 121' ' ' LEU . . . . . 0.525 HD23 HD22 ' B' ' 119' ' ' LEU . 0.4 OUTLIER -124.33 7.59 8.42 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.586 -0.733 . . . . 0.0 111.522 -179.701 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 122' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.244 0.803 0 CA-C-O 118.545 -0.741 . . . . 0.0 110.461 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.606 0.241 . . . . 0.0 110.827 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 84.7 mtp 61.84 -160.66 0.3 Allowed 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.669 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 96.95 -91.05 1.19 Allowed Glycine 0 N--CA 1.451 -0.349 0 N-CA-C 111.336 -0.705 . . . . 0.0 111.336 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -122.6 150.76 42.2 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 25.8 p -88.9 1.56 55.19 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -178.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 45.8 m 58.63 99.24 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.389 0.614 . . . . 0.0 111.634 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.541 HG12 ' HA ' ' A' ' 12' ' ' ALA . 57.3 t -54.46 -45.48 70.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.085 -0.961 . . . . 0.0 113.308 -179.446 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 45.2 tp -54.14 -58.52 7.03 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -178.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -72.29 -1.35 15.01 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -178.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 51.1 tttt -111.79 44.51 1.37 Allowed 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.282 178.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.438 ' O ' HG12 ' A' ' 11' ' ' VAL . 10.7 t 52.77 36.96 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.15 178.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.541 ' HA ' HG12 ' A' ' 7' ' ' VAL . . . 50.27 48.58 22.01 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.891 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.882 ' HB2' HD12 ' A' ' 17' ' ' ILE . 8.4 p 45.06 40.53 4.73 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.018 -0.992 . . . . 0.0 112.963 -179.007 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -112.09 16.45 20.19 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 120.934 0.397 . . . . 0.0 110.547 178.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -91.46 -82.61 0.3 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.028 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.99 -27.72 60.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.945 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.882 HD12 ' HB2' ' A' ' 13' ' ' CYS . 49.2 mt -74.08 -46.84 44.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.69 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' A' ' 14' ' ' ALA . . . -82.18 -15.89 51.64 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.197 179.504 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -82.79 -33.64 23.92 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.115 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.531 ' HB3' HG13 ' A' ' 32' ' ' VAL . . . -74.28 -13.5 60.78 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.831 0.348 . . . . 0.0 110.914 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 17' ' ' ILE . 78.7 t -64.34 -39.46 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.043 179.03 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.92 -31.18 67.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.112 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.13 -43.76 66.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.688 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.431 ' HB3' ' CG ' ' B' ' 113' ' ' HIS . 56.6 m -82.42 -19.34 39.21 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.099 -179.588 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.14 59.1 3.01 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 -179.054 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 122.0 156.63 9.75 Favored Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -177.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.516 HG12 ' N ' ' A' ' 28' ' ' ASP . 5.0 tt -98.87 147.08 7.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 118.125 0.963 . . . . 0.0 112.484 -178.601 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.516 ' N ' HG12 ' A' ' 27' ' ' ILE . 34.4 t0 -161.42 -106.13 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.48 -1.236 . . . . 0.0 107.967 179.133 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.717 HD11 ' HB2' ' A' ' 55' ' ' CYS . 40.2 tp -174.5 -47.94 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 178.423 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.63 ' HD2' ' H ' ' A' ' 29' ' ' LEU . 11.1 Cg_endo -54.52 -15.3 8.6 Favored 'Trans proline' 0 C--N 1.358 1.031 0 C-N-CA 122.959 2.44 . . . . 0.0 114.593 -178.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.553 ' HB2' ' O ' ' B' ' 113' ' ' HIS . 11.0 t -117.89 -31.72 5.01 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.275 0.56 . . . . 0.0 110.744 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.531 HG13 ' HB3' ' A' ' 20' ' ' ALA . 1.7 t -73.26 -9.17 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-N 115.74 -0.663 . . . . 0.0 112.375 -178.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.781 HD13 ' HB ' ' A' ' 54' ' ' VAL . 1.5 pt? -71.87 -14.82 62.06 Favored 'General case' 0 CA--C 1.531 0.25 0 O-C-N 122.221 -0.299 . . . . 0.0 111.64 -179.541 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -56.72 -55.09 38.62 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.876 0.37 . . . . 0.0 111.844 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -89.26 16.72 6.91 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.651 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.0 tp -112.69 -0.25 15.12 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.708 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.563 ' HD3' HD21 ' A' ' 58' ' ' LEU . 26.6 ttpt -98.55 154.52 17.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.256 -179.396 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 71.89 63.12 0.14 Allowed 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.587 0.755 . . . . 0.0 111.607 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -163.39 163.05 25.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.639 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -84.31 70.52 10.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.025 0.44 . . . . 0.0 110.025 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.715 ' HA2' HD22 ' A' ' 60' ' ' LEU . . . 89.34 -111.18 3.8 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.493 -0.861 . . . . 0.0 111.887 -179.439 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 81.1 m 73.09 -34.93 0.31 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.237 0.615 . . . . 0.0 112.318 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.435 ' HB1' ' SG ' ' A' ' 47' ' ' CYS . . . -79.49 17.16 0.9 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.426 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.4 m -66.82 -59.12 3.81 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.768 0.318 . . . . 0.0 110.763 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -66.91 -24.98 66.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.662 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.786 ' HB2' HD13 ' A' ' 17' ' ' ILE . 1.0 OUTLIER -81.4 -72.75 0.41 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.523 -178.948 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.449 ' HB3' ' O ' ' A' ' 50' ' ' HIS . 23.7 m -78.44 39.88 0.34 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.4 -178.303 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -73.05 -54.23 9.07 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.979 0.895 . . . . 0.0 109.161 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -87.84 -9.31 54.19 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.364 -1.289 . . . . 0.0 109.682 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.449 ' O ' ' HB3' ' A' ' 47' ' ' CYS . 15.6 m80 -109.98 90.97 3.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.314 -178.499 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 72.9 m -136.4 55.28 1.85 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.65 ' HB2' ' OD2' ' B' ' 89' ' ' ASP . 40.8 m80 -115.68 -54.73 2.49 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.356 178.385 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 55' ' ' CYS . . . -134.63 -171.62 12.56 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-O 119.171 -0.794 . . . . 0.0 112.059 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.781 ' HB ' HD13 ' A' ' 33' ' ' LEU . 14.2 m 43.75 -62.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 N-CA-C 115.97 1.841 . . . . 0.0 115.97 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.717 ' HB2' HD11 ' A' ' 29' ' ' LEU . 15.7 t -70.16 -44.56 68.56 Favored 'General case' 0 C--N 1.322 -0.601 0 O-C-N 121.641 -0.662 . . . . 0.0 111.457 -179.032 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.526 ' HE3' ' HB2' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -81.13 12.68 3.26 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.958 179.403 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -76.94 -27.57 54.89 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 175.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.563 HD21 ' HD3' ' A' ' 37' ' ' LYS . 32.3 mt -98.51 -16.49 19.15 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 113.596 -1.638 . . . . 0.0 108.981 177.423 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 64.89 82.45 0.19 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.91 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.715 HD22 ' HA2' ' A' ' 41' ' ' GLY . 87.2 mt -125.15 -7.42 7.11 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -178.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 26.3 p . . . . . 0 C--O 1.245 0.836 0 CA-C-O 118.41 -0.805 . . . . 0.0 110.591 178.67 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.286 0 CA-C-O 120.458 0.17 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 63' ' ' MET . . . . . 0.575 ' HA ' ' HG2' ' B' ' 101' ' ' GLU . 33.3 mtt 61.16 75.95 0.39 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.006 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -107.44 -131.08 6.53 Favored Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 111.433 -0.667 . . . . 0.0 111.433 178.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.94 129.12 53.33 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 178.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 66' ' ' CYS . . . . . . . . . . . . . 43.2 m -64.71 -58.06 7.3 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -177.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 19.2 m 70.13 -167.77 0.16 Allowed 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -176.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.512 HG12 ' HA ' ' B' ' 73' ' ' ALA . 43.2 t -122.46 -56.24 2.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 C-N-CA 120.646 -0.421 . . . . 0.0 110.724 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 54.0 tp -58.1 -36.54 73.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.476 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 70' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -84.81 13.42 5.86 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -179.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 14.0 mmtt -138.66 43.95 2.1 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.856 -0.156 . . . . 0.0 110.725 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 6.5 t 51.02 42.41 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 O-C-N 123.899 0.75 . . . . 0.0 109.994 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.512 ' HA ' HG12 ' B' ' 68' ' ' VAL . . . 56.24 45.92 22.24 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.059 -178.233 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 74' ' ' CYS . . . . . 0.525 ' HB2' HD12 ' B' ' 78' ' ' ILE . 18.1 p 44.9 45.01 8.38 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 114.555 -1.202 . . . . 0.0 112.442 -178.375 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.97 4.3 23.13 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 120.997 0.427 . . . . 0.0 110.897 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.8 -76.33 0.09 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.426 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 77' ' ' ALA . . . . . 0.527 ' HB1' ' O ' ' B' ' 96' ' ' ALA . . . -93.85 -10.06 35.22 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -178.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.67 HD13 ' HB2' ' B' ' 107' ' ' PHE . 40.8 mt -89.17 -47.38 15.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.661 -179.176 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.83 -18.27 38.18 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.923 0.392 . . . . 0.0 111.229 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.8 -25.69 62.05 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.336 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 81' ' ' ALA . . . . . 0.779 ' HB2' ' HB3' ' B' ' 96' ' ' ALA . . . -82.93 -9.99 59.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.972 0.415 . . . . 0.0 111.027 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 69.2 t -68.31 -37.16 77.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.998 179.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -79.79 10.17 4.41 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.444 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -109.73 -48.2 3.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.968 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 63.1 m -88.94 -9.57 51.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.329 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.78 44.39 6.09 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.686 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 132.6 173.81 13.42 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.056 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 88' ' ' ILE . . . . . 0.519 HG12 ' N ' ' B' ' 89' ' ' ASP . 0.0 OUTLIER -77.05 136.86 23.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.049 0.452 . . . . 0.0 110.936 179.714 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 89' ' ' ASP . . . . . 0.65 ' OD2' ' HB2' ' A' ' 52' ' ' HIS . 40.5 t0 -153.87 -122.96 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.525 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 90' ' ' LEU . . . . . 0.728 ' HB3' ' HD3' ' B' ' 91' ' ' PRO . 41.5 tp 173.02 -57.81 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 124.318 1.047 . . . . 0.0 109.6 179.202 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 91' ' ' PRO . . . . . 0.728 ' HD3' ' HB3' ' B' ' 90' ' ' LEU . 51.8 Cg_exo -54.19 -25.52 38.34 Favored 'Trans proline' 0 C--N 1.363 1.323 0 C-N-CA 122.684 2.256 . . . . 0.0 112.992 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 29.9 t -107.94 -34.61 6.86 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.18 0.514 . . . . 0.0 110.329 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 93' ' ' VAL . . . . . 0.673 HG13 ' HB3' ' B' ' 81' ' ' ALA . 38.6 t -70.42 -16.62 20.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.821 -179.043 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 94' ' ' LEU . . . . . 0.793 HD13 ' HB ' ' B' ' 115' ' ' VAL . 1.2 pt? -61.45 -18.02 57.03 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 122.25 -0.281 . . . . 0.0 111.743 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.53 -34.2 73.78 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 96' ' ' ALA . . . . . 0.779 ' HB3' ' HB2' ' B' ' 81' ' ' ALA . . . -100.64 -3.49 30.27 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.862 0.363 . . . . 0.0 110.643 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 23.6 tp -92.99 3.07 56.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.379 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -75.78 139.03 41.58 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.405 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . 61.33 -145.89 0.44 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.783 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . 56.93 30.55 18.22 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 122.749 0.42 . . . . 0.0 111.927 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 101' ' ' GLU . . . . . 0.575 ' HG2' ' HA ' ' B' ' 63' ' ' MET . 93.9 mt-10 65.46 21.07 11.82 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 123.754 0.659 . . . . 0.0 112.242 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.18 -84.04 1.61 Allowed Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.944 -0.646 . . . . 0.0 113.119 178.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 79.0 m 67.84 37.24 3.21 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 122.594 0.358 . . . . 0.0 111.169 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 104' ' ' ALA . . . . . 0.549 ' HB1' ' HB2' ' B' ' 108' ' ' CYS . . . -102.68 20.38 17.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.409 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -69.36 -31.77 70.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.83 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 4.2 p -101.97 -29.37 11.84 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.255 0.55 . . . . 0.0 110.29 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 107' ' ' PHE . . . . . 0.67 ' HB2' HD13 ' B' ' 78' ' ' ILE . 1.0 OUTLIER -81.99 -90.86 0.07 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.985 -178.228 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 108' ' ' CYS . . . . . 0.549 ' HB2' ' HB1' ' B' ' 104' ' ' ALA . 36.2 m -70.44 40.99 0.05 Allowed 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 -178.58 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 109' ' ' GLU . . . . . 0.4 ' HA ' ' OE1' ' B' ' 109' ' ' GLU . 4.9 tp10 -77.23 -53.51 7.65 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.48 0.657 . . . . 0.0 109.455 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -97.96 1.08 47.55 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.744 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 10.0 m80 -112.33 88.89 2.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.47 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 71.0 m -135.78 46.79 2.31 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 114.665 1.358 . . . . 0.0 114.665 -177.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 113' ' ' HIS . . . . . 0.553 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 2.9 p80 -135.24 -0.46 2.72 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 118.994 -1.082 . . . . 0.0 111.982 177.416 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 114' ' ' GLY . . . . . 0.453 ' HA3' ' HB2' ' A' ' 30' ' ' PRO . . . -154.64 145.9 13.47 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 119.914 -1.136 . . . . 0.0 112.664 179.06 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 115' ' ' VAL . . . . . 0.793 ' HB ' HD13 ' B' ' 94' ' ' LEU . 27.6 m 50.28 -48.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 C-N-CA 126.648 1.979 . . . . 0.0 115.936 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 116' ' ' CYS . . . . . 0.617 ' HB2' HD11 ' B' ' 90' ' ' LEU . 3.9 t -73.84 -25.65 60.18 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 121.543 -0.723 . . . . 0.0 110.094 -179.355 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 19.3 ttmt -77.58 -22.89 50.25 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.422 178.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -64.2 -40.16 95.5 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 43.1 mt -81.84 -22.6 36.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.14 178.126 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 64.91 79.89 0.24 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.226 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 86.5 mt -123.82 -6.59 7.94 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -178.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 122' ' ' CYS . . . . . . . . . . . . . 26.1 p . . . . . 0 C--O 1.245 0.818 0 CA-C-O 118.473 -0.775 . . . . 0.0 110.59 179.111 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.193 0 N-CA-C 110.4 -0.222 . . . . 0.0 110.4 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 27.9 ttt 60.76 72.79 0.51 Allowed 'General case' 0 N--CA 1.465 0.303 0 O-C-N 123.773 0.67 . . . . 0.0 111.004 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 172.25 -172.83 45.07 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.106 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -111.52 10.61 21.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.528 0.164 . . . . 0.0 110.784 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.591 ' HA ' ' O ' ' A' ' 40' ' ' GLU . 0.6 OUTLIER -156.74 -147.42 0.19 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.627 -179.328 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.4 m -92.56 -134.89 0.15 Allowed 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -178.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.0 m -109.66 -23.79 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -178.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 57.0 tp -104.84 -45.24 4.62 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.856 ' HA ' ' HB3' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -86.95 27.65 0.99 Allowed 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 177.52 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.587 ' C ' ' H ' ' A' ' 12' ' ' ALA . 22.2 ptmt -79.09 0.8 26.54 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.036 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.4 t -69.94 14.68 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 CA-C-O 121.421 0.629 . . . . 0.0 109.86 178.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.587 ' H ' ' C ' ' A' ' 10' ' ' LYS . . . 75.18 -13.69 0.83 Allowed 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 125.312 1.445 . . . . 0.0 113.805 178.36 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.747 ' HB2' HD12 ' A' ' 17' ' ' ILE . 11.7 p 170.25 -32.22 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 O-C-N 123.456 0.472 . . . . 0.0 112.197 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.84 -26.85 62.6 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -177.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.856 ' HB3' ' HA ' ' A' ' 9' ' ' LYS . . . -109.4 29.03 7.93 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.387 -0.525 . . . . 0.0 112.019 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -151.03 -53.12 0.14 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.222 0.534 . . . . 0.0 110.93 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.747 HD12 ' HB2' ' A' ' 13' ' ' CYS . 73.6 mt -74.69 -42.64 47.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.329 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.79 -30.99 72.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.458 178.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.9 -30.83 37.37 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.649 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.28 -24.18 63.0 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 121.031 0.443 . . . . 0.0 110.381 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 17' ' ' ILE . 49.7 t -65.26 -46.55 90.34 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.669 178.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.69 -18.12 62.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.16 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -81.17 -51.04 8.86 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.165 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 49.1 t -76.01 -33.79 59.69 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.913 0.387 . . . . 0.0 110.132 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.18 36.29 2.54 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.47 -0.872 . . . . 0.0 112.532 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 147.73 152.57 5.71 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.127 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -81.9 132.58 31.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.288 0.566 . . . . 0.0 109.767 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.414 ' HB2' ' NE2' ' B' ' 113' ' ' HIS . 46.8 t0 -158.85 -115.45 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.41 -178.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.661 HD21 ' HB2' ' A' ' 55' ' ' CYS . 35.0 tp -174.95 -57.47 0.0 OUTLIER Pre-proline 0 C--O 1.22 -0.48 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.16 178.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.908 ' HA ' HG11 ' A' ' 54' ' ' VAL . 1.0 OUTLIER -45.42 -52.71 6.3 Favored 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 122.959 2.439 . . . . 0.0 114.117 -178.971 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 19.7 p -84.08 -35.7 23.56 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.087 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.425 HG23 ' H ' ' A' ' 32' ' ' VAL . 3.5 t -63.45 -29.78 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.161 -179.33 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.425 HD22 HG13 ' A' ' 54' ' ' VAL . 29.9 tp -63.53 -32.28 73.69 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.086 0.469 . . . . 0.0 110.515 179.415 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.83 -37.55 79.24 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.07 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.53 -9.25 58.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.115 0.484 . . . . 0.0 110.601 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 23.8 tp -76.09 -6.93 53.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.453 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -86.01 5.37 33.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.102 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.66 -4.77 47.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.967 0.413 . . . . 0.0 110.354 178.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -147.17 175.46 10.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.703 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.591 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 43.0 mt-10 -87.14 120.05 28.01 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.53 0.205 . . . . 0.0 110.866 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.71 -105.79 1.27 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.988 179.154 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER 64.04 15.72 9.44 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.082 0.553 . . . . 0.0 111.175 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -97.05 -6.81 34.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.048 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 40.7 t -66.12 -9.44 31.4 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.22 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.535 ' HB3' ' HB3' ' A' ' 13' ' ' CYS . 33.6 t -118.95 -31.8 4.66 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.309 0.575 . . . . 0.0 110.151 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.572 ' HB2' ' CD1' ' A' ' 17' ' ' ILE . 0.6 OUTLIER -73.88 -78.55 0.09 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.327 -0.851 . . . . 0.0 113.228 -178.496 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.549 ' HA ' ' HB2' ' A' ' 50' ' ' HIS . 84.9 m -72.99 27.29 0.06 Allowed 'General case' 0 C--O 1.219 -0.505 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -176.278 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -67.61 -61.82 1.71 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 118.953 0.797 . . . . 0.0 109.762 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -91.14 -7.46 51.49 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.549 ' HB2' ' HA ' ' A' ' 47' ' ' CYS . 62.2 m-70 -107.73 62.24 0.62 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.497 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.517 ' O ' ' HB3' ' A' ' 56' ' ' LYS . 62.6 m -95.95 33.56 1.68 Allowed 'General case' 0 C--N 1.327 -0.393 0 O-C-N 122.031 -0.418 . . . . 0.0 110.908 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.69 ' ND1' ' HB3' ' B' ' 92' ' ' CYS . 27.6 p80 -129.82 157.71 41.47 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.732 0.301 . . . . 0.0 110.782 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.893 ' HA3' ' HB2' ' B' ' 91' ' ' PRO . . . 92.43 -132.99 11.52 Favored Glycine 0 C--O 1.227 -0.34 0 C-N-CA 120.494 -0.86 . . . . 0.0 113.267 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.908 HG11 ' HA ' ' A' ' 30' ' ' PRO . 8.9 p -78.01 -21.74 13.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 122.562 -0.375 . . . . 0.0 111.881 -178.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.661 ' HB2' HD21 ' A' ' 29' ' ' LEU . 7.5 t -77.03 -28.86 55.04 Favored 'General case' 0 C--O 1.224 -0.285 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.747 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.55 ' HG3' ' O ' ' A' ' 53' ' ' GLY . 0.0 OUTLIER -73.96 -31.19 62.91 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.0 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -69.61 -56.33 7.58 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.037 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.453 HD22 ' HA ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -94.7 65.6 3.09 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 106.579 -1.638 . . . . 0.0 106.579 176.363 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 20.3 t60 -35.42 124.44 0.64 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 114.238 -1.347 . . . . 0.0 113.968 -176.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 13.7 mt -146.37 21.84 1.34 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.793 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 8.9 p . . . . . 0 C--O 1.245 0.825 0 CA-C-O 118.124 -0.941 . . . . 0.0 110.756 178.425 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.211 0 CA-C-O 120.264 0.078 . . . . 0.0 110.821 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 63' ' ' MET . . . . . . . . . . . . . 22.7 mtp 51.95 -137.15 1.23 Allowed 'General case' 0 N--CA 1.466 0.334 0 O-C-N 123.707 0.63 . . . . 0.0 110.665 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 60.75 43.25 99.35 Favored Glycine 0 C--N 1.329 0.183 0 C-N-CA 120.953 -0.641 . . . . 0.0 113.096 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 40.2 mttm 60.44 -112.67 0.55 Allowed 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 122.631 0.372 . . . . 0.0 111.568 179.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 66' ' ' CYS . . . . . 0.661 ' O ' ' HB2' ' B' ' 70' ' ' LYS . 13.8 m -130.94 107.41 9.08 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 48.9 m 67.51 175.36 0.26 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.268 0.556 . . . . 0.0 112.028 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.543 ' O ' ' HG2' ' B' ' 71' ' ' LYS . 21.4 t -88.43 -34.84 7.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.478 -179.334 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 44.2 tp -75.61 -31.53 59.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.936 0.398 . . . . 0.0 111.262 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 70' ' ' LYS . . . . . 0.661 ' HB2' ' O ' ' B' ' 66' ' ' CYS . 77.6 mttt -93.79 20.41 7.64 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 120.698 0.285 . . . . 0.0 111.683 -178.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 71' ' ' LYS . . . . . 0.543 ' HG2' ' O ' ' B' ' 68' ' ' VAL . 59.8 pttt -91.68 9.19 33.43 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 4.2 t -82.85 27.94 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.114 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.402 ' H ' ' C ' ' B' ' 71' ' ' LYS . . . 69.49 59.52 0.31 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 114.91 -1.041 . . . . 0.0 113.426 178.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 74' ' ' CYS . . . . . 0.928 ' HB3' HD12 ' B' ' 78' ' ' ILE . 21.9 m 62.53 8.97 3.15 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 177.508 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -73.23 -59.98 2.45 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -80.46 48.03 0.99 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.945 0.402 . . . . 0.0 111.509 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 77' ' ' ALA . . . . . 0.414 ' HB2' ' HD3' ' B' ' 70' ' ' LYS . . . -162.18 -53.74 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.877 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.928 HD12 ' HB3' ' B' ' 74' ' ' CYS . 51.7 mt -92.94 -49.15 13.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.395 -179.305 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.48 -19.36 65.53 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.669 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -75.66 -24.32 70.39 Favored Glycine 0 N--CA 1.452 -0.28 0 N-CA-C 111.53 -0.628 . . . . 0.0 111.53 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 81' ' ' ALA . . . . . 0.83 ' HB2' ' HB3' ' B' ' 96' ' ' ALA . . . -80.94 -30.22 35.28 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.021 0.439 . . . . 0.0 110.469 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 32.0 t -56.76 -40.86 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.904 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.54 -34.62 78.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.543 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.61 -28.23 56.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.997 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 15.7 m -94.15 -14.9 25.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.745 -178.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.67 31.43 60.54 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.246 -178.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 152.46 151.7 5.74 Favored Glycine 0 N--CA 1.449 -0.47 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.76 129.76 55.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.726 0.774 . . . . 0.0 111.786 -178.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 89' ' ' ASP . . . . . 0.666 ' H ' HG21 ' B' ' 93' ' ' VAL . 28.4 m-20 -144.8 -82.73 0.15 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.462 -1.245 . . . . 0.0 108.526 178.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 90' ' ' LEU . . . . . 0.688 HD11 ' HB2' ' B' ' 116' ' ' CYS . 51.9 tp 179.44 -54.38 0.0 OUTLIER Pre-proline 0 C--O 1.227 -0.13 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.292 178.64 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 91' ' ' PRO . . . . . 0.893 ' HB2' ' HA3' ' A' ' 53' ' ' GLY . 4.9 Cg_exo -38.53 -65.94 0.15 Allowed 'Trans proline' 0 C--N 1.361 1.225 0 C-N-CA 123.487 2.792 . . . . 0.0 114.31 -179.014 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 92' ' ' CYS . . . . . 0.69 ' HB3' ' ND1' ' A' ' 52' ' ' HIS . 1.5 t -82.04 -31.42 30.93 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -179.066 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 93' ' ' VAL . . . . . 0.666 HG21 ' H ' ' B' ' 89' ' ' ASP . 1.5 t -64.81 -16.31 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-O 120.804 0.335 . . . . 0.0 111.761 -179.285 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 94' ' ' LEU . . . . . 0.564 HD22 HG13 ' B' ' 115' ' ' VAL . 22.7 tp -73.5 -19.12 61.01 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.859 0.361 . . . . 0.0 111.008 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.07 -53.21 60.84 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.114 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 96' ' ' ALA . . . . . 0.83 ' HB3' ' HB2' ' B' ' 81' ' ' ALA . . . -75.96 -14.15 60.24 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 111.617 0.228 . . . . 0.0 111.617 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 97' ' ' LEU . . . . . 0.423 HD23 HD12 ' B' ' 94' ' ' LEU . 17.6 tp -72.69 -28.74 62.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.979 0.419 . . . . 0.0 110.051 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -65.53 -24.38 67.1 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.216 178.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -81.0 -13.77 58.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.77 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -100.57 -9.04 22.38 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.98 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 71.17 -61.8 0.47 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.683 0.793 . . . . 0.0 112.285 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -127.82 -125.38 2.78 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.858 -179.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 36.3 m 61.29 48.73 5.91 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.407 0.623 . . . . 0.0 110.502 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 104' ' ' ALA . . . . . 0.729 ' HB1' ' HB2' ' B' ' 108' ' ' CYS . . . -95.63 -6.55 39.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.451 -179.578 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 26.6 p -63.26 -20.3 65.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.998 0.428 . . . . 0.0 111.797 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 24.7 p -106.8 -29.2 9.67 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.294 0.569 . . . . 0.0 111.101 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 107' ' ' PHE . . . . . 0.77 ' HB2' HD13 ' B' ' 78' ' ' ILE . 1.0 OUTLIER -100.88 -79.72 0.5 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -177.518 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 108' ' ' CYS . . . . . 0.729 ' HB2' ' HB1' ' B' ' 104' ' ' ALA . 1.8 m -67.45 24.19 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -177.117 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -81.36 -68.31 0.7 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 118.583 0.629 . . . . 0.0 109.715 178.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -73.36 -15.02 61.39 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 177.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 111' ' ' HIS . . . . . 0.447 ' HB3' HD22 ' B' ' 90' ' ' LEU . 21.1 m80 -110.07 65.88 0.62 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.421 -1.263 . . . . 0.0 107.973 178.311 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 36.6 t -106.45 49.46 0.8 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.95 0.405 . . . . 0.0 111.757 -177.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 113' ' ' HIS . . . . . 0.483 ' HA ' ' HG2' ' B' ' 117' ' ' LYS . 18.1 p-80 -156.55 -165.74 1.96 Allowed 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.172 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . 64.64 -137.73 39.69 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.977 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 115' ' ' VAL . . . . . 0.564 HG13 HD22 ' B' ' 94' ' ' LEU . 11.3 p -79.66 -16.71 13.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.814 0.34 . . . . 0.0 111.076 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 116' ' ' CYS . . . . . 0.688 ' HB2' HD11 ' B' ' 90' ' ' LEU . 2.1 t -57.92 -59.75 4.77 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 120.808 0.337 . . . . 0.0 110.716 178.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 117' ' ' LYS . . . . . 0.483 ' HG2' ' HA ' ' B' ' 113' ' ' HIS . 45.3 pttt -101.4 31.94 3.52 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.742 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 118' ' ' ASP . . . . . 0.475 ' HB2' ' HA ' ' B' ' 115' ' ' VAL . 10.3 t70 -54.44 -39.16 67.11 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 178.146 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 119' ' ' LEU . . . . . 0.608 ' O ' ' HB2' ' B' ' 120' ' ' HIS . 3.3 mm? -103.32 -52.66 2.97 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 174.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 120' ' ' HIS . . . . . 0.608 ' HB2' ' O ' ' B' ' 119' ' ' LEU . 42.3 t60 153.6 129.26 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.862 0 O-C-N 124.951 1.407 . . . . 0.0 110.422 176.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 121' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' B' ' 120' ' ' HIS . 14.4 mt -160.33 41.26 0.18 Allowed 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 122' ' ' CYS . . . . . 0.426 ' HB3' ' O ' ' B' ' 108' ' ' CYS . 1.4 p . . . . . 0 C--O 1.246 0.9 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.711 178.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.4 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 43.6 ttp -136.46 133.41 36.57 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.015 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 114.75 151.41 10.17 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.037 -1.078 . . . . 0.0 113.786 178.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.515 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 36.5 mtmt -101.19 -14.64 17.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.857 0.361 . . . . 0.0 110.413 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 7.5 t -126.16 66.22 1.21 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.021 0.439 . . . . 0.0 110.84 -178.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.1 m -84.9 -162.68 0.72 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.131 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 24.7 t -71.29 -41.6 74.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.924 0.392 . . . . 0.0 110.158 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.2 tp -76.51 -33.18 58.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.872 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.515 ' HD3' ' O ' ' A' ' 4' ' ' LYS . 8.9 mttp -90.69 28.96 1.4 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.966 178.423 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -70.58 -21.03 62.72 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.3 t -66.79 -16.84 21.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.933 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.02 9.49 1.92 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.92 0.391 . . . . 0.0 111.329 179.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 13.0 p -65.28 -24.95 67.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.409 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.676 ' HA ' HG22 ' A' ' 17' ' ' ILE . . . -64.85 -19.49 65.91 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.228 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.09 0.82 23.2 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -132.19 -22.48 2.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.777 0.322 . . . . 0.0 111.76 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.676 HG22 ' HA ' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -92.93 -44.58 13.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.945 0.403 . . . . 0.0 111.484 -178.923 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.18 -32.38 66.39 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.769 -178.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.98 -24.04 74.86 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.313 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.798 ' HB2' ' HB3' ' A' ' 35' ' ' ALA . . . -83.92 -24.79 30.6 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 120.821 0.343 . . . . 0.0 111.039 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 17' ' ' ILE . 86.8 t -66.36 -46.65 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.551 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.34 -28.38 65.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.462 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -75.84 -44.9 38.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 112.061 -179.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.8 t -84.87 -37.28 20.84 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.729 0.299 . . . . 0.0 110.869 -179.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.99 48.9 1.3 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.405 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 143.67 -179.51 21.03 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.217 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.547 HD13 HD11 ' A' ' 17' ' ' ILE . 6.0 tp -113.23 117.23 54.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.489 0.661 . . . . 0.0 111.988 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.63 ' H ' HG21 ' A' ' 32' ' ' VAL . 30.6 t0 -134.28 -108.89 0.22 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.784 ' HG ' HG22 ' A' ' 54' ' ' VAL . 41.0 tp -175.01 -57.03 0.0 OUTLIER Pre-proline 0 C--O 1.223 -0.326 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.291 178.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.717 ' HA ' HG21 ' A' ' 54' ' ' VAL . 2.3 Cg_endo -46.24 -60.18 0.95 Allowed 'Trans proline' 0 C--N 1.361 1.231 0 C-N-CA 123.005 2.47 . . . . 0.0 114.357 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 19.9 p -79.41 -33.84 42.29 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.655 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.63 HG21 ' H ' ' A' ' 28' ' ' ASP . 2.4 t -67.1 -17.62 22.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.552 -179.379 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 30.0 tp -64.26 -26.13 68.36 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.495 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.37 -59.73 4.2 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -178.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.798 ' HB3' ' HB2' ' A' ' 20' ' ' ALA . . . -75.15 -17.0 60.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.747 0.308 . . . . 0.0 111.791 -179.107 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.507 HD22 ' CD2' ' A' ' 46' ' ' PHE . 32.8 tp -75.16 -10.33 59.37 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.931 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -74.4 93.13 2.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.894 0.378 . . . . 0.0 110.363 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -111.22 -5.55 14.69 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.698 -179.094 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 72.69 -61.92 0.48 Allowed 'General case' 0 N--CA 1.473 0.694 0 O-C-N 123.989 0.806 . . . . 0.0 113.02 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -60.67 -69.11 0.24 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.834 0.35 . . . . 0.0 111.826 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 42' ' ' CYS . . . -156.16 -139.63 2.79 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.146 -1.026 . . . . 0.0 112.779 -179.438 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 41' ' ' GLY . 96.5 m 73.17 8.81 5.31 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.16 0.584 . . . . 0.0 111.197 -179.581 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -95.51 -21.76 18.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.869 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.7 p -79.89 11.51 3.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.488 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 46.8 t -109.65 -62.29 1.52 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.507 ' CD2' HD22 ' A' ' 36' ' ' LEU . 0.8 OUTLIER -67.48 -59.28 3.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.713 178.697 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.622 ' HA ' ' HB2' ' A' ' 50' ' ' HIS . 87.9 m -74.6 15.54 0.35 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -55.86 -52.55 63.67 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.334 0.587 . . . . 0.0 110.386 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -94.79 -20.07 19.8 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.914 178.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.622 ' HB2' ' HA ' ' A' ' 47' ' ' CYS . 39.8 m80 -98.56 72.56 2.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.443 -179.506 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 97.0 m -92.16 -2.16 56.73 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -178.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 1.015 ' HA ' ' HB3' ' A' ' 56' ' ' LYS . 9.6 p80 -117.2 -160.16 0.76 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 119.808 -0.757 . . . . 0.0 111.112 179.243 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 68.47 -130.99 26.58 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.571 -0.823 . . . . 0.0 111.794 -178.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.784 HG22 ' HG ' ' A' ' 29' ' ' LEU . 30.0 m -75.97 -18.99 15.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.858 0.329 . . . . 0.0 111.633 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.499 ' HB2' HD11 ' A' ' 29' ' ' LEU . 1.4 t -82.57 -23.29 34.53 Favored 'General case' 0 C--O 1.216 -0.691 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.184 -179.08 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 1.015 ' HB3' ' HA ' ' A' ' 52' ' ' HIS . 0.0 OUTLIER -77.58 -13.39 59.92 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.352 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -90.45 -59.86 2.07 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.749 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 20.6 tp -80.12 -75.58 0.25 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.592 0.234 . . . . 0.0 111.316 -179.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 58.1 m-70 -90.28 -129.5 0.09 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 60' ' ' LEU . 8.1 tp -169.83 -87.56 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 177.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.592 ' HB3' ' O ' ' A' ' 47' ' ' CYS . 1.8 p . . . . . 0 C--O 1.245 0.82 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.651 178.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.137 0 CA-C-O 120.808 0.337 . . . . 0.0 111.005 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 63' ' ' MET . . . . . . . . . . . . . 18.9 ptp -104.95 129.08 53.44 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.009 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 111.22 170.64 19.13 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.341 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 65' ' ' LYS . . . . . 0.401 ' HB3' ' HE2' ' B' ' 65' ' ' LYS . 32.1 ttpt -99.91 -39.02 8.38 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.846 0.355 . . . . 0.0 110.924 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 66' ' ' CYS . . . . . . . . . . . . . 51.6 m -109.74 157.61 18.96 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -178.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 77.4 p -178.27 -167.03 0.12 Allowed 'General case' 0 C--O 1.236 0.351 0 CA-C-N 114.373 -1.285 . . . . 0.0 107.887 178.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 7.5 t -87.03 -27.61 5.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.169 0.509 . . . . 0.0 109.775 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 39.8 tp -89.92 -39.39 13.05 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 70' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -87.08 28.24 0.94 Allowed 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -64.48 -19.73 65.75 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.443 179.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 3.8 t -60.74 -19.09 18.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.506 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -93.29 25.82 3.19 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 122.263 -0.273 . . . . 0.0 111.719 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 31.7 p -95.33 -12.91 25.29 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.308 -0.557 . . . . 0.0 111.634 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 75' ' ' ALA . . . . . 0.476 ' HA ' HG22 ' B' ' 78' ' ' ILE . . . -59.21 -35.66 74.0 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 123.253 0.345 . . . . 0.0 111.209 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -74.11 -0.53 16.87 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 77' ' ' ALA . . . . . 0.463 ' O ' ' HA ' ' B' ' 97' ' ' LEU . . . -124.66 -12.73 7.13 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.539 HG13 ' CD2' ' B' ' 107' ' ' PHE . 0.0 OUTLIER -106.5 -46.54 8.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.097 0.475 . . . . 0.0 110.91 -179.238 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -56.91 -23.47 45.17 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.947 -179.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -75.39 -25.26 68.62 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.403 -0.904 . . . . 0.0 112.151 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -82.21 -16.9 48.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.763 0.316 . . . . 0.0 111.348 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 82' ' ' VAL . . . . . 0.401 HG22 HD13 ' B' ' 88' ' ' ILE . 59.6 t -62.46 -45.78 97.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-O 121.033 0.444 . . . . 0.0 110.77 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.87 -31.19 70.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.473 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.19 -36.27 79.3 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.516 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 26.6 m -92.99 -12.27 31.1 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 69.55 42.27 73.2 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.488 -0.863 . . . . 0.0 111.319 -178.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 151.81 137.66 2.65 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 88' ' ' ILE . . . . . 0.401 HD13 HG22 ' B' ' 82' ' ' VAL . 2.9 tp -91.23 114.1 27.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.34 0.59 . . . . 0.0 111.944 -179.252 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 89' ' ' ASP . . . . . 0.588 ' H ' HG21 ' B' ' 93' ' ' VAL . 0.9 OUTLIER -130.44 -91.91 0.44 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.641 179.038 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 90' ' ' LEU . . . . . 0.456 ' HG ' ' CG2' ' B' ' 115' ' ' VAL . 10.8 tp 175.93 -54.4 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.481 0 C-N-CA 123.484 0.714 . . . . 0.0 110.357 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 91' ' ' PRO . . . . . 0.85 ' HA ' HG21 ' B' ' 115' ' ' VAL . 60.9 Cg_exo -35.67 -63.11 0.2 Allowed 'Trans proline' 0 C--N 1.365 1.438 0 C-N-CA 123.492 2.795 . . . . 0.0 115.009 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 29.3 p -90.94 -31.32 16.42 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -178.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 93' ' ' VAL . . . . . 0.588 HG21 ' H ' ' B' ' 89' ' ' ASP . 3.2 t -57.58 -29.5 34.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.079 0.466 . . . . 0.0 111.561 -179.254 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 5.5 tp -62.46 -33.46 74.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.834 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.92 -15.16 54.39 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -177.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -129.07 20.81 5.83 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.667 0.618 . . . . 0.0 112.667 -179.288 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 97' ' ' LEU . . . . . 0.53 ' O ' ' HG ' ' B' ' 97' ' ' LEU . 0.0 OUTLIER -106.21 -9.12 17.02 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.431 179.827 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -40.18 110.37 0.15 Allowed 'General case' 0 N--CA 1.47 0.532 0 O-C-N 123.994 0.809 . . . . 0.0 112.044 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 99' ' ' ALA . . . . . 0.407 ' HB3' ' HB2' ' B' ' 103' ' ' CYS . . . -109.36 -0.94 18.8 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.066 -179.174 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . 72.58 -78.84 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -83.53 48.81 1.47 Allowed 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -177.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 102' ' ' GLY . . . . . 0.437 ' O ' ' HB2' ' B' ' 103' ' ' CYS . . . 103.55 -145.51 16.2 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 119.828 -1.177 . . . . 0.0 113.671 178.299 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 103' ' ' CYS . . . . . 0.437 ' HB2' ' O ' ' B' ' 102' ' ' GLY . 5.5 m 71.94 20.0 4.56 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 122.953 0.501 . . . . 0.0 111.28 -178.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -112.07 -9.48 13.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.038 0.447 . . . . 0.0 110.215 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 8.4 p -79.18 -17.89 54.05 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.603 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 4.0 p -78.3 -62.02 1.82 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.287 0.565 . . . . 0.0 110.511 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 107' ' ' PHE . . . . . 0.539 ' CD2' HG13 ' B' ' 78' ' ' ILE . 0.9 OUTLIER -61.62 -61.03 2.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.168 -0.923 . . . . 0.0 110.75 -179.839 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 108' ' ' CYS . . . . . 0.749 ' O ' ' HB3' ' B' ' 122' ' ' CYS . 61.0 m -90.11 54.12 2.71 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.9 -179.039 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -74.24 -62.89 1.36 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.204 0.526 . . . . 0.0 110.125 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -86.13 -8.74 57.64 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.007 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 111' ' ' HIS . . . . . 0.701 ' O ' ' HB3' ' B' ' 108' ' ' CYS . 3.5 m-70 -106.99 88.26 2.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.554 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 90.3 m -114.48 37.66 3.33 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.381 -0.528 . . . . 0.0 112.101 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 113' ' ' HIS . . . . . 0.74 ' HA ' ' HB3' ' B' ' 117' ' ' LYS . 2.1 p80 -144.38 -149.69 0.29 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 110.202 -0.295 . . . . 0.0 110.202 178.278 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 114' ' ' GLY . . . . . 0.458 ' HA3' ' HG2' ' A' ' 30' ' ' PRO . . . 58.04 -106.37 0.8 Allowed Glycine 0 C--N 1.332 0.34 0 C-N-CA 121.205 -0.522 . . . . 0.0 112.973 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 115' ' ' VAL . . . . . 0.85 HG21 ' HA ' ' B' ' 91' ' ' PRO . 5.4 m -106.36 -23.76 4.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.582 0.23 . . . . 0.0 111.064 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 116' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -76.22 1.83 14.83 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 121.274 0.559 . . . . 0.0 110.966 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 117' ' ' LYS . . . . . 0.74 ' HB3' ' HA ' ' B' ' 113' ' ' HIS . 0.1 OUTLIER -100.27 -3.2 31.88 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.181 178.058 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -102.48 110.58 22.56 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.219 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 39.7 tp 77.55 -51.48 0.53 Allowed 'General case' 0 N--CA 1.474 0.729 0 O-C-N 124.108 0.88 . . . . 0.0 110.666 -178.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 28.5 m80 -94.82 169.06 10.42 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 11.4 tp -167.95 64.79 0.07 Allowed 'General case' 0 C--O 1.233 0.203 0 C-N-CA 120.068 -0.653 . . . . 0.0 112.542 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 122' ' ' CYS . . . . . 0.749 ' HB3' ' O ' ' B' ' 108' ' ' CYS . 0.8 OUTLIER . . . . . 0 C--O 1.248 0.996 0 O-C-N 124.043 0.839 . . . . 0.0 113.162 179.069 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.253 0 CA-C-O 120.684 0.278 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 26.1 mmt -87.47 78.93 8.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.951 0.405 . . . . 0.0 111.026 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 115.34 -169.05 12.75 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.424 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 12.4 mtpt -85.68 44.81 1.14 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.045 0.45 . . . . 0.0 111.078 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.7 t -176.28 170.99 2.52 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.2 t -134.8 -142.74 0.19 Allowed 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.655 HG12 ' HD3' ' A' ' 10' ' ' LYS . 3.1 m -69.99 81.91 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.1 0.476 . . . . 0.0 111.21 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.657 ' HG ' ' H ' ' A' ' 9' ' ' LYS . 0.6 OUTLIER -74.46 -60.51 2.24 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.594 -179.284 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.657 ' H ' ' HG ' ' A' ' 8' ' ' LEU . 34.9 mtmt -96.06 -19.11 19.69 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.655 ' HD3' HG12 ' A' ' 7' ' ' VAL . 30.8 mtpp -58.0 -50.91 71.79 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -177.501 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.578 HG23 ' HB ' ' A' ' 7' ' ' VAL . 8.2 t -89.97 34.14 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.51 0.671 . . . . 0.0 109.457 179.523 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 56.72 30.42 17.56 Favored 'General case' 0 N--CA 1.461 0.089 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.863 -179.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.599 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 18.9 m 63.78 17.92 10.8 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.154 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -89.88 28.38 1.37 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -108.39 -94.81 0.4 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.807 0.337 . . . . 0.0 110.997 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.16 -0.21 16.02 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.642 HD13 ' HB2' ' A' ' 46' ' ' PHE . 60.5 mt -107.99 -61.64 2.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.787 -0.188 . . . . 0.0 111.206 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.58 -31.36 71.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.999 0.428 . . . . 0.0 110.535 179.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.33 -20.48 72.11 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.638 179.215 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.3 -22.63 51.71 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.161 0.505 . . . . 0.0 110.016 179.101 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 75.3 t -64.55 -44.19 96.82 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.594 178.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.78 -16.44 61.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.349 179.101 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.88 -44.38 32.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.121 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.517 ' SG ' ' HB2' ' B' ' 113' ' ' HIS . 24.8 t -85.67 -28.98 24.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.032 0.444 . . . . 0.0 110.831 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 103.52 38.14 2.87 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.432 -0.89 . . . . 0.0 112.198 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 145.62 165.68 11.47 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.916 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.9 tp -95.81 109.59 22.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.256 0.551 . . . . 0.0 110.362 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.732 ' C ' ' HD2' ' A' ' 30' ' ' PRO . 15.9 p-10 -128.73 -50.3 1.25 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 118.963 -0.541 . . . . 0.0 111.27 -179.463 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.664 ' HB3' ' O ' ' A' ' 28' ' ' ASP . 17.0 tp 107.14 -54.39 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 124.913 1.383 . . . . 0.0 111.794 -179.034 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.851 ' HA ' HG21 ' A' ' 54' ' ' VAL . 10.6 Cg_endo -53.75 -36.55 82.5 Favored 'Trans proline' 0 C--N 1.364 1.38 0 C-N-CA 122.325 2.017 . . . . 0.0 112.869 179.368 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 2.4 t -93.9 -36.43 12.21 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.109 0.48 . . . . 0.0 110.711 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.588 HG23 ' OD1' ' A' ' 28' ' ' ASP . 94.0 t -64.25 -25.93 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.359 -179.606 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.418 HD23 HG21 ' A' ' 54' ' ' VAL . 2.9 pp -57.69 -33.27 68.2 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.789 0.328 . . . . 0.0 111.139 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.61 -38.13 62.65 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.67 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.28 -13.46 60.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.47 -179.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -93.11 -41.54 9.89 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.362 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.9 ttmm 55.1 77.42 0.22 Allowed 'General case' 0 N--CA 1.47 0.546 0 O-C-N 123.464 0.478 . . . . 0.0 110.281 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -99.59 138.44 36.67 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.117 0.485 . . . . 0.0 111.972 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -115.71 -99.96 0.44 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.3 178.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -86.42 78.28 9.29 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.463 0.649 . . . . 0.0 110.23 178.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 102.77 -128.94 9.71 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.482 -179.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.54 ' H ' HD13 ' A' ' 8' ' ' LEU . 3.9 m 70.29 -57.49 0.57 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.336 0.654 . . . . 0.0 111.657 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -87.7 13.63 10.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.529 0.204 . . . . 0.0 111.116 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.24 -44.89 96.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.863 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 8.0 p -80.01 -32.5 39.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.17 0.51 . . . . 0.0 110.514 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.642 ' HB2' HD13 ' A' ' 17' ' ' ILE . 0.9 OUTLIER -59.68 -61.12 2.86 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.554 -179.801 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 62.6 m -80.32 52.59 1.62 Allowed 'General case' 0 C--O 1.211 -0.94 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.137 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -78.3 -59.58 2.72 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -101.08 -13.3 18.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.239 179.009 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -96.88 76.21 2.73 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.198 -0.91 . . . . 0.0 108.955 179.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 88.9 m -117.7 19.64 13.76 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -177.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 9.0 p-80 -123.31 -20.98 5.48 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 119.439 -0.904 . . . . 0.0 113.192 -179.023 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.493 ' HA3' ' HG2' ' B' ' 91' ' ' PRO . . . -106.21 119.57 6.06 Favored Glycine 0 C--O 1.221 -0.682 0 C-N-CA 120.034 -1.079 . . . . 0.0 112.606 179.465 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.851 HG21 ' HA ' ' A' ' 30' ' ' PRO . 14.3 m 54.54 -33.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 13.4 t -72.87 -37.75 67.23 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 121.471 -0.768 . . . . 0.0 110.938 -178.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 35.7 tttp -67.29 -8.62 33.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.703 179.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -71.97 -22.86 61.38 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 178.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.4 mp -114.4 -21.56 10.31 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.854 178.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 67.18 87.51 0.12 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.05 0.54 . . . . 0.0 111.059 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.7 mt -125.31 19.58 8.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.707 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 10.6 p . . . . . 0 C--O 1.245 0.817 0 CA-C-O 118.063 -0.97 . . . . 0.0 109.786 179.385 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.167 0 CA-C-O 120.826 0.346 . . . . 0.0 110.578 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 63' ' ' MET . . . . . . . . . . . . . 26.3 mmt -81.74 -49.7 10.13 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.54 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -154.29 -163.41 11.91 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.237 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 31.1 mtmm -94.57 3.14 55.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.105 0.478 . . . . 0.0 110.503 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 66' ' ' CYS . . . . . 0.505 ' HB2' ' HG3' ' B' ' 101' ' ' GLU . 0.0 OUTLIER -152.75 -74.19 0.14 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.589 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 70.1 m 66.48 -58.66 0.36 Allowed 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 178.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.507 HG12 HG21 ' B' ' 72' ' ' VAL . 17.0 m -83.92 43.86 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 -178.412 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.768 ' HB3' ' HA ' ' B' ' 103' ' ' CYS . 0.2 OUTLIER -83.43 -121.81 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.617 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 70' ' ' LYS . . . . . 0.512 ' H ' ' HB2' ' B' ' 69' ' ' LEU . 0.0 OUTLIER -74.93 4.83 5.87 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 121.96 -0.463 . . . . 0.0 110.387 178.576 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 6.0 mtmt -73.11 -56.5 5.02 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.136 -0.484 . . . . 0.0 112.085 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.507 HG21 HG12 ' B' ' 68' ' ' VAL . 2.1 t -92.25 36.72 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . 55.96 28.67 13.02 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 114.69 -1.141 . . . . 0.0 111.1 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 74' ' ' CYS . . . . . 0.942 ' HB3' HD12 ' B' ' 78' ' ' ILE . 51.6 m 54.29 44.16 29.43 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.564 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -90.45 -43.24 10.4 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -178.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.89 -66.55 0.53 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -177.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.89 10.48 2.78 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -177.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.942 HD12 ' HB3' ' B' ' 74' ' ' CYS . 20.8 mt -130.8 -55.37 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 O-C-N 121.778 -0.576 . . . . 0.0 111.432 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.78 -36.22 70.28 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.282 178.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -75.53 -23.7 72.41 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.281 178.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.63 -22.59 63.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.029 0.442 . . . . 0.0 110.693 179.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 54.7 t -65.84 -38.83 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.574 179.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -76.52 -13.98 60.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.805 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.53 -35.01 30.85 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.519 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 54.0 t -92.61 -40.26 10.87 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 121.005 -0.278 . . . . 0.0 111.508 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.02 37.27 1.54 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.502 -0.856 . . . . 0.0 111.628 -179.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 158.4 167.11 18.77 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 121.028 -0.606 . . . . 0.0 111.687 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 3.1 tp -102.48 123.45 55.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.915 0.388 . . . . 0.0 111.363 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 89' ' ' ASP . . . . . 0.49 ' CG ' ' H ' ' B' ' 90' ' ' LEU . 9.9 p-10 -163.7 -111.89 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.581 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 90' ' ' LEU . . . . . 0.682 ' HG ' HG22 ' B' ' 115' ' ' VAL . 37.1 tp -179.32 -49.99 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.404 0 C-N-CA 123.843 0.857 . . . . 0.0 110.454 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 91' ' ' PRO . . . . . 0.719 ' HG3' ' HD3' ' A' ' 30' ' ' PRO . 5.4 Cg_endo -46.9 -34.28 15.98 Favored 'Trans proline' 0 C--N 1.366 1.465 0 C-N-CA 123.39 2.727 . . . . 0.0 114.575 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 15.2 p -108.64 -27.99 9.52 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.161 0.505 . . . . 0.0 110.755 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 48.2 t -60.67 -20.15 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.705 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 94' ' ' LEU . . . . . 0.64 HD12 ' N ' ' B' ' 95' ' ' ALA . 0.8 OUTLIER -53.77 -24.33 14.8 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 179.953 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 95' ' ' ALA . . . . . 0.64 ' N ' HD12 ' B' ' 94' ' ' LEU . . . -60.5 -55.36 34.36 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -178.559 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -82.75 -21.57 34.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.783 0.325 . . . . 0.0 110.705 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 97' ' ' LEU . . . . . 0.429 ' HB3' ' HA ' ' B' ' 94' ' ' LEU . 44.1 tp -62.22 -51.83 66.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.292 178.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 51.1 tttm 63.52 113.11 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.697 177.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -87.29 82.86 7.48 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.823 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -102.47 -103.11 0.28 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.846 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 101' ' ' GLU . . . . . 0.505 ' HG3' ' HB2' ' B' ' 66' ' ' CYS . 22.4 pt-20 -102.98 43.3 1.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.539 0.685 . . . . 0.0 109.949 179.226 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 102' ' ' GLY . . . . . 0.453 ' O ' ' HB2' ' B' ' 103' ' ' CYS . . . 116.33 -128.08 7.8 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.444 -179.29 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 103' ' ' CYS . . . . . 0.768 ' HA ' ' HB3' ' B' ' 69' ' ' LEU . 39.9 m 72.93 -48.41 0.69 Allowed 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.281 0.633 . . . . 0.0 112.428 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -79.37 -9.66 59.64 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 54.4 p -52.46 -52.43 54.22 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 4.8 p -62.37 -30.49 71.22 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.031 0.444 . . . . 0.0 111.179 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 107' ' ' PHE . . . . . 0.445 ' HB2' HD11 ' B' ' 78' ' ' ILE . 0.5 OUTLIER -69.18 -56.7 6.84 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.31 -179.189 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 108' ' ' CYS . . . . . 0.623 ' SG ' ' HB3' ' B' ' 122' ' ' CYS . 0.8 OUTLIER -79.57 18.21 0.77 Allowed 'General case' 0 CA--C 1.514 -0.407 0 C-N-CA 120.631 -0.427 . . . . 0.0 111.973 179.914 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -55.22 -65.11 0.64 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.378 0.609 . . . . 0.0 110.201 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -89.13 -10.36 47.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.254 178.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 16.3 m80 -110.69 64.95 0.61 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.928 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 1.7 m -91.2 39.54 1.0 Allowed 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 112.046 0.388 . . . . 0.0 112.046 -178.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 113' ' ' HIS . . . . . 0.517 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 14.1 p-80 -143.22 -15.39 0.68 Allowed 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.341 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -77.25 -159.97 11.4 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.762 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 115' ' ' VAL . . . . . 0.682 HG22 ' HG ' ' B' ' 90' ' ' LEU . 24.4 m -64.39 -4.96 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -179.402 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 116' ' ' CYS . . . . . 0.512 ' SG ' ' HB2' ' B' ' 121' ' ' LEU . 7.0 t -78.77 -23.45 45.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.685 0.755 . . . . 0.0 109.115 178.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 4.0 ttmt -81.79 -7.57 59.61 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.146 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -65.01 -31.92 73.39 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 16.6 tp -114.23 -8.13 12.95 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.188 178.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 66.51 79.52 0.24 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.024 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 121' ' ' LEU . . . . . 0.512 ' HB2' ' SG ' ' B' ' 116' ' ' CYS . 96.6 mt -116.5 4.64 13.29 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 122' ' ' CYS . . . . . 0.623 ' HB3' ' SG ' ' B' ' 108' ' ' CYS . 21.2 p . . . . . 0 C--O 1.248 0.977 0 CA-C-O 118.177 -0.915 . . . . 0.0 109.335 178.098 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.186 0 N-CA-C 110.499 -0.186 . . . . 0.0 110.499 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.88 -158.78 0.75 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.058 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 170.47 169.35 33.48 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.936 -0.65 . . . . 0.0 111.667 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 31.1 tttm -95.88 -62.08 1.34 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 117.14 0.47 . . . . 0.0 109.998 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.645 ' HB2' ' HB2' ' A' ' 40' ' ' GLU . 26.1 t -131.96 66.65 1.54 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.766 179.214 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.8 m -78.89 152.97 30.89 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.356 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.619 ' HB ' ' HB3' ' A' ' 10' ' ' LYS . 29.3 m 38.18 46.43 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 123.991 0.916 . . . . 0.0 112.409 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.479 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 0.7 OUTLIER -51.56 -54.13 30.74 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.809 -178.987 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.594 ' HA ' ' SG ' ' A' ' 13' ' ' CYS . 11.6 ptmm? -106.22 30.14 6.19 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 121.063 0.459 . . . . 0.0 110.652 -179.462 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.619 ' HB3' ' HB ' ' A' ' 7' ' ' VAL . 87.7 tttt -122.09 -64.18 1.23 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.379 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.3 t -110.57 -28.7 2.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.128 -179.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 8' ' ' LEU . . . -59.78 -28.83 67.76 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.655 0.264 . . . . 0.0 111.562 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.807 ' HA ' HD12 ' A' ' 17' ' ' ILE . 26.7 m -69.77 -16.58 63.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.941 0.401 . . . . 0.0 111.122 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.591 ' HA ' ' HB3' ' A' ' 18' ' ' ALA . . . -106.56 -13.99 15.17 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.789 0.328 . . . . 0.0 111.261 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -88.23 -69.27 0.71 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.151 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.669 ' HB1' ' HA ' ' A' ' 36' ' ' LEU . . . -88.87 2.87 53.01 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.598 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.807 HD12 ' HA ' ' A' ' 13' ' ' CYS . 66.9 mt -119.0 -64.79 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 121.218 -0.193 . . . . 0.0 110.932 -179.584 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.591 ' HB3' ' HA ' ' A' ' 14' ' ' ALA . . . -68.27 -26.68 65.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.126 0.489 . . . . 0.0 110.057 178.534 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -87.47 10.35 69.77 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 178.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -125.12 -2.21 7.65 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 122.801 0.44 . . . . 0.0 110.456 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.566 HG13 ' HA2' ' A' ' 26' ' ' GLY . 64.3 t -66.5 -43.51 90.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.22 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.19 -4.57 30.09 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -84.17 -13.87 51.64 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -149.03 40.85 0.89 Allowed 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.47 -48.27 2.52 Favored Glycine 0 C--O 1.227 -0.336 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.882 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.566 ' HA2' HG13 ' A' ' 21' ' ' VAL . . . -168.57 176.49 42.88 Favored Glycine 0 N--CA 1.442 -0.907 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.44 HG23 HG22 ' A' ' 21' ' ' VAL . 0.9 OUTLIER -49.86 110.83 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.607 0.718 . . . . 0.0 112.18 179.972 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.645 ' HB3' HG23 ' A' ' 32' ' ' VAL . 49.2 t0 -121.47 -118.82 0.3 Allowed 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.448 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.805 HD11 ' HB2' ' A' ' 55' ' ' CYS . 16.1 tp 173.01 -57.94 0.0 OUTLIER Pre-proline 0 C--O 1.223 -0.296 0 O-C-N 123.612 0.57 . . . . 0.0 111.429 178.371 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.722 ' HD3' ' HB3' ' A' ' 29' ' ' LEU . 54.3 Cg_exo -52.06 -49.21 18.1 Favored 'Trans proline' 0 C--N 1.358 1.048 0 C-N-CA 122.268 1.979 . . . . 0.0 113.225 -179.517 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 25.5 p -92.42 -35.15 13.83 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.238 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.645 HG23 ' HB3' ' A' ' 28' ' ' ASP . 65.4 t -65.06 -18.92 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.241 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 25.9 tp -57.93 -25.78 61.36 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.893 178.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.05 -41.13 99.42 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.648 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -86.36 -8.87 57.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.971 0.415 . . . . 0.0 111.057 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.669 ' HA ' ' HB1' ' A' ' 16' ' ' ALA . 33.5 tp -89.17 62.11 6.05 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 178.356 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.647 ' HD3' ' H ' ' A' ' 37' ' ' LYS . 0.3 OUTLIER -75.27 45.08 0.27 Allowed 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -177.1 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.61 156.83 16.61 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 122.189 -0.319 . . . . 0.0 110.386 178.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.416 ' HA ' HD21 ' A' ' 58' ' ' LEU . . . -115.23 -40.97 3.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.983 0.421 . . . . 0.0 110.583 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.645 ' HB2' ' HB2' ' A' ' 5' ' ' CYS . 60.3 mm-40 -93.53 -169.1 2.04 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.069 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -75.31 56.65 2.83 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 121.015 -0.612 . . . . 0.0 113.851 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.449 ' HA ' ' HB2' ' A' ' 8' ' ' LEU . 19.7 m -97.66 5.0 49.94 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 122.466 -0.432 . . . . 0.0 110.396 179.146 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.581 ' HB2' HD11 ' A' ' 36' ' ' LEU . . . -126.07 16.56 7.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.193 179.034 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.567 ' O ' ' HG2' ' A' ' 48' ' ' GLU . 5.9 m -61.86 -32.08 72.4 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.704 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 12.7 p -66.25 -26.74 67.5 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.124 0.488 . . . . 0.0 111.058 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.772 ' HB2' HD13 ' A' ' 17' ' ' ILE . 1.0 OUTLIER -93.29 -63.89 1.16 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.843 -178.67 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.493 ' HA ' ' HB2' ' A' ' 50' ' ' HIS . 72.9 m -82.84 45.44 1.0 Allowed 'General case' 0 C--O 1.217 -0.621 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -177.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.567 ' HG2' ' O ' ' A' ' 44' ' ' SER . 0.9 OUTLIER -72.81 -71.15 0.31 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 119.147 0.885 . . . . 0.0 110.401 179.406 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -78.36 -5.92 53.66 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.493 ' HB2' ' HA ' ' A' ' 47' ' ' CYS . 36.2 m-70 -104.29 66.17 0.81 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.924 -179.203 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.414 ' O ' ' HD2' ' A' ' 56' ' ' LYS . 72.4 m -120.41 50.08 1.36 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 178.389 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.436 ' HB3' ' SG ' ' B' ' 85' ' ' CYS . 13.1 m80 -96.92 -77.01 0.5 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.594 0.712 . . . . 0.0 110.185 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 55' ' ' CYS . . . -120.86 -174.99 15.15 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 179.05 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.646 HG11 ' HA ' ' A' ' 30' ' ' PRO . 9.3 m 47.02 -64.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.805 ' HB2' HD11 ' A' ' 29' ' ' LEU . 8.8 t -64.78 -48.89 72.84 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 121.664 -0.647 . . . . 0.0 111.836 -178.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.414 ' HD2' ' O ' ' A' ' 51' ' ' CYS . 17.0 ptmt -75.23 -2.01 26.02 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 119.42 -0.912 . . . . 0.0 111.296 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -65.97 -35.52 80.8 Favored 'General case' 0 N--CA 1.461 0.114 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 177.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.483 HD22 HD22 ' A' ' 60' ' ' LEU . 7.9 tt -90.26 -33.13 16.26 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 114.58 -1.191 . . . . 0.0 108.011 177.366 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 22.5 t-160 77.25 86.6 0.08 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.274 178.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.541 HD23 ' N ' ' A' ' 60' ' ' LEU . 0.7 OUTLIER -140.57 25.45 2.19 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -179.932 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 6.0 p . . . . . 0 C--O 1.244 0.791 0 CA-C-O 118.17 -0.919 . . . . 0.0 109.856 176.853 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.179 0 CA-C-O 120.788 0.328 . . . . 0.0 111.094 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 63' ' ' MET . . . . . . . . . . . . . 36.5 ttm -75.67 139.15 41.8 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -133.05 119.13 2.3 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 119.594 -1.288 . . . . 0.0 114.208 -178.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 20.8 tttt -120.41 -29.8 4.71 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 66' ' ' CYS . . . . . 0.636 ' SG ' ' HB3' ' B' ' 69' ' ' LEU . 42.7 t -156.97 52.57 0.5 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.328 -1.305 . . . . 0.0 107.981 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 25.0 m -54.9 142.28 30.21 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.14 -178.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.661 ' HB ' ' HB3' ' B' ' 71' ' ' LYS . 23.6 m 40.41 48.27 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 O-C-N 124.251 0.97 . . . . 0.0 112.393 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.636 ' HB3' ' SG ' ' B' ' 66' ' ' CYS . 0.3 OUTLIER -46.19 -72.86 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.039 -0.982 . . . . 0.0 113.17 -179.666 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 70' ' ' LYS . . . . . . . . . . . . . 17.8 mtpp -92.94 27.9 2.27 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.001 0.429 . . . . 0.0 110.036 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 71' ' ' LYS . . . . . 0.661 ' HB3' ' HB ' ' B' ' 68' ' ' VAL . 4.4 tmtp? -116.56 -67.82 0.97 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.638 -178.454 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.405 ' HB ' HG21 ' B' ' 68' ' ' VAL . 18.6 t -116.12 -24.82 3.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.811 0.339 . . . . 0.0 111.033 -179.19 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' B' ' 69' ' ' LEU . . . -60.86 -35.39 76.46 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.445 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 74' ' ' CYS . . . . . 0.615 ' HA ' HD12 ' B' ' 78' ' ' ILE . 13.0 p -89.94 2.86 54.58 Favored 'General case' 0 CA--C 1.521 -0.137 0 C-N-CA 119.538 -0.865 . . . . 0.0 111.285 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -115.61 13.16 16.26 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 120.906 0.384 . . . . 0.0 110.661 178.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -128.48 -76.36 0.56 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.391 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.45 -39.44 90.84 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.884 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.881 HD13 ' HB2' ' B' ' 107' ' ' PHE . 13.5 mt -74.01 -41.2 52.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.03 0.443 . . . . 0.0 110.995 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.53 -32.75 71.77 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.161 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.63 -35.64 9.18 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.872 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.25 -26.51 61.14 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -178.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 82' ' ' VAL . . . . . 0.46 ' CG1' HG22 ' B' ' 88' ' ' ILE . 3.2 t -66.76 -50.51 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.298 179.491 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.34 -26.11 67.13 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.006 0.431 . . . . 0.0 111.34 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.69 -25.14 64.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.033 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 85' ' ' CYS . . . . . 0.436 ' SG ' ' HB3' ' A' ' 52' ' ' HIS . 1.5 t -88.92 -22.62 23.01 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.962 -179.46 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 99.66 43.99 2.38 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.166 -1.016 . . . . 0.0 113.804 179.044 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 114.87 52.01 0.44 Allowed Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.05 -1.072 . . . . 0.0 113.893 178.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 88' ' ' ILE . . . . . 0.479 ' O ' ' HB2' ' B' ' 89' ' ' ASP . 0.5 OUTLIER 56.04 174.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 124.29 1.036 . . . . 0.0 113.184 179.142 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 89' ' ' ASP . . . . . 0.59 ' CG ' ' HD2' ' B' ' 91' ' ' PRO . 39.2 t0 170.41 -124.62 0.0 OUTLIER 'General case' 0 C--O 1.233 0.212 0 CA-C-N 114.348 -1.296 . . . . 0.0 108.403 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 90' ' ' LEU . . . . . 0.801 HD11 ' SG ' ' B' ' 116' ' ' CYS . 21.1 tp 172.46 -58.5 0.0 OUTLIER Pre-proline 0 C--N 1.324 -0.542 0 C-N-CA 124.364 1.066 . . . . 0.0 109.34 178.481 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 91' ' ' PRO . . . . . 1.008 ' HA ' HG11 ' B' ' 115' ' ' VAL . 50.8 Cg_exo -54.07 -43.25 59.99 Favored 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 122.031 1.821 . . . . 0.0 112.281 179.11 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 24.7 p -79.85 -35.82 37.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.055 0.455 . . . . 0.0 110.87 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 93' ' ' VAL . . . . . 0.443 HG23 ' HB3' ' B' ' 89' ' ' ASP . 5.8 t -71.02 -25.4 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.481 -178.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 94' ' ' LEU . . . . . 0.554 HD22 ' HB ' ' B' ' 115' ' ' VAL . 30.8 tp -60.16 -28.33 67.83 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 120.828 0.347 . . . . 0.0 110.934 -179.547 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.86 -36.62 81.76 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.408 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -99.37 9.86 42.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.297 0.57 . . . . 0.0 110.089 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 97' ' ' LEU . . . . . 0.514 HD21 ' HB1' ' B' ' 104' ' ' ALA . 24.3 tp -107.55 68.24 0.71 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.167 -0.924 . . . . 0.0 108.708 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 98' ' ' LYS . . . . . 0.413 ' NZ ' ' HB2' ' B' ' 98' ' ' LYS . 8.1 mtmp? -77.24 30.26 0.14 Allowed 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.426 -178.282 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 99' ' ' ALA . . . . . 0.749 ' HB1' ' HB2' ' B' ' 103' ' ' CYS . . . -118.34 87.49 2.73 Favored 'General case' 0 C--N 1.321 -0.671 0 O-C-N 122.271 -0.268 . . . . 0.0 110.857 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -79.74 47.81 0.89 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.492 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -142.96 -155.71 0.62 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.944 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -71.17 -3.26 51.94 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.183 178.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 103' ' ' CYS . . . . . 0.749 ' HB2' ' HB1' ' B' ' 99' ' ' ALA . 79.4 m -75.38 -15.12 60.49 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.976 0.417 . . . . 0.0 109.932 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 104' ' ' ALA . . . . . 0.514 ' HB1' HD21 ' B' ' 97' ' ' LEU . . . -109.74 -25.63 10.28 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.843 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 22.0 p -60.58 -25.93 66.57 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.754 0.312 . . . . 0.0 111.21 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 106' ' ' CYS . . . . . 0.497 ' HB3' ' HB3' ' B' ' 74' ' ' CYS . 43.5 t -60.33 -18.73 51.81 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.382 0.611 . . . . 0.0 110.389 178.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 107' ' ' PHE . . . . . 0.881 ' HB2' HD13 ' B' ' 78' ' ' ILE . 0.6 OUTLIER -104.16 -65.06 1.05 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.519 -179.535 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 108' ' ' CYS . . . . . 0.444 ' HB2' ' HB3' ' B' ' 122' ' ' CYS . 0.0 OUTLIER -73.69 15.77 0.25 Allowed 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -178.504 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -37.49 -73.23 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.181 0.592 . . . . 0.0 112.364 -178.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -98.71 -33.91 10.74 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -70.63 87.07 0.66 Allowed 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.026 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 112' ' ' CYS . . . . . 0.596 ' HB3' ' HG2' ' B' ' 117' ' ' LYS . 0.5 OUTLIER -154.21 136.63 14.99 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -178.622 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 113' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -153.22 -49.63 0.1 Allowed 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 178.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 114' ' ' GLY . . . . . 0.405 ' HA3' ' HB2' ' A' ' 30' ' ' PRO . . . -127.14 -159.38 10.14 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 177.468 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 115' ' ' VAL . . . . . 1.008 HG11 ' HA ' ' B' ' 91' ' ' PRO . 0.4 OUTLIER 41.45 -86.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 123.903 0.881 . . . . 0.0 113.31 179.644 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 116' ' ' CYS . . . . . 0.801 ' SG ' HD11 ' B' ' 90' ' ' LEU . 36.5 m -61.36 -33.13 73.13 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 118.431 0.56 . . . . 0.0 109.831 178.335 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 117' ' ' LYS . . . . . 0.596 ' HG2' ' HB3' ' B' ' 112' ' ' CYS . 3.9 mmmm -77.53 -21.0 53.31 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.244 178.469 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -62.38 -47.86 82.28 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.332 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 7.9 tt -79.77 -29.28 40.39 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 177.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 8.5 t-160 76.01 67.67 0.06 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.529 178.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -126.81 8.97 6.91 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.475 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 122' ' ' CYS . . . . . 0.444 ' HB3' ' HB2' ' B' ' 108' ' ' CYS . 0.8 OUTLIER . . . . . 0 C--O 1.245 0.852 0 CA-C-O 118.173 -0.918 . . . . 0.0 110.208 178.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.687 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 1.3 p . . . . . 0 N--CA 1.451 -0.379 0 CA-C-O 120.749 0.309 . . . . 0.0 111.072 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.49 28.3 0.08 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.409 ' H ' ' C ' ' A' ' 13' ' ' CYS . . . -138.38 -64.34 0.53 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.929 0.395 . . . . 0.0 110.27 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.42 -43.83 47.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.943 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.838 HD13 ' HB2' ' A' ' 46' ' ' PHE . 10.6 mt -70.28 -38.2 73.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.117 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.1 -39.01 88.33 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.823 178.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.6 -31.52 44.93 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.966 -0.635 . . . . 0.0 111.886 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.59 -28.84 61.09 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.302 0.573 . . . . 0.0 110.293 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.724 HG13 ' H ' ' A' ' 27' ' ' ILE . 1.2 t -68.3 -37.36 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.235 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.82 -6.27 40.35 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.616 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.84 -2.33 58.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.491 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.6 t -147.05 55.23 1.1 Allowed 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.977 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.38 -53.41 4.21 Favored Glycine 0 N--CA 1.455 -0.088 0 C-N-CA 121.2 -0.524 . . . . 0.0 113.936 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.695 ' HA2' HG13 ' A' ' 21' ' ' VAL . . . 131.79 116.66 1.8 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.969 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.724 ' H ' HG13 ' A' ' 21' ' ' VAL . 43.9 mm 72.83 78.62 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.505 -0.773 0 CA-C-O 122.787 1.279 . . . . 0.0 111.58 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.705 ' OD2' ' HB3' ' A' ' 31' ' ' CYS . 40.1 t0 -148.63 161.61 41.37 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-N 112.683 -2.053 . . . . 0.0 107.298 177.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.613 ' HB3' ' HD3' ' A' ' 30' ' ' PRO . 36.0 tp -126.12 -52.63 0.03 OUTLIER Pre-proline 0 C--N 1.296 -1.729 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.026 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.838 ' HB3' HG13 ' B' ' 115' ' ' VAL . 47.2 Cg_exo -54.84 -41.7 75.76 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 121.907 1.738 . . . . 0.0 112.632 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.705 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 5.6 t -85.82 -38.96 17.59 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.187 -178.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.675 HG23 ' HB3' ' A' ' 28' ' ' ASP . 93.0 t -73.44 -16.23 17.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.799 HD22 ' HB ' ' A' ' 54' ' ' VAL . 44.8 tp -55.27 -31.08 61.28 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -56.67 -37.05 70.28 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -104.44 4.37 33.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.808 0.337 . . . . 0.0 111.112 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 52.3 tp -85.87 -25.55 26.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.869 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.82 46.47 1.18 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.451 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -136.59 134.87 37.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.802 -0.181 . . . . 0.0 111.336 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 65.37 -165.54 0.23 Allowed 'General case' 0 N--CA 1.468 0.474 0 O-C-N 123.968 0.793 . . . . 0.0 111.838 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -124.14 53.88 1.38 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.189 0.518 . . . . 0.0 112.005 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -134.39 52.54 0.81 Allowed Glycine 0 CA--C 1.517 0.17 0 C-N-CA 121.062 -0.589 . . . . 0.0 111.881 178.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -127.09 -104.74 0.33 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.733 -0.234 . . . . 0.0 111.089 -179.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 57.99 -154.1 0.36 Allowed 'General case' 0 C--O 1.239 0.503 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 178.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.8 p -66.82 32.88 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -176.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 43.8 t -107.87 -31.56 7.96 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 176.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.838 ' HB2' HD13 ' A' ' 17' ' ' ILE . 1.1 t80 -103.52 -65.53 1.0 Allowed 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.299 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.456 ' HA ' ' HB2' ' A' ' 50' ' ' HIS . 7.6 m -75.77 23.6 0.13 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -177.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.582 ' OE1' ' HA ' ' A' ' 48' ' ' GLU . 7.3 tp10 -69.1 -68.02 0.43 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.95 0.405 . . . . 0.0 110.581 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -79.79 -14.49 58.66 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.564 ' HD2' ' O ' ' A' ' 46' ' ' PHE . 85.2 m-70 -100.44 63.43 1.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.669 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -115.02 68.42 0.7 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.876 0.37 . . . . 0.0 110.595 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -107.82 -64.07 1.25 Allowed 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.276 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.508 ' HA3' ' HB2' ' B' ' 92' ' ' CYS . . . -134.12 -107.54 0.98 Allowed Glycine 0 C--O 1.219 -0.835 0 C-N-CA 120.031 -1.08 . . . . 0.0 113.799 -178.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.799 ' HB ' HD22 ' A' ' 33' ' ' LEU . 2.9 m -12.51 -67.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 N-CA-C 116.496 2.036 . . . . 0.0 116.496 -178.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.595 ' H ' HG23 ' A' ' 54' ' ' VAL . 32.4 t -73.38 -39.79 64.84 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -177.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.7 tttm -63.46 -24.75 67.96 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.02 0.438 . . . . 0.0 109.941 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -62.18 -32.68 73.33 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.213 178.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 60.5 mt -94.36 -4.69 48.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.44 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 66.2 t-80 64.79 84.04 0.16 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.851 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.503 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 8.1 mp -126.98 27.35 5.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.026 178.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.903 0 CA-C-O 118.213 -0.898 . . . . 0.0 109.462 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 74' ' ' CYS . . . . . 1.114 ' HB2' HD12 ' B' ' 78' ' ' ILE . 31.2 p . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.788 0.327 . . . . 0.0 111.305 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 75' ' ' ALA . . . . . 0.45 ' O ' ' HB3' ' B' ' 79' ' ' ALA . . . -69.53 -6.34 30.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.89 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -102.25 -47.91 4.36 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.65 -41.42 13.4 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -178.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 1.114 HD12 ' HB2' ' B' ' 74' ' ' CYS . 84.3 mt -76.27 -43.01 37.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.646 0.26 . . . . 0.0 110.713 -179.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 79' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' B' ' 75' ' ' ALA . . . -78.74 -16.99 56.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.925 0.393 . . . . 0.0 110.906 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -86.62 -34.29 11.92 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.591 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.69 -19.58 65.19 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.652 0.263 . . . . 0.0 111.354 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 77.4 t -62.13 -54.75 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.121 178.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.41 -26.47 65.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.225 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.54 -40.89 96.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.84 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 7.2 t -110.75 25.38 11.84 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.411 -0.516 . . . . 0.0 111.668 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.73 -51.48 4.58 Favored Glycine 0 CA--C 1.518 0.245 0 N-CA-C 114.858 0.703 . . . . 0.0 114.858 178.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . -138.25 -177.4 15.24 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.036 -1.078 . . . . 0.0 113.837 -178.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 3.9 tp -102.11 137.0 31.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.217 0.532 . . . . 0.0 111.187 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 89' ' ' ASP . . . . . 0.428 ' H ' HG21 ' B' ' 93' ' ' VAL . 38.9 t0 -171.2 -104.64 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 90' ' ' LEU . . . . . 0.675 HD21 ' HB2' ' B' ' 116' ' ' CYS . 56.0 tp -176.16 -50.61 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.388 0 CA-C-O 119.476 -0.297 . . . . 0.0 111.494 178.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 91' ' ' PRO . . . . . 0.625 ' HD2' ' N ' ' B' ' 90' ' ' LEU . 3.4 Cg_exo -40.73 -39.83 3.23 Favored 'Trans proline' 0 C--N 1.364 1.344 0 C-N-CA 124.051 3.167 . . . . 0.0 114.67 -179.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 92' ' ' CYS . . . . . 0.508 ' HB2' ' HA3' ' A' ' 53' ' ' GLY . 19.6 t -113.16 -14.8 12.86 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.067 0.461 . . . . 0.0 111.726 -178.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 93' ' ' VAL . . . . . 0.428 HG21 ' H ' ' B' ' 89' ' ' ASP . 12.3 t -72.62 -17.68 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.395 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 94' ' ' LEU . . . . . 0.954 HD22 ' HB ' ' B' ' 115' ' ' VAL . 23.8 tp -62.22 -35.58 79.34 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.46 -54.89 26.33 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 -178.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -87.38 7.97 26.6 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 97' ' ' LEU . . . . . 0.495 HD23 HD12 ' B' ' 94' ' ' LEU . 59.8 tp -79.0 -31.02 44.63 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.288 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . 0.641 ' HE3' HD11 ' B' ' 119' ' ' LEU . 39.0 ttmt . . . . . 0 C--O 1.234 0.279 0 CA-C-O 121.551 0.691 . . . . 0.0 110.743 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 103' ' ' CYS . . . . . 0.826 ' HB2' HD21 ' B' ' 121' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.235 0.314 0 CA-C-O 120.559 0.219 . . . . 0.0 110.49 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . 53.87 -155.24 0.23 Allowed 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.66 33.97 0.05 Allowed 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 115.18 -0.918 . . . . 0.0 113.47 -178.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 38.8 t -105.86 -28.68 10.47 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 177.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . 0.57 ' HB2' HD11 ' B' ' 78' ' ' ILE . 0.0 OUTLIER -123.48 162.4 22.94 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 113.94 -1.482 . . . . 0.0 107.055 176.24 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 66.9 m 68.2 -3.94 1.17 Allowed 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -62.08 -85.41 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 118.563 0.62 . . . . 0.0 111.043 179.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -86.62 -7.96 57.89 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 178.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -101.16 36.17 2.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.324 -1.307 . . . . 0.0 111.158 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.79 63.77 3.37 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 113' ' ' HIS . . . . . 0.484 ' NE2' ' HB2' ' A' ' 28' ' ' ASP . 9.5 t-160 -122.57 -54.48 1.86 Allowed 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.549 -178.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 114' ' ' GLY . . . . . 0.548 ' O ' ' HG3' ' B' ' 117' ' ' LYS . . . -84.01 -137.24 3.37 Favored Glycine 0 C--O 1.227 -0.295 0 C-N-CA 120.511 -0.852 . . . . 0.0 113.452 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . 0.954 ' HB ' HD22 ' B' ' 94' ' ' LEU . 16.8 m -58.96 -10.76 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 116' ' ' CYS . . . . . 0.675 ' HB2' HD21 ' B' ' 90' ' ' LEU . 0.0 OUTLIER -65.21 -32.0 73.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.707 0.289 . . . . 0.0 111.469 -179.714 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 117' ' ' LYS . . . . . 0.548 ' HG3' ' O ' ' B' ' 114' ' ' GLY . 0.3 OUTLIER -87.23 -26.21 23.61 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.272 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.2 -42.62 96.54 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.5 178.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 119' ' ' LEU . . . . . 0.641 HD11 ' HE3' ' B' ' 98' ' ' LYS . 1.8 tt -101.41 63.13 0.96 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 176.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 65.0 t-80 -20.38 114.57 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 113.732 -1.576 . . . . 0.0 114.725 -176.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 121' ' ' LEU . . . . . 0.826 HD21 ' HB2' ' B' ' 103' ' ' CYS . 1.0 OUTLIER -134.03 -33.46 1.03 Allowed 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.451 -1.25 . . . . 0.0 109.293 178.372 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 122' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.247 0.923 0 CA-C-O 118.405 -0.807 . . . . 0.0 109.94 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 17.0 p . . . . . 0 N--CA 1.476 0.871 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.07 178.12 7.01 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 178.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 72.2 -50.35 0.7 Allowed 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.692 0.62 . . . . 0.0 110.161 -178.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.07 -34.34 73.06 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.586 HG12 ' CD1' ' A' ' 46' ' ' PHE . 6.2 tp -89.43 -58.36 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-O 121.022 0.439 . . . . 0.0 110.607 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.489 ' H ' HG23 ' A' ' 17' ' ' ILE . . . -54.75 -34.12 62.11 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.231 -0.895 . . . . 0.0 112.024 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.31 -27.94 50.35 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.231 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.24 -15.83 59.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.845 0.355 . . . . 0.0 110.838 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 17' ' ' ILE . 66.9 t -63.57 -40.46 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.483 179.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.32 -18.65 63.09 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.889 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -72.32 -35.24 68.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.835 0.35 . . . . 0.0 111.442 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.537 ' HB3' ' CG ' ' B' ' 113' ' ' HIS . 71.0 m -99.48 -29.29 12.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.685 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.32 80.02 1.47 Allowed Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.249 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.85 166.08 16.72 Favored Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.407 ' O ' HG23 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -105.94 96.91 4.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.922 0.868 . . . . 0.0 111.283 -179.626 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.649 ' HB2' ' CE1' ' B' ' 113' ' ' HIS . 33.5 m-20 -115.81 -105.72 0.39 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.685 ' HB3' ' HD3' ' A' ' 30' ' ' PRO . 60.2 tp -177.86 -53.7 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.362 0 N-CA-C 111.911 0.338 . . . . 0.0 111.911 178.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.695 ' HA ' HG21 ' A' ' 54' ' ' VAL . 15.2 Cg_exo -70.9 49.07 0.9 Allowed 'Trans proline' 0 C--N 1.362 1.25 0 C-N-CA 122.97 2.447 . . . . 0.0 114.624 -178.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.594 ' HB2' ' O ' ' B' ' 113' ' ' HIS . 50.5 t -168.29 -49.27 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.8 t -73.91 -29.76 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.679 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -55.66 -45.36 77.71 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.112 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.06 3.88 3.1 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -101.46 -38.78 7.85 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.64 0.257 . . . . 0.0 111.239 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.553 HD23 ' H ' ' A' ' 36' ' ' LEU . 2.5 pt? -104.63 6.33 34.35 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.454 -179.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -62.72 -47.8 82.03 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 119.431 -0.319 . . . . 0.0 111.625 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 45.32 -101.59 0.05 Allowed 'General case' 0 N--CA 1.469 0.494 0 O-C-N 123.812 0.695 . . . . 0.0 111.194 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -99.05 -106.66 0.2 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -145.79 155.06 42.68 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.787 0.327 . . . . 0.0 110.598 178.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.428 ' H ' HD21 ' A' ' 60' ' ' LEU . . . 71.13 37.94 63.64 Favored Glycine 0 C--O 1.229 -0.165 0 C-N-CA 121.101 -0.571 . . . . 0.0 113.516 179.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -126.16 -16.46 5.5 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 122.447 -0.443 . . . . 0.0 111.924 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -109.32 15.36 23.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.931 0.396 . . . . 0.0 111.155 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.5 p -66.4 -53.57 34.34 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.713 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.602 ' O ' ' HG2' ' A' ' 48' ' ' GLU . 1.6 p -55.11 -44.94 75.44 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.725 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.586 ' CD1' HG12 ' A' ' 17' ' ' ILE . 65.2 t80 -63.26 -45.48 91.33 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.591 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.432 ' CB ' ' SG ' ' A' ' 61' ' ' CYS . 98.4 m -94.92 37.98 1.13 Allowed 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -177.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.602 ' HG2' ' O ' ' A' ' 45' ' ' CYS . 62.6 mm-40 -44.69 -76.27 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 118.742 0.701 . . . . 0.0 112.499 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -99.03 -14.04 19.61 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.693 0.758 . . . . 0.0 109.461 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -90.36 68.73 6.91 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.703 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 5.8 t -132.53 60.24 1.7 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.958 -177.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.601 ' ND1' ' HB3' ' B' ' 92' ' ' CYS . 5.8 p80 -131.35 17.69 4.91 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.795 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.625 ' O ' ' HG3' ' A' ' 56' ' ' LYS . . . -128.27 -137.89 4.48 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.485 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.695 HG21 ' HA ' ' A' ' 30' ' ' PRO . 35.6 m -58.98 -17.29 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-O 120.892 0.377 . . . . 0.0 111.807 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.586 ' HB2' HD11 ' A' ' 29' ' ' LEU . 3.9 t -78.54 -36.37 44.81 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.134 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.625 ' HG3' ' O ' ' A' ' 53' ' ' GLY . 0.0 OUTLIER -81.08 -5.57 57.79 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.158 0.504 . . . . 0.0 110.373 179.364 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -66.38 -27.42 67.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.705 178.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.474 ' HB2' HD13 ' A' ' 60' ' ' LEU . 45.0 mt -100.6 -19.15 16.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.502 179.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 66.4 78.03 0.27 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.669 0.788 . . . . 0.0 111.021 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.474 HD13 ' HB2' ' A' ' 58' ' ' LEU . 11.0 mp -123.48 -20.81 5.46 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.398 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.432 ' SG ' ' CB ' ' A' ' 47' ' ' CYS . 0.6 OUTLIER . . . . . 0 C--O 1.246 0.873 0 CA-C-O 118.391 -0.814 . . . . 0.0 111.511 -177.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 20.9 p . . . . . 0 N--CA 1.466 0.37 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -89.9 -175.56 4.64 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . 71.46 -50.08 0.69 Allowed 'General case' 0 N--CA 1.474 0.744 0 O-C-N 123.713 0.633 . . . . 0.0 110.514 -178.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -76.5 -50.39 14.11 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.085 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.723 ' HB ' HD13 ' B' ' 97' ' ' LEU . 8.9 tp -80.26 -42.25 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-O 121.215 0.531 . . . . 0.0 110.094 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.59 -29.69 70.33 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.616 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -82.44 -33.21 25.99 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.772 -0.728 . . . . 0.0 111.581 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.13 -19.53 64.03 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.82 0.343 . . . . 0.0 110.898 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 82' ' ' VAL . . . . . 0.653 HG23 ' O ' ' B' ' 78' ' ' ILE . 75.4 t -60.76 -52.32 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.054 178.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.9 -36.36 62.23 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.999 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.34 -43.02 96.84 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.006 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 2.3 t -90.94 -8.93 47.94 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.3 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 74.47 48.49 13.64 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.95 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 143.5 135.98 3.07 Favored Glycine 0 CA--C 1.509 -0.288 0 C-N-CA 120.896 -0.668 . . . . 0.0 111.777 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 88' ' ' ILE . . . . . 0.591 ' HB ' HG22 ' B' ' 82' ' ' VAL . 0.0 OUTLIER -100.9 107.99 22.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.682 0.753 . . . . 0.0 110.645 -179.806 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 89' ' ' ASP . . . . . 0.568 ' HB2' ' HE1' ' A' ' 52' ' ' HIS . 44.0 m-20 -120.9 -86.43 0.65 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 90' ' ' LEU . . . . . 0.659 ' O ' ' HB2' ' B' ' 94' ' ' LEU . 59.3 tp 179.09 -52.43 0.0 OUTLIER Pre-proline 0 C--O 1.217 -0.655 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.108 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 91' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' B' ' 90' ' ' LEU . 1.0 OUTLIER -43.17 -70.49 0.07 OUTLIER 'Trans proline' 0 C--N 1.36 1.177 0 C-N-CA 123.351 2.701 . . . . 0.0 114.767 -179.413 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 92' ' ' CYS . . . . . 0.601 ' HB3' ' ND1' ' A' ' 52' ' ' HIS . 0.8 OUTLIER -72.83 -38.62 67.06 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -178.17 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 93' ' ' VAL . . . . . 0.579 HG12 HD12 ' B' ' 78' ' ' ILE . 0.6 OUTLIER -66.41 -24.5 33.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -178.199 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 94' ' ' LEU . . . . . 0.659 ' HB2' ' O ' ' B' ' 90' ' ' LEU . 1.3 tm? -67.96 -41.94 81.66 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.52 -9.45 8.7 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -178.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -87.67 -37.43 16.74 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 97' ' ' LEU . . . . . 0.723 HD13 ' HB ' ' B' ' 78' ' ' ILE . 1.7 pt? -115.03 17.56 16.76 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -178.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? . . . . . 0 C--N 1.324 -0.519 0 C-N-CA 120.801 -0.36 . . . . 0.0 111.408 -178.611 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 92.6 m . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.741 0.305 . . . . 0.0 111.416 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -96.08 2.71 53.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.187 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 4.3 m -54.43 -42.78 70.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.117 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 1.8 p -55.42 -61.49 2.31 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.045 0.45 . . . . 0.0 111.216 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . 0.585 ' O ' ' HD2' ' B' ' 111' ' ' HIS . 0.8 OUTLIER -58.49 -55.31 36.73 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.342 -179.652 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 12.4 m -76.29 22.63 0.16 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -178.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -63.4 -58.24 7.72 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 118.296 0.498 . . . . 0.0 111.155 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -93.93 -21.48 19.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.293 0.568 . . . . 0.0 109.998 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 111' ' ' HIS . . . . . 0.585 ' HD2' ' O ' ' B' ' 107' ' ' PHE . 45.1 m-70 -92.6 89.9 6.9 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.588 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 96.1 m -123.1 46.36 2.2 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -177.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 113' ' ' HIS . . . . . 0.854 ' HA ' ' HG2' ' B' ' 117' ' ' LYS . 23.1 p80 -140.74 5.96 2.01 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 119.608 -0.837 . . . . 0.0 111.798 177.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 114' ' ' GLY . . . . . 0.59 ' O ' ' HG3' ' B' ' 117' ' ' LYS . . . -98.1 -152.6 28.23 Favored Glycine 0 C--O 1.226 -0.348 0 C-N-CA 120.489 -0.862 . . . . 0.0 111.393 177.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . 0.549 ' CG2' ' HA ' ' B' ' 91' ' ' PRO . 35.1 m -66.17 -5.92 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 117.411 0.606 . . . . 0.0 111.701 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 116' ' ' CYS . . . . . 0.436 ' SG ' HD21 ' B' ' 94' ' ' LEU . 0.9 OUTLIER -79.79 -25.28 40.97 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.294 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 117' ' ' LYS . . . . . 0.854 ' HG2' ' HA ' ' B' ' 113' ' ' HIS . 0.0 OUTLIER -96.03 3.51 53.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.359 178.19 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -44.97 -42.46 8.23 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 119' ' ' LEU . . . . . 0.704 ' O ' ' HB2' ' B' ' 120' ' ' HIS . 87.9 mt -106.66 -64.77 1.14 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 174.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 120' ' ' HIS . . . . . 0.704 ' HB2' ' O ' ' B' ' 119' ' ' LEU . 11.4 t-80 145.16 91.57 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.881 1.672 . . . . 0.0 108.883 177.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 62.1 mt -114.98 31.78 6.46 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -177.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 122' ' ' CYS . . . . . . . . . . . . . 6.3 p . . . . . 0 C--O 1.242 0.699 0 CA-C-O 118.408 -0.806 . . . . 0.0 110.965 178.653 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.422 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 55.9 m . . . . . 0 N--CA 1.474 0.748 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.458 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -70.86 -34.55 71.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.742 0.306 . . . . 0.0 111.736 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.82 38.81 0.66 Allowed 'General case' 0 C--N 1.326 -0.443 0 O-C-N 122.103 -0.373 . . . . 0.0 111.95 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -167.66 -53.06 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.1 0.476 . . . . 0.0 111.017 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.732 HD13 ' HB2' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -78.04 -42.4 27.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.036 -179.748 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' A' ' 14' ' ' ALA . . . -67.97 -31.3 70.93 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.962 0.41 . . . . 0.0 110.721 178.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -76.11 -26.19 64.77 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.663 -0.779 . . . . 0.0 111.84 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.44 -24.44 60.24 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 120.882 0.372 . . . . 0.0 110.743 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 17' ' ' ILE . 98.9 t -66.35 -47.02 85.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.641 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.43 -22.06 66.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.722 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.11 -40.13 86.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.462 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.5 t -99.78 -12.86 19.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.009 0.433 . . . . 0.0 111.207 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.84 -61.76 0.35 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.097 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -105.74 170.23 16.88 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.249 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.456 HD13 HG22 ' A' ' 21' ' ' VAL . 2.6 tp -98.04 104.98 16.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.57 0.7 . . . . 0.0 111.581 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.558 ' OD1' HG23 ' A' ' 32' ' ' VAL . 18.1 p-10 -129.2 -111.33 0.27 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.726 178.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.62 ' HG ' ' CG2' ' A' ' 54' ' ' VAL . 43.3 tp -178.72 -47.03 0.0 OUTLIER Pre-proline 0 C--N 1.324 -0.505 0 C-N-CA 123.575 0.75 . . . . 0.0 110.682 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.832 ' HA ' HG21 ' A' ' 54' ' ' VAL . 32.5 Cg_exo -55.37 -31.59 77.94 Favored 'Trans proline' 0 C--N 1.367 1.528 0 C-N-CA 122.455 2.103 . . . . 0.0 113.227 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 19.5 t -106.93 -25.98 11.41 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.383 -178.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.558 HG23 ' OD1' ' A' ' 28' ' ' ASP . 65.8 t -72.13 -14.28 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.736 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.722 ' HA ' ' HB3' ' A' ' 36' ' ' LEU . 1.0 OUTLIER -59.19 -15.3 14.13 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.896 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.514 ' N ' HD12 ' A' ' 33' ' ' LEU . . . -54.3 -53.92 47.26 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.935 0.398 . . . . 0.0 111.66 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -103.3 28.29 6.51 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.222 0.534 . . . . 0.0 109.851 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.722 ' HB3' ' HA ' ' A' ' 33' ' ' LEU . 42.6 tp -122.67 -48.88 2.02 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.791 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.509 ' HE3' ' HB2' ' A' ' 58' ' ' LEU . 84.3 tttt -73.71 96.01 2.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.868 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -144.93 -80.14 0.17 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.66 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -113.27 150.74 32.02 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.497 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -67.45 143.03 56.45 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.562 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.43 -9.36 77.78 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.506 -0.854 . . . . 0.0 113.572 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 85.6 m -86.34 -23.15 26.33 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 117.331 0.565 . . . . 0.0 110.952 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.469 ' HB3' ' CD2' ' A' ' 60' ' ' LEU . . . -111.54 23.76 13.56 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.681 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 34.7 p -78.95 -49.71 12.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.552 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.7 p -54.55 -36.13 63.98 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.547 0.689 . . . . 0.0 111.103 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.732 ' HB2' HD13 ' A' ' 17' ' ' ILE . 0.8 OUTLIER -83.6 -68.62 0.7 Allowed 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.652 -1.158 . . . . 0.0 111.441 -178.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.483 ' HA ' ' HB2' ' A' ' 50' ' ' HIS . 37.4 m -77.57 32.16 0.16 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -65.35 -57.61 7.96 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.363 0.601 . . . . 0.0 109.385 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -90.4 -10.83 42.44 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.117 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.483 ' HB2' ' HA ' ' A' ' 47' ' ' CYS . 36.7 m-70 -106.23 60.43 0.65 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.119 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 5.2 t -111.18 50.22 0.83 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.033 0.444 . . . . 0.0 111.108 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.501 ' HA ' ' HD2' ' A' ' 56' ' ' LYS . 20.6 p-80 -140.92 -7.46 1.07 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 0.0 112.05 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.427 ' O ' ' HG2' ' A' ' 56' ' ' LYS . . . -104.05 -151.71 22.11 Favored Glycine 0 CA--C 1.521 0.428 0 C-N-CA 120.519 -0.848 . . . . 0.0 113.01 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.832 HG21 ' HA ' ' A' ' 30' ' ' PRO . 31.1 m -55.03 -17.23 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.581 ' HB2' HD21 ' A' ' 29' ' ' LEU . 1.8 t -70.61 -24.52 62.75 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.71 -179.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.546 ' C ' ' H ' ' A' ' 58' ' ' LEU . 10.0 ptmt -94.19 17.17 13.11 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.373 178.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -83.99 29.59 0.55 Allowed 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 123.057 1.408 . . . . 0.0 107.926 177.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.546 ' H ' ' C ' ' A' ' 56' ' ' LYS . 6.9 tt -170.16 -37.3 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 32.6 t60 71.07 91.37 0.09 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 113.88 -1.509 . . . . 0.0 111.834 178.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.546 HD12 HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -131.09 16.07 5.12 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.377 179.927 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.879 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 74' ' ' CYS . . . . . 0.753 ' HB2' HD12 ' B' ' 78' ' ' ILE . 2.0 p . . . . . 0 N--CA 1.468 0.464 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -100.4 7.75 44.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.156 0.503 . . . . 0.0 110.575 178.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -89.61 -64.5 1.13 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.342 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.67 -24.71 23.81 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.812 HD13 ' HB2' ' B' ' 107' ' ' PHE . 23.9 mt -89.13 -55.18 6.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.553 0.216 . . . . 0.0 111.082 -179.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.17 -21.19 46.78 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.391 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.03 -34.16 42.95 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.705 -0.76 . . . . 0.0 111.626 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . 0.523 ' HB2' ' HB3' ' B' ' 96' ' ' ALA . . . -71.29 -18.15 62.43 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 120.956 0.408 . . . . 0.0 110.702 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 82' ' ' VAL . . . . . 0.463 HG23 ' O ' ' B' ' 78' ' ' ILE . 69.9 t -64.07 -41.73 93.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.857 178.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.02 -22.57 60.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.057 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.82 -39.54 30.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.547 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 22.7 t -89.5 -25.37 21.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.757 0.313 . . . . 0.0 110.865 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 96.46 34.5 5.79 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.367 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 147.6 163.8 10.86 Favored Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 111.399 -0.68 . . . . 0.0 111.399 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.36 127.42 63.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 117.199 0.5 . . . . 0.0 110.666 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 89' ' ' ASP . . . . . 0.558 ' OD2' ' HG2' ' B' ' 91' ' ' PRO . 30.2 p-10 -144.67 -59.22 0.37 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.449 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 90' ' ' LEU . . . . . 0.679 HD11 ' HB2' ' B' ' 116' ' ' CYS . 61.0 tp 133.55 -51.63 0.0 OUTLIER Pre-proline 0 N--CA 1.484 1.269 0 C-N-CA 126.2 1.8 . . . . 0.0 110.337 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 91' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' B' ' 90' ' ' LEU . 4.5 Cg_exo -44.06 -38.41 10.5 Favored 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 123.539 2.826 . . . . 0.0 114.686 -179.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 31.5 p -104.98 -31.14 9.36 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 120.241 -0.583 . . . . 0.0 111.581 -179.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 93' ' ' VAL . . . . . 0.493 HG13 ' HB3' ' B' ' 81' ' ' ALA . 3.9 t -63.29 -7.37 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.43 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 94' ' ' LEU . . . . . 0.447 HD22 ' HB ' ' B' ' 115' ' ' VAL . 4.3 pp -61.66 -22.61 65.45 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 122.343 -0.223 . . . . 0.0 111.2 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -53.2 -60.46 3.26 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -178.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . 0.523 ' HB3' ' HB2' ' B' ' 81' ' ' ALA . . . -78.11 -15.58 58.75 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.223 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 18.1 tp -74.61 -41.38 60.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.898 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . 0.746 ' HA ' HD11 ' B' ' 119' ' ' LEU . 43.9 mtpt . . . . . 0 N--CA 1.462 0.172 0 CA-C-O 120.777 0.323 . . . . 0.0 111.195 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 60.8 m . . . . . 0 N--CA 1.462 0.156 0 CA-C-O 120.649 0.261 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 104' ' ' ALA . . . . . 0.563 ' HB3' HD21 ' B' ' 121' ' ' LEU . . . -100.46 27.17 5.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.227 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 3.0 p -73.96 -61.07 1.98 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.952 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 4.5 p -55.63 -37.74 68.58 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.556 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . 0.812 ' HB2' HD13 ' B' ' 78' ' ' ILE . 1.1 t80 -79.38 -75.71 0.24 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.069 -0.969 . . . . 0.0 112.514 -177.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 74.3 m -73.12 33.57 0.07 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -177.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -59.53 -57.92 10.84 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.332 0.587 . . . . 0.0 109.531 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -98.15 -19.65 17.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.483 178.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 -93.77 65.34 3.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.722 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 4.6 t -123.53 58.91 1.12 Allowed 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.466 -0.493 . . . . 0.0 111.0 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 113' ' ' HIS . . . . . 0.57 ' O ' ' HE2' ' B' ' 117' ' ' LYS . 20.7 p-80 -139.96 -25.34 0.81 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 114' ' ' GLY . . . . . 0.447 ' O ' HG22 ' B' ' 115' ' ' VAL . . . -127.8 129.85 6.52 Favored Glycine 0 C--O 1.226 -0.396 0 C-N-CA 120.184 -1.008 . . . . 0.0 112.695 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . 0.447 HG22 ' O ' ' B' ' 114' ' ' GLY . 24.4 m 54.82 -31.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 C-N-CA 126.164 1.786 . . . . 0.0 115.204 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 116' ' ' CYS . . . . . 0.679 ' HB2' HD11 ' B' ' 90' ' ' LEU . 35.2 t -81.18 -37.69 28.3 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 121.807 -0.558 . . . . 0.0 111.291 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 117' ' ' LYS . . . . . 0.57 ' HE2' ' O ' ' B' ' 113' ' ' HIS . 52.1 pttt -77.7 15.05 0.89 Allowed 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 119.697 -0.801 . . . . 0.0 110.957 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -75.38 -24.1 57.18 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 106.824 -1.546 . . . . 0.0 106.824 175.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 119' ' ' LEU . . . . . 0.746 HD11 ' HA ' ' B' ' 98' ' ' LYS . 53.1 mt -94.75 -31.7 13.66 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 114.137 -1.392 . . . . 0.0 107.704 176.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 12.7 t60 55.9 76.28 0.29 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 113.886 -1.507 . . . . 0.0 112.437 178.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 121' ' ' LEU . . . . . 0.609 ' H ' HD13 ' B' ' 121' ' ' LEU . 0.0 OUTLIER -131.69 -3.34 3.71 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-O 120.959 0.409 . . . . 0.0 110.821 179.885 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 122' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.246 0.882 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.39 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.529 ' HB3' HD12 ' A' ' 17' ' ' ILE . 6.5 m . . . . . 0 N--CA 1.472 0.646 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.47 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -79.51 -13.47 59.53 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -178.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -98.04 15.62 23.58 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.912 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.47 -59.53 0.24 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.135 0.493 . . . . 0.0 111.3 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.723 HD13 ' HB3' ' A' ' 46' ' ' PHE . 80.6 mt -75.17 -42.77 44.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.354 -179.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 14' ' ' ALA . . . -59.54 -34.06 72.18 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -179.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -85.99 -33.1 15.9 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.646 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.811 ' HB1' HG13 ' A' ' 32' ' ' VAL . . . -69.6 -34.78 74.6 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.011 0.434 . . . . 0.0 111.343 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.4 t -64.07 -44.36 97.7 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.784 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.15 -22.53 66.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.648 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.65 -43.2 66.52 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 60.3 m -104.03 0.64 30.08 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 -178.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.18 42.95 10.06 Favored Glycine 0 CA--C 1.517 0.197 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.884 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 130.32 -178.88 17.28 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 121.062 -0.589 . . . . 0.0 111.634 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.2 pp -74.18 134.35 29.73 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 CA-C-O 121.748 0.785 . . . . 0.0 110.343 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.532 ' HB3' HG23 ' A' ' 32' ' ' VAL . 32.9 t70 -148.59 -127.7 0.05 Allowed 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.564 -1.198 . . . . 0.0 108.007 -178.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.869 HD21 ' HB2' ' A' ' 55' ' ' CYS . 20.6 tp 175.27 -56.3 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.461 0 O-C-N 123.418 0.449 . . . . 0.0 112.042 178.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.589 ' HA ' HG11 ' A' ' 54' ' ' VAL . 3.8 Cg_endo -49.92 -34.78 38.37 Favored 'Trans proline' 0 C--N 1.364 1.353 0 C-N-CA 122.752 2.301 . . . . 0.0 113.308 -179.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 17.3 p -110.59 -28.85 8.3 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.216 0.531 . . . . 0.0 110.979 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.811 HG13 ' HB1' ' A' ' 20' ' ' ALA . 51.6 t -67.72 -23.91 30.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.44 -179.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.8 pp -54.9 -26.56 36.66 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.95 -61.04 2.66 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -178.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.471 ' HB3' ' HB2' ' A' ' 20' ' ' ALA . . . -77.46 -21.64 52.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.74 0.305 . . . . 0.0 111.389 -179.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 52.6 tp -68.05 -36.47 79.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.498 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -66.12 -39.74 90.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.457 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 58.12 -100.25 0.11 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.577 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -132.64 18.81 4.27 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.715 -0.221 . . . . 0.0 111.396 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -168.26 -110.49 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -110.98 -64.32 0.51 Allowed Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 178.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 12.0 m 48.71 29.4 2.19 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.485 0.714 . . . . 0.0 112.916 177.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.572 ' CB ' ' HG ' ' A' ' 60' ' ' LEU . . . -115.35 -15.99 11.5 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.457 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 2.5 m -58.02 -19.18 29.2 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.013 0.435 . . . . 0.0 111.812 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 42.5 t -64.99 -53.38 47.16 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.723 ' HB3' HD13 ' A' ' 17' ' ' ILE . 0.3 OUTLIER -107.92 -46.63 3.74 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.294 -179.641 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.58 ' O ' ' HB3' ' A' ' 51' ' ' CYS . 0.1 OUTLIER -68.31 21.0 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.634 179.737 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.508 ' H ' ' C ' ' A' ' 46' ' ' PHE . 38.9 tp10 -63.52 -76.2 0.07 Allowed 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 123.246 0.618 . . . . 0.0 111.903 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -69.86 -44.69 69.34 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.858 -178.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -103.3 111.52 23.97 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.168 0.509 . . . . 0.0 111.901 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.695 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 13.5 p -164.99 35.33 0.06 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.613 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.492 ' HA ' ' HE3' ' A' ' 56' ' ' LYS . 3.7 p-80 -82.81 -16.33 48.19 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.541 ' HA3' ' HG2' ' B' ' 91' ' ' PRO . . . -76.86 -123.89 0.21 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.384 -0.913 . . . . 0.0 112.04 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.589 HG11 ' HA ' ' A' ' 30' ' ' PRO . 8.9 p -85.9 18.84 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.745 0.783 . . . . 0.0 110.265 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.869 ' HB2' HD21 ' A' ' 29' ' ' LEU . 5.3 t -91.64 -48.43 6.84 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.492 ' HE3' ' HA ' ' A' ' 52' ' ' HIS . 19.8 pttp -89.27 14.07 11.91 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 120.976 -0.289 . . . . 0.0 110.662 178.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -56.13 -41.63 75.62 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.259 0.552 . . . . 0.0 109.727 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.5 tt -135.67 -79.16 0.43 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 177.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -155.1 118.25 4.41 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.977 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.572 ' HG ' ' CB ' ' A' ' 43' ' ' ALA . 8.1 tp -153.87 -50.97 0.1 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.92 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.533 ' HB3' ' O ' ' A' ' 47' ' ' CYS . 0.8 OUTLIER . . . . . 0 C--O 1.243 0.759 0 CA-C-O 118.474 -0.774 . . . . 0.0 110.518 178.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 74' ' ' CYS . . . . . 0.521 ' HB3' HD12 ' B' ' 78' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.26 0 CA-C-O 120.618 0.247 . . . . 0.0 111.603 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.68 -53.79 8.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.858 0.361 . . . . 0.0 110.965 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.85 42.68 0.72 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.973 0.416 . . . . 0.0 111.381 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -159.21 -44.87 0.05 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.582 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.674 HD13 ' HB2' ' B' ' 107' ' ' PHE . 12.5 mt -100.79 -52.44 8.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.203 -179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.88 -33.63 73.38 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.15 -37.62 17.84 Favored Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.645 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.78 -29.54 63.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.052 0.453 . . . . 0.0 111.49 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 82' ' ' VAL . . . . . 0.478 HG22 ' HA ' ' B' ' 88' ' ' ILE . 2.6 t -66.13 -40.17 86.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.607 179.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.4 -24.05 66.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.261 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.9 -39.08 44.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.319 -0.401 . . . . 0.0 112.049 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 4.8 t -85.52 -25.51 26.78 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.871 -0.331 . . . . 0.0 111.123 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 104.71 39.79 2.29 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.474 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 87' ' ' GLY . . . . . 0.434 ' C ' HG13 ' B' ' 82' ' ' VAL . . . 124.45 170.99 13.31 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.025 -0.607 . . . . 0.0 111.613 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 88' ' ' ILE . . . . . 0.478 ' HA ' HG22 ' B' ' 82' ' ' VAL . 1.2 pt -66.12 143.14 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.438 0 CA-C-O 121.416 0.627 . . . . 0.0 110.436 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 89' ' ' ASP . . . . . 0.484 ' O ' ' HB2' ' B' ' 90' ' ' LEU . 29.6 t70 -157.26 -127.4 0.03 OUTLIER 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.728 -178.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 90' ' ' LEU . . . . . 0.555 HD21 ' HB2' ' B' ' 116' ' ' CYS . 36.5 tp 170.73 -58.14 0.0 OUTLIER Pre-proline 0 C--N 1.323 -0.558 0 O-C-N 123.867 0.73 . . . . 0.0 110.563 178.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 91' ' ' PRO . . . . . 0.541 ' HG2' ' HA3' ' A' ' 53' ' ' GLY . 14.3 Cg_endo -57.8 -16.11 24.14 Favored 'Trans proline' 0 C--N 1.365 1.409 0 C-N-CA 122.681 2.254 . . . . 0.0 113.585 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 20.3 p -110.23 -34.02 6.49 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.217 0.532 . . . . 0.0 110.37 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 93' ' ' VAL . . . . . 0.41 HG12 ' HB2' ' B' ' 97' ' ' LEU . 3.0 t -74.26 -18.05 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.141 -178.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 94' ' ' LEU . . . . . 0.654 HD23 HG11 ' B' ' 115' ' ' VAL . 0.6 OUTLIER -40.95 -31.74 0.19 Allowed 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 -178.206 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . 0.555 ' N ' HD12 ' B' ' 94' ' ' LEU . . . -84.28 -54.53 4.73 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 118.442 0.564 . . . . 0.0 112.257 -178.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.8 -17.48 62.16 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.6 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 97' ' ' LEU . . . . . 0.41 ' HB2' HG12 ' B' ' 93' ' ' VAL . 20.0 tp -67.97 -38.12 82.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.478 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 44.5 mttm . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.757 179.728 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 58.2 m . . . . . 0 N--CA 1.468 0.452 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -113.22 16.31 19.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.864 0.364 . . . . 0.0 110.693 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 105' ' ' SER . . . . . 0.648 ' O ' ' HG2' ' B' ' 109' ' ' GLU . 3.9 p -58.67 -52.05 67.33 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.142 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 18.7 p -53.95 -41.28 67.61 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.78 0.8 . . . . 0.0 111.517 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . 0.674 ' HB2' HD13 ' B' ' 78' ' ' ILE . 0.9 OUTLIER -69.36 -72.32 0.19 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.27 -1.332 . . . . 0.0 112.908 -177.928 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 108' ' ' CYS . . . . . 0.813 ' HA ' ' HB2' ' B' ' 111' ' ' HIS . 36.3 m -81.11 34.8 0.37 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -176.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 109' ' ' GLU . . . . . 0.648 ' HG2' ' O ' ' B' ' 105' ' ' SER . 13.1 mm-40 -60.59 -60.89 3.09 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 177.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -96.69 -0.18 48.74 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 111' ' ' HIS . . . . . 0.813 ' HB2' ' HA ' ' B' ' 108' ' ' CYS . 55.4 m-70 -108.59 39.48 1.99 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.962 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 2.1 t -98.0 49.31 1.01 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 113' ' ' HIS . . . . . . . . . . . . . 22.3 p-80 -123.24 -33.18 3.32 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.097 -178.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 114' ' ' GLY . . . . . 0.427 ' C ' ' H ' ' B' ' 116' ' ' CYS . . . -85.15 -146.33 8.29 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.857 -0.687 . . . . 0.0 113.425 -179.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . 0.654 HG11 HD23 ' B' ' 94' ' ' LEU . 7.7 p -74.65 37.34 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 122.331 1.062 . . . . 0.0 111.436 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 116' ' ' CYS . . . . . 0.555 ' HB2' HD21 ' B' ' 90' ' ' LEU . 2.5 t -120.31 -25.88 5.56 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.527 -0.76 . . . . 0.0 108.986 178.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.78 -9.83 39.11 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.909 178.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -49.54 -52.2 31.52 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.636 -179.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 73.1 mt -107.4 -104.34 0.35 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 177.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -151.18 93.33 1.9 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.228 0.537 . . . . 0.0 109.9 177.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 121' ' ' LEU . . . . . 0.411 ' HB2' ' O ' ' B' ' 116' ' ' CYS . 9.4 mp -121.58 -28.01 4.65 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.982 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 122' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.245 0.859 0 CA-C-O 118.437 -0.792 . . . . 0.0 110.802 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.465 0.298 0 CA-C-O 120.832 0.348 . . . . 0.0 111.125 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -81.21 21.41 0.74 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.619 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -109.75 -42.74 4.19 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.283 0.563 . . . . 0.0 109.838 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.27 -40.8 43.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.979 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.609 HG12 ' CD2' ' A' ' 46' ' ' PHE . 10.9 tp -72.38 -32.16 41.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.517 0.675 . . . . 0.0 110.194 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.404 ' HB2' ' O ' ' A' ' 14' ' ' ALA . . . -56.3 -27.66 56.21 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.527 -1.215 . . . . 0.0 111.595 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.48 -29.67 51.97 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.437 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.92 -28.83 62.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.064 0.459 . . . . 0.0 110.477 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 96.5 t -66.04 -48.88 80.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.297 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.96 -33.91 76.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.179 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.61 -34.66 78.75 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.783 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.545 ' SG ' ' HB2' ' B' ' 113' ' ' HIS . 3.9 t -89.21 -28.93 19.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.772 0.32 . . . . 0.0 111.109 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.6 40.8 3.54 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.362 -0.923 . . . . 0.0 112.209 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 148.11 163.03 10.49 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.761 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -108.18 135.58 46.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.255 0.55 . . . . 0.0 111.938 -179.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.669 ' HB2' ' HE1' ' B' ' 113' ' ' HIS . 7.9 t70 -160.59 -97.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.047 -0.979 . . . . 0.0 108.798 178.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.689 HD21 ' HB2' ' A' ' 55' ' ' CYS . 49.4 tp -178.85 -53.86 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.254 0 CA-C-O 119.263 -0.399 . . . . 0.0 111.484 178.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.664 ' HG3' ' HD3' ' B' ' 91' ' ' PRO . 96.3 Cg_exo -41.35 -65.47 0.19 Allowed 'Trans proline' 0 C--N 1.36 1.183 0 C-N-CA 123.203 2.602 . . . . 0.0 114.463 -178.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.503 ' HB3' ' O ' ' B' ' 113' ' ' HIS . 14.0 p -79.2 -32.49 44.1 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.878 -178.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.519 HG12 HD11 ' A' ' 17' ' ' ILE . 2.6 t -62.57 -31.05 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.988 -179.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 23.6 tp -65.76 -45.57 82.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.306 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.38 -43.76 68.07 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -178.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.57 -20.22 65.36 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -179.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.406 HD13 HD13 ' A' ' 17' ' ' ILE . 7.2 tt -99.05 -23.91 15.1 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.152 0.501 . . . . 0.0 110.214 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.9 mmmt -75.11 99.07 3.83 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -178.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -126.48 -24.88 3.54 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 175.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -171.63 -166.03 0.42 Allowed 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 112.235 -2.257 . . . . 0.0 105.612 178.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -70.15 -59.96 2.58 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 119.92 -0.712 . . . . 0.0 110.258 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 56.45 -118.45 11.57 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 121.133 -0.556 . . . . 0.0 112.59 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 10.5 t -96.64 -94.12 0.21 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 66.93 -51.54 0.47 Allowed 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.1 p -54.84 -22.28 14.02 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 113.715 1.005 . . . . 0.0 113.715 -178.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.1 t -66.75 -49.98 64.23 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.494 0.664 . . . . 0.0 109.924 178.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.609 ' CD2' HG12 ' A' ' 17' ' ' ILE . 0.8 OUTLIER -72.2 -43.57 64.28 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 178.271 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.429 ' O ' ' HB3' ' A' ' 61' ' ' CYS . 86.1 m -94.14 67.58 3.62 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.832 -1.077 . . . . 0.0 109.611 178.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -92.9 -105.33 0.12 Allowed 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.2 p30 -72.85 -10.57 59.94 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 121.934 0.873 . . . . 0.0 108.972 177.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -103.35 99.06 8.89 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 113.687 -1.597 . . . . 0.0 106.793 177.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 44.9 t -169.07 79.92 0.13 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -177.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.514 ' CE1' ' HB2' ' B' ' 89' ' ' ASP . 3.5 p80 -138.93 18.03 2.65 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.415 0.626 . . . . 0.0 110.454 176.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.705 ' HA3' ' HG2' ' B' ' 91' ' ' PRO . . . -119.33 -135.36 5.08 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.657 -0.702 . . . . 0.0 112.337 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.568 ' CG2' ' HG ' ' A' ' 29' ' ' LEU . 16.1 m -55.54 -27.94 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.689 ' HB2' HD21 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -74.38 -38.23 63.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.448 -179.26 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.598 ' HD3' ' O ' ' A' ' 53' ' ' GLY . 0.0 OUTLIER -65.61 -24.91 67.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.697 0.284 . . . . 0.0 111.062 -179.773 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -58.36 -26.09 62.75 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.441 -179.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.552 ' HB2' HD22 ' A' ' 60' ' ' LEU . 3.2 mm? -90.72 -23.66 20.64 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.501 ' HB2' ' O ' ' A' ' 58' ' ' LEU . 39.3 m-70 74.72 63.83 0.07 Allowed 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.144 0.578 . . . . 0.0 111.994 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.552 HD22 ' HB2' ' A' ' 58' ' ' LEU . 1.9 pt? -140.48 14.98 2.37 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.947 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.429 ' HB3' ' O ' ' A' ' 47' ' ' CYS . 1.5 p . . . . . 0 C--O 1.245 0.829 0 CA-C-O 118.136 -0.935 . . . . 0.0 111.287 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 74' ' ' CYS . . . . . 0.646 ' HB3' ' SG ' ' B' ' 103' ' ' CYS . 15.0 p . . . . . 0 C--O 1.225 -0.213 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -69.8 -3.69 16.73 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -105.15 -46.91 4.12 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.172 0.511 . . . . 0.0 109.741 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.6 -39.97 70.16 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.32 -0.855 . . . . 0.0 112.079 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.789 HD13 HD12 ' B' ' 97' ' ' LEU . 6.0 tp -73.23 -37.37 51.96 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 CA-C-O 121.323 0.582 . . . . 0.0 109.706 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.32 -33.09 74.76 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.915 -1.038 . . . . 0.0 110.713 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -74.96 -30.96 58.52 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.646 -0.787 . . . . 0.0 111.699 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.76 -21.43 61.74 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.206 0.527 . . . . 0.0 110.47 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 82' ' ' VAL . . . . . 0.455 HG23 ' O ' ' B' ' 78' ' ' ILE . 44.4 t -64.46 -51.72 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.081 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.45 -19.72 63.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.126 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.65 -39.64 57.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.737 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 1.4 t -88.36 -30.8 19.27 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.804 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 114.66 40.37 0.93 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.299 -0.953 . . . . 0.0 113.806 178.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 136.15 175.05 13.61 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.072 -1.061 . . . . 0.0 112.936 179.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 6.1 tp -91.3 134.3 30.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.183 0.516 . . . . 0.0 111.098 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 89' ' ' ASP . . . . . 0.514 ' HB2' ' CE1' ' A' ' 52' ' ' HIS . 2.6 t0 -156.46 -119.01 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 90' ' ' LEU . . . . . 0.553 ' N ' ' HD2' ' B' ' 91' ' ' PRO . 47.1 tp -177.66 -53.63 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.461 0 C-N-CA 123.077 0.551 . . . . 0.0 111.121 177.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 91' ' ' PRO . . . . . 0.815 ' HA ' HG21 ' B' ' 115' ' ' VAL . 2.9 Cg_endo -48.36 -48.96 15.46 Favored 'Trans proline' 0 C--N 1.359 1.093 0 C-N-CA 123.018 2.479 . . . . 0.0 113.634 -179.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 4.2 t -81.64 -40.34 23.06 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.935 0.398 . . . . 0.0 111.583 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 93' ' ' VAL . . . . . 0.437 HG23 ' H ' ' B' ' 93' ' ' VAL . 2.2 t -62.3 -24.49 35.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.409 -179.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 94' ' ' LEU . . . . . 0.74 HD22 HG23 ' B' ' 115' ' ' VAL . 22.5 tp -63.48 -26.72 68.85 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.27 0.471 . . . . 0.0 112.27 -179.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.05 -31.89 61.47 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -178.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -83.59 -1.85 54.78 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 97' ' ' LEU . . . . . 0.789 HD12 HD13 ' B' ' 78' ' ' ILE . 21.0 mt -136.75 14.88 3.13 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -178.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . 0.728 ' HG3' ' HG ' ' B' ' 94' ' ' LEU . 12.6 mtpt . . . . . 0 C--N 1.322 -0.621 0 C-N-CA 119.554 -0.859 . . . . 0.0 111.73 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 103' ' ' CYS . . . . . 0.646 ' SG ' ' HB3' ' B' ' 74' ' ' CYS . 45.9 t . . . . . 0 N--CA 1.454 -0.266 0 CA-C-O 119.757 -0.163 . . . . 0.0 110.616 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 104' ' ' ALA . . . . . 0.418 ' N ' ' SG ' ' B' ' 103' ' ' CYS . . . 67.82 -59.06 0.43 Allowed 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.682 0.793 . . . . 0.0 112.4 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 105' ' ' SER . . . . . 0.523 ' HA ' ' HB2' ' B' ' 108' ' ' CYS . 5.0 p -63.94 2.8 0.46 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -178.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 8.7 t -72.81 -47.27 47.86 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . 0.619 ' CD2' HG12 ' B' ' 78' ' ' ILE . 1.0 OUTLIER -74.24 -25.93 59.93 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 177.216 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 108' ' ' CYS . . . . . 0.594 ' O ' ' HB3' ' B' ' 122' ' ' CYS . 2.5 m -103.36 67.35 0.92 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.42 -1.263 . . . . 0.0 110.279 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 109' ' ' GLU . . . . . 0.408 ' HB3' ' H ' ' B' ' 110' ' ' ASP . 9.3 tp10 -96.53 -108.04 0.16 Allowed 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 110' ' ' ASP . . . . . 0.408 ' H ' ' HB3' ' B' ' 109' ' ' GLU . 45.8 p30 -72.95 -11.45 60.58 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 177.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -103.03 99.12 8.98 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 113.087 -1.87 . . . . 0.0 106.877 177.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 42.6 t -144.96 83.06 1.68 Allowed 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.791 -176.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 113' ' ' HIS . . . . . 0.725 ' HA ' ' HD2' ' B' ' 117' ' ' LYS . 1.0 OUTLIER -150.01 2.41 0.51 Allowed 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.8 0.666 . . . . 0.0 112.8 179.668 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 114' ' ' GLY . . . . . 0.589 ' HA2' ' HB2' ' A' ' 30' ' ' PRO . . . -98.72 -156.48 29.34 Favored Glycine 0 C--O 1.227 -0.293 0 C-N-CA 120.048 -1.072 . . . . 0.0 112.728 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . 0.815 HG21 ' HA ' ' B' ' 91' ' ' PRO . 19.6 m -56.63 -11.19 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 122.959 0.504 . . . . 0.0 112.35 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 116' ' ' CYS . . . . . . . . . . . . . 35.7 t -84.25 -39.75 18.89 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.377 -178.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 117' ' ' LYS . . . . . 0.725 ' HD2' ' HA ' ' B' ' 113' ' ' HIS . 6.3 ptmm? -64.99 -14.37 60.12 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.71 0.291 . . . . 0.0 110.737 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -57.08 -25.33 58.56 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.138 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 119' ' ' LEU . . . . . 0.565 ' HB2' HD22 ' B' ' 121' ' ' LEU . 3.1 mm? -99.26 -13.18 19.8 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 122.072 -0.392 . . . . 0.0 111.483 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 22.2 m-70 67.34 76.03 0.29 Allowed 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 122.943 0.497 . . . . 0.0 111.365 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 121' ' ' LEU . . . . . 0.565 HD22 ' HB2' ' B' ' 119' ' ' LEU . 1.0 OUTLIER -140.02 18.56 2.46 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.487 -179.334 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 122' ' ' CYS . . . . . 0.594 ' HB3' ' O ' ' B' ' 108' ' ' CYS . 0.9 OUTLIER . . . . . 0 C--O 1.246 0.889 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.767 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.999 ' HB2' HD12 ' A' ' 17' ' ' ILE . 1.8 p . . . . . 0 N--CA 1.47 0.56 0 CA-C-O 121.847 0.832 . . . . 0.0 110.737 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.62 65.23 8.43 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 114.258 -1.337 . . . . 0.0 110.545 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -145.61 -88.6 0.1 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.765 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.59 -21.74 44.63 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.325 0.584 . . . . 0.0 111.732 -178.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.999 HD12 ' HB2' ' A' ' 13' ' ' CYS . 64.5 mt -80.76 -8.79 11.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-O 121.836 0.827 . . . . 0.0 110.808 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -111.01 -9.9 14.39 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.529 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -115.18 -53.69 0.39 Allowed Glycine 0 C--O 1.228 -0.264 0 C-N-CA 120.568 -0.825 . . . . 0.0 113.013 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.88 -22.9 65.08 Favored 'General case' 0 C--O 1.226 -0.172 0 CA-C-N 117.207 0.504 . . . . 0.0 111.469 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.6 t -66.7 -41.9 88.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 O-C-N 122.09 -0.381 . . . . 0.0 110.824 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.03 -30.08 69.22 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.456 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.86 -30.82 71.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.092 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.0 t -87.09 -23.35 24.93 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.787 0.327 . . . . 0.0 110.664 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.64 39.32 4.19 Favored Glycine 0 N--CA 1.453 -0.177 0 C-N-CA 120.51 -0.852 . . . . 0.0 113.115 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 135.14 174.25 13.36 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.188 -1.006 . . . . 0.0 112.782 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 23.0 mm -72.73 125.85 32.28 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 CA-C-O 121.261 0.553 . . . . 0.0 111.412 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.417 ' HB2' ' CD2' ' B' ' 113' ' ' HIS . 35.5 t70 -144.31 -122.01 0.08 Allowed 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.737 -1.12 . . . . 0.0 108.421 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.743 ' HG ' HG21 ' A' ' 54' ' ' VAL . 12.1 tp 165.65 -61.02 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.407 0 C-N-CA 124.134 0.973 . . . . 0.0 109.645 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 1.033 ' HA ' HG11 ' A' ' 54' ' ' VAL . 9.5 Cg_endo -54.32 -41.22 78.31 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.044 1.83 . . . . 0.0 113.216 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.755 ' HB3' ' HA2' ' B' ' 114' ' ' GLY . 23.4 p -81.2 -38.07 27.64 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.552 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.1 t -67.51 -25.11 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.74 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.726 ' HA ' ' HB3' ' A' ' 36' ' ' LEU . 22.2 tp -52.35 -32.43 38.21 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.563 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -45.36 -43.98 11.41 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -115.83 22.41 13.08 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.104 0.478 . . . . 0.0 109.873 178.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.726 ' HB3' ' HA ' ' A' ' 33' ' ' LEU . 27.9 tp -114.81 -14.2 11.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.898 -178.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.611 ' HD3' ' O ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -69.36 85.11 0.4 Allowed 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.794 0.807 . . . . 0.0 111.674 -179.143 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.37 -159.06 0.98 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.047 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.412 ' HA ' ' HB2' ' A' ' 43' ' ' ALA . . . -125.06 -162.78 1.13 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.799 0.333 . . . . 0.0 111.539 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 58.11 -129.46 1.46 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.331 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.532 ' O ' ' HB3' ' A' ' 13' ' ' CYS . . . -62.12 -25.41 66.29 Favored Glycine 0 C--N 1.332 0.341 0 CA-C-N 115.892 -0.595 . . . . 0.0 114.429 -178.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 98.1 m -86.48 -0.45 56.08 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 117.711 0.755 . . . . 0.0 111.579 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' A' ' 47' ' ' CYS . . . -113.61 -61.15 1.78 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.679 0.276 . . . . 0.0 111.534 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 18.4 m -89.22 50.95 2.02 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -178.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.431 ' HB3' ' HB3' ' A' ' 13' ' ' CYS . 11.2 t -150.83 -56.28 0.16 Allowed 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.753 ' HB2' HD13 ' A' ' 17' ' ' ILE . 0.9 OUTLIER -87.99 -47.61 8.41 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.866 178.808 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 43' ' ' ALA . 95.5 m -81.98 47.82 1.16 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.102 -0.954 . . . . 0.0 112.144 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -84.79 -74.94 0.37 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 178.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -100.63 -21.46 15.25 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.356 178.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.402 ' HB3' HD22 ' A' ' 29' ' ' LEU . 55.2 m-70 -84.82 98.43 10.29 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 177.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.672 ' HB3' ' HG2' ' A' ' 56' ' ' LYS . 81.1 m -142.86 -10.28 0.79 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -177.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.651 ' O ' ' HB2' ' B' ' 91' ' ' PRO . 45.6 m80 -30.15 95.9 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 115.459 1.652 . . . . 0.0 115.459 -178.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 64.44 -6.71 0.74 Allowed Glycine 0 CA--C 1.526 0.753 0 N-CA-C 116.287 1.275 . . . . 0.0 116.287 176.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 1.033 HG11 ' HA ' ' A' ' 30' ' ' PRO . 0.1 OUTLIER -106.59 -72.62 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 118.359 1.08 . . . . 0.0 110.896 -179.806 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.624 ' SG ' HD11 ' A' ' 29' ' ' LEU . 57.5 m -71.23 -23.3 61.98 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.672 ' HG2' ' HB3' ' A' ' 51' ' ' CYS . 53.3 mmtt -72.19 -32.65 66.99 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.084 177.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -62.65 -39.2 93.12 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.654 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 38.9 mt -77.45 -16.03 59.0 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.397 178.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 12.4 t-160 58.78 65.19 1.27 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.112 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.1 mt -131.61 13.8 4.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.389 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 7.9 p . . . . . 0 C--O 1.245 0.851 0 CA-C-O 117.793 -1.099 . . . . 0.0 109.573 -179.823 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 74' ' ' CYS . . . . . 0.815 ' HB3' HD12 ' B' ' 78' ' ' ILE . 2.7 m . . . . . 0 C--O 1.233 0.222 0 CA-C-O 121.275 0.559 . . . . 0.0 109.893 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 75' ' ' ALA . . . . . 0.643 ' HA ' ' HB3' ' B' ' 79' ' ' ALA . . . -78.98 64.47 3.92 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -177.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -163.04 -77.07 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.923 0.392 . . . . 0.0 111.127 178.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . 0.494 ' HB1' ' HA ' ' B' ' 97' ' ' LEU . . . -86.51 -2.52 58.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.211 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.815 HD12 ' HB3' ' B' ' 74' ' ' CYS . 44.8 mt -119.03 -68.09 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.637 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 79' ' ' ALA . . . . . 0.643 ' HB3' ' HA ' ' B' ' 75' ' ' ALA . . . -84.57 52.46 2.38 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.563 0.697 . . . . 0.0 109.472 177.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -165.21 -38.68 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 110.306 -1.117 . . . . 0.0 110.306 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.15 -11.44 59.93 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-O 121.253 0.549 . . . . 0.0 109.724 178.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 82' ' ' VAL . . . . . 0.574 HG22 ' HB ' ' B' ' 88' ' ' ILE . 15.3 t -65.43 -36.98 78.97 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.272 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -77.07 -8.77 58.04 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.593 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -103.88 -17.94 14.83 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.779 0.323 . . . . 0.0 111.251 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -109.42 -7.57 15.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.375 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 69.44 56.37 8.74 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.569 -0.824 . . . . 0.0 111.858 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 120.79 152.58 8.88 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.85 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 88' ' ' ILE . . . . . 0.574 ' HB ' HG22 ' B' ' 82' ' ' VAL . 4.3 tp -98.64 137.2 26.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.946 0.403 . . . . 0.0 112.042 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 89' ' ' ASP . . . . . 0.495 ' H ' HG21 ' B' ' 93' ' ' VAL . 7.0 t70 -161.65 -96.3 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.591 -0.732 . . . . 0.0 109.324 178.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 90' ' ' LEU . . . . . 0.557 ' N ' ' HD2' ' B' ' 91' ' ' PRO . 52.6 tp -179.29 -54.42 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.586 0 CA-C-O 119.514 -0.279 . . . . 0.0 111.686 178.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 91' ' ' PRO . . . . . 0.672 ' HA ' HG21 ' B' ' 115' ' ' VAL . 2.7 Cg_endo -41.44 -58.36 1.13 Allowed 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 123.522 2.815 . . . . 0.0 114.486 -178.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 8.8 p -86.91 -34.01 19.53 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.4 -0.52 . . . . 0.0 111.408 -179.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 93' ' ' VAL . . . . . 0.495 HG21 ' H ' ' B' ' 89' ' ' ASP . 2.8 t -58.86 -22.16 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.515 -179.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 94' ' ' LEU . . . . . 1.015 HD22 ' HB ' ' B' ' 115' ' ' VAL . 15.1 tp -54.43 -34.54 61.58 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.527 179.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.82 -46.3 81.73 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -102.83 10.81 38.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.558 0.218 . . . . 0.0 111.504 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 97' ' ' LEU . . . . . 0.494 ' HA ' ' HB1' ' B' ' 77' ' ' ALA . 23.0 tp -81.84 -9.54 59.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.1 0.476 . . . . 0.0 110.294 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.037 179.249 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 13.3 m . . . . . 0 CA--C 1.524 -0.035 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -74.1 -33.61 63.68 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.922 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 13.3 m -85.61 4.28 36.97 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -178.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 32.1 p -110.04 -37.45 5.59 Favored 'General case' 0 C--N 1.327 -0.383 0 O-C-N 121.494 -0.754 . . . . 0.0 110.498 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . 0.721 ' HB2' HD13 ' B' ' 78' ' ' ILE . 0.6 OUTLIER -88.65 -74.28 0.47 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.133 -179.54 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 108' ' ' CYS . . . . . 0.663 ' HB3' ' SG ' ' B' ' 122' ' ' CYS . 13.4 m -66.49 15.19 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 109' ' ' GLU . . . . . 0.541 ' H ' ' C ' ' B' ' 107' ' ' PHE . 19.4 tp10 -71.86 -69.6 0.38 Allowed 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.925 -179.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -59.93 -45.65 91.92 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.72 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -111.32 100.28 8.92 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.994 177.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 112' ' ' CYS . . . . . 0.485 ' O ' ' HD2' ' B' ' 117' ' ' LYS . 35.9 t -114.63 63.35 0.67 Allowed 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.394 -178.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 113' ' ' HIS . . . . . 0.417 ' CD2' ' HB2' ' A' ' 28' ' ' ASP . 13.6 p-80 -146.61 -172.35 3.95 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 114' ' ' GLY . . . . . 0.755 ' HA2' ' HB3' ' A' ' 31' ' ' CYS . . . 72.57 -144.29 35.33 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.747 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . 1.015 ' HB ' HD22 ' B' ' 94' ' ' LEU . 1.4 m -62.77 -22.28 29.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 116' ' ' CYS . . . . . 0.5 ' SG ' ' HB2' ' B' ' 121' ' ' LEU . 4.6 t -65.03 -31.86 73.3 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.304 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 117' ' ' LYS . . . . . 0.485 ' HD2' ' O ' ' B' ' 112' ' ' CYS . 8.8 mtpm? -89.31 -22.81 22.48 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.318 -0.401 . . . . 0.0 109.963 178.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -57.19 -42.86 82.03 Favored 'General case' 0 CA--C 1.522 -0.109 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 119' ' ' LEU . . . . . 0.557 ' O ' ' HB2' ' B' ' 120' ' ' HIS . 5.3 tt -89.54 -72.82 0.54 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 177.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 120' ' ' HIS . . . . . 0.557 ' HB2' ' O ' ' B' ' 119' ' ' LEU . 14.2 t-160 134.02 91.18 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 125.829 1.652 . . . . 0.0 109.733 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 121' ' ' LEU . . . . . 0.5 ' HB2' ' SG ' ' B' ' 116' ' ' CYS . 88.2 mt -117.14 -53.53 2.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.935 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 122' ' ' CYS . . . . . 0.663 ' SG ' ' HB3' ' B' ' 108' ' ' CYS . 1.8 p . . . . . 0 C--O 1.244 0.812 0 CA-C-O 118.607 -0.711 . . . . 0.0 109.398 178.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.435 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 0.5 OUTLIER . . . . . 0 N--CA 1.475 0.824 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -44.89 -81.7 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 115.588 1.699 . . . . 0.0 115.588 -177.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -49.75 -35.43 22.27 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -177.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.82 -28.6 44.48 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -178.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.695 HG12 ' CD1' ' A' ' 46' ' ' PHE . 7.2 tp -86.4 -43.04 16.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.27 0.557 . . . . 0.0 110.883 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.5 -38.08 86.03 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.824 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.19 -17.7 79.64 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.052 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.79 -25.52 32.67 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.857 0.361 . . . . 0.0 111.0 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 93.7 t -62.04 -47.76 91.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.569 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.82 -41.21 97.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.665 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.78 -29.4 67.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.453 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.2 t -85.63 -7.21 58.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.266 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.06 24.12 72.54 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.52 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 146.2 176.93 20.46 Favored Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.589 HG12 ' N ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -79.53 151.14 4.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.564 0.697 . . . . 0.0 110.598 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.776 ' HB3' HG23 ' A' ' 32' ' ' VAL . 44.8 t0 -158.85 -122.94 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.294 -178.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.57 ' O ' ' HB2' ' A' ' 33' ' ' LEU . 23.1 tp 174.0 -62.93 0.0 OUTLIER Pre-proline 0 C--O 1.214 -0.77 0 C-N-CA 124.836 1.254 . . . . 0.0 108.905 178.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.689 ' HG2' ' HA2' ' B' ' 114' ' ' GLY . 9.3 Cg_endo -54.91 -37.16 93.24 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 121.687 1.592 . . . . 0.0 112.155 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.478 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 0.1 OUTLIER -87.37 -43.34 12.19 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.656 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.776 HG23 ' HB3' ' A' ' 28' ' ' ASP . 10.6 t -70.11 -34.77 60.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -178.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.57 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 0.8 OUTLIER -60.52 -35.6 76.37 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.098 0.475 . . . . 0.0 110.273 179.792 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -54.61 -31.48 57.19 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.467 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -72.57 -24.91 61.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.814 0.34 . . . . 0.0 110.843 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.452 HD13 ' HA ' ' A' ' 43' ' ' ALA . 11.8 mt -92.25 9.5 33.55 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.794 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.402 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 18.8 mmtp -68.58 -175.23 0.64 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.834 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 37' ' ' LYS . . . 76.61 -42.9 0.44 Allowed 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.676 0.79 . . . . 0.0 110.318 -178.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -131.22 63.93 1.59 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 178.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -63.37 -8.77 9.66 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -177.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -59.29 -32.64 72.63 Favored Glycine 0 CA--C 1.518 0.244 0 C-N-CA 121.01 -0.614 . . . . 0.0 113.632 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 64.5 m -107.54 24.91 12.15 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 122.385 -0.479 . . . . 0.0 111.321 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.452 ' HA ' HD13 ' A' ' 36' ' ' LEU . . . -88.99 -19.81 25.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.531 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.7 p -56.36 -33.43 65.68 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.331 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.435 ' HB3' ' HB3' ' A' ' 13' ' ' CYS . 7.6 t -47.7 -46.53 29.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.693 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.695 ' CD1' HG12 ' A' ' 17' ' ' ILE . 72.4 t80 -71.31 -50.82 28.65 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -179.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.628 ' HA ' ' HB2' ' A' ' 50' ' ' HIS . 0.1 OUTLIER -86.76 26.8 1.06 Allowed 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 -177.202 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -53.12 -53.68 46.84 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 119.428 1.013 . . . . 0.0 110.48 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -103.77 20.11 18.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.225 0.536 . . . . 0.0 109.789 178.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.628 ' HB2' ' HA ' ' A' ' 47' ' ' CYS . 90.9 m-70 -126.29 62.22 1.27 Allowed 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.278 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 64.6 m -92.49 49.4 1.48 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.632 0.729 . . . . 0.0 109.758 178.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.604 ' CE1' ' HB3' ' B' ' 92' ' ' CYS . 49.7 t-80 -132.33 94.19 3.39 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.551 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.584 ' HA3' ' HB2' ' B' ' 91' ' ' PRO . . . 130.89 -144.91 16.4 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 119.485 -1.341 . . . . 0.0 114.839 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.522 HG21 ' HA ' ' A' ' 30' ' ' PRO . 14.3 m -60.4 -25.97 35.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -177.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.545 ' SG ' ' HB2' ' A' ' 60' ' ' LEU . 34.9 t -76.83 -44.08 33.84 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.044 -0.662 . . . . 0.0 111.826 -178.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.48 -13.45 61.06 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.062 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -66.99 -40.84 87.47 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.988 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.6 mt -93.48 2.7 56.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.517 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 58.98 54.16 5.19 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.619 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.545 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 87.1 mt -94.48 -39.91 10.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.741 -179.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 26.3 p . . . . . 0 C--O 1.245 0.866 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.302 179.751 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 3.2 m . . . . . 0 N--CA 1.469 0.506 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.66 -45.88 88.4 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -177.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.81 -3.06 11.01 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -123.49 -20.11 5.67 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.561 ' O ' HG23 ' B' ' 82' ' ' VAL . 4.0 tp -112.0 -44.95 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.722 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.64 -32.83 74.4 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.186 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.02 -24.01 60.5 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.366 -0.921 . . . . 0.0 111.724 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.4 -19.69 57.87 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.586 0.231 . . . . 0.0 111.332 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 82' ' ' VAL . . . . . 0.561 HG23 ' O ' ' B' ' 78' ' ' ILE . 80.9 t -65.1 -52.51 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.691 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.89 -34.46 77.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.736 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.64 -38.51 89.59 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.44 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 16.0 t -85.84 -26.21 25.82 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.344 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.76 46.04 7.45 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.02 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 152.94 132.71 1.79 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.986 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 4.7 tp -93.19 135.89 26.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.312 0.577 . . . . 0.0 111.261 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 89' ' ' ASP . . . . . 0.517 ' H ' HG21 ' B' ' 93' ' ' VAL . 47.2 t0 -163.85 -98.82 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 90' ' ' LEU . . . . . 0.774 HD12 ' HB2' ' B' ' 94' ' ' LEU . 59.8 tp -170.11 -58.93 0.0 OUTLIER Pre-proline 0 C--O 1.223 -0.332 0 CA-C-O 119.187 -0.435 . . . . 0.0 111.03 178.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 91' ' ' PRO . . . . . 0.584 ' HB2' ' HA3' ' A' ' 53' ' ' GLY . 2.0 Cg_endo -39.59 -58.79 0.77 Allowed 'Trans proline' 0 C--N 1.363 1.301 0 C-N-CA 123.623 2.882 . . . . 0.0 114.705 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 92' ' ' CYS . . . . . 0.604 ' HB3' ' CE1' ' A' ' 52' ' ' HIS . 8.6 t -84.2 -30.71 25.56 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -178.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 93' ' ' VAL . . . . . 0.517 HG21 ' H ' ' B' ' 89' ' ' ASP . 2.6 t -71.69 -49.62 44.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -178.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 94' ' ' LEU . . . . . 0.774 ' HB2' HD12 ' B' ' 90' ' ' LEU . 2.1 tm? -63.43 -35.16 79.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.955 0.407 . . . . 0.0 110.91 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -53.83 -33.28 55.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.431 -179.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -82.61 -16.96 46.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.95 0.405 . . . . 0.0 111.37 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 97' ' ' LEU . . . . . 0.411 HD13 HD13 ' B' ' 78' ' ' ILE . 6.6 tt -81.69 -10.16 59.46 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.732 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 42.5 mtpt . . . . . 0 CA--C 1.535 0.379 0 CA-C-O 121.063 0.459 . . . . 0.0 111.924 -179.61 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 71.6 m . . . . . 0 C--O 1.224 -0.284 0 N-CA-C 111.537 0.199 . . . . 0.0 111.537 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.16 -13.62 13.07 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 13.0 m -64.94 -27.25 68.71 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.517 0.192 . . . . 0.0 111.517 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 106' ' ' CYS . . . . . 0.429 ' SG ' ' N ' ' B' ' 107' ' ' PHE . 16.6 p -48.9 -57.42 6.48 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.276 0.56 . . . . 0.0 111.415 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . 0.536 ' CD2' HG12 ' B' ' 78' ' ' ILE . 0.5 OUTLIER -80.27 -54.21 5.94 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.574 -179.693 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 76.1 m -82.27 42.84 0.76 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -178.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -77.11 -62.36 1.68 Allowed 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -90.92 7.35 40.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.876 178.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 40.4 m-70 -126.58 79.55 1.87 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.976 -1.011 . . . . 0.0 108.294 178.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 112' ' ' CYS . . . . . 0.411 ' O ' ' HB3' ' B' ' 117' ' ' LYS . 4.0 t -98.28 32.59 2.42 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -177.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 113' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -121.87 -160.38 0.86 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 178.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 114' ' ' GLY . . . . . 0.689 ' HA2' ' HG2' ' A' ' 30' ' ' PRO . . . 66.86 -145.13 46.25 Favored Glycine 0 C--O 1.226 -0.346 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.364 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . 0.507 HG23 ' HB3' ' B' ' 94' ' ' LEU . 8.2 m -78.56 -2.82 5.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 117.228 0.514 . . . . 0.0 110.518 178.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 116' ' ' CYS . . . . . 0.462 ' SG ' ' HG ' ' B' ' 94' ' ' LEU . 0.5 OUTLIER -82.56 -26.86 32.01 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.709 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 117' ' ' LYS . . . . . 0.561 ' HG2' ' O ' ' B' ' 114' ' ' GLY . 14.0 ptmm? -84.33 -6.67 59.42 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 177.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -65.17 -45.77 83.55 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 178.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 66.0 mt -87.13 -33.62 19.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.974 -1.012 . . . . 0.0 108.585 177.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 58.75 75.28 0.4 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 114.464 -1.243 . . . . 0.0 111.866 179.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.97 21.75 4.15 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.856 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 122' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.243 0.759 0 CA-C-O 118.426 -0.797 . . . . 0.0 110.753 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.488 ' O ' HG22 ' A' ' 17' ' ' ILE . 18.1 p . . . . . 0 N--CA 1.476 0.869 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.412 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -70.76 -34.77 72.18 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 118.213 0.46 . . . . 0.0 112.134 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.83 -6.25 36.53 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.97 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -114.34 -35.18 5.05 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.5 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.812 HG12 ' CD2' ' A' ' 46' ' ' PHE . 5.3 tp -93.53 -50.81 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.114 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.619 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.436 ' N ' HG23 ' A' ' 17' ' ' ILE . . . -63.71 -31.64 72.88 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.119 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.53 -24.67 74.34 Favored Glycine 0 N--CA 1.451 -0.357 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 177.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.503 ' CB ' ' HB3' ' A' ' 35' ' ' ALA . . . -76.31 -26.58 55.98 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.114 0.483 . . . . 0.0 110.392 178.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 17' ' ' ILE . 57.9 t -63.46 -50.08 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.473 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.51 -31.64 71.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.93 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.7 -41.67 78.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.759 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.6 t -84.77 -22.97 29.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.861 0.363 . . . . 0.0 110.74 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 111.1 -38.38 3.31 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.683 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -137.19 167.25 24.75 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.236 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.8 tp -96.2 133.86 35.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.071 0.463 . . . . 0.0 111.061 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.515 ' OD2' ' HD2' ' A' ' 30' ' ' PRO . 9.2 t70 -163.82 -111.16 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.699 HD11 ' HB2' ' A' ' 55' ' ' CYS . 38.8 tp -168.16 -54.01 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 178.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.744 ' HB2' ' HA3' ' B' ' 114' ' ' GLY . 86.5 Cg_exo -46.7 -53.03 6.65 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 122.596 2.197 . . . . 0.0 113.887 -179.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.635 ' HB3' ' CE1' ' B' ' 113' ' ' HIS . 7.7 t -81.33 -33.11 32.71 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.555 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.465 HG23 ' HE1' ' B' ' 113' ' ' HIS . 2.8 t -65.14 -28.72 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-O 121.055 0.455 . . . . 0.0 110.895 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.423 ' O ' HD13 ' A' ' 33' ' ' LEU . 1.9 tm? -61.98 -39.0 90.67 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.641 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.33 -46.23 89.18 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.503 ' HB3' ' CB ' ' A' ' 20' ' ' ALA . . . -78.84 -13.61 59.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.785 0.326 . . . . 0.0 111.402 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 23.0 tp -73.76 -53.05 11.18 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -167.11 -21.99 0.02 OUTLIER 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.251 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 66.61 25.78 9.88 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.118 -179.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -166.57 -170.64 1.67 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.79 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.424 ' HG2' HD11 ' A' ' 60' ' ' LEU . 48.2 mt-10 -64.22 131.37 47.19 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 123.064 0.228 . . . . 0.0 111.249 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 145.7 140.59 3.53 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 119.945 -1.122 . . . . 0.0 113.371 179.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 90.2 m 61.64 31.85 18.61 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.624 ' CB ' ' HB3' ' A' ' 60' ' ' LEU . . . -80.59 -44.36 19.07 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.384 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 12.2 m -68.8 -16.11 63.69 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.903 0.383 . . . . 0.0 111.268 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 42.5 t -78.09 -54.91 5.73 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.944 0.402 . . . . 0.0 111.276 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.812 ' CD2' HG12 ' A' ' 17' ' ' ILE . 3.6 t80 -102.18 -49.75 3.82 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -178.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.417 ' SG ' ' HD1' ' A' ' 46' ' ' PHE . 21.2 m -72.96 13.56 0.38 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -177.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 44' ' ' SER . 16.5 tp10 -69.6 -53.66 17.72 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.142 0.496 . . . . 0.0 111.185 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -66.38 -23.95 66.41 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.079 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -135.23 103.78 5.65 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 96.0 m -112.65 81.07 1.42 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 177.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.644 ' CE1' ' HB3' ' B' ' 92' ' ' CYS . 2.6 t-80 -142.16 -34.52 0.46 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -177.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.807 ' HA2' ' HB2' ' B' ' 91' ' ' PRO . . . -87.16 -162.45 37.7 Favored Glycine 0 CA--C 1.518 0.266 0 N-CA-C 115.587 0.995 . . . . 0.0 115.587 -178.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.4 ' CG1' ' HA ' ' A' ' 30' ' ' PRO . 7.7 p -58.44 -10.49 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 124.409 1.084 . . . . 0.0 112.575 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.699 ' HB2' HD11 ' A' ' 29' ' ' LEU . 18.0 t -77.99 -31.49 50.73 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 121.999 -0.438 . . . . 0.0 111.071 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.607 ' HG3' ' O ' ' A' ' 53' ' ' GLY . 0.1 OUTLIER -90.34 -2.35 57.98 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.466 179.819 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.424 ' O ' ' HB3' ' A' ' 58' ' ' LEU . 52.9 t0 -56.46 122.47 12.0 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.647 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.685 ' O ' ' HB2' ' A' ' 59' ' ' HIS . 45.2 tp 90.24 -64.94 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.029 1.332 . . . . 0.0 108.699 -177.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.685 ' HB2' ' O ' ' A' ' 58' ' ' LEU . 26.5 t-80 153.03 121.13 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.911 0 O-C-N 124.763 1.289 . . . . 0.0 109.303 178.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.624 ' HB3' ' CB ' ' A' ' 43' ' ' ALA . 22.1 mt -147.3 -55.85 0.24 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 19.1 p . . . . . 0 C--O 1.246 0.906 0 CA-C-O 118.435 -0.793 . . . . 0.0 110.747 -179.812 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 74' ' ' CYS . . . . . 0.501 ' O ' HG22 ' B' ' 78' ' ' ILE . 9.7 p . . . . . 0 N--CA 1.478 0.936 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 75' ' ' ALA . . . . . 0.487 ' HA ' HG22 ' B' ' 78' ' ' ILE . . . -67.13 -26.32 66.62 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.82 -9.09 25.65 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -120.75 -34.28 3.61 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.606 HG12 ' CD1' ' B' ' 107' ' ' PHE . 7.8 tp -82.79 -48.5 17.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.118 0.485 . . . . 0.0 111.683 -179.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.81 -24.9 59.54 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.106 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.18 -22.85 70.0 Favored Glycine 0 C--N 1.329 0.183 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.12 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -80.65 -17.81 50.04 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.092 0.472 . . . . 0.0 110.623 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 82' ' ' VAL . . . . . 0.469 HG22 HD13 ' B' ' 88' ' ' ILE . 60.4 t -66.78 -43.44 89.86 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.453 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.24 6.48 11.76 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.917 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -110.26 -19.68 12.92 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 3.0 t -120.03 12.23 11.9 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.515 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 71.06 33.82 65.08 Favored Glycine 0 CA--C 1.519 0.285 0 N-CA-C 114.693 0.637 . . . . 0.0 114.693 178.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 148.36 -177.05 26.87 Favored Glycine 0 CA--C 1.51 -0.269 0 C-N-CA 119.864 -1.16 . . . . 0.0 112.543 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 88' ' ' ILE . . . . . 0.469 HD13 HG22 ' B' ' 82' ' ' VAL . 4.4 tp -123.23 134.7 65.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.994 0.426 . . . . 0.0 111.043 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 89' ' ' ASP . . . . . 0.565 ' H ' HG21 ' B' ' 93' ' ' VAL . 28.7 t70 -156.47 -102.38 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 90' ' ' LEU . . . . . 0.598 HD11 ' HB2' ' B' ' 116' ' ' CYS . 22.1 tp -167.09 -59.06 0.01 OUTLIER Pre-proline 0 N--CA 1.469 0.488 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 177.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 91' ' ' PRO . . . . . 0.998 ' HA ' HG11 ' B' ' 115' ' ' VAL . 2.1 Cg_endo -43.87 -56.2 2.58 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 123.049 2.499 . . . . 0.0 114.631 -178.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 92' ' ' CYS . . . . . 0.644 ' HB3' ' CE1' ' A' ' 52' ' ' HIS . 12.3 t -81.22 -32.85 33.25 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 93' ' ' VAL . . . . . 0.565 HG21 ' H ' ' B' ' 89' ' ' ASP . 0.2 OUTLIER -68.02 -29.2 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-O 120.668 0.27 . . . . 0.0 111.217 -179.197 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -62.21 -39.15 91.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.222 0.534 . . . . 0.0 110.252 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.35 -43.53 85.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.206 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.6 19.51 4.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.68 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 97' ' ' LEU . . . . . 0.44 HD13 HD13 ' B' ' 78' ' ' ILE . 35.8 tp -77.04 -52.62 9.01 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.17 0.509 . . . . 0.0 109.708 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.181 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 87.7 m . . . . . 0 N--CA 1.468 0.429 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -90.1 -24.92 20.99 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 18.0 t -64.45 -47.2 79.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.72 0.295 . . . . 0.0 110.863 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 37.0 t -60.16 -50.24 74.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.917 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . 0.606 ' CD1' HG12 ' B' ' 78' ' ' ILE . 52.9 t80 -73.09 -58.55 3.23 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -178.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 21.7 m -79.03 34.14 0.23 Allowed 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -177.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 19.1 tp10 -63.31 -80.99 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 118.154 0.433 . . . . 0.0 110.373 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -76.32 -30.55 57.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.505 0.669 . . . . 0.0 109.294 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 111' ' ' HIS . . . . . 0.418 ' HD2' ' O ' ' B' ' 107' ' ' PHE . 5.6 m-70 -81.87 71.07 8.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.647 179.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 9.8 t -128.84 84.47 2.23 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.116 0.484 . . . . 0.0 110.057 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 113' ' ' HIS . . . . . 0.635 ' CE1' ' HB3' ' A' ' 31' ' ' CYS . 9.3 t-80 -126.08 -47.48 1.63 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.289 -178.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 114' ' ' GLY . . . . . 0.744 ' HA3' ' HB2' ' A' ' 30' ' ' PRO . . . -147.41 164.68 28.71 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 119.997 -1.097 . . . . 0.0 113.401 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . 0.998 HG11 ' HA ' ' B' ' 91' ' ' PRO . 0.5 OUTLIER 61.88 -45.0 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 125.581 1.552 . . . . 0.0 113.253 179.626 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 116' ' ' CYS . . . . . 0.598 ' HB2' HD11 ' B' ' 90' ' ' LEU . 6.9 t -87.2 -30.23 21.14 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -90.74 4.47 51.47 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.375 178.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -63.01 -32.44 73.8 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.352 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 25.5 tp -112.78 -114.71 0.33 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -141.51 59.13 1.51 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 86.2 mt -99.24 -35.93 9.81 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 122' ' ' CYS . . . . . . . . . . . . . 3.4 p . . . . . 0 C--O 1.245 0.824 0 CA-C-O 118.345 -0.836 . . . . 0.0 110.286 179.339 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.83 ' HB3' HD12 ' A' ' 17' ' ' ILE . 76.4 m . . . . . 0 N--CA 1.471 0.605 0 N-CA-C 112.97 0.729 . . . . 0.0 112.97 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.673 ' HA ' ' HB3' ' A' ' 18' ' ' ALA . . . -73.7 16.99 0.17 Allowed 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -104.44 -31.46 9.48 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.733 0.302 . . . . 0.0 111.109 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -123.37 -48.84 1.94 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.476 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.83 HD12 ' HB3' ' A' ' 13' ' ' CYS . 69.3 mt -64.19 -45.92 94.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-O 121.42 0.629 . . . . 0.0 109.569 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.673 ' HB3' ' HA ' ' A' ' 14' ' ' ALA . . . -110.44 31.71 5.73 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.156 178.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -129.63 -43.23 0.21 Allowed Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.73 -0.747 . . . . 0.0 111.968 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.669 ' HB3' HG13 ' A' ' 32' ' ' VAL . . . -87.35 19.92 3.05 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.997 0.427 . . . . 0.0 111.343 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.452 HG13 ' N ' ' A' ' 22' ' ' ALA . 12.5 p -65.92 -45.57 90.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.974 0.892 . . . . 0.0 110.286 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.452 ' N ' HG13 ' A' ' 21' ' ' VAL . . . -64.46 -26.42 68.44 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.555 -1.202 . . . . 0.0 111.629 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.8 -40.06 95.73 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.587 ' SG ' ' HA3' ' B' ' 114' ' ' GLY . 4.5 t -97.07 1.6 50.27 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.768 0.318 . . . . 0.0 110.801 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.42 42.43 82.02 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.519 -0.848 . . . . 0.0 111.426 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 144.35 156.03 6.66 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.403 ' HB ' HG23 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -87.19 133.92 28.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 117.595 0.697 . . . . 0.0 111.389 -179.035 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.632 ' OD1' ' HB3' ' A' ' 31' ' ' CYS . 1.2 p30 -143.55 -112.25 0.11 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.308 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.785 HD21 ' HB3' ' A' ' 55' ' ' CYS . 12.5 tp -179.28 -56.56 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.449 0 C-N-CA 122.358 0.263 . . . . 0.0 111.7 178.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.916 ' HB3' HG13 ' A' ' 54' ' ' VAL . 8.7 Cg_exo -76.05 -4.12 14.73 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 121.874 1.716 . . . . 0.0 113.177 -178.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.707 ' HB2' HG13 ' B' ' 115' ' ' VAL . 21.6 t -104.88 -38.95 6.45 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 177.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.669 HG13 ' HB3' ' A' ' 20' ' ' ALA . 42.3 t -78.64 -10.77 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.221 178.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.581 ' HG ' ' HB2' ' A' ' 37' ' ' LYS . 6.3 tp -54.21 -29.17 45.23 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.945 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -46.95 -45.82 21.04 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -178.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -102.88 33.23 3.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.982 0.42 . . . . 0.0 111.16 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.411 ' HG ' ' HA2' ' A' ' 41' ' ' GLY . 5.5 tp -137.14 -41.59 0.58 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.761 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.581 ' HB2' ' HG ' ' A' ' 33' ' ' LEU . 1.8 tmtp? -59.96 -35.11 74.25 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -177.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.23 -64.18 1.04 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -178.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -93.81 55.01 2.07 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -178.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.854 ' HG2' ' H ' ' A' ' 42' ' ' CYS . 85.0 tt0 70.83 137.63 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.337 0.589 . . . . 0.0 111.517 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.562 ' HA3' HD11 ' A' ' 60' ' ' LEU . . . -79.32 -11.23 85.19 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.715 -0.755 . . . . 0.0 113.186 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.854 ' H ' ' HG2' ' A' ' 40' ' ' GLU . 33.9 m 69.75 94.61 0.07 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 122.96 0.504 . . . . 0.0 111.193 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.44 ' C ' ' H ' ' A' ' 45' ' ' CYS . . . -65.96 153.43 42.11 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.902 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.6 p 66.76 -29.09 0.13 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.624 1.169 . . . . 0.0 112.365 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.44 ' H ' ' C ' ' A' ' 43' ' ' ALA . 6.0 t -78.15 -70.13 0.51 Allowed 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.56 ' HD1' ' CE1' ' A' ' 50' ' ' HIS . 0.1 OUTLIER -90.18 165.31 14.03 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 175.514 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.788 ' HB3' ' SG ' ' A' ' 61' ' ' CYS . 73.4 m 72.66 -0.68 3.24 Favored 'General case' 0 C--O 1.216 -0.68 0 O-C-N 123.364 0.415 . . . . 0.0 111.642 -178.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.549 ' OE1' ' HA ' ' A' ' 48' ' ' GLU . 5.1 tp10 -61.35 -93.32 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.274 0.559 . . . . 0.0 111.187 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.458 ' H ' ' HB3' ' A' ' 48' ' ' GLU . 17.8 t70 -70.35 -33.33 71.33 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 178.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.56 ' CE1' ' HD1' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -88.61 56.95 3.97 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 112.466 -2.152 . . . . 0.0 109.535 178.463 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 14.8 t -93.63 63.77 3.46 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 17.2 t-160 -163.49 136.25 5.35 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.06 -177.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 117.0 -157.7 14.91 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 119.864 -1.16 . . . . 0.0 113.78 178.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.916 HG13 ' HB3' ' A' ' 30' ' ' PRO . 3.5 m -70.73 -5.13 5.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.39 -0.405 . . . . 0.0 112.001 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.785 ' HB3' HD21 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -76.79 -40.94 46.46 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.119 0.485 . . . . 0.0 110.573 -178.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.404 ' HE2' ' HB3' ' A' ' 56' ' ' LYS . 31.6 mtpt -67.46 -10.75 54.45 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.818 179.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -65.59 -33.03 74.96 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.497 HD23 ' O ' ' A' ' 58' ' ' LEU . 2.4 tt -90.19 -21.16 22.31 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.937 178.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 75.06 97.87 0.07 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.377 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.643 ' HB2' ' SG ' ' A' ' 47' ' ' CYS . 26.3 mt -136.84 2.37 2.61 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.144 -179.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.788 ' SG ' ' HB3' ' A' ' 47' ' ' CYS . 29.2 p . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.107 -0.949 . . . . 0.0 109.707 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 74' ' ' CYS . . . . . 0.856 ' HB3' HD12 ' B' ' 78' ' ' ILE . 12.2 m . . . . . 0 N--CA 1.466 0.34 0 N-CA-C 112.854 0.686 . . . . 0.0 112.854 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 75' ' ' ALA . . . . . 0.954 ' HA ' ' HB3' ' B' ' 79' ' ' ALA . . . -82.6 6.62 17.11 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . 0.408 ' O ' ' HA3' ' B' ' 80' ' ' GLY . . . -99.17 -57.52 2.14 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.733 0.302 . . . . 0.0 111.789 -179.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.19 -38.66 12.57 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.856 HD12 ' HB3' ' B' ' 74' ' ' CYS . 71.9 mt -81.71 -55.5 7.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.979 0.419 . . . . 0.0 110.383 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 79' ' ' ALA . . . . . 0.954 ' HB3' ' HA ' ' B' ' 75' ' ' ALA . . . -83.39 14.47 3.61 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.276 0.56 . . . . 0.0 110.853 178.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 80' ' ' GLY . . . . . 0.408 ' HA3' ' O ' ' B' ' 76' ' ' ALA . . . -114.24 -41.22 0.9 Allowed Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 178.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . 0.685 ' HB3' HG13 ' B' ' 93' ' ' VAL . . . -73.51 -7.31 51.31 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-O 120.976 0.417 . . . . 0.0 110.358 178.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 82' ' ' VAL . . . . . 0.409 HG13 ' N ' ' B' ' 83' ' ' ALA . 13.0 p -60.14 -42.16 89.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-O 121.619 0.723 . . . . 0.0 109.445 178.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . 0.409 ' N ' HG13 ' B' ' 82' ' ' VAL . . . -70.36 -27.29 64.22 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.429 -1.26 . . . . 0.0 111.467 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.69 -46.06 14.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.84 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 38.0 t -79.33 -48.33 14.27 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.903 0.382 . . . . 0.0 110.85 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 117.98 41.09 0.67 Allowed Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.908 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 140.1 176.19 14.89 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.525 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 18.1 mm -104.65 118.85 52.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.158 0.504 . . . . 0.0 111.232 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 89' ' ' ASP . . . . . 0.458 ' CG ' ' H ' ' B' ' 90' ' ' LEU . 7.7 p-10 -138.24 -108.5 0.18 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.029 178.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 90' ' ' LEU . . . . . 0.732 HD11 ' SG ' ' B' ' 108' ' ' CYS . 0.1 OUTLIER -174.87 -53.76 0.0 OUTLIER Pre-proline 0 N--CA 1.451 -0.402 0 C-N-CA 122.367 0.267 . . . . 0.0 111.105 179.621 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 91' ' ' PRO . . . . . 0.947 ' HB3' HG11 ' B' ' 115' ' ' VAL . 27.1 Cg_exo -63.97 -29.9 66.76 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.212 1.941 . . . . 0.0 115.293 -176.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 14.3 p -92.07 -40.5 11.04 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 119.695 -0.802 . . . . 0.0 110.042 179.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 93' ' ' VAL . . . . . 0.685 HG13 ' HB3' ' B' ' 81' ' ' ALA . 2.5 t -65.83 -27.76 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.699 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 26.1 tp -55.43 -45.3 76.81 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.355 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.8 -45.66 91.63 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.245 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.25 -21.27 59.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.178 0.514 . . . . 0.0 110.787 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 97' ' ' LEU . . . . . 0.652 HD21 ' HB2' ' B' ' 103' ' ' CYS . 10.2 tt -78.66 -29.02 45.48 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.086 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 29.5 tttm . . . . . 0 C--O 1.235 0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 112.115 -179.463 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 103' ' ' CYS . . . . . 0.652 ' HB2' HD21 ' B' ' 97' ' ' LEU . 82.5 m . . . . . 0 N--CA 1.466 0.329 0 CA-C-O 121.7 0.762 . . . . 0.0 110.711 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 104' ' ' ALA . . . . . 0.518 ' HB2' HD12 ' B' ' 121' ' ' LEU . . . -114.64 -160.28 0.73 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 177.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 105' ' ' SER . . . . . 0.525 ' O ' ' HB2' ' B' ' 109' ' ' GLU . 15.0 m 68.37 -56.15 0.51 Allowed 'General case' 0 N--CA 1.467 0.418 0 O-C-N 123.584 0.553 . . . . 0.0 112.317 178.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 29.9 p -80.04 -35.74 36.74 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 122.001 -0.437 . . . . 0.0 110.566 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . 0.584 ' CE1' HD22 ' B' ' 90' ' ' LEU . 0.7 OUTLIER -88.63 -97.78 0.09 Allowed 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.248 -178.536 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 108' ' ' CYS . . . . . 0.732 ' SG ' HD11 ' B' ' 90' ' ' LEU . 33.7 m -63.43 33.75 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 115.011 1.486 . . . . 0.0 115.011 -177.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 109' ' ' GLU . . . . . 0.525 ' HB2' ' O ' ' B' ' 105' ' ' SER . 44.3 tp10 -59.92 -70.44 0.17 Allowed 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 119.301 0.955 . . . . 0.0 110.709 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -92.53 -20.31 21.07 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.082 0.468 . . . . 0.0 110.137 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -86.88 86.63 7.33 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 112' ' ' CYS . . . . . 0.427 ' O ' ' HE2' ' B' ' 117' ' ' LYS . 1.6 t -121.05 43.03 2.9 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.942 0.401 . . . . 0.0 110.416 -178.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 113' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -88.37 121.03 30.31 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.556 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 114' ' ' GLY . . . . . 0.587 ' HA3' ' SG ' ' A' ' 24' ' ' CYS . . . 45.45 -99.86 0.02 OUTLIER Glycine 0 C--O 1.223 -0.566 0 N-CA-C 115.681 1.032 . . . . 0.0 115.681 177.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . 0.947 HG11 ' HB3' ' B' ' 91' ' ' PRO . 12.5 m -29.57 -60.54 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 -177.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 116' ' ' CYS . . . . . 0.524 ' H ' HG23 ' B' ' 115' ' ' VAL . 0.9 OUTLIER -73.34 -30.5 63.38 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.102 -0.639 . . . . 0.0 112.019 -177.755 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 117' ' ' LYS . . . . . 0.427 ' HE2' ' O ' ' B' ' 112' ' ' CYS . 11.9 ttmm -76.08 -11.05 59.87 Favored 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 122.024 -0.422 . . . . 0.0 110.09 178.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -67.83 -43.29 79.89 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 178.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 119' ' ' LEU . . . . . 0.581 ' HB3' ' CD2' ' B' ' 121' ' ' LEU . 5.1 tt -78.28 -36.47 46.68 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 177.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 14.1 t-80 78.82 75.58 0.05 Allowed 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 114.693 -1.14 . . . . 0.0 111.656 178.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 121' ' ' LEU . . . . . 0.581 ' CD2' ' HB3' ' B' ' 119' ' ' LEU . 0.4 OUTLIER -128.16 13.39 6.68 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.378 179.47 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 122' ' ' CYS . . . . . . . . . . . . . 3.6 p . . . . . 0 C--O 1.246 0.869 0 CA-C-O 118.293 -0.861 . . . . 0.0 110.478 179.212 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.434 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 95.7 m . . . . . 0 N--CA 1.475 0.803 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -99.31 14.86 28.13 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.41 -68.97 0.79 Allowed 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -87.65 -3.15 58.98 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -178.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.744 HD13 ' HB2' ' A' ' 46' ' ' PHE . 45.3 mt -112.64 -62.86 2.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.548 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.27 -34.72 72.6 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.86 -37.84 18.03 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.689 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.04 -28.21 60.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.021 0.439 . . . . 0.0 111.677 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.462 HG13 ' N ' ' A' ' 27' ' ' ILE . 1.9 t -66.36 -43.17 91.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.617 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.64 -25.66 64.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.149 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.75 -24.39 63.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.651 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 12.4 t -89.17 -31.93 17.71 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.755 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 128.55 17.23 1.95 Allowed Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.093 -1.051 . . . . 0.0 113.88 178.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 116.14 114.65 2.86 Favored Glycine 0 C--O 1.227 -0.309 0 C-N-CA 120.24 -0.981 . . . . 0.0 112.29 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.462 ' N ' HG13 ' A' ' 21' ' ' VAL . 1.4 tt 19.13 94.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.621 ' HB3' HG23 ' A' ' 32' ' ' VAL . 6.8 t0 -127.73 143.34 51.15 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 114.18 -1.373 . . . . 0.0 107.616 177.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.781 ' HB3' ' HD3' ' A' ' 30' ' ' PRO . 36.7 tp -106.88 -58.49 0.05 OUTLIER Pre-proline 0 C--N 1.303 -1.429 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.232 -179.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.781 ' HD3' ' HB3' ' A' ' 29' ' ' LEU . 25.9 Cg_exo -62.59 -28.22 77.0 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 121.93 1.753 . . . . 0.0 112.594 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.602 ' HB3' ' CG ' ' A' ' 28' ' ' ASP . 0.1 OUTLIER -84.46 -41.31 16.73 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.764 -179.147 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.621 HG23 ' HB3' ' A' ' 28' ' ' ASP . 45.1 t -84.91 -6.22 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-O 121.174 0.511 . . . . 0.0 111.021 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.461 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 2.4 tm? -54.37 -45.46 72.79 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.326 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.77 -36.86 80.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.529 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.08 2.02 52.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.805 0.336 . . . . 0.0 111.493 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 57.4 tp -97.3 -32.32 11.95 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.322 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -75.93 -26.5 56.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.19 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -106.9 -179.71 4.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.628 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 57.49 31.91 20.99 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 123.568 0.542 . . . . 0.0 112.286 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 53.69 67.91 0.93 Allowed 'General case' 0 CA--C 1.534 0.348 0 O-C-N 123.611 0.569 . . . . 0.0 110.509 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -79.5 -166.07 31.67 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.73 -0.668 . . . . 0.0 113.493 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 47.0 t -160.31 88.83 0.82 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.635 ' CB ' ' HB3' ' A' ' 60' ' ' LEU . . . -68.44 -42.03 79.46 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -178.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.4 p -75.56 28.4 0.1 Allowed 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.363 0.602 . . . . 0.0 112.438 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.445 ' H ' ' C ' ' A' ' 43' ' ' ALA . 20.1 t -139.6 -18.21 0.97 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.744 ' HB2' HD13 ' A' ' 17' ' ' ILE . 0.8 OUTLIER -111.0 -63.17 1.43 Allowed 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.785 -179.311 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 19.8 m -79.12 25.34 0.29 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.473 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -52.94 -62.31 1.74 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.642 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -92.74 -31.8 14.93 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -79.47 76.05 6.07 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.432 ' SG ' ' HB3' ' A' ' 56' ' ' LYS . 4.0 t -128.31 52.45 1.9 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -177.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 15.9 p-80 -122.46 82.64 2.0 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.637 0.732 . . . . 0.0 110.712 178.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.75 172.77 44.21 Favored Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.479 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.768 HG11 ' HA ' ' A' ' 30' ' ' PRO . 44.9 t 63.61 -73.32 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 123.297 0.639 . . . . 0.0 112.59 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.735 ' HB2' HD11 ' A' ' 29' ' ' LEU . 38.9 t -71.72 -44.38 64.23 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.407 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.432 ' HB3' ' SG ' ' A' ' 51' ' ' CYS . 0.1 OUTLIER -88.05 13.31 11.4 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 119.899 -0.72 . . . . 0.0 110.603 179.17 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -69.14 -35.35 76.26 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 177.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -95.58 -4.13 45.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 113.972 -1.467 . . . . 0.0 108.521 177.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.402 ' H ' ' C ' ' A' ' 56' ' ' LYS . 75.1 m-70 65.91 75.25 0.35 Allowed 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 114.414 -1.266 . . . . 0.0 110.912 -178.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.635 ' HB3' ' CB ' ' A' ' 43' ' ' ALA . 88.6 mt -106.06 -31.29 8.79 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.36 -179.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.7 p . . . . . 0 C--O 1.245 0.845 0 CA-C-O 118.304 -0.855 . . . . 0.0 110.179 179.059 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 74' ' ' CYS . . . . . 0.711 ' HB3' HD12 ' B' ' 78' ' ' ILE . 30.3 m . . . . . 0 N--CA 1.475 0.788 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -90.64 -31.23 16.72 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -178.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -71.15 -75.16 0.13 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -178.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.01 29.67 0.13 Allowed 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -177.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.711 HD12 ' HB3' ' B' ' 74' ' ' CYS . 23.2 mt -142.2 -58.3 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 O-C-N 122.246 -0.284 . . . . 0.0 110.408 178.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.79 -35.58 77.21 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.927 0.394 . . . . 0.0 110.65 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -75.34 -23.82 72.61 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.363 178.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.78 -28.32 63.54 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.783 0.325 . . . . 0.0 110.747 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 82' ' ' VAL . . . . . 0.516 HG23 ' O ' ' B' ' 78' ' ' ILE . 52.8 t -70.72 -28.11 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.031 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.44 -32.81 72.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.089 0.471 . . . . 0.0 109.883 178.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -87.12 1.3 53.43 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.754 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 64.3 m -148.49 64.97 1.07 Allowed 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -28.72 -48.09 0.08 OUTLIER Glycine 0 N--CA 1.469 0.899 0 O-C-N 124.881 1.363 . . . . 0.0 114.414 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . -96.36 86.41 0.91 Allowed Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 177.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 88' ' ' ILE . . . . . 0.502 ' HB ' HG13 ' B' ' 82' ' ' VAL . 0.0 OUTLIER -62.08 135.77 26.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.637 0.732 . . . . 0.0 112.406 -177.551 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 89' ' ' ASP . . . . . 0.477 ' O ' ' HB2' ' B' ' 90' ' ' LEU . 10.3 t70 -146.92 -71.47 0.23 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.146 178.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 90' ' ' LEU . . . . . 0.653 ' N ' ' HD2' ' B' ' 91' ' ' PRO . 29.1 tp 172.37 -49.54 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.434 0 O-C-N 123.995 0.81 . . . . 0.0 109.844 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 91' ' ' PRO . . . . . 0.653 ' HD2' ' N ' ' B' ' 90' ' ' LEU . 5.4 Cg_exo -31.9 -70.11 0.05 OUTLIER 'Trans proline' 0 C--N 1.367 1.505 0 C-N-CA 124.842 3.695 . . . . 0.0 115.341 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 26.8 p -83.81 -31.84 25.64 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -177.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 93' ' ' VAL . . . . . 0.452 ' H ' HG23 ' B' ' 93' ' ' VAL . 1.1 t -62.02 -22.49 28.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.943 0.401 . . . . 0.0 111.002 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 94' ' ' LEU . . . . . 0.691 ' HG ' HG12 ' B' ' 115' ' ' VAL . 2.8 tm? -67.97 -37.12 81.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.663 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.53 -47.32 79.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.978 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -83.48 -2.52 56.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.684 0.278 . . . . 0.0 111.717 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 97' ' ' LEU . . . . . 0.449 HD13 ' HE2' ' B' ' 107' ' ' PHE . 27.1 tp -86.84 -21.66 26.28 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.27 0.557 . . . . 0.0 110.055 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.442 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 103' ' ' CYS . . . . . 0.667 ' SG ' ' HB2' ' B' ' 106' ' ' CYS . 35.3 t . . . . . 0 C--O 1.234 0.279 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 104' ' ' ALA . . . . . 0.572 ' CB ' ' HB3' ' B' ' 121' ' ' LEU . . . -67.0 -40.14 87.26 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -178.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 8.0 t -75.94 29.94 0.11 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.168 0.508 . . . . 0.0 111.488 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 106' ' ' CYS . . . . . 0.667 ' HB2' ' SG ' ' B' ' 103' ' ' CYS . 44.6 t -118.73 -50.17 2.42 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.756 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . 0.47 ' HB3' HD13 ' B' ' 78' ' ' ILE . 0.1 OUTLIER -102.41 -46.0 4.92 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.35 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -70.26 30.13 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.487 -0.778 . . . . 0.0 112.727 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 109' ' ' GLU . . . . . 0.423 ' H ' ' C ' ' B' ' 107' ' ' PHE . 23.5 tt0 -69.06 -64.2 0.91 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.49 0.186 . . . . 0.0 110.581 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -76.15 -31.68 58.71 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 59.2 m-70 -74.16 85.67 1.87 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.97 -1.014 . . . . 0.0 108.826 178.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 112' ' ' CYS . . . . . 0.473 ' SG ' ' HG3' ' B' ' 117' ' ' LYS . 4.5 t -151.0 71.58 1.03 Allowed 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.264 -0.574 . . . . 0.0 112.097 -177.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 113' ' ' HIS . . . . . . . . . . . . . 49.4 p-80 -128.64 -17.4 4.09 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 179.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -155.25 -73.18 0.01 OUTLIER Glycine 0 C--O 1.226 -0.396 0 C-N-CA 119.06 -1.543 . . . . 0.0 114.713 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . 0.691 HG12 ' HG ' ' B' ' 94' ' ' LEU . 2.8 t -58.42 -55.6 21.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -177.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 116' ' ' CYS . . . . . 0.446 ' SG ' HD11 ' B' ' 90' ' ' LEU . 1.0 OUTLIER -73.07 -19.86 61.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.831 0.348 . . . . 0.0 111.675 -179.607 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 117' ' ' LYS . . . . . 0.473 ' HG3' ' SG ' ' B' ' 112' ' ' CYS . 15.5 mttm -82.72 -24.44 33.58 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.877 178.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -63.43 -45.42 91.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.93 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -90.24 7.66 37.08 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.23 -0.441 . . . . 0.0 112.053 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 53.3 62.52 2.62 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.022 0.439 . . . . 0.0 110.683 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 121' ' ' LEU . . . . . 0.572 ' HB3' ' CB ' ' B' ' 104' ' ' ALA . 96.3 mt -110.13 -12.55 14.49 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -178.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 122' ' ' CYS . . . . . 0.438 ' SG ' ' HB3' ' B' ' 116' ' ' CYS . 1.8 p . . . . . 0 C--O 1.245 0.848 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.402 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 6.1 p . . . . . 0 CA--C 1.515 -0.387 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.21 -38.87 92.62 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.12 -12.69 60.01 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.438 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . . . -101.79 -38.57 7.8 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -179.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.924 HD13 HD13 ' A' ' 36' ' ' LEU . 10.9 tp -73.28 -35.06 45.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.42 0.628 . . . . 0.0 111.017 -179.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.34 -22.39 53.1 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.973 -1.012 . . . . 0.0 112.806 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -77.79 -29.38 54.93 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.349 -179.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.14 -17.37 52.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.65 0.262 . . . . 0.0 111.143 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.1 t -63.07 -46.34 96.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 CA-C-O 120.898 0.38 . . . . 0.0 110.733 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.7 -23.75 64.41 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.165 -0.471 . . . . 0.0 112.201 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -85.71 -23.91 27.19 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.551 0.691 . . . . 0.0 110.947 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.554 ' SG ' ' CD2' ' B' ' 113' ' ' HIS . 0.7 OUTLIER -86.17 -28.1 24.14 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.151 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.21 39.62 9.08 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.131 -1.033 . . . . 0.0 110.684 -179.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 143.63 178.16 19.17 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 -178.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.593 HD12 HG21 ' A' ' 32' ' ' VAL . 3.0 tp -129.47 121.81 54.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 117.871 0.836 . . . . 0.0 112.117 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.595 ' HB3' ' HD2' ' A' ' 30' ' ' PRO . 2.1 m-20 -140.45 -75.83 0.33 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.051 178.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.678 ' HG ' ' CG2' ' A' ' 54' ' ' VAL . 26.6 tp 172.26 -49.63 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.411 0 O-C-N 124.136 0.898 . . . . 0.0 111.354 179.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.723 ' HA ' HG11 ' A' ' 54' ' ' VAL . 5.4 Cg_endo -48.23 -63.66 0.3 Allowed 'Trans proline' 0 C--N 1.359 1.11 0 C-N-CA 123.093 2.529 . . . . 0.0 114.31 -179.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.424 ' HB3' ' O ' ' B' ' 113' ' ' HIS . 4.4 p -66.93 -37.87 85.12 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.41 -178.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.593 HG21 HD12 ' A' ' 27' ' ' ILE . 0.2 OUTLIER -70.57 -18.29 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.722 -178.486 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.554 HD22 ' HB ' ' A' ' 54' ' ' VAL . 58.9 tp -64.88 -21.7 66.86 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.722 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.34 -31.86 35.45 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -178.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -121.43 43.56 2.79 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.838 0.352 . . . . 0.0 110.744 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.924 HD13 HD13 ' A' ' 17' ' ' ILE . 14.3 tp -133.91 -6.2 2.77 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -178.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.412 ' O ' ' HB2' ' A' ' 38' ' ' ALA . 77.9 tttt -85.49 74.42 10.33 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 122.032 -0.418 . . . . 0.0 111.989 -179.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.412 ' HB2' ' O ' ' A' ' 37' ' ' LYS . . . 171.79 169.82 0.1 Allowed 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.124 0.569 . . . . 0.0 110.523 179.061 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.96 -39.32 87.21 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.456 ' H ' ' HG2' ' A' ' 40' ' ' GLU . 3.2 pt-20 -78.03 88.59 4.17 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 176.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.438 ' HA2' ' HB3' ' A' ' 16' ' ' ALA . . . 137.94 -39.53 1.59 Allowed Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 108.05 -2.02 . . . . 0.0 108.05 -176.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 1.1 m 55.07 93.38 0.02 OUTLIER 'General case' 0 C--O 1.235 0.325 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 176.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.5 ' HA ' ' HG ' ' A' ' 36' ' ' LEU . . . -70.59 -24.99 62.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.476 176.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.8 p -76.15 12.9 1.01 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.925 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 37.8 t -113.14 -56.35 2.42 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.616 ' CD2' HG12 ' A' ' 17' ' ' ILE . 1.1 t80 -77.03 -54.65 6.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.755 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.576 ' O ' ' HB2' ' A' ' 51' ' ' CYS . 53.9 m -68.49 6.23 0.86 Allowed 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -178.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -66.98 -71.02 0.22 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.279 0.561 . . . . 0.0 110.685 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.06 -17.56 58.67 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.372 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.411 ' HD2' ' O ' ' A' ' 46' ' ' PHE . 39.8 m-70 -113.08 83.26 1.8 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.481 -0.782 . . . . 0.0 109.943 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.576 ' HB2' ' O ' ' A' ' 47' ' ' CYS . 22.2 t -140.03 86.94 2.12 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.158 -0.617 . . . . 0.0 112.526 -178.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.699 ' O ' ' HB3' ' B' ' 92' ' ' CYS . 0.0 OUTLIER -144.11 -3.02 0.87 Allowed 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.022 0.439 . . . . 0.0 110.444 177.742 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.868 ' HA3' ' HB2' ' B' ' 91' ' ' PRO . . . -157.42 163.97 32.76 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-O 118.914 -0.936 . . . . 0.0 111.695 178.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.723 HG11 ' HA ' ' A' ' 30' ' ' PRO . 6.0 m 46.55 -64.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 115.377 1.621 . . . . 0.0 115.377 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.462 ' N ' ' O ' ' A' ' 53' ' ' GLY . 0.6 OUTLIER -63.04 -34.13 76.91 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 122.111 -0.368 . . . . 0.0 111.16 -178.676 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.0 pttp -70.58 -28.53 64.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.009 0.433 . . . . 0.0 110.321 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -65.83 -39.34 90.73 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.395 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.439 HD12 HD21 ' A' ' 33' ' ' LEU . 91.3 mt -87.24 4.21 43.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.74 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 58.5 m170 59.5 57.65 3.22 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 123.425 0.453 . . . . 0.0 111.809 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.412 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 80.4 mt -112.55 -2.68 14.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.02 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.452 ' SG ' ' HB3' ' A' ' 47' ' ' CYS . 6.3 p . . . . . 0 C--O 1.247 0.946 0 CA-C-O 117.907 -1.044 . . . . 0.0 109.513 179.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 74' ' ' CYS . . . . . 0.484 ' HB3' ' HB3' ' B' ' 106' ' ' CYS . 4.6 p . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.937 0.399 . . . . 0.0 110.774 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 75' ' ' ALA . . . . . 0.475 ' HA ' HG22 ' B' ' 78' ' ' ILE . . . -68.4 -5.67 20.32 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.539 -179.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.77 -27.39 63.89 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.359 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -128.79 -29.99 2.31 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 1.016 HD13 HD13 ' B' ' 97' ' ' LEU . 6.4 tp -73.68 -36.22 46.23 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 C-N-CA 120.634 -0.426 . . . . 0.0 111.309 -178.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.05 -34.02 71.45 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.869 -178.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -76.69 -33.83 45.78 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.381 -0.914 . . . . 0.0 111.297 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . 0.485 ' HB2' ' HB3' ' B' ' 96' ' ' ALA . . . -66.65 -24.81 66.34 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.687 0.28 . . . . 0.0 111.478 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 82' ' ' VAL . . . . . 0.576 HG22 HD13 ' B' ' 88' ' ' ILE . 91.6 t -58.23 -38.5 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-O 121.156 0.503 . . . . 0.0 110.663 179.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.79 -33.25 12.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.373 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.78 -19.15 64.3 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -179.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 85' ' ' CYS . . . . . 0.418 ' HB2' ' O ' ' B' ' 81' ' ' ALA . 0.8 OUTLIER -98.94 -1.01 41.03 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 121.21 -0.196 . . . . 0.0 111.506 -179.858 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 59.68 37.03 91.73 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.298 -179.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 143.35 137.81 3.33 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 110.106 -1.197 . . . . 0.0 110.106 -178.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 88' ' ' ILE . . . . . 0.576 HD13 HG22 ' B' ' 82' ' ' VAL . 3.4 tp -103.25 118.54 50.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 121.493 0.663 . . . . 0.0 112.639 -178.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -133.52 -83.54 0.46 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.261 -0.882 . . . . 0.0 108.876 178.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 90' ' ' LEU . . . . . 0.632 HD11 ' HB2' ' B' ' 116' ' ' CYS . 38.0 tp 176.85 -51.79 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.94 179.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 91' ' ' PRO . . . . . 0.868 ' HB2' ' HA3' ' A' ' 53' ' ' GLY . 4.0 Cg_exo -38.93 -60.99 0.43 Allowed 'Trans proline' 0 C--N 1.363 1.334 0 C-N-CA 123.66 2.907 . . . . 0.0 114.587 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 92' ' ' CYS . . . . . 0.699 ' HB3' ' O ' ' A' ' 52' ' ' HIS . 24.5 p -83.15 -33.02 26.34 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -178.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 93' ' ' VAL . . . . . 0.433 ' H ' HG23 ' B' ' 93' ' ' VAL . 1.8 t -59.24 -21.44 20.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.881 -178.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 94' ' ' LEU . . . . . 0.834 HD22 ' HB ' ' B' ' 115' ' ' VAL . 15.9 tp -63.17 -35.19 79.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.654 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.35 -28.91 70.09 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . 0.485 ' HB3' ' HB2' ' B' ' 81' ' ' ALA . . . -103.58 10.0 37.17 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.93 0.395 . . . . 0.0 111.375 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 97' ' ' LEU . . . . . 1.016 HD13 HD13 ' B' ' 78' ' ' ILE . 40.9 tp -93.81 -28.89 15.63 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.571 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 81.4 tttt . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.472 179.693 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.68 0 N-CA-C 110.892 -0.04 . . . . 0.0 110.892 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 104' ' ' ALA . . . . . 0.759 ' HB1' ' HB3' ' B' ' 121' ' ' LEU . . . 70.51 -59.69 0.52 Allowed 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 178.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 12.8 p -50.07 -43.84 51.49 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -178.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 106' ' ' CYS . . . . . 0.484 ' HB3' ' HB3' ' B' ' 74' ' ' CYS . 0.0 OUTLIER -52.35 -45.71 65.81 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.108 0.48 . . . . 0.0 111.711 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . 0.696 ' CD2' HG12 ' B' ' 78' ' ' ILE . 20.3 t80 -75.57 -60.88 2.11 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.339 -179.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 108' ' ' CYS . . . . . 0.65 ' HA ' ' HB2' ' B' ' 111' ' ' HIS . 38.1 m -78.84 43.54 0.5 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -178.103 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -74.99 -52.39 11.24 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -102.84 12.84 35.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.894 0.854 . . . . 0.0 108.737 178.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 111' ' ' HIS . . . . . 0.65 ' HB2' ' HA ' ' B' ' 108' ' ' CYS . 89.4 m-70 -119.68 58.45 0.89 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.684 -179.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 72.0 m -110.61 61.73 0.61 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.02 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 113' ' ' HIS . . . . . 0.554 ' CD2' ' SG ' ' A' ' 24' ' ' CYS . 0.2 OUTLIER -138.24 -15.68 1.27 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.219 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 114' ' ' GLY . . . . . 0.418 ' O ' ' HG3' ' B' ' 117' ' ' LYS . . . -120.17 -145.08 7.34 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 119.8 -1.19 . . . . 0.0 113.86 -179.124 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . 0.834 ' HB ' HD22 ' B' ' 94' ' ' LEU . 20.2 m -46.16 -28.76 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -179.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 116' ' ' CYS . . . . . 0.632 ' HB2' HD11 ' B' ' 90' ' ' LEU . 2.8 t -71.23 -39.3 71.78 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -177.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 117' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' B' ' 114' ' ' GLY . 0.0 OUTLIER -77.28 -14.72 59.7 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.214 -179.949 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 118' ' ' ASP . . . . . 0.416 ' N ' ' HD3' ' B' ' 117' ' ' LYS . 12.3 t70 -70.0 -37.61 75.75 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.653 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 89.0 mt -94.89 6.95 47.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.417 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 56.5 m170 60.36 69.02 0.72 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.341 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 121' ' ' LEU . . . . . 0.759 ' HB3' ' HB1' ' B' ' 104' ' ' ALA . 98.3 mt -112.7 3.19 16.42 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 122' ' ' CYS . . . . . . . . . . . . . 25.3 p . . . . . 0 C--O 1.246 0.906 0 CA-C-O 118.028 -0.986 . . . . 0.0 109.874 178.078 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.914 ' HB3' HD12 ' A' ' 17' ' ' ILE . 24.0 m . . . . . 0 N--CA 1.467 0.401 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.67 -66.92 0.49 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.65 38.32 0.19 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -147.46 -52.02 0.2 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.102 0.477 . . . . 0.0 110.497 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.914 HD12 ' HB3' ' A' ' 13' ' ' CYS . 5.3 mt -83.81 -46.8 18.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.343 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.22 -20.09 60.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.137 0.494 . . . . 0.0 109.838 177.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -82.01 -34.94 22.81 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 111.291 -0.724 . . . . 0.0 111.291 178.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.91 -26.71 68.72 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 121.085 0.469 . . . . 0.0 110.881 179.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 17' ' ' ILE . 57.0 t -63.76 -45.24 97.8 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.299 179.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.42 -18.99 62.31 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.461 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.14 -47.07 15.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.775 0.322 . . . . 0.0 111.844 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.7 t -88.33 -15.31 36.03 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.93 -179.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 108.51 -63.15 0.28 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.216 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -122.53 155.36 17.0 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.334 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -86.38 141.89 13.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.06 0.457 . . . . 0.0 111.15 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.528 ' H ' HG21 ' A' ' 32' ' ' VAL . 26.6 t70 -163.97 -98.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 178.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.791 HD11 ' SG ' ' A' ' 55' ' ' CYS . 32.8 tp -174.07 -55.32 0.0 OUTLIER Pre-proline 0 C--O 1.222 -0.363 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 178.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.571 ' HA ' HG11 ' A' ' 54' ' ' VAL . 3.4 Cg_endo -47.74 -61.71 0.56 Allowed 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 122.786 2.324 . . . . 0.0 114.262 -178.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 13.0 p -76.6 -33.11 58.43 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.459 -178.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.528 HG21 ' H ' ' A' ' 28' ' ' ASP . 13.0 t -63.09 -26.22 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.727 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.578 ' HG ' HG22 ' A' ' 54' ' ' VAL . 3.1 tm? -55.56 -38.59 69.52 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.767 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -57.45 -41.92 81.46 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.284 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -98.35 12.28 35.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.263 0.554 . . . . 0.0 110.743 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.447 HD21 ' SG ' ' A' ' 47' ' ' CYS . 46.5 tp -99.34 -61.91 1.31 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.654 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.437 ' HB2' ' HE2' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -110.16 167.24 10.33 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.372 0.606 . . . . 0.0 111.539 -179.28 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -172.56 -112.05 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' A' ' 40' ' ' GLU . . . -92.26 73.08 5.37 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 176.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.405 ' HB2' ' O ' ' A' ' 39' ' ' ALA . 93.0 mt-10 71.22 92.16 0.09 Allowed 'General case' 0 N--CA 1.464 0.272 0 O-C-N 124.084 0.865 . . . . 0.0 109.707 -177.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -115.43 -173.73 17.67 Favored Glycine 0 C--N 1.33 0.209 0 C-N-CA 120.556 -0.831 . . . . 0.0 113.063 -179.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.423 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 57.3 m -82.56 62.41 6.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.751 0.31 . . . . 0.0 111.714 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -96.56 -7.59 34.1 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.809 0.338 . . . . 0.0 110.829 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.4 m -81.54 -16.27 52.24 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.886 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.423 ' SG ' ' HB3' ' A' ' 42' ' ' CYS . 6.3 p -98.48 -33.47 11.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.296 0.569 . . . . 0.0 111.131 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.736 ' HB2' ' CD1' ' A' ' 17' ' ' ILE . 0.9 OUTLIER -86.13 -60.99 1.85 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.665 -178.511 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.447 ' SG ' HD21 ' A' ' 36' ' ' LEU . 4.5 m -72.61 14.08 0.3 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.637 -177.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -51.84 -74.98 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 121.179 0.514 . . . . 0.0 110.457 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -84.86 -27.01 27.01 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 53.7 m-70 -86.71 56.58 4.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.019 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.403 ' O ' ' HB2' ' A' ' 56' ' ' LYS . 7.6 t -108.37 39.62 1.94 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.243 0.544 . . . . 0.0 110.126 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.607 ' CD2' ' HB2' ' B' ' 89' ' ' ASP . 7.8 p-80 -117.82 -12.91 10.14 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.55 -179.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.529 ' HA3' HD23 ' A' ' 29' ' ' LEU . . . -95.32 -136.14 8.46 Favored Glycine 0 C--O 1.228 -0.226 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.812 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.578 HG22 ' HG ' ' A' ' 33' ' ' LEU . 2.2 p -70.19 -16.11 19.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 120.747 0.308 . . . . 0.0 111.561 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.791 ' SG ' HD11 ' A' ' 29' ' ' LEU . 89.2 m -72.21 -21.17 61.45 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.603 0.716 . . . . 0.0 109.112 176.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.519 ' HB3' ' O ' ' A' ' 53' ' ' GLY . 22.7 tptm -79.6 -20.38 47.04 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.474 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -59.44 -50.25 74.65 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.291 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.512 HD23 ' O ' ' A' ' 58' ' ' LEU . 5.7 tt -83.26 -29.37 28.47 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 9.6 t-160 64.26 55.86 1.4 Allowed 'General case' 0 C--O 1.235 0.301 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.04 179.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.52 20.4 16.13 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.473 179.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.244 0.805 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.541 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 74' ' ' CYS . . . . . 0.734 ' O ' ' HB ' ' B' ' 78' ' ' ILE . 8.5 p . . . . . 0 N--CA 1.475 0.818 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -88.87 -3.14 58.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.741 0.305 . . . . 0.0 110.86 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -98.74 22.76 9.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.214 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -163.58 -38.17 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.378 0.608 . . . . 0.0 110.285 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.734 ' HB ' ' O ' ' B' ' 74' ' ' CYS . 1.4 mt -83.66 -46.69 18.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.741 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.8 -29.27 68.41 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.883 0.373 . . . . 0.0 110.682 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.4 -35.71 28.79 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.045 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . 0.416 ' CB ' HG13 ' B' ' 93' ' ' VAL . . . -69.61 -26.57 64.5 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.181 0.515 . . . . 0.0 110.626 179.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 82' ' ' VAL . . . . . 0.498 HG23 ' O ' ' B' ' 78' ' ' ILE . 25.5 t -65.82 -43.14 93.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.567 178.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.38 -27.4 67.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.063 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.05 -44.57 46.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.651 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 73.0 m -83.43 -11.83 57.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.762 0.315 . . . . 0.0 110.725 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.3 42.6 10.34 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.605 -0.807 . . . . 0.0 113.171 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.05 176.71 14.51 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.56 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 7.4 tp -74.87 132.93 32.54 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 CA-C-O 121.388 0.613 . . . . 0.0 110.191 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 89' ' ' ASP . . . . . 0.607 ' HB2' ' CD2' ' A' ' 52' ' ' HIS . 32.5 t70 -152.9 -133.85 0.05 OUTLIER 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.479 -178.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 90' ' ' LEU . . . . . 0.874 HD11 ' HB2' ' B' ' 116' ' ' CYS . 31.9 tp 179.61 -57.4 0.0 OUTLIER Pre-proline 0 C--N 1.317 -0.826 0 C-N-CA 123.804 0.841 . . . . 0.0 110.129 179.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 91' ' ' PRO . . . . . 0.727 ' HD3' ' HB3' ' B' ' 90' ' ' LEU . 74.2 Cg_exo -51.77 -38.63 67.49 Favored 'Trans proline' 0 C--N 1.363 1.321 0 C-N-CA 122.347 2.031 . . . . 0.0 112.225 179.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 9.4 t -88.83 -40.43 13.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.676 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 93' ' ' VAL . . . . . 0.508 HG11 ' HE2' ' B' ' 107' ' ' PHE . 7.3 t -66.6 -23.4 31.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.779 -179.204 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 94' ' ' LEU . . . . . 0.586 ' HG ' HG22 ' B' ' 115' ' ' VAL . 2.7 tm? -50.35 -38.76 43.81 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 123.19 0.596 . . . . 0.0 111.929 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -42.67 -51.32 5.3 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -179.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -108.79 21.66 16.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.021 0.438 . . . . 0.0 111.07 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 97' ' ' LEU . . . . . 0.467 ' HB3' ' HA ' ' B' ' 94' ' ' LEU . 32.4 tp -105.25 -49.31 3.49 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.476 -179.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . 0.525 ' HG2' HD13 ' B' ' 94' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.275 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -178.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 103' ' ' CYS . . . . . 0.454 ' HA ' ' HB3' ' B' ' 74' ' ' CYS . 58.5 m . . . . . 0 N--CA 1.451 -0.415 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -66.65 -16.24 64.06 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.445 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 19.8 m -72.95 -39.45 66.17 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.623 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 13.4 p -63.6 -24.77 67.93 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 122.077 0.941 . . . . 0.0 109.679 179.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . 0.648 ' HB2' HD13 ' B' ' 78' ' ' ILE . 0.8 OUTLIER -88.81 -69.94 0.68 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.099 -1.41 . . . . 0.0 111.959 -178.87 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 108' ' ' CYS . . . . . 0.401 ' O ' ' HB2' ' B' ' 112' ' ' CYS . 82.5 m -74.27 28.42 0.08 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -177.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -53.69 -69.73 0.11 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.17 0.51 . . . . 0.0 110.266 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -89.93 -35.16 15.74 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -79.51 70.71 6.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.763 179.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 112' ' ' CYS . . . . . 0.401 ' HB2' ' O ' ' B' ' 108' ' ' CYS . 13.0 t -127.46 54.68 1.65 Allowed 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.924 -178.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 113' ' ' HIS . . . . . 0.428 ' HE1' ' HB3' ' A' ' 28' ' ' ASP . 0.1 OUTLIER -129.95 -12.38 4.2 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -179.843 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -94.69 -142.95 13.15 Favored Glycine 0 C--O 1.228 -0.272 0 C-N-CA 120.442 -0.885 . . . . 0.0 113.333 -179.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . 0.706 HG11 ' HA ' ' B' ' 91' ' ' PRO . 14.6 p -62.86 -15.46 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-O 121.142 0.496 . . . . 0.0 111.605 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 116' ' ' CYS . . . . . 0.874 ' HB2' HD11 ' B' ' 90' ' ' LEU . 6.8 t -76.19 -22.83 54.84 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.408 0.623 . . . . 0.0 109.76 178.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 117' ' ' LYS . . . . . 0.463 ' O ' ' HG3' ' B' ' 117' ' ' LYS . 13.5 tptt -79.16 -19.33 51.25 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.134 179.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -57.01 -41.55 78.69 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.2 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 119' ' ' LEU . . . . . 0.525 HD22 HD23 ' B' ' 121' ' ' LEU . 5.7 tt -86.19 -29.58 23.09 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 65.51 75.03 0.36 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.721 179.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 121' ' ' LEU . . . . . 0.525 HD23 HD22 ' B' ' 119' ' ' LEU . 0.4 OUTLIER -124.33 7.59 8.42 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.586 -0.733 . . . . 0.0 111.522 -179.701 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 122' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.244 0.803 0 CA-C-O 118.545 -0.741 . . . . 0.0 110.461 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.882 ' HB2' HD12 ' A' ' 17' ' ' ILE . 8.4 p . . . . . 0 N--CA 1.47 0.537 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -112.09 16.45 20.19 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 120.934 0.397 . . . . 0.0 110.547 178.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -91.46 -82.61 0.3 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.028 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.99 -27.72 60.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.945 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.882 HD12 ' HB2' ' A' ' 13' ' ' CYS . 49.2 mt -74.08 -46.84 44.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.69 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' A' ' 14' ' ' ALA . . . -82.18 -15.89 51.64 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.197 179.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -82.79 -33.64 23.92 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.115 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.531 ' HB3' HG13 ' A' ' 32' ' ' VAL . . . -74.28 -13.5 60.78 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.831 0.348 . . . . 0.0 110.914 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 17' ' ' ILE . 78.7 t -64.34 -39.46 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.043 179.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.92 -31.18 67.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.112 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.13 -43.76 66.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.688 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.431 ' HB3' ' CG ' ' B' ' 113' ' ' HIS . 56.6 m -82.42 -19.34 39.21 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.099 -179.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.14 59.1 3.01 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 -179.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 122.0 156.63 9.75 Favored Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -177.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.516 HG12 ' N ' ' A' ' 28' ' ' ASP . 5.0 tt -98.87 147.08 7.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 118.125 0.963 . . . . 0.0 112.484 -178.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.516 ' N ' HG12 ' A' ' 27' ' ' ILE . 34.4 t0 -161.42 -106.13 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.48 -1.236 . . . . 0.0 107.967 179.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.717 HD11 ' HB2' ' A' ' 55' ' ' CYS . 40.2 tp -174.5 -47.94 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 178.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.63 ' HD2' ' H ' ' A' ' 29' ' ' LEU . 11.1 Cg_endo -54.52 -15.3 8.6 Favored 'Trans proline' 0 C--N 1.358 1.031 0 C-N-CA 122.959 2.44 . . . . 0.0 114.593 -178.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.553 ' HB2' ' O ' ' B' ' 113' ' ' HIS . 11.0 t -117.89 -31.72 5.01 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.275 0.56 . . . . 0.0 110.744 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.531 HG13 ' HB3' ' A' ' 20' ' ' ALA . 1.7 t -73.26 -9.17 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-N 115.74 -0.663 . . . . 0.0 112.375 -178.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.781 HD13 ' HB ' ' A' ' 54' ' ' VAL . 1.5 pt? -71.87 -14.82 62.06 Favored 'General case' 0 CA--C 1.531 0.25 0 O-C-N 122.221 -0.299 . . . . 0.0 111.64 -179.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -56.72 -55.09 38.62 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.876 0.37 . . . . 0.0 111.844 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -89.26 16.72 6.91 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.651 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.0 tp -112.69 -0.25 15.12 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.708 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.563 ' HD3' HD21 ' A' ' 58' ' ' LEU . 26.6 ttpt -98.55 154.52 17.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.256 -179.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 71.89 63.12 0.14 Allowed 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.587 0.755 . . . . 0.0 111.607 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -163.39 163.05 25.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.639 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -84.31 70.52 10.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.025 0.44 . . . . 0.0 110.025 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.715 ' HA2' HD22 ' A' ' 60' ' ' LEU . . . 89.34 -111.18 3.8 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.493 -0.861 . . . . 0.0 111.887 -179.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 81.1 m 73.09 -34.93 0.31 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.237 0.615 . . . . 0.0 112.318 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.435 ' HB1' ' SG ' ' A' ' 47' ' ' CYS . . . -79.49 17.16 0.9 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.4 m -66.82 -59.12 3.81 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.768 0.318 . . . . 0.0 110.763 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -66.91 -24.98 66.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.662 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.786 ' HB2' HD13 ' A' ' 17' ' ' ILE . 1.0 OUTLIER -81.4 -72.75 0.41 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.523 -178.948 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.449 ' HB3' ' O ' ' A' ' 50' ' ' HIS . 23.7 m -78.44 39.88 0.34 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.4 -178.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -73.05 -54.23 9.07 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.979 0.895 . . . . 0.0 109.161 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -87.84 -9.31 54.19 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.364 -1.289 . . . . 0.0 109.682 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.449 ' O ' ' HB3' ' A' ' 47' ' ' CYS . 45.4 m-70 -109.98 90.97 3.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.314 -178.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 72.9 m -136.4 55.28 1.85 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.65 ' HB2' ' OD2' ' B' ' 89' ' ' ASP . 40.8 m80 -115.68 -54.73 2.49 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.356 178.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 55' ' ' CYS . . . -134.63 -171.62 12.56 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-O 119.171 -0.794 . . . . 0.0 112.059 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.781 ' HB ' HD13 ' A' ' 33' ' ' LEU . 14.2 m 43.75 -62.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 N-CA-C 115.97 1.841 . . . . 0.0 115.97 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.717 ' HB2' HD11 ' A' ' 29' ' ' LEU . 15.7 t -70.16 -44.56 68.56 Favored 'General case' 0 C--N 1.322 -0.601 0 O-C-N 121.641 -0.662 . . . . 0.0 111.457 -179.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.526 ' HE3' ' HB2' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -81.13 12.68 3.26 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.958 179.403 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -76.94 -27.57 54.89 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 175.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.563 HD21 ' HD3' ' A' ' 37' ' ' LYS . 32.3 mt -98.51 -16.49 19.15 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 113.596 -1.638 . . . . 0.0 108.981 177.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 64.89 82.45 0.19 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.91 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.715 HD22 ' HA2' ' A' ' 41' ' ' GLY . 87.2 mt -125.15 -7.42 7.11 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -178.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 26.3 p . . . . . 0 C--O 1.245 0.836 0 CA-C-O 118.41 -0.805 . . . . 0.0 110.591 178.67 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 74' ' ' CYS . . . . . 0.525 ' HB2' HD12 ' B' ' 78' ' ' ILE . 18.1 p . . . . . 0 N--CA 1.47 0.55 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.97 4.3 23.13 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 120.997 0.427 . . . . 0.0 110.897 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.8 -76.33 0.09 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.426 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . 0.527 ' HB1' ' O ' ' B' ' 96' ' ' ALA . . . -93.85 -10.06 35.22 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -178.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.67 HD13 ' HB2' ' B' ' 107' ' ' PHE . 40.8 mt -89.17 -47.38 15.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.661 -179.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.83 -18.27 38.18 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.923 0.392 . . . . 0.0 111.229 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.8 -25.69 62.05 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.336 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . 0.779 ' HB2' ' HB3' ' B' ' 96' ' ' ALA . . . -82.93 -9.99 59.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.972 0.415 . . . . 0.0 111.027 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 69.2 t -68.31 -37.16 77.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.998 179.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -79.79 10.17 4.41 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.444 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -109.73 -48.2 3.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.968 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 63.1 m -88.94 -9.57 51.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.329 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.78 44.39 6.09 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.686 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 132.6 173.81 13.42 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.056 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 88' ' ' ILE . . . . . 0.519 HG12 ' N ' ' B' ' 89' ' ' ASP . 0.0 OUTLIER -77.05 136.86 23.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.049 0.452 . . . . 0.0 110.936 179.714 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 89' ' ' ASP . . . . . 0.65 ' OD2' ' HB2' ' A' ' 52' ' ' HIS . 40.5 t0 -153.87 -122.96 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.525 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 90' ' ' LEU . . . . . 0.728 ' HB3' ' HD3' ' B' ' 91' ' ' PRO . 41.5 tp 173.02 -57.81 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 124.318 1.047 . . . . 0.0 109.6 179.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 91' ' ' PRO . . . . . 0.728 ' HD3' ' HB3' ' B' ' 90' ' ' LEU . 51.8 Cg_exo -54.19 -25.52 38.34 Favored 'Trans proline' 0 C--N 1.363 1.323 0 C-N-CA 122.684 2.256 . . . . 0.0 112.992 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 29.9 t -107.94 -34.61 6.86 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.18 0.514 . . . . 0.0 110.329 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 93' ' ' VAL . . . . . 0.673 HG13 ' HB3' ' B' ' 81' ' ' ALA . 38.6 t -70.42 -16.62 20.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.821 -179.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 94' ' ' LEU . . . . . 0.793 HD13 ' HB ' ' B' ' 115' ' ' VAL . 1.2 pt? -61.45 -18.02 57.03 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 122.25 -0.281 . . . . 0.0 111.743 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.53 -34.2 73.78 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . 0.779 ' HB3' ' HB2' ' B' ' 81' ' ' ALA . . . -100.64 -3.49 30.27 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.862 0.363 . . . . 0.0 110.643 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 23.6 tp -92.99 3.07 56.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.379 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt . . . . . 0 C--O 1.235 0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.405 179.574 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 79.0 m . . . . . 0 N--CA 1.466 0.347 0 CA-C-O 120.732 0.301 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 104' ' ' ALA . . . . . 0.549 ' HB1' ' HB2' ' B' ' 108' ' ' CYS . . . -102.68 20.38 17.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.409 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -69.36 -31.77 70.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.83 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 4.2 p -101.97 -29.37 11.84 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.255 0.55 . . . . 0.0 110.29 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . 0.67 ' HB2' HD13 ' B' ' 78' ' ' ILE . 1.0 OUTLIER -81.99 -90.86 0.07 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.985 -178.228 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 108' ' ' CYS . . . . . 0.549 ' HB2' ' HB1' ' B' ' 104' ' ' ALA . 36.2 m -70.44 40.99 0.05 Allowed 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 -178.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 109' ' ' GLU . . . . . 0.4 ' HA ' ' OE1' ' B' ' 109' ' ' GLU . 4.9 tp10 -77.23 -53.51 7.65 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.48 0.657 . . . . 0.0 109.455 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -97.96 1.08 47.55 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.744 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 22.4 m-70 -112.33 88.89 2.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.47 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 71.0 m -135.78 46.79 2.31 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 114.665 1.358 . . . . 0.0 114.665 -177.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 113' ' ' HIS . . . . . 0.553 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 2.9 p80 -135.24 -0.46 2.72 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 118.994 -1.082 . . . . 0.0 111.982 177.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 114' ' ' GLY . . . . . 0.453 ' HA3' ' HB2' ' A' ' 30' ' ' PRO . . . -154.64 145.9 13.47 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 119.914 -1.136 . . . . 0.0 112.664 179.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . 0.793 ' HB ' HD13 ' B' ' 94' ' ' LEU . 27.6 m 50.28 -48.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 C-N-CA 126.648 1.979 . . . . 0.0 115.936 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 116' ' ' CYS . . . . . 0.617 ' HB2' HD11 ' B' ' 90' ' ' LEU . 3.9 t -73.84 -25.65 60.18 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 121.543 -0.723 . . . . 0.0 110.094 -179.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 19.3 ttmt -77.58 -22.89 50.25 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.422 178.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -64.2 -40.16 95.5 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 43.1 mt -81.84 -22.6 36.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.14 178.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 64.91 79.89 0.24 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.226 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 86.5 mt -123.82 -6.59 7.94 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -178.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 122' ' ' CYS . . . . . . . . . . . . . 26.1 p . . . . . 0 C--O 1.245 0.818 0 CA-C-O 118.473 -0.775 . . . . 0.0 110.59 179.111 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.747 ' HB2' HD12 ' A' ' 17' ' ' ILE . 11.7 p . . . . . 0 N--CA 1.467 0.394 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.84 -26.85 62.6 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -177.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -109.4 29.03 7.93 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.387 -0.525 . . . . 0.0 112.019 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -151.03 -53.12 0.14 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.222 0.534 . . . . 0.0 110.93 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.747 HD12 ' HB2' ' A' ' 13' ' ' CYS . 73.6 mt -74.69 -42.64 47.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.329 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.79 -30.99 72.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.458 178.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.9 -30.83 37.37 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.649 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.28 -24.18 63.0 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 121.031 0.443 . . . . 0.0 110.381 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 17' ' ' ILE . 49.7 t -65.26 -46.55 90.34 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.669 178.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.69 -18.12 62.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.16 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -81.17 -51.04 8.86 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.165 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 49.1 t -76.01 -33.79 59.69 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.913 0.387 . . . . 0.0 110.132 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.18 36.29 2.54 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.47 -0.872 . . . . 0.0 112.532 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 147.73 152.57 5.71 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.127 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -81.9 132.58 31.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.288 0.566 . . . . 0.0 109.767 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.414 ' HB2' ' NE2' ' B' ' 113' ' ' HIS . 46.8 t0 -158.85 -115.45 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.41 -178.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.661 HD21 ' HB2' ' A' ' 55' ' ' CYS . 35.0 tp -174.95 -57.47 0.0 OUTLIER Pre-proline 0 C--O 1.22 -0.48 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.16 178.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.908 ' HA ' HG11 ' A' ' 54' ' ' VAL . 1.0 OUTLIER -45.42 -52.71 6.3 Favored 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 122.959 2.439 . . . . 0.0 114.117 -178.971 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 19.7 p -84.08 -35.7 23.56 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.087 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.425 HG23 ' H ' ' A' ' 32' ' ' VAL . 3.5 t -63.45 -29.78 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.161 -179.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.425 HD22 HG13 ' A' ' 54' ' ' VAL . 29.9 tp -63.53 -32.28 73.69 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.086 0.469 . . . . 0.0 110.515 179.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.83 -37.55 79.24 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.07 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.53 -9.25 58.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.115 0.484 . . . . 0.0 110.601 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 23.8 tp -76.09 -6.93 53.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.453 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -86.01 5.37 33.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.102 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.66 -4.77 47.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.967 0.413 . . . . 0.0 110.354 178.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -147.17 175.46 10.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.703 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -87.14 120.05 28.01 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.53 0.205 . . . . 0.0 110.866 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.71 -105.79 1.27 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.988 179.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER 64.04 15.72 9.44 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.082 0.553 . . . . 0.0 111.175 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -97.05 -6.81 34.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.048 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 40.7 t -66.12 -9.44 31.4 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.22 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.535 ' HB3' ' HB3' ' A' ' 13' ' ' CYS . 33.6 t -118.95 -31.8 4.66 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.309 0.575 . . . . 0.0 110.151 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.572 ' HB2' ' CD1' ' A' ' 17' ' ' ILE . 0.6 OUTLIER -73.88 -78.55 0.09 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.327 -0.851 . . . . 0.0 113.228 -178.496 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.549 ' HA ' ' HB2' ' A' ' 50' ' ' HIS . 84.9 m -72.99 27.29 0.06 Allowed 'General case' 0 C--O 1.219 -0.505 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -176.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -67.61 -61.82 1.71 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 118.953 0.797 . . . . 0.0 109.762 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -91.14 -7.46 51.49 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.549 ' HB2' ' HA ' ' A' ' 47' ' ' CYS . 62.2 m-70 -107.73 62.24 0.62 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.497 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.517 ' O ' ' HB3' ' A' ' 56' ' ' LYS . 62.6 m -95.95 33.56 1.68 Allowed 'General case' 0 C--N 1.327 -0.393 0 O-C-N 122.031 -0.418 . . . . 0.0 110.908 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.69 ' ND1' ' HB3' ' B' ' 92' ' ' CYS . 27.6 p80 -129.82 157.71 41.47 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.732 0.301 . . . . 0.0 110.782 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.893 ' HA3' ' HB2' ' B' ' 91' ' ' PRO . . . 92.43 -132.99 11.52 Favored Glycine 0 C--O 1.227 -0.34 0 C-N-CA 120.494 -0.86 . . . . 0.0 113.267 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.908 HG11 ' HA ' ' A' ' 30' ' ' PRO . 8.9 p -78.01 -21.74 13.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 122.562 -0.375 . . . . 0.0 111.881 -178.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.661 ' HB2' HD21 ' A' ' 29' ' ' LEU . 7.5 t -77.03 -28.86 55.04 Favored 'General case' 0 C--O 1.224 -0.285 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.747 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.55 ' HG3' ' O ' ' A' ' 53' ' ' GLY . 0.0 OUTLIER -73.96 -31.19 62.91 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.0 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -69.61 -56.33 7.58 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.453 HD22 ' HA ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -94.7 65.6 3.09 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 106.579 -1.638 . . . . 0.0 106.579 176.363 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 20.3 t60 -35.42 124.44 0.64 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 114.238 -1.347 . . . . 0.0 113.968 -176.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 13.7 mt -146.37 21.84 1.34 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.793 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 8.9 p . . . . . 0 C--O 1.245 0.825 0 CA-C-O 118.124 -0.941 . . . . 0.0 110.756 178.425 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 74' ' ' CYS . . . . . 0.928 ' HB3' HD12 ' B' ' 78' ' ' ILE . 21.9 m . . . . . 0 N--CA 1.468 0.473 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -73.23 -59.98 2.45 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -80.46 48.03 0.99 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.945 0.402 . . . . 0.0 111.509 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -162.18 -53.74 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.877 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.928 HD12 ' HB3' ' B' ' 74' ' ' CYS . 51.7 mt -92.94 -49.15 13.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.395 -179.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.48 -19.36 65.53 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.669 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -75.66 -24.32 70.39 Favored Glycine 0 N--CA 1.452 -0.28 0 N-CA-C 111.53 -0.628 . . . . 0.0 111.53 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . 0.83 ' HB2' ' HB3' ' B' ' 96' ' ' ALA . . . -80.94 -30.22 35.28 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.021 0.439 . . . . 0.0 110.469 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 32.0 t -56.76 -40.86 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.904 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.54 -34.62 78.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.543 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.61 -28.23 56.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.997 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 15.7 m -94.15 -14.9 25.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.745 -178.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.67 31.43 60.54 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.246 -178.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 152.46 151.7 5.74 Favored Glycine 0 N--CA 1.449 -0.47 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.76 129.76 55.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.726 0.774 . . . . 0.0 111.786 -178.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 89' ' ' ASP . . . . . 0.666 ' H ' HG21 ' B' ' 93' ' ' VAL . 28.4 m-20 -144.8 -82.73 0.15 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.462 -1.245 . . . . 0.0 108.526 178.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 90' ' ' LEU . . . . . 0.688 HD11 ' HB2' ' B' ' 116' ' ' CYS . 51.9 tp 179.44 -54.38 0.0 OUTLIER Pre-proline 0 C--O 1.227 -0.13 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.292 178.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 91' ' ' PRO . . . . . 0.893 ' HB2' ' HA3' ' A' ' 53' ' ' GLY . 4.9 Cg_exo -38.53 -65.94 0.15 Allowed 'Trans proline' 0 C--N 1.361 1.225 0 C-N-CA 123.487 2.792 . . . . 0.0 114.31 -179.014 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 92' ' ' CYS . . . . . 0.69 ' HB3' ' ND1' ' A' ' 52' ' ' HIS . 1.5 t -82.04 -31.42 30.93 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -179.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 93' ' ' VAL . . . . . 0.666 HG21 ' H ' ' B' ' 89' ' ' ASP . 1.5 t -64.81 -16.31 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-O 120.804 0.335 . . . . 0.0 111.761 -179.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 94' ' ' LEU . . . . . 0.564 HD22 HG13 ' B' ' 115' ' ' VAL . 22.7 tp -73.5 -19.12 61.01 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.859 0.361 . . . . 0.0 111.008 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.07 -53.21 60.84 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.114 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . 0.83 ' HB3' ' HB2' ' B' ' 81' ' ' ALA . . . -75.96 -14.15 60.24 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 111.617 0.228 . . . . 0.0 111.617 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 97' ' ' LEU . . . . . 0.423 HD23 HD12 ' B' ' 94' ' ' LEU . 17.6 tp -72.69 -28.74 62.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.979 0.419 . . . . 0.0 110.051 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp . . . . . 0 C--N 1.332 -0.195 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.216 178.881 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 36.3 m . . . . . 0 N--CA 1.465 0.286 0 CA-C-O 121.407 0.623 . . . . 0.0 110.502 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 104' ' ' ALA . . . . . 0.729 ' HB1' ' HB2' ' B' ' 108' ' ' CYS . . . -95.63 -6.55 39.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.451 -179.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 26.6 p -63.26 -20.3 65.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.998 0.428 . . . . 0.0 111.797 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 24.7 p -106.8 -29.2 9.67 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.294 0.569 . . . . 0.0 111.101 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . 0.77 ' HB2' HD13 ' B' ' 78' ' ' ILE . 1.0 OUTLIER -100.88 -79.72 0.5 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -177.518 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 108' ' ' CYS . . . . . 0.729 ' HB2' ' HB1' ' B' ' 104' ' ' ALA . 1.8 m -67.45 24.19 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -177.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -81.36 -68.31 0.7 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 118.583 0.629 . . . . 0.0 109.715 178.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -73.36 -15.02 61.39 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 177.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 111' ' ' HIS . . . . . 0.447 ' HB3' HD22 ' B' ' 90' ' ' LEU . 61.3 m-70 -110.07 65.88 0.62 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.421 -1.263 . . . . 0.0 107.973 178.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 36.6 t -106.45 49.46 0.8 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.95 0.405 . . . . 0.0 111.757 -177.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 113' ' ' HIS . . . . . 0.483 ' HA ' ' HG2' ' B' ' 117' ' ' LYS . 18.1 p-80 -156.55 -165.74 1.96 Allowed 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . 64.64 -137.73 39.69 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.977 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . 0.564 HG13 HD22 ' B' ' 94' ' ' LEU . 11.3 p -79.66 -16.71 13.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.814 0.34 . . . . 0.0 111.076 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 116' ' ' CYS . . . . . 0.688 ' HB2' HD11 ' B' ' 90' ' ' LEU . 2.1 t -57.92 -59.75 4.77 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 120.808 0.337 . . . . 0.0 110.716 178.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 117' ' ' LYS . . . . . 0.483 ' HG2' ' HA ' ' B' ' 113' ' ' HIS . 45.3 pttt -101.4 31.94 3.52 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.742 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 118' ' ' ASP . . . . . 0.475 ' HB2' ' HA ' ' B' ' 115' ' ' VAL . 10.3 t70 -54.44 -39.16 67.11 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 178.146 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 119' ' ' LEU . . . . . 0.608 ' O ' ' HB2' ' B' ' 120' ' ' HIS . 3.3 mm? -103.32 -52.66 2.97 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 174.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 120' ' ' HIS . . . . . 0.608 ' HB2' ' O ' ' B' ' 119' ' ' LEU . 42.3 t60 153.6 129.26 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.862 0 O-C-N 124.951 1.407 . . . . 0.0 110.422 176.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 121' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' B' ' 120' ' ' HIS . 14.4 mt -160.33 41.26 0.18 Allowed 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 122' ' ' CYS . . . . . 0.426 ' HB3' ' O ' ' B' ' 108' ' ' CYS . 1.4 p . . . . . 0 C--O 1.246 0.9 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.711 178.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 13.0 p . . . . . 0 CA--C 1.528 0.101 0 CA-C-O 120.836 0.35 . . . . 0.0 111.409 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.676 ' HA ' HG22 ' A' ' 17' ' ' ILE . . . -64.85 -19.49 65.91 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.228 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.09 0.82 23.2 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -132.19 -22.48 2.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.777 0.322 . . . . 0.0 111.76 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.676 HG22 ' HA ' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -92.93 -44.58 13.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.945 0.403 . . . . 0.0 111.484 -178.923 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.18 -32.38 66.39 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.769 -178.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.98 -24.04 74.86 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.313 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.798 ' HB2' ' HB3' ' A' ' 35' ' ' ALA . . . -83.92 -24.79 30.6 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 120.821 0.343 . . . . 0.0 111.039 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 17' ' ' ILE . 86.8 t -66.36 -46.65 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.551 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.34 -28.38 65.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.462 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -75.84 -44.9 38.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 112.061 -179.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.8 t -84.87 -37.28 20.84 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.729 0.299 . . . . 0.0 110.869 -179.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.99 48.9 1.3 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.405 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 143.67 -179.51 21.03 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.217 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.547 HD13 HD11 ' A' ' 17' ' ' ILE . 6.0 tp -113.23 117.23 54.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.489 0.661 . . . . 0.0 111.988 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.63 ' H ' HG21 ' A' ' 32' ' ' VAL . 30.6 t0 -134.28 -108.89 0.22 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.784 ' HG ' HG22 ' A' ' 54' ' ' VAL . 41.0 tp -175.01 -57.03 0.0 OUTLIER Pre-proline 0 C--O 1.223 -0.326 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.291 178.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.717 ' HA ' HG21 ' A' ' 54' ' ' VAL . 2.3 Cg_endo -46.24 -60.18 0.95 Allowed 'Trans proline' 0 C--N 1.361 1.231 0 C-N-CA 123.005 2.47 . . . . 0.0 114.357 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 19.9 p -79.41 -33.84 42.29 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.655 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.63 HG21 ' H ' ' A' ' 28' ' ' ASP . 2.4 t -67.1 -17.62 22.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.552 -179.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 30.0 tp -64.26 -26.13 68.36 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.495 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.37 -59.73 4.2 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -178.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.798 ' HB3' ' HB2' ' A' ' 20' ' ' ALA . . . -75.15 -17.0 60.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.747 0.308 . . . . 0.0 111.791 -179.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.507 HD22 ' CD2' ' A' ' 46' ' ' PHE . 32.8 tp -75.16 -10.33 59.37 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.931 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -74.4 93.13 2.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.894 0.378 . . . . 0.0 110.363 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -111.22 -5.55 14.69 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.698 -179.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 72.69 -61.92 0.48 Allowed 'General case' 0 N--CA 1.473 0.694 0 O-C-N 123.989 0.806 . . . . 0.0 113.02 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -60.67 -69.11 0.24 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.834 0.35 . . . . 0.0 111.826 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 42' ' ' CYS . . . -156.16 -139.63 2.79 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.146 -1.026 . . . . 0.0 112.779 -179.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 41' ' ' GLY . 96.5 m 73.17 8.81 5.31 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.16 0.584 . . . . 0.0 111.197 -179.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -95.51 -21.76 18.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.869 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.7 p -79.89 11.51 3.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.488 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 46.8 t -109.65 -62.29 1.52 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.536 ' O ' ' HD2' ' A' ' 50' ' ' HIS . 0.8 OUTLIER -67.48 -59.28 3.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.713 178.697 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.622 ' HA ' ' HB2' ' A' ' 50' ' ' HIS . 87.9 m -74.6 15.54 0.35 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -55.86 -52.55 63.67 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.334 0.587 . . . . 0.0 110.386 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -94.79 -20.07 19.8 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.914 178.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.622 ' HB2' ' HA ' ' A' ' 47' ' ' CYS . 70.0 m-70 -98.56 72.56 2.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.443 -179.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 97.0 m -92.16 -2.16 56.73 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -178.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 1.015 ' HA ' ' HB3' ' A' ' 56' ' ' LYS . 9.6 p80 -117.2 -160.16 0.76 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 119.808 -0.757 . . . . 0.0 111.112 179.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 68.47 -130.99 26.58 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.571 -0.823 . . . . 0.0 111.794 -178.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.784 HG22 ' HG ' ' A' ' 29' ' ' LEU . 30.0 m -75.97 -18.99 15.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.858 0.329 . . . . 0.0 111.633 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.499 ' HB2' HD11 ' A' ' 29' ' ' LEU . 1.4 t -82.57 -23.29 34.53 Favored 'General case' 0 C--O 1.216 -0.691 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.184 -179.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 1.015 ' HB3' ' HA ' ' A' ' 52' ' ' HIS . 0.0 OUTLIER -77.58 -13.39 59.92 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.352 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -90.45 -59.86 2.07 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.749 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 20.6 tp -80.12 -75.58 0.25 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.592 0.234 . . . . 0.0 111.316 -179.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 58.1 m-70 -90.28 -129.5 0.09 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 60' ' ' LEU . 8.1 tp -169.83 -87.56 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 177.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.592 ' HB3' ' O ' ' A' ' 47' ' ' CYS . 1.8 p . . . . . 0 C--O 1.245 0.82 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.651 178.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 31.7 p . . . . . 0 CA--C 1.515 -0.404 0 N-CA-C 111.634 0.235 . . . . 0.0 111.634 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 75' ' ' ALA . . . . . 0.476 ' HA ' HG22 ' B' ' 78' ' ' ILE . . . -59.21 -35.66 74.0 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 123.253 0.345 . . . . 0.0 111.209 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -74.11 -0.53 16.87 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . 0.463 ' O ' ' HA ' ' B' ' 97' ' ' LEU . . . -124.66 -12.73 7.13 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.539 HG13 ' CD2' ' B' ' 107' ' ' PHE . 0.0 OUTLIER -106.5 -46.54 8.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.097 0.475 . . . . 0.0 110.91 -179.238 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -56.91 -23.47 45.17 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.947 -179.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -75.39 -25.26 68.62 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.403 -0.904 . . . . 0.0 112.151 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -82.21 -16.9 48.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.763 0.316 . . . . 0.0 111.348 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 82' ' ' VAL . . . . . 0.401 HG22 HD13 ' B' ' 88' ' ' ILE . 59.6 t -62.46 -45.78 97.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-O 121.033 0.444 . . . . 0.0 110.77 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.87 -31.19 70.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.473 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.19 -36.27 79.3 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.516 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 26.6 m -92.99 -12.27 31.1 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 69.55 42.27 73.2 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.488 -0.863 . . . . 0.0 111.319 -178.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 151.81 137.66 2.65 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 88' ' ' ILE . . . . . 0.401 HD13 HG22 ' B' ' 82' ' ' VAL . 2.9 tp -91.23 114.1 27.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.34 0.59 . . . . 0.0 111.944 -179.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 89' ' ' ASP . . . . . 0.588 ' H ' HG21 ' B' ' 93' ' ' VAL . 0.9 OUTLIER -130.44 -91.91 0.44 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.641 179.038 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 90' ' ' LEU . . . . . 0.456 ' HG ' ' CG2' ' B' ' 115' ' ' VAL . 10.8 tp 175.93 -54.4 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.481 0 C-N-CA 123.484 0.714 . . . . 0.0 110.357 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 91' ' ' PRO . . . . . 0.85 ' HA ' HG21 ' B' ' 115' ' ' VAL . 60.9 Cg_exo -35.67 -63.11 0.2 Allowed 'Trans proline' 0 C--N 1.365 1.438 0 C-N-CA 123.492 2.795 . . . . 0.0 115.009 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 29.3 p -90.94 -31.32 16.42 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -178.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 93' ' ' VAL . . . . . 0.588 HG21 ' H ' ' B' ' 89' ' ' ASP . 3.2 t -57.58 -29.5 34.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.079 0.466 . . . . 0.0 111.561 -179.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 5.5 tp -62.46 -33.46 74.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.834 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.92 -15.16 54.39 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -177.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -129.07 20.81 5.83 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.667 0.618 . . . . 0.0 112.667 -179.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 97' ' ' LEU . . . . . 0.53 ' HG ' ' O ' ' B' ' 97' ' ' LEU . 0.0 OUTLIER -106.21 -9.12 17.02 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.431 179.827 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 60.4 tttm . . . . . 0 N--CA 1.47 0.532 0 O-C-N 123.994 0.809 . . . . 0.0 112.044 -179.457 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 5.5 m . . . . . 0 N--CA 1.466 0.342 0 CA-C-O 120.657 0.265 . . . . 0.0 111.28 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -112.07 -9.48 13.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.038 0.447 . . . . 0.0 110.215 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 8.4 p -79.18 -17.89 54.05 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.603 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 4.0 p -78.3 -62.02 1.82 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.287 0.565 . . . . 0.0 110.511 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . 0.539 ' CD2' HG13 ' B' ' 78' ' ' ILE . 0.9 OUTLIER -61.62 -61.03 2.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.168 -0.923 . . . . 0.0 110.75 -179.839 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 108' ' ' CYS . . . . . 0.749 ' O ' ' HB3' ' B' ' 122' ' ' CYS . 61.0 m -90.11 54.12 2.71 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.9 -179.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -74.24 -62.89 1.36 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.204 0.526 . . . . 0.0 110.125 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -86.13 -8.74 57.64 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 111' ' ' HIS . . . . . 0.701 ' O ' ' HB3' ' B' ' 108' ' ' CYS . 3.5 m-70 -106.99 88.26 2.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.554 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 90.3 m -114.48 37.66 3.33 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.381 -0.528 . . . . 0.0 112.101 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 113' ' ' HIS . . . . . 0.74 ' HA ' ' HB3' ' B' ' 117' ' ' LYS . 2.1 p80 -144.38 -149.69 0.29 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 110.202 -0.295 . . . . 0.0 110.202 178.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 114' ' ' GLY . . . . . 0.458 ' HA3' ' HG2' ' A' ' 30' ' ' PRO . . . 58.04 -106.37 0.8 Allowed Glycine 0 C--N 1.332 0.34 0 C-N-CA 121.205 -0.522 . . . . 0.0 112.973 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . 0.85 HG21 ' HA ' ' B' ' 91' ' ' PRO . 5.4 m -106.36 -23.76 4.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.582 0.23 . . . . 0.0 111.064 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 116' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -76.22 1.83 14.83 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 121.274 0.559 . . . . 0.0 110.966 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 117' ' ' LYS . . . . . 0.74 ' HB3' ' HA ' ' B' ' 113' ' ' HIS . 0.1 OUTLIER -100.27 -3.2 31.88 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.181 178.058 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -102.48 110.58 22.56 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.219 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 39.7 tp 77.55 -51.48 0.53 Allowed 'General case' 0 N--CA 1.474 0.729 0 O-C-N 124.108 0.88 . . . . 0.0 110.666 -178.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 -94.82 169.06 10.42 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 11.4 tp -167.95 64.79 0.07 Allowed 'General case' 0 C--O 1.233 0.203 0 C-N-CA 120.068 -0.653 . . . . 0.0 112.542 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 122' ' ' CYS . . . . . 0.749 ' HB3' ' O ' ' B' ' 108' ' ' CYS . 0.8 OUTLIER . . . . . 0 C--O 1.248 0.996 0 O-C-N 124.043 0.839 . . . . 0.0 113.162 179.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.599 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 18.9 m . . . . . 0 N--CA 1.468 0.47 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -89.88 28.38 1.37 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -108.39 -94.81 0.4 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.807 0.337 . . . . 0.0 110.997 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.16 -0.21 16.02 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.642 HD13 ' HB2' ' A' ' 46' ' ' PHE . 60.5 mt -107.99 -61.64 2.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.787 -0.188 . . . . 0.0 111.206 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.58 -31.36 71.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.999 0.428 . . . . 0.0 110.535 179.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.33 -20.48 72.11 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.638 179.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.3 -22.63 51.71 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.161 0.505 . . . . 0.0 110.016 179.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 75.3 t -64.55 -44.19 96.82 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.594 178.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.78 -16.44 61.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.349 179.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.88 -44.38 32.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.121 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.517 ' SG ' ' HB2' ' B' ' 113' ' ' HIS . 24.8 t -85.67 -28.98 24.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.032 0.444 . . . . 0.0 110.831 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 103.52 38.14 2.87 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.432 -0.89 . . . . 0.0 112.198 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 145.62 165.68 11.47 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.916 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.9 tp -95.81 109.59 22.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.256 0.551 . . . . 0.0 110.362 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.732 ' C ' ' HD2' ' A' ' 30' ' ' PRO . 15.9 p-10 -128.73 -50.3 1.25 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 118.963 -0.541 . . . . 0.0 111.27 -179.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.664 ' HB3' ' O ' ' A' ' 28' ' ' ASP . 17.0 tp 107.14 -54.39 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 124.913 1.383 . . . . 0.0 111.794 -179.034 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.851 ' HA ' HG21 ' A' ' 54' ' ' VAL . 10.6 Cg_endo -53.75 -36.55 82.5 Favored 'Trans proline' 0 C--N 1.364 1.38 0 C-N-CA 122.325 2.017 . . . . 0.0 112.869 179.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 2.4 t -93.9 -36.43 12.21 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.109 0.48 . . . . 0.0 110.711 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.588 HG23 ' OD1' ' A' ' 28' ' ' ASP . 94.0 t -64.25 -25.93 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.359 -179.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.418 HD23 HG21 ' A' ' 54' ' ' VAL . 2.9 pp -57.69 -33.27 68.2 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.789 0.328 . . . . 0.0 111.139 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.61 -38.13 62.65 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.67 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.28 -13.46 60.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.47 -179.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -93.11 -41.54 9.89 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.362 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.9 ttmm 55.1 77.42 0.22 Allowed 'General case' 0 N--CA 1.47 0.546 0 O-C-N 123.464 0.478 . . . . 0.0 110.281 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -99.59 138.44 36.67 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.117 0.485 . . . . 0.0 111.972 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -115.71 -99.96 0.44 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.3 178.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -86.42 78.28 9.29 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.463 0.649 . . . . 0.0 110.23 178.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 102.77 -128.94 9.71 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.482 -179.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 3.9 m 70.29 -57.49 0.57 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.336 0.654 . . . . 0.0 111.657 179.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -87.7 13.63 10.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.529 0.204 . . . . 0.0 111.116 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.24 -44.89 96.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.863 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 8.0 p -80.01 -32.5 39.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.17 0.51 . . . . 0.0 110.514 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.642 ' HB2' HD13 ' A' ' 17' ' ' ILE . 0.9 OUTLIER -59.68 -61.12 2.86 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.554 -179.801 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 62.6 m -80.32 52.59 1.62 Allowed 'General case' 0 C--O 1.211 -0.94 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.137 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -78.3 -59.58 2.72 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -101.08 -13.3 18.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.239 179.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -96.88 76.21 2.73 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.198 -0.91 . . . . 0.0 108.955 179.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 88.9 m -117.7 19.64 13.76 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -177.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 9.0 p-80 -123.31 -20.98 5.48 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 119.439 -0.904 . . . . 0.0 113.192 -179.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.493 ' HA3' ' HG2' ' B' ' 91' ' ' PRO . . . -106.21 119.57 6.06 Favored Glycine 0 C--O 1.221 -0.682 0 C-N-CA 120.034 -1.079 . . . . 0.0 112.606 179.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.851 HG21 ' HA ' ' A' ' 30' ' ' PRO . 14.3 m 54.54 -33.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 13.4 t -72.87 -37.75 67.23 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 121.471 -0.768 . . . . 0.0 110.938 -178.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 35.7 tttp -67.29 -8.62 33.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.703 179.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -71.97 -22.86 61.38 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 178.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.4 mp -114.4 -21.56 10.31 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.854 178.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 67.18 87.51 0.12 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.05 0.54 . . . . 0.0 111.059 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.7 mt -125.31 19.58 8.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.707 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 10.6 p . . . . . 0 C--O 1.245 0.817 0 CA-C-O 118.063 -0.97 . . . . 0.0 109.786 179.385 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 74' ' ' CYS . . . . . 0.942 ' HB3' HD12 ' B' ' 78' ' ' ILE . 51.6 m . . . . . 0 N--CA 1.465 0.322 0 CA-C-O 120.608 0.242 . . . . 0.0 111.564 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -90.45 -43.24 10.4 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -178.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.89 -66.55 0.53 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -177.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.89 10.48 2.78 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -177.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.942 HD12 ' HB3' ' B' ' 74' ' ' CYS . 20.8 mt -130.8 -55.37 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 O-C-N 121.778 -0.576 . . . . 0.0 111.432 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.78 -36.22 70.28 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.282 178.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -75.53 -23.7 72.41 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.281 178.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.63 -22.59 63.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.029 0.442 . . . . 0.0 110.693 179.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 54.7 t -65.84 -38.83 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.574 179.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -76.52 -13.98 60.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.805 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.53 -35.01 30.85 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.519 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 54.0 t -92.61 -40.26 10.87 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 121.005 -0.278 . . . . 0.0 111.508 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.02 37.27 1.54 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.502 -0.856 . . . . 0.0 111.628 -179.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 158.4 167.11 18.77 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 121.028 -0.606 . . . . 0.0 111.687 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 3.1 tp -102.48 123.45 55.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.915 0.388 . . . . 0.0 111.363 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 89' ' ' ASP . . . . . 0.49 ' CG ' ' H ' ' B' ' 90' ' ' LEU . 9.9 p-10 -163.7 -111.89 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.581 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 90' ' ' LEU . . . . . 0.682 ' HG ' HG22 ' B' ' 115' ' ' VAL . 37.1 tp -179.32 -49.99 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.404 0 C-N-CA 123.843 0.857 . . . . 0.0 110.454 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 91' ' ' PRO . . . . . 0.719 ' HG3' ' HD3' ' A' ' 30' ' ' PRO . 5.4 Cg_endo -46.9 -34.28 15.98 Favored 'Trans proline' 0 C--N 1.366 1.465 0 C-N-CA 123.39 2.727 . . . . 0.0 114.575 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 15.2 p -108.64 -27.99 9.52 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.161 0.505 . . . . 0.0 110.755 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 48.2 t -60.67 -20.15 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.705 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 94' ' ' LEU . . . . . 0.64 HD12 ' N ' ' B' ' 95' ' ' ALA . 0.8 OUTLIER -53.77 -24.33 14.8 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 179.953 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . 0.64 ' N ' HD12 ' B' ' 94' ' ' LEU . . . -60.5 -55.36 34.36 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -178.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -82.75 -21.57 34.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.783 0.325 . . . . 0.0 110.705 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 97' ' ' LEU . . . . . 0.429 ' HB3' ' HA ' ' B' ' 94' ' ' LEU . 44.1 tp -62.22 -51.83 66.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.292 178.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 51.1 tttm . . . . . 0 N--CA 1.465 0.277 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.697 177.957 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 39.9 m . . . . . 0 N--CA 1.469 0.525 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -79.37 -9.66 59.64 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 54.4 p -52.46 -52.43 54.22 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 4.8 p -62.37 -30.49 71.22 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.031 0.444 . . . . 0.0 111.179 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . 0.445 ' HB2' HD11 ' B' ' 78' ' ' ILE . 0.5 OUTLIER -69.18 -56.7 6.84 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.31 -179.189 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 108' ' ' CYS . . . . . 0.623 ' SG ' ' HB3' ' B' ' 122' ' ' CYS . 0.8 OUTLIER -79.57 18.21 0.77 Allowed 'General case' 0 CA--C 1.514 -0.407 0 C-N-CA 120.631 -0.427 . . . . 0.0 111.973 179.914 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -55.22 -65.11 0.64 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.378 0.609 . . . . 0.0 110.201 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -89.13 -10.36 47.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.254 178.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 47.3 m-70 -110.69 64.95 0.61 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.928 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 1.7 m -91.2 39.54 1.0 Allowed 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 112.046 0.388 . . . . 0.0 112.046 -178.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 113' ' ' HIS . . . . . 0.517 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 14.1 p-80 -143.22 -15.39 0.68 Allowed 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.341 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -77.25 -159.97 11.4 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.762 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . 0.682 HG22 ' HG ' ' B' ' 90' ' ' LEU . 24.4 m -64.39 -4.96 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -179.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 116' ' ' CYS . . . . . 0.512 ' SG ' ' HB2' ' B' ' 121' ' ' LEU . 7.0 t -78.77 -23.45 45.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.685 0.755 . . . . 0.0 109.115 178.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 4.0 ttmt -81.79 -7.57 59.61 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.146 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -65.01 -31.92 73.39 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 16.6 tp -114.23 -8.13 12.95 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.188 178.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 66.51 79.52 0.24 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.024 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 121' ' ' LEU . . . . . 0.512 ' HB2' ' SG ' ' B' ' 116' ' ' CYS . 96.6 mt -116.5 4.64 13.29 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 122' ' ' CYS . . . . . 0.623 ' HB3' ' SG ' ' B' ' 108' ' ' CYS . 21.2 p . . . . . 0 C--O 1.248 0.977 0 CA-C-O 118.177 -0.915 . . . . 0.0 109.335 178.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.807 ' HA ' HD12 ' A' ' 17' ' ' ILE . 26.7 m . . . . . 0 C--O 1.227 -0.099 0 CA-C-O 120.941 0.401 . . . . 0.0 111.122 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.591 ' HA ' ' HB3' ' A' ' 18' ' ' ALA . . . -106.56 -13.99 15.17 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.789 0.328 . . . . 0.0 111.261 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -88.23 -69.27 0.71 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.669 ' HB1' ' HA ' ' A' ' 36' ' ' LEU . . . -88.87 2.87 53.01 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.807 HD12 ' HA ' ' A' ' 13' ' ' CYS . 66.9 mt -119.0 -64.79 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 121.218 -0.193 . . . . 0.0 110.932 -179.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.591 ' HB3' ' HA ' ' A' ' 14' ' ' ALA . . . -68.27 -26.68 65.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.126 0.489 . . . . 0.0 110.057 178.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -87.47 10.35 69.77 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 178.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -125.12 -2.21 7.65 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 122.801 0.44 . . . . 0.0 110.456 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.566 HG13 ' HA2' ' A' ' 26' ' ' GLY . 64.3 t -66.5 -43.51 90.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.22 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.19 -4.57 30.09 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -84.17 -13.87 51.64 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -149.03 40.85 0.89 Allowed 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.47 -48.27 2.52 Favored Glycine 0 C--O 1.227 -0.336 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.882 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.566 ' HA2' HG13 ' A' ' 21' ' ' VAL . . . -168.57 176.49 42.88 Favored Glycine 0 N--CA 1.442 -0.907 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.44 HG23 HG22 ' A' ' 21' ' ' VAL . 0.9 OUTLIER -49.86 110.83 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.607 0.718 . . . . 0.0 112.18 179.972 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.645 ' HB3' HG23 ' A' ' 32' ' ' VAL . 49.2 t0 -121.47 -118.82 0.3 Allowed 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.805 HD11 ' HB2' ' A' ' 55' ' ' CYS . 16.1 tp 173.01 -57.94 0.0 OUTLIER Pre-proline 0 C--O 1.223 -0.296 0 O-C-N 123.612 0.57 . . . . 0.0 111.429 178.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.722 ' HD3' ' HB3' ' A' ' 29' ' ' LEU . 54.3 Cg_exo -52.06 -49.21 18.1 Favored 'Trans proline' 0 C--N 1.358 1.048 0 C-N-CA 122.268 1.979 . . . . 0.0 113.225 -179.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 25.5 p -92.42 -35.15 13.83 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.238 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.645 HG23 ' HB3' ' A' ' 28' ' ' ASP . 65.4 t -65.06 -18.92 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.241 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 25.9 tp -57.93 -25.78 61.36 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.893 178.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.05 -41.13 99.42 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.648 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -86.36 -8.87 57.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.971 0.415 . . . . 0.0 111.057 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.669 ' HA ' ' HB1' ' A' ' 16' ' ' ALA . 33.5 tp -89.17 62.11 6.05 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 178.356 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.647 ' HD3' ' H ' ' A' ' 37' ' ' LYS . 0.3 OUTLIER -75.27 45.08 0.27 Allowed 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -177.1 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.61 156.83 16.61 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 122.189 -0.319 . . . . 0.0 110.386 178.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.416 ' HA ' HD21 ' A' ' 58' ' ' LEU . . . -115.23 -40.97 3.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.983 0.421 . . . . 0.0 110.583 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -93.53 -169.1 2.04 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.069 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -75.31 56.65 2.83 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 121.015 -0.612 . . . . 0.0 113.851 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 19.7 m -97.66 5.0 49.94 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 122.466 -0.432 . . . . 0.0 110.396 179.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.581 ' HB2' HD11 ' A' ' 36' ' ' LEU . . . -126.07 16.56 7.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.193 179.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.567 ' O ' ' HG2' ' A' ' 48' ' ' GLU . 5.9 m -61.86 -32.08 72.4 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.704 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 12.7 p -66.25 -26.74 67.5 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.124 0.488 . . . . 0.0 111.058 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.772 ' HB2' HD13 ' A' ' 17' ' ' ILE . 1.0 OUTLIER -93.29 -63.89 1.16 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.843 -178.67 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.493 ' HA ' ' HB2' ' A' ' 50' ' ' HIS . 72.9 m -82.84 45.44 1.0 Allowed 'General case' 0 C--O 1.217 -0.621 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -177.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.567 ' HG2' ' O ' ' A' ' 44' ' ' SER . 0.9 OUTLIER -72.81 -71.15 0.31 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 119.147 0.885 . . . . 0.0 110.401 179.406 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -78.36 -5.92 53.66 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.493 ' HB2' ' HA ' ' A' ' 47' ' ' CYS . 36.2 m-70 -104.29 66.17 0.81 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.924 -179.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.414 ' O ' ' HD2' ' A' ' 56' ' ' LYS . 72.4 m -120.41 50.08 1.36 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 178.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.436 ' HB3' ' SG ' ' B' ' 85' ' ' CYS . 13.1 m80 -96.92 -77.01 0.5 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.594 0.712 . . . . 0.0 110.185 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 55' ' ' CYS . . . -120.86 -174.99 15.15 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 179.05 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.646 HG11 ' HA ' ' A' ' 30' ' ' PRO . 9.3 m 47.02 -64.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.805 ' HB2' HD11 ' A' ' 29' ' ' LEU . 8.8 t -64.78 -48.89 72.84 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 121.664 -0.647 . . . . 0.0 111.836 -178.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.414 ' HD2' ' O ' ' A' ' 51' ' ' CYS . 17.0 ptmt -75.23 -2.01 26.02 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 119.42 -0.912 . . . . 0.0 111.296 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -65.97 -35.52 80.8 Favored 'General case' 0 N--CA 1.461 0.114 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 177.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.483 HD22 HD22 ' A' ' 60' ' ' LEU . 7.9 tt -90.26 -33.13 16.26 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 114.58 -1.191 . . . . 0.0 108.011 177.366 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 22.5 t-160 77.25 86.6 0.08 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.274 178.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.541 ' N ' HD23 ' A' ' 60' ' ' LEU . 0.7 OUTLIER -140.57 25.45 2.19 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -179.932 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 6.0 p . . . . . 0 C--O 1.244 0.791 0 CA-C-O 118.17 -0.919 . . . . 0.0 109.856 176.853 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 74' ' ' CYS . . . . . 0.615 ' HA ' HD12 ' B' ' 78' ' ' ILE . 13.0 p . . . . . 0 CA--C 1.521 -0.137 0 CA-C-O 120.85 0.357 . . . . 0.0 111.285 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -115.61 13.16 16.26 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 120.906 0.384 . . . . 0.0 110.661 178.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -128.48 -76.36 0.56 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.391 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.45 -39.44 90.84 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.884 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.881 HD13 ' HB2' ' B' ' 107' ' ' PHE . 13.5 mt -74.01 -41.2 52.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.03 0.443 . . . . 0.0 110.995 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.53 -32.75 71.77 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.161 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.63 -35.64 9.18 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.872 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.25 -26.51 61.14 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -178.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 82' ' ' VAL . . . . . 0.46 ' CG1' HG22 ' B' ' 88' ' ' ILE . 3.2 t -66.76 -50.51 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.298 179.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.34 -26.11 67.13 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.006 0.431 . . . . 0.0 111.34 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.69 -25.14 64.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.033 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 85' ' ' CYS . . . . . 0.436 ' SG ' ' HB3' ' A' ' 52' ' ' HIS . 1.5 t -88.92 -22.62 23.01 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.962 -179.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 99.66 43.99 2.38 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.166 -1.016 . . . . 0.0 113.804 179.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 114.87 52.01 0.44 Allowed Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.05 -1.072 . . . . 0.0 113.893 178.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 88' ' ' ILE . . . . . 0.479 ' O ' ' HB2' ' B' ' 89' ' ' ASP . 0.5 OUTLIER 56.04 174.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 124.29 1.036 . . . . 0.0 113.184 179.142 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 89' ' ' ASP . . . . . 0.59 ' CG ' ' HD2' ' B' ' 91' ' ' PRO . 39.2 t0 170.41 -124.62 0.0 OUTLIER 'General case' 0 C--O 1.233 0.212 0 CA-C-N 114.348 -1.296 . . . . 0.0 108.403 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 90' ' ' LEU . . . . . 0.801 HD11 ' SG ' ' B' ' 116' ' ' CYS . 21.1 tp 172.46 -58.5 0.0 OUTLIER Pre-proline 0 C--N 1.324 -0.542 0 C-N-CA 124.364 1.066 . . . . 0.0 109.34 178.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 91' ' ' PRO . . . . . 1.008 ' HA ' HG11 ' B' ' 115' ' ' VAL . 50.8 Cg_exo -54.07 -43.25 59.99 Favored 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 122.031 1.821 . . . . 0.0 112.281 179.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 24.7 p -79.85 -35.82 37.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.055 0.455 . . . . 0.0 110.87 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 93' ' ' VAL . . . . . 0.443 HG23 ' HB3' ' B' ' 89' ' ' ASP . 5.8 t -71.02 -25.4 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.481 -178.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 94' ' ' LEU . . . . . 0.554 HD22 ' HB ' ' B' ' 115' ' ' VAL . 30.8 tp -60.16 -28.33 67.83 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 120.828 0.347 . . . . 0.0 110.934 -179.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.86 -36.62 81.76 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.408 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -99.37 9.86 42.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.297 0.57 . . . . 0.0 110.089 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 97' ' ' LEU . . . . . 0.514 HD21 ' HB1' ' B' ' 104' ' ' ALA . 24.3 tp -107.55 68.24 0.71 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.167 -0.924 . . . . 0.0 108.708 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . 0.413 ' NZ ' ' HB2' ' B' ' 98' ' ' LYS . 8.1 mtmp? . . . . . 0 N--CA 1.468 0.469 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.426 -178.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 79.4 m . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 120.976 0.417 . . . . 0.0 109.932 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 104' ' ' ALA . . . . . 0.514 ' HB1' HD21 ' B' ' 97' ' ' LEU . . . -109.74 -25.63 10.28 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.843 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 22.0 p -60.58 -25.93 66.57 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.754 0.312 . . . . 0.0 111.21 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 106' ' ' CYS . . . . . 0.497 ' HB3' ' HB3' ' B' ' 74' ' ' CYS . 43.5 t -60.33 -18.73 51.81 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.382 0.611 . . . . 0.0 110.389 178.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . 0.881 ' HB2' HD13 ' B' ' 78' ' ' ILE . 0.6 OUTLIER -104.16 -65.06 1.05 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.519 -179.535 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 108' ' ' CYS . . . . . 0.444 ' HB2' ' HB3' ' B' ' 122' ' ' CYS . 0.0 OUTLIER -73.69 15.77 0.25 Allowed 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -178.504 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -37.49 -73.23 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.181 0.592 . . . . 0.0 112.364 -178.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -98.71 -33.91 10.74 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -70.63 87.07 0.66 Allowed 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 112' ' ' CYS . . . . . 0.596 ' HB3' ' HG2' ' B' ' 117' ' ' LYS . 0.5 OUTLIER -154.21 136.63 14.99 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -178.622 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 113' ' ' HIS . . . . . 0.426 ' CD2' ' HB2' ' A' ' 28' ' ' ASP . 1.5 t60 -153.22 -49.63 0.1 Allowed 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 178.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 114' ' ' GLY . . . . . 0.405 ' HA3' ' HB2' ' A' ' 30' ' ' PRO . . . -127.14 -159.38 10.14 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 177.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . 1.008 HG11 ' HA ' ' B' ' 91' ' ' PRO . 0.4 OUTLIER 41.45 -86.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 123.903 0.881 . . . . 0.0 113.31 179.644 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 116' ' ' CYS . . . . . 0.801 ' SG ' HD11 ' B' ' 90' ' ' LEU . 36.5 m -61.36 -33.13 73.13 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 118.431 0.56 . . . . 0.0 109.831 178.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 117' ' ' LYS . . . . . 0.596 ' HG2' ' HB3' ' B' ' 112' ' ' CYS . 3.9 mmmm -77.53 -21.0 53.31 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.244 178.469 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -62.38 -47.86 82.28 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 7.9 tt -79.77 -29.28 40.39 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 177.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 8.5 t-160 76.01 67.67 0.06 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.529 178.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -126.81 8.97 6.91 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 122' ' ' CYS . . . . . 0.444 ' HB3' ' HB2' ' B' ' 108' ' ' CYS . 0.8 OUTLIER . . . . . 0 C--O 1.245 0.852 0 CA-C-O 118.173 -0.918 . . . . 0.0 110.208 178.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 120.704 0.288 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 51.7 mtt -107.67 116.75 32.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.505 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -162.36 45.95 0.35 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 119.836 -1.174 . . . . 0.0 113.63 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.437 ' O ' ' HD2' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -71.3 99.72 1.99 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.113 0.482 . . . . 0.0 110.261 178.911 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.469 ' H ' ' CB ' ' A' ' 40' ' ' GLU . 13.9 t 63.07 56.6 1.75 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.216 -178.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.0 t -94.35 -159.01 0.67 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.401 -178.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.713 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 0.2 OUTLIER -90.31 -173.76 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.545 -178.588 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.713 ' HG ' ' O ' ' A' ' 7' ' ' VAL . 2.8 pp 62.17 -59.36 0.12 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.582 1.553 . . . . 0.0 113.358 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.425 ' N ' HD12 ' A' ' 8' ' ' LEU . 19.7 ptmt -87.08 17.9 3.94 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 121.817 -0.552 . . . . 0.0 110.481 179.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.477 ' HB2' ' HB3' ' A' ' 43' ' ' ALA . 19.1 pttp -76.97 -8.85 58.12 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.225 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.427 ' C ' ' H ' ' A' ' 13' ' ' CYS . 2.5 t -78.83 -3.96 6.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.938 179.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.69 7.03 4.13 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.672 0.748 . . . . 0.0 109.65 177.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.687 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 1.3 p -58.23 -35.3 71.48 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.072 179.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.49 28.3 0.08 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.409 ' H ' ' C ' ' A' ' 13' ' ' CYS . . . -138.38 -64.34 0.53 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.929 0.395 . . . . 0.0 110.27 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.42 -43.83 47.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.943 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.838 HD13 ' HB2' ' A' ' 46' ' ' PHE . 10.6 mt -70.28 -38.2 73.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.117 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.1 -39.01 88.33 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.823 178.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.6 -31.52 44.93 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.966 -0.635 . . . . 0.0 111.886 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.59 -28.84 61.09 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.302 0.573 . . . . 0.0 110.293 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.724 HG13 ' H ' ' A' ' 27' ' ' ILE . 1.2 t -68.3 -37.36 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.235 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.82 -6.27 40.35 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.616 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.84 -2.33 58.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.491 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.6 t -147.05 55.23 1.1 Allowed 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.977 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.38 -53.41 4.21 Favored Glycine 0 N--CA 1.455 -0.088 0 C-N-CA 121.2 -0.524 . . . . 0.0 113.936 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.695 ' HA2' HG13 ' A' ' 21' ' ' VAL . . . 131.79 116.66 1.8 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.969 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.724 ' H ' HG13 ' A' ' 21' ' ' VAL . 43.9 mm 72.83 78.62 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.505 -0.773 0 CA-C-O 122.787 1.279 . . . . 0.0 111.58 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.705 ' OD2' ' HB3' ' A' ' 31' ' ' CYS . 40.1 t0 -148.63 161.61 41.37 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-N 112.683 -2.053 . . . . 0.0 107.298 177.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.613 ' HB3' ' HD3' ' A' ' 30' ' ' PRO . 36.0 tp -126.12 -52.63 0.03 OUTLIER Pre-proline 0 C--N 1.296 -1.729 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.026 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.838 ' HB3' HG13 ' B' ' 115' ' ' VAL . 47.2 Cg_exo -54.84 -41.7 75.76 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 121.907 1.738 . . . . 0.0 112.632 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.705 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 5.6 t -85.82 -38.96 17.59 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.187 -178.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.675 HG23 ' HB3' ' A' ' 28' ' ' ASP . 93.0 t -73.44 -16.23 17.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.799 HD22 ' HB ' ' A' ' 54' ' ' VAL . 44.8 tp -55.27 -31.08 61.28 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -56.67 -37.05 70.28 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -104.44 4.37 33.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.808 0.337 . . . . 0.0 111.112 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 52.3 tp -85.87 -25.55 26.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.869 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.82 46.47 1.18 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.451 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -136.59 134.87 37.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.802 -0.181 . . . . 0.0 111.336 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 65.37 -165.54 0.23 Allowed 'General case' 0 N--CA 1.468 0.474 0 O-C-N 123.968 0.793 . . . . 0.0 111.838 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.469 ' CB ' ' H ' ' A' ' 5' ' ' CYS . 6.0 pt-20 -124.14 53.88 1.38 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.189 0.518 . . . . 0.0 112.005 -179.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -134.39 52.54 0.81 Allowed Glycine 0 CA--C 1.517 0.17 0 C-N-CA 121.062 -0.589 . . . . 0.0 111.881 178.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -127.09 -104.74 0.33 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.733 -0.234 . . . . 0.0 111.089 -179.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.477 ' HB3' ' HB2' ' A' ' 10' ' ' LYS . . . 57.99 -154.1 0.36 Allowed 'General case' 0 C--O 1.239 0.503 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 178.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.8 p -66.82 32.88 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -176.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 43.8 t -107.87 -31.56 7.96 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 176.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.838 ' HB2' HD13 ' A' ' 17' ' ' ILE . 1.1 t80 -103.52 -65.53 1.0 Allowed 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.299 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.456 ' HA ' ' HB2' ' A' ' 50' ' ' HIS . 7.6 m -75.77 23.6 0.13 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -177.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.582 ' OE1' ' HA ' ' A' ' 48' ' ' GLU . 7.3 tp10 -69.1 -68.02 0.43 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.95 0.405 . . . . 0.0 110.581 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -79.79 -14.49 58.66 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.564 ' HD2' ' O ' ' A' ' 46' ' ' PHE . 85.2 m-70 -100.44 63.43 1.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.669 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -115.02 68.42 0.7 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.876 0.37 . . . . 0.0 110.595 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -107.82 -64.07 1.25 Allowed 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.276 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.508 ' HA3' ' HB2' ' B' ' 92' ' ' CYS . . . -134.12 -107.54 0.98 Allowed Glycine 0 C--O 1.219 -0.835 0 C-N-CA 120.031 -1.08 . . . . 0.0 113.799 -178.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.799 ' HB ' HD22 ' A' ' 33' ' ' LEU . 2.9 m -12.51 -67.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 N-CA-C 116.496 2.036 . . . . 0.0 116.496 -178.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.595 ' H ' HG23 ' A' ' 54' ' ' VAL . 32.4 t -73.38 -39.79 64.84 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -177.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.7 tttm -63.46 -24.75 67.96 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.02 0.438 . . . . 0.0 109.941 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -62.18 -32.68 73.33 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.213 178.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 60.5 mt -94.36 -4.69 48.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.44 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 66.2 t-80 64.79 84.04 0.16 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.851 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.503 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 8.1 mp -126.98 27.35 5.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.026 178.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.903 0 CA-C-O 118.213 -0.898 . . . . 0.0 109.462 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.082 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -96.73 70.76 2.55 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.189 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -149.08 78.11 0.23 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 119.861 -1.161 . . . . 0.0 113.743 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -88.04 125.11 34.38 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' CYS . . . . . . . . . . . . . 43.9 t 55.91 52.86 10.01 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.322 0.582 . . . . 0.0 109.778 -178.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 9.9 p -105.27 169.37 8.49 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.579 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 14.8 t -75.5 85.78 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.577 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.428 ' C ' ' H ' ' B' ' 71' ' ' LYS . 42.4 tp -178.45 -53.21 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -87.5 31.52 0.74 Allowed 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . 0.428 ' H ' ' C ' ' B' ' 69' ' ' LEU . 3.1 tmmm? -71.34 -30.28 66.0 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 113.957 -1.474 . . . . 0.0 110.215 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 12.5 t -62.88 -24.77 36.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.275 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.61 11.04 1.43 Allowed 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' CYS . . . . . 1.114 ' HB2' HD12 ' B' ' 78' ' ' ILE . 31.2 p -73.56 -15.08 61.3 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.788 0.327 . . . . 0.0 111.305 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' ALA . . . . . 0.45 ' O ' ' HB3' ' B' ' 79' ' ' ALA . . . -69.53 -6.34 30.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.89 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -102.25 -47.91 4.36 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.65 -41.42 13.4 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -178.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 1.114 HD12 ' HB2' ' B' ' 74' ' ' CYS . 84.3 mt -76.27 -43.01 37.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.646 0.26 . . . . 0.0 110.713 -179.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' B' ' 75' ' ' ALA . . . -78.74 -16.99 56.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.925 0.393 . . . . 0.0 110.906 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -86.62 -34.29 11.92 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.591 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.69 -19.58 65.19 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.652 0.263 . . . . 0.0 111.354 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 77.4 t -62.13 -54.75 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.121 178.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.41 -26.47 65.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.225 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.54 -40.89 96.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.84 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 7.2 t -110.75 25.38 11.84 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.411 -0.516 . . . . 0.0 111.668 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.73 -51.48 4.58 Favored Glycine 0 CA--C 1.518 0.245 0 N-CA-C 114.858 0.703 . . . . 0.0 114.858 178.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . -138.25 -177.4 15.24 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.036 -1.078 . . . . 0.0 113.837 -178.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 3.9 tp -102.11 137.0 31.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.217 0.532 . . . . 0.0 111.187 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 89' ' ' ASP . . . . . 0.428 ' H ' HG21 ' B' ' 93' ' ' VAL . 38.9 t0 -171.2 -104.64 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 90' ' ' LEU . . . . . 0.675 HD21 ' HB2' ' B' ' 116' ' ' CYS . 56.0 tp -176.16 -50.61 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.388 0 CA-C-O 119.476 -0.297 . . . . 0.0 111.494 178.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 91' ' ' PRO . . . . . 0.625 ' HD2' ' N ' ' B' ' 90' ' ' LEU . 3.4 Cg_exo -40.73 -39.83 3.23 Favored 'Trans proline' 0 C--N 1.364 1.344 0 C-N-CA 124.051 3.167 . . . . 0.0 114.67 -179.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 92' ' ' CYS . . . . . 0.508 ' HB2' ' HA3' ' A' ' 53' ' ' GLY . 19.6 t -113.16 -14.8 12.86 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.067 0.461 . . . . 0.0 111.726 -178.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . 0.428 HG21 ' H ' ' B' ' 89' ' ' ASP . 12.3 t -72.62 -17.68 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.395 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 94' ' ' LEU . . . . . 0.954 HD22 ' HB ' ' B' ' 115' ' ' VAL . 23.8 tp -62.22 -35.58 79.34 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.46 -54.89 26.33 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 -178.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -87.38 7.97 26.6 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 97' ' ' LEU . . . . . 0.495 HD23 HD12 ' B' ' 94' ' ' LEU . 59.8 tp -79.0 -31.02 44.63 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.288 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . 0.641 ' HE3' HD11 ' B' ' 119' ' ' LEU . 39.0 ttmt -88.53 66.92 8.39 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.551 0.691 . . . . 0.0 110.743 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -104.99 64.53 0.72 Allowed 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . 77.03 -66.69 0.24 Allowed 'General case' 0 N--CA 1.467 0.414 0 O-C-N 124.439 1.087 . . . . 0.0 109.074 -176.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -160.71 -138.19 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.761 177.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . 0.584 ' O ' ' HA ' ' B' ' 74' ' ' CYS . . . 73.8 25.05 72.87 Favored Glycine 0 N--CA 1.453 -0.18 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.068 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 103' ' ' CYS . . . . . 0.826 ' HB2' HD21 ' B' ' 121' ' ' LEU . 0.5 OUTLIER -106.55 -84.73 0.51 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.559 0.219 . . . . 0.0 110.49 -179.737 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 104' ' ' ALA . . . . . 0.415 ' HB3' ' HA ' ' B' ' 71' ' ' LYS . . . 53.87 -155.24 0.23 Allowed 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 178.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.66 33.97 0.05 Allowed 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 115.18 -0.918 . . . . 0.0 113.47 -178.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 38.8 t -105.86 -28.68 10.47 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 177.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . 0.57 ' HB2' HD11 ' B' ' 78' ' ' ILE . 0.0 OUTLIER -123.48 162.4 22.94 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 113.94 -1.482 . . . . 0.0 107.055 176.24 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 66.9 m 68.2 -3.94 1.17 Allowed 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -62.08 -85.41 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 118.563 0.62 . . . . 0.0 111.043 179.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -86.62 -7.96 57.89 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 178.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -101.16 36.17 2.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.324 -1.307 . . . . 0.0 111.158 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.79 63.77 3.37 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 113' ' ' HIS . . . . . 0.484 ' NE2' ' HB2' ' A' ' 28' ' ' ASP . 9.5 t-160 -122.57 -54.48 1.86 Allowed 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.549 -178.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 114' ' ' GLY . . . . . 0.548 ' O ' ' HG3' ' B' ' 117' ' ' LYS . . . -84.01 -137.24 3.37 Favored Glycine 0 C--O 1.227 -0.295 0 C-N-CA 120.511 -0.852 . . . . 0.0 113.452 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . 0.954 ' HB ' HD22 ' B' ' 94' ' ' LEU . 16.8 m -58.96 -10.76 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 116' ' ' CYS . . . . . 0.675 ' HB2' HD21 ' B' ' 90' ' ' LEU . 0.0 OUTLIER -65.21 -32.0 73.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.707 0.289 . . . . 0.0 111.469 -179.714 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 117' ' ' LYS . . . . . 0.548 ' HG3' ' O ' ' B' ' 114' ' ' GLY . 0.3 OUTLIER -87.23 -26.21 23.61 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.272 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.2 -42.62 96.54 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.5 178.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 119' ' ' LEU . . . . . 0.641 HD11 ' HE3' ' B' ' 98' ' ' LYS . 1.8 tt -101.41 63.13 0.96 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 176.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 65.0 t-80 -20.38 114.57 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 113.732 -1.576 . . . . 0.0 114.725 -176.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 121' ' ' LEU . . . . . 0.826 HD21 ' HB2' ' B' ' 103' ' ' CYS . 1.0 OUTLIER -134.03 -33.46 1.03 Allowed 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.451 -1.25 . . . . 0.0 109.293 178.372 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 122' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.247 0.923 0 CA-C-O 118.405 -0.807 . . . . 0.0 109.94 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.307 0 CA-C-O 120.553 0.216 . . . . 0.0 110.618 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -75.18 95.39 3.11 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 97.76 -135.51 12.23 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.236 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.2 mtpp 58.73 -112.23 0.61 Allowed 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 122.624 0.37 . . . . 0.0 110.63 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 8.7 m -108.77 7.48 26.32 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 45.1 t -66.67 104.59 1.33 Allowed 'General case' 0 C--O 1.224 -0.27 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 32.8 t -45.44 -60.44 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -177.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 44.2 tp -64.47 -38.13 89.96 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 36.2 mtpt -88.95 27.15 1.39 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.661 0.743 . . . . 0.0 111.529 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.4 tptm -137.55 38.87 2.44 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.8 t 55.77 44.04 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.749 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 55.91 46.17 22.59 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.352 -178.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 17.0 p 52.51 12.24 0.23 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.201 1.401 . . . . 0.0 113.956 -178.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.07 178.12 7.01 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 178.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 72.2 -50.35 0.7 Allowed 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.692 0.62 . . . . 0.0 110.161 -178.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.07 -34.34 73.06 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.586 HG12 ' CD1' ' A' ' 46' ' ' PHE . 6.2 tp -89.43 -58.36 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-O 121.022 0.439 . . . . 0.0 110.607 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.489 ' H ' HG23 ' A' ' 17' ' ' ILE . . . -54.75 -34.12 62.11 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.231 -0.895 . . . . 0.0 112.024 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.31 -27.94 50.35 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.231 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.24 -15.83 59.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.845 0.355 . . . . 0.0 110.838 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 17' ' ' ILE . 66.9 t -63.57 -40.46 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.483 179.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.32 -18.65 63.09 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.889 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -72.32 -35.24 68.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.835 0.35 . . . . 0.0 111.442 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.537 ' HB3' ' CG ' ' B' ' 113' ' ' HIS . 71.0 m -99.48 -29.29 12.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.685 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.32 80.02 1.47 Allowed Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.249 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.85 166.08 16.72 Favored Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.407 ' O ' HG23 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -105.94 96.91 4.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.922 0.868 . . . . 0.0 111.283 -179.626 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.649 ' HB2' ' CE1' ' B' ' 113' ' ' HIS . 33.5 m-20 -115.81 -105.72 0.39 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.685 ' HB3' ' HD3' ' A' ' 30' ' ' PRO . 60.2 tp -177.86 -53.7 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.362 0 N-CA-C 111.911 0.338 . . . . 0.0 111.911 178.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.695 ' HA ' HG21 ' A' ' 54' ' ' VAL . 15.2 Cg_exo -70.9 49.07 0.9 Allowed 'Trans proline' 0 C--N 1.362 1.25 0 C-N-CA 122.97 2.447 . . . . 0.0 114.624 -178.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.594 ' HB2' ' O ' ' B' ' 113' ' ' HIS . 50.5 t -168.29 -49.27 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.8 t -73.91 -29.76 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.679 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -55.66 -45.36 77.71 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.112 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.06 3.88 3.1 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -101.46 -38.78 7.85 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.64 0.257 . . . . 0.0 111.239 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.553 HD23 ' H ' ' A' ' 36' ' ' LEU . 2.5 pt? -104.63 6.33 34.35 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.454 -179.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -62.72 -47.8 82.03 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 119.431 -0.319 . . . . 0.0 111.625 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 45.32 -101.59 0.05 Allowed 'General case' 0 N--CA 1.469 0.494 0 O-C-N 123.812 0.695 . . . . 0.0 111.194 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -99.05 -106.66 0.2 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -145.79 155.06 42.68 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.787 0.327 . . . . 0.0 110.598 178.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.428 ' H ' HD21 ' A' ' 60' ' ' LEU . . . 71.13 37.94 63.64 Favored Glycine 0 C--O 1.229 -0.165 0 C-N-CA 121.101 -0.571 . . . . 0.0 113.516 179.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -126.16 -16.46 5.5 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 122.447 -0.443 . . . . 0.0 111.924 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -109.32 15.36 23.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.931 0.396 . . . . 0.0 111.155 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.5 p -66.4 -53.57 34.34 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.713 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.602 ' O ' ' HG2' ' A' ' 48' ' ' GLU . 1.6 p -55.11 -44.94 75.44 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.725 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.586 ' CD1' HG12 ' A' ' 17' ' ' ILE . 65.2 t80 -63.26 -45.48 91.33 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.591 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.432 ' CB ' ' SG ' ' A' ' 61' ' ' CYS . 98.4 m -94.92 37.98 1.13 Allowed 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -177.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.602 ' HG2' ' O ' ' A' ' 45' ' ' CYS . 62.6 mm-40 -44.69 -76.27 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 118.742 0.701 . . . . 0.0 112.499 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -99.03 -14.04 19.61 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.693 0.758 . . . . 0.0 109.461 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -90.36 68.73 6.91 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.703 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 5.8 t -132.53 60.24 1.7 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.958 -177.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.601 ' ND1' ' HB3' ' B' ' 92' ' ' CYS . 5.8 p80 -131.35 17.69 4.91 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.795 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.625 ' O ' ' HG3' ' A' ' 56' ' ' LYS . . . -128.27 -137.89 4.48 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.485 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.695 HG21 ' HA ' ' A' ' 30' ' ' PRO . 35.6 m -58.98 -17.29 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-O 120.892 0.377 . . . . 0.0 111.807 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.586 ' HB2' HD11 ' A' ' 29' ' ' LEU . 3.9 t -78.54 -36.37 44.81 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.134 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.625 ' HG3' ' O ' ' A' ' 53' ' ' GLY . 0.0 OUTLIER -81.08 -5.57 57.79 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.158 0.504 . . . . 0.0 110.373 179.364 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -66.38 -27.42 67.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.705 178.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.474 ' HB2' HD13 ' A' ' 60' ' ' LEU . 45.0 mt -100.6 -19.15 16.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.502 179.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 66.4 78.03 0.27 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.669 0.788 . . . . 0.0 111.021 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.474 HD13 ' HB2' ' A' ' 58' ' ' LEU . 11.0 mp -123.48 -20.81 5.46 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.398 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.432 ' SG ' ' CB ' ' A' ' 47' ' ' CYS . 0.6 OUTLIER . . . . . 0 C--O 1.246 0.873 0 CA-C-O 118.391 -0.814 . . . . 0.0 111.511 -177.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.273 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' MET . . . . . . . . . . . . . 2.2 tmt? -129.12 132.97 47.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.865 0.364 . . . . 0.0 111.508 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 97.06 -116.83 5.6 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.585 -0.817 . . . . 0.0 114.17 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp 64.95 -109.09 0.18 Allowed 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 122.895 0.478 . . . . 0.0 109.996 -177.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' CYS . . . . . . . . . . . . . 3.2 t -167.03 91.36 0.4 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.771 0.32 . . . . 0.0 110.443 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.467 ' HB3' ' HB2' ' B' ' 70' ' ' LYS . 33.7 t -124.56 164.74 19.16 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.192 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 21.8 t -98.52 -56.55 5.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.922 0.391 . . . . 0.0 110.726 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 52.5 tp -67.11 -47.44 71.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.236 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 70' ' ' LYS . . . . . 0.467 ' HB2' ' HB3' ' B' ' 67' ' ' SER . 97.2 mttt -61.76 -19.94 63.01 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 120.848 0.356 . . . . 0.0 111.832 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . 0.451 ' HB3' ' HA ' ' B' ' 74' ' ' CYS . 6.3 mmtp -86.94 30.47 0.75 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.694 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 17.0 t 56.5 47.44 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . 58.13 38.43 26.43 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.236 -0.893 . . . . 0.0 108.782 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 74' ' ' CYS . . . . . 0.451 ' HA ' ' HB3' ' B' ' 71' ' ' LYS . 20.9 p 48.66 26.66 1.28 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 114.076 -1.42 . . . . 0.0 112.94 -178.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -89.9 -175.56 4.64 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . 71.46 -50.08 0.69 Allowed 'General case' 0 N--CA 1.474 0.744 0 O-C-N 123.713 0.633 . . . . 0.0 110.514 -178.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -76.5 -50.39 14.11 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.085 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.723 ' HB ' HD13 ' B' ' 97' ' ' LEU . 8.9 tp -80.26 -42.25 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-O 121.215 0.531 . . . . 0.0 110.094 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.59 -29.69 70.33 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.616 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -82.44 -33.21 25.99 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.772 -0.728 . . . . 0.0 111.581 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.13 -19.53 64.03 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.82 0.343 . . . . 0.0 110.898 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 82' ' ' VAL . . . . . 0.653 HG23 ' O ' ' B' ' 78' ' ' ILE . 75.4 t -60.76 -52.32 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.054 178.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.9 -36.36 62.23 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.999 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.34 -43.02 96.84 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.006 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 2.3 t -90.94 -8.93 47.94 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.3 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 74.47 48.49 13.64 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.95 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 143.5 135.98 3.07 Favored Glycine 0 CA--C 1.509 -0.288 0 C-N-CA 120.896 -0.668 . . . . 0.0 111.777 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 88' ' ' ILE . . . . . 0.591 ' HB ' HG22 ' B' ' 82' ' ' VAL . 0.0 OUTLIER -100.9 107.99 22.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.682 0.753 . . . . 0.0 110.645 -179.806 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 89' ' ' ASP . . . . . 0.568 ' HB2' ' HE1' ' A' ' 52' ' ' HIS . 44.0 m-20 -120.9 -86.43 0.65 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 90' ' ' LEU . . . . . 0.659 ' O ' ' HB2' ' B' ' 94' ' ' LEU . 59.3 tp 179.09 -52.43 0.0 OUTLIER Pre-proline 0 C--O 1.217 -0.655 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.108 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 91' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' B' ' 90' ' ' LEU . 1.0 OUTLIER -43.17 -70.49 0.07 OUTLIER 'Trans proline' 0 C--N 1.36 1.177 0 C-N-CA 123.351 2.701 . . . . 0.0 114.767 -179.413 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 92' ' ' CYS . . . . . 0.601 ' HB3' ' ND1' ' A' ' 52' ' ' HIS . 0.8 OUTLIER -72.83 -38.62 67.06 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -178.17 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . 0.579 HG12 HD12 ' B' ' 78' ' ' ILE . 0.6 OUTLIER -66.41 -24.5 33.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -178.199 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 94' ' ' LEU . . . . . 0.659 ' HB2' ' O ' ' B' ' 90' ' ' LEU . 1.3 tm? -67.96 -41.94 81.66 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.52 -9.45 8.7 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -178.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -87.67 -37.43 16.74 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 97' ' ' LEU . . . . . 0.723 HD13 ' HB ' ' B' ' 78' ' ' ILE . 1.7 pt? -115.03 17.56 16.76 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -178.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -70.67 -83.95 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.801 -0.36 . . . . 0.0 111.408 -178.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . 65.6 -84.05 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 O-C-N 123.562 0.539 . . . . 0.0 111.186 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.86 -163.65 1.43 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.396 -0.224 . . . . 0.0 110.396 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -84.11 131.68 34.77 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.655 0.264 . . . . 0.0 110.923 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 110.07 6.89 27.58 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.38 -0.914 . . . . 0.0 113.767 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 92.6 m -110.56 -43.26 3.89 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 117.405 0.603 . . . . 0.0 111.416 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -96.08 2.71 53.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.187 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 4.3 m -54.43 -42.78 70.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.117 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 1.8 p -55.42 -61.49 2.31 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.045 0.45 . . . . 0.0 111.216 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . 0.585 ' O ' ' HD2' ' B' ' 111' ' ' HIS . 0.8 OUTLIER -58.49 -55.31 36.73 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.342 -179.652 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 12.4 m -76.29 22.63 0.16 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -178.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -63.4 -58.24 7.72 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 118.296 0.498 . . . . 0.0 111.155 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -93.93 -21.48 19.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.293 0.568 . . . . 0.0 109.998 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 111' ' ' HIS . . . . . 0.585 ' HD2' ' O ' ' B' ' 107' ' ' PHE . 45.1 m-70 -92.6 89.9 6.9 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.588 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 96.1 m -123.1 46.36 2.2 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -177.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 113' ' ' HIS . . . . . 0.854 ' HA ' ' HG2' ' B' ' 117' ' ' LYS . 23.1 p80 -140.74 5.96 2.01 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 119.608 -0.837 . . . . 0.0 111.798 177.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 114' ' ' GLY . . . . . 0.59 ' O ' ' HG3' ' B' ' 117' ' ' LYS . . . -98.1 -152.6 28.23 Favored Glycine 0 C--O 1.226 -0.348 0 C-N-CA 120.489 -0.862 . . . . 0.0 111.393 177.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . 0.549 ' CG2' ' HA ' ' B' ' 91' ' ' PRO . 35.1 m -66.17 -5.92 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 117.411 0.606 . . . . 0.0 111.701 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 116' ' ' CYS . . . . . 0.436 ' SG ' HD21 ' B' ' 94' ' ' LEU . 0.9 OUTLIER -79.79 -25.28 40.97 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.294 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 117' ' ' LYS . . . . . 0.854 ' HG2' ' HA ' ' B' ' 113' ' ' HIS . 0.0 OUTLIER -96.03 3.51 53.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.359 178.19 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -44.97 -42.46 8.23 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 119' ' ' LEU . . . . . 0.704 ' O ' ' HB2' ' B' ' 120' ' ' HIS . 87.9 mt -106.66 -64.77 1.14 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 174.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 120' ' ' HIS . . . . . 0.704 ' HB2' ' O ' ' B' ' 119' ' ' LEU . 11.4 t-80 145.16 91.57 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.881 1.672 . . . . 0.0 108.883 177.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 62.1 mt -114.98 31.78 6.46 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -177.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 122' ' ' CYS . . . . . . . . . . . . . 6.3 p . . . . . 0 C--O 1.242 0.699 0 CA-C-O 118.408 -0.806 . . . . 0.0 110.965 178.653 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.197 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -100.02 144.55 28.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.747 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -77.79 99.41 1.5 Allowed Glycine 0 CA--C 1.509 -0.339 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.484 ' HD3' ' OG ' ' A' ' 44' ' ' SER . 64.2 mttp 67.77 -84.01 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -177.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.436 ' HB3' ' O ' ' A' ' 40' ' ' GLU . 13.7 p -159.81 20.18 0.17 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 177.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.563 ' HB3' ' HD3' ' A' ' 9' ' ' LYS . 14.5 m 64.79 55.5 1.23 Allowed 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.106 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -87.0 -16.1 9.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.349 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.509 HD12 ' N ' ' A' ' 9' ' ' LYS . 3.3 pp -68.61 -35.16 76.94 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.563 ' HD3' ' HB3' ' A' ' 6' ' ' SER . 0.0 OUTLIER -88.51 3.28 50.8 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 121.304 0.573 . . . . 0.0 110.408 178.783 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.4 tptt -98.42 37.65 1.44 Allowed 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 177.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.411 ' O ' HG12 ' A' ' 11' ' ' VAL . 20.7 t 58.79 41.84 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.972 -178.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 55.71 48.89 17.43 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.035 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.422 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 55.9 m 71.58 -4.82 1.78 Allowed 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 179.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.458 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -70.86 -34.55 71.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.742 0.306 . . . . 0.0 111.736 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.82 38.81 0.66 Allowed 'General case' 0 C--N 1.326 -0.443 0 O-C-N 122.103 -0.373 . . . . 0.0 111.95 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -167.66 -53.06 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.1 0.476 . . . . 0.0 111.017 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.732 HD13 ' HB2' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -78.04 -42.4 27.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.036 -179.748 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' A' ' 14' ' ' ALA . . . -67.97 -31.3 70.93 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.962 0.41 . . . . 0.0 110.721 178.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -76.11 -26.19 64.77 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.663 -0.779 . . . . 0.0 111.84 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.44 -24.44 60.24 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 120.882 0.372 . . . . 0.0 110.743 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 17' ' ' ILE . 98.9 t -66.35 -47.02 85.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.641 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.43 -22.06 66.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.722 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.11 -40.13 86.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.462 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.5 t -99.78 -12.86 19.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.009 0.433 . . . . 0.0 111.207 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.84 -61.76 0.35 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.097 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -105.74 170.23 16.88 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.249 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.456 HD13 HG22 ' A' ' 21' ' ' VAL . 2.6 tp -98.04 104.98 16.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.57 0.7 . . . . 0.0 111.581 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.558 ' OD1' HG23 ' A' ' 32' ' ' VAL . 18.1 p-10 -129.2 -111.33 0.27 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.726 178.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.62 ' HG ' ' CG2' ' A' ' 54' ' ' VAL . 43.3 tp -178.72 -47.03 0.0 OUTLIER Pre-proline 0 C--N 1.324 -0.505 0 C-N-CA 123.575 0.75 . . . . 0.0 110.682 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.832 ' HA ' HG21 ' A' ' 54' ' ' VAL . 32.5 Cg_exo -55.37 -31.59 77.94 Favored 'Trans proline' 0 C--N 1.367 1.528 0 C-N-CA 122.455 2.103 . . . . 0.0 113.227 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 19.5 t -106.93 -25.98 11.41 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.383 -178.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.558 HG23 ' OD1' ' A' ' 28' ' ' ASP . 65.8 t -72.13 -14.28 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.736 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.722 ' HA ' ' HB3' ' A' ' 36' ' ' LEU . 1.0 OUTLIER -59.19 -15.3 14.13 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.896 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.514 ' N ' HD12 ' A' ' 33' ' ' LEU . . . -54.3 -53.92 47.26 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.935 0.398 . . . . 0.0 111.66 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -103.3 28.29 6.51 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.222 0.534 . . . . 0.0 109.851 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.722 ' HB3' ' HA ' ' A' ' 33' ' ' LEU . 42.6 tp -122.67 -48.88 2.02 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.791 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.509 ' HE3' ' HB2' ' A' ' 58' ' ' LEU . 84.3 tttt -73.71 96.01 2.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.868 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -144.93 -80.14 0.17 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.66 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -113.27 150.74 32.02 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.497 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.436 ' O ' ' HB3' ' A' ' 5' ' ' CYS . 4.7 mp0 -67.45 143.03 56.45 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.562 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.43 -9.36 77.78 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.506 -0.854 . . . . 0.0 113.572 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 85.6 m -86.34 -23.15 26.33 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 117.331 0.565 . . . . 0.0 110.952 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.469 ' HB3' ' CD2' ' A' ' 60' ' ' LEU . . . -111.54 23.76 13.56 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.681 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.484 ' OG ' ' HD3' ' A' ' 4' ' ' LYS . 34.7 p -78.95 -49.71 12.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.552 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.7 p -54.55 -36.13 63.98 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.547 0.689 . . . . 0.0 111.103 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.732 ' HB2' HD13 ' A' ' 17' ' ' ILE . 0.8 OUTLIER -83.6 -68.62 0.7 Allowed 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.652 -1.158 . . . . 0.0 111.441 -178.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.483 ' HA ' ' HB2' ' A' ' 50' ' ' HIS . 37.4 m -77.57 32.16 0.16 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -65.35 -57.61 7.96 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.363 0.601 . . . . 0.0 109.385 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -90.4 -10.83 42.44 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.117 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.483 ' HB2' ' HA ' ' A' ' 47' ' ' CYS . 36.7 m-70 -106.23 60.43 0.65 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.119 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 5.2 t -111.18 50.22 0.83 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.033 0.444 . . . . 0.0 111.108 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.501 ' HA ' ' HD2' ' A' ' 56' ' ' LYS . 20.6 p-80 -140.92 -7.46 1.07 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 0.0 112.05 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.427 ' O ' ' HG2' ' A' ' 56' ' ' LYS . . . -104.05 -151.71 22.11 Favored Glycine 0 CA--C 1.521 0.428 0 C-N-CA 120.519 -0.848 . . . . 0.0 113.01 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.832 HG21 ' HA ' ' A' ' 30' ' ' PRO . 31.1 m -55.03 -17.23 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.581 ' HB2' HD21 ' A' ' 29' ' ' LEU . 1.8 t -70.61 -24.52 62.75 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.71 -179.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.546 ' C ' ' H ' ' A' ' 58' ' ' LEU . 10.0 ptmt -94.19 17.17 13.11 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.373 178.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -83.99 29.59 0.55 Allowed 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 123.057 1.408 . . . . 0.0 107.926 177.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.546 ' H ' ' C ' ' A' ' 56' ' ' LYS . 6.9 tt -170.16 -37.3 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 32.6 t60 71.07 91.37 0.09 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 113.88 -1.509 . . . . 0.0 111.834 178.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.546 HD12 HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -131.09 16.07 5.12 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.377 179.927 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.879 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.131 0 CA-C-O 120.733 0.302 . . . . 0.0 110.373 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -81.31 114.92 20.41 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.715 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -78.93 80.35 1.5 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.615 -0.802 . . . . 0.0 111.651 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . 0.432 ' HE2' ' HB3' ' B' ' 65' ' ' LYS . 6.1 ptpt 46.93 -80.92 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.638 1.175 . . . . 0.0 113.414 -179.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' CYS . . . . . . . . . . . . . 29.5 p -154.75 17.33 0.45 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.595 ' HB3' ' HG2' ' B' ' 70' ' ' LYS . 18.9 m 55.59 70.2 0.66 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.347 0.594 . . . . 0.0 110.116 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.468 HG13 ' HB3' ' B' ' 74' ' ' CYS . 42.5 t -65.73 -37.26 79.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -177.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.439 ' HG ' ' N ' ' B' ' 70' ' ' LYS . 0.7 OUTLIER -65.88 -44.48 85.24 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -178.629 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 70' ' ' LYS . . . . . 0.595 ' HG2' ' HB3' ' B' ' 67' ' ' SER . 18.7 pttp -77.96 -1.54 32.47 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.126 0.488 . . . . 0.0 110.861 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 10.9 tttt -96.57 41.07 1.12 Allowed 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 177.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 12.5 t 59.73 39.78 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 114.499 -1.228 . . . . 0.0 110.422 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . 51.55 51.47 16.66 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.997 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 74' ' ' CYS . . . . . 0.753 ' HB2' HD12 ' B' ' 78' ' ' ILE . 2.0 p 48.14 37.5 8.18 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 114.506 -1.225 . . . . 0.0 113.638 -178.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -100.4 7.75 44.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.156 0.503 . . . . 0.0 110.575 178.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -89.61 -64.5 1.13 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.342 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.67 -24.71 23.81 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.812 HD13 ' HB2' ' B' ' 107' ' ' PHE . 23.9 mt -89.13 -55.18 6.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.553 0.216 . . . . 0.0 111.082 -179.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.17 -21.19 46.78 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.391 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.03 -34.16 42.95 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.705 -0.76 . . . . 0.0 111.626 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . 0.523 ' HB2' ' HB3' ' B' ' 96' ' ' ALA . . . -71.29 -18.15 62.43 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 120.956 0.408 . . . . 0.0 110.702 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 82' ' ' VAL . . . . . 0.463 HG23 ' O ' ' B' ' 78' ' ' ILE . 69.9 t -64.07 -41.73 93.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.857 178.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.02 -22.57 60.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.057 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.82 -39.54 30.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.547 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 22.7 t -89.5 -25.37 21.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.757 0.313 . . . . 0.0 110.865 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 96.46 34.5 5.79 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.367 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 147.6 163.8 10.86 Favored Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 111.399 -0.68 . . . . 0.0 111.399 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.36 127.42 63.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 117.199 0.5 . . . . 0.0 110.666 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 89' ' ' ASP . . . . . 0.558 ' OD2' ' HG2' ' B' ' 91' ' ' PRO . 30.2 p-10 -144.67 -59.22 0.37 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.449 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 90' ' ' LEU . . . . . 0.679 HD11 ' HB2' ' B' ' 116' ' ' CYS . 61.0 tp 133.55 -51.63 0.0 OUTLIER Pre-proline 0 N--CA 1.484 1.269 0 C-N-CA 126.2 1.8 . . . . 0.0 110.337 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 91' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' B' ' 90' ' ' LEU . 4.5 Cg_exo -44.06 -38.41 10.5 Favored 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 123.539 2.826 . . . . 0.0 114.686 -179.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 31.5 p -104.98 -31.14 9.36 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 120.241 -0.583 . . . . 0.0 111.581 -179.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . 0.493 HG13 ' HB3' ' B' ' 81' ' ' ALA . 3.9 t -63.29 -7.37 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.43 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 94' ' ' LEU . . . . . 0.447 HD22 ' HB ' ' B' ' 115' ' ' VAL . 4.3 pp -61.66 -22.61 65.45 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 122.343 -0.223 . . . . 0.0 111.2 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -53.2 -60.46 3.26 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -178.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . 0.523 ' HB3' ' HB2' ' B' ' 81' ' ' ALA . . . -78.11 -15.58 58.75 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.223 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 18.1 tp -74.61 -41.38 60.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.898 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . 0.746 ' HA ' HD11 ' B' ' 119' ' ' LEU . 43.9 mtpt -67.74 -20.26 65.22 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.777 0.323 . . . . 0.0 111.195 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -78.91 -11.1 59.99 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.617 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . 0.652 ' HB1' ' SG ' ' B' ' 103' ' ' CYS . . . -108.43 111.5 23.42 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.816 0.341 . . . . 0.0 110.951 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 12.0 mp0 -67.17 99.24 0.66 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.46 -178.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 70.77 35.45 66.33 Favored Glycine 0 CA--C 1.517 0.194 0 N-CA-C 114.396 0.518 . . . . 0.0 114.396 177.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 103' ' ' CYS . . . . . 0.652 ' SG ' ' HB1' ' B' ' 100' ' ' ALA . 60.8 m -107.38 13.88 26.55 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 117.567 0.683 . . . . 0.0 111.178 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 104' ' ' ALA . . . . . 0.563 ' HB3' HD21 ' B' ' 121' ' ' LEU . . . -100.46 27.17 5.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.227 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 3.0 p -73.96 -61.07 1.98 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.952 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 4.5 p -55.63 -37.74 68.58 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.556 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . 0.812 ' HB2' HD13 ' B' ' 78' ' ' ILE . 1.1 t80 -79.38 -75.71 0.24 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.069 -0.969 . . . . 0.0 112.514 -177.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 74.3 m -73.12 33.57 0.07 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -177.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -59.53 -57.92 10.84 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.332 0.587 . . . . 0.0 109.531 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -98.15 -19.65 17.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.483 178.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 -93.77 65.34 3.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.722 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 4.6 t -123.53 58.91 1.12 Allowed 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.466 -0.493 . . . . 0.0 111.0 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 113' ' ' HIS . . . . . 0.57 ' O ' ' HE2' ' B' ' 117' ' ' LYS . 20.7 p-80 -139.96 -25.34 0.81 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 114' ' ' GLY . . . . . 0.447 ' O ' HG22 ' B' ' 115' ' ' VAL . . . -127.8 129.85 6.52 Favored Glycine 0 C--O 1.226 -0.396 0 C-N-CA 120.184 -1.008 . . . . 0.0 112.695 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . 0.447 HG22 ' O ' ' B' ' 114' ' ' GLY . 24.4 m 54.82 -31.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 C-N-CA 126.164 1.786 . . . . 0.0 115.204 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 116' ' ' CYS . . . . . 0.679 ' HB2' HD11 ' B' ' 90' ' ' LEU . 35.2 t -81.18 -37.69 28.3 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 121.807 -0.558 . . . . 0.0 111.291 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 117' ' ' LYS . . . . . 0.57 ' HE2' ' O ' ' B' ' 113' ' ' HIS . 52.1 pttt -77.7 15.05 0.89 Allowed 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 119.697 -0.801 . . . . 0.0 110.957 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -75.38 -24.1 57.18 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 106.824 -1.546 . . . . 0.0 106.824 175.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 119' ' ' LEU . . . . . 0.746 HD11 ' HA ' ' B' ' 98' ' ' LYS . 53.1 mt -94.75 -31.7 13.66 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 114.137 -1.392 . . . . 0.0 107.704 176.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 12.7 t60 55.9 76.28 0.29 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 113.886 -1.507 . . . . 0.0 112.437 178.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 121' ' ' LEU . . . . . 0.609 ' H ' HD13 ' B' ' 121' ' ' LEU . 0.0 OUTLIER -131.69 -3.34 3.71 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-O 120.959 0.409 . . . . 0.0 110.821 179.885 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 122' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.246 0.882 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.39 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.601 ' O ' ' HE2' ' A' ' 9' ' ' LYS . . . . . . . . 0 N--CA 1.484 1.259 0 CA-C-O 120.663 0.268 . . . . 0.0 110.549 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 7.7 mtp -101.54 114.52 28.62 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -105.49 176.55 22.45 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.466 -0.873 . . . . 0.0 113.552 -178.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.0 ptmm? -95.14 -27.03 15.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.836 0.351 . . . . 0.0 110.337 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 9.3 t -176.46 65.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.699 ' HB2' ' HB2' ' A' ' 9' ' ' LYS . 16.6 m -70.99 168.57 16.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.336 -178.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.0 m -75.56 -46.79 36.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -178.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.5 pp -89.48 -22.15 22.61 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 119.879 -0.728 . . . . 0.0 109.582 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.699 ' HB2' ' HB2' ' A' ' 6' ' ' SER . 19.1 mtpp -96.29 30.82 2.38 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 177.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -73.78 -6.35 46.48 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.697 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.442 ' O ' HG12 ' A' ' 11' ' ' VAL . 22.6 t 58.45 41.44 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.355 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 51.57 28.72 4.86 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 114.569 -1.196 . . . . 0.0 112.791 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.529 ' HB3' HD12 ' A' ' 17' ' ' ILE . 6.5 m 66.74 5.58 4.02 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.47 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -79.51 -13.47 59.53 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -178.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -98.04 15.62 23.58 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.912 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.47 -59.53 0.24 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.135 0.493 . . . . 0.0 111.3 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.723 HD13 ' HB3' ' A' ' 46' ' ' PHE . 80.6 mt -75.17 -42.77 44.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.354 -179.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 14' ' ' ALA . . . -59.54 -34.06 72.18 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -179.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -85.99 -33.1 15.9 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.646 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.811 ' HB1' HG13 ' A' ' 32' ' ' VAL . . . -69.6 -34.78 74.6 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.011 0.434 . . . . 0.0 111.343 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.4 t -64.07 -44.36 97.7 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.784 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.15 -22.53 66.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.648 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.65 -43.2 66.52 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 60.3 m -104.03 0.64 30.08 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 -178.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.18 42.95 10.06 Favored Glycine 0 CA--C 1.517 0.197 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.884 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 130.32 -178.88 17.28 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 121.062 -0.589 . . . . 0.0 111.634 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.2 pp -74.18 134.35 29.73 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 CA-C-O 121.748 0.785 . . . . 0.0 110.343 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.532 ' HB3' HG23 ' A' ' 32' ' ' VAL . 32.9 t70 -148.59 -127.7 0.05 Allowed 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.564 -1.198 . . . . 0.0 108.007 -178.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.869 HD21 ' HB2' ' A' ' 55' ' ' CYS . 20.6 tp 175.27 -56.3 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.461 0 O-C-N 123.418 0.449 . . . . 0.0 112.042 178.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.589 ' HA ' HG11 ' A' ' 54' ' ' VAL . 3.8 Cg_endo -49.92 -34.78 38.37 Favored 'Trans proline' 0 C--N 1.364 1.353 0 C-N-CA 122.752 2.301 . . . . 0.0 113.308 -179.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 17.3 p -110.59 -28.85 8.3 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.216 0.531 . . . . 0.0 110.979 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.811 HG13 ' HB1' ' A' ' 20' ' ' ALA . 51.6 t -67.72 -23.91 30.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.44 -179.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.8 pp -54.9 -26.56 36.66 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.95 -61.04 2.66 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -178.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.471 ' HB3' ' HB2' ' A' ' 20' ' ' ALA . . . -77.46 -21.64 52.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.74 0.305 . . . . 0.0 111.389 -179.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 52.6 tp -68.05 -36.47 79.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.498 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -66.12 -39.74 90.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.457 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 58.12 -100.25 0.11 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.577 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -132.64 18.81 4.27 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.715 -0.221 . . . . 0.0 111.396 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -168.26 -110.49 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -110.98 -64.32 0.51 Allowed Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 178.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 12.0 m 48.71 29.4 2.19 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.485 0.714 . . . . 0.0 112.916 177.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.572 ' CB ' ' HG ' ' A' ' 60' ' ' LEU . . . -115.35 -15.99 11.5 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.457 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 2.5 m -58.02 -19.18 29.2 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.013 0.435 . . . . 0.0 111.812 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 42.5 t -64.99 -53.38 47.16 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.723 ' HB3' HD13 ' A' ' 17' ' ' ILE . 0.3 OUTLIER -107.92 -46.63 3.74 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.294 -179.641 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.58 ' O ' ' HB3' ' A' ' 51' ' ' CYS . 0.1 OUTLIER -68.31 21.0 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.634 179.737 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.508 ' H ' ' C ' ' A' ' 46' ' ' PHE . 38.9 tp10 -63.52 -76.2 0.07 Allowed 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 123.246 0.618 . . . . 0.0 111.903 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -69.86 -44.69 69.34 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.858 -178.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -103.3 111.52 23.97 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.168 0.509 . . . . 0.0 111.901 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.695 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 13.5 p -164.99 35.33 0.06 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.613 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.492 ' HA ' ' HE3' ' A' ' 56' ' ' LYS . 3.7 p-80 -82.81 -16.33 48.19 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.541 ' HA3' ' HG2' ' B' ' 91' ' ' PRO . . . -76.86 -123.89 0.21 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.384 -0.913 . . . . 0.0 112.04 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.589 HG11 ' HA ' ' A' ' 30' ' ' PRO . 8.9 p -85.9 18.84 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.745 0.783 . . . . 0.0 110.265 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.869 ' HB2' HD21 ' A' ' 29' ' ' LEU . 5.3 t -91.64 -48.43 6.84 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.492 ' HE3' ' HA ' ' A' ' 52' ' ' HIS . 19.8 pttp -89.27 14.07 11.91 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 120.976 -0.289 . . . . 0.0 110.662 178.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -56.13 -41.63 75.62 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.259 0.552 . . . . 0.0 109.727 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.5 tt -135.67 -79.16 0.43 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 177.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -155.1 118.25 4.41 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.977 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.572 ' HG ' ' CB ' ' A' ' 43' ' ' ALA . 8.1 tp -153.87 -50.97 0.1 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.92 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.533 ' HB3' ' O ' ' A' ' 47' ' ' CYS . 0.8 OUTLIER . . . . . 0 C--O 1.243 0.759 0 CA-C-O 118.474 -0.774 . . . . 0.0 110.518 178.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.044 0 CA-C-O 120.771 0.319 . . . . 0.0 110.945 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' MET . . . . . . . . . . . . . 23.7 mmt -73.67 134.46 43.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.48 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -80.78 118.03 4.56 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.897 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . 0.623 ' HE2' ' O ' ' B' ' 100' ' ' ALA . 69.6 tttt -73.25 -63.03 1.27 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.869 0.366 . . . . 0.0 110.052 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' CYS . . . . . 0.939 ' HB3' ' HB3' ' B' ' 101' ' ' GLU . 32.1 t 177.6 152.94 0.26 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.406 ' O ' ' HB3' ' B' ' 71' ' ' LYS . 15.8 t -162.06 -170.55 2.54 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 27.5 m -94.25 -13.03 8.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.012 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.407 ' HG ' ' N ' ' B' ' 70' ' ' LYS . 0.7 OUTLIER -108.5 -45.68 3.83 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 121.281 -0.168 . . . . 0.0 111.228 179.811 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 70' ' ' LYS . . . . . 0.505 ' HE3' ' HB2' ' B' ' 70' ' ' LYS . 14.9 ptmt -96.24 38.29 1.2 Allowed 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 122.05 0.928 . . . . 0.0 109.075 178.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . 0.406 ' HB3' ' O ' ' B' ' 67' ' ' SER . 60.9 pttt -74.23 -11.42 60.28 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 114.113 -1.403 . . . . 0.0 107.726 177.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 6.7 t 58.33 43.09 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 113.981 -1.463 . . . . 0.0 110.435 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . 51.25 24.99 2.26 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.171 -178.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 74' ' ' CYS . . . . . 0.521 ' HB3' HD12 ' B' ' 78' ' ' ILE . 0.0 OUTLIER 53.49 27.25 6.29 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.603 -178.714 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.68 -53.79 8.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.858 0.361 . . . . 0.0 110.965 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.85 42.68 0.72 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.973 0.416 . . . . 0.0 111.381 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -159.21 -44.87 0.05 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.582 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.674 HD13 ' HB2' ' B' ' 107' ' ' PHE . 12.5 mt -100.79 -52.44 8.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.203 -179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.88 -33.63 73.38 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.15 -37.62 17.84 Favored Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.645 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.78 -29.54 63.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.052 0.453 . . . . 0.0 111.49 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 82' ' ' VAL . . . . . 0.478 HG22 ' HA ' ' B' ' 88' ' ' ILE . 2.6 t -66.13 -40.17 86.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.607 179.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.4 -24.05 66.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.261 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.9 -39.08 44.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.319 -0.401 . . . . 0.0 112.049 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 4.8 t -85.52 -25.51 26.78 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.871 -0.331 . . . . 0.0 111.123 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 104.71 39.79 2.29 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.474 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 87' ' ' GLY . . . . . 0.434 ' C ' HG13 ' B' ' 82' ' ' VAL . . . 124.45 170.99 13.31 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.025 -0.607 . . . . 0.0 111.613 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 88' ' ' ILE . . . . . 0.478 ' HA ' HG22 ' B' ' 82' ' ' VAL . 1.2 pt -66.12 143.14 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.438 0 CA-C-O 121.416 0.627 . . . . 0.0 110.436 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 89' ' ' ASP . . . . . 0.484 ' O ' ' HB2' ' B' ' 90' ' ' LEU . 29.6 t70 -157.26 -127.4 0.03 OUTLIER 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.728 -178.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 90' ' ' LEU . . . . . 0.555 HD21 ' HB2' ' B' ' 116' ' ' CYS . 36.5 tp 170.73 -58.14 0.0 OUTLIER Pre-proline 0 C--N 1.323 -0.558 0 O-C-N 123.867 0.73 . . . . 0.0 110.563 178.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 91' ' ' PRO . . . . . 0.541 ' HG2' ' HA3' ' A' ' 53' ' ' GLY . 14.3 Cg_endo -57.8 -16.11 24.14 Favored 'Trans proline' 0 C--N 1.365 1.409 0 C-N-CA 122.681 2.254 . . . . 0.0 113.585 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 20.3 p -110.23 -34.02 6.49 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.217 0.532 . . . . 0.0 110.37 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . 0.41 HG12 ' HB2' ' B' ' 97' ' ' LEU . 3.0 t -74.26 -18.05 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.141 -178.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 94' ' ' LEU . . . . . 0.654 HD23 HG11 ' B' ' 115' ' ' VAL . 0.6 OUTLIER -40.95 -31.74 0.19 Allowed 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 -178.206 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . 0.555 ' N ' HD12 ' B' ' 94' ' ' LEU . . . -84.28 -54.53 4.73 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 118.442 0.564 . . . . 0.0 112.257 -178.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.8 -17.48 62.16 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.6 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 97' ' ' LEU . . . . . 0.41 ' HB2' HG12 ' B' ' 93' ' ' VAL . 20.0 tp -67.97 -38.12 82.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.478 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 44.5 mttm -56.69 -51.86 67.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.757 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . 72.01 -54.94 0.67 Allowed 'General case' 0 N--CA 1.471 0.612 0 O-C-N 124.024 0.828 . . . . 0.0 110.68 -178.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . 0.623 ' O ' ' HE2' ' B' ' 65' ' ' LYS . . . -163.39 -27.11 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.547 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . 0.939 ' HB3' ' HB3' ' B' ' 66' ' ' CYS . 32.1 tt0 -141.79 -85.28 0.18 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.043 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.99 -85.06 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 58.2 m 59.37 24.85 13.45 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 178.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -113.22 16.31 19.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.864 0.364 . . . . 0.0 110.693 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 105' ' ' SER . . . . . 0.648 ' O ' ' HG2' ' B' ' 109' ' ' GLU . 3.9 p -58.67 -52.05 67.33 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.142 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 18.7 p -53.95 -41.28 67.61 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.78 0.8 . . . . 0.0 111.517 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . 0.674 ' HB2' HD13 ' B' ' 78' ' ' ILE . 0.9 OUTLIER -69.36 -72.32 0.19 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.27 -1.332 . . . . 0.0 112.908 -177.928 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 108' ' ' CYS . . . . . 0.813 ' HA ' ' HB2' ' B' ' 111' ' ' HIS . 36.3 m -81.11 34.8 0.37 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -176.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . 0.648 ' HG2' ' O ' ' B' ' 105' ' ' SER . 13.1 mm-40 -60.59 -60.89 3.09 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 177.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -96.69 -0.18 48.74 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 111' ' ' HIS . . . . . 0.813 ' HB2' ' HA ' ' B' ' 108' ' ' CYS . 55.4 m-70 -108.59 39.48 1.99 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.962 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 2.1 t -98.0 49.31 1.01 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 113' ' ' HIS . . . . . . . . . . . . . 22.3 p-80 -123.24 -33.18 3.32 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.097 -178.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 114' ' ' GLY . . . . . 0.427 ' C ' ' H ' ' B' ' 116' ' ' CYS . . . -85.15 -146.33 8.29 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.857 -0.687 . . . . 0.0 113.425 -179.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . 0.654 HG11 HD23 ' B' ' 94' ' ' LEU . 7.7 p -74.65 37.34 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 122.331 1.062 . . . . 0.0 111.436 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 116' ' ' CYS . . . . . 0.555 ' HB2' HD21 ' B' ' 90' ' ' LEU . 2.5 t -120.31 -25.88 5.56 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.527 -0.76 . . . . 0.0 108.986 178.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.78 -9.83 39.11 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.909 178.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -49.54 -52.2 31.52 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.636 -179.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 73.1 mt -107.4 -104.34 0.35 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 177.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -151.18 93.33 1.9 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.228 0.537 . . . . 0.0 109.9 177.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 121' ' ' LEU . . . . . 0.411 ' HB2' ' O ' ' B' ' 116' ' ' CYS . 9.4 mp -121.58 -28.01 4.65 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.982 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 122' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.245 0.859 0 CA-C-O 118.437 -0.792 . . . . 0.0 110.802 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.243 0 CA-C-O 120.624 0.249 . . . . 0.0 110.74 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 54.1 mtm -80.8 178.44 8.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.03 0.443 . . . . 0.0 110.943 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -95.19 80.49 0.86 Allowed Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.01 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.41 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 0.9 OUTLIER -78.55 53.35 1.3 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.47 0.176 . . . . 0.0 111.41 -179.746 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.768 ' HA ' ' HB3' ' A' ' 9' ' ' LYS . 28.5 m 56.78 45.2 22.14 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.169 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.8 m -97.22 123.21 40.94 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 22.0 t 49.19 -83.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 O-C-N 124.318 1.011 . . . . 0.0 113.59 178.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.7 tp -65.06 -48.29 74.29 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.712 0.291 . . . . 0.0 110.519 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.768 ' HB3' ' HA ' ' A' ' 5' ' ' CYS . 0.0 OUTLIER -73.46 10.73 0.95 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.191 178.904 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -97.0 -19.39 18.79 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.4 t -119.66 -43.1 2.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.044 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.4 16.86 1.19 Allowed 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -80.02 -17.11 53.66 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.832 0.348 . . . . 0.0 111.125 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -81.21 21.41 0.74 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.619 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -109.75 -42.74 4.19 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.283 0.563 . . . . 0.0 109.838 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.27 -40.8 43.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.979 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.609 HG12 ' CD2' ' A' ' 46' ' ' PHE . 10.9 tp -72.38 -32.16 41.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.517 0.675 . . . . 0.0 110.194 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.404 ' HB2' ' O ' ' A' ' 14' ' ' ALA . . . -56.3 -27.66 56.21 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.527 -1.215 . . . . 0.0 111.595 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.48 -29.67 51.97 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.437 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.92 -28.83 62.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.064 0.459 . . . . 0.0 110.477 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 96.5 t -66.04 -48.88 80.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.297 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.96 -33.91 76.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.179 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.61 -34.66 78.75 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.783 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.545 ' SG ' ' HB2' ' B' ' 113' ' ' HIS . 3.9 t -89.21 -28.93 19.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.772 0.32 . . . . 0.0 111.109 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.6 40.8 3.54 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.362 -0.923 . . . . 0.0 112.209 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 148.11 163.03 10.49 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.761 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -108.18 135.58 46.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.255 0.55 . . . . 0.0 111.938 -179.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.669 ' HB2' ' HE1' ' B' ' 113' ' ' HIS . 7.9 t70 -160.59 -97.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.047 -0.979 . . . . 0.0 108.798 178.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.689 HD21 ' HB2' ' A' ' 55' ' ' CYS . 49.4 tp -178.85 -53.86 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.254 0 CA-C-O 119.263 -0.399 . . . . 0.0 111.484 178.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.664 ' HG3' ' HD3' ' B' ' 91' ' ' PRO . 96.3 Cg_exo -41.35 -65.47 0.19 Allowed 'Trans proline' 0 C--N 1.36 1.183 0 C-N-CA 123.203 2.602 . . . . 0.0 114.463 -178.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.503 ' HB3' ' O ' ' B' ' 113' ' ' HIS . 14.0 p -79.2 -32.49 44.1 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.878 -178.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.519 HG12 HD11 ' A' ' 17' ' ' ILE . 2.6 t -62.57 -31.05 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.988 -179.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 23.6 tp -65.76 -45.57 82.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.306 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.38 -43.76 68.07 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -178.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.57 -20.22 65.36 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -179.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.406 HD13 HD13 ' A' ' 17' ' ' ILE . 7.2 tt -99.05 -23.91 15.1 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.152 0.501 . . . . 0.0 110.214 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.9 mmmt -75.11 99.07 3.83 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -178.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -126.48 -24.88 3.54 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 175.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -171.63 -166.03 0.42 Allowed 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 112.235 -2.257 . . . . 0.0 105.612 178.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -70.15 -59.96 2.58 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 119.92 -0.712 . . . . 0.0 110.258 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 4' ' ' LYS . . . 56.45 -118.45 11.57 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 121.133 -0.556 . . . . 0.0 112.59 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 10.5 t -96.64 -94.12 0.21 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 66.93 -51.54 0.47 Allowed 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.1 p -54.84 -22.28 14.02 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 113.715 1.005 . . . . 0.0 113.715 -178.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.1 t -66.75 -49.98 64.23 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.494 0.664 . . . . 0.0 109.924 178.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.609 ' CD2' HG12 ' A' ' 17' ' ' ILE . 0.8 OUTLIER -72.2 -43.57 64.28 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 178.271 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.429 ' O ' ' HB3' ' A' ' 61' ' ' CYS . 86.1 m -94.14 67.58 3.62 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.832 -1.077 . . . . 0.0 109.611 178.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -92.9 -105.33 0.12 Allowed 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.2 p30 -72.85 -10.57 59.94 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 121.934 0.873 . . . . 0.0 108.972 177.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -103.35 99.06 8.89 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 113.687 -1.597 . . . . 0.0 106.793 177.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 44.9 t -169.07 79.92 0.13 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -177.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.514 ' CE1' ' HB2' ' B' ' 89' ' ' ASP . 3.5 p80 -138.93 18.03 2.65 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.415 0.626 . . . . 0.0 110.454 176.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.705 ' HA3' ' HG2' ' B' ' 91' ' ' PRO . . . -119.33 -135.36 5.08 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.657 -0.702 . . . . 0.0 112.337 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.568 ' CG2' ' HG ' ' A' ' 29' ' ' LEU . 16.1 m -55.54 -27.94 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.689 ' HB2' HD21 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -74.38 -38.23 63.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.448 -179.26 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.598 ' HD3' ' O ' ' A' ' 53' ' ' GLY . 0.0 OUTLIER -65.61 -24.91 67.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.697 0.284 . . . . 0.0 111.062 -179.773 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -58.36 -26.09 62.75 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.441 -179.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.552 ' HB2' HD22 ' A' ' 60' ' ' LEU . 3.2 mm? -90.72 -23.66 20.64 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.501 ' HB2' ' O ' ' A' ' 58' ' ' LEU . 39.3 m-70 74.72 63.83 0.07 Allowed 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.144 0.578 . . . . 0.0 111.994 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.552 HD22 ' HB2' ' A' ' 58' ' ' LEU . 1.9 pt? -140.48 14.98 2.37 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.947 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.429 ' HB3' ' O ' ' A' ' 47' ' ' CYS . 1.5 p . . . . . 0 C--O 1.245 0.829 0 CA-C-O 118.136 -0.935 . . . . 0.0 111.287 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.286 0 CA-C-O 120.763 0.316 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' MET . . . . . 0.558 ' HG3' ' H ' ' B' ' 64' ' ' GLY . 6.0 ptt? -89.69 -85.47 0.21 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.533 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . 0.558 ' H ' ' HG3' ' B' ' 63' ' ' MET . . . 79.16 175.65 47.36 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.608 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 21.8 mttp -111.16 94.27 4.9 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 122.619 -0.342 . . . . 0.0 110.972 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 66' ' ' CYS . . . . . 0.727 ' HA ' ' CB ' ' B' ' 70' ' ' LYS . 0.0 OUTLIER 56.39 60.37 3.17 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.328 178.964 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 1.7 p -102.24 131.18 48.95 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.289 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.52 ' O ' ' HB2' ' B' ' 71' ' ' LYS . 12.0 t 51.14 -95.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 123.984 0.914 . . . . 0.0 113.411 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.4 ' H ' ' HB ' ' B' ' 68' ' ' VAL . 46.1 tp -60.29 -42.25 95.09 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 120.836 0.351 . . . . 0.0 111.341 -178.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 70' ' ' LYS . . . . . 0.727 ' CB ' ' HA ' ' B' ' 66' ' ' CYS . 17.9 mmtm -64.45 -23.35 67.25 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.614 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . 0.52 ' HB2' ' O ' ' B' ' 68' ' ' VAL . 0.0 OUTLIER -65.64 -25.88 67.56 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.009 179.85 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 4.9 t -94.38 -16.95 7.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.43 0.633 . . . . 0.0 109.755 179.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.65 -33.96 40.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.761 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 74' ' ' CYS . . . . . 0.646 ' HB3' ' SG ' ' B' ' 103' ' ' CYS . 15.0 p -64.67 -43.28 94.08 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.772 -179.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -69.8 -3.69 16.73 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -105.15 -46.91 4.12 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.172 0.511 . . . . 0.0 109.741 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.6 -39.97 70.16 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.32 -0.855 . . . . 0.0 112.079 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.789 HD13 HD12 ' B' ' 97' ' ' LEU . 6.0 tp -73.23 -37.37 51.96 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 CA-C-O 121.323 0.582 . . . . 0.0 109.706 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.32 -33.09 74.76 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.915 -1.038 . . . . 0.0 110.713 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -74.96 -30.96 58.52 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.646 -0.787 . . . . 0.0 111.699 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.76 -21.43 61.74 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.206 0.527 . . . . 0.0 110.47 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 82' ' ' VAL . . . . . 0.455 HG23 ' O ' ' B' ' 78' ' ' ILE . 44.4 t -64.46 -51.72 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.081 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.45 -19.72 63.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.126 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.65 -39.64 57.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.737 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 1.4 t -88.36 -30.8 19.27 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.804 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 114.66 40.37 0.93 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.299 -0.953 . . . . 0.0 113.806 178.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 136.15 175.05 13.61 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.072 -1.061 . . . . 0.0 112.936 179.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 6.1 tp -91.3 134.3 30.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.183 0.516 . . . . 0.0 111.098 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 89' ' ' ASP . . . . . 0.514 ' HB2' ' CE1' ' A' ' 52' ' ' HIS . 2.6 t0 -156.46 -119.01 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 90' ' ' LEU . . . . . 0.553 ' N ' ' HD2' ' B' ' 91' ' ' PRO . 47.1 tp -177.66 -53.63 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.461 0 C-N-CA 123.077 0.551 . . . . 0.0 111.121 177.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 91' ' ' PRO . . . . . 0.815 ' HA ' HG21 ' B' ' 115' ' ' VAL . 2.9 Cg_endo -48.36 -48.96 15.46 Favored 'Trans proline' 0 C--N 1.359 1.093 0 C-N-CA 123.018 2.479 . . . . 0.0 113.634 -179.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 4.2 t -81.64 -40.34 23.06 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.935 0.398 . . . . 0.0 111.583 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . 0.437 HG23 ' H ' ' B' ' 93' ' ' VAL . 2.2 t -62.3 -24.49 35.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.409 -179.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 94' ' ' LEU . . . . . 0.74 HD22 HG23 ' B' ' 115' ' ' VAL . 22.5 tp -63.48 -26.72 68.85 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.27 0.471 . . . . 0.0 112.27 -179.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.05 -31.89 61.47 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -178.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -83.59 -1.85 54.78 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 97' ' ' LEU . . . . . 0.789 HD12 HD13 ' B' ' 78' ' ' ILE . 21.0 mt -136.75 14.88 3.13 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -178.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . 0.728 ' HG3' ' HG ' ' B' ' 94' ' ' LEU . 12.6 mtpt -84.68 102.54 13.04 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 119.554 -0.859 . . . . 0.0 111.73 -179.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -162.16 170.9 18.3 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.35 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -80.09 127.38 32.23 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 58.23 -143.75 0.63 Allowed 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -178.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.37 -72.45 1.19 Allowed Glycine 0 C--N 1.329 0.189 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.676 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 103' ' ' CYS . . . . . 0.646 ' SG ' ' HB3' ' B' ' 74' ' ' CYS . 45.9 t -164.56 -109.63 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 119.757 -0.163 . . . . 0.0 110.616 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 104' ' ' ALA . . . . . 0.418 ' N ' ' SG ' ' B' ' 103' ' ' CYS . . . 67.82 -59.06 0.43 Allowed 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.682 0.793 . . . . 0.0 112.4 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 105' ' ' SER . . . . . 0.523 ' HA ' ' HB2' ' B' ' 108' ' ' CYS . 5.0 p -63.94 2.8 0.46 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -178.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 106' ' ' CYS . . . . . 0.453 ' HB2' ' SG ' ' B' ' 66' ' ' CYS . 8.7 t -72.81 -47.27 47.86 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . 0.619 ' CD2' HG12 ' B' ' 78' ' ' ILE . 1.0 OUTLIER -74.24 -25.93 59.93 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 177.216 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 108' ' ' CYS . . . . . 0.594 ' O ' ' HB3' ' B' ' 122' ' ' CYS . 2.5 m -103.36 67.35 0.92 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.42 -1.263 . . . . 0.0 110.279 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . 0.408 ' HB3' ' H ' ' B' ' 110' ' ' ASP . 9.3 tp10 -96.53 -108.04 0.16 Allowed 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 110' ' ' ASP . . . . . 0.408 ' H ' ' HB3' ' B' ' 109' ' ' GLU . 45.8 p30 -72.95 -11.45 60.58 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 177.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -103.03 99.12 8.98 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 113.087 -1.87 . . . . 0.0 106.877 177.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 42.6 t -144.96 83.06 1.68 Allowed 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.791 -176.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 113' ' ' HIS . . . . . 0.725 ' HA ' ' HD2' ' B' ' 117' ' ' LYS . 1.0 OUTLIER -150.01 2.41 0.51 Allowed 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.8 0.666 . . . . 0.0 112.8 179.668 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 114' ' ' GLY . . . . . 0.589 ' HA2' ' HB2' ' A' ' 30' ' ' PRO . . . -98.72 -156.48 29.34 Favored Glycine 0 C--O 1.227 -0.293 0 C-N-CA 120.048 -1.072 . . . . 0.0 112.728 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . 0.815 HG21 ' HA ' ' B' ' 91' ' ' PRO . 19.6 m -56.63 -11.19 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 122.959 0.504 . . . . 0.0 112.35 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 116' ' ' CYS . . . . . . . . . . . . . 35.7 t -84.25 -39.75 18.89 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.377 -178.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 117' ' ' LYS . . . . . 0.725 ' HD2' ' HA ' ' B' ' 113' ' ' HIS . 6.3 ptmm? -64.99 -14.37 60.12 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.71 0.291 . . . . 0.0 110.737 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -57.08 -25.33 58.56 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.138 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 119' ' ' LEU . . . . . 0.565 ' HB2' HD22 ' B' ' 121' ' ' LEU . 3.1 mm? -99.26 -13.18 19.8 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 122.072 -0.392 . . . . 0.0 111.483 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 22.2 m-70 67.34 76.03 0.29 Allowed 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 122.943 0.497 . . . . 0.0 111.365 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 121' ' ' LEU . . . . . 0.565 HD22 ' HB2' ' B' ' 119' ' ' LEU . 1.0 OUTLIER -140.02 18.56 2.46 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.487 -179.334 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 122' ' ' CYS . . . . . 0.594 ' HB3' ' O ' ' B' ' 108' ' ' CYS . 0.9 OUTLIER . . . . . 0 C--O 1.246 0.889 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.767 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.191 0 CA-C-O 120.801 0.334 . . . . 0.0 110.762 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 4.6 ptm -148.18 172.84 13.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.306 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 144.67 178.28 20.18 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.646 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 27.3 mtmm -89.42 144.94 25.67 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.521 0.201 . . . . 0.0 110.87 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 34.6 m 64.85 29.93 12.35 Favored 'General case' 0 N--CA 1.463 0.203 0 O-C-N 123.852 0.72 . . . . 0.0 110.883 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 27.2 m -99.57 164.97 11.85 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -179.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.838 HG13 ' H ' ' A' ' 8' ' ' LEU . 5.7 p 36.76 -92.25 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 179.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.838 ' H ' HG13 ' A' ' 7' ' ' VAL . 22.0 tp -66.74 -31.41 72.04 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 117.957 0.344 . . . . 0.0 111.63 -177.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.2 mmmm -91.71 12.59 20.74 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.491 ' O ' ' HG3' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -111.47 11.56 21.4 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.609 -179.84 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 8' ' ' LEU . 95.0 t -51.31 -55.14 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 121.243 0.544 . . . . 0.0 110.624 178.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -167.32 62.49 0.08 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.975 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.999 ' HB2' HD12 ' A' ' 17' ' ' ILE . 1.8 p 46.98 33.1 2.11 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 124.129 0.893 . . . . 0.0 110.737 -177.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.62 65.23 8.43 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 114.258 -1.337 . . . . 0.0 110.545 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -145.61 -88.6 0.1 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.765 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.59 -21.74 44.63 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.325 0.584 . . . . 0.0 111.732 -178.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.999 HD12 ' HB2' ' A' ' 13' ' ' CYS . 64.5 mt -80.76 -8.79 11.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-O 121.836 0.827 . . . . 0.0 110.808 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -111.01 -9.9 14.39 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.529 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -115.18 -53.69 0.39 Allowed Glycine 0 C--O 1.228 -0.264 0 C-N-CA 120.568 -0.825 . . . . 0.0 113.013 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.88 -22.9 65.08 Favored 'General case' 0 C--O 1.226 -0.172 0 CA-C-N 117.207 0.504 . . . . 0.0 111.469 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.6 t -66.7 -41.9 88.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 O-C-N 122.09 -0.381 . . . . 0.0 110.824 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.03 -30.08 69.22 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.456 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.86 -30.82 71.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.092 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.0 t -87.09 -23.35 24.93 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.787 0.327 . . . . 0.0 110.664 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.64 39.32 4.19 Favored Glycine 0 N--CA 1.453 -0.177 0 C-N-CA 120.51 -0.852 . . . . 0.0 113.115 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 135.14 174.25 13.36 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.188 -1.006 . . . . 0.0 112.782 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 23.0 mm -72.73 125.85 32.28 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 CA-C-O 121.261 0.553 . . . . 0.0 111.412 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.417 ' HB2' ' CD2' ' B' ' 113' ' ' HIS . 35.5 t70 -144.31 -122.01 0.08 Allowed 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.737 -1.12 . . . . 0.0 108.421 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.743 ' HG ' HG21 ' A' ' 54' ' ' VAL . 12.1 tp 165.65 -61.02 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.407 0 C-N-CA 124.134 0.973 . . . . 0.0 109.645 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 1.033 ' HA ' HG11 ' A' ' 54' ' ' VAL . 9.5 Cg_endo -54.32 -41.22 78.31 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.044 1.83 . . . . 0.0 113.216 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.755 ' HB3' ' HA2' ' B' ' 114' ' ' GLY . 23.4 p -81.2 -38.07 27.64 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.552 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.1 t -67.51 -25.11 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.74 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.726 ' HA ' ' HB3' ' A' ' 36' ' ' LEU . 22.2 tp -52.35 -32.43 38.21 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.563 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -45.36 -43.98 11.41 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -115.83 22.41 13.08 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.104 0.478 . . . . 0.0 109.873 178.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.726 ' HB3' ' HA ' ' A' ' 33' ' ' LEU . 27.9 tp -114.81 -14.2 11.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.898 -178.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.611 ' HD3' ' O ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -69.36 85.11 0.4 Allowed 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.794 0.807 . . . . 0.0 111.674 -179.143 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.37 -159.06 0.98 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.047 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.412 ' HA ' ' HB2' ' A' ' 43' ' ' ALA . . . -125.06 -162.78 1.13 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.799 0.333 . . . . 0.0 111.539 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 58.11 -129.46 1.46 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.331 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.532 ' O ' ' HB3' ' A' ' 13' ' ' CYS . . . -62.12 -25.41 66.29 Favored Glycine 0 C--N 1.332 0.341 0 CA-C-N 115.892 -0.595 . . . . 0.0 114.429 -178.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 98.1 m -86.48 -0.45 56.08 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 117.711 0.755 . . . . 0.0 111.579 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' A' ' 47' ' ' CYS . . . -113.61 -61.15 1.78 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.679 0.276 . . . . 0.0 111.534 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 18.4 m -89.22 50.95 2.02 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -178.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.431 ' HB3' ' HB3' ' A' ' 13' ' ' CYS . 11.2 t -150.83 -56.28 0.16 Allowed 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.753 ' HB2' HD13 ' A' ' 17' ' ' ILE . 0.9 OUTLIER -87.99 -47.61 8.41 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.866 178.808 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 43' ' ' ALA . 95.5 m -81.98 47.82 1.16 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.102 -0.954 . . . . 0.0 112.144 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -84.79 -74.94 0.37 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 178.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -100.63 -21.46 15.25 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.356 178.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.402 ' HB3' HD22 ' A' ' 29' ' ' LEU . 55.2 m-70 -84.82 98.43 10.29 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 177.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.672 ' HB3' ' HG2' ' A' ' 56' ' ' LYS . 81.1 m -142.86 -10.28 0.79 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -177.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.651 ' O ' ' HB2' ' B' ' 91' ' ' PRO . 45.6 m80 -30.15 95.9 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 115.459 1.652 . . . . 0.0 115.459 -178.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 64.44 -6.71 0.74 Allowed Glycine 0 CA--C 1.526 0.753 0 N-CA-C 116.287 1.275 . . . . 0.0 116.287 176.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 1.033 HG11 ' HA ' ' A' ' 30' ' ' PRO . 0.1 OUTLIER -106.59 -72.62 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 118.359 1.08 . . . . 0.0 110.896 -179.806 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.624 ' SG ' HD11 ' A' ' 29' ' ' LEU . 57.5 m -71.23 -23.3 61.98 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.672 ' HG2' ' HB3' ' A' ' 51' ' ' CYS . 53.3 mmtt -72.19 -32.65 66.99 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.084 177.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -62.65 -39.2 93.12 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.654 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 38.9 mt -77.45 -16.03 59.0 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.397 178.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 12.4 t-160 58.78 65.19 1.27 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.112 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.1 mt -131.61 13.8 4.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.389 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 7.9 p . . . . . 0 C--O 1.245 0.851 0 CA-C-O 117.793 -1.099 . . . . 0.0 109.573 -179.823 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.264 0 CA-C-O 120.7 0.286 . . . . 0.0 110.831 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' MET . . . . . . . . . . . . . 16.1 ptp -93.69 164.74 13.03 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 140.74 166.75 10.81 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.185 -1.007 . . . . 0.0 113.153 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 29.7 mttm -69.27 120.61 15.37 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.516 0.198 . . . . 0.0 111.084 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 66' ' ' CYS . . . . . 0.571 ' SG ' ' HB3' ' B' ' 76' ' ' ALA . 30.9 m 65.38 55.95 1.02 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.407 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 71.0 m -79.46 -85.84 0.08 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.676 -0.238 . . . . 0.0 110.992 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.466 HG13 ' H ' ' B' ' 69' ' ' LEU . 4.2 p -122.6 -58.68 2.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.679 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.466 ' H ' HG13 ' B' ' 68' ' ' VAL . 31.5 tp -73.73 -23.84 59.82 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.247 0.546 . . . . 0.0 110.135 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 70' ' ' LYS . . . . . 0.776 ' HB3' ' HB2' ' B' ' 76' ' ' ALA . 1.0 OUTLIER -88.38 11.18 17.52 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.912 178.789 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . 0.573 ' HG3' ' HA3' ' B' ' 102' ' ' GLY . 25.1 ttpp -114.78 17.73 16.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.611 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.413 HG23 ' O ' ' B' ' 69' ' ' LEU . 63.1 t -71.92 -59.81 3.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 120.836 0.351 . . . . 0.0 110.755 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -141.61 55.62 1.51 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.874 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 74' ' ' CYS . . . . . 0.815 ' HB3' HD12 ' B' ' 78' ' ' ILE . 2.7 m 58.56 29.68 18.77 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.893 -179.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 75' ' ' ALA . . . . . 0.643 ' HA ' ' HB3' ' B' ' 79' ' ' ALA . . . -78.98 64.47 3.92 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -177.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . 0.776 ' HB2' ' HB3' ' B' ' 70' ' ' LYS . . . -163.04 -77.07 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.923 0.392 . . . . 0.0 111.127 178.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . 0.494 ' HB1' ' HA ' ' B' ' 97' ' ' LEU . . . -86.51 -2.52 58.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.211 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.815 HD12 ' HB3' ' B' ' 74' ' ' CYS . 44.8 mt -119.03 -68.09 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.637 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 79' ' ' ALA . . . . . 0.643 ' HB3' ' HA ' ' B' ' 75' ' ' ALA . . . -84.57 52.46 2.38 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.563 0.697 . . . . 0.0 109.472 177.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -165.21 -38.68 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 110.306 -1.117 . . . . 0.0 110.306 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.15 -11.44 59.93 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-O 121.253 0.549 . . . . 0.0 109.724 178.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 82' ' ' VAL . . . . . 0.574 HG22 ' HB ' ' B' ' 88' ' ' ILE . 15.3 t -65.43 -36.98 78.97 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.272 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -77.07 -8.77 58.04 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.593 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -103.88 -17.94 14.83 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.779 0.323 . . . . 0.0 111.251 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -109.42 -7.57 15.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.375 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 69.44 56.37 8.74 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.569 -0.824 . . . . 0.0 111.858 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 120.79 152.58 8.88 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.85 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 88' ' ' ILE . . . . . 0.574 ' HB ' HG22 ' B' ' 82' ' ' VAL . 4.3 tp -98.64 137.2 26.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.946 0.403 . . . . 0.0 112.042 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 89' ' ' ASP . . . . . 0.495 ' H ' HG21 ' B' ' 93' ' ' VAL . 7.0 t70 -161.65 -96.3 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.591 -0.732 . . . . 0.0 109.324 178.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 90' ' ' LEU . . . . . 0.557 ' N ' ' HD2' ' B' ' 91' ' ' PRO . 52.6 tp -179.29 -54.42 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.586 0 CA-C-O 119.514 -0.279 . . . . 0.0 111.686 178.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 91' ' ' PRO . . . . . 0.672 ' HA ' HG21 ' B' ' 115' ' ' VAL . 2.7 Cg_endo -41.44 -58.36 1.13 Allowed 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 123.522 2.815 . . . . 0.0 114.486 -178.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 8.8 p -86.91 -34.01 19.53 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.4 -0.52 . . . . 0.0 111.408 -179.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . 0.495 HG21 ' H ' ' B' ' 89' ' ' ASP . 2.8 t -58.86 -22.16 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.515 -179.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 94' ' ' LEU . . . . . 1.015 HD22 ' HB ' ' B' ' 115' ' ' VAL . 15.1 tp -54.43 -34.54 61.58 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.527 179.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.82 -46.3 81.73 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -102.83 10.81 38.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.558 0.218 . . . . 0.0 111.504 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 97' ' ' LEU . . . . . 0.494 ' HA ' ' HB1' ' B' ' 77' ' ' ALA . 23.0 tp -81.84 -9.54 59.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.1 0.476 . . . . 0.0 110.294 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -62.89 101.24 0.25 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.037 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -130.46 -179.68 5.41 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.987 0.422 . . . . 0.0 111.867 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -92.04 -87.52 0.21 Allowed 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.041 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -119.83 155.85 31.81 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -178.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . 0.573 ' HA3' ' HG3' ' B' ' 71' ' ' LYS . . . 63.4 30.05 76.39 Favored Glycine 0 C--N 1.332 0.336 0 N-CA-C 115.559 0.983 . . . . 0.0 115.559 177.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 13.3 m -138.25 -42.56 0.51 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 118.053 0.926 . . . . 0.0 111.897 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -74.1 -33.61 63.68 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.922 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 13.3 m -85.61 4.28 36.97 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -178.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 32.1 p -110.04 -37.45 5.59 Favored 'General case' 0 C--N 1.327 -0.383 0 O-C-N 121.494 -0.754 . . . . 0.0 110.498 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . 0.721 ' HB2' HD13 ' B' ' 78' ' ' ILE . 0.6 OUTLIER -88.65 -74.28 0.47 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.133 -179.54 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 108' ' ' CYS . . . . . 0.663 ' HB3' ' SG ' ' B' ' 122' ' ' CYS . 13.4 m -66.49 15.19 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . 0.541 ' H ' ' C ' ' B' ' 107' ' ' PHE . 19.4 tp10 -71.86 -69.6 0.38 Allowed 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.925 -179.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -59.93 -45.65 91.92 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.72 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -111.32 100.28 8.92 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.994 177.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 112' ' ' CYS . . . . . 0.485 ' O ' ' HD2' ' B' ' 117' ' ' LYS . 35.9 t -114.63 63.35 0.67 Allowed 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.394 -178.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 113' ' ' HIS . . . . . 0.417 ' CD2' ' HB2' ' A' ' 28' ' ' ASP . 13.6 p-80 -146.61 -172.35 3.95 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 114' ' ' GLY . . . . . 0.755 ' HA2' ' HB3' ' A' ' 31' ' ' CYS . . . 72.57 -144.29 35.33 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.747 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . 1.015 ' HB ' HD22 ' B' ' 94' ' ' LEU . 1.4 m -62.77 -22.28 29.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 116' ' ' CYS . . . . . 0.5 ' SG ' ' HB2' ' B' ' 121' ' ' LEU . 4.6 t -65.03 -31.86 73.3 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.304 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 117' ' ' LYS . . . . . 0.485 ' HD2' ' O ' ' B' ' 112' ' ' CYS . 8.8 mtpm? -89.31 -22.81 22.48 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.318 -0.401 . . . . 0.0 109.963 178.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -57.19 -42.86 82.03 Favored 'General case' 0 CA--C 1.522 -0.109 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 119' ' ' LEU . . . . . 0.557 ' O ' ' HB2' ' B' ' 120' ' ' HIS . 5.3 tt -89.54 -72.82 0.54 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 177.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 120' ' ' HIS . . . . . 0.557 ' HB2' ' O ' ' B' ' 119' ' ' LEU . 14.2 t-160 134.02 91.18 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 125.829 1.652 . . . . 0.0 109.733 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 121' ' ' LEU . . . . . 0.5 ' HB2' ' SG ' ' B' ' 116' ' ' CYS . 88.2 mt -117.14 -53.53 2.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.935 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 122' ' ' CYS . . . . . 0.663 ' SG ' ' HB3' ' B' ' 108' ' ' CYS . 1.8 p . . . . . 0 C--O 1.244 0.812 0 CA-C-O 118.607 -0.711 . . . . 0.0 109.398 178.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.595 0.236 . . . . 0.0 110.407 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 15.1 mmt -126.14 64.46 1.23 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.882 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -125.82 29.37 4.69 Favored Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.209 -0.996 . . . . 0.0 114.047 -178.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.484 ' O ' ' HB2' ' A' ' 5' ' ' CYS . 0.0 OUTLIER -77.43 134.58 38.36 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.281 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.619 ' O ' ' HG3' ' A' ' 9' ' ' LYS . 52.8 m 73.62 23.19 2.45 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.3 m 37.45 -113.8 0.11 Allowed 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 178.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.411 HG23 HD23 ' A' ' 8' ' ' LEU . 9.2 m -123.34 -54.3 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -177.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.483 HD23 ' H ' ' A' ' 8' ' ' LEU . 0.3 OUTLIER -67.08 -47.2 71.97 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 120.726 0.298 . . . . 0.0 111.743 -178.799 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.619 ' HG3' ' O ' ' A' ' 5' ' ' CYS . 0.4 OUTLIER -83.98 11.75 7.34 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.058 0.456 . . . . 0.0 109.93 179.131 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 51.1 tptt -81.38 13.85 2.75 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.436 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 18.7 t -60.61 -11.54 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 176.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.426 ' C ' ' H ' ' A' ' 14' ' ' ALA . . . 60.04 29.51 19.07 Favored 'General case' 0 C--N 1.344 0.351 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.529 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.435 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 0.5 OUTLIER 66.22 -30.58 0.14 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 114.318 -1.31 . . . . 0.0 113.543 179.774 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.426 ' H ' ' C ' ' A' ' 12' ' ' ALA . . . -44.89 -81.7 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 115.588 1.699 . . . . 0.0 115.588 -177.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -49.75 -35.43 22.27 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -177.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.82 -28.6 44.48 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -178.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.695 HG12 ' CD1' ' A' ' 46' ' ' PHE . 7.2 tp -86.4 -43.04 16.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.27 0.557 . . . . 0.0 110.883 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.5 -38.08 86.03 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.824 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.19 -17.7 79.64 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.052 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.79 -25.52 32.67 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.857 0.361 . . . . 0.0 111.0 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 93.7 t -62.04 -47.76 91.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.569 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.82 -41.21 97.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.665 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.78 -29.4 67.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.453 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.2 t -85.63 -7.21 58.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.266 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.06 24.12 72.54 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.52 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 146.2 176.93 20.46 Favored Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.589 HG12 ' N ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -79.53 151.14 4.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.564 0.697 . . . . 0.0 110.598 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.776 ' HB3' HG23 ' A' ' 32' ' ' VAL . 44.8 t0 -158.85 -122.94 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.294 -178.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.57 ' O ' ' HB2' ' A' ' 33' ' ' LEU . 23.1 tp 174.0 -62.93 0.0 OUTLIER Pre-proline 0 C--O 1.214 -0.77 0 C-N-CA 124.836 1.254 . . . . 0.0 108.905 178.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.689 ' HG2' ' HA2' ' B' ' 114' ' ' GLY . 9.3 Cg_endo -54.91 -37.16 93.24 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 121.687 1.592 . . . . 0.0 112.155 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.478 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 0.1 OUTLIER -87.37 -43.34 12.19 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.656 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.776 HG23 ' HB3' ' A' ' 28' ' ' ASP . 10.6 t -70.11 -34.77 60.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -178.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.57 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 0.8 OUTLIER -60.52 -35.6 76.37 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.098 0.475 . . . . 0.0 110.273 179.792 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -54.61 -31.48 57.19 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.467 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -72.57 -24.91 61.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.814 0.34 . . . . 0.0 110.843 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.452 HD13 ' HA ' ' A' ' 43' ' ' ALA . 11.8 mt -92.25 9.5 33.55 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.794 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.402 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 18.8 mmtp -68.58 -175.23 0.64 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.834 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 37' ' ' LYS . . . 76.61 -42.9 0.44 Allowed 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.676 0.79 . . . . 0.0 110.318 -178.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -131.22 63.93 1.59 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 178.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -63.37 -8.77 9.66 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -177.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -59.29 -32.64 72.63 Favored Glycine 0 CA--C 1.518 0.244 0 C-N-CA 121.01 -0.614 . . . . 0.0 113.632 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.513 ' SG ' ' HB2' ' A' ' 9' ' ' LYS . 64.5 m -107.54 24.91 12.15 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 122.385 -0.479 . . . . 0.0 111.321 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.452 ' HA ' HD13 ' A' ' 36' ' ' LEU . . . -88.99 -19.81 25.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.531 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.7 p -56.36 -33.43 65.68 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.331 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.435 ' HB3' ' HB3' ' A' ' 13' ' ' CYS . 7.6 t -47.7 -46.53 29.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.693 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.695 ' CD1' HG12 ' A' ' 17' ' ' ILE . 72.4 t80 -71.31 -50.82 28.65 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -179.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.628 ' HA ' ' HB2' ' A' ' 50' ' ' HIS . 0.1 OUTLIER -86.76 26.8 1.06 Allowed 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 -177.202 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -53.12 -53.68 46.84 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 119.428 1.013 . . . . 0.0 110.48 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -103.77 20.11 18.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.225 0.536 . . . . 0.0 109.789 178.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.628 ' HB2' ' HA ' ' A' ' 47' ' ' CYS . 90.9 m-70 -126.29 62.22 1.27 Allowed 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.278 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 64.6 m -92.49 49.4 1.48 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.632 0.729 . . . . 0.0 109.758 178.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.604 ' CE1' ' HB3' ' B' ' 92' ' ' CYS . 49.7 t-80 -132.33 94.19 3.39 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.551 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.584 ' HA3' ' HB2' ' B' ' 91' ' ' PRO . . . 130.89 -144.91 16.4 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 119.485 -1.341 . . . . 0.0 114.839 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.522 HG21 ' HA ' ' A' ' 30' ' ' PRO . 14.3 m -60.4 -25.97 35.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -177.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.545 ' SG ' ' HB2' ' A' ' 60' ' ' LEU . 34.9 t -76.83 -44.08 33.84 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.044 -0.662 . . . . 0.0 111.826 -178.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.48 -13.45 61.06 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.062 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -66.99 -40.84 87.47 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.988 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.6 mt -93.48 2.7 56.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.517 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 58.98 54.16 5.19 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.619 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.545 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 87.1 mt -94.48 -39.91 10.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.741 -179.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 26.3 p . . . . . 0 C--O 1.245 0.866 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.302 179.751 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.261 0 CA-C-O 120.597 0.237 . . . . 0.0 110.468 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' MET . . . . . . . . . . . . . 15.4 ptp -132.88 -22.02 2.11 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.751 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -164.38 -161.64 13.83 Favored Glycine 0 CA--C 1.507 -0.439 0 C-N-CA 120.387 -0.911 . . . . 0.0 112.458 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -115.38 -53.54 2.6 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 121.005 -0.278 . . . . 0.0 111.255 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 66' ' ' CYS . . . . . . . . . . . . . 46.0 t -111.64 105.22 13.69 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -178.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.572 ' OG ' ' HE2' ' B' ' 70' ' ' LYS . 49.1 m 53.59 -160.96 0.13 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.258 -0.883 . . . . 0.0 113.377 178.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 13.3 m -120.62 -50.29 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.995 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 3.9 pp -86.22 -18.51 31.94 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.479 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 70' ' ' LYS . . . . . 0.572 ' HE2' ' OG ' ' B' ' 67' ' ' SER . 37.1 mtmt -91.87 14.87 14.32 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 177.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . 0.416 ' C ' ' H ' ' B' ' 73' ' ' ALA . 70.0 tttt -89.11 22.22 2.87 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.026 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 2.4 t -68.66 0.01 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-O 121.252 0.549 . . . . 0.0 109.816 178.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.416 ' H ' ' C ' ' B' ' 71' ' ' LYS . . . 72.29 25.82 2.79 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.558 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 3.2 m 64.04 -5.97 0.28 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.378 -0.828 . . . . 0.0 113.182 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.66 -45.88 88.4 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -177.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.81 -3.06 11.01 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -123.49 -20.11 5.67 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.561 ' O ' HG23 ' B' ' 82' ' ' VAL . 4.0 tp -112.0 -44.95 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.722 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.64 -32.83 74.4 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.186 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.02 -24.01 60.5 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.366 -0.921 . . . . 0.0 111.724 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.4 -19.69 57.87 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.586 0.231 . . . . 0.0 111.332 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 82' ' ' VAL . . . . . 0.561 HG23 ' O ' ' B' ' 78' ' ' ILE . 80.9 t -65.1 -52.51 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.691 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.89 -34.46 77.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.736 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.64 -38.51 89.59 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.44 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 16.0 t -85.84 -26.21 25.82 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.344 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.76 46.04 7.45 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.02 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 152.94 132.71 1.79 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.986 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 4.7 tp -93.19 135.89 26.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.312 0.577 . . . . 0.0 111.261 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 89' ' ' ASP . . . . . 0.517 ' H ' HG21 ' B' ' 93' ' ' VAL . 47.2 t0 -163.85 -98.82 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 90' ' ' LEU . . . . . 0.774 HD12 ' HB2' ' B' ' 94' ' ' LEU . 59.8 tp -170.11 -58.93 0.0 OUTLIER Pre-proline 0 C--O 1.223 -0.332 0 CA-C-O 119.187 -0.435 . . . . 0.0 111.03 178.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 91' ' ' PRO . . . . . 0.584 ' HB2' ' HA3' ' A' ' 53' ' ' GLY . 2.0 Cg_endo -39.59 -58.79 0.77 Allowed 'Trans proline' 0 C--N 1.363 1.301 0 C-N-CA 123.623 2.882 . . . . 0.0 114.705 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 92' ' ' CYS . . . . . 0.604 ' HB3' ' CE1' ' A' ' 52' ' ' HIS . 8.6 t -84.2 -30.71 25.56 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -178.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . 0.517 HG21 ' H ' ' B' ' 89' ' ' ASP . 2.6 t -71.69 -49.62 44.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -178.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 94' ' ' LEU . . . . . 0.774 ' HB2' HD12 ' B' ' 90' ' ' LEU . 2.1 tm? -63.43 -35.16 79.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.955 0.407 . . . . 0.0 110.91 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -53.83 -33.28 55.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.431 -179.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -82.61 -16.96 46.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.95 0.405 . . . . 0.0 111.37 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 97' ' ' LEU . . . . . 0.411 HD13 HD13 ' B' ' 78' ' ' ILE . 6.6 tt -81.69 -10.16 59.46 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.732 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 42.5 mtpt -67.16 72.17 0.11 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.063 0.459 . . . . 0.0 111.924 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -156.67 -40.18 0.07 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -110.25 63.72 0.61 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.874 178.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -59.22 162.42 4.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.06 -178.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 88.05 -45.55 3.31 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.312 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 71.6 m -78.38 -6.26 54.66 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 111.537 0.199 . . . . 0.0 111.537 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.16 -13.62 13.07 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 13.0 m -64.94 -27.25 68.71 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.517 0.192 . . . . 0.0 111.517 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 106' ' ' CYS . . . . . 0.429 ' SG ' ' N ' ' B' ' 107' ' ' PHE . 16.6 p -48.9 -57.42 6.48 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.276 0.56 . . . . 0.0 111.415 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . 0.536 ' CD2' HG12 ' B' ' 78' ' ' ILE . 0.5 OUTLIER -80.27 -54.21 5.94 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.574 -179.693 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 76.1 m -82.27 42.84 0.76 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -178.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -77.11 -62.36 1.68 Allowed 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -90.92 7.35 40.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.876 178.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 40.4 m-70 -126.58 79.55 1.87 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.976 -1.011 . . . . 0.0 108.294 178.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 112' ' ' CYS . . . . . 0.411 ' O ' ' HB3' ' B' ' 117' ' ' LYS . 4.0 t -98.28 32.59 2.42 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -177.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 113' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -121.87 -160.38 0.86 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 178.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 114' ' ' GLY . . . . . 0.689 ' HA2' ' HG2' ' A' ' 30' ' ' PRO . . . 66.86 -145.13 46.25 Favored Glycine 0 C--O 1.226 -0.346 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.364 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . 0.507 HG23 ' HB3' ' B' ' 94' ' ' LEU . 8.2 m -78.56 -2.82 5.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 117.228 0.514 . . . . 0.0 110.518 178.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 116' ' ' CYS . . . . . 0.462 ' SG ' ' HG ' ' B' ' 94' ' ' LEU . 0.5 OUTLIER -82.56 -26.86 32.01 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.709 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 117' ' ' LYS . . . . . 0.561 ' HG2' ' O ' ' B' ' 114' ' ' GLY . 14.0 ptmm? -84.33 -6.67 59.42 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 177.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -65.17 -45.77 83.55 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 178.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 66.0 mt -87.13 -33.62 19.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.974 -1.012 . . . . 0.0 108.585 177.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 58.75 75.28 0.4 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 114.464 -1.243 . . . . 0.0 111.866 179.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.97 21.75 4.15 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.856 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 122' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.243 0.759 0 CA-C-O 118.426 -0.797 . . . . 0.0 110.753 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.291 0 CA-C-O 120.88 0.371 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 85.8 mtp -127.74 168.18 15.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.826 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -166.72 159.95 33.44 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.321 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -76.49 -61.43 1.96 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.997 0.427 . . . . 0.0 110.078 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 14.4 t -122.86 26.82 8.0 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.513 0.673 . . . . 0.0 109.375 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.1 p -131.5 -175.92 3.86 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.29 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 49.5 t 66.56 -74.99 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 O-C-N 123.649 0.593 . . . . 0.0 111.327 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 28.7 tp -82.52 -32.94 28.45 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.5 mptt -88.34 19.83 3.6 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.906 177.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.41 ' HB3' ' HE2' ' A' ' 10' ' ' LYS . 32.6 ttpt -66.68 -15.19 63.32 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.681 179.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.3 t -90.96 35.02 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.883 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 60.32 46.57 9.95 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.319 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.488 ' O ' HG22 ' A' ' 17' ' ' ILE . 18.1 p 50.38 9.31 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.412 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -70.76 -34.77 72.18 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 118.213 0.46 . . . . 0.0 112.134 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.83 -6.25 36.53 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.97 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -114.34 -35.18 5.05 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.5 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.812 HG12 ' CD2' ' A' ' 46' ' ' PHE . 5.3 tp -93.53 -50.81 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.114 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.619 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.436 ' N ' HG23 ' A' ' 17' ' ' ILE . . . -63.71 -31.64 72.88 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.119 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.53 -24.67 74.34 Favored Glycine 0 N--CA 1.451 -0.357 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 177.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.503 ' CB ' ' HB3' ' A' ' 35' ' ' ALA . . . -76.31 -26.58 55.98 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.114 0.483 . . . . 0.0 110.392 178.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 17' ' ' ILE . 57.9 t -63.46 -50.08 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.473 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.51 -31.64 71.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.93 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.7 -41.67 78.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.759 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.6 t -84.77 -22.97 29.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.861 0.363 . . . . 0.0 110.74 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 111.1 -38.38 3.31 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.683 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -137.19 167.25 24.75 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.236 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.8 tp -96.2 133.86 35.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.071 0.463 . . . . 0.0 111.061 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.515 ' OD2' ' HD2' ' A' ' 30' ' ' PRO . 9.2 t70 -163.82 -111.16 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.699 HD11 ' HB2' ' A' ' 55' ' ' CYS . 38.8 tp -168.16 -54.01 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 178.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.744 ' HB2' ' HA3' ' B' ' 114' ' ' GLY . 86.5 Cg_exo -46.7 -53.03 6.65 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 122.596 2.197 . . . . 0.0 113.887 -179.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.635 ' HB3' ' CE1' ' B' ' 113' ' ' HIS . 7.7 t -81.33 -33.11 32.71 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.555 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.465 HG23 ' HE1' ' B' ' 113' ' ' HIS . 2.8 t -65.14 -28.72 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-O 121.055 0.455 . . . . 0.0 110.895 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.423 ' O ' HD13 ' A' ' 33' ' ' LEU . 1.9 tm? -61.98 -39.0 90.67 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.641 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.33 -46.23 89.18 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.503 ' HB3' ' CB ' ' A' ' 20' ' ' ALA . . . -78.84 -13.61 59.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.785 0.326 . . . . 0.0 111.402 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 23.0 tp -73.76 -53.05 11.18 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -167.11 -21.99 0.02 OUTLIER 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.251 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 66.61 25.78 9.88 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.118 -179.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -166.57 -170.64 1.67 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.79 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.424 ' HG2' HD11 ' A' ' 60' ' ' LEU . 48.2 mt-10 -64.22 131.37 47.19 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 123.064 0.228 . . . . 0.0 111.249 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 145.7 140.59 3.53 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 119.945 -1.122 . . . . 0.0 113.371 179.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 90.2 m 61.64 31.85 18.61 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.624 ' CB ' ' HB3' ' A' ' 60' ' ' LEU . . . -80.59 -44.36 19.07 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.384 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 12.2 m -68.8 -16.11 63.69 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.903 0.383 . . . . 0.0 111.268 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 42.5 t -78.09 -54.91 5.73 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.944 0.402 . . . . 0.0 111.276 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.812 ' CD2' HG12 ' A' ' 17' ' ' ILE . 3.6 t80 -102.18 -49.75 3.82 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -178.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.417 ' SG ' ' HD1' ' A' ' 46' ' ' PHE . 21.2 m -72.96 13.56 0.38 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -177.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 44' ' ' SER . 16.5 tp10 -69.6 -53.66 17.72 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.142 0.496 . . . . 0.0 111.185 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -66.38 -23.95 66.41 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.079 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -135.23 103.78 5.65 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 96.0 m -112.65 81.07 1.42 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 177.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.644 ' CE1' ' HB3' ' B' ' 92' ' ' CYS . 2.6 t-80 -142.16 -34.52 0.46 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -177.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.807 ' HA2' ' HB2' ' B' ' 91' ' ' PRO . . . -87.16 -162.45 37.7 Favored Glycine 0 CA--C 1.518 0.266 0 N-CA-C 115.587 0.995 . . . . 0.0 115.587 -178.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.4 ' CG1' ' HA ' ' A' ' 30' ' ' PRO . 7.7 p -58.44 -10.49 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 124.409 1.084 . . . . 0.0 112.575 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.699 ' HB2' HD11 ' A' ' 29' ' ' LEU . 18.0 t -77.99 -31.49 50.73 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 121.999 -0.438 . . . . 0.0 111.071 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.607 ' HG3' ' O ' ' A' ' 53' ' ' GLY . 0.1 OUTLIER -90.34 -2.35 57.98 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.466 179.819 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.424 ' O ' ' HB3' ' A' ' 58' ' ' LEU . 52.9 t0 -56.46 122.47 12.0 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.647 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.685 ' O ' ' HB2' ' A' ' 59' ' ' HIS . 45.2 tp 90.24 -64.94 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.029 1.332 . . . . 0.0 108.699 -177.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.685 ' HB2' ' O ' ' A' ' 58' ' ' LEU . 26.5 t-80 153.03 121.13 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.911 0 O-C-N 124.763 1.289 . . . . 0.0 109.303 178.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.624 ' HB3' ' CB ' ' A' ' 43' ' ' ALA . 22.1 mt -147.3 -55.85 0.24 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 19.1 p . . . . . 0 C--O 1.246 0.906 0 CA-C-O 118.435 -0.793 . . . . 0.0 110.747 -179.812 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.199 0 CA-C-O 120.738 0.304 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' MET . . . . . . . . . . . . . 9.9 ptm -149.33 -37.49 0.16 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.074 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 48.11 -144.47 6.36 Favored Glycine 0 C--N 1.334 0.446 0 N-CA-C 115.05 0.78 . . . . 0.0 115.05 178.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . 0.444 ' O ' ' HD3' ' B' ' 70' ' ' LYS . 33.9 ttmt -89.41 -98.83 0.1 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.201 -0.5 . . . . 0.0 110.017 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 66' ' ' CYS . . . . . . . . . . . . . 66.0 m -119.47 19.87 12.58 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.342 0.591 . . . . 0.0 109.872 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 10.3 p -127.05 -176.99 3.88 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.225 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 22.7 t 64.68 -80.64 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 O-C-N 123.704 0.627 . . . . 0.0 111.519 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 44.2 tp -78.75 -38.48 38.67 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 70' ' ' LYS . . . . . 0.444 ' HD3' ' O ' ' B' ' 65' ' ' LYS . 6.6 mptt -87.15 22.27 2.13 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.258 178.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . 0.45 ' C ' ' H ' ' B' ' 73' ' ' ALA . 33.0 ttmt -66.41 -15.18 63.11 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.863 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 2.3 t -80.54 33.55 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.015 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.45 ' H ' ' C ' ' B' ' 71' ' ' LYS . . . 62.03 55.45 2.51 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.863 -1.062 . . . . 0.0 112.048 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 74' ' ' CYS . . . . . 0.501 ' O ' HG22 ' B' ' 78' ' ' ILE . 9.7 p 57.58 -4.18 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.624 1.169 . . . . 0.0 114.138 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 75' ' ' ALA . . . . . 0.487 ' HA ' HG22 ' B' ' 78' ' ' ILE . . . -67.13 -26.32 66.62 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.82 -9.09 25.65 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -120.75 -34.28 3.61 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.606 HG12 ' CD1' ' B' ' 107' ' ' PHE . 7.8 tp -82.79 -48.5 17.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.118 0.485 . . . . 0.0 111.683 -179.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.81 -24.9 59.54 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.106 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.18 -22.85 70.0 Favored Glycine 0 C--N 1.329 0.183 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.12 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -80.65 -17.81 50.04 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.092 0.472 . . . . 0.0 110.623 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 82' ' ' VAL . . . . . 0.469 HG22 HD13 ' B' ' 88' ' ' ILE . 60.4 t -66.78 -43.44 89.86 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.453 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.24 6.48 11.76 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.917 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -110.26 -19.68 12.92 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 3.0 t -120.03 12.23 11.9 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.515 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 71.06 33.82 65.08 Favored Glycine 0 CA--C 1.519 0.285 0 N-CA-C 114.693 0.637 . . . . 0.0 114.693 178.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 148.36 -177.05 26.87 Favored Glycine 0 CA--C 1.51 -0.269 0 C-N-CA 119.864 -1.16 . . . . 0.0 112.543 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 88' ' ' ILE . . . . . 0.469 HD13 HG22 ' B' ' 82' ' ' VAL . 4.4 tp -123.23 134.7 65.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.994 0.426 . . . . 0.0 111.043 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 89' ' ' ASP . . . . . 0.565 ' H ' HG21 ' B' ' 93' ' ' VAL . 28.7 t70 -156.47 -102.38 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 90' ' ' LEU . . . . . 0.598 HD11 ' HB2' ' B' ' 116' ' ' CYS . 22.1 tp -167.09 -59.06 0.01 OUTLIER Pre-proline 0 N--CA 1.469 0.488 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 177.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 91' ' ' PRO . . . . . 0.998 ' HA ' HG11 ' B' ' 115' ' ' VAL . 2.1 Cg_endo -43.87 -56.2 2.58 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 123.049 2.499 . . . . 0.0 114.631 -178.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 92' ' ' CYS . . . . . 0.644 ' HB3' ' CE1' ' A' ' 52' ' ' HIS . 12.3 t -81.22 -32.85 33.25 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . 0.565 HG21 ' H ' ' B' ' 89' ' ' ASP . 0.2 OUTLIER -68.02 -29.2 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-O 120.668 0.27 . . . . 0.0 111.217 -179.197 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -62.21 -39.15 91.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.222 0.534 . . . . 0.0 110.252 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.35 -43.53 85.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.206 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.6 19.51 4.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.68 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 97' ' ' LEU . . . . . 0.44 HD13 HD13 ' B' ' 78' ' ' ILE . 35.8 tp -77.04 -52.62 9.01 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.17 0.509 . . . . 0.0 109.708 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -140.82 -64.33 0.46 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.181 179.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -176.35 -60.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.893 -1.049 . . . . 0.0 108.578 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -131.89 -56.28 0.99 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.116 178.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -130.56 156.46 44.8 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.883 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 128.91 127.12 2.93 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 119.86 -1.162 . . . . 0.0 114.002 178.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 87.7 m 58.43 31.81 21.38 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -90.1 -24.92 20.99 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 18.0 t -64.45 -47.2 79.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.72 0.295 . . . . 0.0 110.863 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 37.0 t -60.16 -50.24 74.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.917 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . 0.606 ' CD1' HG12 ' B' ' 78' ' ' ILE . 52.9 t80 -73.09 -58.55 3.23 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -178.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 21.7 m -79.03 34.14 0.23 Allowed 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -177.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 19.1 tp10 -63.31 -80.99 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 118.154 0.433 . . . . 0.0 110.373 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -76.32 -30.55 57.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.505 0.669 . . . . 0.0 109.294 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 111' ' ' HIS . . . . . 0.418 ' HD2' ' O ' ' B' ' 107' ' ' PHE . 5.6 m-70 -81.87 71.07 8.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.647 179.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 9.8 t -128.84 84.47 2.23 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.116 0.484 . . . . 0.0 110.057 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 113' ' ' HIS . . . . . 0.635 ' CE1' ' HB3' ' A' ' 31' ' ' CYS . 9.3 t-80 -126.08 -47.48 1.63 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.289 -178.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 114' ' ' GLY . . . . . 0.744 ' HA3' ' HB2' ' A' ' 30' ' ' PRO . . . -147.41 164.68 28.71 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 119.997 -1.097 . . . . 0.0 113.401 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . 0.998 HG11 ' HA ' ' B' ' 91' ' ' PRO . 0.5 OUTLIER 61.88 -45.0 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 125.581 1.552 . . . . 0.0 113.253 179.626 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 116' ' ' CYS . . . . . 0.598 ' HB2' HD11 ' B' ' 90' ' ' LEU . 6.9 t -87.2 -30.23 21.14 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -90.74 4.47 51.47 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.375 178.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -63.01 -32.44 73.8 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.352 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 25.5 tp -112.78 -114.71 0.33 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -141.51 59.13 1.51 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 86.2 mt -99.24 -35.93 9.81 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 122' ' ' CYS . . . . . . . . . . . . . 3.4 p . . . . . 0 C--O 1.245 0.824 0 CA-C-O 118.345 -0.836 . . . . 0.0 110.286 179.339 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.231 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 18.9 ptm -72.18 125.35 27.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.947 0.403 . . . . 0.0 110.54 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 128.85 128.31 3.05 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.77 -0.728 . . . . 0.0 111.904 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.4 ttmm -67.02 -30.09 70.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.175 0.512 . . . . 0.0 110.747 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 52.3 t -67.19 -40.47 86.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.338 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.1 p -76.79 29.88 0.13 Allowed 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 46.2 t -120.78 -55.98 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 178.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 34.9 tp -98.99 -39.11 8.7 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.506 ' HD3' ' N ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -92.24 26.15 2.65 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 176.915 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.51 ' C ' ' H ' ' A' ' 12' ' ' ALA . 46.7 pttt -59.64 -17.79 36.52 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.098 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.5 t -75.2 26.38 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.043 179.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.51 ' H ' ' C ' ' A' ' 10' ' ' LYS . . . 60.36 51.07 5.58 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.709 0.804 . . . . 0.0 111.9 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.83 ' HB3' HD12 ' A' ' 17' ' ' ILE . 76.4 m 73.21 -17.97 0.39 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.97 0.729 . . . . 0.0 112.97 179.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.673 ' HA ' ' HB3' ' A' ' 18' ' ' ALA . . . -73.7 16.99 0.17 Allowed 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.454 ' HB3' ' HA ' ' A' ' 9' ' ' LYS . . . -104.44 -31.46 9.48 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.733 0.302 . . . . 0.0 111.109 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -123.37 -48.84 1.94 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.476 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.83 HD12 ' HB3' ' A' ' 13' ' ' CYS . 69.3 mt -64.19 -45.92 94.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-O 121.42 0.629 . . . . 0.0 109.569 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.673 ' HB3' ' HA ' ' A' ' 14' ' ' ALA . . . -110.44 31.71 5.73 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.156 178.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -129.63 -43.23 0.21 Allowed Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.73 -0.747 . . . . 0.0 111.968 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.669 ' HB3' HG13 ' A' ' 32' ' ' VAL . . . -87.35 19.92 3.05 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.997 0.427 . . . . 0.0 111.343 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.452 HG13 ' N ' ' A' ' 22' ' ' ALA . 12.5 p -65.92 -45.57 90.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.974 0.892 . . . . 0.0 110.286 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.452 ' N ' HG13 ' A' ' 21' ' ' VAL . . . -64.46 -26.42 68.44 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.555 -1.202 . . . . 0.0 111.629 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.8 -40.06 95.73 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.587 ' SG ' ' HA3' ' B' ' 114' ' ' GLY . 4.5 t -97.07 1.6 50.27 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.768 0.318 . . . . 0.0 110.801 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.42 42.43 82.02 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.519 -0.848 . . . . 0.0 111.426 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 144.35 156.03 6.66 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.403 ' HB ' HG23 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -87.19 133.92 28.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 117.595 0.697 . . . . 0.0 111.389 -179.035 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.632 ' OD1' ' HB3' ' A' ' 31' ' ' CYS . 1.2 p30 -143.55 -112.25 0.11 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.308 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.785 HD21 ' HB3' ' A' ' 55' ' ' CYS . 12.5 tp -179.28 -56.56 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.449 0 C-N-CA 122.358 0.263 . . . . 0.0 111.7 178.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.916 ' HB3' HG13 ' A' ' 54' ' ' VAL . 8.7 Cg_exo -76.05 -4.12 14.73 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 121.874 1.716 . . . . 0.0 113.177 -178.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.707 ' HB2' HG13 ' B' ' 115' ' ' VAL . 21.6 t -104.88 -38.95 6.45 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 177.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.669 HG13 ' HB3' ' A' ' 20' ' ' ALA . 42.3 t -78.64 -10.77 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.221 178.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.581 ' HG ' ' HB2' ' A' ' 37' ' ' LYS . 6.3 tp -54.21 -29.17 45.23 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.945 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -46.95 -45.82 21.04 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -178.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -102.88 33.23 3.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.982 0.42 . . . . 0.0 111.16 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.411 ' HG ' ' HA2' ' A' ' 41' ' ' GLY . 5.5 tp -137.14 -41.59 0.58 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.761 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.581 ' HB2' ' HG ' ' A' ' 33' ' ' LEU . 1.8 tmtp? -59.96 -35.11 74.25 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -177.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.23 -64.18 1.04 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -178.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.487 ' O ' ' HE2' ' A' ' 9' ' ' LYS . . . -93.81 55.01 2.07 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -178.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.854 ' HG2' ' H ' ' A' ' 42' ' ' CYS . 85.0 tt0 70.83 137.63 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.337 0.589 . . . . 0.0 111.517 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.562 ' HA3' HD11 ' A' ' 60' ' ' LEU . . . -79.32 -11.23 85.19 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.715 -0.755 . . . . 0.0 113.186 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.854 ' H ' ' HG2' ' A' ' 40' ' ' GLU . 33.9 m 69.75 94.61 0.07 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 122.96 0.504 . . . . 0.0 111.193 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.44 ' C ' ' H ' ' A' ' 45' ' ' CYS . . . -65.96 153.43 42.11 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.902 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.6 p 66.76 -29.09 0.13 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.624 1.169 . . . . 0.0 112.365 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.44 ' H ' ' C ' ' A' ' 43' ' ' ALA . 6.0 t -78.15 -70.13 0.51 Allowed 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.56 ' HD1' ' CE1' ' A' ' 50' ' ' HIS . 0.1 OUTLIER -90.18 165.31 14.03 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 175.514 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.788 ' HB3' ' SG ' ' A' ' 61' ' ' CYS . 73.4 m 72.66 -0.68 3.24 Favored 'General case' 0 C--O 1.216 -0.68 0 O-C-N 123.364 0.415 . . . . 0.0 111.642 -178.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.549 ' OE1' ' HA ' ' A' ' 48' ' ' GLU . 5.1 tp10 -61.35 -93.32 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.274 0.559 . . . . 0.0 111.187 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.458 ' H ' ' HB3' ' A' ' 48' ' ' GLU . 17.8 t70 -70.35 -33.33 71.33 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 178.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.56 ' CE1' ' HD1' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -88.61 56.95 3.97 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 112.466 -2.152 . . . . 0.0 109.535 178.463 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 14.8 t -93.63 63.77 3.46 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 17.2 t-160 -163.49 136.25 5.35 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.06 -177.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 117.0 -157.7 14.91 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 119.864 -1.16 . . . . 0.0 113.78 178.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.916 HG13 ' HB3' ' A' ' 30' ' ' PRO . 3.5 m -70.73 -5.13 5.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.39 -0.405 . . . . 0.0 112.001 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.785 ' HB3' HD21 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -76.79 -40.94 46.46 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.119 0.485 . . . . 0.0 110.573 -178.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.404 ' HE2' ' HB3' ' A' ' 56' ' ' LYS . 31.6 mtpt -67.46 -10.75 54.45 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.818 179.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -65.59 -33.03 74.96 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.497 HD23 ' O ' ' A' ' 58' ' ' LEU . 2.4 tt -90.19 -21.16 22.31 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.937 178.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 75.06 97.87 0.07 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.377 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.643 ' HB2' ' SG ' ' A' ' 47' ' ' CYS . 26.3 mt -136.84 2.37 2.61 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.144 -179.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.788 ' SG ' ' HB3' ' A' ' 47' ' ' CYS . 29.2 p . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.107 -0.949 . . . . 0.0 109.707 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.169 0 CA-C-O 120.707 0.289 . . . . 0.0 110.399 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' MET . . . . . . . . . . . . . 22.9 ptm -111.01 151.87 27.49 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.395 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.65 173.16 26.87 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.077 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 3.4 ttpm? -131.84 44.59 2.89 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.346 0.593 . . . . 0.0 109.832 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 66' ' ' CYS . . . . . 0.577 ' HB2' ' O ' ' B' ' 101' ' ' GLU . 48.9 t -120.38 -40.89 2.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.274 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 35.1 m -74.17 34.31 0.09 Allowed 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 22.8 t -122.69 -59.01 2.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.407 ' C ' ' H ' ' B' ' 71' ' ' LYS . 52.3 tp -96.04 -40.3 9.32 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 70' ' ' LYS . . . . . 0.407 ' HA ' ' HB3' ' B' ' 76' ' ' ALA . 0.8 OUTLIER -85.26 24.68 1.1 Allowed 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 177.227 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . 0.549 ' C ' ' H ' ' B' ' 73' ' ' ALA . 0.0 OUTLIER -65.51 -10.09 31.62 Favored 'General case' 0 C--N 1.341 0.223 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.558 179.819 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 2.4 t -70.76 21.58 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.868 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.549 ' H ' ' C ' ' B' ' 71' ' ' LYS . . . 63.79 56.98 1.43 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.844 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 74' ' ' CYS . . . . . 0.856 ' HB3' HD12 ' B' ' 78' ' ' ILE . 12.2 m 67.45 0.74 2.26 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.854 0.686 . . . . 0.0 112.854 178.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 75' ' ' ALA . . . . . 0.954 ' HA ' ' HB3' ' B' ' 79' ' ' ALA . . . -82.6 6.62 17.11 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . 0.408 ' O ' ' HA3' ' B' ' 80' ' ' GLY . . . -99.17 -57.52 2.14 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.733 0.302 . . . . 0.0 111.789 -179.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.19 -38.66 12.57 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.856 HD12 ' HB3' ' B' ' 74' ' ' CYS . 71.9 mt -81.71 -55.5 7.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.979 0.419 . . . . 0.0 110.383 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 79' ' ' ALA . . . . . 0.954 ' HB3' ' HA ' ' B' ' 75' ' ' ALA . . . -83.39 14.47 3.61 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.276 0.56 . . . . 0.0 110.853 178.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . 0.408 ' HA3' ' O ' ' B' ' 76' ' ' ALA . . . -114.24 -41.22 0.9 Allowed Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 178.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . 0.685 ' HB3' HG13 ' B' ' 93' ' ' VAL . . . -73.51 -7.31 51.31 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-O 120.976 0.417 . . . . 0.0 110.358 178.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 82' ' ' VAL . . . . . 0.409 HG13 ' N ' ' B' ' 83' ' ' ALA . 13.0 p -60.14 -42.16 89.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-O 121.619 0.723 . . . . 0.0 109.445 178.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . 0.409 ' N ' HG13 ' B' ' 82' ' ' VAL . . . -70.36 -27.29 64.22 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.429 -1.26 . . . . 0.0 111.467 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.69 -46.06 14.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.84 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 38.0 t -79.33 -48.33 14.27 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.903 0.382 . . . . 0.0 110.85 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 117.98 41.09 0.67 Allowed Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.908 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 140.1 176.19 14.89 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.525 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 18.1 mm -104.65 118.85 52.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.158 0.504 . . . . 0.0 111.232 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 89' ' ' ASP . . . . . 0.458 ' CG ' ' H ' ' B' ' 90' ' ' LEU . 7.7 p-10 -138.24 -108.5 0.18 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.029 178.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 90' ' ' LEU . . . . . 0.732 HD11 ' SG ' ' B' ' 108' ' ' CYS . 0.1 OUTLIER -174.87 -53.76 0.0 OUTLIER Pre-proline 0 N--CA 1.451 -0.402 0 C-N-CA 122.367 0.267 . . . . 0.0 111.105 179.621 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 91' ' ' PRO . . . . . 0.947 ' HB3' HG11 ' B' ' 115' ' ' VAL . 27.1 Cg_exo -63.97 -29.9 66.76 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.212 1.941 . . . . 0.0 115.293 -176.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 14.3 p -92.07 -40.5 11.04 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 119.695 -0.802 . . . . 0.0 110.042 179.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . 0.685 HG13 ' HB3' ' B' ' 81' ' ' ALA . 2.5 t -65.83 -27.76 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.699 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 26.1 tp -55.43 -45.3 76.81 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.355 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.8 -45.66 91.63 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.245 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.25 -21.27 59.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.178 0.514 . . . . 0.0 110.787 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 97' ' ' LEU . . . . . 0.652 HD21 ' HB2' ' B' ' 103' ' ' CYS . 10.2 tt -78.66 -29.02 45.48 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.086 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 29.5 tttm -74.7 45.8 0.26 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 112.115 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -98.87 -12.4 20.81 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -151.37 -150.33 0.34 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.504 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . 0.577 ' O ' ' HB2' ' B' ' 66' ' ' CYS . 47.1 mt-10 -112.33 160.64 17.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.765 0.317 . . . . 0.0 111.461 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.35 -141.29 29.69 Favored Glycine 0 N--CA 1.452 -0.285 0 CA-C-N 115.801 -0.636 . . . . 0.0 113.724 178.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 103' ' ' CYS . . . . . 0.652 ' HB2' HD21 ' B' ' 97' ' ' LEU . 82.5 m 72.79 40.13 0.62 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.7 0.762 . . . . 0.0 110.711 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 104' ' ' ALA . . . . . 0.518 ' HB2' HD12 ' B' ' 121' ' ' LEU . . . -114.64 -160.28 0.73 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 177.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 105' ' ' SER . . . . . 0.525 ' O ' ' HB2' ' B' ' 109' ' ' GLU . 15.0 m 68.37 -56.15 0.51 Allowed 'General case' 0 N--CA 1.467 0.418 0 O-C-N 123.584 0.553 . . . . 0.0 112.317 178.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 29.9 p -80.04 -35.74 36.74 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 122.001 -0.437 . . . . 0.0 110.566 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . 0.584 ' CE1' HD22 ' B' ' 90' ' ' LEU . 0.7 OUTLIER -88.63 -97.78 0.09 Allowed 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.248 -178.536 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 108' ' ' CYS . . . . . 0.732 ' SG ' HD11 ' B' ' 90' ' ' LEU . 33.7 m -63.43 33.75 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 115.011 1.486 . . . . 0.0 115.011 -177.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . 0.525 ' HB2' ' O ' ' B' ' 105' ' ' SER . 44.3 tp10 -59.92 -70.44 0.17 Allowed 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 119.301 0.955 . . . . 0.0 110.709 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -92.53 -20.31 21.07 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.082 0.468 . . . . 0.0 110.137 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -86.88 86.63 7.33 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 112' ' ' CYS . . . . . 0.427 ' O ' ' HE2' ' B' ' 117' ' ' LYS . 1.6 t -121.05 43.03 2.9 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.942 0.401 . . . . 0.0 110.416 -178.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 113' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -88.37 121.03 30.31 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.556 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 114' ' ' GLY . . . . . 0.587 ' HA3' ' SG ' ' A' ' 24' ' ' CYS . . . 45.45 -99.86 0.02 OUTLIER Glycine 0 C--O 1.223 -0.566 0 N-CA-C 115.681 1.032 . . . . 0.0 115.681 177.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . 0.947 HG11 ' HB3' ' B' ' 91' ' ' PRO . 12.5 m -29.57 -60.54 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 -177.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 116' ' ' CYS . . . . . 0.524 ' H ' HG23 ' B' ' 115' ' ' VAL . 0.9 OUTLIER -73.34 -30.5 63.38 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.102 -0.639 . . . . 0.0 112.019 -177.755 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 117' ' ' LYS . . . . . 0.427 ' HE2' ' O ' ' B' ' 112' ' ' CYS . 11.9 ttmm -76.08 -11.05 59.87 Favored 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 122.024 -0.422 . . . . 0.0 110.09 178.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -67.83 -43.29 79.89 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 178.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 119' ' ' LEU . . . . . 0.581 ' HB3' ' CD2' ' B' ' 121' ' ' LEU . 5.1 tt -78.28 -36.47 46.68 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 177.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 14.1 t-80 78.82 75.58 0.05 Allowed 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 114.693 -1.14 . . . . 0.0 111.656 178.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 121' ' ' LEU . . . . . 0.581 ' CD2' ' HB3' ' B' ' 119' ' ' LEU . 0.4 OUTLIER -128.16 13.39 6.68 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.378 179.47 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 122' ' ' CYS . . . . . . . . . . . . . 3.6 p . . . . . 0 C--O 1.246 0.869 0 CA-C-O 118.293 -0.861 . . . . 0.0 110.478 179.212 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.242 0 CA-C-O 120.527 0.203 . . . . 0.0 111.012 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 73.8 mtp -124.06 -11.71 7.53 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -71.17 92.27 0.48 Allowed Glycine 0 CA--C 1.516 0.128 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.872 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.45 ' HB3' ' H ' ' A' ' 5' ' ' CYS . 19.4 tptm 57.45 -93.62 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.422 0.689 . . . . 0.0 110.575 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.605 ' HB2' ' OG ' ' A' ' 44' ' ' SER . 49.5 t -141.75 143.05 33.3 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.518 ' HB2' ' HE2' ' A' ' 10' ' ' LYS . 6.2 m -66.17 117.57 8.66 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 12' ' ' ALA . 18.8 m -119.71 -27.2 2.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -178.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.757 HD23 ' H ' ' A' ' 8' ' ' LEU . 0.4 OUTLIER -73.2 -51.07 19.13 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 -178.826 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.7 mmtt -83.79 -12.96 54.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.716 0.293 . . . . 0.0 111.333 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.656 ' NZ ' ' HG3' ' A' ' 40' ' ' GLU . 16.7 ttmm -91.81 33.8 1.02 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.703 0.287 . . . . 0.0 111.335 -178.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.3 t 53.15 41.33 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 123.514 0.726 . . . . 0.0 112.138 178.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.414 ' HA ' ' O ' ' A' ' 7' ' ' VAL . . . 51.68 36.18 16.86 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.973 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.434 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 95.7 m 64.89 14.14 9.05 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -99.31 14.86 28.13 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.41 -68.97 0.79 Allowed 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -87.65 -3.15 58.98 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -178.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.744 HD13 ' HB2' ' A' ' 46' ' ' PHE . 45.3 mt -112.64 -62.86 2.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.548 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.27 -34.72 72.6 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.86 -37.84 18.03 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.689 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.04 -28.21 60.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.021 0.439 . . . . 0.0 111.677 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.462 HG13 ' N ' ' A' ' 27' ' ' ILE . 1.9 t -66.36 -43.17 91.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.617 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.64 -25.66 64.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.149 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.75 -24.39 63.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.651 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 12.4 t -89.17 -31.93 17.71 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.755 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 128.55 17.23 1.95 Allowed Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.093 -1.051 . . . . 0.0 113.88 178.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 116.14 114.65 2.86 Favored Glycine 0 C--O 1.227 -0.309 0 C-N-CA 120.24 -0.981 . . . . 0.0 112.29 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.462 ' N ' HG13 ' A' ' 21' ' ' VAL . 1.4 tt 19.13 94.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.621 ' HB3' HG23 ' A' ' 32' ' ' VAL . 6.8 t0 -127.73 143.34 51.15 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 114.18 -1.373 . . . . 0.0 107.616 177.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.781 ' HB3' ' HD3' ' A' ' 30' ' ' PRO . 36.7 tp -106.88 -58.49 0.05 OUTLIER Pre-proline 0 C--N 1.303 -1.429 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.232 -179.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.781 ' HD3' ' HB3' ' A' ' 29' ' ' LEU . 25.9 Cg_exo -62.59 -28.22 77.0 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 121.93 1.753 . . . . 0.0 112.594 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.602 ' HB3' ' CG ' ' A' ' 28' ' ' ASP . 0.1 OUTLIER -84.46 -41.31 16.73 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.764 -179.147 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.621 HG23 ' HB3' ' A' ' 28' ' ' ASP . 45.1 t -84.91 -6.22 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-O 121.174 0.511 . . . . 0.0 111.021 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.461 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 2.4 tm? -54.37 -45.46 72.79 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.326 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.77 -36.86 80.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.529 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.08 2.02 52.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.805 0.336 . . . . 0.0 111.493 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 57.4 tp -97.3 -32.32 11.95 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.322 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -75.93 -26.5 56.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.19 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -106.9 -179.71 4.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.628 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 57.49 31.91 20.99 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 123.568 0.542 . . . . 0.0 112.286 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.656 ' HG3' ' NZ ' ' A' ' 10' ' ' LYS . 11.6 tp10 53.69 67.91 0.93 Allowed 'General case' 0 CA--C 1.534 0.348 0 O-C-N 123.611 0.569 . . . . 0.0 110.509 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -79.5 -166.07 31.67 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.73 -0.668 . . . . 0.0 113.493 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.488 ' HB2' ' CD ' ' A' ' 10' ' ' LYS . 47.0 t -160.31 88.83 0.82 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.635 ' CB ' ' HB3' ' A' ' 60' ' ' LEU . . . -68.44 -42.03 79.46 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -178.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.605 ' OG ' ' HB2' ' A' ' 5' ' ' CYS . 2.4 p -75.56 28.4 0.1 Allowed 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.363 0.602 . . . . 0.0 112.438 -179.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.445 ' H ' ' C ' ' A' ' 43' ' ' ALA . 20.1 t -139.6 -18.21 0.97 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.744 ' HB2' HD13 ' A' ' 17' ' ' ILE . 0.8 OUTLIER -111.0 -63.17 1.43 Allowed 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.785 -179.311 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 19.8 m -79.12 25.34 0.29 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.473 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -52.94 -62.31 1.74 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.642 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -92.74 -31.8 14.93 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -79.47 76.05 6.07 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.432 ' SG ' ' HB3' ' A' ' 56' ' ' LYS . 4.0 t -128.31 52.45 1.9 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -177.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 15.9 p-80 -122.46 82.64 2.0 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.637 0.732 . . . . 0.0 110.712 178.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.75 172.77 44.21 Favored Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.479 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.768 HG11 ' HA ' ' A' ' 30' ' ' PRO . 44.9 t 63.61 -73.32 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 123.297 0.639 . . . . 0.0 112.59 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.735 ' HB2' HD11 ' A' ' 29' ' ' LEU . 38.9 t -71.72 -44.38 64.23 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.407 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.432 ' HB3' ' SG ' ' A' ' 51' ' ' CYS . 0.1 OUTLIER -88.05 13.31 11.4 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 119.899 -0.72 . . . . 0.0 110.603 179.17 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -69.14 -35.35 76.26 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 177.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -95.58 -4.13 45.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 113.972 -1.467 . . . . 0.0 108.521 177.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.402 ' H ' ' C ' ' A' ' 56' ' ' LYS . 75.1 m-70 65.91 75.25 0.35 Allowed 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 114.414 -1.266 . . . . 0.0 110.912 -178.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.635 ' HB3' ' CB ' ' A' ' 43' ' ' ALA . 88.6 mt -106.06 -31.29 8.79 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.36 -179.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.7 p . . . . . 0 C--O 1.245 0.845 0 CA-C-O 118.304 -0.855 . . . . 0.0 110.179 179.059 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . 0.416 ' O ' ' HB2' ' B' ' 63' ' ' MET . . . . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 120.454 0.169 . . . . 0.0 111.017 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' MET . . . . . 0.416 ' HB2' ' O ' ' B' ' 62' ' ' ALA . 56.9 mtp 73.03 -76.17 0.07 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.577 0.751 . . . . 0.0 112.434 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -153.61 173.28 32.36 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 119.871 -1.157 . . . . 0.0 113.361 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 38.6 mtpt 53.09 -104.15 0.19 Allowed 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.435 0.694 . . . . 0.0 111.81 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 66' ' ' CYS . . . . . 0.464 ' SG ' ' HE3' ' B' ' 71' ' ' LYS . 42.2 t -161.02 133.27 5.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.562 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 31.1 m -80.94 86.06 6.14 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.406 HG12 ' SG ' ' B' ' 74' ' ' CYS . 27.7 m -63.37 -38.94 83.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -176.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.71 -43.93 93.91 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -177.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 70' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -91.29 12.51 20.1 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.712 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . 0.797 ' HD2' ' HB2' ' B' ' 103' ' ' CYS . 13.0 ttmm -122.64 38.67 4.11 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.87 0.367 . . . . 0.0 110.824 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.436 HG12 ' O ' ' B' ' 72' ' ' VAL . 9.7 t 56.1 32.91 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 123.57 0.748 . . . . 0.0 112.087 179.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . 50.58 34.41 9.58 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 178.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 74' ' ' CYS . . . . . 0.711 ' HB3' HD12 ' B' ' 78' ' ' ILE . 30.3 m 66.15 23.65 10.93 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 178.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -90.64 -31.23 16.72 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -178.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -71.15 -75.16 0.13 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -178.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.01 29.67 0.13 Allowed 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -177.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.711 HD12 ' HB3' ' B' ' 74' ' ' CYS . 23.2 mt -142.2 -58.3 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 O-C-N 122.246 -0.284 . . . . 0.0 110.408 178.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.79 -35.58 77.21 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.927 0.394 . . . . 0.0 110.65 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -75.34 -23.82 72.61 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.363 178.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.78 -28.32 63.54 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.783 0.325 . . . . 0.0 110.747 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 82' ' ' VAL . . . . . 0.516 HG23 ' O ' ' B' ' 78' ' ' ILE . 52.8 t -70.72 -28.11 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.031 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.44 -32.81 72.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.089 0.471 . . . . 0.0 109.883 178.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -87.12 1.3 53.43 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.754 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 64.3 m -148.49 64.97 1.07 Allowed 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -28.72 -48.09 0.08 OUTLIER Glycine 0 N--CA 1.469 0.899 0 O-C-N 124.881 1.363 . . . . 0.0 114.414 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . -96.36 86.41 0.91 Allowed Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 177.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 88' ' ' ILE . . . . . 0.502 ' HB ' HG13 ' B' ' 82' ' ' VAL . 0.0 OUTLIER -62.08 135.77 26.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.637 0.732 . . . . 0.0 112.406 -177.551 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 89' ' ' ASP . . . . . 0.477 ' O ' ' HB2' ' B' ' 90' ' ' LEU . 10.3 t70 -146.92 -71.47 0.23 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.146 178.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 90' ' ' LEU . . . . . 0.653 ' N ' ' HD2' ' B' ' 91' ' ' PRO . 29.1 tp 172.37 -49.54 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.434 0 O-C-N 123.995 0.81 . . . . 0.0 109.844 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 91' ' ' PRO . . . . . 0.653 ' HD2' ' N ' ' B' ' 90' ' ' LEU . 5.4 Cg_exo -31.9 -70.11 0.05 OUTLIER 'Trans proline' 0 C--N 1.367 1.505 0 C-N-CA 124.842 3.695 . . . . 0.0 115.341 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 26.8 p -83.81 -31.84 25.64 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -177.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . 0.452 ' H ' HG23 ' B' ' 93' ' ' VAL . 1.1 t -62.02 -22.49 28.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.943 0.401 . . . . 0.0 111.002 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 94' ' ' LEU . . . . . 0.691 ' HG ' HG12 ' B' ' 115' ' ' VAL . 2.8 tm? -67.97 -37.12 81.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.663 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.53 -47.32 79.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.978 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -83.48 -2.52 56.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.684 0.278 . . . . 0.0 111.717 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 97' ' ' LEU . . . . . 0.449 HD13 ' HE2' ' B' ' 107' ' ' PHE . 27.1 tp -86.84 -21.66 26.28 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.27 0.557 . . . . 0.0 110.055 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.25 -3.02 27.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.442 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -121.84 160.7 24.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.651 0.262 . . . . 0.0 111.457 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . 55.92 56.61 5.85 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.161 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 52.53 60.45 3.8 Favored 'General case' 0 N--CA 1.465 0.277 0 O-C-N 123.728 0.642 . . . . 0.0 110.533 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' B' ' 97' ' ' LEU . . . -77.66 164.89 52.31 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.847 -0.692 . . . . 0.0 113.328 -178.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 103' ' ' CYS . . . . . 0.797 ' HB2' ' HD2' ' B' ' 71' ' ' LYS . 35.3 t -136.44 77.73 1.67 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 104' ' ' ALA . . . . . 0.572 ' CB ' ' HB3' ' B' ' 121' ' ' LEU . . . -67.0 -40.14 87.26 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -178.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 8.0 t -75.94 29.94 0.11 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.168 0.508 . . . . 0.0 111.488 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 106' ' ' CYS . . . . . 0.667 ' HB2' ' SG ' ' B' ' 103' ' ' CYS . 44.6 t -118.73 -50.17 2.42 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.756 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . 0.47 ' HB3' HD13 ' B' ' 78' ' ' ILE . 0.1 OUTLIER -102.41 -46.0 4.92 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.35 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 108' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -70.26 30.13 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.487 -0.778 . . . . 0.0 112.727 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . 0.423 ' H ' ' C ' ' B' ' 107' ' ' PHE . 23.5 tt0 -69.06 -64.2 0.91 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.49 0.186 . . . . 0.0 110.581 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -76.15 -31.68 58.71 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 59.2 m-70 -74.16 85.67 1.87 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.97 -1.014 . . . . 0.0 108.826 178.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 112' ' ' CYS . . . . . 0.473 ' SG ' ' HG3' ' B' ' 117' ' ' LYS . 4.5 t -151.0 71.58 1.03 Allowed 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.264 -0.574 . . . . 0.0 112.097 -177.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 113' ' ' HIS . . . . . . . . . . . . . 49.4 p-80 -128.64 -17.4 4.09 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 179.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -155.25 -73.18 0.01 OUTLIER Glycine 0 C--O 1.226 -0.396 0 C-N-CA 119.06 -1.543 . . . . 0.0 114.713 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . 0.691 HG12 ' HG ' ' B' ' 94' ' ' LEU . 2.8 t -58.42 -55.6 21.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -177.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 116' ' ' CYS . . . . . 0.446 ' SG ' HD11 ' B' ' 90' ' ' LEU . 1.0 OUTLIER -73.07 -19.86 61.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.831 0.348 . . . . 0.0 111.675 -179.607 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 117' ' ' LYS . . . . . 0.473 ' HG3' ' SG ' ' B' ' 112' ' ' CYS . 15.5 mttm -82.72 -24.44 33.58 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.877 178.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -63.43 -45.42 91.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.93 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -90.24 7.66 37.08 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.23 -0.441 . . . . 0.0 112.053 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 53.3 62.52 2.62 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.022 0.439 . . . . 0.0 110.683 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 121' ' ' LEU . . . . . 0.572 ' HB3' ' CB ' ' B' ' 104' ' ' ALA . 96.3 mt -110.13 -12.55 14.49 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -178.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 122' ' ' CYS . . . . . 0.438 ' SG ' ' HB3' ' B' ' 116' ' ' CYS . 1.8 p . . . . . 0 C--O 1.245 0.848 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.402 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.169 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 4.0 ptm 46.48 -170.22 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.193 0.997 . . . . 0.0 113.553 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -122.19 58.33 0.6 Allowed Glycine 0 CA--C 1.505 -0.549 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.547 -179.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 67.0 mttm 57.03 -122.51 1.62 Allowed 'General case' 0 C--N 1.328 -0.328 0 O-C-N 123.882 0.401 . . . . 0.0 109.991 -179.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 59.2 m -137.47 139.59 40.69 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.311 -0.556 . . . . 0.0 111.989 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.5 p -106.99 -164.45 0.99 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.284 -0.871 . . . . 0.0 108.919 178.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.5 p -78.39 -19.6 13.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.558 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.631 HD23 ' H ' ' A' ' 8' ' ' LEU . 1.0 OUTLIER -96.8 -35.46 10.95 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 121.052 -0.259 . . . . 0.0 110.408 178.728 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.532 ' HD2' ' HG ' ' A' ' 8' ' ' LEU . 1.7 mptm? -84.18 22.96 1.12 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.811 0.339 . . . . 0.0 110.322 178.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.7 -9.46 58.61 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 121.433 0.635 . . . . 0.0 110.299 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.6 t -67.27 -22.62 29.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.783 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -81.76 -10.26 59.4 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -178.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 6.1 p -104.36 -47.78 4.02 Favored 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 119.806 -0.757 . . . . 0.0 112.326 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.21 -38.87 92.62 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.12 -12.69 60.01 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.438 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . . . -101.79 -38.57 7.8 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -179.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.924 HD13 HD13 ' A' ' 36' ' ' LEU . 10.9 tp -73.28 -35.06 45.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.42 0.628 . . . . 0.0 111.017 -179.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.34 -22.39 53.1 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.973 -1.012 . . . . 0.0 112.806 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -77.79 -29.38 54.93 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.349 -179.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.14 -17.37 52.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.65 0.262 . . . . 0.0 111.143 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.1 t -63.07 -46.34 96.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 CA-C-O 120.898 0.38 . . . . 0.0 110.733 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.7 -23.75 64.41 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.165 -0.471 . . . . 0.0 112.201 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -85.71 -23.91 27.19 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.551 0.691 . . . . 0.0 110.947 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.554 ' SG ' ' CD2' ' B' ' 113' ' ' HIS . 0.7 OUTLIER -86.17 -28.1 24.14 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.151 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.21 39.62 9.08 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.131 -1.033 . . . . 0.0 110.684 -179.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 143.63 178.16 19.17 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 -178.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.593 HD12 HG21 ' A' ' 32' ' ' VAL . 3.0 tp -129.47 121.81 54.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 117.871 0.836 . . . . 0.0 112.117 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.595 ' HB3' ' HD2' ' A' ' 30' ' ' PRO . 2.1 m-20 -140.45 -75.83 0.33 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.051 178.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.678 ' HG ' ' CG2' ' A' ' 54' ' ' VAL . 26.6 tp 172.26 -49.63 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.411 0 O-C-N 124.136 0.898 . . . . 0.0 111.354 179.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.723 ' HA ' HG11 ' A' ' 54' ' ' VAL . 5.4 Cg_endo -48.23 -63.66 0.3 Allowed 'Trans proline' 0 C--N 1.359 1.11 0 C-N-CA 123.093 2.529 . . . . 0.0 114.31 -179.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.424 ' HB3' ' O ' ' B' ' 113' ' ' HIS . 4.4 p -66.93 -37.87 85.12 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.41 -178.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.593 HG21 HD12 ' A' ' 27' ' ' ILE . 0.2 OUTLIER -70.57 -18.29 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.722 -178.486 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.554 HD22 ' HB ' ' A' ' 54' ' ' VAL . 58.9 tp -64.88 -21.7 66.86 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.722 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.34 -31.86 35.45 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -178.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -121.43 43.56 2.79 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.838 0.352 . . . . 0.0 110.744 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.924 HD13 HD13 ' A' ' 17' ' ' ILE . 14.3 tp -133.91 -6.2 2.77 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -178.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.412 ' O ' ' HB2' ' A' ' 38' ' ' ALA . 77.9 tttt -85.49 74.42 10.33 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 122.032 -0.418 . . . . 0.0 111.989 -179.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.412 ' HB2' ' O ' ' A' ' 37' ' ' LYS . . . 171.79 169.82 0.1 Allowed 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.124 0.569 . . . . 0.0 110.523 179.061 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.96 -39.32 87.21 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.456 ' H ' ' HG2' ' A' ' 40' ' ' GLU . 3.2 pt-20 -78.03 88.59 4.17 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 176.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.438 ' HA2' ' HB3' ' A' ' 16' ' ' ALA . . . 137.94 -39.53 1.59 Allowed Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 108.05 -2.02 . . . . 0.0 108.05 -176.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 1.1 m 55.07 93.38 0.02 OUTLIER 'General case' 0 C--O 1.235 0.325 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 176.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.5 ' HA ' ' HG ' ' A' ' 36' ' ' LEU . . . -70.59 -24.99 62.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.476 176.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.8 p -76.15 12.9 1.01 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.925 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 37.8 t -113.14 -56.35 2.42 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.616 ' CD2' HG12 ' A' ' 17' ' ' ILE . 1.1 t80 -77.03 -54.65 6.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.755 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.576 ' O ' ' HB2' ' A' ' 51' ' ' CYS . 53.9 m -68.49 6.23 0.86 Allowed 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -178.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -66.98 -71.02 0.22 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.279 0.561 . . . . 0.0 110.685 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.06 -17.56 58.67 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.372 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.411 ' HD2' ' O ' ' A' ' 46' ' ' PHE . 39.8 m-70 -113.08 83.26 1.8 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.481 -0.782 . . . . 0.0 109.943 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.576 ' HB2' ' O ' ' A' ' 47' ' ' CYS . 22.2 t -140.03 86.94 2.12 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.158 -0.617 . . . . 0.0 112.526 -178.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.699 ' O ' ' HB3' ' B' ' 92' ' ' CYS . 0.0 OUTLIER -144.11 -3.02 0.87 Allowed 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.022 0.439 . . . . 0.0 110.444 177.742 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.868 ' HA3' ' HB2' ' B' ' 91' ' ' PRO . . . -157.42 163.97 32.76 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-O 118.914 -0.936 . . . . 0.0 111.695 178.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.723 HG11 ' HA ' ' A' ' 30' ' ' PRO . 6.0 m 46.55 -64.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 115.377 1.621 . . . . 0.0 115.377 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.462 ' N ' ' O ' ' A' ' 53' ' ' GLY . 0.6 OUTLIER -63.04 -34.13 76.91 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 122.111 -0.368 . . . . 0.0 111.16 -178.676 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.0 pttp -70.58 -28.53 64.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.009 0.433 . . . . 0.0 110.321 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -65.83 -39.34 90.73 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.395 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.439 HD12 HD21 ' A' ' 33' ' ' LEU . 91.3 mt -87.24 4.21 43.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.74 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 58.5 m170 59.5 57.65 3.22 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 123.425 0.453 . . . . 0.0 111.809 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.412 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 80.4 mt -112.55 -2.68 14.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.02 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.452 ' SG ' ' HB3' ' A' ' 47' ' ' CYS . 6.3 p . . . . . 0 C--O 1.247 0.946 0 CA-C-O 117.907 -1.044 . . . . 0.0 109.513 179.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 120.587 0.232 . . . . 0.0 110.602 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 63' ' ' MET . . . . . . . . . . . . . 4.9 mtm 71.86 -40.89 0.49 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.125 0.97 . . . . 0.0 112.369 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.23 -36.56 4.21 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.711 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 45.2 mttp 56.24 -154.7 0.32 Allowed 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 122.893 0.477 . . . . 0.0 111.15 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -96.19 71.86 2.85 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 14.5 p -87.81 -131.04 0.07 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.16 -179.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 6.0 p -103.12 -41.96 7.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.657 0.265 . . . . 0.0 111.239 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.758 HD23 ' H ' ' B' ' 69' ' ' LEU . 2.4 pt? -86.56 -39.75 15.89 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.349 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 70' ' ' LYS . . . . . . . . . . . . . 7.5 mtpm? -89.03 24.81 1.99 Allowed 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.257 0.551 . . . . 0.0 110.572 179.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.55 -27.24 63.03 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.28 178.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 2.7 t -82.48 6.71 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.448 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.11 -8.59 31.89 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.483 0.659 . . . . 0.0 110.456 178.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 74' ' ' CYS . . . . . 0.484 ' HB3' ' HB3' ' B' ' 106' ' ' CYS . 4.6 p -71.42 -30.69 66.37 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.774 179.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 75' ' ' ALA . . . . . 0.475 ' HA ' HG22 ' B' ' 78' ' ' ILE . . . -68.4 -5.67 20.32 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.539 -179.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.77 -27.39 63.89 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.359 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -128.79 -29.99 2.31 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 1.016 HD13 HD13 ' B' ' 97' ' ' LEU . 6.4 tp -73.68 -36.22 46.23 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 C-N-CA 120.634 -0.426 . . . . 0.0 111.309 -178.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.05 -34.02 71.45 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.869 -178.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -76.69 -33.83 45.78 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.381 -0.914 . . . . 0.0 111.297 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . 0.485 ' HB2' ' HB3' ' B' ' 96' ' ' ALA . . . -66.65 -24.81 66.34 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.687 0.28 . . . . 0.0 111.478 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 82' ' ' VAL . . . . . 0.576 HG22 HD13 ' B' ' 88' ' ' ILE . 91.6 t -58.23 -38.5 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-O 121.156 0.503 . . . . 0.0 110.663 179.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.79 -33.25 12.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.373 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.78 -19.15 64.3 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -179.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 85' ' ' CYS . . . . . 0.418 ' HB2' ' O ' ' B' ' 81' ' ' ALA . 0.8 OUTLIER -98.94 -1.01 41.03 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 121.21 -0.196 . . . . 0.0 111.506 -179.858 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 59.68 37.03 91.73 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.298 -179.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 143.35 137.81 3.33 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 110.106 -1.197 . . . . 0.0 110.106 -178.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 88' ' ' ILE . . . . . 0.576 HD13 HG22 ' B' ' 82' ' ' VAL . 3.4 tp -103.25 118.54 50.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 121.493 0.663 . . . . 0.0 112.639 -178.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -133.52 -83.54 0.46 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.261 -0.882 . . . . 0.0 108.876 178.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 90' ' ' LEU . . . . . 0.632 HD11 ' HB2' ' B' ' 116' ' ' CYS . 38.0 tp 176.85 -51.79 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.94 179.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 91' ' ' PRO . . . . . 0.868 ' HB2' ' HA3' ' A' ' 53' ' ' GLY . 4.0 Cg_exo -38.93 -60.99 0.43 Allowed 'Trans proline' 0 C--N 1.363 1.334 0 C-N-CA 123.66 2.907 . . . . 0.0 114.587 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 92' ' ' CYS . . . . . 0.699 ' HB3' ' O ' ' A' ' 52' ' ' HIS . 24.5 p -83.15 -33.02 26.34 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -178.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . 0.433 ' H ' HG23 ' B' ' 93' ' ' VAL . 1.8 t -59.24 -21.44 20.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.881 -178.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 94' ' ' LEU . . . . . 0.834 HD22 ' HB ' ' B' ' 115' ' ' VAL . 15.9 tp -63.17 -35.19 79.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.654 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.35 -28.91 70.09 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . 0.485 ' HB3' ' HB2' ' B' ' 81' ' ' ALA . . . -103.58 10.0 37.17 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.93 0.395 . . . . 0.0 111.375 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 97' ' ' LEU . . . . . 1.016 HD13 HD13 ' B' ' 78' ' ' ILE . 40.9 tp -93.81 -28.89 15.63 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.571 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -81.8 103.04 11.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.472 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -158.56 -175.34 5.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.302 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -80.25 -0.21 35.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.231 0.538 . . . . 0.0 110.3 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -147.36 47.09 1.13 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.217 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . 0.479 ' O ' ' HA ' ' B' ' 74' ' ' CYS . . . -103.9 -44.68 1.6 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.303 -0.951 . . . . 0.0 113.426 -178.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 75.74 -51.25 0.63 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.136 0.574 . . . . 0.0 110.892 -179.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 104' ' ' ALA . . . . . 0.759 ' HB1' ' HB3' ' B' ' 121' ' ' LEU . . . 70.51 -59.69 0.52 Allowed 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 178.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 12.8 p -50.07 -43.84 51.49 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -178.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 106' ' ' CYS . . . . . 0.484 ' HB3' ' HB3' ' B' ' 74' ' ' CYS . 0.0 OUTLIER -52.35 -45.71 65.81 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.108 0.48 . . . . 0.0 111.711 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . 0.696 ' CD2' HG12 ' B' ' 78' ' ' ILE . 20.3 t80 -75.57 -60.88 2.11 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.339 -179.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 108' ' ' CYS . . . . . 0.65 ' HA ' ' HB2' ' B' ' 111' ' ' HIS . 38.1 m -78.84 43.54 0.5 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -178.103 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -74.99 -52.39 11.24 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -102.84 12.84 35.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.894 0.854 . . . . 0.0 108.737 178.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 111' ' ' HIS . . . . . 0.65 ' HB2' ' HA ' ' B' ' 108' ' ' CYS . 89.4 m-70 -119.68 58.45 0.89 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.684 -179.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 72.0 m -110.61 61.73 0.61 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.02 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 113' ' ' HIS . . . . . 0.554 ' CD2' ' SG ' ' A' ' 24' ' ' CYS . 0.2 OUTLIER -138.24 -15.68 1.27 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.219 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 114' ' ' GLY . . . . . 0.418 ' O ' ' HG3' ' B' ' 117' ' ' LYS . . . -120.17 -145.08 7.34 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 119.8 -1.19 . . . . 0.0 113.86 -179.124 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . 0.834 ' HB ' HD22 ' B' ' 94' ' ' LEU . 20.2 m -46.16 -28.76 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -179.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 116' ' ' CYS . . . . . 0.632 ' HB2' HD11 ' B' ' 90' ' ' LEU . 2.8 t -71.23 -39.3 71.78 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -177.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 117' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' B' ' 114' ' ' GLY . 0.0 OUTLIER -77.28 -14.72 59.7 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.214 -179.949 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 118' ' ' ASP . . . . . 0.416 ' N ' ' HD3' ' B' ' 117' ' ' LYS . 12.3 t70 -70.0 -37.61 75.75 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.653 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 89.0 mt -94.89 6.95 47.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.417 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 56.5 m170 60.36 69.02 0.72 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.341 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 121' ' ' LEU . . . . . 0.759 ' HB3' ' HB1' ' B' ' 104' ' ' ALA . 98.3 mt -112.7 3.19 16.42 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 122' ' ' CYS . . . . . . . . . . . . . 25.3 p . . . . . 0 C--O 1.246 0.906 0 CA-C-O 118.028 -0.986 . . . . 0.0 109.874 178.078 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.854 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 21.2 ptp -81.45 167.62 19.19 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.212 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 145.82 82.05 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.408 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -62.63 -50.0 72.95 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.839 0.352 . . . . 0.0 110.349 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 75.1 m -81.9 -64.1 1.25 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.228 0.537 . . . . 0.0 110.677 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.506 ' HB3' ' HB2' ' A' ' 9' ' ' LYS . 34.6 t -160.71 -176.89 5.81 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.838 -178.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.1 p -79.27 -28.66 13.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.783 0.325 . . . . 0.0 110.794 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.649 HD23 ' H ' ' A' ' 8' ' ' LEU . 1.1 pt? -94.04 -27.66 16.17 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 121.162 0.506 . . . . 0.0 109.828 178.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.506 ' HB2' ' HB3' ' A' ' 6' ' ' SER . 10.4 mtmt -91.74 29.0 1.62 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 177.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.465 ' C ' ' H ' ' A' ' 12' ' ' ALA . 32.5 tttm -81.11 -4.59 55.79 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 114.071 -1.422 . . . . 0.0 110.227 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.483 HG12 ' HB3' ' A' ' 14' ' ' ALA . 2.3 t -69.75 13.14 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.64 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.465 ' H ' ' C ' ' A' ' 10' ' ' LYS . . . 59.11 48.65 10.3 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 123.429 0.692 . . . . 0.0 112.55 178.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.914 ' HB3' HD12 ' A' ' 17' ' ' ILE . 24.0 m 67.02 1.75 2.45 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 178.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.483 ' HB3' HG12 ' A' ' 11' ' ' VAL . . . -66.67 -66.92 0.49 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.65 38.32 0.19 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -147.46 -52.02 0.2 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.102 0.477 . . . . 0.0 110.497 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.914 HD12 ' HB3' ' A' ' 13' ' ' CYS . 5.3 mt -83.81 -46.8 18.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.343 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.22 -20.09 60.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.137 0.494 . . . . 0.0 109.838 177.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -82.01 -34.94 22.81 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 111.291 -0.724 . . . . 0.0 111.291 178.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.91 -26.71 68.72 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 121.085 0.469 . . . . 0.0 110.881 179.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 17' ' ' ILE . 57.0 t -63.76 -45.24 97.8 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.299 179.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.42 -18.99 62.31 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.461 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.14 -47.07 15.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.775 0.322 . . . . 0.0 111.844 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.7 t -88.33 -15.31 36.03 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.93 -179.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 108.51 -63.15 0.28 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.216 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -122.53 155.36 17.0 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.334 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -86.38 141.89 13.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.06 0.457 . . . . 0.0 111.15 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.528 ' H ' HG21 ' A' ' 32' ' ' VAL . 26.6 t70 -163.97 -98.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 178.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.791 HD11 ' SG ' ' A' ' 55' ' ' CYS . 32.8 tp -174.07 -55.32 0.0 OUTLIER Pre-proline 0 C--O 1.222 -0.363 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 178.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.571 ' HA ' HG11 ' A' ' 54' ' ' VAL . 3.4 Cg_endo -47.74 -61.71 0.56 Allowed 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 122.786 2.324 . . . . 0.0 114.262 -178.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 13.0 p -76.6 -33.11 58.43 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.459 -178.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.528 HG21 ' H ' ' A' ' 28' ' ' ASP . 13.0 t -63.09 -26.22 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.727 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.578 ' HG ' HG22 ' A' ' 54' ' ' VAL . 3.1 tm? -55.56 -38.59 69.52 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.767 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -57.45 -41.92 81.46 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.284 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -98.35 12.28 35.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.263 0.554 . . . . 0.0 110.743 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.447 HD21 ' SG ' ' A' ' 47' ' ' CYS . 46.5 tp -99.34 -61.91 1.31 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.654 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.437 ' HB2' ' HE2' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -110.16 167.24 10.33 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.372 0.606 . . . . 0.0 111.539 -179.28 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -172.56 -112.05 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' A' ' 40' ' ' GLU . . . -92.26 73.08 5.37 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 176.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.405 ' HB2' ' O ' ' A' ' 39' ' ' ALA . 93.0 mt-10 71.22 92.16 0.09 Allowed 'General case' 0 N--CA 1.464 0.272 0 O-C-N 124.084 0.865 . . . . 0.0 109.707 -177.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -115.43 -173.73 17.67 Favored Glycine 0 C--N 1.33 0.209 0 C-N-CA 120.556 -0.831 . . . . 0.0 113.063 -179.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.423 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 57.3 m -82.56 62.41 6.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.751 0.31 . . . . 0.0 111.714 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -96.56 -7.59 34.1 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.809 0.338 . . . . 0.0 110.829 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.4 m -81.54 -16.27 52.24 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.886 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.423 ' SG ' ' HB3' ' A' ' 42' ' ' CYS . 6.3 p -98.48 -33.47 11.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.296 0.569 . . . . 0.0 111.131 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.736 ' HB2' ' CD1' ' A' ' 17' ' ' ILE . 0.9 OUTLIER -86.13 -60.99 1.85 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.665 -178.511 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.447 ' SG ' HD21 ' A' ' 36' ' ' LEU . 4.5 m -72.61 14.08 0.3 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.637 -177.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -51.84 -74.98 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 121.179 0.514 . . . . 0.0 110.457 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -84.86 -27.01 27.01 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 53.7 m-70 -86.71 56.58 4.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.019 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.403 ' O ' ' HB2' ' A' ' 56' ' ' LYS . 7.6 t -108.37 39.62 1.94 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.243 0.544 . . . . 0.0 110.126 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.607 ' CD2' ' HB2' ' B' ' 89' ' ' ASP . 7.8 p-80 -117.82 -12.91 10.14 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.55 -179.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.529 ' HA3' HD23 ' A' ' 29' ' ' LEU . . . -95.32 -136.14 8.46 Favored Glycine 0 C--O 1.228 -0.226 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.812 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.578 HG22 ' HG ' ' A' ' 33' ' ' LEU . 2.2 p -70.19 -16.11 19.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 120.747 0.308 . . . . 0.0 111.561 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.791 ' SG ' HD11 ' A' ' 29' ' ' LEU . 89.2 m -72.21 -21.17 61.45 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.603 0.716 . . . . 0.0 109.112 176.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.519 ' HB3' ' O ' ' A' ' 53' ' ' GLY . 22.7 tptm -79.6 -20.38 47.04 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.474 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -59.44 -50.25 74.65 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.291 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.512 HD23 ' O ' ' A' ' 58' ' ' LEU . 5.7 tt -83.26 -29.37 28.47 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 9.6 t-160 64.26 55.86 1.4 Allowed 'General case' 0 C--O 1.235 0.301 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.04 179.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.52 20.4 16.13 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.473 179.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.244 0.805 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.541 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.272 0 CA-C-O 120.867 0.365 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 63' ' ' MET . . . . . . . . . . . . . 8.9 ptp -136.13 131.45 34.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.98 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -99.29 49.46 1.22 Allowed Glycine 0 C--O 1.229 -0.209 0 C-N-CA 120.542 -0.837 . . . . 0.0 114.734 -177.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 12.2 mtmt -133.36 -35.98 1.0 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 117.245 0.522 . . . . 0.0 110.427 178.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 66' ' ' CYS . . . . . 0.494 ' HB3' ' HB2' ' B' ' 70' ' ' LYS . 10.4 m -153.71 -108.25 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.656 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 30.0 t -142.65 -179.6 6.41 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 14.0 p -68.61 -28.07 38.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 CA-C-O 120.554 0.216 . . . . 0.0 111.307 -179.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.73 HD23 ' H ' ' B' ' 69' ' ' LEU . 1.4 pt? -98.38 -26.74 14.38 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 70' ' ' LYS . . . . . 0.494 ' HB2' ' HB3' ' B' ' 66' ' ' CYS . 25.2 mmtp -87.16 21.46 2.37 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 177.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -66.83 -6.23 15.42 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.592 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 2.7 t -71.84 12.82 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.654 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . 62.76 67.02 0.72 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.009 0.523 . . . . 0.0 111.763 179.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 74' ' ' CYS . . . . . 0.734 ' O ' ' HB ' ' B' ' 78' ' ' ILE . 8.5 p 52.77 7.99 0.08 Allowed 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 114.381 -1.282 . . . . 0.0 113.593 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -88.87 -3.14 58.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.741 0.305 . . . . 0.0 110.86 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -98.74 22.76 9.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.214 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -163.58 -38.17 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.378 0.608 . . . . 0.0 110.285 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.734 ' HB ' ' O ' ' B' ' 74' ' ' CYS . 1.4 mt -83.66 -46.69 18.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.741 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.8 -29.27 68.41 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.883 0.373 . . . . 0.0 110.682 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.4 -35.71 28.79 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.045 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . 0.416 ' CB ' HG13 ' B' ' 93' ' ' VAL . . . -69.61 -26.57 64.5 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.181 0.515 . . . . 0.0 110.626 179.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 82' ' ' VAL . . . . . 0.498 HG23 ' O ' ' B' ' 78' ' ' ILE . 25.5 t -65.82 -43.14 93.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.567 178.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.38 -27.4 67.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.063 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.05 -44.57 46.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.651 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 73.0 m -83.43 -11.83 57.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.762 0.315 . . . . 0.0 110.725 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.3 42.6 10.34 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.605 -0.807 . . . . 0.0 113.171 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.05 176.71 14.51 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.56 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 7.4 tp -74.87 132.93 32.54 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 CA-C-O 121.388 0.613 . . . . 0.0 110.191 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 89' ' ' ASP . . . . . 0.607 ' HB2' ' CD2' ' A' ' 52' ' ' HIS . 32.5 t70 -152.9 -133.85 0.05 OUTLIER 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.479 -178.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 90' ' ' LEU . . . . . 0.874 HD11 ' HB2' ' B' ' 116' ' ' CYS . 31.9 tp 179.61 -57.4 0.0 OUTLIER Pre-proline 0 C--N 1.317 -0.826 0 C-N-CA 123.804 0.841 . . . . 0.0 110.129 179.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 91' ' ' PRO . . . . . 0.727 ' HD3' ' HB3' ' B' ' 90' ' ' LEU . 74.2 Cg_exo -51.77 -38.63 67.49 Favored 'Trans proline' 0 C--N 1.363 1.321 0 C-N-CA 122.347 2.031 . . . . 0.0 112.225 179.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 9.4 t -88.83 -40.43 13.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.676 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . 0.508 HG11 ' HE2' ' B' ' 107' ' ' PHE . 7.3 t -66.6 -23.4 31.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.779 -179.204 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 94' ' ' LEU . . . . . 0.586 ' HG ' HG22 ' B' ' 115' ' ' VAL . 2.7 tm? -50.35 -38.76 43.81 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 123.19 0.596 . . . . 0.0 111.929 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -42.67 -51.32 5.3 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -179.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -108.79 21.66 16.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.021 0.438 . . . . 0.0 111.07 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 97' ' ' LEU . . . . . 0.467 ' HB3' ' HA ' ' B' ' 94' ' ' LEU . 32.4 tp -105.25 -49.31 3.49 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.476 -179.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . 0.525 ' HG2' HD13 ' B' ' 94' ' ' LEU . 0.0 OUTLIER -63.45 -19.56 64.83 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -178.989 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.74 -23.87 41.99 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -179.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -109.33 93.1 4.33 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -66.69 148.79 51.43 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 83.39 -46.98 3.74 Favored Glycine 0 N--CA 1.451 -0.345 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 -178.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 103' ' ' CYS . . . . . 0.454 ' HA ' ' HB3' ' B' ' 74' ' ' CYS . 58.5 m -66.75 -45.48 78.47 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -66.65 -16.24 64.06 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.445 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 19.8 m -72.95 -39.45 66.17 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.623 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 13.4 p -63.6 -24.77 67.93 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 122.077 0.941 . . . . 0.0 109.679 179.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . 0.648 ' HB2' HD13 ' B' ' 78' ' ' ILE . 0.8 OUTLIER -88.81 -69.94 0.68 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.099 -1.41 . . . . 0.0 111.959 -178.87 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 108' ' ' CYS . . . . . 0.401 ' O ' ' HB2' ' B' ' 112' ' ' CYS . 82.5 m -74.27 28.42 0.08 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -177.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -53.69 -69.73 0.11 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.17 0.51 . . . . 0.0 110.266 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -89.93 -35.16 15.74 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -79.51 70.71 6.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.763 179.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 112' ' ' CYS . . . . . 0.401 ' HB2' ' O ' ' B' ' 108' ' ' CYS . 13.0 t -127.46 54.68 1.65 Allowed 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.924 -178.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 113' ' ' HIS . . . . . 0.428 ' HE1' ' HB3' ' A' ' 28' ' ' ASP . 0.1 OUTLIER -129.95 -12.38 4.2 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -179.843 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -94.69 -142.95 13.15 Favored Glycine 0 C--O 1.228 -0.272 0 C-N-CA 120.442 -0.885 . . . . 0.0 113.333 -179.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . 0.706 HG11 ' HA ' ' B' ' 91' ' ' PRO . 14.6 p -62.86 -15.46 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-O 121.142 0.496 . . . . 0.0 111.605 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 116' ' ' CYS . . . . . 0.874 ' HB2' HD11 ' B' ' 90' ' ' LEU . 6.8 t -76.19 -22.83 54.84 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.408 0.623 . . . . 0.0 109.76 178.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 117' ' ' LYS . . . . . 0.463 ' O ' ' HG3' ' B' ' 117' ' ' LYS . 13.5 tptt -79.16 -19.33 51.25 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.134 179.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -57.01 -41.55 78.69 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.2 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 119' ' ' LEU . . . . . 0.525 HD22 HD23 ' B' ' 121' ' ' LEU . 5.7 tt -86.19 -29.58 23.09 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 65.51 75.03 0.36 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.721 179.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 121' ' ' LEU . . . . . 0.525 HD23 HD22 ' B' ' 119' ' ' LEU . 0.4 OUTLIER -124.33 7.59 8.42 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.586 -0.733 . . . . 0.0 111.522 -179.701 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 122' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.244 0.803 0 CA-C-O 118.545 -0.741 . . . . 0.0 110.461 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.606 0.241 . . . . 0.0 110.827 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 84.7 mtp 61.84 -160.66 0.3 Allowed 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.669 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 96.95 -91.05 1.19 Allowed Glycine 0 N--CA 1.451 -0.349 0 N-CA-C 111.336 -0.705 . . . . 0.0 111.336 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -122.6 150.76 42.2 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 25.8 p -88.9 1.56 55.19 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -178.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 45.8 m 58.63 99.24 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.389 0.614 . . . . 0.0 111.634 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.541 HG12 ' HA ' ' A' ' 12' ' ' ALA . 57.3 t -54.46 -45.48 70.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.085 -0.961 . . . . 0.0 113.308 -179.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 45.2 tp -54.14 -58.52 7.03 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -178.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -72.29 -1.35 15.01 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -178.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 51.1 tttt -111.79 44.51 1.37 Allowed 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.282 178.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.438 ' O ' HG12 ' A' ' 11' ' ' VAL . 10.7 t 52.77 36.96 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.15 178.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.541 ' HA ' HG12 ' A' ' 7' ' ' VAL . . . 50.27 48.58 22.01 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.891 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.882 ' HB2' HD12 ' A' ' 17' ' ' ILE . 8.4 p 45.06 40.53 4.73 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.018 -0.992 . . . . 0.0 112.963 -179.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -112.09 16.45 20.19 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 120.934 0.397 . . . . 0.0 110.547 178.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -91.46 -82.61 0.3 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.028 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.99 -27.72 60.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.945 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.882 HD12 ' HB2' ' A' ' 13' ' ' CYS . 49.2 mt -74.08 -46.84 44.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.69 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' A' ' 14' ' ' ALA . . . -82.18 -15.89 51.64 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.197 179.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -82.79 -33.64 23.92 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.115 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.531 ' HB3' HG13 ' A' ' 32' ' ' VAL . . . -74.28 -13.5 60.78 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.831 0.348 . . . . 0.0 110.914 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 17' ' ' ILE . 78.7 t -64.34 -39.46 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.043 179.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.92 -31.18 67.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.112 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.13 -43.76 66.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.688 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.431 ' HB3' ' CG ' ' B' ' 113' ' ' HIS . 56.6 m -82.42 -19.34 39.21 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.099 -179.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.14 59.1 3.01 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 -179.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 122.0 156.63 9.75 Favored Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -177.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.516 HG12 ' N ' ' A' ' 28' ' ' ASP . 5.0 tt -98.87 147.08 7.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 118.125 0.963 . . . . 0.0 112.484 -178.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.516 ' N ' HG12 ' A' ' 27' ' ' ILE . 34.4 t0 -161.42 -106.13 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.48 -1.236 . . . . 0.0 107.967 179.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.717 HD11 ' HB2' ' A' ' 55' ' ' CYS . 40.2 tp -174.5 -47.94 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 178.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.63 ' HD2' ' H ' ' A' ' 29' ' ' LEU . 11.1 Cg_endo -54.52 -15.3 8.6 Favored 'Trans proline' 0 C--N 1.358 1.031 0 C-N-CA 122.959 2.44 . . . . 0.0 114.593 -178.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.553 ' HB2' ' O ' ' B' ' 113' ' ' HIS . 11.0 t -117.89 -31.72 5.01 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.275 0.56 . . . . 0.0 110.744 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.531 HG13 ' HB3' ' A' ' 20' ' ' ALA . 1.7 t -73.26 -9.17 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-N 115.74 -0.663 . . . . 0.0 112.375 -178.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.781 HD13 ' HB ' ' A' ' 54' ' ' VAL . 1.5 pt? -71.87 -14.82 62.06 Favored 'General case' 0 CA--C 1.531 0.25 0 O-C-N 122.221 -0.299 . . . . 0.0 111.64 -179.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -56.72 -55.09 38.62 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.876 0.37 . . . . 0.0 111.844 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -89.26 16.72 6.91 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.651 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.0 tp -112.69 -0.25 15.12 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.708 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.563 ' HD3' HD21 ' A' ' 58' ' ' LEU . 26.6 ttpt -98.55 154.52 17.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.256 -179.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 71.89 63.12 0.14 Allowed 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.587 0.755 . . . . 0.0 111.607 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -163.39 163.05 25.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.639 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -84.31 70.52 10.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.025 0.44 . . . . 0.0 110.025 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.715 ' HA2' HD22 ' A' ' 60' ' ' LEU . . . 89.34 -111.18 3.8 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.493 -0.861 . . . . 0.0 111.887 -179.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 81.1 m 73.09 -34.93 0.31 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.237 0.615 . . . . 0.0 112.318 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.435 ' HB1' ' SG ' ' A' ' 47' ' ' CYS . . . -79.49 17.16 0.9 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.4 m -66.82 -59.12 3.81 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.768 0.318 . . . . 0.0 110.763 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -66.91 -24.98 66.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.662 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.786 ' HB2' HD13 ' A' ' 17' ' ' ILE . 1.0 OUTLIER -81.4 -72.75 0.41 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.523 -178.948 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.449 ' HB3' ' O ' ' A' ' 50' ' ' HIS . 23.7 m -78.44 39.88 0.34 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.4 -178.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -73.05 -54.23 9.07 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.979 0.895 . . . . 0.0 109.161 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -87.84 -9.31 54.19 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.364 -1.289 . . . . 0.0 109.682 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.449 ' O ' ' HB3' ' A' ' 47' ' ' CYS . 45.4 m-70 -109.98 90.97 3.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.314 -178.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 72.9 m -136.4 55.28 1.85 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.65 ' HB2' ' OD2' ' B' ' 89' ' ' ASP . 40.8 m80 -115.68 -54.73 2.49 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.356 178.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 55' ' ' CYS . . . -134.63 -171.62 12.56 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-O 119.171 -0.794 . . . . 0.0 112.059 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.781 ' HB ' HD13 ' A' ' 33' ' ' LEU . 14.2 m 43.75 -62.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 N-CA-C 115.97 1.841 . . . . 0.0 115.97 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.717 ' HB2' HD11 ' A' ' 29' ' ' LEU . 15.7 t -70.16 -44.56 68.56 Favored 'General case' 0 C--N 1.322 -0.601 0 O-C-N 121.641 -0.662 . . . . 0.0 111.457 -179.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.526 ' HE3' ' HB2' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -81.13 12.68 3.26 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.958 179.403 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -76.94 -27.57 54.89 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 175.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.563 HD21 ' HD3' ' A' ' 37' ' ' LYS . 32.3 mt -98.51 -16.49 19.15 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 113.596 -1.638 . . . . 0.0 108.981 177.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 64.89 82.45 0.19 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.91 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.715 HD22 ' HA2' ' A' ' 41' ' ' GLY . 87.2 mt -125.15 -7.42 7.11 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -178.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 26.3 p . . . . . 0 C--O 1.245 0.836 0 CA-C-O 118.41 -0.805 . . . . 0.0 110.591 178.67 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.286 0 CA-C-O 120.458 0.17 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 63' ' ' MET . . . . . 0.575 ' HA ' ' HG2' ' B' ' 101' ' ' GLU . 33.3 mtt 61.16 75.95 0.39 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.006 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -107.44 -131.08 6.53 Favored Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 111.433 -0.667 . . . . 0.0 111.433 178.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.94 129.12 53.33 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 178.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 66' ' ' CYS . . . . . . . . . . . . . 43.2 m -64.71 -58.06 7.3 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -177.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 19.2 m 70.13 -167.77 0.16 Allowed 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -176.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.512 HG12 ' HA ' ' B' ' 73' ' ' ALA . 43.2 t -122.46 -56.24 2.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 C-N-CA 120.646 -0.421 . . . . 0.0 110.724 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 54.0 tp -58.1 -36.54 73.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.476 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 70' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -84.81 13.42 5.86 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -179.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 14.0 mmtt -138.66 43.95 2.1 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.856 -0.156 . . . . 0.0 110.725 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 6.5 t 51.02 42.41 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 O-C-N 123.899 0.75 . . . . 0.0 109.994 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.512 ' HA ' HG12 ' B' ' 68' ' ' VAL . . . 56.24 45.92 22.24 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.059 -178.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 74' ' ' CYS . . . . . 0.525 ' HB2' HD12 ' B' ' 78' ' ' ILE . 18.1 p 44.9 45.01 8.38 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 114.555 -1.202 . . . . 0.0 112.442 -178.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.97 4.3 23.13 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 120.997 0.427 . . . . 0.0 110.897 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.8 -76.33 0.09 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.426 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . 0.527 ' HB1' ' O ' ' B' ' 96' ' ' ALA . . . -93.85 -10.06 35.22 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -178.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.67 HD13 ' HB2' ' B' ' 107' ' ' PHE . 40.8 mt -89.17 -47.38 15.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.661 -179.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.83 -18.27 38.18 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.923 0.392 . . . . 0.0 111.229 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.8 -25.69 62.05 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.336 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . 0.779 ' HB2' ' HB3' ' B' ' 96' ' ' ALA . . . -82.93 -9.99 59.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.972 0.415 . . . . 0.0 111.027 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 69.2 t -68.31 -37.16 77.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.998 179.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -79.79 10.17 4.41 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.444 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -109.73 -48.2 3.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.968 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 63.1 m -88.94 -9.57 51.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.329 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.78 44.39 6.09 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.686 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 132.6 173.81 13.42 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.056 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 88' ' ' ILE . . . . . 0.519 HG12 ' N ' ' B' ' 89' ' ' ASP . 0.0 OUTLIER -77.05 136.86 23.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.049 0.452 . . . . 0.0 110.936 179.714 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 89' ' ' ASP . . . . . 0.65 ' OD2' ' HB2' ' A' ' 52' ' ' HIS . 40.5 t0 -153.87 -122.96 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.525 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 90' ' ' LEU . . . . . 0.728 ' HB3' ' HD3' ' B' ' 91' ' ' PRO . 41.5 tp 173.02 -57.81 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 124.318 1.047 . . . . 0.0 109.6 179.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 91' ' ' PRO . . . . . 0.728 ' HD3' ' HB3' ' B' ' 90' ' ' LEU . 51.8 Cg_exo -54.19 -25.52 38.34 Favored 'Trans proline' 0 C--N 1.363 1.323 0 C-N-CA 122.684 2.256 . . . . 0.0 112.992 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 29.9 t -107.94 -34.61 6.86 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.18 0.514 . . . . 0.0 110.329 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . 0.673 HG13 ' HB3' ' B' ' 81' ' ' ALA . 38.6 t -70.42 -16.62 20.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.821 -179.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 94' ' ' LEU . . . . . 0.793 HD13 ' HB ' ' B' ' 115' ' ' VAL . 1.2 pt? -61.45 -18.02 57.03 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 122.25 -0.281 . . . . 0.0 111.743 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.53 -34.2 73.78 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . 0.779 ' HB3' ' HB2' ' B' ' 81' ' ' ALA . . . -100.64 -3.49 30.27 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.862 0.363 . . . . 0.0 110.643 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 97' ' ' LEU . . . . . . . . . . . . . 23.6 tp -92.99 3.07 56.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.379 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -75.78 139.03 41.58 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.405 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . 61.33 -145.89 0.44 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.783 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . 56.93 30.55 18.22 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 122.749 0.42 . . . . 0.0 111.927 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . 0.575 ' HG2' ' HA ' ' B' ' 63' ' ' MET . 93.9 mt-10 65.46 21.07 11.82 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 123.754 0.659 . . . . 0.0 112.242 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.18 -84.04 1.61 Allowed Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.944 -0.646 . . . . 0.0 113.119 178.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 79.0 m 67.84 37.24 3.21 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 122.594 0.358 . . . . 0.0 111.169 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 104' ' ' ALA . . . . . 0.549 ' HB1' ' HB2' ' B' ' 108' ' ' CYS . . . -102.68 20.38 17.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.409 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -69.36 -31.77 70.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.83 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 4.2 p -101.97 -29.37 11.84 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.255 0.55 . . . . 0.0 110.29 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . 0.67 ' HB2' HD13 ' B' ' 78' ' ' ILE . 1.0 OUTLIER -81.99 -90.86 0.07 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.985 -178.228 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 108' ' ' CYS . . . . . 0.549 ' HB2' ' HB1' ' B' ' 104' ' ' ALA . 36.2 m -70.44 40.99 0.05 Allowed 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 -178.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . 0.4 ' HA ' ' OE1' ' B' ' 109' ' ' GLU . 4.9 tp10 -77.23 -53.51 7.65 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.48 0.657 . . . . 0.0 109.455 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -97.96 1.08 47.55 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.744 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 22.4 m-70 -112.33 88.89 2.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.47 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 71.0 m -135.78 46.79 2.31 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 114.665 1.358 . . . . 0.0 114.665 -177.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 113' ' ' HIS . . . . . 0.553 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 2.9 p80 -135.24 -0.46 2.72 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 118.994 -1.082 . . . . 0.0 111.982 177.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 114' ' ' GLY . . . . . 0.453 ' HA3' ' HB2' ' A' ' 30' ' ' PRO . . . -154.64 145.9 13.47 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 119.914 -1.136 . . . . 0.0 112.664 179.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . 0.793 ' HB ' HD13 ' B' ' 94' ' ' LEU . 27.6 m 50.28 -48.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 C-N-CA 126.648 1.979 . . . . 0.0 115.936 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 116' ' ' CYS . . . . . 0.617 ' HB2' HD11 ' B' ' 90' ' ' LEU . 3.9 t -73.84 -25.65 60.18 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 121.543 -0.723 . . . . 0.0 110.094 -179.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 19.3 ttmt -77.58 -22.89 50.25 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.422 178.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -64.2 -40.16 95.5 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 43.1 mt -81.84 -22.6 36.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.14 178.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 64.91 79.89 0.24 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.226 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 86.5 mt -123.82 -6.59 7.94 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -178.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 122' ' ' CYS . . . . . . . . . . . . . 26.1 p . . . . . 0 C--O 1.245 0.818 0 CA-C-O 118.473 -0.775 . . . . 0.0 110.59 179.111 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.193 0 N-CA-C 110.4 -0.222 . . . . 0.0 110.4 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 27.9 ttt 60.76 72.79 0.51 Allowed 'General case' 0 N--CA 1.465 0.303 0 O-C-N 123.773 0.67 . . . . 0.0 111.004 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 172.25 -172.83 45.07 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.106 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -111.52 10.61 21.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.528 0.164 . . . . 0.0 110.784 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.591 ' HA ' ' O ' ' A' ' 40' ' ' GLU . 0.6 OUTLIER -156.74 -147.42 0.19 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.627 -179.328 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.4 m -92.56 -134.89 0.15 Allowed 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -178.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.0 m -109.66 -23.79 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -178.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 57.0 tp -104.84 -45.24 4.62 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.856 ' HA ' ' HB3' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -86.95 27.65 0.99 Allowed 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 177.52 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.587 ' C ' ' H ' ' A' ' 12' ' ' ALA . 22.2 ptmt -79.09 0.8 26.54 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.036 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.4 t -69.94 14.68 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 CA-C-O 121.421 0.629 . . . . 0.0 109.86 178.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.587 ' H ' ' C ' ' A' ' 10' ' ' LYS . . . 75.18 -13.69 0.83 Allowed 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 125.312 1.445 . . . . 0.0 113.805 178.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.747 ' HB2' HD12 ' A' ' 17' ' ' ILE . 11.7 p 170.25 -32.22 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 O-C-N 123.456 0.472 . . . . 0.0 112.197 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.84 -26.85 62.6 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -177.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.856 ' HB3' ' HA ' ' A' ' 9' ' ' LYS . . . -109.4 29.03 7.93 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.387 -0.525 . . . . 0.0 112.019 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -151.03 -53.12 0.14 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.222 0.534 . . . . 0.0 110.93 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.747 HD12 ' HB2' ' A' ' 13' ' ' CYS . 73.6 mt -74.69 -42.64 47.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.329 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.79 -30.99 72.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.458 178.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.9 -30.83 37.37 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.649 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.28 -24.18 63.0 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 121.031 0.443 . . . . 0.0 110.381 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 17' ' ' ILE . 49.7 t -65.26 -46.55 90.34 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.669 178.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.69 -18.12 62.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.16 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -81.17 -51.04 8.86 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.165 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 49.1 t -76.01 -33.79 59.69 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.913 0.387 . . . . 0.0 110.132 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.18 36.29 2.54 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.47 -0.872 . . . . 0.0 112.532 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 147.73 152.57 5.71 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.127 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -81.9 132.58 31.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.288 0.566 . . . . 0.0 109.767 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.414 ' HB2' ' NE2' ' B' ' 113' ' ' HIS . 46.8 t0 -158.85 -115.45 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.41 -178.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.661 HD21 ' HB2' ' A' ' 55' ' ' CYS . 35.0 tp -174.95 -57.47 0.0 OUTLIER Pre-proline 0 C--O 1.22 -0.48 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.16 178.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.908 ' HA ' HG11 ' A' ' 54' ' ' VAL . 1.0 OUTLIER -45.42 -52.71 6.3 Favored 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 122.959 2.439 . . . . 0.0 114.117 -178.971 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 19.7 p -84.08 -35.7 23.56 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.087 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.425 HG23 ' H ' ' A' ' 32' ' ' VAL . 3.5 t -63.45 -29.78 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.161 -179.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.425 HD22 HG13 ' A' ' 54' ' ' VAL . 29.9 tp -63.53 -32.28 73.69 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.086 0.469 . . . . 0.0 110.515 179.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.83 -37.55 79.24 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.07 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.53 -9.25 58.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.115 0.484 . . . . 0.0 110.601 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 23.8 tp -76.09 -6.93 53.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.453 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -86.01 5.37 33.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.102 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.66 -4.77 47.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.967 0.413 . . . . 0.0 110.354 178.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -147.17 175.46 10.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.703 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.591 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 43.0 mt-10 -87.14 120.05 28.01 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.53 0.205 . . . . 0.0 110.866 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.71 -105.79 1.27 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.988 179.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER 64.04 15.72 9.44 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.082 0.553 . . . . 0.0 111.175 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -97.05 -6.81 34.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.048 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 40.7 t -66.12 -9.44 31.4 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.22 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.535 ' HB3' ' HB3' ' A' ' 13' ' ' CYS . 33.6 t -118.95 -31.8 4.66 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.309 0.575 . . . . 0.0 110.151 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.572 ' HB2' ' CD1' ' A' ' 17' ' ' ILE . 0.6 OUTLIER -73.88 -78.55 0.09 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.327 -0.851 . . . . 0.0 113.228 -178.496 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.549 ' HA ' ' HB2' ' A' ' 50' ' ' HIS . 84.9 m -72.99 27.29 0.06 Allowed 'General case' 0 C--O 1.219 -0.505 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -176.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -67.61 -61.82 1.71 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 118.953 0.797 . . . . 0.0 109.762 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -91.14 -7.46 51.49 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.549 ' HB2' ' HA ' ' A' ' 47' ' ' CYS . 62.2 m-70 -107.73 62.24 0.62 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.497 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.517 ' O ' ' HB3' ' A' ' 56' ' ' LYS . 62.6 m -95.95 33.56 1.68 Allowed 'General case' 0 C--N 1.327 -0.393 0 O-C-N 122.031 -0.418 . . . . 0.0 110.908 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.69 ' ND1' ' HB3' ' B' ' 92' ' ' CYS . 27.6 p80 -129.82 157.71 41.47 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.732 0.301 . . . . 0.0 110.782 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.893 ' HA3' ' HB2' ' B' ' 91' ' ' PRO . . . 92.43 -132.99 11.52 Favored Glycine 0 C--O 1.227 -0.34 0 C-N-CA 120.494 -0.86 . . . . 0.0 113.267 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.908 HG11 ' HA ' ' A' ' 30' ' ' PRO . 8.9 p -78.01 -21.74 13.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 122.562 -0.375 . . . . 0.0 111.881 -178.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.661 ' HB2' HD21 ' A' ' 29' ' ' LEU . 7.5 t -77.03 -28.86 55.04 Favored 'General case' 0 C--O 1.224 -0.285 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.747 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.55 ' HG3' ' O ' ' A' ' 53' ' ' GLY . 0.0 OUTLIER -73.96 -31.19 62.91 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.0 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -69.61 -56.33 7.58 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.453 HD22 ' HA ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -94.7 65.6 3.09 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 106.579 -1.638 . . . . 0.0 106.579 176.363 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 20.3 t60 -35.42 124.44 0.64 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 114.238 -1.347 . . . . 0.0 113.968 -176.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 13.7 mt -146.37 21.84 1.34 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.793 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 8.9 p . . . . . 0 C--O 1.245 0.825 0 CA-C-O 118.124 -0.941 . . . . 0.0 110.756 178.425 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.211 0 CA-C-O 120.264 0.078 . . . . 0.0 110.821 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 63' ' ' MET . . . . . . . . . . . . . 22.7 mtp 51.95 -137.15 1.23 Allowed 'General case' 0 N--CA 1.466 0.334 0 O-C-N 123.707 0.63 . . . . 0.0 110.665 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 60.75 43.25 99.35 Favored Glycine 0 C--N 1.329 0.183 0 C-N-CA 120.953 -0.641 . . . . 0.0 113.096 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 40.2 mttm 60.44 -112.67 0.55 Allowed 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 122.631 0.372 . . . . 0.0 111.568 179.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 66' ' ' CYS . . . . . 0.661 ' O ' ' HB2' ' B' ' 70' ' ' LYS . 13.8 m -130.94 107.41 9.08 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 48.9 m 67.51 175.36 0.26 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.268 0.556 . . . . 0.0 112.028 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.543 ' O ' ' HG2' ' B' ' 71' ' ' LYS . 21.4 t -88.43 -34.84 7.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.478 -179.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 44.2 tp -75.61 -31.53 59.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.936 0.398 . . . . 0.0 111.262 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 70' ' ' LYS . . . . . 0.661 ' HB2' ' O ' ' B' ' 66' ' ' CYS . 77.6 mttt -93.79 20.41 7.64 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 120.698 0.285 . . . . 0.0 111.683 -178.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . 0.543 ' HG2' ' O ' ' B' ' 68' ' ' VAL . 59.8 pttt -91.68 9.19 33.43 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 4.2 t -82.85 27.94 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.114 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.402 ' H ' ' C ' ' B' ' 71' ' ' LYS . . . 69.49 59.52 0.31 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 114.91 -1.041 . . . . 0.0 113.426 178.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 74' ' ' CYS . . . . . 0.928 ' HB3' HD12 ' B' ' 78' ' ' ILE . 21.9 m 62.53 8.97 3.15 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 177.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -73.23 -59.98 2.45 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -80.46 48.03 0.99 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.945 0.402 . . . . 0.0 111.509 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . 0.414 ' HB2' ' HD3' ' B' ' 70' ' ' LYS . . . -162.18 -53.74 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.877 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.928 HD12 ' HB3' ' B' ' 74' ' ' CYS . 51.7 mt -92.94 -49.15 13.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.395 -179.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.48 -19.36 65.53 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.669 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -75.66 -24.32 70.39 Favored Glycine 0 N--CA 1.452 -0.28 0 N-CA-C 111.53 -0.628 . . . . 0.0 111.53 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . 0.83 ' HB2' ' HB3' ' B' ' 96' ' ' ALA . . . -80.94 -30.22 35.28 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.021 0.439 . . . . 0.0 110.469 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 32.0 t -56.76 -40.86 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.904 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.54 -34.62 78.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.543 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.61 -28.23 56.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.997 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 15.7 m -94.15 -14.9 25.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.745 -178.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.67 31.43 60.54 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.246 -178.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 152.46 151.7 5.74 Favored Glycine 0 N--CA 1.449 -0.47 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.76 129.76 55.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.726 0.774 . . . . 0.0 111.786 -178.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 89' ' ' ASP . . . . . 0.666 ' H ' HG21 ' B' ' 93' ' ' VAL . 28.4 m-20 -144.8 -82.73 0.15 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.462 -1.245 . . . . 0.0 108.526 178.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 90' ' ' LEU . . . . . 0.688 HD11 ' HB2' ' B' ' 116' ' ' CYS . 51.9 tp 179.44 -54.38 0.0 OUTLIER Pre-proline 0 C--O 1.227 -0.13 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.292 178.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 91' ' ' PRO . . . . . 0.893 ' HB2' ' HA3' ' A' ' 53' ' ' GLY . 4.9 Cg_exo -38.53 -65.94 0.15 Allowed 'Trans proline' 0 C--N 1.361 1.225 0 C-N-CA 123.487 2.792 . . . . 0.0 114.31 -179.014 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 92' ' ' CYS . . . . . 0.69 ' HB3' ' ND1' ' A' ' 52' ' ' HIS . 1.5 t -82.04 -31.42 30.93 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -179.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . 0.666 HG21 ' H ' ' B' ' 89' ' ' ASP . 1.5 t -64.81 -16.31 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-O 120.804 0.335 . . . . 0.0 111.761 -179.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 94' ' ' LEU . . . . . 0.564 HD22 HG13 ' B' ' 115' ' ' VAL . 22.7 tp -73.5 -19.12 61.01 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.859 0.361 . . . . 0.0 111.008 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.07 -53.21 60.84 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.114 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . 0.83 ' HB3' ' HB2' ' B' ' 81' ' ' ALA . . . -75.96 -14.15 60.24 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 111.617 0.228 . . . . 0.0 111.617 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 97' ' ' LEU . . . . . 0.423 HD23 HD12 ' B' ' 94' ' ' LEU . 17.6 tp -72.69 -28.74 62.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.979 0.419 . . . . 0.0 110.051 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -65.53 -24.38 67.1 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.216 178.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -81.0 -13.77 58.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.77 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -100.57 -9.04 22.38 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.98 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 71.17 -61.8 0.47 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.683 0.793 . . . . 0.0 112.285 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -127.82 -125.38 2.78 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.858 -179.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 36.3 m 61.29 48.73 5.91 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.407 0.623 . . . . 0.0 110.502 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 104' ' ' ALA . . . . . 0.729 ' HB1' ' HB2' ' B' ' 108' ' ' CYS . . . -95.63 -6.55 39.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.451 -179.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 26.6 p -63.26 -20.3 65.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.998 0.428 . . . . 0.0 111.797 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 24.7 p -106.8 -29.2 9.67 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.294 0.569 . . . . 0.0 111.101 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . 0.77 ' HB2' HD13 ' B' ' 78' ' ' ILE . 1.0 OUTLIER -100.88 -79.72 0.5 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -177.518 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 108' ' ' CYS . . . . . 0.729 ' HB2' ' HB1' ' B' ' 104' ' ' ALA . 1.8 m -67.45 24.19 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -177.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -81.36 -68.31 0.7 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 118.583 0.629 . . . . 0.0 109.715 178.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -73.36 -15.02 61.39 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 177.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 111' ' ' HIS . . . . . 0.447 ' HB3' HD22 ' B' ' 90' ' ' LEU . 61.3 m-70 -110.07 65.88 0.62 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.421 -1.263 . . . . 0.0 107.973 178.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 36.6 t -106.45 49.46 0.8 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.95 0.405 . . . . 0.0 111.757 -177.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 113' ' ' HIS . . . . . 0.483 ' HA ' ' HG2' ' B' ' 117' ' ' LYS . 18.1 p-80 -156.55 -165.74 1.96 Allowed 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . 64.64 -137.73 39.69 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.977 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . 0.564 HG13 HD22 ' B' ' 94' ' ' LEU . 11.3 p -79.66 -16.71 13.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.814 0.34 . . . . 0.0 111.076 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 116' ' ' CYS . . . . . 0.688 ' HB2' HD11 ' B' ' 90' ' ' LEU . 2.1 t -57.92 -59.75 4.77 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 120.808 0.337 . . . . 0.0 110.716 178.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 117' ' ' LYS . . . . . 0.483 ' HG2' ' HA ' ' B' ' 113' ' ' HIS . 45.3 pttt -101.4 31.94 3.52 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.742 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 118' ' ' ASP . . . . . 0.475 ' HB2' ' HA ' ' B' ' 115' ' ' VAL . 10.3 t70 -54.44 -39.16 67.11 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 178.146 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 119' ' ' LEU . . . . . 0.608 ' O ' ' HB2' ' B' ' 120' ' ' HIS . 3.3 mm? -103.32 -52.66 2.97 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 174.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 120' ' ' HIS . . . . . 0.608 ' HB2' ' O ' ' B' ' 119' ' ' LEU . 42.3 t60 153.6 129.26 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.862 0 O-C-N 124.951 1.407 . . . . 0.0 110.422 176.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 121' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' B' ' 120' ' ' HIS . 14.4 mt -160.33 41.26 0.18 Allowed 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 122' ' ' CYS . . . . . 0.426 ' HB3' ' O ' ' B' ' 108' ' ' CYS . 1.4 p . . . . . 0 C--O 1.246 0.9 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.711 178.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.4 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 43.6 ttp -136.46 133.41 36.57 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.015 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 114.75 151.41 10.17 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.037 -1.078 . . . . 0.0 113.786 178.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.515 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 36.5 mtmt -101.19 -14.64 17.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.857 0.361 . . . . 0.0 110.413 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 7.5 t -126.16 66.22 1.21 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.021 0.439 . . . . 0.0 110.84 -178.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.1 m -84.9 -162.68 0.72 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.131 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 24.7 t -71.29 -41.6 74.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.924 0.392 . . . . 0.0 110.158 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.2 tp -76.51 -33.18 58.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.872 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.515 ' HD3' ' O ' ' A' ' 4' ' ' LYS . 8.9 mttp -90.69 28.96 1.4 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.966 178.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -70.58 -21.03 62.72 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.3 t -66.79 -16.84 21.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.933 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.02 9.49 1.92 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.92 0.391 . . . . 0.0 111.329 179.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 13.0 p -65.28 -24.95 67.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.409 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.676 ' HA ' HG22 ' A' ' 17' ' ' ILE . . . -64.85 -19.49 65.91 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.228 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.09 0.82 23.2 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -132.19 -22.48 2.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.777 0.322 . . . . 0.0 111.76 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.676 HG22 ' HA ' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -92.93 -44.58 13.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.945 0.403 . . . . 0.0 111.484 -178.923 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.18 -32.38 66.39 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.769 -178.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.98 -24.04 74.86 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.313 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.798 ' HB2' ' HB3' ' A' ' 35' ' ' ALA . . . -83.92 -24.79 30.6 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 120.821 0.343 . . . . 0.0 111.039 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 17' ' ' ILE . 86.8 t -66.36 -46.65 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.551 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.34 -28.38 65.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.462 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -75.84 -44.9 38.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 112.061 -179.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.8 t -84.87 -37.28 20.84 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.729 0.299 . . . . 0.0 110.869 -179.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.99 48.9 1.3 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.405 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 143.67 -179.51 21.03 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.217 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.547 HD13 HD11 ' A' ' 17' ' ' ILE . 6.0 tp -113.23 117.23 54.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.489 0.661 . . . . 0.0 111.988 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.63 ' H ' HG21 ' A' ' 32' ' ' VAL . 30.6 t0 -134.28 -108.89 0.22 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.784 ' HG ' HG22 ' A' ' 54' ' ' VAL . 41.0 tp -175.01 -57.03 0.0 OUTLIER Pre-proline 0 C--O 1.223 -0.326 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.291 178.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.717 ' HA ' HG21 ' A' ' 54' ' ' VAL . 2.3 Cg_endo -46.24 -60.18 0.95 Allowed 'Trans proline' 0 C--N 1.361 1.231 0 C-N-CA 123.005 2.47 . . . . 0.0 114.357 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 19.9 p -79.41 -33.84 42.29 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.655 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.63 HG21 ' H ' ' A' ' 28' ' ' ASP . 2.4 t -67.1 -17.62 22.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.552 -179.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 30.0 tp -64.26 -26.13 68.36 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.495 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.37 -59.73 4.2 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -178.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.798 ' HB3' ' HB2' ' A' ' 20' ' ' ALA . . . -75.15 -17.0 60.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.747 0.308 . . . . 0.0 111.791 -179.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.507 HD22 ' CD2' ' A' ' 46' ' ' PHE . 32.8 tp -75.16 -10.33 59.37 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.931 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -74.4 93.13 2.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.894 0.378 . . . . 0.0 110.363 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -111.22 -5.55 14.69 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.698 -179.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 72.69 -61.92 0.48 Allowed 'General case' 0 N--CA 1.473 0.694 0 O-C-N 123.989 0.806 . . . . 0.0 113.02 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -60.67 -69.11 0.24 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.834 0.35 . . . . 0.0 111.826 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 42' ' ' CYS . . . -156.16 -139.63 2.79 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.146 -1.026 . . . . 0.0 112.779 -179.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 41' ' ' GLY . 96.5 m 73.17 8.81 5.31 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.16 0.584 . . . . 0.0 111.197 -179.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -95.51 -21.76 18.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.869 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.7 p -79.89 11.51 3.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.488 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 46.8 t -109.65 -62.29 1.52 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.536 ' O ' ' HD2' ' A' ' 50' ' ' HIS . 0.8 OUTLIER -67.48 -59.28 3.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.713 178.697 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.622 ' HA ' ' HB2' ' A' ' 50' ' ' HIS . 87.9 m -74.6 15.54 0.35 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -55.86 -52.55 63.67 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.334 0.587 . . . . 0.0 110.386 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -94.79 -20.07 19.8 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.914 178.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.622 ' HB2' ' HA ' ' A' ' 47' ' ' CYS . 70.0 m-70 -98.56 72.56 2.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.443 -179.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 97.0 m -92.16 -2.16 56.73 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -178.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 1.015 ' HA ' ' HB3' ' A' ' 56' ' ' LYS . 9.6 p80 -117.2 -160.16 0.76 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 119.808 -0.757 . . . . 0.0 111.112 179.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 68.47 -130.99 26.58 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.571 -0.823 . . . . 0.0 111.794 -178.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.784 HG22 ' HG ' ' A' ' 29' ' ' LEU . 30.0 m -75.97 -18.99 15.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.858 0.329 . . . . 0.0 111.633 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.499 ' HB2' HD11 ' A' ' 29' ' ' LEU . 1.4 t -82.57 -23.29 34.53 Favored 'General case' 0 C--O 1.216 -0.691 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.184 -179.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 1.015 ' HB3' ' HA ' ' A' ' 52' ' ' HIS . 0.0 OUTLIER -77.58 -13.39 59.92 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.352 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -90.45 -59.86 2.07 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.749 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 20.6 tp -80.12 -75.58 0.25 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.592 0.234 . . . . 0.0 111.316 -179.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 58.1 m-70 -90.28 -129.5 0.09 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 60' ' ' LEU . 8.1 tp -169.83 -87.56 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 177.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.592 ' HB3' ' O ' ' A' ' 47' ' ' CYS . 1.8 p . . . . . 0 C--O 1.245 0.82 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.651 178.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.137 0 CA-C-O 120.808 0.337 . . . . 0.0 111.005 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 63' ' ' MET . . . . . . . . . . . . . 18.9 ptp -104.95 129.08 53.44 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.009 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 111.22 170.64 19.13 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.341 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . 0.401 ' HB3' ' HE2' ' B' ' 65' ' ' LYS . 32.1 ttpt -99.91 -39.02 8.38 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.846 0.355 . . . . 0.0 110.924 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 66' ' ' CYS . . . . . . . . . . . . . 51.6 m -109.74 157.61 18.96 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -178.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 77.4 p -178.27 -167.03 0.12 Allowed 'General case' 0 C--O 1.236 0.351 0 CA-C-N 114.373 -1.285 . . . . 0.0 107.887 178.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 7.5 t -87.03 -27.61 5.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.169 0.509 . . . . 0.0 109.775 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 39.8 tp -89.92 -39.39 13.05 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 70' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -87.08 28.24 0.94 Allowed 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -64.48 -19.73 65.75 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.443 179.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 3.8 t -60.74 -19.09 18.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.506 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -93.29 25.82 3.19 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 122.263 -0.273 . . . . 0.0 111.719 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 31.7 p -95.33 -12.91 25.29 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.308 -0.557 . . . . 0.0 111.634 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 75' ' ' ALA . . . . . 0.476 ' HA ' HG22 ' B' ' 78' ' ' ILE . . . -59.21 -35.66 74.0 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 123.253 0.345 . . . . 0.0 111.209 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -74.11 -0.53 16.87 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . 0.463 ' O ' ' HA ' ' B' ' 97' ' ' LEU . . . -124.66 -12.73 7.13 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.539 HG13 ' CD2' ' B' ' 107' ' ' PHE . 0.0 OUTLIER -106.5 -46.54 8.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.097 0.475 . . . . 0.0 110.91 -179.238 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -56.91 -23.47 45.17 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.947 -179.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -75.39 -25.26 68.62 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.403 -0.904 . . . . 0.0 112.151 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -82.21 -16.9 48.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.763 0.316 . . . . 0.0 111.348 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 82' ' ' VAL . . . . . 0.401 HG22 HD13 ' B' ' 88' ' ' ILE . 59.6 t -62.46 -45.78 97.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-O 121.033 0.444 . . . . 0.0 110.77 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.87 -31.19 70.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.473 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.19 -36.27 79.3 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.516 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 26.6 m -92.99 -12.27 31.1 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 69.55 42.27 73.2 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.488 -0.863 . . . . 0.0 111.319 -178.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 151.81 137.66 2.65 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 88' ' ' ILE . . . . . 0.401 HD13 HG22 ' B' ' 82' ' ' VAL . 2.9 tp -91.23 114.1 27.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.34 0.59 . . . . 0.0 111.944 -179.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 89' ' ' ASP . . . . . 0.588 ' H ' HG21 ' B' ' 93' ' ' VAL . 0.9 OUTLIER -130.44 -91.91 0.44 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.641 179.038 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 90' ' ' LEU . . . . . 0.456 ' HG ' ' CG2' ' B' ' 115' ' ' VAL . 10.8 tp 175.93 -54.4 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.481 0 C-N-CA 123.484 0.714 . . . . 0.0 110.357 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 91' ' ' PRO . . . . . 0.85 ' HA ' HG21 ' B' ' 115' ' ' VAL . 60.9 Cg_exo -35.67 -63.11 0.2 Allowed 'Trans proline' 0 C--N 1.365 1.438 0 C-N-CA 123.492 2.795 . . . . 0.0 115.009 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 29.3 p -90.94 -31.32 16.42 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -178.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . 0.588 HG21 ' H ' ' B' ' 89' ' ' ASP . 3.2 t -57.58 -29.5 34.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.079 0.466 . . . . 0.0 111.561 -179.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 5.5 tp -62.46 -33.46 74.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.834 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.92 -15.16 54.39 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -177.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -129.07 20.81 5.83 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.667 0.618 . . . . 0.0 112.667 -179.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 97' ' ' LEU . . . . . 0.53 ' HG ' ' O ' ' B' ' 97' ' ' LEU . 0.0 OUTLIER -106.21 -9.12 17.02 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.431 179.827 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -40.18 110.37 0.15 Allowed 'General case' 0 N--CA 1.47 0.532 0 O-C-N 123.994 0.809 . . . . 0.0 112.044 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 99' ' ' ALA . . . . . 0.407 ' HB3' ' HB2' ' B' ' 103' ' ' CYS . . . -109.36 -0.94 18.8 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.066 -179.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . 72.58 -78.84 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -83.53 48.81 1.47 Allowed 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -177.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . 0.437 ' O ' ' HB2' ' B' ' 103' ' ' CYS . . . 103.55 -145.51 16.2 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 119.828 -1.177 . . . . 0.0 113.671 178.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 103' ' ' CYS . . . . . 0.437 ' HB2' ' O ' ' B' ' 102' ' ' GLY . 5.5 m 71.94 20.0 4.56 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 122.953 0.501 . . . . 0.0 111.28 -178.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -112.07 -9.48 13.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.038 0.447 . . . . 0.0 110.215 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 8.4 p -79.18 -17.89 54.05 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.603 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 4.0 p -78.3 -62.02 1.82 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.287 0.565 . . . . 0.0 110.511 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . 0.539 ' CD2' HG13 ' B' ' 78' ' ' ILE . 0.9 OUTLIER -61.62 -61.03 2.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.168 -0.923 . . . . 0.0 110.75 -179.839 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 108' ' ' CYS . . . . . 0.749 ' O ' ' HB3' ' B' ' 122' ' ' CYS . 61.0 m -90.11 54.12 2.71 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.9 -179.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -74.24 -62.89 1.36 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.204 0.526 . . . . 0.0 110.125 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -86.13 -8.74 57.64 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 111' ' ' HIS . . . . . 0.701 ' O ' ' HB3' ' B' ' 108' ' ' CYS . 3.5 m-70 -106.99 88.26 2.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.554 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 90.3 m -114.48 37.66 3.33 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.381 -0.528 . . . . 0.0 112.101 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 113' ' ' HIS . . . . . 0.74 ' HA ' ' HB3' ' B' ' 117' ' ' LYS . 2.1 p80 -144.38 -149.69 0.29 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 110.202 -0.295 . . . . 0.0 110.202 178.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 114' ' ' GLY . . . . . 0.458 ' HA3' ' HG2' ' A' ' 30' ' ' PRO . . . 58.04 -106.37 0.8 Allowed Glycine 0 C--N 1.332 0.34 0 C-N-CA 121.205 -0.522 . . . . 0.0 112.973 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . 0.85 HG21 ' HA ' ' B' ' 91' ' ' PRO . 5.4 m -106.36 -23.76 4.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.582 0.23 . . . . 0.0 111.064 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 116' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -76.22 1.83 14.83 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 121.274 0.559 . . . . 0.0 110.966 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 117' ' ' LYS . . . . . 0.74 ' HB3' ' HA ' ' B' ' 113' ' ' HIS . 0.1 OUTLIER -100.27 -3.2 31.88 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.181 178.058 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -102.48 110.58 22.56 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.219 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 39.7 tp 77.55 -51.48 0.53 Allowed 'General case' 0 N--CA 1.474 0.729 0 O-C-N 124.108 0.88 . . . . 0.0 110.666 -178.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 -94.82 169.06 10.42 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 11.4 tp -167.95 64.79 0.07 Allowed 'General case' 0 C--O 1.233 0.203 0 C-N-CA 120.068 -0.653 . . . . 0.0 112.542 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 122' ' ' CYS . . . . . 0.749 ' HB3' ' O ' ' B' ' 108' ' ' CYS . 0.8 OUTLIER . . . . . 0 C--O 1.248 0.996 0 O-C-N 124.043 0.839 . . . . 0.0 113.162 179.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.253 0 CA-C-O 120.684 0.278 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 26.1 mmt -87.47 78.93 8.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.951 0.405 . . . . 0.0 111.026 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 115.34 -169.05 12.75 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.424 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 12.4 mtpt -85.68 44.81 1.14 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.045 0.45 . . . . 0.0 111.078 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.7 t -176.28 170.99 2.52 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.2 t -134.8 -142.74 0.19 Allowed 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.655 HG12 ' HD3' ' A' ' 10' ' ' LYS . 3.1 m -69.99 81.91 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.1 0.476 . . . . 0.0 111.21 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.657 ' HG ' ' H ' ' A' ' 9' ' ' LYS . 0.6 OUTLIER -74.46 -60.51 2.24 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.594 -179.284 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.657 ' H ' ' HG ' ' A' ' 8' ' ' LEU . 34.9 mtmt -96.06 -19.11 19.69 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.655 ' HD3' HG12 ' A' ' 7' ' ' VAL . 30.8 mtpp -58.0 -50.91 71.79 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -177.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.578 HG23 ' HB ' ' A' ' 7' ' ' VAL . 8.2 t -89.97 34.14 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.51 0.671 . . . . 0.0 109.457 179.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 56.72 30.42 17.56 Favored 'General case' 0 N--CA 1.461 0.089 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.863 -179.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.599 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 18.9 m 63.78 17.92 10.8 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.154 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -89.88 28.38 1.37 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -108.39 -94.81 0.4 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.807 0.337 . . . . 0.0 110.997 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.16 -0.21 16.02 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.642 HD13 ' HB2' ' A' ' 46' ' ' PHE . 60.5 mt -107.99 -61.64 2.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.787 -0.188 . . . . 0.0 111.206 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.58 -31.36 71.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.999 0.428 . . . . 0.0 110.535 179.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.33 -20.48 72.11 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.638 179.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.3 -22.63 51.71 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.161 0.505 . . . . 0.0 110.016 179.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 75.3 t -64.55 -44.19 96.82 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.594 178.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.78 -16.44 61.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.349 179.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.88 -44.38 32.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.121 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.517 ' SG ' ' HB2' ' B' ' 113' ' ' HIS . 24.8 t -85.67 -28.98 24.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.032 0.444 . . . . 0.0 110.831 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 103.52 38.14 2.87 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.432 -0.89 . . . . 0.0 112.198 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 145.62 165.68 11.47 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.916 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.9 tp -95.81 109.59 22.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.256 0.551 . . . . 0.0 110.362 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.732 ' C ' ' HD2' ' A' ' 30' ' ' PRO . 15.9 p-10 -128.73 -50.3 1.25 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 118.963 -0.541 . . . . 0.0 111.27 -179.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.664 ' HB3' ' O ' ' A' ' 28' ' ' ASP . 17.0 tp 107.14 -54.39 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 124.913 1.383 . . . . 0.0 111.794 -179.034 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.851 ' HA ' HG21 ' A' ' 54' ' ' VAL . 10.6 Cg_endo -53.75 -36.55 82.5 Favored 'Trans proline' 0 C--N 1.364 1.38 0 C-N-CA 122.325 2.017 . . . . 0.0 112.869 179.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 2.4 t -93.9 -36.43 12.21 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.109 0.48 . . . . 0.0 110.711 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.588 HG23 ' OD1' ' A' ' 28' ' ' ASP . 94.0 t -64.25 -25.93 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.359 -179.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.418 HD23 HG21 ' A' ' 54' ' ' VAL . 2.9 pp -57.69 -33.27 68.2 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.789 0.328 . . . . 0.0 111.139 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.61 -38.13 62.65 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.67 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.28 -13.46 60.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.47 -179.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -93.11 -41.54 9.89 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.362 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.9 ttmm 55.1 77.42 0.22 Allowed 'General case' 0 N--CA 1.47 0.546 0 O-C-N 123.464 0.478 . . . . 0.0 110.281 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -99.59 138.44 36.67 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.117 0.485 . . . . 0.0 111.972 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -115.71 -99.96 0.44 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.3 178.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -86.42 78.28 9.29 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.463 0.649 . . . . 0.0 110.23 178.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 102.77 -128.94 9.71 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.482 -179.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.54 ' H ' HD13 ' A' ' 8' ' ' LEU . 3.9 m 70.29 -57.49 0.57 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.336 0.654 . . . . 0.0 111.657 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -87.7 13.63 10.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.529 0.204 . . . . 0.0 111.116 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.24 -44.89 96.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.863 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 8.0 p -80.01 -32.5 39.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.17 0.51 . . . . 0.0 110.514 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.642 ' HB2' HD13 ' A' ' 17' ' ' ILE . 0.9 OUTLIER -59.68 -61.12 2.86 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.554 -179.801 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 62.6 m -80.32 52.59 1.62 Allowed 'General case' 0 C--O 1.211 -0.94 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.137 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -78.3 -59.58 2.72 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -101.08 -13.3 18.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.239 179.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -96.88 76.21 2.73 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.198 -0.91 . . . . 0.0 108.955 179.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 88.9 m -117.7 19.64 13.76 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -177.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 9.0 p-80 -123.31 -20.98 5.48 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 119.439 -0.904 . . . . 0.0 113.192 -179.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.493 ' HA3' ' HG2' ' B' ' 91' ' ' PRO . . . -106.21 119.57 6.06 Favored Glycine 0 C--O 1.221 -0.682 0 C-N-CA 120.034 -1.079 . . . . 0.0 112.606 179.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.851 HG21 ' HA ' ' A' ' 30' ' ' PRO . 14.3 m 54.54 -33.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 13.4 t -72.87 -37.75 67.23 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 121.471 -0.768 . . . . 0.0 110.938 -178.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 35.7 tttp -67.29 -8.62 33.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.703 179.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -71.97 -22.86 61.38 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 178.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.4 mp -114.4 -21.56 10.31 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.854 178.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 67.18 87.51 0.12 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.05 0.54 . . . . 0.0 111.059 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.7 mt -125.31 19.58 8.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.707 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 10.6 p . . . . . 0 C--O 1.245 0.817 0 CA-C-O 118.063 -0.97 . . . . 0.0 109.786 179.385 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.167 0 CA-C-O 120.826 0.346 . . . . 0.0 110.578 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 63' ' ' MET . . . . . . . . . . . . . 26.3 mmt -81.74 -49.7 10.13 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.54 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -154.29 -163.41 11.91 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.237 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 31.1 mtmm -94.57 3.14 55.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.105 0.478 . . . . 0.0 110.503 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 66' ' ' CYS . . . . . 0.505 ' HB2' ' HG3' ' B' ' 101' ' ' GLU . 0.0 OUTLIER -152.75 -74.19 0.14 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.589 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 70.1 m 66.48 -58.66 0.36 Allowed 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 178.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.507 HG12 HG21 ' B' ' 72' ' ' VAL . 17.0 m -83.92 43.86 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 -178.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.768 ' HB3' ' HA ' ' B' ' 103' ' ' CYS . 0.2 OUTLIER -83.43 -121.81 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.617 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 70' ' ' LYS . . . . . 0.512 ' H ' ' HB2' ' B' ' 69' ' ' LEU . 0.0 OUTLIER -74.93 4.83 5.87 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 121.96 -0.463 . . . . 0.0 110.387 178.576 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 6.0 mtmt -73.11 -56.5 5.02 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.136 -0.484 . . . . 0.0 112.085 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.507 HG21 HG12 ' B' ' 68' ' ' VAL . 2.1 t -92.25 36.72 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . 55.96 28.67 13.02 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 114.69 -1.141 . . . . 0.0 111.1 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 74' ' ' CYS . . . . . 0.942 ' HB3' HD12 ' B' ' 78' ' ' ILE . 51.6 m 54.29 44.16 29.43 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.564 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -90.45 -43.24 10.4 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -178.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.89 -66.55 0.53 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -177.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.89 10.48 2.78 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -177.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.942 HD12 ' HB3' ' B' ' 74' ' ' CYS . 20.8 mt -130.8 -55.37 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 O-C-N 121.778 -0.576 . . . . 0.0 111.432 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.78 -36.22 70.28 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.282 178.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -75.53 -23.7 72.41 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.281 178.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.63 -22.59 63.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.029 0.442 . . . . 0.0 110.693 179.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 54.7 t -65.84 -38.83 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.574 179.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -76.52 -13.98 60.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.805 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.53 -35.01 30.85 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.519 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 85' ' ' CYS . . . . . . . . . . . . . 54.0 t -92.61 -40.26 10.87 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 121.005 -0.278 . . . . 0.0 111.508 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.02 37.27 1.54 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.502 -0.856 . . . . 0.0 111.628 -179.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 158.4 167.11 18.77 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 121.028 -0.606 . . . . 0.0 111.687 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 3.1 tp -102.48 123.45 55.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.915 0.388 . . . . 0.0 111.363 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 89' ' ' ASP . . . . . 0.49 ' CG ' ' H ' ' B' ' 90' ' ' LEU . 9.9 p-10 -163.7 -111.89 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.581 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 90' ' ' LEU . . . . . 0.682 ' HG ' HG22 ' B' ' 115' ' ' VAL . 37.1 tp -179.32 -49.99 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.404 0 C-N-CA 123.843 0.857 . . . . 0.0 110.454 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 91' ' ' PRO . . . . . 0.719 ' HG3' ' HD3' ' A' ' 30' ' ' PRO . 5.4 Cg_endo -46.9 -34.28 15.98 Favored 'Trans proline' 0 C--N 1.366 1.465 0 C-N-CA 123.39 2.727 . . . . 0.0 114.575 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 15.2 p -108.64 -27.99 9.52 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.161 0.505 . . . . 0.0 110.755 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 48.2 t -60.67 -20.15 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.705 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 94' ' ' LEU . . . . . 0.64 HD12 ' N ' ' B' ' 95' ' ' ALA . 0.8 OUTLIER -53.77 -24.33 14.8 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 179.953 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . 0.64 ' N ' HD12 ' B' ' 94' ' ' LEU . . . -60.5 -55.36 34.36 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -178.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -82.75 -21.57 34.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.783 0.325 . . . . 0.0 110.705 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 97' ' ' LEU . . . . . 0.429 ' HB3' ' HA ' ' B' ' 94' ' ' LEU . 44.1 tp -62.22 -51.83 66.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.292 178.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 51.1 tttm 63.52 113.11 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.697 177.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -87.29 82.86 7.48 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.823 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -102.47 -103.11 0.28 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.846 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . 0.505 ' HG3' ' HB2' ' B' ' 66' ' ' CYS . 22.4 pt-20 -102.98 43.3 1.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.539 0.685 . . . . 0.0 109.949 179.226 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . 0.453 ' O ' ' HB2' ' B' ' 103' ' ' CYS . . . 116.33 -128.08 7.8 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.444 -179.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 103' ' ' CYS . . . . . 0.768 ' HA ' ' HB3' ' B' ' 69' ' ' LEU . 39.9 m 72.93 -48.41 0.69 Allowed 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.281 0.633 . . . . 0.0 112.428 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -79.37 -9.66 59.64 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 54.4 p -52.46 -52.43 54.22 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 4.8 p -62.37 -30.49 71.22 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.031 0.444 . . . . 0.0 111.179 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . 0.445 ' HB2' HD11 ' B' ' 78' ' ' ILE . 0.5 OUTLIER -69.18 -56.7 6.84 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.31 -179.189 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 108' ' ' CYS . . . . . 0.623 ' SG ' ' HB3' ' B' ' 122' ' ' CYS . 0.8 OUTLIER -79.57 18.21 0.77 Allowed 'General case' 0 CA--C 1.514 -0.407 0 C-N-CA 120.631 -0.427 . . . . 0.0 111.973 179.914 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -55.22 -65.11 0.64 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.378 0.609 . . . . 0.0 110.201 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -89.13 -10.36 47.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.254 178.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 47.3 m-70 -110.69 64.95 0.61 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.928 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 1.7 m -91.2 39.54 1.0 Allowed 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 112.046 0.388 . . . . 0.0 112.046 -178.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 113' ' ' HIS . . . . . 0.517 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 14.1 p-80 -143.22 -15.39 0.68 Allowed 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.341 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 114' ' ' GLY . . . . . . . . . . . . . . . -77.25 -159.97 11.4 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.762 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . 0.682 HG22 ' HG ' ' B' ' 90' ' ' LEU . 24.4 m -64.39 -4.96 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -179.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 116' ' ' CYS . . . . . 0.512 ' SG ' ' HB2' ' B' ' 121' ' ' LEU . 7.0 t -78.77 -23.45 45.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.685 0.755 . . . . 0.0 109.115 178.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 4.0 ttmt -81.79 -7.57 59.61 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.146 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -65.01 -31.92 73.39 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 16.6 tp -114.23 -8.13 12.95 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.188 178.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 66.51 79.52 0.24 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.024 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 121' ' ' LEU . . . . . 0.512 ' HB2' ' SG ' ' B' ' 116' ' ' CYS . 96.6 mt -116.5 4.64 13.29 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 122' ' ' CYS . . . . . 0.623 ' HB3' ' SG ' ' B' ' 108' ' ' CYS . 21.2 p . . . . . 0 C--O 1.248 0.977 0 CA-C-O 118.177 -0.915 . . . . 0.0 109.335 178.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.186 0 N-CA-C 110.499 -0.186 . . . . 0.0 110.499 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.88 -158.78 0.75 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.058 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 170.47 169.35 33.48 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.936 -0.65 . . . . 0.0 111.667 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 31.1 tttm -95.88 -62.08 1.34 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 117.14 0.47 . . . . 0.0 109.998 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.645 ' HB2' ' HB2' ' A' ' 40' ' ' GLU . 26.1 t -131.96 66.65 1.54 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.766 179.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.8 m -78.89 152.97 30.89 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.356 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.619 ' HB ' ' HB3' ' A' ' 10' ' ' LYS . 29.3 m 38.18 46.43 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 123.991 0.916 . . . . 0.0 112.409 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.479 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 0.7 OUTLIER -51.56 -54.13 30.74 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.809 -178.987 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.594 ' HA ' ' SG ' ' A' ' 13' ' ' CYS . 11.6 ptmm? -106.22 30.14 6.19 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 121.063 0.459 . . . . 0.0 110.652 -179.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.619 ' HB3' ' HB ' ' A' ' 7' ' ' VAL . 87.7 tttt -122.09 -64.18 1.23 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.379 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.3 t -110.57 -28.7 2.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.128 -179.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 8' ' ' LEU . . . -59.78 -28.83 67.76 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.655 0.264 . . . . 0.0 111.562 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.807 ' HA ' HD12 ' A' ' 17' ' ' ILE . 26.7 m -69.77 -16.58 63.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.941 0.401 . . . . 0.0 111.122 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.591 ' HA ' ' HB3' ' A' ' 18' ' ' ALA . . . -106.56 -13.99 15.17 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.789 0.328 . . . . 0.0 111.261 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -88.23 -69.27 0.71 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.669 ' HB1' ' HA ' ' A' ' 36' ' ' LEU . . . -88.87 2.87 53.01 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.807 HD12 ' HA ' ' A' ' 13' ' ' CYS . 66.9 mt -119.0 -64.79 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 121.218 -0.193 . . . . 0.0 110.932 -179.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.591 ' HB3' ' HA ' ' A' ' 14' ' ' ALA . . . -68.27 -26.68 65.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.126 0.489 . . . . 0.0 110.057 178.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -87.47 10.35 69.77 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 178.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -125.12 -2.21 7.65 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 122.801 0.44 . . . . 0.0 110.456 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.566 HG13 ' HA2' ' A' ' 26' ' ' GLY . 64.3 t -66.5 -43.51 90.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.22 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.19 -4.57 30.09 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -84.17 -13.87 51.64 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -149.03 40.85 0.89 Allowed 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.47 -48.27 2.52 Favored Glycine 0 C--O 1.227 -0.336 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.882 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.566 ' HA2' HG13 ' A' ' 21' ' ' VAL . . . -168.57 176.49 42.88 Favored Glycine 0 N--CA 1.442 -0.907 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.44 HG23 HG22 ' A' ' 21' ' ' VAL . 0.9 OUTLIER -49.86 110.83 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.607 0.718 . . . . 0.0 112.18 179.972 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.645 ' HB3' HG23 ' A' ' 32' ' ' VAL . 49.2 t0 -121.47 -118.82 0.3 Allowed 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.805 HD11 ' HB2' ' A' ' 55' ' ' CYS . 16.1 tp 173.01 -57.94 0.0 OUTLIER Pre-proline 0 C--O 1.223 -0.296 0 O-C-N 123.612 0.57 . . . . 0.0 111.429 178.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.722 ' HD3' ' HB3' ' A' ' 29' ' ' LEU . 54.3 Cg_exo -52.06 -49.21 18.1 Favored 'Trans proline' 0 C--N 1.358 1.048 0 C-N-CA 122.268 1.979 . . . . 0.0 113.225 -179.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 25.5 p -92.42 -35.15 13.83 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.238 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.645 HG23 ' HB3' ' A' ' 28' ' ' ASP . 65.4 t -65.06 -18.92 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.241 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 25.9 tp -57.93 -25.78 61.36 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.893 178.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.05 -41.13 99.42 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.648 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -86.36 -8.87 57.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.971 0.415 . . . . 0.0 111.057 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.669 ' HA ' ' HB1' ' A' ' 16' ' ' ALA . 33.5 tp -89.17 62.11 6.05 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 178.356 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.647 ' HD3' ' H ' ' A' ' 37' ' ' LYS . 0.3 OUTLIER -75.27 45.08 0.27 Allowed 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -177.1 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.61 156.83 16.61 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 122.189 -0.319 . . . . 0.0 110.386 178.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.416 ' HA ' HD21 ' A' ' 58' ' ' LEU . . . -115.23 -40.97 3.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.983 0.421 . . . . 0.0 110.583 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.645 ' HB2' ' HB2' ' A' ' 5' ' ' CYS . 60.3 mm-40 -93.53 -169.1 2.04 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.069 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -75.31 56.65 2.83 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 121.015 -0.612 . . . . 0.0 113.851 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.449 ' HA ' ' HB2' ' A' ' 8' ' ' LEU . 19.7 m -97.66 5.0 49.94 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 122.466 -0.432 . . . . 0.0 110.396 179.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.581 ' HB2' HD11 ' A' ' 36' ' ' LEU . . . -126.07 16.56 7.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.193 179.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.567 ' O ' ' HG2' ' A' ' 48' ' ' GLU . 5.9 m -61.86 -32.08 72.4 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.704 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 12.7 p -66.25 -26.74 67.5 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.124 0.488 . . . . 0.0 111.058 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.772 ' HB2' HD13 ' A' ' 17' ' ' ILE . 1.0 OUTLIER -93.29 -63.89 1.16 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.843 -178.67 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.493 ' HA ' ' HB2' ' A' ' 50' ' ' HIS . 72.9 m -82.84 45.44 1.0 Allowed 'General case' 0 C--O 1.217 -0.621 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -177.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.567 ' HG2' ' O ' ' A' ' 44' ' ' SER . 0.9 OUTLIER -72.81 -71.15 0.31 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 119.147 0.885 . . . . 0.0 110.401 179.406 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -78.36 -5.92 53.66 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.493 ' HB2' ' HA ' ' A' ' 47' ' ' CYS . 36.2 m-70 -104.29 66.17 0.81 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.924 -179.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.414 ' O ' ' HD2' ' A' ' 56' ' ' LYS . 72.4 m -120.41 50.08 1.36 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 178.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.436 ' HB3' ' SG ' ' B' ' 85' ' ' CYS . 13.1 m80 -96.92 -77.01 0.5 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.594 0.712 . . . . 0.0 110.185 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 55' ' ' CYS . . . -120.86 -174.99 15.15 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 179.05 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.646 HG11 ' HA ' ' A' ' 30' ' ' PRO . 9.3 m 47.02 -64.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.805 ' HB2' HD11 ' A' ' 29' ' ' LEU . 8.8 t -64.78 -48.89 72.84 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 121.664 -0.647 . . . . 0.0 111.836 -178.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.414 ' HD2' ' O ' ' A' ' 51' ' ' CYS . 17.0 ptmt -75.23 -2.01 26.02 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 119.42 -0.912 . . . . 0.0 111.296 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -65.97 -35.52 80.8 Favored 'General case' 0 N--CA 1.461 0.114 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 177.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.483 HD22 HD22 ' A' ' 60' ' ' LEU . 7.9 tt -90.26 -33.13 16.26 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 114.58 -1.191 . . . . 0.0 108.011 177.366 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 22.5 t-160 77.25 86.6 0.08 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.274 178.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.541 ' N ' HD23 ' A' ' 60' ' ' LEU . 0.7 OUTLIER -140.57 25.45 2.19 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -179.932 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 6.0 p . . . . . 0 C--O 1.244 0.791 0 CA-C-O 118.17 -0.919 . . . . 0.0 109.856 176.853 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.179 0 CA-C-O 120.788 0.328 . . . . 0.0 111.094 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 63' ' ' MET . . . . . . . . . . . . . 36.5 ttm -75.67 139.15 41.8 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -133.05 119.13 2.3 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 119.594 -1.288 . . . . 0.0 114.208 -178.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 20.8 tttt -120.41 -29.8 4.71 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 66' ' ' CYS . . . . . 0.636 ' SG ' ' HB3' ' B' ' 69' ' ' LEU . 42.7 t -156.97 52.57 0.5 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.328 -1.305 . . . . 0.0 107.981 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 25.0 m -54.9 142.28 30.21 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.14 -178.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.661 ' HB ' ' HB3' ' B' ' 71' ' ' LYS . 23.6 m 40.41 48.27 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 O-C-N 124.251 0.97 . . . . 0.0 112.393 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.636 ' HB3' ' SG ' ' B' ' 66' ' ' CYS . 0.3 OUTLIER -46.19 -72.86 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.039 -0.982 . . . . 0.0 113.17 -179.666 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 70' ' ' LYS . . . . . . . . . . . . . 17.8 mtpp -92.94 27.9 2.27 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.001 0.429 . . . . 0.0 110.036 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . 0.661 ' HB3' ' HB ' ' B' ' 68' ' ' VAL . 4.4 tmtp? -116.56 -67.82 0.97 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.638 -178.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.405 ' HB ' HG21 ' B' ' 68' ' ' VAL . 18.6 t -116.12 -24.82 3.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.811 0.339 . . . . 0.0 111.033 -179.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' B' ' 69' ' ' LEU . . . -60.86 -35.39 76.46 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 74' ' ' CYS . . . . . 0.615 ' HA ' HD12 ' B' ' 78' ' ' ILE . 13.0 p -89.94 2.86 54.58 Favored 'General case' 0 CA--C 1.521 -0.137 0 C-N-CA 119.538 -0.865 . . . . 0.0 111.285 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -115.61 13.16 16.26 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 120.906 0.384 . . . . 0.0 110.661 178.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -128.48 -76.36 0.56 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.391 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.45 -39.44 90.84 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.884 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.881 HD13 ' HB2' ' B' ' 107' ' ' PHE . 13.5 mt -74.01 -41.2 52.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.03 0.443 . . . . 0.0 110.995 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.53 -32.75 71.77 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.161 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.63 -35.64 9.18 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.872 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.25 -26.51 61.14 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -178.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 82' ' ' VAL . . . . . 0.46 ' CG1' HG22 ' B' ' 88' ' ' ILE . 3.2 t -66.76 -50.51 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.298 179.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.34 -26.11 67.13 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.006 0.431 . . . . 0.0 111.34 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.69 -25.14 64.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.033 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 85' ' ' CYS . . . . . 0.436 ' SG ' ' HB3' ' A' ' 52' ' ' HIS . 1.5 t -88.92 -22.62 23.01 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.962 -179.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 99.66 43.99 2.38 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.166 -1.016 . . . . 0.0 113.804 179.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . 114.87 52.01 0.44 Allowed Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.05 -1.072 . . . . 0.0 113.893 178.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 88' ' ' ILE . . . . . 0.479 ' O ' ' HB2' ' B' ' 89' ' ' ASP . 0.5 OUTLIER 56.04 174.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 124.29 1.036 . . . . 0.0 113.184 179.142 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 89' ' ' ASP . . . . . 0.59 ' CG ' ' HD2' ' B' ' 91' ' ' PRO . 39.2 t0 170.41 -124.62 0.0 OUTLIER 'General case' 0 C--O 1.233 0.212 0 CA-C-N 114.348 -1.296 . . . . 0.0 108.403 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 90' ' ' LEU . . . . . 0.801 HD11 ' SG ' ' B' ' 116' ' ' CYS . 21.1 tp 172.46 -58.5 0.0 OUTLIER Pre-proline 0 C--N 1.324 -0.542 0 C-N-CA 124.364 1.066 . . . . 0.0 109.34 178.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 91' ' ' PRO . . . . . 1.008 ' HA ' HG11 ' B' ' 115' ' ' VAL . 50.8 Cg_exo -54.07 -43.25 59.99 Favored 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 122.031 1.821 . . . . 0.0 112.281 179.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 24.7 p -79.85 -35.82 37.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.055 0.455 . . . . 0.0 110.87 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . 0.443 HG23 ' HB3' ' B' ' 89' ' ' ASP . 5.8 t -71.02 -25.4 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.481 -178.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 94' ' ' LEU . . . . . 0.554 HD22 ' HB ' ' B' ' 115' ' ' VAL . 30.8 tp -60.16 -28.33 67.83 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 120.828 0.347 . . . . 0.0 110.934 -179.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.86 -36.62 81.76 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.408 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -99.37 9.86 42.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.297 0.57 . . . . 0.0 110.089 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 97' ' ' LEU . . . . . 0.514 HD21 ' HB1' ' B' ' 104' ' ' ALA . 24.3 tp -107.55 68.24 0.71 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.167 -0.924 . . . . 0.0 108.708 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . 0.413 ' NZ ' ' HB2' ' B' ' 98' ' ' LYS . 8.1 mtmp? -77.24 30.26 0.14 Allowed 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.426 -178.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 99' ' ' ALA . . . . . 0.749 ' HB1' ' HB2' ' B' ' 103' ' ' CYS . . . -118.34 87.49 2.73 Favored 'General case' 0 C--N 1.321 -0.671 0 O-C-N 122.271 -0.268 . . . . 0.0 110.857 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -79.74 47.81 0.89 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.492 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -142.96 -155.71 0.62 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.944 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -71.17 -3.26 51.94 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.183 178.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 103' ' ' CYS . . . . . 0.749 ' HB2' ' HB1' ' B' ' 99' ' ' ALA . 79.4 m -75.38 -15.12 60.49 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.976 0.417 . . . . 0.0 109.932 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 104' ' ' ALA . . . . . 0.514 ' HB1' HD21 ' B' ' 97' ' ' LEU . . . -109.74 -25.63 10.28 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.843 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 22.0 p -60.58 -25.93 66.57 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.754 0.312 . . . . 0.0 111.21 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 106' ' ' CYS . . . . . 0.497 ' HB3' ' HB3' ' B' ' 74' ' ' CYS . 43.5 t -60.33 -18.73 51.81 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.382 0.611 . . . . 0.0 110.389 178.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . 0.881 ' HB2' HD13 ' B' ' 78' ' ' ILE . 0.6 OUTLIER -104.16 -65.06 1.05 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.519 -179.535 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 108' ' ' CYS . . . . . 0.444 ' HB2' ' HB3' ' B' ' 122' ' ' CYS . 0.0 OUTLIER -73.69 15.77 0.25 Allowed 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -178.504 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -37.49 -73.23 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.181 0.592 . . . . 0.0 112.364 -178.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 110' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -98.71 -33.91 10.74 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 111' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -70.63 87.07 0.66 Allowed 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 112' ' ' CYS . . . . . 0.596 ' HB3' ' HG2' ' B' ' 117' ' ' LYS . 0.5 OUTLIER -154.21 136.63 14.99 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -178.622 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 113' ' ' HIS . . . . . 0.426 ' CD2' ' HB2' ' A' ' 28' ' ' ASP . 1.5 t60 -153.22 -49.63 0.1 Allowed 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 178.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 114' ' ' GLY . . . . . 0.405 ' HA3' ' HB2' ' A' ' 30' ' ' PRO . . . -127.14 -159.38 10.14 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 177.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . 1.008 HG11 ' HA ' ' B' ' 91' ' ' PRO . 0.4 OUTLIER 41.45 -86.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 123.903 0.881 . . . . 0.0 113.31 179.644 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 116' ' ' CYS . . . . . 0.801 ' SG ' HD11 ' B' ' 90' ' ' LEU . 36.5 m -61.36 -33.13 73.13 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 118.431 0.56 . . . . 0.0 109.831 178.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 117' ' ' LYS . . . . . 0.596 ' HG2' ' HB3' ' B' ' 112' ' ' CYS . 3.9 mmmm -77.53 -21.0 53.31 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.244 178.469 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -62.38 -47.86 82.28 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 7.9 tt -79.77 -29.28 40.39 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 177.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 120' ' ' HIS . . . . . . . . . . . . . 8.5 t-160 76.01 67.67 0.06 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.529 178.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -126.81 8.97 6.91 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 122' ' ' CYS . . . . . 0.444 ' HB3' ' HB2' ' B' ' 108' ' ' CYS . 0.8 OUTLIER . . . . . 0 C--O 1.245 0.852 0 CA-C-O 118.173 -0.918 . . . . 0.0 110.208 178.741 . . . . . . . . 2 2 . 1 stop_ save_